Citrus Sinensis ID: 017301
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 374 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LUC3 | 598 | Mitogen-activated protein | yes | no | 0.989 | 0.618 | 0.905 | 0.0 | |
| Q9C5C0 | 615 | Mitogen-activated protein | no | no | 0.994 | 0.604 | 0.895 | 0.0 | |
| Q5SN53 | 569 | Mitogen-activated protein | yes | no | 0.959 | 0.630 | 0.852 | 0.0 | |
| Q9SJG9 | 606 | Mitogen-activated protein | no | no | 0.994 | 0.613 | 0.852 | 0.0 | |
| Q5ZCI1 | 611 | Mitogen-activated protein | no | no | 0.994 | 0.608 | 0.862 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | no | no | 0.959 | 0.662 | 0.827 | 0.0 | |
| Q67C40 | 569 | Mitogen-activated protein | no | no | 0.959 | 0.630 | 0.852 | 0.0 | |
| Q8W4J2 | 567 | Mitogen-activated protein | no | no | 0.994 | 0.656 | 0.798 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | no | no | 0.959 | 0.720 | 0.818 | 0.0 | |
| Q6L5D4 | 700 | Mitogen-activated protein | no | no | 0.962 | 0.514 | 0.841 | 0.0 |
| >sp|Q9LUC3|MPK19_ARATH Mitogen-activated protein kinase 19 OS=Arabidopsis thaliana GN=MPK19 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 681 bits (1757), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/370 (90%), Positives = 350/370 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+ Q KK +K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDT TGEKVAIKKI+DVF
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV+F+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP ETIA VRNEKARKYL EMRKK VP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA EALADPYFK LAK+EREPSCQPISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYING 370
PQLLKDY+N
Sbjct: 361 PQLLKDYMNS 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q9C5C0|MPK18_ARATH Mitogen-activated protein kinase 18 OS=Arabidopsis thaliana GN=MPK18 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 679 bits (1751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/372 (89%), Positives = 352/372 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQ+Q KK K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI+DVF
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+LITDLLGTP ETI+ VRN+KARKYLTEMRKK PV QKF DPLALRLLQRL+AFD
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPT EALADPYFKGL+KIEREPS Q ISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTE 372
PQLLKDY++G+E
Sbjct: 361 PQLLKDYMSGSE 372
|
Mitogen-activated protein kinase (MAPK) that is specifically regulated by PHS1 and mediates signaling that regulates cortical microtubule functions, maybe through regulation of microtubule dynamic instability. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5SN53|MPK8_ORYSJ Mitogen-activated protein kinase 8 OS=Oryza sativa subsp. japonica GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 671 bits (1730), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 306/359 (85%), Positives = 343/359 (95%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFF+EYGDANRYKI EVIGKGSYGVVC+AID HTG+KVAIKKIH++FEH+SDA RILRE+
Sbjct: 2 DFFSEYGDANRYKIQEVIGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELM++DLHQVIKANDDLT+EHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DTP TVFWTDYVATR
Sbjct: 122 QMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFF+KY+PAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLDL+TDLLGTPS +
Sbjct: 182 WYRAPELCGSFFTKYSPAIDIWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSMD 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
T+ +RNEKAR+YL+ MRKK PVP ++FP DP AL+LLQRL+AFDPKDRPTAEEALAD
Sbjct: 242 TVTRIRNEKARRYLSSMRKKQPVPFSERFPKADPAALKLLQRLLAFDPKDRPTAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTE 372
PYFKGLAK EREPSCQPI+K+EFEFERR+VTK+D++ELI+REILEYHPQLLKDY+NGTE
Sbjct: 302 PYFKGLAKAEREPSCQPITKMEFEFERRKVTKEDVKELIFREILEYHPQLLKDYMNGTE 360
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9SJG9|MPK20_ARATH Mitogen-activated protein kinase 20 OS=Arabidopsis thaliana GN=MPK20 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 670 bits (1728), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/372 (85%), Positives = 352/372 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQD KK + +FF++YGDANR+K+ EVIGKGSYGVVC+AIDT TGEKVAIKKIHD+F
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGK+VVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI+ VRNEKAR+YLT MRKKPP+P QKFPN DPL+L+LL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAK+EREPSCQPI+K+EFEFERR+VTK+DIRELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQLLKDYINGTE 372
PQLLKD++NG +
Sbjct: 361 PQLLKDHMNGAD 372
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5ZCI1|MPK10_ORYSJ Mitogen-activated protein kinase 10 OS=Oryza sativa subsp. japonica GN=MPK10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 669 bits (1727), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/372 (86%), Positives = 352/372 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK + DFFTEYGDA+RYKI EVIGKGSYGVVC+AID HTGEKVAIKKIHD+F
Sbjct: 1 MQQDQRKKSSTEADFFTEYGDASRYKIQEVIGKGSYGVVCSAIDVHTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT+EH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILAN+NCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANSNCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI+ VRN+KAR+YL+ MRKK P+ QKFP+ DPLAL LLQ+L+AFD
Sbjct: 241 DLMTDLLGTPSMDTISRVRNDKARRYLSSMRKKEPILFSQKFPSADPLALDLLQKLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALA PYFKGLAK+EREPSCQPI+K+EFEFERRRVTK+DIRELI+REILEYH
Sbjct: 301 PKDRPTAEEALAHPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYH 360
Query: 361 PQLLKDYINGTE 372
PQLLKDYINGTE
Sbjct: 361 PQLLKDYINGTE 372
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 655 bits (1689), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 297/359 (82%), Positives = 340/359 (94%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFFTEYG+ NRYKI EVIGKGSYGVVC+A+DTHTG+KVAIKKI+D+FEH+SDA RILRE+
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKANDDLT EH+QFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAFSDTP +FWTDY+ATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLD+ITDLLGTPSPE
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSPE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
TI+ +RNEKAR+YL MR+K P+P QKFPN DPLA+RLL+R++AFDPKDRP+AEEALAD
Sbjct: 242 TISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTE 372
PYFK +A ++REPS QPI+KLEFEFERRR+TK+DIRELIYREILEYHP++L++++ GTE
Sbjct: 302 PYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGTE 360
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q67C40|MPK7_ORYSJ Mitogen-activated protein kinase 7 OS=Oryza sativa subsp. japonica GN=MPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 653 bits (1685), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 306/359 (85%), Positives = 346/359 (96%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFF+EYGD++RYKI E++GKGSYGVVC+AID HTG+KVAIKKIH++FEH+SDA RILRE+
Sbjct: 2 DFFSEYGDSSRYKIQEIVGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELM++DLHQVIKANDDLT+EHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DTP TVFWTDYVATR
Sbjct: 122 QMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKY+PAID WSIGCIFAE+LTGKPLFPGK+VVHQLDL+TDLLGTPS +
Sbjct: 182 WYRAPELCGSFFSKYSPAIDTWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSMD 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
I+ +RN+KAR+YL+ MR+K PVP +KFPNVDPLAL+LLQRL+AFDPKDRPTAEEALAD
Sbjct: 242 AISRIRNDKARRYLSSMRRKQPVPFSEKFPNVDPLALKLLQRLLAFDPKDRPTAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTE 372
PYFKGLAK+EREPSCQPISK+EFEFERR+VTKDDI+ELI+REILEYHPQLLKDY+NG+E
Sbjct: 302 PYFKGLAKVEREPSCQPISKMEFEFERRKVTKDDIKELIFREILEYHPQLLKDYMNGSE 360
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q8W4J2|MPK16_ARATH Mitogen-activated protein kinase 16 OS=Arabidopsis thaliana GN=MPK16 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 649 bits (1673), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 297/372 (79%), Positives = 343/372 (92%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ D KK + DFFTEYG+ +RY+I EVIGKGSYGVVC+A DTHTGEKVAIKKI+D+F
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPDIVEIK I+LPPS+REF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT EH+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P +FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TD+LGTPS E I VRNEKAR+YL+ MRKK P+P KFP+ DPLALRLL+++++F+
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALAD YFKGLAK+EREPS QP++KLEFEFERRR+TK+D+RELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQLLKDYINGTE 372
P++LK+Y++G+E
Sbjct: 361 PKMLKEYLDGSE 372
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 648 bits (1671), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 294/359 (81%), Positives = 337/359 (93%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFFTEYG+ NRYKI EVIGKGSYGVVC+A+DTHTGEKVAIKKI+D+FEH+SDA RILRE+
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKANDDLT EH+QFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAFSDTP +FWTDYVATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLD+ITDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSTE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
I+ +RNEKAR+YL+ MR+K P+P QKFPN DPLALRLL+R+++F+PKDRP AEEALAD
Sbjct: 242 AISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTE 372
PYF+ +A ++REPS QP++KLEFEFERRR+TK+DIRELIYR+ILEYHP +L++Y+ GTE
Sbjct: 302 PYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGTE 360
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5D4|MPK9_ORYSJ Mitogen-activated protein kinase 9 OS=Oryza sativa subsp. japonica GN=MPK9 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 639 bits (1649), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 303/360 (84%), Positives = 342/360 (95%)
Query: 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILRE 72
++FFTEYGDANRY+I EVIGKGSYGVVC+AID HT +KVAIKK+H++FEH+SDA RILRE
Sbjct: 95 EEFFTEYGDANRYRIQEVIGKGSYGVVCSAIDLHTRQKVAIKKVHNIFEHVSDAARILRE 154
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL 132
+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKANDDLT+EH+QFFL
Sbjct: 155 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTKEHYQFFL 214
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+LRALKY+HTA+VYHRDLKPKNILAN+NCKLK+CDFGLARVAF+DTP TVFWTDYVAT
Sbjct: 215 YQLLRALKYIHTASVYHRDLKPKNILANSNCKLKICDFGLARVAFNDTPTTVFWTDYVAT 274
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQLDL+TDLLGTPS
Sbjct: 275 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSM 334
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+TI+ VRNEKAR+YL+ MRKK PVP QKFPN DPLAL+LLQRL+AFDPKDRPTAEEAL
Sbjct: 335 DTISRVRNEKARRYLSSMRKKDPVPFSQKFPNADPLALKLLQRLLAFDPKDRPTAEEALT 394
Query: 313 DPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTE 372
DPYFKGL+KI+REPSCQPI KLEFEFE+++++K+DIRELI++EILEYHPQL K+Y NG E
Sbjct: 395 DPYFKGLSKIDREPSCQPIRKLEFEFEQKKLSKEDIRELIFQEILEYHPQLQKNYRNGRE 454
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 374 | ||||||
| 183584854 | 383 | MAP kinase [Gossypium raimondii] | 0.994 | 0.971 | 0.913 | 0.0 | |
| 356556856 | 607 | PREDICTED: mitogen-activated protein kin | 0.994 | 0.612 | 0.922 | 0.0 | |
| 224119110 | 596 | predicted protein [Populus trichocarpa] | 0.959 | 0.602 | 0.927 | 0.0 | |
| 224056591 | 610 | predicted protein [Populus trichocarpa] | 0.994 | 0.609 | 0.932 | 0.0 | |
| 255575145 | 606 | big map kinase/bmk, putative [Ricinus co | 0.975 | 0.602 | 0.936 | 0.0 | |
| 356549594 | 588 | PREDICTED: LOW QUALITY PROTEIN: mitogen- | 0.994 | 0.632 | 0.916 | 0.0 | |
| 224062744 | 621 | predicted protein [Populus trichocarpa] | 0.994 | 0.599 | 0.881 | 0.0 | |
| 358348772 | 608 | Mitogen-activated protein kinase [Medica | 0.994 | 0.611 | 0.903 | 0.0 | |
| 4732123 | 608 | mitogen-activated protein kinase homolog | 0.994 | 0.611 | 0.900 | 0.0 | |
| 255575287 | 627 | big map kinase/bmk, putative [Ricinus co | 0.991 | 0.591 | 0.881 | 0.0 |
| >gi|183584854|gb|ACC63895.1| MAP kinase [Gossypium raimondii] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1847), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/372 (91%), Positives = 360/372 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQ+Q KKELK+ DFFTEYGDANRYKILEVIGKGSYGVVCAA+DTHTGEKVAIKKI DVF
Sbjct: 1 MQQNQLKKELKEMDFFTEYGDANRYKILEVIGKGSYGVVCAALDTHTGEKVAIKKIQDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDAIRILREVKL+RLLRHPDIVEIKRIMLPPSKREFKD++VVFELMESDLHQVIKAN
Sbjct: 61 EHMSDAIRILREVKLVRLLRHPDIVEIKRIMLPPSKREFKDLFVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRA+KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHHQFFLYQMLRAMKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+LITDL+GTPS ETI+ VRN+KARKYL+EMRKK PVP QKFPN DPLA+RLLQRL+AFD
Sbjct: 241 ELITDLIGTPSLETISGVRNDKARKYLSEMRKKKPVPFSQKFPNADPLAVRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGL+KIEREPSCQPISKLEFEFERRRVTK+D+RELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLSKIEREPSCQPISKLEFEFERRRVTKEDVRELIYREALEYH 360
Query: 361 PQLLKDYINGTE 372
PQLLKDY+NG E
Sbjct: 361 PQLLKDYLNGHE 372
|
Source: Gossypium raimondii Species: Gossypium raimondii Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556856|ref|XP_003546736.1| PREDICTED: mitogen-activated protein kinase 19-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1816), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/372 (92%), Positives = 359/372 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK++K+ +FFTEYGDANRYKILEV+GKGSYGVVC+AIDTHTG KVAIKKIHD+F
Sbjct: 1 MQQDQLKKDMKEVEFFTEYGDANRYKILEVVGKGSYGVVCSAIDTHTGGKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRA+KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD
Sbjct: 121 DDLTREHHQFFLYQMLRAMKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDA 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP PETIA VRN+KARKYL EMRKK PVP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPPPETIAGVRNDKARKYLMEMRKKSPVPFEQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGLAK+EREPSCQPIS+LEFEFERRRVTKDD+RELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLAKVEREPSCQPISRLEFEFERRRVTKDDVRELIYREILEYH 360
Query: 361 PQLLKDYINGTE 372
PQLLKDY+NGTE
Sbjct: 361 PQLLKDYMNGTE 372
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119110|ref|XP_002331327.1| predicted protein [Populus trichocarpa] gi|222873910|gb|EEF11041.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/359 (92%), Positives = 347/359 (96%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
+FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI++VFEHISDA RILREV
Sbjct: 2 EFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKINNVFEHISDAFRILREV 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIKRIMLPPSKREFKDI+VVFELMESDLHQVIKANDDLTREHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKRIMLPPSKREFKDIFVVFELMESDLHQVIKANDDLTREHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKYMHTAN+YHRDLKPKNILANANCKLKVCDFGLARVAFSDTP TVFWTDYVATR
Sbjct: 122 QMLRALKYMHTANMYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKYT AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTRAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSLE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
TI+ VRN+KARKYLTEMRKK PVP QKFPN DP A RLLQRL+AFDPKDRPTAEEALAD
Sbjct: 242 TISRVRNDKARKYLTEMRKKQPVPFAQKFPNADPSAHRLLQRLLAFDPKDRPTAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTE 372
PYFKGLAK+EREPSCQPI+KLEFEFERRRVTK+D+REL+YREILEYHPQLLKDY+NG E
Sbjct: 302 PYFKGLAKVEREPSCQPITKLEFEFERRRVTKEDVRELLYREILEYHPQLLKDYMNGNE 360
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224056591|ref|XP_002298926.1| predicted protein [Populus trichocarpa] gi|222846184|gb|EEE83731.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1808), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/372 (93%), Positives = 360/372 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQD KK+LK+ DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTG+KVAIKKI+DVF
Sbjct: 1 MQQDHPKKDLKEIDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGDKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI+VVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIFVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTPS ETI+ VRN+KARKYLTEMRKK PVP QKF NVDPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPSSETISGVRNDKARKYLTEMRKKQPVPFAQKFLNVDPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDR TAEEALADPYFKGLAK+EREPSCQPISKLEFEFERRRVTK+D+REL+YREILEYH
Sbjct: 301 PKDRLTAEEALADPYFKGLAKVEREPSCQPISKLEFEFERRRVTKEDVRELLYREILEYH 360
Query: 361 PQLLKDYINGTE 372
PQLLKDY+NG E
Sbjct: 361 PQLLKDYMNGNE 372
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575145|ref|XP_002528477.1| big map kinase/bmk, putative [Ricinus communis] gi|223532086|gb|EEF33894.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1804), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/365 (93%), Positives = 356/365 (97%)
Query: 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 67
++LK+ DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI
Sbjct: 3 QDLKEIDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 62
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREH 127
RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI+VVFELMESDLHQVIKANDDLTREH
Sbjct: 63 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIFVVFELMESDLHQVIKANDDLTREH 122
Query: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP TVFWT
Sbjct: 123 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPTTVFWT 182
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
DYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVL+GKPLFPGKSVVHQLDLITDLL
Sbjct: 183 DYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLSGKPLFPGKSVVHQLDLITDLL 242
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
GTPSPET++ VRN+KARKYLTEMRKK PV QKFPN DPLALRLLQRL+AFDPKDRPTA
Sbjct: 243 GTPSPETVSGVRNDKARKYLTEMRKKHPVSFTQKFPNADPLALRLLQRLLAFDPKDRPTA 302
Query: 308 EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDY 367
EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK+D+REL+YREILEYHPQLLKDY
Sbjct: 303 EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKEDVRELLYREILEYHPQLLKDY 362
Query: 368 INGTE 372
+NG E
Sbjct: 363 LNGNE 367
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549594|ref|XP_003543177.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase 19-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1803), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/372 (91%), Positives = 359/372 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK++K+ +FFTEYGDANRYKILEV+GKGSYGVVC+AIDTHTG KVAIKKIHD+F
Sbjct: 1 MQQDQLKKDIKEVEFFTEYGDANRYKILEVVGKGSYGVVCSAIDTHTGGKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRI+LPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIVLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD
Sbjct: 121 DDLTREHYQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDA 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTPSPETIA VRN+KARKYL EMRKK PVP QKF N DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPSPETIAGVRNDKARKYLMEMRKKSPVPFEQKFQNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGL+K+EREPSCQPISKLEFEFERRRVTKDD+RELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLSKVEREPSCQPISKLEFEFERRRVTKDDVRELIYREILEYH 360
Query: 361 PQLLKDYINGTE 372
PQLLKDY+NGTE
Sbjct: 361 PQLLKDYMNGTE 372
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224062744|ref|XP_002300882.1| predicted protein [Populus trichocarpa] gi|222842608|gb|EEE80155.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1770), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/372 (88%), Positives = 358/372 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK + DFF+EYGDANRYKI EVIGKGSYGVVC+AIDTHTGEKVAIKKIHD+F
Sbjct: 1 MQQDQRKKNSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PSTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI++VRN+KAR+YLT MRKK PVPL QKFPN DPLALRLL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDTISLVRNDKARRYLTSMRKKQPVPLAQKFPNADPLALRLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGLA++EREPSCQPI+K+EFEFERRRVTK+D+RELI+REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLARVEREPSCQPITKMEFEFERRRVTKEDVRELIFREILEYH 360
Query: 361 PQLLKDYINGTE 372
PQLLKDY+NGTE
Sbjct: 361 PQLLKDYLNGTE 372
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358348772|ref|XP_003638417.1| Mitogen-activated protein kinase [Medicago truncatula] gi|355504352|gb|AES85555.1| Mitogen-activated protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 684 bits (1765), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/372 (90%), Positives = 355/372 (95%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+DQ KK++K+ FFT+YGDANRYKILEV+GKGSYGVVCAAIDTHTG KVAIKKIHDVF
Sbjct: 1 MQKDQLKKDVKEVKFFTDYGDANRYKILEVVGKGSYGVVCAAIDTHTGGKVAIKKIHDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH QFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHQQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFF+KYTPAIDIWSIGCIFAEVLTGKPLFPGKS+VHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFAKYTPAIDIWSIGCIFAEVLTGKPLFPGKSIVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP PE I+ VRNEKARKYL EMRKK PVP +KFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPPPEIISGVRNEKARKYLMEMRKKLPVPFERKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGLAKIEREPS Q IS++EFEFERRRV+KDDI+ELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLAKIEREPSSQSISRMEFEFERRRVSKDDIKELIYREILEYH 360
Query: 361 PQLLKDYINGTE 372
PQLLKDYINGTE
Sbjct: 361 PQLLKDYINGTE 372
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|4732123|gb|AAD28617.1|AF129087_1 mitogen-activated protein kinase homologue [Medicago sativa] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/372 (90%), Positives = 356/372 (95%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+DQ KK++K+ FFT+YGDANRYKILEV+GKGSYGVVCAAIDTHTG KVAIKKIHDVF
Sbjct: 1 MQKDQLKKDVKEVKFFTDYGDANRYKILEVVGKGSYGVVCAAIDTHTGGKVAIKKIHDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH QFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHQQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFF+KYTPAIDIWSIGCIFAEVLTGKPLFPGKS+VHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFAKYTPAIDIWSIGCIFAEVLTGKPLFPGKSIVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP PE I+ VRNEKARKYL EMRKK PVP +KFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPPPEIISGVRNEKARKYLMEMRKKLPVPFERKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGLAKIEREPS QPIS++EF+FERRRV+KDDI+ELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLAKIEREPSSQPISRMEFDFERRRVSKDDIKELIYREILEYH 360
Query: 361 PQLLKDYINGTE 372
PQLLKDYI+GTE
Sbjct: 361 PQLLKDYISGTE 372
|
Source: Medicago sativa Species: Medicago sativa Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575287|ref|XP_002528547.1| big map kinase/bmk, putative [Ricinus communis] gi|223532049|gb|EEF33859.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1758), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/371 (88%), Positives = 354/371 (95%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
QQD KK + DFF+EYGDANRYKI EVIGKGSYGVVC+AIDTHTGEKVAIKKIHD+FE
Sbjct: 3 QQDHRKKNSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 62
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND 121
HISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKAND
Sbjct: 63 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND 122
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
DLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DTP
Sbjct: 123 DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 182
Query: 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
T+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQLD
Sbjct: 183 ATIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 242
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301
L+TDLLGTPS +TI+ VRNEKAR+YLT MRKK PVP QKFPN DPLALRLL+RL+AFDP
Sbjct: 243 LMTDLLGTPSLDTISRVRNEKARRYLTSMRKKQPVPFAQKFPNADPLALRLLERLLAFDP 302
Query: 302 KDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
KDRPTAEEALADPYFKGL+K+EREPSCQPI+K+EFEFERRRVTK+DIRELI+REILEYHP
Sbjct: 303 KDRPTAEEALADPYFKGLSKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYHP 362
Query: 362 QLLKDYINGTE 372
QLLKDY+NGTE
Sbjct: 363 QLLKDYVNGTE 373
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 374 | ||||||
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.986 | 0.617 | 0.907 | 5.4e-182 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.994 | 0.604 | 0.895 | 4.8e-181 | |
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.994 | 0.613 | 0.852 | 1.2e-177 | |
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.994 | 0.656 | 0.798 | 7.4e-169 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.986 | 0.723 | 0.799 | 1.2e-166 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.973 | 0.631 | 0.791 | 8.1e-163 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.994 | 0.631 | 0.764 | 4.5e-162 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.965 | 0.742 | 0.767 | 1.8e-158 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.893 | 0.631 | 0.516 | 4.5e-91 | |
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.877 | 0.872 | 0.504 | 1.9e-90 |
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1766 (626.7 bits), Expect = 5.4e-182, P = 5.4e-182
Identities = 335/369 (90%), Positives = 350/369 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+ Q KK +K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDT TGEKVAIKKI+DVF
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV+F+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP ETIA VRNEKARKYL EMRKK VP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA EALADPYFK LAK+EREPSCQPISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYIN 369
PQLLKDY+N
Sbjct: 361 PQLLKDYMN 369
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1757 (623.6 bits), Expect = 4.8e-181, P = 4.8e-181
Identities = 333/372 (89%), Positives = 352/372 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQ+Q KK K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI+DVF
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+LITDLLGTP ETI+ VRN+KARKYLTEMRKK PV QKF DPLALRLLQRL+AFD
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPT EALADPYFKGL+KIEREPS Q ISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTE 372
PQLLKDY++G+E
Sbjct: 361 PQLLKDYMSGSE 372
|
|
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1725 (612.3 bits), Expect = 1.2e-177, P = 1.2e-177
Identities = 317/372 (85%), Positives = 352/372 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQD KK + +FF++YGDANR+K+ EVIGKGSYGVVC+AIDT TGEKVAIKKIHD+F
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGK+VVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI+ VRNEKAR+YLT MRKKPP+P QKFPN DPL+L+LL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAK+EREPSCQPI+K+EFEFERR+VTK+DIRELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQLLKDYINGTE 372
PQLLKD++NG +
Sbjct: 361 PQLLKDHMNGAD 372
|
|
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1642 (583.1 bits), Expect = 7.4e-169, P = 7.4e-169
Identities = 297/372 (79%), Positives = 343/372 (92%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ D KK + DFFTEYG+ +RY+I EVIGKGSYGVVC+A DTHTGEKVAIKKI+D+F
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPDIVEIK I+LPPS+REF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT EH+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P +FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TD+LGTPS E I VRNEKAR+YL+ MRKK P+P KFP+ DPLALRLL+++++F+
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALAD YFKGLAK+EREPS QP++KLEFEFERRR+TK+D+RELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQLLKDYINGTE 372
P++LK+Y++G+E
Sbjct: 361 PKMLKEYLDGSE 372
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1621 (575.7 bits), Expect = 1.2e-166, P = 1.2e-166
Identities = 295/369 (79%), Positives = 339/369 (91%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
D KK + +FFTEYG+A+RY+I EVIGKGSYGVV +AIDTH+GEKVAIKKI+DVFEH+
Sbjct: 2 DPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHV 61
Query: 64 SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDL 123
SDA RILRE+KLLRLLRHPDIVEIK +MLPPS+REF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 62 SDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 121
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
T EH+QFFLYQ+LR LK++HTANV+HRDLKPKNILAN++CKLK+CDFGLARV+F+D P
Sbjct: 122 TPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSA 181
Query: 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLD++
Sbjct: 182 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIM 241
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
TDLLGTP PE IA +RNEKAR+YL MR+KPPVP KFP+VDPLALRLL RL+AFDPKD
Sbjct: 242 TDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKD 301
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363
RP+AEEALADPYF GLA ++REPS QPI KLEFEFERR++TK+D+RELIYREILEYHPQ+
Sbjct: 302 RPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQM 361
Query: 364 LKDYINGTE 372
L++Y+ G E
Sbjct: 362 LQEYLRGGE 370
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1585 (563.0 bits), Expect = 8.1e-163, P = 8.1e-163
Identities = 288/364 (79%), Positives = 331/364 (90%)
Query: 7 KKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA 66
KK + + +FFTEYG+ANRY+I EV+GKGSYGVV +AIDTHTGE+VAIKKI+DVF+HISDA
Sbjct: 72 KKGIPNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDA 131
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE 126
RILRE+KLLRLL HPD+VEIK IMLPPS+REF+D+YVVFELMESDLHQVIKANDDLT E
Sbjct: 132 TRILREIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPE 191
Query: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
HHQFFLYQ+LR LKY+H ANV+HRDLKPKNILANA+CKLK+CDFGLARV+F+D P +FW
Sbjct: 192 HHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFW 251
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
TDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGK+VVHQLD++TD
Sbjct: 252 TDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDF 311
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
LGTP PE I+ +RN+KAR+YL MRKK PVP +KFP DP ALRLL+RLIAFDPKDRP+
Sbjct: 312 LGTPPPEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPS 371
Query: 307 AEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKD 366
AEEALADPYF GL+ REPS QPISKLEFEFER+++TKDDIRELIYREILEYHPQ+L++
Sbjct: 372 AEEALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEE 431
Query: 367 YING 370
Y+ G
Sbjct: 432 YLRG 435
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1578 (560.5 bits), Expect = 4.5e-162, P = 4.5e-162
Identities = 286/374 (76%), Positives = 336/374 (89%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
+ D KK + +FFTEYG+ANRY+I EV+GKGSYGVV +A+D+HTGE+VAIKKI+DVF
Sbjct: 82 LPMDPHKKG--ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVF 139
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPD+VEIK IMLPPS+REF+DIYVVFELMESDLHQVIKAN
Sbjct: 140 EHVSDATRILREIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKAN 199
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT EH+QFFLYQ+LR LKY+H ANV+HRDLKPKNILANA+CKLK+CDFGLARV+F+D
Sbjct: 200 DDLTPEHYQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 259
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P +FWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGK+VVHQL
Sbjct: 260 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQL 319
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TD LGTP PE+I+ +RNEKAR+YL+ MRKK PVP KFP DPLALRLL+RL+AFD
Sbjct: 320 DLMTDFLGTPPPESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAFD 379
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDR +AE+ALADPYF GL+ EREP+ QPISKLEF+FER+++ KDD+RELIYREILEYH
Sbjct: 380 PKDRASAEDALADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDVRELIYREILEYH 439
Query: 361 PQLLKDYINGTEVL 374
PQ+L++Y+ G + L
Sbjct: 440 PQMLEEYLRGGDQL 453
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1544 (548.6 bits), Expect = 1.8e-158, P = 1.8e-158
Identities = 277/361 (76%), Positives = 331/361 (91%)
Query: 12 DKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR 71
+K+FFTEYG+A++Y+I EV+GKGSYGVV +A HTG KVAIKK+ +VFEH+SDAIRILR
Sbjct: 3 EKEFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRILR 62
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF 131
E+KLLRLLRHPDIVEIK IMLPP ++EFKDIYVVFELMESDLH V+K NDDLT +HHQFF
Sbjct: 63 EIKLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQFF 122
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
LYQ+LR LK+MH+A+V+HRDLKPKNILANA+CK+K+CD GLARV+F+D+P VFWTDYVA
Sbjct: 123 LYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYVA 182
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
TRWYRAPELCGSF+S YTPAID+WS+GCIFAE+LTGKPLFPGK+VVHQL+L+TDLLGTPS
Sbjct: 183 TRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTPS 242
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
P T++ +RNEKARKYL MR+K PVP KFPN+DP+AL+LLQRLIAFDPKDRP+AEEAL
Sbjct: 243 PITLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEEAL 302
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGT 371
ADPYF+GLA ++ EPS QPISKLEFEFERR++T+DD+REL+YREILEYHPQ+L++Y+ G
Sbjct: 303 ADPYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVRELMYREILEYHPQMLQEYLQGE 362
Query: 372 E 372
E
Sbjct: 363 E 363
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 908 (324.7 bits), Expect = 4.5e-91, P = 4.5e-91
Identities = 175/339 (51%), Positives = 236/339 (69%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY I++ IG G+YGVVC+A D TGEKVAIKKI F+++ D R LRE+ LLR +H +
Sbjct: 148 RYSIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLLRHFKHEN 207
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
++ IK I+ P SK +F+D+Y+V ELM++DLHQ+I + L+ +H Q+F+YQMLR LK++H
Sbjct: 208 LISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIH 267
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L N +C LK+CD GLARV D F T+YVATRWYRAPE+ S
Sbjct: 268 SANVLHRDLKPSNLLINEDCLLKICDLGLARV--EDATHQGFMTEYVATRWYRAPEVILS 325
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ +KYT AIDIWS+GCIFAE+L KPLF GK +HQ+ LI + +G+PS E I + NE+A
Sbjct: 326 W-NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQA 384
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R+++ M +P V FP +P A+ LL+R++ FDP R T EEALA PYF+ L
Sbjct: 385 RQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYFQSLHDPS 444
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
EP C + K FE + +D ++ELIY E+L YHP+
Sbjct: 445 DEPIC--LHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481
|
|
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 902 (322.6 bits), Expect = 1.9e-90, P = 1.9e-90
Identities = 169/335 (50%), Positives = 242/335 (72%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
L IG+G+YG+VCAA ++ TGE+VAIKKI + F++I DA R LRE+KLL+ + H +++ +
Sbjct: 46 LRPIGRGAYGIVCAATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAV 105
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
K I+ PP + F D+Y+V+ELM++DLHQ+I++N LT +H +FFLYQ+LR LKY+H+ANV
Sbjct: 106 KDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANV 165
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP N+L NANC LK+ DFGLAR S+T F T+YV TRWYRAPEL + S+
Sbjct: 166 LHRDLKPSNLLLNANCDLKLGDFGLARTK-SETD---FMTEYVVTRWYRAPELLLNC-SE 220
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267
YT AIDIWS+GCI E +T +PLFPGK VHQL LIT+L+G+P ++ +R++ AR+Y+
Sbjct: 221 YTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYV 280
Query: 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
++ + P +FPN+ A+ LL++++ FDP R T +EAL PY L I EP
Sbjct: 281 RQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPV 340
Query: 328 CQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
C + F+FE+ +T+++I+ELIYRE ++++PQ
Sbjct: 341 C--VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5SN53 | MPK8_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8523 | 0.9598 | 0.6309 | yes | no |
| Q9LUC3 | MPK19_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.9054 | 0.9893 | 0.6187 | yes | no |
| P42525 | ERK1_DICDI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5162 | 0.8930 | 0.6313 | yes | no |
| O42781 | MAPK2_PNECA | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5073 | 0.8930 | 0.9515 | N/A | no |
| Q40532 | NTF4_TOBAC | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5090 | 0.8663 | 0.8244 | N/A | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7855 | 0.9598 | 0.7094 | N/A | no |
| Q07176 | MMK1_MEDSA | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5074 | 0.8582 | 0.8294 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | 0.946 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_1680031 | hypothetical protein (597 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 374 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-159 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-144 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-138 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-126 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-117 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-116 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-105 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-104 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-103 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-98 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-90 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-89 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-89 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-88 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-88 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-87 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-87 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-86 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-85 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-82 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-82 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-78 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-77 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-76 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-76 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-74 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-70 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-69 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-68 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-68 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-67 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-67 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-63 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-63 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-63 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-62 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-62 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-62 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-62 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-61 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-61 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-60 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-60 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-59 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-57 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-56 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-55 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-55 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-53 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-49 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-48 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-46 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-44 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-41 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-40 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-39 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-37 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-34 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-31 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-27 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-21 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-21 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-21 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-16 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-14 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-04 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 721 bits (1862), Expect = 0.0
Identities = 302/338 (89%), Positives = 325/338 (96%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RYKI EVIGKGSYGVVC+AIDTHTGEKVAIKKI+DVFEH+SDA RILRE+KLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKANDDLT EHHQFFLYQ+LRALKY+H
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
TANV+HRDLKPKNILANA+CKLK+CDFGLARVAF+DTP +FWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQLDLITDLLGTPSPETI+ VRNEKA
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R+YL+ MRKK PVP QKFPN DPLALRLL+RL+AFDPKDRPTAEEALADPYFKGLAK+E
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
REPS QPI+KLEFEFERRR+TK+D+RELIYREILEYHP
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 521 bits (1345), Expect = 0.0
Identities = 186/332 (56%), Positives = 242/332 (72%), Gaps = 2/332 (0%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY++L+ IG G+YGVVC+A+D TG KVAIKKI +VF+ + DA RILRE+KLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I+ + I+ PPS +F D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LR LKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP NIL N+NC LK+CDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
S+YT AIDIWS+GCIFAE+LT KPLFPG+ + QL+LI ++LGTPS E + + +EKA
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R YL + KKP PL + FP P A+ LL++++ FDPK R TA+EALA PY L E
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYRE 355
EP +P +F F+ +T+++++ELIY E
Sbjct: 300 DEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 449 bits (1157), Expect = e-159
Identities = 182/338 (53%), Positives = 245/338 (72%), Gaps = 6/338 (1%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y ++ IG+G+YG+VC+A ++ T EKVAIKKI + F++ DA R LRE+KLLR L H +
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
++ IK IM PP + F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQ+LR LKY+H
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L NANC LK+CDFGLAR S+ F T+YV TRWYRAPEL +
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTT-SEKGD--FMTEYVVTRWYRAPELLLN 182
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
S+YT AID+WS+GCIFAE+L KPLFPGK VHQL LIT+LLG+PS E + +RNEKA
Sbjct: 183 -CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R+Y+ + P + FP+ +PLA+ LL++++ FDP R T EEALA PY L
Sbjct: 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
EP CQ + F+FE +T++DI+ELIY E+L YHP
Sbjct: 302 DEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 412 bits (1061), Expect = e-144
Identities = 168/334 (50%), Positives = 226/334 (67%), Gaps = 4/334 (1%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L IG+G+YG+VC+A TG KVAIKKI FEH + R LRE+K+LR +H +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKHEN 64
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LR LKY+H
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKYIH 123
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L N NC LK+CDFGLAR+A + T F T+YVATRWYRAPE+ +
Sbjct: 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
YT AIDIWS+GCI AE+L+ +PLFPGK +HQL+LI +LGTPS E + + + +A
Sbjct: 184 S-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R Y+ + KP VP + FPN DP AL LL +++ F+P R T EEALA PY +
Sbjct: 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS 302
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREIL 357
EP + +FE + K+ ++ELI+ EI+
Sbjct: 303 DEPVAEEPFPFDFEL-FDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 395 bits (1018), Expect = e-138
Identities = 166/333 (49%), Positives = 235/333 (70%), Gaps = 5/333 (1%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RYK +E IG G+YGVVC+AIDT +G+KVAIKKI F+ + A R LRE+K+LR +H +
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I+ I+ I+ PP +FKD+YVV +LMESDLH +I ++ LT EH ++FLYQ+LR LKY+H
Sbjct: 66 IIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLAR-VAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ANV HRDLKP N+L N +C+L++ DFG+AR ++ S T F T+YVATRWYRAPEL
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
S +YT AID+WS+GCIFAE+L + LFPGK+ VHQL LI +LG+PS E + + +++
Sbjct: 185 SL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
RKY+ + +K PVP + FP P AL LL +++ FDP++R T E+AL P+
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYRE 355
+ EP+C P +F+FE ++++ ++E I +E
Sbjct: 304 DDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 365 bits (940), Expect = e-126
Identities = 149/337 (44%), Positives = 214/337 (63%), Gaps = 11/337 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP 82
+Y+IL+ +GKG+YG+V AID T E VA+KKI D F + +DA R RE+ L+ L HP
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV++ ++ ++ + KDIY+VFE ME+DLH VI+AN L H ++ +YQ+L+ALKY+
Sbjct: 68 NIVKLLNVI--KAEND-KDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALKYI 123
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVA--FSDTPMTVFWTDYVATRWYRAPE- 199
H+ NV HRDLKP NIL N++C++K+ DFGLAR + P TDYVATRWYRAPE
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
L GS ++YT +D+WS+GCI E+L GKPLFPG S ++QL+ I +++G PS E I ++
Sbjct: 184 LLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
+ A L + +P PL + P AL LL++L+ F+P R TAEEAL PY
Sbjct: 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301
Query: 320 AKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
EP + + + +++ + R +Y EI
Sbjct: 302 HNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 343 bits (882), Expect = e-117
Identities = 160/339 (47%), Positives = 220/339 (64%), Gaps = 13/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLLR- 80
RY++++ +G+G+YG+VC+A + T E VAIKKI +VF A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 81 HPDIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
H +I + + + P F ++Y+ ELME+DLHQ+I++ LT H Q F+YQ+L L
Sbjct: 61 HKNITCLYDMDIVFPGN--FNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV--FWTDYVATRWYRA 197
KY+H+ANV HRDLKP N+L NA+C+LK+CDFGLAR FS+ P F T+YVATRWYRA
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATRWYRA 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ SF YT AID+WS+GCI AE+L KP+F GK V QL+ I +LGTP ET++
Sbjct: 178 PEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KA+ Y+ + P P FPN +PLAL LL++L+AFDP R + EEAL PY
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 318 GLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
+ EP CQ FE E + +++R++I E+
Sbjct: 297 IWHDPDDEPVCQKPFDFSFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 339 bits (872), Expect = e-116
Identities = 149/346 (43%), Positives = 213/346 (61%), Gaps = 12/346 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
T + +RY+ L +G G+YG VC+A DT TG KVAIKK+ F+ A R RE++LL
Sbjct: 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 77 RLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ + H +++ + + P S E F+D+Y+V LM +DL+ ++K L+ +H QF +YQ+
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQI 127
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR LKY+H+A + HRDLKP NI N +C+LK+ DFGLAR D MT YVATRWY
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEMT----GYVATRWY 181
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ ++ Y +DIWS+GCI AE+LTGK LFPG + QL I +L+GTP E +
Sbjct: 182 RAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ +E AR Y+ + + P + F +PLA+ LL++++ DP R TA EALA PY
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E EP P + FE R +T D+ +EL+Y+EI+ + P
Sbjct: 301 LAEYHDPEDEPVAPPYDQS---FESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 310 bits (796), Expect = e-105
Identities = 128/296 (43%), Positives = 179/296 (60%), Gaps = 18/296 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHP 82
Y+ LE +G+G+YGVV A D TGE VA+KKI ++ + I LRE+ LL+ L+HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHP 58
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKY 141
+IV++ ++ K +Y+VFE + DL + + L+ + +YQ+LR L Y
Sbjct: 59 NIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
H+ + HRDLKP+NIL N + LK+ DFGLAR AF P+ + T V T WYRAPE L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLAR-AFG-IPLRTY-THEVVTLWYRAPEIL 170
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
GS Y+ A+DIWS+GCIFAE++TGKPLFPG S + QL I +LGTP+ E+ V
Sbjct: 171 LGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV-- 226
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
K Y K PP L + P +DP + LL +++ ++P R +A+EAL PYF
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 309 bits (793), Expect = e-104
Identities = 135/294 (45%), Positives = 178/294 (60%), Gaps = 13/294 (4%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y+ L IG+G+YGVV A D TGE VAIKKI FE LRE+KLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKYMH 143
+++ + D+Y+VFE M++DL+++IK E + +LYQ+L+ L + H
Sbjct: 61 IKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
+ + HRDLKP+N+L N LK+ DFGLAR S +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP---YTHYVVTRWYRAPELLLG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y+ +DIWS+GCIFAE+L+ +PLFPGKS + QL I LGTP PE +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-L 229
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
AR Y KK +PL + FPN P AL LL +++ +DP R TAE+ALA PYF
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 308 bits (790), Expect = e-103
Identities = 154/343 (44%), Positives = 220/343 (64%), Gaps = 18/343 (5%)
Query: 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK 74
F T + NRY L+ +G G++G+VC+A D TG+ VAIKKI F A R RE+K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 75 LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQ 134
LL+ LRH +I+ + I + P +DIY V EL+ +DLH+++ + L ++ Q+FLYQ
Sbjct: 62 LLKHLRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQ 116
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+LR LKY+H+A V HRDLKP NIL N NC LK+CDFGLAR+ D MT YV+TR+
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMT----GYVSTRY 170
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
YRAPE+ ++ KY +DIWS GCIFAE+L GKPLFPGK V+Q +ITDLLGTP +
Sbjct: 171 YRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
I + +E +++ + K+ PVP +KF N DP A+ LL++++ FDP+ R +A EALA P
Sbjct: 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
Query: 315 YFKGLAKIEREPSCQPISKLEFE--FERRRVTKDDIRELIYRE 355
Y +P+ +P+++ +F+ F + D + ++Y E
Sbjct: 290 YLAPY----HDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 297 bits (761), Expect = 1e-98
Identities = 143/353 (40%), Positives = 208/353 (58%), Gaps = 30/353 (8%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG G++GVV + D G++VA+KK+ +VF+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
+ PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LR LKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYT 209
D+KP N+L N+NC LK+CDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 210 PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTE 269
A+DIWS+GCIFAE+L + LF +S + QLDLITDLLGTPS E + E AR ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILR 242
Query: 270 MRKKPPV--PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG--------- 318
KPP L+ A+ LL R++ FDP R +A +ALA PY
Sbjct: 243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCM 302
Query: 319 -----------LAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
+ + EPS P + E+E+ + ++E +++ ILE
Sbjct: 303 CKCCYTTSGGRVYTSDFEPSANP--PFDDEYEKNLTSVRQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 274 bits (703), Expect = 3e-90
Identities = 142/339 (41%), Positives = 208/339 (61%), Gaps = 12/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L +G G+YG VCAA DT TG +VA+KK+ F+ I A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 84 IVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+LR LKY+
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A++ HRDLKP N+ N +C+LK+ DFGLAR +D MT YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMT----GYVATRWYRAPEIML 190
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ Y +DIWS+GCI AE+LTG+ LFPG + QL LI L+GTP E + + +E
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
AR Y+ + + P + F +PLA+ LL++++ D R TA +ALA YF
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
+ EP P + FE R + D+ + L Y E++ + P
Sbjct: 310 DDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 271 bits (695), Expect = 4e-89
Identities = 134/339 (39%), Positives = 197/339 (58%), Gaps = 13/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY L+ +G G+YG VC+AID TGEKVAIKK+ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 84 IVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + S EF+D Y+V M++DL +++ L+ + Q+ +YQML LKY+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N +C+LK+ DFGLAR A D MT YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMT----GYVVTRWYRAPEVIL 187
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ Y +DIWS+GCI AE+LTGK LF GK + QL I + G P PE + + ++
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
A+ Y+ + K P FP P A+ LL++++ D R TA EAL PYF
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
+ E QP E +++ D+ ++ IY+E+ + P
Sbjct: 307 DEETEQQPYDD---SLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 271 bits (693), Expect = 8e-89
Identities = 140/339 (41%), Positives = 208/339 (61%), Gaps = 12/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L +G G+YG VC+A DT +KVA+KK+ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 84 IVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + P S F ++Y+V LM +DL+ ++K L+ EH QF +YQ+LR LKY+
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N +C+L++ DFGLAR A D MT YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA--DDEMT----GYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ Y +DIWS+GCI AE+L GK LFPG + QL I +++GTPSPE + + +E
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
ARKY+ + P L + F +PLA+ LL++++ D R +A EALA PYF
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E EP +P + E + T ++ +EL Y E+ + P
Sbjct: 308 EDEPEAEPYDE---SPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 2e-88
Identities = 121/302 (40%), Positives = 176/302 (58%), Gaps = 29/302 (9%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHPD 83
YK+++ +G G++G V A + TGE VAIKK+ F + + LREVK L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKY 141
IV++K + RE ++Y VFE ME +L+Q++K + + +YQ+L+ L +
Sbjct: 60 IVKLKEVF-----RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL- 200
+H +HRDLKP+N+L + +K+ DFGLAR S P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 201 --CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS----PET 254
S Y+ +DIW++GCI AE+ T +PLFPG S + QL I +LGTP+ PE
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ A K + P L Q PN P A+ L++ ++ +DPK RPTA +AL P
Sbjct: 227 YKL-----ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 315 YF 316
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 2e-88
Identities = 126/300 (42%), Positives = 167/300 (55%), Gaps = 20/300 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRI--LREVKLLRLLR 80
RY+ + +G+G+Y VV A D TG VAIKKI + D I LRE+KLL+ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRAL 139
HP+I+ + + K +I +VFE ME+DL +VIK LT + ++ LR L
Sbjct: 61 HPNIIGLLDVF--GHK---SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+H+ + HRDLKP N+L ++ LK+ DFGLAR +F P T V TRWYRAPE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGS-PNRKM-THQVVTRWYRAPE 172
Query: 200 LCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L F Y +D+WS+GCIFAE+L P PG S + QL I + LGTP+ E
Sbjct: 173 L---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
V + E + PP PL Q FP AL LLQRL+ +P R TA +AL PYF
Sbjct: 230 V---TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 267 bits (685), Expect = 1e-87
Identities = 135/339 (39%), Positives = 206/339 (60%), Gaps = 12/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L+ +G G+YG VC+A+D TG KVAIKK++ F+ A R RE++LL+ ++H +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 84 IVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + P S F D Y+V M +DL +++K ++ L+ + QF +YQML+ LKY+
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYI 134
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H A + HRDLKP N+ N +C+LK+ DFGLAR D+ M T YV TRWYRAPE+
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT--DSEM----TGYVVTRWYRAPEVIL 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ YT +DIWS+GCI AE+LTGKPLF G + QL I + GTPS E + +++E
Sbjct: 189 NWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
A+ Y+ ++ + PN +PLA+ +L++++ D + R TA EALA PYF+
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E E P + F+ + ++ + L + EIL + P
Sbjct: 308 EDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 263 bits (675), Expect = 4e-87
Identities = 108/293 (36%), Positives = 154/293 (52%), Gaps = 40/293 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y+ILE +G+GS+G V A D TG+ VAIK I D RILRE+K+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V + + +Y+V E E DL ++K L+ + +F+L Q+L AL+Y+H
Sbjct: 60 VRLYDVFEDE-----DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + + +K+ DFGLAR + T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL----TTFVGTPEYMAPEVLLG 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
Y A+DIWS+G I E+LTGKP FPG QL + +G
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIG--------------- 210
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
KP P ++ P A L+++L+ DP+ R TAEEAL P+F
Sbjct: 211 ---------KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 262 bits (671), Expect = 4e-86
Identities = 115/297 (38%), Positives = 171/297 (57%), Gaps = 15/297 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y+ + IG+G+YG V A + TGE VA+KKI E I +RE+KLL+ LRHP+I
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLRALKYMH 143
V +K I+ K IY+VFE M+ DL ++ T + ++ Q+L L+Y+H
Sbjct: 61 VRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
+ + HRD+K NIL N + LK+ DFGLAR ++ + T+ V T WYR PE L G
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELLLG 175
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ ++Y P +D+WS+GCI AE+ GKP+F G + + QL+ I +L G+P+ E V
Sbjct: 176 A--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK-- 231
Query: 263 ARKYLTEMRKKPPVP--LFQKFPNV-DPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ ++ K P L + F ++ DP AL LL +L+ DPK R +A++AL YF
Sbjct: 232 -LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 259 bits (665), Expect = 3e-85
Identities = 119/301 (39%), Positives = 176/301 (58%), Gaps = 24/301 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRH 81
RYKIL IG+G++G+V A D TGE VA+KK+ + I + LRE+K L+ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA--LREIKALQACQH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALK 140
P +V++ + S +V E M SDL +V++ + L + ++ +L+ +
Sbjct: 59 PYVVKLLDVFPHGS-----GFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
YMH + HRDLKP N+L +A+ LK+ DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPEL 171
Query: 201 C-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
G+ KY P +D+W++GCIFAE+L G PLFPG++ + QL ++ LGTP+ ET +
Sbjct: 172 LYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229
Query: 260 N----EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ K + P+PL + FP+ P AL LL+ L+ +DP R +A EAL PY
Sbjct: 230 SLPDYNKIT-----FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
Query: 316 F 316
F
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 253 bits (647), Expect = 2e-82
Identities = 118/299 (39%), Positives = 176/299 (58%), Gaps = 16/299 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
N+Y++L V+G+G+YGVV + TGE VAIKK + + + ++ LREVK+LR LR
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLR 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRAL 139
H +IV +K +R+ + +Y+VFE +E L ++++A+ L + + +++Q+L+A+
Sbjct: 59 HENIVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAI 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H+ N+ HRD+KP+NIL + + LK+CDFG AR TDYVATRWYRAPE
Sbjct: 114 AYCHSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPE 171
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L G + Y +D+W+IGCI AE+L G+PLFPG S + QL LI LG P +
Sbjct: 172 LLVGD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + P L +++P V AL L+ + DPK+R T +E L PYF
Sbjct: 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 253 bits (649), Expect = 5e-82
Identities = 129/348 (37%), Positives = 195/348 (56%), Gaps = 24/348 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
RY+ L+ IG G+ G+VCAA DT TG+ VAIKK+ F++++ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 83 DIVEIKRIMLPPSK-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+I+ + + P EF+D+Y+V ELM+++L QVI DL E + LYQML +K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYYRAPEVI 189
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y +DIWS+GCI E++ G LFPG + Q + I + LGTPS E ++ +
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QP 246
Query: 262 KARKYLTEMRKKPPVPLFQKFPNV-------DPLALR------LLQRLIAFDPKDRPTAE 308
R Y+ K + FP+V L+ LL +++ DP+ R + +
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 309 EALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
+AL PY E P + + + R T ++ +ELIY+E+
Sbjct: 307 DALQHPYINVWYD-PSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 241 bits (618), Expect = 2e-78
Identities = 94/294 (31%), Positives = 143/294 (48%), Gaps = 36/294 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y++L +G GS+G V A TG+ VA+K + E RE+++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V + + +Y+V E E DL + L+ + + Q+LR L+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + N +K+ DFGLA+ + T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ Y P +D+WS+G I E+LTGKP F G++++ QL
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL----------------------- 208
Query: 264 RKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
L PP+ K+ + A L+++ + DP RPTAEE L P+F
Sbjct: 209 --QLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 241 bits (618), Expect = 2e-77
Identities = 130/361 (36%), Positives = 194/361 (53%), Gaps = 44/361 (12%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---LREVKL 75
+ +RY L +G GS G+V +A+D+ ++VA+KKI ++D + LRE+K+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 76 LRLLRHPDIVEIKRIMLPPSKR---------EFKDIYVVFELMESDLHQVIKANDDLTRE 126
+R L H +IV++ ++ P E +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVF 185
H + F+YQ+LR LKY+H+ANV HRDLKP N+ N + LK+ DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTGKPLF G + Q+ LI +
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 246 LLGTPSPETIAVVRNE-----------KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
++ VVR E R E R+ PL P V+P AL L+
Sbjct: 234 --------SVPVVREEDRNELLNVIPSFVRNDGGEPRR----PLRDLLPGVNPEALDFLE 281
Query: 295 RLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYR 354
+++ F+P DR TAEEAL PY + EP +E E + + +I +IY
Sbjct: 282 QILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELD-DILLMTEIHSIIYN 340
Query: 355 E 355
Sbjct: 341 W 341
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 1e-76
Identities = 120/298 (40%), Positives = 168/298 (56%), Gaps = 17/298 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHP 82
Y+ L I +G+YGVV A D TGE VA+KK+ E + I LRE+ +L L+HP
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHP 64
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKY 141
+IV +K +++ IY+V E +E DL +++ + + + Q+L + +
Sbjct: 65 NIVTVKEVVV---GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
+H + HRDLK N+L N LK+CDFGLAR + P+ + T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGS-PLKPY-TQLVVTLWYRAPELL 178
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G+ +Y+ AID+WS+GCIFAE+LT KPLFPGKS + QL+ I LLGTP+ +
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 261 EKARKYLTEMRKKPPVPLFQKFPN--VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
K T K P L +KFP + LL RL+ +DP R +AE+AL PYF
Sbjct: 237 LPGAKKKT-FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 8e-76
Identities = 134/321 (41%), Positives = 179/321 (55%), Gaps = 32/321 (9%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVK 74
TE+ NR IG+G+YG+V A DT +GE VA+KK+ ++ D I I LRE+
Sbjct: 7 TEFEKLNR------IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREIT 58
Query: 75 LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLY 133
LL LRHP+IVE+K +++ + I++V E E DL ++ + + +
Sbjct: 59 LLLNLRHPNIVELKEVVV---GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYVAT 192
Q+LR L+Y+H + HRDLK N+L LK+ DFGLAR PMT V T
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT----PKVVT 171
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
WYRAPE L G + YT AID+W++GCI AE+L KPL PGKS + QLDLI LLGTP+
Sbjct: 172 LWYRAPELLLGC--TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN 229
Query: 252 PETI--AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
E+I K+ + K+P L KFP + LRLL L+ +DPK R TAEE
Sbjct: 230 -ESIWPGFSDLPLVGKF--TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE 286
Query: 310 ALADPYFKGLAKIEREPSCQP 330
AL YFK E+ C+P
Sbjct: 287 ALESSYFK-----EKPLPCEP 302
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 4e-74
Identities = 115/313 (36%), Positives = 166/313 (53%), Gaps = 28/313 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y+IL +G+G++G V A TG VA+KKI E I LRE+K+L+ L+HP
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 83 DIVEIKRIML---PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF--FLYQMLR 137
++V + + + SKR+ +Y+V M+ DL +++ N + Q ++ Q+L
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYMLQLLE 126
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM--------TVFWTDY 189
+ Y+H ++ HRD+K NIL + LK+ DFGLAR P T +T+
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 190 VATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
V TRWYR PEL G +YT A+DIW IGC+FAE+ T +P+ GKS + QL LI L G
Sbjct: 187 VVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244
Query: 249 TPSPETIAVVRNEKARKYL---TEMRKKPPVP--LFQKFPNVDPLALRLLQRLIAFDPKD 303
TP+ ET R L + P L ++F + P L LL +L++ DP
Sbjct: 245 TPTEETWPGWR------SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298
Query: 304 RPTAEEALADPYF 316
R TA +AL PYF
Sbjct: 299 RLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 1e-70
Identities = 119/297 (40%), Positives = 167/297 (56%), Gaps = 19/297 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI--RILREVKLLRLLRHP 82
Y+ +E IG+G+YGVV A D TGE VA+KKI E + + +RE+ LL+ L HP
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAIREISLLKELNHP 58
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI--KANDDLTREHHQFFLYQMLRALK 140
+IV + ++ +K +Y+VFE ++ DL + + L + +LYQ+L+ +
Sbjct: 59 NIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE- 199
Y H+ V HRDLKP+N+L + LK+ DFGLAR AF P+ + T V T WYRAPE
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEI 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
L GS Y+ +DIWSIGCIFAE++ +PLFPG S + QL I LGTP + V
Sbjct: 171 LLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV- 227
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
Y K L + PN+D L LL +++ +DP R +A+ AL PYF
Sbjct: 228 -TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 2e-69
Identities = 108/306 (35%), Positives = 163/306 (53%), Gaps = 33/306 (10%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA---IRILREVKLLRLLR- 80
Y+ L IG+G+YG V A D +TG VA+KK+ +S+ + LRE+ LL+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 81 --HPDIVEIKRIML-PPSKREFKDIYVVFELMESDLHQVIK--ANDDLTREHHQFFLYQM 135
HP+IV + + P + RE + +VFE ++ DL + L E + + Q+
Sbjct: 58 FEHPNIVRLLDVCHGPRTDREL-KLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR + ++H+ + HRDLKP+NIL ++ ++K+ DFGLAR+ + +T V T WY
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT----SVVVTLWY 172
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS--- 251
RAPE L S Y +D+WS+GCIFAE+ +PLF G S QLD I D++G PS
Sbjct: 173 RAPEVLLQS---SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 252 -PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
P +++ R + P P + L LL++++ F+P R +A EA
Sbjct: 230 WPRNVSLPR--------SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281
Query: 311 LADPYF 316
L PYF
Sbjct: 282 LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 2e-68
Identities = 117/299 (39%), Positives = 172/299 (57%), Gaps = 20/299 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI----LREVKLLRLL 79
+Y+ L IG+GSYGVV + TG+ VAIKK F D I LRE+++L+ L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQL 57
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRA 138
+HP++V + + R + +++VFE + + L+++ K + + ++Q L+A
Sbjct: 58 KHPNLVNLIEVF-----RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ + H N HRD+KP+NIL ++K+CDFG AR+ T +TDYVATRWYRAP
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAP 169
Query: 199 EL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
EL G ++Y P +D+W+IGC+FAE+LTG+PL+PGKS V QL LI LG P +
Sbjct: 170 ELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ K L+ + PL KFPN+ AL L+ + DP +R + EE L PYF
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 2e-68
Identities = 118/298 (39%), Positives = 173/298 (58%), Gaps = 21/298 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHI-SDAIRILREVKLLRLLRHP 82
+K LE +G+G+Y V + TGE VA+K+IH D E S AIR E+ L++ L+H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHE 58
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD---LTREHHQFFLYQMLRAL 139
+IV + ++ +K + +VFE M+ DL + + + L + F YQ+L+ +
Sbjct: 59 NIVRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H V HRDLKP+N+L N +LK+ DFGLAR AF P+ F + V T WYRAP+
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPD 170
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L GS Y+ +IDIWS+GCI AE++TG+PLFPG + QL I ++GTP+ T +
Sbjct: 171 VLLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI 228
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+Y + PP L Q FP+ DPL + LL RL+ +P+ R +A +AL P+F
Sbjct: 229 SQ--LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 217 bits (553), Expect = 1e-67
Identities = 126/348 (36%), Positives = 195/348 (56%), Gaps = 23/348 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L+ IG G+ G+VCAA DT G VA+KK+ F++ + A R RE+ LL+ + H +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 84 IVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+ + + P S EF+D+Y+V ELM+++L QVI +L E + LYQML +K++
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHL 139
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ ++C LK+ DFGLAR A ++ M T YV TR+YRAPE+
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM----TPYVVTRYYRAPEVIL 195
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y +DIWS+GCI E++ G +F G + Q + + + LGTPS E + ++
Sbjct: 196 GM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ-PT 252
Query: 263 ARKYLTEMRKKPPVPLFQKFPN--------VDPL----ALRLLQRLIAFDPKDRPTAEEA 310
R Y+ + P + + FP+ D L A LL +++ DP R + +EA
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 311 LADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
L PY + E P + + E R ++ +ELIY+E+++
Sbjct: 313 LRHPYIT-VWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 2e-67
Identities = 111/302 (36%), Positives = 173/302 (57%), Gaps = 30/302 (9%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPD 83
YKIL IG+G++ V A TG+ AIK + F+ + LRE++ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 84 IVEIKRIML-PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH------QFFLYQML 136
I+ + ++ + R + +VFELM+ +L+++IK R+ + ++YQ+L
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKG-----RKRPLPEKRVKSYMYQLL 110
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
++L +MH ++HRD+KP+NIL + LK+ DFG R +S P +T+Y++TRWYR
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYR 165
Query: 197 APE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE L + Y P +DIW++GC+F E+L+ PLFPG + + Q+ I D+LGTP E
Sbjct: 166 APECLLTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV 222
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ R + Y K L + PN L LL++L+A+DP +R TA++AL P
Sbjct: 223 LKKFRKSRHMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280
Query: 315 YF 316
YF
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 207 bits (527), Expect = 1e-63
Identities = 133/369 (36%), Positives = 205/369 (55%), Gaps = 31/369 (8%)
Query: 11 KDKDFFT-EYGDAN-----RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS 64
+D +F++ E GD+ RY+ L+ IG G+ G+VCAA D VAIKK+ F++ +
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 65 DAIRILREVKLLRLLRHPDIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDL 123
A R RE+ L++ + H +I+ + + P S EF+D+Y+V ELM+++L QVI+ +L
Sbjct: 66 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--EL 123
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
E + LYQML +K++H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM- 182
Query: 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + Q + +
Sbjct: 183 ---TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK-FPNV------------DPLAL 290
+ LGTP PE + ++ R Y+ E R K F+K FP+V A
Sbjct: 238 IEQLGTPCPEFMKKLQ-PTVRTYV-ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 295
Query: 291 RLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRE 350
LL +++ D R + +EAL PY + E P + + + R T ++ +E
Sbjct: 296 DLLSKMLVIDASKRISVDEALQHPYIN-VWYDPSEAEAPPPKIPDKQLDEREHTIEEWKE 354
Query: 351 LIYREILEY 359
LIY+E+++
Sbjct: 355 LIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 1e-63
Identities = 117/306 (38%), Positives = 173/306 (56%), Gaps = 35/306 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHI-SDAIRILREVKLLRLLR 80
+Y+ LE IG+G+YG V A + T E VA+K++ D E + S A LRE+ LL+ L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELK 57
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV + ++ K + +VFE + DL + + N D+ E + F++Q+L+ L
Sbjct: 58 HKNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H+ NV HRDLKP+N+L N N +LK+ DFGLAR AF P+ + + V T WYR P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPD 169
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG V QL I LLGTP
Sbjct: 170 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP------- 220
Query: 258 VRNEKARKYLTEMRKKPPVPLF-------QKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
E++ ++++ P P++ P ++ LLQ L+ +P R +AEEA
Sbjct: 221 --TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278
Query: 311 LADPYF 316
L PYF
Sbjct: 279 LQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 1e-63
Identities = 120/302 (39%), Positives = 174/302 (57%), Gaps = 16/302 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++Y+ +E IG+G+YGVV A D T E +A+KKI E +RE+ LL+ ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH--QFFLYQMLRALK 140
+IV ++ ++ K +Y+VFE ++ DL + + ++ D + + +LYQ+LR +
Sbjct: 62 NIVRLQDVV-----HSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 141 YMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H+ V HRDLKP+N+L + LK+ DFGLAR AF P+ F T V T WYRAPE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPE 173
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L GS Y+ +DIWS+GCIFAE++ KPLFPG S + +L I +LGTP+ ET V
Sbjct: 174 ILLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ Y + K PP L P ++P + LL +++ DP R TA AL YFK
Sbjct: 232 TS--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289
Query: 319 LA 320
L
Sbjct: 290 LG 291
|
Length = 294 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 2e-62
Identities = 127/361 (35%), Positives = 197/361 (54%), Gaps = 28/361 (7%)
Query: 15 FFTEYGDAN-----RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI 69
+ E GD+ RY+ L+ IG G+ G+VCAA D VAIKK+ F++ + A R
Sbjct: 4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 63
Query: 70 LREVKLLRLLRHPDIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHH 128
RE+ L++ + H +I+ + + P S EF+D+Y+V ELM+++L QVI+ +L E
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERM 121
Query: 129 QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
+ LYQML +K++H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M T
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TP 177
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG+ + Q + + + LG
Sbjct: 178 YVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV------------DPLALRLLQRL 296
TP PE + ++ R Y+ K + + FP+ A LL ++
Sbjct: 236 TPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294
Query: 297 IAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
+ DP R + +EAL PY + E P + + + R T ++ +ELIY+E+
Sbjct: 295 LVIDPAKRISVDEALQHPYIN-VWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEV 353
Query: 357 L 357
+
Sbjct: 354 M 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 4e-62
Identities = 110/304 (36%), Positives = 174/304 (57%), Gaps = 28/304 (9%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
+Y+ L ++G+GSYG+V TG+ VAIKK + + ++ +RE+++L+ LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-------QFFLY 133
H ++V + + R K +Y+VFE ++ H V+ DDL + + + +L+
Sbjct: 59 HENLVNLIEVF-----RRKKRLYLVFEFVD---HTVL---DDLEKYPNGLDESRVRKYLF 107
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+LR +++ H+ N+ HRD+KP+NIL + + +K+CDFG AR P V+ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 194 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
WYRAPEL G +KY A+DIW++GC+ E+LTG+PLFPG S + QL I LG P
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ + + K PL ++FP + L L L ++ + DP DRP++ + L
Sbjct: 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
Query: 313 DPYF 316
+F
Sbjct: 283 HEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 4e-62
Identities = 114/300 (38%), Positives = 167/300 (55%), Gaps = 16/300 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PD 83
Y+ LE IG+G+YG V A D +TG+ VA+KK + LRE+ LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRA 138
IV + + K +Y+VFE ++SDL + + +N L + + F+YQ+L+
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 139 LKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ + H V HRDLKP+N+L + LK+ D GL R AFS P+ + T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFS-IPVKSY-THEIVTLWYRA 179
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE L GS + Y+ +DIWS+GCIFAE+ +PLFPG S + QL I LLGTP+ +
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
V + E + P L + P++ P L LLQ+++ +DP R +A+ AL PYF
Sbjct: 238 GVSKLRD---WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 6e-62
Identities = 117/305 (38%), Positives = 169/305 (55%), Gaps = 21/305 (6%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G YK L+ +G+GSY V TG+ VA+K+I EH A +RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLK 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ K + +VFE +++DL Q + H+ + FL+Q+L
Sbjct: 59 DLKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L + +LK+ DFGLAR A S T +++ V T WYR
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKT--YSNEVVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPET 254
P+ L GS ++Y+ ++D+W +GCIF E+ TG+PLFPG V QL I +LGTP+ ET
Sbjct: 171 PPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228
Query: 255 I-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVD--PLALRLLQRLIAFDPKDRPTAEEAL 311
V N + + Y PP PL P +D P L + + ++PK R +A EA+
Sbjct: 229 WPGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286
Query: 312 ADPYF 316
PYF
Sbjct: 287 KHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 4e-61
Identities = 113/296 (38%), Positives = 168/296 (56%), Gaps = 16/296 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y +E IG+G+YGVV + TG+ VA+KKI E +RE+ LL+ L+HP+I
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQ---VIKANDDLTREHHQFFLYQMLRALKY 141
V ++ +++ S+ +Y++FE + DL + + + E + +LYQ+L+ + +
Sbjct: 62 VCLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
H+ V HRDLKP+N+L + +K+ DFGLAR AF P+ V+ T V T WYRAPE L
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAPEVL 173
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
GS +Y+ +DIWSIG IFAE+ T KPLF G S + QL I +LGTP+ + V
Sbjct: 174 LGS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV-- 229
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
Y K L N+D L LL++++ +DP R +A++AL PYF
Sbjct: 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 6e-61
Identities = 112/292 (38%), Positives = 164/292 (56%), Gaps = 15/292 (5%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+E IG+G+YGVV A + TGE VA+KKI E +RE+ LL+ L HP+IV++
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA 145
++ +K +Y+VFE + DL + + A+ + + +L+Q+L+ L + H+
Sbjct: 65 LDVIHTENK-----LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSF 204
V HRDLKP+N+L N +K+ DFGLAR AF P+ + T V T WYRAPE L G
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEILLGCK 176
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
+ Y+ A+DIWS+GCIFAE++T + LFPG S + QL I LGTP V +
Sbjct: 177 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP-- 232
Query: 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
Y K + P +D LL +++ +DP R +A+ ALA P+F
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 2e-60
Identities = 117/315 (37%), Positives = 165/315 (52%), Gaps = 42/315 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-------------ILREVKLLR 77
+G+G+YG V A DT TG+ VAIKK+ + E +D + LRE+K++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLR 137
++H +I+ + + + + +F I +V ++M SDL +V+ LT + L Q+L
Sbjct: 76 EIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQVKCILLQILN 130
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM-----------TVFW 186
L +H HRDL P NI N+ K+ DFGLAR
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 187 TDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
T V T WYRAPEL G+ KY A+D+WS+GCIFAE+LTGKPLFPG++ + QL I +
Sbjct: 191 TSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248
Query: 246 LLGTPSPETIAVVRNEKARKYL---TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK 302
LLGTP+ + N K L TE + P L FPN A+ LLQ L+ +P
Sbjct: 249 LLGTPNED------NWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302
Query: 303 DRPTAEEALADPYFK 317
+R +A+EAL YFK
Sbjct: 303 ERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 3e-60
Identities = 115/300 (38%), Positives = 164/300 (54%), Gaps = 16/300 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+ I+ IG+G+YG V A D TGE VA+KK+ E I +RE+K+LR L H +I
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 85 VEIKRIMLPPS-----KREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRA 138
V +K I+ K++ Y+VFE M+ DL ++++ + +H + F+ Q+L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L Y H N HRD+K NIL N ++K+ DFGLAR+ S+ +T+ V T WYR P
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--YTNKVITLWYRPP 186
Query: 199 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
EL G +Y PAID+WS GCI E+ T KP+F + QL+LI+ L G+P P AV
Sbjct: 187 ELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP---AV 241
Query: 258 VRNEKARKYLTEMRKKPPV--PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ Y M+ K L ++F + AL LL ++ DP R TAEEAL P+
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 1e-59
Identities = 114/324 (35%), Positives = 164/324 (50%), Gaps = 39/324 (12%)
Query: 24 RYKILEVIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRL 78
+Y+I IG+G+YG V A + G++ AIKK E IS + RE+ LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF-----LY 133
L+H ++V + + L + + +Y++F+ E DL Q+IK + R L+
Sbjct: 59 LKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 134 QMLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTD- 188
Q+L + Y+H+ V HRDLKP NIL +K+ D GLAR+ F+ + D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDP 174
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-----KSVV----H 238
V T WYRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F G K
Sbjct: 175 VVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPP------VPLFQKFPNVDPLALRL 292
QL+ I ++LGTP+ + ++ L + K +K D L
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292
Query: 293 LQRLIAFDPKDRPTAEEALADPYF 316
L++L+ +DP R TAEEAL PYF
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 1e-57
Identities = 111/304 (36%), Positives = 155/304 (50%), Gaps = 11/304 (3%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ ++Y+ L IG+G++G V A T + VA+KK+ E I LRE+K+L+LL+
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK 69
Query: 81 HPDIV---EIKRIMLPPSKREFKDIYVVFELMESDLHQVIK-ANDDLTREHHQFFLYQML 136
H ++V EI R P R Y+VFE E DL ++ N T + + +L
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS--DTPMTVFWTDYVATRW 194
L Y+H + HRD+K NIL + LK+ DFGLAR AFS +T+ V T W
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR-AFSLSKNSKPNRYTNRVVTLW 188
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
YR PE L G Y P ID+W GCI AE+ T P+ G + HQL LI+ L G+ +PE
Sbjct: 189 YRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246
Query: 254 TI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
V + E +K +K V K DP AL L+ +L+ DP R A+ AL
Sbjct: 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306
Query: 313 DPYF 316
+F
Sbjct: 307 HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 3e-56
Identities = 117/306 (38%), Positives = 172/306 (56%), Gaps = 18/306 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G Y LE +G+G+Y V T VA+K+I EH A +REV LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ K + +VFE ++ DL Q + ++ H+ + FLYQ+L
Sbjct: 60 DLKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQIL 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L N +LK+ DFGLAR + + T +++ V T WYR
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 171
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
P+ L GS S+Y+ ID+W +GCIF E+ +G+PLFPG +V +L LI LLGTP+ ET
Sbjct: 172 PPDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
Query: 256 -AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ N++ + Y K P PL P +D + LL + + ++ K R +AEEA+
Sbjct: 230 PGISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287
Query: 315 YFKGLA 320
YF+ L
Sbjct: 288 YFRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 1e-55
Identities = 115/307 (37%), Positives = 169/307 (55%), Gaps = 18/307 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G Y L+ +G+G+Y V T VA+K+I EH A +REV LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ K + +VFE ++ DL Q + + H+ + FL+Q+L
Sbjct: 60 DLKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLL 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L N +LK+ DFGLAR + + T +++ V T WYR
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYR 171
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
P+ L GS + Y+ ID+W +GCIF E+ TG+PLFPG +V QL I +LGTP+ ET
Sbjct: 172 PPDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229
Query: 256 -AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
++ NE+ + Y K L P +D LL +L+ F+ + R +AEEA+ P
Sbjct: 230 PGILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287
Query: 315 YFKGLAK 321
YF L +
Sbjct: 288 YFHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 182 bits (462), Expect = 6e-55
Identities = 113/302 (37%), Positives = 169/302 (55%), Gaps = 18/302 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G Y L+ +G+G+Y V T VA+K+I EH A +REV LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ + + +VFE ++SDL Q + +L H+ + F++Q+L
Sbjct: 59 NLKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLL 113
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H + HRDLKP+N+L N +LK+ DFGLAR + + T +++ V T WYR
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
P+ L GS ++Y+ ID+W +GCI E+ TG+P+FPG +V +L LI LLGTP+ ET
Sbjct: 171 PPDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228
Query: 256 -AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ NE+ R YL + PL P +D + LL L+ ++ K R +AE AL
Sbjct: 229 PGITSNEEFRSYLFPQYR--AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286
Query: 315 YF 316
YF
Sbjct: 287 YF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 6e-53
Identities = 103/296 (34%), Positives = 168/296 (56%), Gaps = 11/296 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
N++++L V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKY 141
+IVE+K R +Y+VFE +E ++ ++++ + + E + ++YQ+++A+ +
Sbjct: 61 NIVELKEAF-----RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H ++ HRD+KP+N+L + N LK+CDFG AR + +T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELL 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ Y A+D+WS+GCI E+ G+PLFPG+S + QL I +LG E + + +
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 262 KARKYLTEMRKKPPVPLFQKFPNV-DPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
L P L +++ + + L L++ L+ +P DR E+ L P F
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 7e-50
Identities = 108/304 (35%), Positives = 157/304 (51%), Gaps = 19/304 (6%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
+G A Y LE +G+GSY V I G+ VA+K I E +RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKG 59
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLR 137
L+H +IV + I+ F VFE M +DL Q + + ++ + F++Q+LR
Sbjct: 60 LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H ++ HRDLKP+N+L + +LK+ DFGLAR P + ++ V T WYR
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETI 255
P+ L G+ + Y+ A+DIW GCIF E+L G+P FPG S V QL+ I +LG P+ +T
Sbjct: 172 PDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPN---VDPLALRLLQRLIAFDPKDRPTAEEALA 312
V K Y E + P A L +++ PKDR +A++AL
Sbjct: 230 PGV--SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287
Query: 313 DPYF 316
PYF
Sbjct: 288 HPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 2e-49
Identities = 76/294 (25%), Positives = 131/294 (44%), Gaps = 35/294 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+ E++G+GS+G V A+D TGE +A+K + + + + RE+++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV E + + E + L ++K L + + Q+L L Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL +++ +K+ DFG A+ D T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+Y A DIWS+GC E+ TGKP + + + + + + P
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEP---------- 222
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
P +P ++ A L++ + DPK RPTA+E L P+
Sbjct: 223 -----------PEIP-----EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 9e-48
Identities = 104/304 (34%), Positives = 162/304 (53%), Gaps = 26/304 (8%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLR-- 80
+Y+ + IG+G+YG V A D G + VA+K++ + +REV +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 81 -HPDIVEIKRI-MLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQML 136
HP++V + + + + RE K + +VFE ++ DL + + + E + ++Q+L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ +T V T WYR
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV----VVTLWYR 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE--- 253
APE+ S Y +D+WS+GCIFAE+ KPLF G S V QL I D++G P E
Sbjct: 177 APEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 254 -TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+A+ R K P+ + ++D L LL + + F+P R +A AL+
Sbjct: 235 RDVALPRQAFH--------SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286
Query: 313 DPYF 316
PYF
Sbjct: 287 HPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-47
Identities = 113/337 (33%), Positives = 179/337 (53%), Gaps = 29/337 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
YK+ +IG GS+GVV AI T EKVAIKK+ + D RE+ +++ L H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINI 121
Query: 85 VEIKRIMLPPS-KREFKDIY--VVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLR 137
+ +K K+ K+I+ VV E + +H+ +K N L + + YQ+ R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 138 ALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL Y+H+ + HRDLKP+N+L + N LK+CDFG A+ + Y+ +R+YR
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV----SYICSRFYR 237
Query: 197 APEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APEL G+ + YT ID+WS+GCI AE++ G P+F G+S V QL I +LGTP+ + +
Sbjct: 238 APELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP-LALRLLQRLIAFDPKDRPTAEEALADP 314
+ A +++ K L + FP P A+ + + + ++P R EALADP
Sbjct: 296 KEMNPNYADIKFPDVKPK---DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
+F L R+P + ++ + +I+E+
Sbjct: 353 FFDDL----RDPCIKLPKYIDKLPDLFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 164 bits (414), Expect = 5e-47
Identities = 89/355 (25%), Positives = 147/355 (41%), Gaps = 35/355 (9%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLRHPD 83
Y+IL +G+GS+G V A D + VA+K + E S + R LRE+++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 84 -IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD---LTREHHQFFLYQMLRAL 139
IV++ V+ + L ++K L+ F L Q+L AL
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 140 KYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVA---FSDTPMTVFWTDYVATRWY 195
+Y+H+ + HRD+KP+NIL + + +K+ DFGLA++ S + + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE+ G + + + DIWS+G E+LTG P F G+ +T
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-----------QT 223
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ ++ + + P + A LL++L+A DPK+R ++ L+
Sbjct: 224 LKIILELPTPSLASPLSPSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYIN 369
L E + S + + L D N
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSN 331
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-46
Identities = 70/196 (35%), Positives = 107/196 (54%), Gaps = 13/196 (6%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
+G+G +G V A D TG+KVAIK I S +LRE+++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 91 MLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVY 148
+ +Y+V E E L ++K N+ L+ + L Q+L L+Y+H+ +
Sbjct: 60 FE-----DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 149 HRDLKPKNIL-ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP+NIL + N K+K+ DFGL+++ SD + V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL---KTIVGTPAYMAPEVL-LGKGY 170
Query: 208 YTPAIDIWSIGCIFAE 223
Y+ DIWS+G I E
Sbjct: 171 YSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-44
Identities = 103/303 (33%), Positives = 150/303 (49%), Gaps = 25/303 (8%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y+ + IG G+YG V A D H+G VA+K + + +REV LL+ L D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 84 IVEIKRIM----LPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLR 137
I R+M + RE K + +VFE ++ DL + L E + + Q LR
Sbjct: 61 HPNIVRLMDVCATSRTDRETK-VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L ++H + HRDLKP+NIL + ++K+ DFGLAR+ +T V T WYRA
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT----PVVVTLWYRA 175
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS----PE 253
PE+ S Y +D+WS+GCIFAE+ KPLF G S QL I DL+G P P
Sbjct: 176 PEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ + R + P P+ P ++ +LL ++ F+P R +A AL
Sbjct: 234 DVTLPRG--------AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285
Query: 314 PYF 316
P+F
Sbjct: 286 PFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-44
Identities = 88/303 (29%), Positives = 142/303 (46%), Gaps = 55/303 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y+I++ IGKGS+G V G+ +K+I + L EVK+L+ L HP+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF--------LYQ 134
I++ S E + +V E + DL Q IK ++ + F Q
Sbjct: 61 IIKYYE-----SFEEKGKLCIVMEYADGGDLSQKIKK----QKKEGKPFPEEQILDWFVQ 111
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ ALKY+H+ + HRD+KP+NI +N +K+ DFG+++V S + V T +
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGTPY 168
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL-GTPSPE 253
Y +PELC + Y DIWS+GC+ E+ T K F G++ L+L +L G P
Sbjct: 169 YLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQYPP- 222
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ + +Y +E+R L LLQ+ DP++RP+ + L
Sbjct: 223 ----IPS----QYSSELRN---------------LVSSLLQK----DPEERPSIAQILQS 255
Query: 314 PYF 316
P+
Sbjct: 256 PFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-41
Identities = 81/302 (26%), Positives = 134/302 (44%), Gaps = 61/302 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++ILE IGKG +G V A TG++VAIK I + + +I+ E+++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE--KIINEIQILKKCKHPNI 59
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYM 142
V+ L + +++V E L ++K+ + LT + ++L+ L+Y+
Sbjct: 60 VKYYGSYLKKDE-----LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL ++ ++K+ DFGL+ SDT V T ++ APE+
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI- 169
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y DIWS+G E+ GKP +
Sbjct: 170 -NGKPYDYKADIWSLGITAIELAEGKPPY---------------------------SELP 201
Query: 263 ARKYLTEMRKKPPVPL---------FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
K L ++ P L F+ F + LQ +P+ RPTAE+ L
Sbjct: 202 PMKALFKIATNGPPGLRNPEKWSDEFKDFLK------KCLQ----KNPEKRPTAEQLLKH 251
Query: 314 PY 315
P+
Sbjct: 252 PF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-41
Identities = 87/308 (28%), Positives = 140/308 (45%), Gaps = 62/308 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
Y++LE IGKGS+G V G+ + K+I + ++++ + ++ EV +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 83 DIVE-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF--------L 132
+IV RI+ ++ +Y+V E E DL Q+I+ ++ ++ L
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQK----CKKERKYIEEEFIWRIL 111
Query: 133 YQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
Q+L AL H + V HRDLKP NI +AN +K+ DFGLA++ D+
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA---K 168
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
YV T +Y +PE Y DIWS+GC+ E+ P F ++ QL L + +
Sbjct: 169 TYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKI- 222
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
K K+ +P L +++ ++ DP RP+
Sbjct: 223 --------------KEGKF-------RRIPYRYS----SELN-EVIKSMLNVDPDKRPST 256
Query: 308 EEALADPY 315
EE L P
Sbjct: 257 EELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 8e-41
Identities = 86/294 (29%), Positives = 136/294 (46%), Gaps = 41/294 (13%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y++ ++IG+G++GVV ++ TG+ VAIK+I I++E+ LL+ L+HP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV K I + Y++ E E+ L Q+IK ++YQ+L+ L Y+
Sbjct: 61 IV--KYIGSIETSDSL---YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H V HRD+K NIL + +K+ DFG+A + V T ++ APE+
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD---ASVVGTPYWMAPEVIE 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
S + A DIWS+GC E+LTG P + DL P +V+++
Sbjct: 173 --MSGASTASDIWSLGCTVIELLTGNPPY--------YDL------NPMAALFRIVQDD- 215
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
PP+P + P L + DP RPTA++ L P+
Sbjct: 216 ----------HPPLP-----EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 3e-40
Identities = 107/306 (34%), Positives = 164/306 (53%), Gaps = 17/306 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
+G A+ Y+ LE +G+GSY V G+ VA+K I + E +RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR-LQEEEGTPFTAIREASLLKG 59
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLR 137
L+H +IV + I+ + + +VFE + +DL Q + K L E+ + FL+Q+LR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H + HRDLKP+N+L + +LK+ DFGLAR P + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPETI 255
P+ L GS ++Y+ +D+W +GCIF E++ G FPG K + QL+ I +LGTP+ +T
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 256 AVVRNEKARK--YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
V + K T K + K V+ A L +L+ PK+R +A+ AL+
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNH-AEDLASKLLQCFPKNRLSAQAALSH 288
Query: 314 PYFKGL 319
YF L
Sbjct: 289 EYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 114/330 (34%), Positives = 163/330 (49%), Gaps = 65/330 (19%)
Query: 31 IGKGSYGVVCAA--IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G+G+YG V A D ++ A+K+I E ++ RE+ LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 89 RIMLPPSKREFKDIYVVFELMESDL------HQVIKAND---DLTREHHQFFLYQMLRAL 139
++ L S R+ ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 140 KYMHTANVYHRDLKPKNILANANC----KLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
Y+H V HRDLKP NIL ++K+ D G AR+ S V T WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------SVVH--QLDLITD 245
RAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + + H QLD I
Sbjct: 182 RAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
Query: 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK------FPNV-------------D 286
++G P A K ++RK P P QK + N D
Sbjct: 240 VMGFP------------ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPD 287
Query: 287 PLALRLLQRLIAFDPKDRPTAEEALADPYF 316
LLQ+L+ DP R T+E+AL DPYF
Sbjct: 288 SKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-39
Identities = 110/329 (33%), Positives = 166/329 (50%), Gaps = 63/329 (19%)
Query: 31 IGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G+G+YG V A D A+K+I E ++ RE+ LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 89 RIMLPPSKREFKDIYVVFELMESDL------HQVIKAND---DLTREHHQFFLYQMLRAL 139
++ L + R+ ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 140 KYMHTANVYHRDLKPKNILANANC----KLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
Y+H V HRDLKP NIL ++K+ D G AR+ S V T WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------SVVH--QLDLITD 245
RAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + + H QLD I +
Sbjct: 182 RAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239
Query: 246 LLGTPS----------PETIAVVRNEKAR--------KYLTEMRKKPPVPLFQKFPNVDP 287
++G P+ PE ++++ + KY+ + + KP D
Sbjct: 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP-----------DS 288
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYF 316
A LLQ+L+ DP R T+E+A+ DPYF
Sbjct: 289 KAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 91/323 (28%), Positives = 143/323 (44%), Gaps = 59/323 (18%)
Query: 4 DQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DV 59
++ K LKD GD YK LE IG+G+ G V A D TG++VAIKK+
Sbjct: 2 EELKAALKD---IVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN 58
Query: 60 FEHISDAIRILREVKLLRLLRHPDIVE-IKRIMLPPSKREFKDIYVVFELMES-DLHQVI 117
E I+ E+ +++ +HP+IV+ S +++VV E M+ L +I
Sbjct: 59 KE------LIINEILIMKDCKHPNIVDYYD------SYLVGDELWVVMEYMDGGSLTDII 106
Query: 118 KAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
N + + ++L+ L+Y+H+ NV HRD+K NIL + + +K+ DFG A
Sbjct: 107 TQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166
Query: 177 FSDTPM--TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ +V V T ++ APE+ Y P +DIWS+G + E+ G+P + +
Sbjct: 167 TKEKSKRNSV-----VGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
+ L LIT G P + P L
Sbjct: 220 PPLRALFLITT-KGIPPLKNPE---------------------------KWSPEFKDFLN 251
Query: 295 RLIAFDPKDRPTAEEALADPYFK 317
+ + DP+ RP+AEE L P+ K
Sbjct: 252 KCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 86/295 (29%), Positives = 135/295 (45%), Gaps = 35/295 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
R++ IG G++G V A++ TGE +A+K+I I E+K+L LL+HP+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFEL-MESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+V+ + + RE +Y+ E L ++++ L + + Q+L L Y+
Sbjct: 61 LVKYYGVEV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYL 115
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLA-RVAFSDTPMTVFWTDYVATRWYRAPEL- 200
H+ + HRD+KP NI + N +K+ DFG A ++ + T M T Y APE+
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G + A DIWS+GC+ E+ TGK + +LD N
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPW------SELD------------------N 211
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
E + KPP+P + + P L R + DPK RPTA E L P+
Sbjct: 212 EFQIMFHVGAGHKPPIPDSLQ---LSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 84/297 (28%), Positives = 132/297 (44%), Gaps = 58/297 (19%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---LREVKLLRLLRHPDIVEI 87
+GKGS+G V TG+ A+K + + I + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKK--KKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 88 KRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
F+ +Y+V E +L + + E +F+ +++ AL+Y+H
Sbjct: 59 HY--------AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + +RDLKP+NIL +A+ +K+ DFGLA+ S+ T + T Y APE+
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG 167
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
Y A+D WS+G + E+LTGKP F +
Sbjct: 168 --KGYGKAVDWWSLGVLLYEMLTGKPPFYAED---------------------------- 197
Query: 264 RKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDRPT---AEEALADPYF 316
RK + E K P+ +FP + P A L+ L+ DP R AEE A P+F
Sbjct: 198 RKEIYEKILKDPL----RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 53/294 (18%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
+ + +G+G++G V +VA+K + + + I LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE--DASEQQIEEFLREARIMRKLD 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
HP++V++ + + +Y+V E ME DL ++ N L+ F Q+ R
Sbjct: 60 HPNVVKLLGVCTEE-----EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
++Y+ + N HRDL +N L N +K+ DFGL+R + D + RW AP
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGK-LPIRWM-AP 172
Query: 199 ELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
E S K+T D+WS G + E+ T G+ +PG S
Sbjct: 173 E---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS--------------------- 208
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
NE+ +YL + P P P L L+ + A DP+DRPT E
Sbjct: 209 ---NEEVLEYLKNGYRLPQ-------PPNCPPELYDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 8e-34
Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
+ + +G+G++G V +VA+K + + + I LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE--DASEQQIEEFLREARIMRKLD 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLR 137
HP+IV++ + + +V E M DL ++ N L+ F Q+ R
Sbjct: 60 HPNIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
++Y+ + N HRDL +N L N +K+ DFGL+R + D + RW A
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRWM-A 172
Query: 198 PELCGSFF-SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255
PE S K+T D+WS G + E+ T G+ +PG S
Sbjct: 173 PE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-------------------- 209
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
N + +YL + + P P P L +L+ + A DP+DRPT E
Sbjct: 210 ----NAEVLEYLKKGYRLPK-------PPNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 7e-33
Identities = 93/330 (28%), Positives = 144/330 (43%), Gaps = 86/330 (26%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILREVKLLRLL 79
+ +K ++IG+GS+ V A + T ++ AIK K + E ++I +EV L RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLN 59
Query: 80 RHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQM 135
HP I IK F+D +Y V E + +L Q I+ L + +F+ ++
Sbjct: 60 GHPGI--IKLYY------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEI 111
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV-----------------AFS 178
L AL+Y+H+ + HRDLKP+NIL + + +K+ DFG A+V
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238
+ +V T Y +PEL + D+W++GCI ++LTGKP F G +
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSN--- 226
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK-------FP-NVDPLAL 290
+YLT FQK FP N P A
Sbjct: 227 --------------------------EYLT----------FQKILKLEYSFPPNFPPDAK 250
Query: 291 RLLQRLIAFDPKDRPTA----EEALADPYF 316
L+++L+ DP+DR +E A P+F
Sbjct: 251 DLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 83/296 (28%), Positives = 133/296 (44%), Gaps = 41/296 (13%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ ++V+G+GS GVV TG+ A+KKIH V ++LRE+K LR P +V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+ +I +V E M+ L ++K + + Q+L+ L Y+HT
Sbjct: 63 KCYGAFYKEG-----EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 145 -ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
++ HRD+KP N+L N+ ++K+ DFG+++V + + T +V T Y +PE
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNT-FVGTVTYMSPERIQG 174
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y+ A DIWS+G E GK P P +L+ + P P A + +
Sbjct: 175 --ESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-FFELMQAICDGPPPSLPAEEFSPE 231
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
R +++ LQ+ DPK RP+A E L P+ K
Sbjct: 232 FRDFIS----------------------ACLQK----DPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 89/314 (28%), Positives = 137/314 (43%), Gaps = 76/314 (24%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI---------HDVFEHISDAIRILR-EVKLLRL 78
E+IGKG+YG V A++ TGE +A+K++ HD D ++ LR E++ L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHD--SRQKDMVKALRSEIETLKD 64
Query: 79 LRHPDIV---------EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ 129
L H +IV E I L YV + S L + + L R
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLE---------YVPGGSIGSCLRTYGRFEEQLVR---- 111
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA------FSDTPM- 182
FF Q+L L Y+H+ + HRDLK N+L +A+ K+ DFG+++ + + M
Sbjct: 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 183 -TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
+VFW APE+ S+ Y+ +DIWS+GC+ E+ G+ + + +
Sbjct: 172 GSVFWM---------APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---- 218
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301
A L R PP+P N+ P+AL L +P
Sbjct: 219 --------------------AAMFKLGNKRSAPPIPP-DVSMNLSPVALDFLNACFTINP 257
Query: 302 KDRPTAEEALADPY 315
+RPTA E L P+
Sbjct: 258 DNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-31
Identities = 92/305 (30%), Positives = 144/305 (47%), Gaps = 61/305 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRIL-REVKLLRLLR 80
R++ E++G GS+G V ++ G+ A+K + D + +A++ L +E+ LL L+
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP+IV+ ++RE ++Y+ EL+ L +++K + + Q+L L
Sbjct: 61 HPNIVQYL-----GTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWYRA 197
+Y+H N HRD+K NIL + N +K+ DFG+A+ V FS F + + ++ A
Sbjct: 116 EYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS------FAKSFKGSPYWMA 169
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ Y A DIWS+GC E+ TGKP + QL E +A
Sbjct: 170 PEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPW------SQL------------EGVAA 210
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA-------LRLLQRLIAFDPKDRPTAEEA 310
V K L PP+P D L+ L+ LQR DP RPTA E
Sbjct: 211 VFKIGRSKEL------PPIP--------DHLSDEAKDFILKCLQR----DPSLRPTAAEL 252
Query: 311 LADPY 315
L P+
Sbjct: 253 LEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 71/292 (24%), Positives = 121/292 (41%), Gaps = 48/292 (16%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
++ + +G+G++G V T KVA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF-FLYQMLRAL 139
P+IV + + +Y+V E M DL ++ + + Q+ + +
Sbjct: 61 PNIVRLLGVCTQGEP-----LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+ + N HRDL +N L N +K+ DFGL+R + D + +W APE
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
K+T D+WS G + E+ T G+ +PG S
Sbjct: 175 SL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS----------------------- 209
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
NE+ + L + + P P P L L+ + A+DP+DRPT E
Sbjct: 210 -NEEVLELLEDGYRLPR-------PENCPDELYELMLQCWAYDPEDRPTFSE 253
|
Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 84/301 (27%), Positives = 139/301 (46%), Gaps = 50/301 (16%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI---HDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
I KG+YG V A TG+ AIK I + ++ D ++L E +L + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD--QVLTERDILSQAQSPYVVK- 57
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L S + K++Y+V E + DL +++ L + + ++ +++ AL+Y+H+
Sbjct: 58 ----LYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY-----VATRWYRAPELC 201
+ HRDLKP NIL ++N LK+ DFGL++V + + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +D WS+GCI E L G P F G++ E + N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETP---------------EEIFQNILNG 216
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEALADPYFKG 318
K + + V A+ L+ +L+ DP+ R A EE P+FKG
Sbjct: 217 KIE--------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
Query: 319 L 319
+
Sbjct: 263 I 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 70/220 (31%), Positives = 100/220 (45%), Gaps = 37/220 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ +LE IGKGS+G V AID T + VAIK I D+ E + I +E++ L R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRA 138
I + L SK ++++ E DL + K L + F L ++L
Sbjct: 60 YITKYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLLG 110
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA---------RVAFSDTPMTVFWTDY 189
L+Y+H HRD+K NIL + +K+ DFG++ R F TP FW
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTP---FWM-- 165
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
APE+ S Y DIWS+G E+ G+P
Sbjct: 166 -------APEVIKQ--SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 63/218 (28%), Positives = 112/218 (51%), Gaps = 23/218 (10%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-DAIR-ILREVKLLRLLRHP 82
+++L VIGKG++G VC T + A+K ++ + + ++R +L E ++L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNHP 60
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+V + F+D +Y+V +L+ DL + + E +F++ +++ A
Sbjct: 61 FLVNLWY--------SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA 112
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+Y+H+ + HRD+KP NIL + + + DF +A + +T T T Y AP
Sbjct: 113 LEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLT---TSTSGTPGYMAP 168
Query: 199 ELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
E+ + Y+ A+D WS+G E L GK + G S
Sbjct: 169 EV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 40/287 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A D TG +VA+KK+ D+ + + + EV ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRREL-LFNEVVIMRDYQHPNIVEMYSS 84
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L +++VV E +E I + + E +L+AL ++H V HR
Sbjct: 85 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL ++ ++K+ DFG + P V T ++ APE+ Y
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEVISR--LPYGT 194
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + NE + + +
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPY---------------------------FNEPPLQAMKRI 227
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
R P P + V P L R++ DP R TA E L P+
Sbjct: 228 RDNLP-PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 82/304 (26%), Positives = 131/304 (43%), Gaps = 63/304 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRH 81
Y + V+GKG++G T V K+++ +S+ R L E+ +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN--LTRLSEKERRDALNEIVILSLLQH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQ--FFLYQM 135
P+I+ F D + ME L+ I E ++L+Q+
Sbjct: 59 PNIIAYYN--------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM--TVFWTDYVATR 193
+ A+ Y+H A + HRD+K NI +K+ DFG++++ S+ M TV V T
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-----VGTP 165
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG---TP 250
+Y +PELC KY DIW++GC+ E+LT K F + L+L+ ++ TP
Sbjct: 166 YYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTP 220
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
Y +E+ L+ L+ DP+ RPTA+E
Sbjct: 221 VVS-----------VYSSELIS-------------------LVHSLLQQDPEKRPTADEV 250
Query: 311 LADP 314
L P
Sbjct: 251 LDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
+KI + IGKG + VV AI G VA+KK+ +FE + R L+E+ LL+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFEMMDAKARQDCLKEIDLLKQLD 60
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK--ANDDLTREHHQF--FLYQM 135
HP++ I S E ++ +V EL ++ DL ++IK + Q+
Sbjct: 61 HPNV-----IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL++MH+ + HRD+KP N+ A +K+ D GL R FS V T +Y
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAH--SLVGTPYY 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAE 223
+PE + Y DIWS+GC+ E
Sbjct: 173 MSPERIHE--NGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 74/286 (25%), Positives = 134/286 (46%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A + H+G +VA+K + D+ + + + EV ++R +H ++VE+ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM-DLRKQQRREL-LFNEVVIMRDYQHQNVVEMYKS 86
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L ++++V+ E ++ I + L E +L+AL Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL + ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + S V + +
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQA---------------------------MKRL 229
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
R PP P + + P+ L+R++ +P++R TA+E L P+
Sbjct: 230 RDSPP-PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 71/300 (23%), Positives = 132/300 (44%), Gaps = 44/300 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE----HISDAIRILR-EVKLLR 77
++ +++G+G++G V D TG ++A+K++ F+ + L E++LL+
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLK 59
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
L+H IV+ + R+ + + + E M + +KA LT + + Q+L
Sbjct: 60 NLQHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++
Sbjct: 115 EGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
+PE+ Y D+WS+GC E+LT KP + + E +A
Sbjct: 175 SPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPW------------AEF------EAMA 214
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + +P P Q +V P A L+R + K RP+AEE L +
Sbjct: 215 AIFK---------IATQPTNP--QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 80/303 (26%), Positives = 126/303 (41%), Gaps = 45/303 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y+++EVIG G+ VV AAI EKVAIK+I D+ + + + +EV+ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK---ANDDLTREHHQFFLYQMLRA 138
++V+ S ++++V + L ++K L L ++L+
Sbjct: 60 NVVKYY-----TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF-WTDYVATRWYRA 197
L+Y+H+ HRD+K NIL + +K+ DFG++ T +V T + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP----LFPGKSVVHQLDLITDLLGTPSPE 253
PE+ Y DIWS G E+ TG P K ++ L P
Sbjct: 175 PEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML-------TLQNDPP- 225
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
T K F+K ++L L + DP RPTAEE L
Sbjct: 226 -----------SLETGADYKKYSKSFRKM-----ISLCLQK-----DPSKRPTAEELLKH 264
Query: 314 PYF 316
+F
Sbjct: 265 KFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 58/301 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+ ILE +G+GSYG V AI TG+ VAIK + V E + + I++E+ +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQE---IIKEISILKQCDSPYI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
V+ S + D+++V E SD+ ++ N LT E LYQ L+ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIVMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLE 113
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLA-----RVAFSDTPMTVFWTDYVATRWY 195
Y+H+ HRD+K NIL N + K+ DFG++ +A +T + T ++
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--------VIGTPFW 165
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ Y DIWS+G E+ GKP +
Sbjct: 166 MAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPY------------------------ 199
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ + + + KPP P P +++ + DP++RP+A + L P+
Sbjct: 200 ---SDIHPMRAIFMIPNKPP-PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255
Query: 316 F 316
Sbjct: 256 I 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-R 80
++++EVIG+G+YG V A TG+ VAIK + + + + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE---IKEEYNILRKYSN 61
Query: 81 HPDIVEIKRIMLPPSKREFKD-IYVVFELME----SDLHQVIKANDDLTREHH-QFFLYQ 134
HP+I + + D +++V EL +DL + ++ +E + L +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
LR L Y+H V HRD+K +NIL N ++K+ DFG++ A D+ + T ++ T +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS--AQLDSTLGRRNT-FIGTPY 178
Query: 195 YRAPE--LCG-SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ APE C + Y D+WS+G E+ GKP
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 4e-24
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI--HDVF-----EHISDAIRILREVKLLRLLRHPD 83
+G G +G V A+K + + EHI E ++L HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHI------FSEKEILEECNHPF 54
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQMLRAL 139
IV++ R FKD ++ LME +L +++ +F++ ++ A
Sbjct: 55 IVKLYR--------TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAF 106
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+H + +RDLKP+N+L ++N +K+ DFG A+ S WT + T Y APE
Sbjct: 107 EYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPE 162
Query: 200 LCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLF 231
+ +K Y ++D WS+G + E+LTG+P F
Sbjct: 163 II---LNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-23
Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 44/298 (14%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A + HTG++VA+KK+ D+ + + + EV ++R H ++V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM-DLRKQQRREL-LFNEVVIMRDYHHENVVDMYNS 87
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L +++VV E +E I + + E +LRAL Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL ++ ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + NE + + +
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY---------------------------FNEPPLQAMRRI 230
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC 328
R P P + V + L ++ +P R TA+E L P+ K+ PSC
Sbjct: 231 RDNLP-PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL----KLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 85/312 (27%), Positives = 132/312 (42%), Gaps = 60/312 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRH 81
Y+ LE+IG+G+YG V TG VA+K I+ + +SD I REV LL LR
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSD---IQREVALLSQLRQ 58
Query: 82 PDIVEIKR----IMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
I + + P ++++ E E + ++KA + ++ + ++L
Sbjct: 59 SQPPNITKYYGSYLKGPR------LWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVL 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
ALKY+H V HRD+K NIL +K+CDFG VA + + +V T ++
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTPYWM 168
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ Y DIWS+G E+ TG P + + LI
Sbjct: 169 APEVITE-GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP------------ 215
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF----DPKDRPTAEEALA 312
+ KPP + D +LL+ +A +PK+R +AEE L
Sbjct: 216 --------------KSKPP-----RLE--DNGYSKLLREFVAACLDEEPKERLSAEELLK 254
Query: 313 DPYFKGLAKIER 324
+ K +K
Sbjct: 255 SKWIKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-23
Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 51/295 (17%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
V+GKG+YG+V AA D T ++AIK+I + + E+ L L+H +IV +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIV---Q 69
Query: 90 IMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQ---FFLYQMLRALKYM 142
+ S+ F I+ ME L ++++ +++ Q F+ Q+L LKY+
Sbjct: 70 YLGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL 124
Query: 143 HTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H + HRD+K N+L N + +K+ DFG ++ P T +T T Y APE+
Sbjct: 125 HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVI 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y DIWS+GC E+ TGKP F + LG P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPF------IE-------LGEP----------- 217
Query: 262 KARKYLTEMRKK-PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+A + M K P +P ++ A + R DP R +A + L DP+
Sbjct: 218 QAAMFKVGMFKIHPEIP-----ESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 85/296 (28%), Positives = 129/296 (43%), Gaps = 44/296 (14%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIV 85
L +G G+ GVV + TG+ +A+K I I++AI+ ILRE+ +L P IV
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIR---LEINEAIQKQILRELDILHKCNSPYIV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHH-QFFLYQMLRALKYMH 143
DI + E M+ L +++K E +L+ L Y+H
Sbjct: 63 GFYGAFY----NN-GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 144 TA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ HRD+KP NIL N+ ++K+CDFG++ + T +V T Y APE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-----FVGTSSYMAPERIQ 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ Y+ DIWS+G E+ TG+ FP D I +LL +V NE
Sbjct: 173 G--NDYSVKSDIWSLGLSLIELATGR--FPYPPENDPPDGIFELLQ-------YIV-NEP 220
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ + FQ F N L + DP++RP+ +E L P+ K
Sbjct: 221 PPRLPSGKFSPD----FQDFVN------LCLIK----DPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-23
Identities = 85/304 (27%), Positives = 130/304 (42%), Gaps = 62/304 (20%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH---------DVFEHISDAIRILREVKLLRLLR 80
+IG GS+G V ++ +GE +A+K++ D + DA+ RE+ LL+ L+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA--REIALLKELQ 64
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
H +IV+ L YV + + L+ + L R F+ Q+L+ L
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQILKGLN 120
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+H + HRD+K NIL + +K+ DFG+++ +++ T T R P L
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST-------KTNGAR-PSL 172
Query: 201 CGSFF---------SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
GS F + YT DIWS+GC+ E+LTGK FP QL I + S
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFKIGENAS 229
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
PE P N+ A+ L++ D RPTA E L
Sbjct: 230 PE--------------------IP-------SNISSEAIDFLEKTFEIDHNKRPTAAELL 262
Query: 312 ADPY 315
P+
Sbjct: 263 KHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-23
Identities = 78/286 (27%), Positives = 124/286 (43%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A +G+ VA+KK+ D+ + + + EV ++R +H ++VE+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRREL-LFNEVVIMRDYQHENVVEMYNS 85
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L +++VV E +E I + + E +L+AL +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL + ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + NE K + +
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY---------------------------FNEPPLKAMKMI 228
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
R P P + V P L RL+ DP R TA E L P+
Sbjct: 229 RDNLP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-23
Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 55/300 (18%)
Query: 24 RYKILEVIGKGSYGVV--CAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLL 79
+Y+ + V+G+G++G+V C + V IK+I E ++ R E ++L+LL
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQ--KLVIIKQIP--VEQMTKDERLAAQNECQVLKLL 56
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI--KANDDLTREHHQFFLYQML 136
HP+I+E L E K + +V E L + I + N L + F Q+L
Sbjct: 57 SHPNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 137 RALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPM-TVFWTDYVATRW 194
AL ++HT + HRDLK +NIL + + +K+ DFG++++ S + TV V T
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-----VGTPC 166
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y +PELC Y DIW++GC+ E+ + K F ++ + I GT +P
Sbjct: 167 YISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--GTFAP-- 220
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ +Y ++R +L+ ++ DP RP + +A P
Sbjct: 221 -------ISDRYSPDLR-------------------QLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-22
Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 43/293 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++IL IGKGS+GVV + A+K+I + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALKY 141
+ L K + +V E E+ DLH+++K L + F Q+L L +
Sbjct: 62 IRYYESFLDKGK-----LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ + HRD+K N+ +A +K+ D G+A++ + T F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y D+W++G + E TGK F + A++
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQG------------------ALILKI 213
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ PPV Q + +L+ + + D + RP + L +P
Sbjct: 214 IRGVF-------PPVS--QMY---SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-22
Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y +L V+G+GS+G ++ +K A+K+I + + S +E LL ++HP+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALK 140
IV K S +Y+V E + DL Q IK + + QM ++
Sbjct: 60 IVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
++H V HRD+K KNI N K+K+ DFG AR+ S P + YV T +Y PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPPEI 171
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
+ Y DIWS+GCI E+ T K F S
Sbjct: 172 WENM--PYNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-22
Identities = 69/296 (23%), Positives = 120/296 (40%), Gaps = 55/296 (18%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDI 84
+ +G+G++G V K VA+K + + + + + L+E ++++ L HP++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKE--DASEEERKDFLKEARVMKKLGHPNV 58
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN---------DDLTREHHQFFLYQ 134
V + + +Y+V E ME DL ++ + L+ + F Q
Sbjct: 59 VRLLGVCTEEEP-----LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ + ++Y+ + HRDL +N L + +K+ DFGL+R + D + RW
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 195 YRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
APE S +T D+WS G + E+ T L TP P
Sbjct: 174 M-APE---SLKDGIFTSKSDVWSFGVLLWEIFT-------------------LGATPYPG 210
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ NE+ +YL + + P P L+ DP+DRPT E
Sbjct: 211 ----LSNEEVLEYLRK-GYRLPKP-----EYCPDELYELMLSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-22
Identities = 80/303 (26%), Positives = 129/303 (42%), Gaps = 61/303 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRH 81
+K+L+ +GKGSYG V + A+K++ +S R + E+++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTR-----EHHQFFLYQM 135
P+I+ K L +K + +V E DL + I + E + F+ Q+
Sbjct: 59 PNIISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR L+ +H + HRDLK NIL AN +K+ D G+++V + T + T Y
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-----IGTPHY 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ Y+ DIWS+GC+ E+ T P F +S
Sbjct: 168 MAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------------------- 205
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF----DPKDRPTAEEAL 311
+ ++R K K+P + P+ + LQ I PK RP ++ L
Sbjct: 206 -----------MQDLRYK---VQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
Query: 312 ADP 314
A P
Sbjct: 252 ASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 84/318 (26%), Positives = 127/318 (39%), Gaps = 85/318 (26%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLL 79
Y++++ IG G+YG V A D TGE VAIK I D FE I I +L+E
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC------ 57
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQM 135
RHP+IV R K +++V E D++QV L+ + +
Sbjct: 58 RHPNIVA----YFGSYLRRDK-LWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRET 110
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA---------RVAFSDTPMTVFW 186
L+ L Y+H HRD+K NIL + +K+ DFG++ R +F TP +W
Sbjct: 111 LKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP---YW 167
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
APE Y DIW++G E+ +P P +H +
Sbjct: 168 M---------APEVAAVERKGGYDGKCDIWALGITAIELAELQP--P-MFDLHPM----- 210
Query: 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPV--------PLFQKFPNVDPLALRLLQRLI 297
+A +++ PP P+F F +++ +
Sbjct: 211 ----------------RALFLISKSNFPPPKLKDKEKWSPVFHDF----------IKKCL 244
Query: 298 AFDPKDRPTAEEALADPY 315
DPK RPTA + L P+
Sbjct: 245 TKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-22
Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 15/223 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+I++ IG+GS+G + A E IK+I + + +EV LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLY--QMLRALK 140
IV S +E +++V E + DL + I + Q + Q+ LK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 141 YMHTANVYHRDLKPKNILANANCKL-KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
++H + HRD+K +NI + N + K+ DFG+AR +D+ V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDS--MELAYTCVGTPYYLSPE 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
+C + Y DIWS+GC+ E+ T K F G + +HQL L
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 8e-22
Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 29/216 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVF-----EHISDAIRILREVKLLR 77
++ ++ +G GS+G V +G+ A+K + EH+ + RIL+ +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI---- 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML 136
RHP +V L S ++ ++Y+V E + +L ++ + +F+ Q++
Sbjct: 59 --RHPFLVN-----LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL+Y+H+ ++ +RDLKP+N+L +++ +K+ DFG A+ T +T T Y
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-----YT-LCGTPEYL 165
Query: 197 APELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLF 231
APE+ SK Y A+D W++G + E+L G P F
Sbjct: 166 APEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 9e-22
Identities = 70/227 (30%), Positives = 104/227 (45%), Gaps = 46/227 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRI--LREVKL 75
D + I +VIG G +G VC G+K VAIK + SD R+ L E +
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASI 58
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF---- 131
+ HP+I+ ++ ++ +K + + ++ E ME+ + D RE+ F
Sbjct: 59 MGQFDHPNIIRLEGVV---TKS--RPVMIITEYMENG------SLDKFLRENDGKFTVGQ 107
Query: 132 LYQMLR----ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV--AFSDTPMT-- 183
L MLR +KY+ N HRDL +NIL N+N KV DFGL+R T T
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167
Query: 184 ----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ WT APE + K+T A D+WS G + EV++
Sbjct: 168 GKIPIRWT---------APEAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 75/301 (24%), Positives = 131/301 (43%), Gaps = 50/301 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR----ILREVKLLRLLRHPDI 84
+ +G G++ A D TG +A+K++ V S+ + +E++L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 85 VEIKRIMLPPSKREFKDIYVVFELM-----ESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ R++ + +++V E M L + + + + Q+LR L
Sbjct: 66 I---RMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRGL 116
Query: 140 KYMHTANVYHRDLKPKNILANANCK-LKVCDFGLA-RVAFSDTPMTVFWTDYVATRWYRA 197
Y+H + HRD+K N+L ++ + L++ DFG A R+A T F + T + A
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE L G +Y + D+WS+GC+ E+ T KP + + + L LI + +
Sbjct: 177 PEVLRG---EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA---- 229
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
P +P P + + LR L+ P+DRP + E L P F
Sbjct: 230 -----------------PSIPEHLS-PGLRDVTLRCLEL----QPEDRPPSRELLKHPVF 267
Query: 317 K 317
+
Sbjct: 268 R 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 79/304 (25%), Positives = 134/304 (44%), Gaps = 48/304 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRH 81
++IL +G+G YG V A TGE VA+K++ + +R +L E +L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLR 137
+V++ F+D ++ ME D ++ L+ +H +F++ +M
Sbjct: 61 EWLVKLLY--------AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
A+ +H HRDLKP+N L +A+ +K+ DFGL++ + V DY+ A
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------A 166
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ Y +D WS+GC+ E L G P F G + ET
Sbjct: 167 PEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---------------NETWEN 209
Query: 258 VRNEKARKYLTEMRKKPPVPLF-QKFPNVDPLALRLLQRLIAFDPKDR-PTAEEALADPY 315
++ K E ++ P++ N+ A L+ +LI DP R + E+ P+
Sbjct: 210 LKYWK------ETLQR---PVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPF 259
Query: 316 FKGL 319
FK +
Sbjct: 260 FKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 9e-21
Identities = 93/296 (31%), Positives = 130/296 (43%), Gaps = 56/296 (18%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---SDAIRILREVKLLRLLRHPDIVEI 87
IGKGS+G V T A+K I HI S+ L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 88 KRIMLPPSKREFKDIYVVFELM---ESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
K P K +Y+V + E H + DL+R +F+ ++L AL+ +H
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRA--RFYTAELLCALENLHK 111
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF 204
NV +RDLKP+NIL + + +CDFGL ++ D T + T Y APEL
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH 168
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
YT A+D W++G + E+LTG P F ++V NE R
Sbjct: 169 --GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------------------NEMYR 203
Query: 265 KYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR---PTAEEALADPYF 316
K L E PL +FP D A LL L++ DP R A+E P+F
Sbjct: 204 KILQE-------PL--RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y ++ IG+GS+G G++ IK+I+ + +EV +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALK 140
IV+ + S E ++Y+V + E DL++ I A + Q + Q+ ALK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
++H + HRD+K +NI + +K+ DFG+ARV S + + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA---RTCIGTPYYLSPEI 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
C + Y DIW++GC+ E+ T K F G + ++R
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEA--------------GNMKNLVLKIIRG 216
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
PPV ++ L +L +R +P+DRP+ L +
Sbjct: 217 S-----------YPPVSS-HYSYDLRNLVSQLFKR----NPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 48/297 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
Y + V+GKGSYG V G++ IKK++ + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRAL 139
+IV + + E +Y+V E DL+ +K +Q + Q+ AL
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+H ++ HRDLK +N+ +KV D G+ARV + M + + T +Y +PE
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPYYMSPE 172
Query: 200 LCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L F +K Y D+W++GC E+ T K F K +
Sbjct: 173 L---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---------------------- 207
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ Y K PP+P + P L+ +++ P+ RP+ + L PY
Sbjct: 208 ---NSLVYRIIEGKLPPMP-----KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-20
Identities = 69/250 (27%), Positives = 119/250 (47%), Gaps = 33/250 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEK-VAIKKIH--------DVFEHISDAIRILREVKL 75
Y +LE +G G++G V + G+ +A+K+I+ D E I+ EV +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 76 LR-LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQF--- 130
++ LRHP+IV + L E +Y+V +L+E + L + + L + +F
Sbjct: 62 IKEQLRHPNIVRYYKTFL-----ENDRLYIVMDLIEGAPLGEHFNS---LKEKKQRFTEE 113
Query: 131 ----FLYQMLRALKYMHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
QM+ AL+Y+H + HRDL P NI+ + K+ + DFGLA+ ++ +
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--- 170
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
T V T Y PE+ + Y D+W+ GCI ++ T +P F +++ I +
Sbjct: 171 -TSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
Query: 246 LLGTPSPETI 255
+ P PE +
Sbjct: 228 AVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 5e-20
Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 33/221 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR--ILREVKL 75
DA+ KI +VIG G +G VC+ G++ VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQ 134
+ HP+I+ ++ ++ + K + +V E ME+ + D R+H QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSKPVMIVTEYMENG------SLDAFLRKHDGQFTVIQ 107
Query: 135 ---MLRA----LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
MLR +KY+ HRDL +NIL N+N KV DFGL+RV D P + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 188 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW APE + K+T A D+WS G + EV++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 90/330 (27%), Positives = 142/330 (43%), Gaps = 72/330 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ +++++VIG+G++G V D TG+ A+K + SD I+ ++ +R R
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK-----SDMIK-RNQIAHVRAER-- 52
Query: 83 DI-VEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
DI + + F+D +Y+V E M DL ++ D E +F++ +++
Sbjct: 53 DILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----------------RVAFSDTP 181
AL +H HRD+KP NIL +A+ +K+ DFGL
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 182 MTVFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
+ V D+ V T Y APE L G + Y D WS+G I E+L G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECDWWSLGVILYEMLYGFPP 229
Query: 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290
F ++ ET + N K + L F P V P A+
Sbjct: 230 FYSDTLQ---------------ETYNKIINWK--ESLR----------FPPDPPVSPEAI 262
Query: 291 RLLQRLIAFDPKDR-PTAEEALADPYFKGL 319
L+ RL+ DP+DR + EE + P+FKG+
Sbjct: 263 DLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-20
Identities = 83/302 (27%), Positives = 141/302 (46%), Gaps = 49/302 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y E IG+G+ G V AID TG++VAIK+I+ + I+ E+ +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IV L +++VV E + + + + L+AL+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
V HRD+K N+L + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---SPETIAVVR 259
Y P +DIWS+G + E++ G+P + ++ + L LI GTP +PE ++
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLS--- 242
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
P+F+ F L R + D + R +A+E L P+ K L
Sbjct: 243 -----------------PIFRDF----------LNRCLEMDVEKRGSAKELLQHPFLK-L 274
Query: 320 AK 321
AK
Sbjct: 275 AK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 27/219 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVF-----EHISDAIRILREVKLLR 77
+ ++ +G G++G V D + A+K I +V +H+ + R+L+EV
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV---- 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
HP I+ L ++ + + +Y++ E + +L ++ + + F+ +++
Sbjct: 59 --SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL+Y+H+ + +RDLKP+NIL + +K+ DFG A+ T WT T Y
Sbjct: 112 CALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPEYL 165
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
APE+ S + A+D W++G + E+L G P F +
Sbjct: 166 APEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 2e-19
Identities = 83/302 (27%), Positives = 138/302 (45%), Gaps = 49/302 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y E IG+G+ G V AID TG++VAIK+++ + I+ E+ ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IV L +++VV E + + + + L+AL ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---SPETIAVVR 259
Y P +DIWS+G + E++ G+P + ++ + L LI GTP +PE ++ V
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPERLSAV- 244
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
F+ F L R + D R +A+E L P+ K L
Sbjct: 245 -------------------FRDF----------LNRCLEMDVDRRGSAKELLQHPFLK-L 274
Query: 320 AK 321
AK
Sbjct: 275 AK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-19
Identities = 88/310 (28%), Positives = 146/310 (47%), Gaps = 56/310 (18%)
Query: 20 GDANR-YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
GD + Y E IG+G+ G V AID TG++VAIK+++ + I+ E+ ++R
Sbjct: 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRE 72
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFE-LMESDLHQVIKANDDLTREHHQF--FLYQM 135
+HP+IV L +++VV E L L V+ + + Q +
Sbjct: 73 NKHPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCREC 124
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRW 194
L+AL+++H+ V HRD+K NIL + +K+ DFG A++ TP + V T +
Sbjct: 125 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPY 180
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---S 251
+ APE+ Y P +DIWS+G + E++ G+P + ++ + L LI GTP +
Sbjct: 181 WMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQN 237
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
PE ++ +F+ F L R + D + R +A+E L
Sbjct: 238 PEKLS--------------------AIFRDF----------LNRCLEMDVEKRGSAKELL 267
Query: 312 ADPYFKGLAK 321
P+ K +AK
Sbjct: 268 QHPFLK-IAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 3e-19
Identities = 66/239 (27%), Positives = 120/239 (50%), Gaps = 18/239 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y E IG+G+ G V A+D TG++VAI++++ + I+ E+ ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IV L +++VV E + + + + L+AL+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---SPETIAVV 258
Y P +DIWS+G + E++ G+P + ++ + L LI GTP +PE ++ +
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAI 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 72/230 (31%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI----HDVFEHISDAIRI 69
+ F++ + L IG GS+G V A D T E VAIKK+ E D I
Sbjct: 6 ELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD---I 62
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME------SDLHQVIKANDDL 123
++EV+ L+ LRHP+ +E K L RE + + +ME SD+ +V K L
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYL----RE----HTAWLVMEYCLGSASDILEVHK--KPL 112
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
+ L+ L Y+H+ HRD+K NIL +K+ DFG A + +P
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPAN 169
Query: 184 VFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGK-PLF 231
F V T ++ APE+ + +Y +D+WS+G E+ K PLF
Sbjct: 170 SF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-19
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+VIG G +G V I G K VAIK + + L E ++ H +I+
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNII 69
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRA----LK 140
++ ++ +FK ++ E ME+ L + ++ +D E + L MLR +K
Sbjct: 70 RLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMK 121
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD--YVATRWYRAP 198
Y+ N HRDL +NIL N+N + KV DFGL+RV D P + T + RW AP
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TAP 179
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
E + K+T A D+WS G + EV++
Sbjct: 180 EAIA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-19
Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 33/222 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR--ILREVKL 75
D + KI EVIG G +G VC G++ VAIK + + ++ R L E +
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQ 134
+ HP+I+ ++ ++ + + + ++ E ME+ L ++ ND QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSRPVMIITEFMENGALDSFLRQNDG------QFTVIQ 107
Query: 135 ---MLRA----LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV---AFSDTPMTV 184
MLR +KY+ N HRDL +NIL N+N KV DFGL+R SD T
Sbjct: 108 LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 167
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW APE + K+T A D+WS G + EV++
Sbjct: 168 SLGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-19
Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 38/229 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKL 75
D + L+ +G G +GVV H G+ VAIK I + D I E K+
Sbjct: 2 DPSELTFLKELGSGQFGVV------HLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKV 52
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ L HP++V++ + + + I++V E M + + + RE +
Sbjct: 53 MMKLSHPNLVQLYGVCT-----KQRPIFIVTEYMA---NGCLL---NYLRERKGKLGTEW 101
Query: 136 L--------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
L A++Y+ + HRDL +N L + +KV DFGLAR D + T
Sbjct: 102 LLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
+ +W PE+ +S+++ D+WS G + EV + GK + S
Sbjct: 162 KF-PVKW-APPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 9e-19
Identities = 86/307 (28%), Positives = 142/307 (46%), Gaps = 40/307 (13%)
Query: 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 67
K+ + D F + + L IG GS+G V A ++HT E VA+KK+ + ++
Sbjct: 6 KDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKW 65
Query: 68 R-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME------SDLHQVIKAN 120
+ I++EVK L+ L+HP+ +E K L K+ + + +ME SDL +V K
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYL-------KE-HTAWLVMEYCLGSASDLLEVHK-- 115
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L + L+ L Y+H+ N+ HRD+K NIL ++K+ DFG A + +
Sbjct: 116 KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---S 172
Query: 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKP-LFPGKSVVH 238
P F V T ++ APE+ + +Y +D+WS+G E+ KP LF
Sbjct: 173 PANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------- 221
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298
++ ++ L ++ + NE T+ + QK P P + LL+
Sbjct: 222 NMNAMSALYHIAQNDSPTLQSNE-----WTDSFRGFVDYCLQKIPQERPASAELLRH--D 274
Query: 299 FDPKDRP 305
F +DRP
Sbjct: 275 FVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-18
Identities = 80/306 (26%), Positives = 124/306 (40%), Gaps = 67/306 (21%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
L+ I KG++G V A TG+ AIK + SD I +V ++ R
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKK-----SDMIA-KNQVTNVKAER------- 47
Query: 88 KRIMLPPSKREF----------KD-IYVVFE-LMESDLHQVIKANDDLTREHHQFFLYQM 135
IM+ + + KD +Y+V E L D +IK L + + ++ ++
Sbjct: 48 -AIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV 106
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ ++ +H + HRD+KP+N+L + LK+ DFGL+R + +V T Y
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDY 159
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE + G D WS+GC+ E L G P F TP
Sbjct: 160 LAPETILG---VGDDKMSDWWSLGCVIFEFLFGYPPFHA--------------ETPD--- 199
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEAL 311
AV N +R+ P A+ L+ RL+ DP R A +E
Sbjct: 200 -AVFDNILSRRINWPEE---------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249
Query: 312 ADPYFK 317
+ P+FK
Sbjct: 250 SHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 75/306 (24%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
L +G+G+ G V +TG A+K I + +ILRE+++ + + P IV+
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKY 64
Query: 88 KRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQ-MLRALKYM 142
L S I + E E +++ +K E + + +L+ L Y+
Sbjct: 65 YGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LC 201
H+ + HRD+KP NIL ++K+CDFG++ + T + T +Y APE +
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-----FTGTSFYMAPERIQ 176
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
G Y+ D+WS+G EV + FP + G P I ++
Sbjct: 177 GK---PYSITSDVWSLGLTLLEVAQNRFPFPPE-------------GEPPLGPIELL--- 217
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF----DPKDRPTAEEALADPYFK 317
Y+ M P P + P + I DP RPT + L P+ K
Sbjct: 218 ---SYIVNM----PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
Query: 318 GLAKIE 323
K +
Sbjct: 271 AQMKKK 276
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 88/328 (26%), Positives = 143/328 (43%), Gaps = 53/328 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
R+KIL ++G+G++G V A D E A+K + +V ++ DA +I E++ + +R D
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDA-KI--EIQFMEKVRQAD 186
Query: 84 IVEIKRIMLPPSKREFKD----IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ R L +R F++ + +V L I + + H ++Q AL
Sbjct: 187 PAD--RFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244
Query: 140 KYMHTA-NVYHRDLKPKNILANAN----------------CKLKVCDFGLARVAFSDTPM 182
Y HT ++ H DLKP+NIL + C++++CD G D
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG----GCCDERH 300
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
+ T V+TR YR+PE+ Y+ D+WS+GCI E+ TGK L+ + L L
Sbjct: 301 SR--TAIVSTRHYRSPEVVLGLGWMYS--TDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356
Query: 243 ITDLLGTPSPETIAVVRNEKAR---------------KYLTEMRKKPPVPLFQKFPNVDP 287
+ LG E E+AR K+L + + PV + D
Sbjct: 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR----DD 412
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPY 315
L L+ L+ +D + R A + PY
Sbjct: 413 LLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-18
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 26/222 (11%)
Query: 31 IGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G G +GVV H G+ KVAIK I++ D I E K++ L HP +V
Sbjct: 12 LGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
++ + + K +Y+V E ME+ L+ + + L+++ + ++Y+
Sbjct: 63 QLYGVCT-----QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ HRDL +N L ++ +KV DFG+ R D + + +W PE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN- 174
Query: 204 FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
FSKY+ D+WS G + EV T GK F KS +++I+
Sbjct: 175 -FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 8e-18
Identities = 76/305 (24%), Positives = 122/305 (40%), Gaps = 59/305 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-------DAIRILREVKLL 76
RY + + +GKGS+G V D + +K V + I + ++ +E +LL
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLK----VLKEIPVGELNPNETVQANQEAQLL 56
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-----DLHQVIKANDDLTREHHQFF 131
L HP IV+ L E ++ E E L ++ L+ +
Sbjct: 57 SKLDHPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
Q+L + YMH + HRDLK KNI N LK+ DFG++R+ + T +
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFTG 167
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T +Y +PE Y DIWS+GCI E+ F G++ L ++ ++ P+
Sbjct: 168 TPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT 222
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAEEA 310
P P L ++Q ++ DP RP+A E
Sbjct: 223 PS----------------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEI 254
Query: 311 LADPY 315
L +P+
Sbjct: 255 LRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 8e-18
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI----HDVFEHISDAIRILREVKLLRLLRHPDI 84
EV+GKG+YG V + T+ G+ +A+K++ +V + ++ EV LL+ L+H +I
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V+ L + I + E + + ++ L + Q+L + Y+H
Sbjct: 65 VQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLAR--------VAFSDTPMTVFWTDYVATRWY 195
V HRD+K N++ N +K+ DFG AR S+ ++ T Y +
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY-----W 174
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
APE+ S Y DIWSIGC E+ TGKP
Sbjct: 175 MAPEVINE--SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 66/200 (33%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 47 TGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105
TG +VAIK + D E R RE L L HP+IV +L + ++ V
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVA----LLDSGEAPPGLLFAV 57
Query: 106 FELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANA 161
FE + L +V+ A+ L + Q+L AL H + HRDLKP+NI+
Sbjct: 58 FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 162 NCKLKVCDFGLAR----VAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWS 216
KV DFG+ V +D T+ + T Y APE L G TP D+++
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSDLYA 174
Query: 217 IGCIFAEVLTGKPLFPGKSV 236
G IF E LTG+ + G SV
Sbjct: 175 WGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
++I + IG+G + V A + VA+KK+ +FE + R ++E+ LL+ L HP
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTREHHQF-FLYQMLR 137
++++ + E ++ +V EL ++ DL Q+I K L E + + Q+
Sbjct: 63 NVIKYLDSFI-----EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
A+++MH+ V HRD+KP N+ A +K+ D GL R S T V T +Y +
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYYMS 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEV 224
PE + Y DIWS+GC+ E+
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRH 81
+++ +++G+G++G V D TG ++A+K++ + E + + E++LL+ L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
IV+ + P +R + E M + +K+ LT + + Q+L +
Sbjct: 64 ERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLAR----VAFSDTPMTVFWTDYVATRWYR 196
Y+H+ + HRD+K NIL ++ +K+ DFG ++ + S T M T ++
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM----KSVTGTPYWM 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+PE+ Y DIWS+GC E+LT KP
Sbjct: 177 SPEVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 67/241 (27%), Positives = 114/241 (47%), Gaps = 18/241 (7%)
Query: 28 LEVIGKGSYG---VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
L+V+G+GS+G +V G+ A+K + + D +R E +L + HP I
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V++ K +Y++ + + DL + T E +F+L ++ AL ++H
Sbjct: 61 VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + +RDLKP+NIL + +K+ DFGL++ + + T Y APE+
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR 172
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL-LGTP---SPETIAVVR 259
+T + D WS G + E+LTG F GK + +I LG P SPE +++R
Sbjct: 173 --RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 230
Query: 260 N 260
Sbjct: 231 A 231
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 56/212 (26%), Positives = 109/212 (51%), Gaps = 15/212 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRH 81
+++ +++G+G++G V D TG ++A+K++ D E + + E++LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV+ + P +++ I+V + + + +KA LT + + Q+L+ + Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLAR----VAFSDTPMTVFWTDYVATRWYRA 197
+H+ + HRD+K NIL ++ +K+ DFG ++ + S T + T ++ +
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI----KSVTGTPYWMS 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
PE+ Y D+WS+ C E+LT KP
Sbjct: 178 PEVISG--EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 26 KILEVIGKGSYGVVCAA----IDTHTGEKVAIKKI-HD-VFEHISDAIRILREVKLLRLL 79
K ++ +G+G +G V + +TGE+VA+K + H +H SD RE+++LR L
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTL 63
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQM 135
H +IV+ K + P R + ++ E + S D Q + +L R F Q+
Sbjct: 64 DHENIVKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQINLKRL--LLFSSQI 118
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA-FSDTPMTVFWTDYVATRW 194
+ + Y+ + HRDL +NIL + +K+ DFGLA+V V W
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
Y APE C SK++ A D+WS G E+ T
Sbjct: 179 Y-APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 105/353 (29%), Positives = 161/353 (45%), Gaps = 69/353 (19%)
Query: 10 LKDKD----FFTEYGDANR-YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS 64
LKD + FF E D + + L IG GS+G V A D T E VAIKK+ + +
Sbjct: 9 LKDPEIAELFFKE--DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66
Query: 65 DAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM---ESDLHQVIKAN 120
+ + I++EVK L+ ++HP+ +E K L RE ++V E SDL +V K
Sbjct: 67 EKWQDIIKEVKFLQRIKHPNSIEYKGCYL----RE-HTAWLVMEYCLGSASDLLEVHK-- 119
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L + L+ L Y+H+ N+ HRD+K NIL ++K+ DFG A +A +
Sbjct: 120 KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---S 176
Query: 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVH 238
P F V T ++ APE+ + +Y +D+WS+G E+ K PLF
Sbjct: 177 PANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------- 225
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298
++ ++ L E+ + NE + F+ F VD LQ++
Sbjct: 226 NMNAMSALYHIAQNESPTLQSNEWS-------------DYFRNF--VD----SCLQKI-- 264
Query: 299 FDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
P+DRPT+EE L K + + P I ++ TKD +REL
Sbjct: 265 --PQDRPTSEELL-----KHMFVLRERPETVLIDLIQ-------RTKDAVREL 303
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-17
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 16 FTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILR 71
F + D ++ ++I+E IGKG+YG V ++ G K A+K IHD+ E I IL+
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK 69
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQ-VIKANDDLTRE 126
L HP++V+ + + +++V EL +DL + +K + +
Sbjct: 70 A-----LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
+ L++ L L+++H HRD+K NIL +K+ DFG V+ T +
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRR 181
Query: 187 TDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
V T ++ APE+ S Y D+WS+G E+ G P
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-17
Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 49/296 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRHPDIV 85
+++G+G++G V D TG ++A K++ + E + + E++LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+ + R K + + E M + +KA LT + + Q+L + Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFG----LARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+ HRD+K NIL ++ +K+ DFG L + S T + T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI----RSVTGTPYWMSPEV 180
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPETIAVVR 259
Y D+WS+GC E+LT KP + +++ + T P I+
Sbjct: 181 ISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHIS--- 235
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
E AR +L I + + RP+AEE L P+
Sbjct: 236 -EHARDFL---------------------------GCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIV 85
L +G G+ GVV + +G +A K IH E I AIR I+RE+K+L P IV
Sbjct: 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+I + E M+ L QV+K + +LR L Y+
Sbjct: 63 GFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 145 A-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
+ HRD+KP NIL N+ ++K+CDFG+ S + +V TR Y +PE L G
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPERLQG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
+ YT DIWS+G E+ G+ +P
Sbjct: 173 ---THYTVQSDIWSLGLSLVEMAIGR--YP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
++I + IG+G + V A G VA+KK+ +F+ + R ++E+ LL+ L HP
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTREHHQF-FLYQMLR 137
++++ + E ++ +V EL ++ DL ++I K L E + + Q+
Sbjct: 63 NVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
AL++MH+ V HRD+KP N+ A +K+ D GL R S T V T +Y +
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYYMS 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
PE + Y DIWS+GC+ E+ + F G
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 26 KILEVIGKGSYGVV--CA--AIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLR 80
K ++ +GKG++G V C + +TGE VA+KK+ H EH+ D RE+++L+ L+
Sbjct: 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQ 63
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFE-LMESDLHQVIKANDDLTREHHQFFLY--QMLR 137
H +IV+ K + +R + +V E L L ++ + + +H + LY Q+ +
Sbjct: 64 HDNIVKYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICK 119
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR---- 193
++Y+ + HRDL +NIL + ++K+ DFGL +V D +Y R
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-------KEYYKVREPGE 172
Query: 194 ----WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE SK++ A D+WS G + E+ T
Sbjct: 173 SPIFWY-APESLTE--SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 31/239 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLRHPD 83
+ + +G G +G V + +VAIK + D D +EV+ L+ LRH
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQD---FQKEVQALKRLRHKH 63
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALK 140
++ + + + +Y++ ELME L +++ + L Q+ +
Sbjct: 64 LISLFAVC-----SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARV------AFSDTPMTVFWTDYVATRW 194
Y+ N HRDL +NIL + KV DFGLAR+ SD + WT
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT------- 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252
APE ++ D+WS G + E+ T G+ +PG + D IT P P
Sbjct: 172 --APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
L IG GS+G V A D E VAIKK+ + ++ + I++EV+ L+ LRHP+ ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 87 IKRIMLPPSKREFKDIYVVFELME------SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
+ L RE + + +ME SDL +V K L + L+ L
Sbjct: 80 YRGCYL----RE----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLA 129
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+H+ N+ HRD+K NIL + +K+ DFG A + P F V T ++ APE+
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXF----VGTPYWMAPEV 182
Query: 201 CGSF-FSKYTPAIDIWSIGCIFAEVLTGKP 229
+ +Y +D+WS+G E+ KP
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-16
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKL 75
+ +++ IG G +G+V G KVAIK I + D I E ++
Sbjct: 2 HPSELTLVQEIGSGQFGLV------WLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQV 52
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKAND-DLTREHHQFFLY 133
+ L HP +V++ + E I +VFE ME L ++A ++E
Sbjct: 53 MMKLSHPKLVQLYGVCT-----ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL 107
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ + Y+ ++NV HRDL +N L N +KV DFG+ R D + T + +
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVK 166
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
W +PE+ FSKY+ D+WS G + EV +
Sbjct: 167 W-SSPEVFS--FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 83/312 (26%), Positives = 126/312 (40%), Gaps = 40/312 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+ ILE G+ G A ID T E V IK E +LR + HP I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKA--------GQRGGTATEAHILRAINHPSI 145
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+++K ++ ++DL+ + A ++ +LRA++Y+H
Sbjct: 146 IQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE 200
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF-WTDYVATRWYRAPELCGS 203
+ HRD+K +NI N + + DFG A + W +AT APEL
Sbjct: 201 NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT---NAPELLAR 257
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSV------VHQLDLITDLLGT-PSPETI 255
Y PA+DIWS G + E+ T LF + Q+ LI GT P+ I
Sbjct: 258 --DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315
Query: 256 ---AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAE--- 308
A + RK PL+ + P+ L L+ +++AFD RP+AE
Sbjct: 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL-PIDLEYLICKMLAFDAHHRPSAEALL 374
Query: 309 -----EALADPY 315
+ + DPY
Sbjct: 375 DFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 26 KILEVIGKGSYGVVCAAI-DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
K+ +G G +G V + T KVA+K + L+E ++++ LRH +
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTT--KVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKL 63
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKY 141
V++ + S+ E IY+V E M L +K+ + L Q+ + Y
Sbjct: 64 VQLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARV-------AFSDTPMTVFWTDYVATRW 194
+ + N HRDL +NIL N K+ DFGLAR+ A + WT
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT------- 171
Query: 195 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLDL 242
APE G F K D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 172 --APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-16
Identities = 77/311 (24%), Positives = 134/311 (43%), Gaps = 55/311 (17%)
Query: 25 YKILEVIGKGSYG---VVCAAIDTHTG--------EKVAIKKIHDVFEHISDAIRILREV 73
+++L+V+G G+YG +V TG +K A+ + EH +L V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
+ + P +V + +K YV M + L+Q D+ + + +F+
Sbjct: 62 R-----QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSG 112
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+++ AL+++H + +RD+K +NIL ++ + + DFGL++ S+ + + T
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE+ + A+D WS+G + E+LTG SP
Sbjct: 171 EYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGA----------------------SPF 207
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAE 308
T+ RN ++ ++ PP P + P A LL +L+ DPK R A
Sbjct: 208 TLEGERNTQSEVSRRILKCDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGAS 262
Query: 309 EALADPYFKGL 319
E P+FKGL
Sbjct: 263 EIKEHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILREVKLLRLLRH 81
++I+E IGKG+YG V + G A+K I DV E I IL+ L H
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS-----LPNH 78
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD-----LHQVIKANDDLTREHHQFFLYQML 136
P++V+ + K +++V EL + ++ L + LY L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L+++H + HRD+K NIL +K+ DFG V+ T + V T ++
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 195
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
APE+ + Y D+WS+G E+ G P
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
+++ E +G GS+G V A TGE AIK K ++ + + + +E +L L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK-MKQVQHVAQEKSILMELSHP 78
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV + ++ F +VV + + L + + +D+ + F+ +++ A +Y+
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK----FYHAELVLAFEYL 134
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+N+L + +KV DFG A+ D T+ T Y APE+
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTL-----CGTPEYLAPEVIQ 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
S + A+D W++G + E + G P F
Sbjct: 189 S--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 72/306 (23%), Positives = 136/306 (44%), Gaps = 44/306 (14%)
Query: 25 YKILEVIGKGSYGVV--CAAIDTH-TGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL 79
+++L+V+G G+YG V + H +G+ A+K K + + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 80 RH-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRA 138
R P +V + +K Y+ + + L Q + + Q + +++ A
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLA 117
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+++H + +RD+K +NIL ++N + + DFGL++ D + + T Y AP
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAP 175
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
++ + A+D WS+G + E+LTG SP T+
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGA----------------------SPFTVDGE 213
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AEEALAD 313
+N +A ++ +PP P + LA ++QRL+ DPK R P+ A+E
Sbjct: 214 KNSQAEISRRILKSEPPYP-----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 269 PFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 77/299 (25%), Positives = 137/299 (45%), Gaps = 46/299 (15%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKL-LRLLRHPDIV 85
++E +G+G+YGVV TG +A+K+I + R+L ++ + +R + P V
Sbjct: 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQKRLLMDLDISMRSVDCPYTV 63
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM----LRALKY 141
+ RE D+++ E+M++ L + K D + L ++ ++AL+Y
Sbjct: 64 TFYGALF----RE-GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 142 MHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+H+ +V HRD+KP N+L N N ++K+CDFG++ T+ + Y APE
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI----DAGCKPYMAPER 174
Query: 201 CGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
++ Y D+WS+G E+ TG+ FP S + ++ PSP
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPSP------ 226
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
++ + P FQ F N + L++ + K+RP E L P+F+
Sbjct: 227 ----------QLPAEKFSPEFQDFVN------KCLKK----NYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 82/285 (28%), Positives = 126/285 (44%), Gaps = 43/285 (15%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
LE IGKGS+G V ID T E VAIK I E D I I +E+ +L P I
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITR 66
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L +K ++++ E + + L + L ++L+ L Y+H+
Sbjct: 67 YYGSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRD+K N+L + +K+ DFG+A +DT + +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKR--NTFVGTPFWMAPEVIKQ--S 176
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266
Y DIWS+G E+ G+P S +H + ++ L+ SP T
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPN---SDLHPMRVLF-LIPKNSPPT------------ 220
Query: 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
L KP F++F ++ + DP+ RPTA+E L
Sbjct: 221 LEGQYSKP----FKEF----------VEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 28 LEVIGKGSYGVVCAAIDTH---TGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
L+V+GKG YG V TG+ A+K K + + D E +L ++HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFE-LMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV++ K +Y++ E L +L ++ + F+L ++ AL++
Sbjct: 61 FIVDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEH 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + +RDLKP+NIL +A +K+ DFGL + + + +T + T Y APE+
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT---HTFCGTIEYMAPEIL 172
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
S + A+D WS+G + ++LTG P F ++ +D I
Sbjct: 173 MR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHD-VFEHISDAIRILREVK-LLRLLRHPDIVE 86
+VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ S + + +Y V + + +L ++ +F+ ++ AL Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWYRAPELCGS 203
N+ +RDLKP+NIL ++ + + DFGL + +A SDT T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-----FCGTPEYLAPEVIRK 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
Y +D W +G + E+L G P F + V D I
Sbjct: 171 --QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 72/309 (23%), Positives = 132/309 (42%), Gaps = 52/309 (16%)
Query: 25 YKILEVIGKGSYG---VVCAAIDTHTGEKVAIKKIHDV--------FEHISDAIRILREV 73
+++L V+G G+YG +V G+ A+K + EH R R+V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT----RTERQV 57
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
L + R P +V + +K YV + + L+Q + T + ++
Sbjct: 58 -LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIA 112
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+++ AL ++H + +RD+K +NIL ++ + + DFGL++ ++ + + T
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE+ + A+D WS+G + E+LTG SP
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA----------------------SPF 208
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEA 310
T+ +N ++ ++ KPP P + A +Q+L+ DPK R A+E
Sbjct: 209 TVDGEQNSQSEISRRILKSKPPFP-----KTMSAEARDFIQKLLEKDPKKRLGANGADEI 263
Query: 311 LADPYFKGL 319
P+F+G+
Sbjct: 264 KNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 5e-15
Identities = 75/303 (24%), Positives = 122/303 (40%), Gaps = 53/303 (17%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ + +G G+ G V TG +A K +H + S +ILRE++++ R P IV
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH-IGAKSSVRKQILRELQIMHECRSPYIV 66
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
L + +I + E M+ L ++ K + E ++ L Y++
Sbjct: 67 SFYGAFLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 145 AN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + HRD+KP NIL N+ ++K+CDFG++ + T +V T Y +PE
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-----FVGTSTYMSPERIQG 176
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFP-------GKSVVHQ---LDLITDLLGTPSPE 253
KYT D+WS+G E+ GK FP LDL+ ++ P P
Sbjct: 177 --GKYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP- 231
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ P FP + + DP +RPT ++ A
Sbjct: 232 ------------------RLPS----SDFP---EDLRDFVDACLLKDPTERPTPQQLCAM 266
Query: 314 PYF 316
P F
Sbjct: 267 PPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLR---LLRHPDIVE 86
IGKG++G V T A+K + + + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+K S D+Y+V + M +L ++ + + +F++ +++ AL+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
++ +RDLKP+NIL +A + +CDFGL++ +D T + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 206 SKYTPAIDIWSIGCIFAEVLTG 227
YT +D WS+G + E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 35/214 (16%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIVEIK 88
IG G+ G V I TG A+K I+ E D +R I RE+++LR + HP++V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHE---DTVRRQICREIEILRDVNHPNVVKCH 138
Query: 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL----YQMLRALKYMHT 144
+ +I V+ E M+ + + T + FL Q+L + Y+H
Sbjct: 139 DMF-----DHNGEIQVLLEFMD-------GGSLEGTHIADEQFLADVARQILSGIAYLHR 186
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYVATRWYRAPE---- 199
++ HRD+KP N+L N+ +K+ DFG++R+ A + P V T Y +PE
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC----NSSVGTIAYMSPERINT 242
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
L + Y A DIWS+G E G+ FP
Sbjct: 243 DLNHGAYDGY--AGDIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 72/299 (24%), Positives = 119/299 (39%), Gaps = 61/299 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D ++L +G G +G V + +T VA+K + D L E ++++ LR
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKKLR 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQF--FLYQMLR 137
HP ++++ + + E IY+V ELM+ L + ++ + Q Q+
Sbjct: 60 HPKLIQLYAVC---TLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD-------TPMTVFWTDYV 190
+ Y+ N HRDL +N+L N KV DFGLARV D + WT
Sbjct: 115 GMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT--- 171
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGT 249
APE + +++++ D+WS G + E++T G+ +PG + L +
Sbjct: 172 ------APE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM 223
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
P P P L+ ++ DP DRPT E
Sbjct: 224 PCPPGC-------------------PKELYD-----------IMLDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 74/294 (25%), Positives = 118/294 (40%), Gaps = 61/294 (20%)
Query: 29 EVIGKGSYGVVCAAIDT-HTGEKVAIK-KIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
IG+G +G V + EK+A+ K S + L+E ++R HP IV+
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 87 -IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMH 143
I I P +++V EL +L ++ N L + YQ+ AL Y+
Sbjct: 72 LIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR------WYRA 197
+ HRD+ +N+L ++ +K+ DFGL+R D + Y A++ W A
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDE------SYYKASKGKLPIKWM-A 176
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITDLLGTPSPETI 255
PE F ++T A D+W G E+L KP G + + I
Sbjct: 177 PESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ----------------GVKNNDVI 218
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ N ++ P+P PN P L+ + A+DP RP E
Sbjct: 219 GRIENG----------ERLPMP-----PNCPPTLYSLMTKCWAYDPSKRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
LE IGKGS+G V ID T + VAIK I E D I I +E+ +L P + +
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L +K ++++ E + + L L ++L+ L Y+H+
Sbjct: 67 YYGSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRD+K N+L + + ++K+ DFG+A +DT + +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKR--NTFVGTPFWMAPEVIKQ--S 176
Query: 207 KYTPAIDIWSIGCIFAEVLTGKP 229
Y DIWS+G E+ G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 43/228 (18%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+ IGKG +G V + G+KVA+K + D + A L E ++ LRHP++V
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLV 63
Query: 86 EIKRIMLPPSKREFKDIYVVFELME---------SDLHQVIKANDDLTREHHQFFLYQML 136
++ ++L + +Y+V E M S VI T F +
Sbjct: 64 QLLGVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVI------TLAQQLGFALDVC 112
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---TPMTVFWTDYVATR 193
++Y+ N HRDL +N+L + + KV DFGLA+ A + V WT
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT------ 166
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKSVV 237
APE K++ D+WS G + E+ + G+ P P K VV
Sbjct: 167 ---APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 48/232 (20%)
Query: 27 ILEVIGKGSYGVV-----CAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
+ +G+G++G V + E VA+K + + +DA + RE +LL +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQ 66
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND--------------DLTR 125
H +IV+ + E +VFE ME DL++ ++++ +LT
Sbjct: 67 HENIVKFYGVCT-----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
Q+ + Y+ + + HRDL +N L + +K+ DFG++R V+
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVY 173
Query: 186 WTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
TDY + RW PE + K+T D+WS G + E+ T GK
Sbjct: 174 TTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 84/273 (30%), Positives = 124/273 (45%), Gaps = 43/273 (15%)
Query: 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
ELKD DF +I E +G G+ GVV +G +A K IH I AIR
Sbjct: 1 ELKDDDF---------ERISE-LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIR 47
Query: 69 --ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTR 125
I+RE+++L P IV +I + E M+ L QV+K +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPE 102
Query: 126 EHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
E +LR L Y+ + + HRD+KP NIL N+ ++K+CDFG+ S +
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDS 157
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDL 242
+V TR Y +PE L G+ +S + DIWS+G E+ G+ P+ P + +L+
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQS---DIWSMGLSLVELAIGRYPIPPPDA--KELEA 212
Query: 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPP 275
I G P VV E+ + R +PP
Sbjct: 213 I---FGRP------VVDGEEGEPHSISPRPRPP 236
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 42/221 (19%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
E+IG+G +G V +TG+KVA+K I DV A L E ++ L H ++V +
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRL 64
Query: 88 KRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLR-------AL 139
++L +Y+V ELM + +L ++ TR + Q+L+ +
Sbjct: 65 LGVIL------HNGLYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQFSLDVAEGM 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV---AFSDTPMTVFWTDYVATRWYR 196
+Y+ + + HRDL +NIL + + KV DFGLARV ++ + V WT
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT--------- 164
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236
APE K++ D+WS G + EV + G+ +P S+
Sbjct: 165 APEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 75/307 (24%), Positives = 126/307 (41%), Gaps = 60/307 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL--- 79
++ L V+G+G +G V A TGE AIK K D+ D + L K +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR--DEVESLMCEKRIFETANS 58
Query: 80 -RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
RHP +V + + V E DL I D + F+ ++
Sbjct: 59 ERHPFLVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVL 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWY 195
L+Y+H + +RDLK N+L + +K+ DFGL + + F D T + T +
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-----FCGTPEF 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ + YT A+D W +G + E+L G+ FPG D
Sbjct: 168 LAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD-------------- 211
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEA 310
++V +E + +F + + A+ +++RL+ +P+ R AE+
Sbjct: 212 SIVNDE---------------VRYPRFLSRE--AISIMRRLLRRNPERRLGSGEKDAEDV 254
Query: 311 LADPYFK 317
P+F+
Sbjct: 255 KKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 33/279 (11%)
Query: 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
ELKD DF KI E +G G+ GVV +G +A K IH I AIR
Sbjct: 1 ELKDDDF---------EKISE-LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIR 47
Query: 69 --ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTR 125
I+RE+++L P IV +I + E M+ L QV+K +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPE 102
Query: 126 EHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
+ +++ L Y+ + + HRD+KP NIL N+ ++K+CDFG+ S +
Sbjct: 103 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDS 157
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDL 242
+V TR Y +PE L G+ +S + DIWS+G E+ G+ P+ P + +L
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQS---DIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214
Query: 243 ITDLLGTPSPETIAVVRNEKARKYLTE-MRKKPPVPLFQ 280
+ G P+ + R + +PP+ +F+
Sbjct: 215 GCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFE 253
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK--------LLRLLRH 81
VIGKGS+G V A G+ A+K + AI +E K LL+ ++H
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQ------KKAILKKKEQKHIMAERNVLLKNVKH 55
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM---ESDLHQVIKANDDLTREHH------QFFL 132
P +V + K +Y V + + E H L RE +F+
Sbjct: 56 PFLVGLHYSFQTADK-----LYFVLDYVNGGELFFH--------LQRERSFPEPRARFYA 102
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYV 190
++ AL Y+H+ N+ +RDLKP+NIL ++ + + DFGL + + S T T +
Sbjct: 103 AEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FC 157
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
T Y APE+ Y +D W +G + E+L G P F + D I
Sbjct: 158 GTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 16/234 (6%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHD---VFEHISDAIRILREVKLLRLLRHPDIV 85
+VIGKGS+G V A G A+K + + + + I R V LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+ K +Y V + + +L ++ +F+ ++ A+ Y+H+
Sbjct: 60 GLHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS 114
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF 204
N+ +RDLKP+NIL ++ + + DFGL + T + + T Y APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK- 170
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD-LITDLLGTPSPETIAV 257
Y +D W +G + E+L G P F + V D ++ L P +T+A
Sbjct: 171 -EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAA 223
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 57/291 (19%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
E IGKG++G V + +VA+K + + + L+E ++L+ HP+IV+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVK 56
Query: 87 IKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLR----ALK 140
+ + + + + IY+V EL+ S L + K + LT + L QM ++
Sbjct: 57 LIGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK----LLQMSLDAAAGME 107
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ + N HRDL +N L N LK+ DFG++R + +W APE
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEA 166
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ +YT D+WS G + E + G +PG S
Sbjct: 167 LN--YGRYTSESDVWSYGILLWETFSLGDTPYPGMS------------------------ 200
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
N++ R+ + + P P + P + RL+ + A+DP++RP+ E
Sbjct: 201 NQQTRERIESGYRMPA-------PQLCPEEIYRLMLQCWAYDPENRPSFSE 244
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 78/313 (24%), Positives = 122/313 (38%), Gaps = 41/313 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y +++ + GS G V A + V +K I L E LL+ + HP +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK--------IGQKGTTLIEAMLLQNVNHPSV 119
Query: 85 VEIKRIMLPPSKREFKDIY-VVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALKYM 142
+ +K ++ I +V SDL+ + L + Q+L L+Y+
Sbjct: 120 IRMKDTLV------SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRD+K +NI N ++ + D G A+ P + V T APE+
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVET---NAPEVLA 229
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-------GKPLFPGKSVV----HQLDLITDLLGTP- 250
KY DIWS G + E+L P P + V H L +I+ L P
Sbjct: 230 R--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287
Query: 251 ----SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
P + + E + P FQ+ N+ L+ +++ FD RP+
Sbjct: 288 EFPRDPGS--RLVRGFIEYASLERQPYTRYPCFQRV-NLPIDGEFLVHKMLTFDAAMRPS 344
Query: 307 AEEALADPYFKGL 319
AEE L P F L
Sbjct: 345 AEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 81/312 (25%), Positives = 140/312 (44%), Gaps = 59/312 (18%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLRLLRHPD 83
++I++VIG+G++G V A + E++ KI + +E + A RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVI-KANDDLTREHHQFFLYQMLRA 138
I + F+D ++ +M+ DL ++ K D L + +F++ +M+ A
Sbjct: 60 CQWITTL-----HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ +H + HRD+KP N+L + N +++ DFG D TV + V T Y +P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYISP 172
Query: 199 ELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
E+ + KY P D WS+G E+L G+ F +S+V ET
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------ETY 217
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFP----NVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+ N + R FQ FP +V A L+QRLI ++R + +
Sbjct: 218 GKIMNHEER--------------FQ-FPSHITDVSEEAKDLIQRLIC--SRERRLGQNGI 260
Query: 312 AD----PYFKGL 319
D +F+G+
Sbjct: 261 EDFKKHAFFEGI 272
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 12/228 (5%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--SDAIRILREVKLLRLL 79
A Y +++VIG+G++G V + + +KV K+ FE I SD+ E ++
Sbjct: 42 AEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
P +V+ L + ++ K +Y+V E M + +N D+ + +F+ +++ AL
Sbjct: 101 NSPWVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H+ + HRD+KP N+L + + LK+ DFG + +T M V V T Y +PE
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGM-VRCDTAVGTPDYISPE 213
Query: 200 LCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
+ S Y D WS+G E+L G F S+V I D
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-14
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
LE IGKGS+G V ID T + VAIK I E D I I +E+ +L P + +
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L +K ++++ E + + L ++L+ L Y+H+
Sbjct: 67 YYGSYLKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRD+K N+L + +K+ DFG+A +DT + +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKR--NTFVGTPFWMAPEVIQQ--S 176
Query: 207 KYTPAIDIWSIGCIFAEVLTGKP 229
Y DIWS+G E+ G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 9e-14
Identities = 73/315 (23%), Positives = 124/315 (39%), Gaps = 61/315 (19%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
+L+ +GKG+YG V + TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVD 63
Query: 87 IKRIMLPPSKREFKDIYVVFELMES---------DLHQVIKANDDLTREHHQFFLYQMLR 137
+Y+ E M++ + D L R + + + L+
Sbjct: 64 FYGAFFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLK 116
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
LK H N+ HRD+KP N+L N N ++K+CDFG++ + T + + Y A
Sbjct: 117 FLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-----NIGCQSYMA 169
Query: 198 PE----LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK---SVVHQLDLITDLLGTP 250
PE + YT D+WS+G E+ G+ +P + ++ QL I D G P
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDP 227
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
P +P A + + + P RPT +
Sbjct: 228 -----------------------PTLP-----SGYSDDAQDFVAKCLNKIPNRRPTYAQL 259
Query: 311 LADPYFKGLAKIERE 325
L P+ + +
Sbjct: 260 LEHPWLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (177), Expect = 1e-13
Identities = 78/328 (23%), Positives = 135/328 (41%), Gaps = 84/328 (25%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
N Y++++ IG G +G V T E K I + +++ EV ++R L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 83 DIVE-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIK------------ANDDLTREHH 128
+IV I R + +++ +Y++ E ++ DL + I+ A D+TR
Sbjct: 73 NIVRYIDRFLNKANQK----LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR--- 125
Query: 129 QFFLYQMLRALKYMHT-------ANVYHRDLKPKNILANANCK----------------- 164
Q+L AL Y H V HRDLKP+NI + +
Sbjct: 126 -----QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
K+ DFGL++ + + V T +Y +PEL Y D+W++GCI E+
Sbjct: 181 AKIGDFGLSK----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284
+GK F + QL ++E+++ P +P+ K
Sbjct: 237 CSGKTPFHKANNFSQL--------------------------ISELKRGPDLPIKGKSKE 270
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALA 312
++ L++ L+ K+RP+A + L
Sbjct: 271 LN----ILIKNLLNLSAKERPSALQCLG 294
|
Length = 1021 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 72/306 (23%), Positives = 118/306 (38%), Gaps = 63/306 (20%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---------LREVKLLRLLRH 81
+GKG +G VCA TG+ A KK+ D R+ L E K+L +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL--------DKKRLKKRKGEQMALNEKKILEKVSS 52
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRA 138
IV + D+ +V LM DL I + F+ Q++
Sbjct: 53 RFIVSLAYAFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG 107
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + + +++ D GLA V T Y AP
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI---KGRAGTPGYMAP 163
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y ++D +++GC E++ G+ F +
Sbjct: 164 EVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQR------------------------ 197
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALAD 313
+ + ++ L + V KF P A L + L+ DP+ R +A+E
Sbjct: 198 KEKVEKEELKRRTLEMAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254
Query: 314 PYFKGL 319
P FK L
Sbjct: 255 PLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 51/301 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++I+ +G G++G V A TG A K I + E + D + E+ +L +HP+
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKHPN 63
Query: 84 IVEIKRIMLPPSKR----EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
IV + +K EF D + +M + LT ++ QML AL
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIML-------ELERGLTEPQIRYVCRQMLEAL 116
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAP 198
++H+ V HRDLK NIL + +K+ DFG+ A+ + F + T ++ AP
Sbjct: 117 NFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF----IGTPYWMAP 172
Query: 199 EL--CGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
E+ C +F Y DIWS+G E+ +P P ++ + ++ +L + P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEPPTL- 228
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
++ K+ + F F L+ + DP DRPTA E L P+
Sbjct: 229 -----DQPSKWSSS---------FNDF----------LKSCLVKDPDDRPTAAELLKHPF 264
Query: 316 F 316
Sbjct: 265 V 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 17/221 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++IL+VIG+G++G V A + +KV KI + +E + A E R R +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRA-----ETACFREERDV-L 55
Query: 85 VEIKRIMLPPSKREFKD---IYVVFEL-MESDLHQVI-KANDDLTREHHQFFLYQMLRAL 139
V + F+D +Y+V + + DL ++ K D L + +F+L +M+ A+
Sbjct: 56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H + HRD+KP NIL + N +++ DFG D TV + V T Y +PE
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPE 173
Query: 200 LCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
+ + KY P D WS+G E+L G+ F +S+V
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 70/254 (27%), Positives = 108/254 (42%), Gaps = 49/254 (19%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRL 78
D N + L IG G+ G V TG +A+K++ E RIL ++ ++ L
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK---RILMDLDVV-L 68
Query: 79 LRH--PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF----- 131
H P IV+ + S D+++ ELM + L D L +
Sbjct: 69 KSHDCPYIVKCYGYFITDS-----DVFICMELMSTCL-------DKLLKRIQGPIPEDIL 116
Query: 132 ---LYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
+++AL Y+ V HRD+KP NIL +A+ +K+CDFG++
Sbjct: 117 GKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLV 166
Query: 188 DYVA-TR-----WYRAPELCG--SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239
D A TR Y APE KY D+WS+G E+ TG+ FP K+ +
Sbjct: 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTE 224
Query: 240 LDLITDLLGTPSPE 253
+++T +L P
Sbjct: 225 FEVLTKILQEEPPS 238
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR-HPDIVE 86
+V+GKGS+G V A T E AIK + DV D + E ++L L HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP---- 56
Query: 87 IKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
L F+ +F +ME DL I+ + +F+ ++ AL ++
Sbjct: 57 ----FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H V +RDLK NIL +A K+ DFG+ + + T T + T Y APE+
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQ 169
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
+Y P++D W++G + E++ G+P F
Sbjct: 170 EL--EYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 86/324 (26%), Positives = 137/324 (42%), Gaps = 62/324 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
RY I+ +IGKG G V A D +VA+KKI D+ E+ R LRE K+ L HP
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ-----FFL---YQ 134
IV + I + Y+ ++S L V + + L++E + FL ++
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQK-ESLSKELAEKTSVGAFLSIFHK 121
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--------VAFSDTP----- 181
+ ++Y+H+ V HRDLKP NIL ++ + D+G A + D
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 182 ---MTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
MT+ V T Y APE L G S+ T DI+++G I ++LT FP
Sbjct: 182 YSSMTIP-GKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQMLTLS--FP----- 230
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297
R +K RK P+ + + + P ++ + +
Sbjct: 231 --------------------YRRKKGRKISYRDVILSPIEV-APYREIPPFLSQIAMKAL 269
Query: 298 AFDPKDRPTAEEALAD---PYFKG 318
A DP +R ++ + L P+ +G
Sbjct: 270 AVDPAERYSSVQELKQDLEPHLQG 293
|
Length = 932 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 62/250 (24%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFE-----HISDAIRILREVKLLRLLR 80
++VIG+G++G V TG A+KK+ ++ E H+ IL E
Sbjct: 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------ 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQML 136
+P +V++ F+D ++ +ME D+ ++ D T E +F++ + +
Sbjct: 60 NPWVVKLYY--------SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL----------------------AR 174
A+ +H HRD+KP N+L +A +K+ DFGL
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 175 VAFSDTPMT-------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
+ F PM+ V T Y APE+ + Y D WS+G I
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIM 229
Query: 222 AEVLTGKPLF 231
E+L G P F
Sbjct: 230 YEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 29 EVIGKGSYGVVCAA--IDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
VIGKG +G V ID+ + A+K ++ + + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMH 143
+ I LP E + V+ + DL I+ ++ ++ F L Q+ + ++Y+
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-QVAKGMEYLA 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ HRDL +N + + + +KV DFGLAR ++ +Y + + +L
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVK 167
Query: 204 FFS-------KYTPAIDIWSIGCIFAEVLT-GKPLFP 232
+ + K+T D+WS G + E++T G P +P
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-13
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 15/218 (6%)
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHH 128
L+E ++++ LRH +V++ ++ + IY+V E M + L +K
Sbjct: 49 LQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 102
Query: 129 QF--FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
Q Q+ + Y+ N HRDL+ NIL N KV DFGLAR+ D T
Sbjct: 103 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 161
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD 245
+W APE + + ++T D+WS G + E+ T G+ +PG LD +
Sbjct: 162 GAKFPIKW-TAPE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
Query: 246 LLGTPSP-ETIAVVRNEKARKYLTEMRKKPPVPLFQKF 282
P P E + + + + E ++P Q F
Sbjct: 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 256
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 79/342 (23%), Positives = 140/342 (40%), Gaps = 66/342 (19%)
Query: 24 RYKILEVIGKGSYG--VVCAAIDTHTGEKVAIKKIHDVFEHISD---------------A 66
+++++ + G++G +CA + T E A + ++ + A
Sbjct: 149 HFRVIDDLPAGAFGKIFICA-LRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAA 207
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLH-----QVIKAND 121
I++ E+ L L H +I++I+ I+ + + Y++ + + DL+ + D
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWKD 262
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
+ + + Q+L A++Y+H + HRD+K +NI N + K+ + DFG A + F +
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPF-EKE 320
Query: 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
F +V T +PE+ Y DIWS G I ++L+ H
Sbjct: 321 REAFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLS-----------HDFC 367
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP---------NVDPLALRL 292
I D G P + + ++ + E PP LF +V PL L
Sbjct: 368 PIGDGGGKPGKQLLKIID---SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL 424
Query: 293 ---------LQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325
L +++ FD RP A E LA P F A+ E E
Sbjct: 425 GLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS--AEEEEE 464
|
Length = 501 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 20/225 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRH 81
+ + ++G+G +G V + TG+ A+K + + + E + +L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHH-QFFLYQML 136
P +P + F+D +Y+V E DL ++ +D E QF+L +++
Sbjct: 61 P--------WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV 112
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
A+ +H HRD+KP+N+L + +K+ DFG A A V V T Y
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYI 170
Query: 197 APELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
APE+ G Y D WS+G I E++ G+ F +
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 65/236 (27%), Positives = 113/236 (47%), Gaps = 26/236 (11%)
Query: 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 67
+ L D D A ++++EV+G G+YG V TG+ AIK + DV E + I
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEI 59
Query: 68 RILREVKLLRLLRHPDIVE------IKRIMLPPSKREFKDIYVVFELME----SDLHQVI 117
++ E+ +L+ H + IK+ PP + +++V E +DL +
Sbjct: 60 KL--EINMLKKYSHHRNIATYYGAFIKKS--PPGHDD--QLWLVMEFCGAGSVTDLVKNT 113
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
K N L + + ++LR L ++H V HRD+K +N+L N ++K+ DFG++
Sbjct: 114 KGNA-LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS---- 168
Query: 178 SDTPMTVFWTD-YVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ TV + ++ T ++ APE+ + + Y DIWS+G E+ G P
Sbjct: 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 9e-13
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + +G+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
K + F YV + L + ++D TR F+ +++ AL Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR----FYGAEIVSALDYLHSGKI 116
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + + +K+ DFGL + +D + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLF 231
Y A+D W +G + E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 80/333 (24%), Positives = 136/333 (40%), Gaps = 78/333 (23%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD--AIRILREVKLLRLLRH 81
+K ++++GKG G V TG+ A+K + D E I R+L E ++L L H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVL-DKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFEL-MESDLHQVIKANDD--LTREHHQFFLYQMLRA 138
P + L S + + +V + +L ++++ L+ E +F+ ++L A
Sbjct: 61 PFLPT-----LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM---------------- 182
L+Y+H + +RDLKP+NIL + + + + DF L++ + + P
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 183 ---------TVFWT-DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
F + +V T Y APE+ G + A+D W++G + E+L G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEMLYGTT 230
Query: 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA 289
F G + R+E L KK F P V A
Sbjct: 231 PFKGSN-----------------------RDETFSNIL----KKE--VTFPGSPPVSSSA 261
Query: 290 LRLLQRLIAFDPKDR----PTAEEALADPYFKG 318
L+++L+ DP R A E P+F+G
Sbjct: 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLL-RHPDIVEI 87
V+GKGS+G V A T E A+K + DV D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 88 KRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
+ +F +ME DL I+ + +F+ +++ L+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ +RDLK N+L ++ +K+ DFG+ + T + + T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS- 169
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ Y PA+D W++G + E+L G+ F G
Sbjct: 170 -YQPYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 26 KILEVIGKGSYGVV-CAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
K+ + +G G +G V A + HT KVA+K + + L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALKY 141
V++ ++ +E IY++ E M L +K+++ + + F Q+ + +
Sbjct: 64 VKLHAVV----TKE--PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ N HRDL+ NIL +A+ K+ DFGLARV D T +W APE
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKW-TAPEAI 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
F +T D+WS G + E++T G+ +PG S
Sbjct: 176 N--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHPDIVE 86
L IG+G++G V + +G +A+K+I + + R+L ++ ++R P IV+
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 87 IKRIMLPPSKREFK--DIYVVFELMESDLHQVIK-ANDDLTREHHQFFL----YQMLRAL 139
+ F+ D ++ ELM+ L + K + L + L ++AL
Sbjct: 68 FYGAL-------FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 140 KYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
Y+ + HRD+KP NIL + N +K+CDFG++ T D R Y AP
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR---D-AGCRPYMAP 176
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQL 240
E + S Y D+WS+G EV TGK +P SV QL
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 11/145 (7%)
Query: 93 PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDL 152
P S + D V L+ D + + D L+ F YQ+ R ++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAI 212
+N+L +K+CDFGLAR D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 213 DIWSIGCIFAEVLT-GKPLFPGKSV 236
D+WS G + E+ + G +PG V
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPGMIV 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 72/313 (23%), Positives = 117/313 (37%), Gaps = 43/313 (13%)
Query: 30 VIGKGSYG--VVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVE 86
+IGK +V A T VA+KKI+ D D + +E+ R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILP 63
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH---------QFFLYQMLR 137
+ S ++YVV LM + +DL + H F L +L
Sbjct: 64 YVTSFIVDS-----ELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLN 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS----DTPMTVFWTDYVATR 193
AL Y+H+ HR +K +IL + + K+ + + + F V
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS-- 251
+ +PE+ Y DI+S+G E+ G P K + L+ + GT
Sbjct: 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEKVRGTVPCL 230
Query: 252 ------PETIAVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDR 304
P + ++ R P + F + LQR DP+ R
Sbjct: 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR----DPESR 286
Query: 305 PTAEEALADPYFK 317
P+A + L +FK
Sbjct: 287 PSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR-HPDIVE 86
V+GKGS+G V A +G A+K + DV D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ P + ++ V E + DL I+ + +F+ ++ AL ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
+ +RDLK N+L + K+ DFG+ + + T + + T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT---STFCGTPDYIAPEILQEML 172
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLF 231
Y P++D W++G + E+L G F
Sbjct: 173 --YGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 80/307 (26%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHP 82
++ V+GKG +G VCA TG+ A KK+ + + +A+ L E ++L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSR 60
Query: 83 DIVEIKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRA 138
+V + E KD + +V LM DL H N E F+ ++
Sbjct: 61 FVVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+ +H + +RDLKP+NIL + +++ D GLA + P V T Y AP
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ + +YT + D W +GC+ E++ GK F
Sbjct: 171 EVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQ------------------------- 203
Query: 259 RNEKARKYLTEMR-KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALA 312
R EK ++ E R K+ +KF A + ++L+ DP R AEE A
Sbjct: 204 RKEKVKREEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260
Query: 313 DPYFKGL 319
P+F+
Sbjct: 261 HPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 66/317 (20%), Positives = 119/317 (37%), Gaps = 82/317 (25%)
Query: 26 KILEVIGKGSYGVV---CAA--IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+GS+G+V A + +VAIK +++ + + I L E +++
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFN 67
Query: 81 HPDIVEIKRIML---PPSKREFKDIYVVFELM-ESDLHQVIKA---NDD-------LTRE 126
+V + ++ P VV ELM + DL +++ + T +
Sbjct: 68 CHHVVRLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 127 HHQFFLY--QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
+F ++ + Y+ HRDL +N + + +K+ DFG+ R +
Sbjct: 120 --KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DI 169
Query: 185 FWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
+ TDY + RW APE +T D+WS G + E+ T + + G S
Sbjct: 170 YETDYYRKGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226
Query: 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQR 295
L + D PE P L L L++
Sbjct: 227 NEEVLKFVIDGGHLDLPEN-------------------CPDKL-----------LELMRM 256
Query: 296 LIAFDPKDRPTAEEALA 312
++PK RPT E ++
Sbjct: 257 CWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 87/351 (24%), Positives = 150/351 (42%), Gaps = 54/351 (15%)
Query: 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILRE 72
KD T A +Y I V+G G+ G V A GE A+K + +D R E
Sbjct: 22 KDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAE 81
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTR--- 125
V L IV+ R +++ ++ +++ DL Q IK+ R
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 126 EHHQFFLY-QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
EH L+ Q+L A+ ++H+ ++ HRD+K NIL +N +K+ DFG +++ ++ T
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM-YAATVSDD 200
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244
+ T +Y APE+ Y+ D++S+G + E+LT K F G+++
Sbjct: 201 VGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------ 252
Query: 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304
V+ A +Y P+P P++ P ++ L++ DPK R
Sbjct: 253 ------------VMHKTLAGRY-------DPLP-----PSISPEMQEIVTALLSSDPKRR 288
Query: 305 PTAEEALADP----YFKGLAKI-EREPSCQPISKLEFEFERRRVTKDDIRE 350
P++ + L P + GL +I + +P F R I++
Sbjct: 289 PSSSKLLNMPICKLFISGLLEIVQTQPG--------FSGPLRDTISRQIQQ 331
|
Length = 496 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+L+ IGKG +G V + + G KVA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDD--LTREHHQFFLYQMLRALKYM 142
++ +++ E +Y+V E M + L +++ L + F + A++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS--DT-PMTVFWTDYVATRWYRAPE 199
N HRDL +N+L + + KV DFGL + A S DT + V WT APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APE 169
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKSVVHQLD 241
K++ D+WS G + E+ + G+ P P K VV +++
Sbjct: 170 ALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 17/233 (7%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+++ +G G +G V + KVA+K + + L E L++ L+H +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLV 64
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKAND--DLTREHHQFFLYQMLRALKYM 142
+ ++ +K E IY++ E M + L +K+++ + F Q+ + Y+
Sbjct: 65 RLYAVV---TKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
N HRDL+ N+L + + K+ DFGLARV D T +W APE
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKW-TAPEAIN 177
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254
F +T D+WS G + E++T GK +PG S + + P E
Sbjct: 178 --FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN 228
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 55/223 (24%), Positives = 106/223 (47%), Gaps = 28/223 (12%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---LREVKLLRLLRHPDIVEI 87
+G G YG V + VA+K + + D + + L+E +++ ++HP++V+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQ- 66
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHT 144
+L RE Y++ E M +L ++ + ++ + Q+ A++Y+
Sbjct: 67 ---LLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW---YRAPELC 201
N HRDL +N L N +KV DFGL+R+ DT +T + ++ + APE
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-----YTAHAGAKFPIKWTAPE-- 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLI 243
++K++ D+W+ G + E+ T G +PG + +L+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 11/212 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L V+GKGS+G V A T E AIK + DV D + E ++L L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ L + +Y V E + DL I+ H F+ ++ L ++
Sbjct: 62 FL----TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + +RDLK N++ ++ +K+ DFG+ + D T + T Y APE+
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ Y ++D W+ G + E+L G+ F G+
Sbjct: 175 --YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y++++ +G G+YG V A + HTGE A+K I E D I +E+ +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V L K +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYLSREK-----LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL N +K+ DFG VA T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
Y DIW++G E+ +P
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 57/267 (21%), Positives = 104/267 (38%), Gaps = 57/267 (21%)
Query: 50 KVAIKKIHDVFEHI-SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108
+VA+K + EHI + LRE ++ L HP IV + + + +V EL
Sbjct: 25 EVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP------LMLVMEL 76
Query: 109 ME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167
L + +K ++ + +Q+ + Y+ + + HRDL +N+L + K+
Sbjct: 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKI 136
Query: 168 CDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCI 220
DFG++R + + Y AT +WY APE C ++ K++ D+WS G
Sbjct: 137 SDFGMSRALGAGS------DYYRATTAGRWPLKWY-APE-CINYG-KFSSKSDVWSYGVT 187
Query: 221 FAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF 279
E + G + + ++ P PE + P ++
Sbjct: 188 LWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPE-------------------ECPQEIY 228
Query: 280 QKFPNVDPLALRLLQRLIAFDPKDRPT 306
++ + P+DRPT
Sbjct: 229 S-----------IMLSCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 72/286 (25%), Positives = 126/286 (44%), Gaps = 48/286 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
E++GKG++G V VA+K D+ + + I+ L E ++L+ HP+IV++
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKL 57
Query: 88 KRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ ++R+ IY+V EL+ L + K D+L + F + Y+ +
Sbjct: 58 IGVC---TQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
N HRDL +N L N LK+ DFG++R D + + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN--Y 168
Query: 206 SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
+Y+ D+WS G + E + G +PG + N++AR
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMT------------------------NQQAR 204
Query: 265 KYLTE-MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ + + R P QK P+ +++QR + P++RP E
Sbjct: 205 EQVEKGYRMSCP----QKCPDD---VYKVMQRCWDYKPENRPKFSE 243
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 61/251 (24%), Positives = 120/251 (47%), Gaps = 21/251 (8%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + TG+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
K S + + V E +L + + + +F+ +++ AL Y+H+ +
Sbjct: 61 KY-----SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
V +RDLK +N++ + + +K+ DFGL + SD + T Y APE+ +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGK--SVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
Y A+D W +G + E++ G+ F + + +L L+ ++ P T++ +A+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---RFPRTLS----PEAK 223
Query: 265 KYLTEMRKKPP 275
L + KK P
Sbjct: 224 SLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-12
Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 38/293 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+++++ IG G+YG V A + +TGE AIK I E D + +E+ +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V L K +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYLRRDK-----LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL N +K+ DFG V+ T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y DIW++G E+ +P + L L+T P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP----------- 229
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ K + F + +AL +PK RPTAE+ L P+
Sbjct: 230 --------KLKDKMKWSNSFHHFVKMAL-------TKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-12
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR 77
N + +G G++G V A + KVA+K + H S+ ++ E+K++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMS 93
Query: 78 LL-RHPDIVEIKRIMLPPSKREFKDIYVVFEL-MESDLHQVIKANDD--LTREHHQFFLY 133
L H +IV L + I V+ E DL ++ + LT E F Y
Sbjct: 94 HLGNHENIVN-----LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+ + + ++ + N HRDL +N+L +K+CDFGLAR +D+ V + +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
W APE F YT D+WS G + E+ + G +PG
Sbjct: 209 WM-APE--SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 64/286 (22%), Positives = 119/286 (41%), Gaps = 52/286 (18%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
E IG+G++G V + VA+K + A + L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRL- 58
Query: 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLR-------ALKY 141
I + K+ IY+V EL++ L E + + ++++ ++Y
Sbjct: 59 -IGVCTQKQP---IYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ + + HRDL +N L LK+ DFG++R + + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ +Y+ D+WS G + E + L P + N+
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS-------------------LGAVPYAN----LSNQ 203
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPT 306
+ R+ + + + P P + P A+ RL++R +DP RP+
Sbjct: 204 QTREAIEQGVRLPC-------PELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPD 83
++ V+GKG +G VCA TG+ A K++ + L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 84 IVEIKRIMLPPSKREFKD-IYVVFELMES---DLHQVIKANDDLTREHHQFFLYQMLRAL 139
+V + E KD + +V +M H N E F+ ++L L
Sbjct: 62 VVNLAYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ +H N +RDLKP+NIL + +++ D GLA P V T Y APE
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLA----VKIPEGESIRGRVGTVGYMAPE 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ + +YT + D W +GC+ E++ G+ F G+
Sbjct: 172 VLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-12
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 22/222 (9%)
Query: 28 LEV-IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
L+V +G+G +G V T KVAIK + L+E ++++ LRH +V
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 87 IKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQF--FLYQMLRALKYMH 143
+ ++ + IY+V E M + L +K D + Q Q+ + Y+
Sbjct: 66 LYAVV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
N HRDL+ NIL N K+ DFGLAR+ D T +W APE +
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--AA 175
Query: 204 FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KSVVHQLD 241
+ ++T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 21/223 (9%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
++++ +G G +G V KVA+K + L E ++++ LRH +V
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQF--FLYQMLRALKYM 142
++ ++ S+ IY+V E M + L +K + + Q+ + Y+
Sbjct: 65 QLYAVV---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
N HRDL+ NIL K+ DFGLAR+ D T +W APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--A 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KSVVHQLD 241
+ + ++T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-12
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 12/185 (6%)
Query: 46 HTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103
+TGE+VA+K K HI+D + +E+++LR L H +IV+ K I K
Sbjct: 31 NTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGICTEDGGNGIK--- 84
Query: 104 VVFELMES-DLHQVIKANDDLTREHHQF-FLYQMLRALKYMHTANVYHRDLKPKNILANA 161
++ E + S L + + N + Q + Q+ + + Y+ + HRDL +N+L +
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
++K+ DFGL + +D D + ++ APE SK+ A D+WS G
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTL 202
Query: 222 AEVLT 226
E+LT
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 102 IYVVFELMESDLHQVIKANDDL-----TREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156
++ F+ S + DDL T E + +Q+ R ++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 215
IL + N +K+CDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 216 SIGCIFAEVLT-GKPLFPG 233
S G + E+ + G +PG
Sbjct: 261 SFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 11/211 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L V+GKGS+G V A T E AIK + DV D + E ++L L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ L + +Y V E + DL I+ H F+ ++ L ++
Sbjct: 62 FL----TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + +RDLK N++ +A +K+ DFG+ + T + T Y APE+
Sbjct: 118 HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT---RTFCGTPDYIAPEIIA 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ Y ++D W+ G + E+L G+P F G
Sbjct: 175 --YQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRL 78
A ++++E++G G+YG V TG+ AIK + D E I I +L++ R
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 64
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQ 134
+ IK+ PP + +++V E +DL + K N L E + +
Sbjct: 65 IATYYGAFIKKN--PPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICRE 119
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD-YVATR 193
+LR L ++H V HRD+K +N+L N ++K+ DFG++ + TV + ++ T
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGTP 175
Query: 194 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
++ APE+ + + Y D+WS+G E+ G P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 56/227 (24%), Positives = 99/227 (43%), Gaps = 31/227 (13%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+VIGKGS+G V A H E+ A+++L++ +L+ I+ +
Sbjct: 1 KVIGKGSFGKVLLA--RHKAEEKFY------------AVKVLQKKAILKKKEEKHIMSER 46
Query: 89 RIMLPPSKREF-----------KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
++L K F +Y V + + +L ++ +F+ ++
Sbjct: 47 NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 106
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T + + T Y
Sbjct: 107 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYL 163
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
APE+ Y +D W +G + E+L G P F ++ D I
Sbjct: 164 APEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 64/252 (25%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + +V + + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
K + F V E +L + T E +F+ +++ AL+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSD-TPMTVFWTDYVATRWYRAPELCGSFF 205
V +RD+K +N++ + + +K+ DFGL + SD M F T Y APE+
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF----CGTPEYLAPEVLED-- 169
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN--EKA 263
+ Y A+D W +G + E++ G+ F + +LI E I R +A
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-------MEEIRFPRTLSPEA 222
Query: 264 RKYLTEMRKKPP 275
+ L + KK P
Sbjct: 223 KSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 40/239 (16%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEH 62
+ K++ K K Y D N + +G GS+G V+ A VAIK+ FE
Sbjct: 19 KEPKRKNKMK-----YEDFN---FIRTLGTGSFGRVILATYKNEDFPPVAIKR----FEK 66
Query: 63 ISDAIR------ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFE-LMESD 112
S I+ + E K+L + HP V + FKD +Y+V E ++ +
Sbjct: 67 -SKIIKQKQVDHVFSERKILNYINHPFCVNLYG--------SFKDESYLYLVLEFVIGGE 117
Query: 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
++ N + F+ Q++ +Y+ + N+ +RDLKP+N+L + + +K+ DFG
Sbjct: 118 FFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177
Query: 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
A+V + T T Y APE+ + + A D W++G E+L G P F
Sbjct: 178 AKVVDTRT------YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+++ +G G +G V KVAIK + + L E L++ L+HP +V
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLY-------QMLR 137
+ ++ + IY++ E ME+ L +K T E + + Q+
Sbjct: 65 RLYAVVTQ------EPIYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMAAQIAE 113
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ ++ N HRDL+ NIL + K+ DFGLAR+ D T +W A
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKW-TA 171
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
PE + +T D+WS G + E++T G+ +PG
Sbjct: 172 PEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 31 IGKGSYGVVCAAI-DTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G G++G V + EK VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 89 RIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
I E + +V EL E L++ ++ N +T ++ ++Q+ +KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSD-----TPMTVFWTDYVATRWYRAPELCG 202
HRDL +N+L K+ DFGL++ +D W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT 226
+++ K++ D+WS G + E +
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 75/328 (22%), Positives = 141/328 (42%), Gaps = 34/328 (10%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRL-LRHPDIVEI 87
V+GKGS+G V A T E AIK + DV D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH- 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L + + + ++ V E + DL I+++ +F+ +++ L+++H
Sbjct: 61 ----LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L + + +K+ DFG+ + + + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKG--Q 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR-- 264
KY ++D WS G + E+L G+ F G+ E + N++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGED---------------EDELFDSILNDRPHFP 216
Query: 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIER 324
+++++ K LF++ P +++ F D E+ P FK K++
Sbjct: 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFK--PKVKS 274
Query: 325 EPSCQPISKLEFEFERRRVTKDDIRELI 352
+ EF E+ R++ D ++L+
Sbjct: 275 PSDASNFDR-EFTNEKVRLSPVD-KKLL 300
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 35/214 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDI 84
+ +G GS+GVV + +G K VA+K + + +SD + L+E ++ L H ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS--DKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-----SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ + ++L + +V EL L + + ++ + Q+ +
Sbjct: 59 IRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCD--YAVQIANGM 110
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR--- 196
+Y+ + HRDL +NIL ++ K+K+ DFGL R A D+ +
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMR-ALPQN------EDHYVMEEHLKVP 163
Query: 197 ----APELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
APE ++ A D+W G E+ T
Sbjct: 164 FAWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 20/125 (16%)
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
+ LT E + +Q+ R ++++ + HRDL +NIL + N +K+CDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 178 SDTPMTVFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GK 228
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KD-------PDYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 229 PLFPG 233
+PG
Sbjct: 274 SPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 12/220 (5%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--SDAIRILREVKLLRLL 79
A Y++++VIG+G++G V + + KV K+ FE I SD+ E ++
Sbjct: 42 AEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
P +V+ L + ++ + +Y+V E M + +N D+ + +F+ +++ AL
Sbjct: 101 NSPWVVQ-----LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H+ HRD+KP N+L + + LK+ DFG + V V T Y +PE
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPE 213
Query: 200 LCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
+ S Y D WS+G E+L G F S+V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 17/217 (7%)
Query: 30 VIGKGSYGVVCAA---IDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIV 85
++GKG +G V A + + +KVA+K + D+F SD LRE ++ HP+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVI 64
Query: 86 EIKRIML-PPSKREFKDIYVVFELME-SDLHQVIKAND------DLTREHHQFFLYQMLR 137
++ + L +K V+ M+ DLH + + L + F+ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
++Y+ + N HRDL +N + N N + V DFGL++ +S + +W
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
L + YT D+W+ G E++T G+ + G
Sbjct: 185 ESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 35/307 (11%)
Query: 24 RYKILEVIGKGSYG--VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+Y IL + GS G VC +KV +K + + RE+ +L+ + H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV-------TGGKTPGREIDILKTISH 145
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I I L + R + +V + DL + + L E ++L AL Y
Sbjct: 146 RAI-----INLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAY 200
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLA--RVAFSDTPMTVFWTDYVATRWYRAPE 199
+H + HRD+K +NI + + DFG A A DTP W+ + T +PE
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET---NSPE 257
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---VHQLDLITDLLGT-----PS 251
L Y DIWS G + E+ GK V QL I + P
Sbjct: 258 L--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVP-LFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ + ++ K +Y +R +P + +K+ ++D L+ +++ FD + RP+A++
Sbjct: 316 NGSTNLCKHFK--QYAIVLRPPYTIPPVIRKYGMHMD--VEYLIAKMLTFDQEFRPSAQD 371
Query: 310 ALADPYF 316
L+ P F
Sbjct: 372 ILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 11/212 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L V+GKGS+G V A T E AIK + DV D + E ++L L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ L + +Y V E + DL I+ F+ ++ L ++
Sbjct: 62 FL----TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + +RDLK N++ ++ +K+ DFG+ + D T + T Y APE+
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ Y ++D W+ G + E+L G+P F G+
Sbjct: 175 --YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 45/222 (20%)
Query: 112 DLHQVIKANDDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNILANANCK 164
DL++ IK +EH F YQ++ AL +H+ + HRDLK NI
Sbjct: 151 DLNKQIKQR---LKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI 207
Query: 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
+K+ DFG ++ +SD+ + + T +Y APEL +Y+ D+WS+G I E+
Sbjct: 208 IKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYEL 264
Query: 225 LTGKPLFPGKSVVHQLDLITDLL-GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP 283
LT F G S Q +++ +L G P V KA
Sbjct: 265 LTLHRPFKGPS---QREIMQQVLYGKYDPFPCPVSSGMKA-------------------- 301
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325
LL L++ +P RPT ++ L + K +A + ++
Sbjct: 302 --------LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+++ L Y+ + + HRD+KP N+L N ++K+CDFG++ + T YV T
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-----YVGTNA 158
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
Y APE +Y D+WS+G F E+ G+ +P
Sbjct: 159 YMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYP 194
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 6/115 (5%)
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
LT E + +Q+ + ++++ + HRDL +NIL + N +K+CDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GKPLFPG 233
P V D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---------LREVKLLRLLR 80
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 81 H---PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
P IV + P K F + +LM DLH + + + + +F+ +++
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L++MH V +RDLKP NIL + + +++ D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 162
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPET 254
APE+ + Y + D +S+GC+ ++L G F H++D +T + P++
Sbjct: 163 APEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221
Query: 255 IA 256
+
Sbjct: 222 FS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK-----VAIKKIHDVFE-HISDAIRILREVKLLRLL 79
+ LE +G+G++G V T E+ VAIK + + E + R +E +L+ L
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--QEAELMSDL 65
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQ----------VIKANDDLTREH- 127
+HP+IV + + + + ++FE + DLH+ V + D T +
Sbjct: 66 QHPNIVCLLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 128 --HQFFL---YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182
FL Q+ ++Y+ + + HRDL +N L +K+ DFGL+R +S
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
V + RW PE + K+T DIWS G + E+
Sbjct: 181 RVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 31/228 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++IL+VIG+G++G V V +K V+ A++IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEVAV---------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 85 VEIKRIMLPPSKR-------EFKDIYVVFELME----SDLHQVI-KANDDLTREHHQFFL 132
E + +++ +R F+D ++ +M+ DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
+M+ A+ +H HRD+KP N+L + N +++ DFG +D TV V T
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGT 166
Query: 193 RWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
Y +PE+ + +Y P D WS+G E+L G+ F +S+V
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 6/146 (4%)
Query: 94 PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF--FLYQMLRALKYMHTANVYHRD 151
P+K + + ++ D+ I D+L + F YQ+ + + ++ + N HRD
Sbjct: 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD 239
Query: 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPA 211
L +NIL K+CDFGLAR +D+ V + +W APE F YT
Sbjct: 240 LAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFE 296
Query: 212 IDIWSIGCIFAEVLT-GKPLFPGKSV 236
D+WS G + E+ + G +PG V
Sbjct: 297 SDVWSYGILLWEIFSLGSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 28/192 (14%)
Query: 51 VAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108
VA+K + D SD R RE +LL L+H IV+ + + E + +VFE
Sbjct: 38 VAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EGDPLIMVFEY 88
Query: 109 ME-SDLHQVIKAN-------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154
M+ DL++ ++A+ +LT+ Q+ + Y+ + + HRDL
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148
Query: 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
+N L N +K+ DFG++R +S V + RW PE + K+T D+
Sbjct: 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 205
Query: 215 WSIGCIFAEVLT 226
WS+G + E+ T
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 17/238 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLL 79
+ ++V+G G++G V + GEK VAIK + + ++ IL E ++ +
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK-EILDEAYVMASV 66
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLR 137
HP +V + I L + ++ +LM L V D++ ++ + Q+ +
Sbjct: 67 DHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ Y+ + HRDL +N+L +K+ DFGLA++ D V +W A
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM-A 179
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254
E YT D+WS G E++T G + G V DL+ P P
Sbjct: 180 LESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 45/243 (18%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDA-IRILREVKLLRLLRH 81
++ L+VIG+G++G V TG A+K + D+ E A IR R++ L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI-----LVE 57
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
D + ++ S ++ +++Y++ E + D+ ++ D L+ E QF++ + + A+
Sbjct: 58 ADGAWVVKMFY--SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLA-------RVAF----SDTPMTVF---- 185
+H HRD+KP N+L +A +K+ DFGL R F + P + F
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 186 ---------WT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
W V T Y APE+ + Y D WS+G I E+L G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233
Query: 229 PLF 231
P F
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA---IRILREVKLLRLLRHP 82
K ++V+G G++G V I GE V I + + + + E ++ + HP
Sbjct: 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALK 140
+V + + L P+ I +V +LM L V + D++ + + Q+ + +
Sbjct: 70 HLVRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ + HRDL +N+L + +K+ DFGLAR+ D + +W L
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---AL 180
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT--GKP 229
+ K+T D+WS G E++T GKP
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 39/244 (15%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---------LREVKLLRLLR 80
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 81 H---PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
P IV + P K F + +LM DLH + + + +F+ +++
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L++MH V +RDLKP NIL + + +++ D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 162
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV--HQLDLIT-----DLLGT 249
APE+ + Y + D +S+GC+ ++L G F H++D +T +L +
Sbjct: 163 APEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 221
Query: 250 PSPE 253
SPE
Sbjct: 222 FSPE 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLL-RHPDIVE 86
+V+GKGS+G V A GE A+K + I D + + E ++L L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 87 IKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ + K+ ++ V E + DL H K DL R F+ +++ L+++
Sbjct: 61 LY------CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRA--TFYAAEIVCGLQFL 112
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYVATRWYRAPELC 201
H+ + +RDLK N++ + + +K+ DFG+ + F D + F T Y APE+
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEIL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
KYT ++D WS G + E+L G+ F G
Sbjct: 169 QGL--KYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 38/123 (30%), Positives = 57/123 (46%), Gaps = 22/123 (17%)
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
F YQ+ ++++ + N HRDL +N+L +K+CDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
+W APE F + YT D+WS G + E+ T L GTP
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFT-------------------LGGTP 341
Query: 251 SPE 253
PE
Sbjct: 342 YPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPD 83
++I+ +G G++G V A + TG A K I E + D + E+++L HP
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV---EIEILATCNHPY 70
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKY 141
IV++ K ++++ E I D LT Q QML AL+Y
Sbjct: 71 IVKLLGAFYWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ + HRDLK N+L + +K+ DFG V+ + ++ T ++ APE+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 202 GSFFSKYTP---AIDIWSIGCIFAEVLTGKP 229
K TP DIWS+G E+ +P
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTR 125
L+E+K++ L+ P+I+ + + + + ++ E ME+ DL+Q + + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 126 EHHQFFLYQMLR--------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
Y L +KY+ + N HRDL +N L N +K+ DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
S + + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 64/246 (26%), Positives = 103/246 (41%), Gaps = 51/246 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHIS-DAIRILREVKLLRLLRH 81
++ L+VIG+G++G V TG A+K + D+ E IR R++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI-------- 54
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
+VE + + F+D +Y++ E + D+ ++ D LT E QF++ + +
Sbjct: 55 --LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-------RVAF---------SDTP 181
A+ +H HRD+KP N+L ++ +K+ DFGL R F SD
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 182 MTVFWTDYVATRWYR----------------APELCGSFFSKYTPAIDIWSIGCIFAEVL 225
+ A W R APE+ + Y D WS+G I E+L
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEML 230
Query: 226 TGKPLF 231
G P F
Sbjct: 231 IGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 48/220 (21%), Positives = 90/220 (40%), Gaps = 21/220 (9%)
Query: 29 EVIGKGSYGVVCAAI---DTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDI 84
+++G+G +G V D + KVA+K + D+ + S+ L E ++ HP++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNV 63
Query: 85 VEIKRIMLPPSKRE-FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML------ 136
+++ + S + V+ M+ DLH + + + Q L
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKFMVD 121
Query: 137 --RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
++Y+ N HRDL +N + + + V DFGL++ +S + +W
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
L YT D+W+ G E+ T G+ +PG
Sbjct: 182 IAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 63/251 (25%), Positives = 117/251 (46%), Gaps = 20/251 (7%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA- 145
K S + + V E +L + + + +F+ +++ AL Y+H+
Sbjct: 61 KY-----SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD-TPMTVFWTDYVATRWYRAPELCGSF 204
NV +RDLK +N++ + + +K+ DFGL + D M F T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF----CGTPEYLAPEVLED- 170
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
+ Y A+D W +G + E++ G+ F + +LI + P T++ +A+
Sbjct: 171 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRFPRTLS----PEAK 224
Query: 265 KYLTEMRKKPP 275
L+ + KK P
Sbjct: 225 SLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 19/226 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLRH 81
++ +++I G+YG V T ++ A+KKI+ + + I ++ E +L +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
P +V + S + + +V E +E D ++K L + + + + + AL+
Sbjct: 61 PFVVS-----MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA--TRWYRAP 198
Y+H + HRDLKP N+L + +K+ DFGL+++ T + ++ TR +
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL-TTNLYEGHIEKDTREFLDK 174
Query: 199 ELCGS---------FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
++CG+ Y +D W++G I E L G F G +
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLL-RHPDIVE 86
+++GKGS+G V A T + AIK + DV D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
L + + ++++ V E + DL I++ F+ +++ L+++H+
Sbjct: 61 -----LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
+ +RDLK NIL + + +K+ DFG+ + T + T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEIL--LG 170
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
KY ++D WS G + E+L G+ F G
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 74/306 (24%), Positives = 127/306 (41%), Gaps = 51/306 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHP 82
++ V+GKG +G VCA TG+ A KK+ + + +++ L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM-ALNEKQILEKVNSR 60
Query: 83 DIVEIKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRA 138
+V + E KD + +V LM DL H F+ ++
Sbjct: 61 FVVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+ +H + +RDLKP+NIL + + +++ D GLA P V T Y AP
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVGYMAP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ + +YT + D W++GC+ E++ G+ F +
Sbjct: 171 EVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQR------------------------ 204
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALAD 313
+ + R+ + + K+ +KF P A L + L+ DPK+R A E
Sbjct: 205 KKKIKREEVERLVKEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261
Query: 314 PYFKGL 319
P FK +
Sbjct: 262 PLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 72/316 (22%), Positives = 134/316 (42%), Gaps = 63/316 (19%)
Query: 23 NRYKILEVIGKGSYGVV--CAAID------------THTGEKVAIKKIH-DVFEHISDAI 67
+ ++ E +G+G +G V C A VA+K + DV + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN-- 62
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI--------- 117
L+E+K++ L++P+I+ + + + + ++ E ME+ DL+Q +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMENGDLNQFLSQREIESTF 117
Query: 118 -KAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174
AN+ ++ + + Q+ +KY+ + N HRDL +N L + +K+ DFG++R
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+S + + RW + K+T A D+W+ G E+ T P
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFTLCKEQP-Y 233
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKP--PVPLFQKFPNVDPLALRL 292
S++ +I + T RN+ + YL++ P P P+F+ L
Sbjct: 234 SLLSDEQVIEN--------TGEFFRNQGRQIYLSQ---TPLCPSPVFK-----------L 271
Query: 293 LQRLIAFDPKDRPTAE 308
+ R + D KDRPT
Sbjct: 272 MMRCWSRDIKDRPTFN 287
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 55/245 (22%)
Query: 24 RYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIH-DVFEHISDAIRILREVKLLR 77
R + + +G+G++G V A +D VA+K + D E D ++ E+++++
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMMK 70
Query: 78 LL-RHPDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKAN--------------- 120
++ +H +I+ +L +E +YVV E +L ++A
Sbjct: 71 MIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 121 -DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179
+ LT++ F YQ+ R ++++ + HRDL +N+L + +K+ DFGLAR
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----- 180
Query: 180 TPMTVFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GK 228
+ DY + +W APE + F + YT D+WS G + E+ T G
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233
Query: 229 PLFPG 233
P +PG
Sbjct: 234 P-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 31 IGKGSYGVV----CAAIDTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G+G++G V C + + VA+K + + E S RE +LL +L+H IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIV 70
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND---------------DLTREHHQ 129
+ E + + +VFE M DL++ ++++ LT
Sbjct: 71 RFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
Q+ + Y+ + + HRDL +N L +K+ DFG++R +S V
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+ RW PE + K+T DIWS G + E+ T GK + S ++ IT
Sbjct: 186 LPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 9/117 (7%)
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDL R F Q+ + + ++ + N HRD+ +N+L K+CDFGLAR +D+
Sbjct: 212 DDLLR-----FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236
V + +W APE F YT D+WS G + E+ + GK +PG V
Sbjct: 267 NYVVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHPDIVEI 87
V+GKG +G VCA TG+ A KK+ + + +A+ L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-ALNEKRILEKVNSRFVVSL 65
Query: 88 KRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRALKYMH 143
E KD + +V +M DL H N + F+ ++ L+ +
Sbjct: 66 AYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ +RDLKP+NIL + +++ D GLA P V T Y APE+ +
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
KYT + D W +GC+ E++ G+ F
Sbjct: 176 --EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 8/106 (7%)
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
F +Q+ R ++Y+ + HRDL +N+L K+K+ DFGL+R + + +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191
Query: 191 ATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
+W A E S F YT D+WS G + E++T G P +PG
Sbjct: 192 PVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 9e-10
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
L+ +G G +GVV G+ VAIK I E + E K++ L H +V
Sbjct: 8 FLKELGTGQFGVV--KYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLT---REH-HQFFLYQMLR---- 137
++ + +K+ + IY+V E M +N L REH +F Q+L
Sbjct: 63 QLYGVC---TKQ--RPIYIVTEYM---------SNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 138 ---ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ Y+ + HRDL +N L + +KV DFGL+R D + + + RW
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW 167
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
PE+ +SK++ D+W+ G + EV +
Sbjct: 168 -SPPEVL--LYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 48/294 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
+ +G+G +G V KVA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 87 IKRIMLPPSKRE-FKDIYVVFELME-SDLHQVI---KANDD---LTREHHQFFLYQMLRA 138
+ + L + E + V+ M+ DLH + + D L + F+ +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
++Y+ + + HRDL +N + N N + V DFGL++ ++ + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG------------------------ 217
Query: 258 VRNEKARKYLTEMR--KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
V N + YL + K+PP L D L L+ +PKDRP+ E
Sbjct: 218 VENSEIYDYLRQGNRLKQPPDCL-------DGL-YSLMSSCWLLNPKDRPSFET 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++I+ +G G++G V A + TG A K I E + + E+ +L HP+I
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV--EIDILASCDHPNI 64
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVI--KANDDLTREHHQFFLYQMLRALKYM 142
V+ +L E +++++ E + + LT + Q L AL Y+
Sbjct: 65 VK----LLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLK NIL + +K+ DFG V+ +T ++ T ++ APE+
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 203 SFFSKYTP---AIDIWSIGCIFAEVLTGKP 229
SK P D+WS+G E+ +P
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 11/204 (5%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL--RLLRHPDIVEI 87
VIG+GSY V T A+K + + + I ++ K + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
+ E + +V+ + DL ++ L EH +F+ ++ AL Y+H +
Sbjct: 62 HSCF----QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 117
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N+L ++ +K+ D+G+ + T + + T Y APE+
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--ED 172
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 31 IGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G+G++G V A T VA+K + D ++ RE +LL L+H IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIV 70
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN--------DDLTREHH-QFFLYQM 135
+ + + + +VFE M+ DL++ ++A+ D R+ + L QM
Sbjct: 71 KFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 136 LR-------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
L + Y+ + + HRDL +N L AN +K+ DFG++R +S V
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW PE + K+T D+WS G I E+ T
Sbjct: 186 MLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--SDAIRILREVKLLRLLRHP 82
+ +++VIG+G++G V + + A+K + FE I SD+ E ++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSE 103
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV++ K +Y+V E M + +N D+ + +F+ +++ AL +
Sbjct: 104 WIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAI 158
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ HRD+KP N+L + + LK+ DFG + M T V T Y +PE+
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTA-VGTPDYISPEVLK 216
Query: 203 S--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
S Y D WS+G E+L G F S+V
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL--RLLRHPDIVEI 87
VIG+GSY V + A+K + H + I ++ K + + +P +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
S+ +++V E + DL ++ L EH +F+ ++ AL ++H
Sbjct: 62 HSCFQTTSR-----LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A+ +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
+Y ++D W++G + E++ G+ F D+ITD
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPF---------DIITD 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL--RLLRHPDIVEI 87
VIG+GSY V T A+K I + + I ++ K + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
S+ ++ V E + DL ++ L EH +F+ ++ AL ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
+GKG +G VCA +TG+ A KK+ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 90 IMLPPSKREFKDIYVVFELME-SDL--HQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
SK + +V LM DL H L E + Q+ + ++H+ +
Sbjct: 61 AF--ESKTH---LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RD+KP+N+L + ++ D GLA V D T T Y APE+
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTI---TQRAGTNGYMAPEILKE--E 169
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLF 231
Y+ +D +++GC E++ G+ F
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 9e-09
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 24 RY-KILEVIGKGSYGVVCA----AIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLL 76
RY K + V+G+G +G V + TGE VA+K K ++ S + E+ +L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINIL 60
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQ 134
+ L H +IV+ K S++ K + ++ E + S + K +L + F Q
Sbjct: 61 KTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ--LLLFAQQ 115
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----------RVAFSDTPMTV 184
+ + Y+H+ + HRDL +N+L + + +K+ DFGLA RV D V
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR-EDGDSPV 174
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
FW A E K++ A D+WS G E+LT
Sbjct: 175 FWY---------AVECLKEN--KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 37/115 (32%), Positives = 55/115 (47%), Gaps = 6/115 (5%)
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+ R ++Y+ + HRDL +N+L N +K+ DFGLAR + +
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITD 245
+W APE F YT D+WS G + E+ T G P +PG V L+ +
Sbjct: 204 KWM-APE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 47/201 (23%)
Query: 51 VAIKKIHDVFEHISDAIRI--LREVKLLRLLRHPDIVEIKRIML--PPSKREFKDIYVVF 106
VA+K + SD R L+EVK+L L P+I + + PP + ++
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP-------LCMIM 98
Query: 107 ELME-SDLHQVIKANDDLTREH--------HQFFLY---QMLRALKYMHTANVYHRDLKP 154
E ME DL+Q ++ + T LY Q+ ++Y+ + N HRDL
Sbjct: 99 EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158
Query: 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY--------VATRWYRAPELCGSFF- 205
+N L N +K+ DFG++R +S +DY + RW A E S
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYS--------SDYYRVQGRAPLPIRWM-AWE---SVLL 206
Query: 206 SKYTPAIDIWSIGCIFAEVLT 226
K+T D+W+ G E+LT
Sbjct: 207 GKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 71/274 (25%), Positives = 109/274 (39%), Gaps = 52/274 (18%)
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM-------ESDLHQVIKAN-DDL 123
E +LLR L HP ++ + D+ VV L SDL+ + A L
Sbjct: 210 EARLLRRLSHPAVLALL------------DVRVVGGLTCLVLPKYRSDLYTYLGARLRPL 257
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG---LARVAFSDT 180
Q+L A+ Y+H + HRD+K +N+L N + + DFG AR ++S
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-- 315
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKS---- 235
T F T APE+ YTP++DIWS G IF + LF
Sbjct: 316 --TPFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDER 371
Query: 236 ---------VVHQLDLITDLLGT-PSPETIAVVRNEKARKYLTEMRKKPPV--PLFQKFP 283
++ Q + D ++ R+ AR ++P P + ++
Sbjct: 372 RPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARN------RRPAYTRPAWTRYY 425
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+D L+ R + FD RP+A E L P F+
Sbjct: 426 KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 41/226 (18%)
Query: 31 IGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPD 83
IG+G++G V A + VA+K + E S ++ RE L+ HP+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDHPN 69
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND--------------------- 121
IV++ + K + ++FE M DL++ ++
Sbjct: 70 IVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 122 -DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L+ Q+ + Y+ HRDL +N L N +K+ DFGL+R +S
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
D + RW PE F+++YT D+W+ G + E+ +
Sbjct: 185 YYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
+ KG Y + ID VAIK + + E S ++RE +++ L +P IV + +
Sbjct: 11 VKKGVYKMRKKQID------VAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMIGV 63
Query: 91 MLPPSKREFKDIYVVFELMESD-LHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVY 148
E + + +V E+ L++ + D++T + ++Q+ +KY+ N
Sbjct: 64 C------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 149 HRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW---YRAPELCGSFF 205
HRDL +N+L K+ DFGL++ +D ++ A +W + APE F
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDS---YYKARSAGKWPLKWYAPECIN--F 172
Query: 206 SKYTPAIDIWSIGCIFAEVLT--GKP 229
K++ D+WS G E + KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 28/213 (13%)
Query: 31 IGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
IG G +G V + H G +V +K++ + + L+EV+ R L HP++
Sbjct: 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNV--- 57
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR-----ALKY 141
+ E +V E DL +++N + + Q + Q + L +
Sbjct: 58 --LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD---YVATRWYRAP 198
+H A+ H DL +N A+ +K+ D+GL A P + T V RW AP
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGL---ALEQYPEDYYITKDCHAVPLRWL-AP 171
Query: 199 ELCGSFFS-----KYTPAIDIWSIGCIFAEVLT 226
EL T +IWS+G E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 4/114 (3%)
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR + +
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD 245
+W APE F YT D+WS G + E+ T G +PG V L+ +
Sbjct: 201 KWM-APE--ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHD-----VFEHISDAIRILREVKLL 76
+ L+++G G +G V I G+ VAIK I D F+ I+D + +
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS---- 65
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQ 134
L H IV + I S + +V +L S L V + D L + + Q
Sbjct: 66 --LDHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ 117
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ + + Y+ + HR+L +NIL ++ +++ DFG+A + + D + +W
Sbjct: 118 IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
L F +YT D+WS G E+++
Sbjct: 178 M---ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 45/176 (25%), Positives = 78/176 (44%), Gaps = 28/176 (15%)
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN-------- 120
L+EVK+L L+ P+I+ + + + + ++ E ME+ DL+Q + ++
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDP-----LCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 121 -DDLTREHHQFFL--YQML--------RALKYMHTANVYHRDLKPKNILANANCKLKVCD 169
+D H Y L +KY+ + N HRDL +N L N +K+ D
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
FG++R ++ + + RW A E K+T A D+W+ G E+L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 61/239 (25%), Positives = 108/239 (45%), Gaps = 55/239 (23%)
Query: 31 IGKGSYGVVCAA----IDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLL-RHP 82
+G+G +G V A ID ++ VA+K + D D ++ E++L++L+ +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHK 78
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKAND--------DLTREHHQFF-- 131
+I+ + + +YV+ E + +L + ++A D+T+ +
Sbjct: 79 NIINLLGVCTQEGP-----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 132 ------LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR V
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--------GVH 185
Query: 186 WTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
DY + +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 186 DIDYYKKTSNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 38/124 (30%), Positives = 59/124 (47%), Gaps = 24/124 (19%)
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY--- 189
YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR + DY
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKK 198
Query: 190 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLD 241
+ +W APE + F + YT D+WS G + E+ T G P +PG V
Sbjct: 199 TTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFK 253
Query: 242 LITD 245
L+ +
Sbjct: 254 LLKE 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 31/196 (15%)
Query: 51 VAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE- 107
VAIK + D+ + + +E L+ L HP+IV +L +E + + ++FE
Sbjct: 37 VAIKTLKDINNPQQWGE---FQQEASLMAELHHPNIV----CLLGVVTQE-QPVCMLFEY 88
Query: 108 LMESDLHQVI-----------KANDDLTREH---HQFFLY---QMLRALKYMHTANVYHR 150
L + DLH+ + +++D T + H FL+ Q+ ++Y+ + H+
Sbjct: 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHK 148
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
DL +NIL +K+ D GL+R +S V + RW PE + K++
Sbjct: 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM-PPE--AIMYGKFSS 205
Query: 211 AIDIWSIGCIFAEVLT 226
DIWS G + E+ +
Sbjct: 206 DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK-KIHDVFEHISDAI--RILREVKLLRLLRH 81
+K ++V+G G++G V + GEKV I I ++ E S IL E ++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRAL 139
P + + I L + + ++ +LM L V + D++ ++ + Q+ + +
Sbjct: 69 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y+ + HRDL +N+L +K+ DFGLA++ +D V +W
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ YT D+WS G E++T
Sbjct: 183 I---LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 17/206 (8%)
Query: 31 IGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
IG G +G V+ + I T TG + K + L++ R+L+HP+I++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 90 IMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML----RALKYMHT 144
+ E +VFE E DL + R L +M + +MH
Sbjct: 63 QCV-----EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF 204
N H DL +N ++ +KV D+G+ + + + V RW APEL G F
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEF 176
Query: 205 F-----SKYTPAIDIWSIGCIFAEVL 225
++ T ++W++G E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIV 85
+VIG+G++G V A+ G K+ AIK + + F +D E+++L +L HP+I+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNII 66
Query: 86 EIKRIMLPPSKREFKDIYVVFE----------LMESDLHQVIKANDDLTREH---HQFFL 132
+ + R + +Y+ E L +S +V++ + +EH
Sbjct: 67 NL---LGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTASTLTS 118
Query: 133 YQMLR-------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
Q+L+ ++Y+ HRDL +N+L N K+ DFGL+R T+
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM- 177
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 178 --GRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 26/227 (11%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLL-R 77
+ N K +VIG+G++G V A G ++ AIK++ + + D E+++L +
Sbjct: 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCK 63
Query: 78 LLRHPDIVEIK-----------RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE 126
L HP+I+ + I P D ++E+D I + T
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHG-NLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 127 HHQF--FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
Q F + R + Y+ HRDL +NIL N K+ DFGL+R T+
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 183 ---GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 29/225 (12%)
Query: 31 IGKGSYGVVC--AAID---THTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+G G++G V A D +G +VA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML------- 136
V++ + L + Y++ ELME DL ++ L ++L
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 137 RALKYMHTANVYHRDLKPKNILA-----NANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
+ Y+ + HRDL +N L +A+ +K+ DFGLAR + +
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
RW APE K+T D+WS G + E+LT G+ +P +
Sbjct: 177 VRWM-APE--SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 30/221 (13%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIV 85
+VIG+G++G V A G ++ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDL-----HQVIKANDDLTREH---HQFFLYQMLR 137
+ + R + + + + + L +V++ + + Q+L
Sbjct: 60 NL---LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 138 -------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
+ Y+ HRDL +NIL N K+ DFGL+R T+ +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRL 173
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
RW L +S YT D+WS G + E+ L G P
Sbjct: 174 PVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 40/159 (25%), Positives = 79/159 (49%), Gaps = 19/159 (11%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILREVKLLRLLRH 81
+ I++ I +G++G V + + A+K K + +++ ++ R+ L L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDA--LALSKS 63
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM-----ESDLHQVIKANDDLTREHHQFFLYQML 136
P IV L S + ++Y+V E + +S LH ++++ ++ ++
Sbjct: 64 PFIVH-----LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV----KYISEVA 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
AL Y+H + HRDLKP N+L + +K+ DFGL++V
Sbjct: 115 LALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDV-------FEHISDAIRILREVKLLRLLRHPD 83
+GKG +G V A TG+ A KK++ +E RIL +V H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-----DLHQVIKANDDLTREHHQFFLYQMLRA 138
+ + L + + D+ +V +M ++ V + N F+ Q++
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + + +++ D GLA V D Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
EL +Y ++D +++G E++ + F
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 23/219 (10%)
Query: 26 KILEVIGKGSYGVVCAA--IDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ +E +G+ +G V T GE+ VAIK + D E E + L+
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQ 66
Query: 81 HPDIVEI-------KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLT----REHHQ 129
HP+IV + + + + S D++ F +M S V +DD T E
Sbjct: 67 HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE-FLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 130 FF--LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
F + Q+ ++++ + +V H+DL +N+L +K+ D GL R ++ +
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW +PE + K++ DIWS G + EV +
Sbjct: 186 SLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 22/222 (9%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIK-KIHDVFEHISDAI--RILREVKLLRLLRHP 82
K ++V+G G++G V I GE V I I + E+ S IL E ++ + P
Sbjct: 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALK 140
+ + I L + + +V +LM L V + D + + + Q+ + +
Sbjct: 70 YVCRLLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD--YVATRWYRAP 198
Y+ + HRDL +N+L + +K+ DFGLAR+ D T + D V +W
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKWMALE 181
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPL--FPGKSV 236
+ ++T D+WS G E++T KP P + +
Sbjct: 182 SI---LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 67/309 (21%), Positives = 117/309 (37%), Gaps = 75/309 (24%)
Query: 30 VIGKGSYGVVCAA----IDTHTGEKVAIKKIHDVFEHISDAIRIL---REVKLLRLLRHP 82
+G+G +G V A I+ GE + + K + D RE+ + R L H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVK---ALQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD---------LTREHHQFFL 132
++V + + RE + Y++ E + DL Q ++A L+ +
Sbjct: 69 NVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY--- 189
Q+ + ++ A HRDL +N L ++ ++KV L++ ++ +Y
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS--------EYYKL 175
Query: 190 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+ RW APE ++ D+WS G + EV T G+ F G S
Sbjct: 176 RNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--------- 223
Query: 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKD 303
E + ++ K P P L +L+ R A +PKD
Sbjct: 224 ------DEEVLNRLQAGKLE---------------LPVPEGCPSRLYKLMTRCWAVNPKD 262
Query: 304 RPTAEEALA 312
RP+ E ++
Sbjct: 263 RPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 32/104 (30%), Positives = 46/104 (44%), Gaps = 22/104 (21%)
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY---- 189
+M+ AL +H + RDL P NIL + +++ F W++
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR-------------WSEVEDSC 139
Query: 190 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
Y APE+ G S+ T A D WS+G I E+LTGK L
Sbjct: 140 DGEAVENMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 63/266 (23%), Positives = 102/266 (38%), Gaps = 75/266 (28%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-------HDVFEHISDAIRILREVKL 75
+ ++VIGKG++G V TG+ A+K + D H+ +L E
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFF 131
P +V + F+D ++ +ME DL ++ D + + +F+
Sbjct: 60 -----SPWVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY 106
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA------------------ 173
+ + + A++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 174 -----------RVAFSDTPMTVFWTDYVATRW----------------YRAPELCGSFFS 206
VA +T+ D +AT W Y APE+ F
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIAT-WKKNRRLMAYSTVGTPDYIAPEI---FLQ 222
Query: 207 K-YTPAIDIWSIGCIFAEVLTGKPLF 231
+ Y D WS+G I E L G P F
Sbjct: 223 QGYGQECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 49/223 (21%), Positives = 84/223 (37%), Gaps = 39/223 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRL 78
D KI ++G G +G +C ++ IH + SD R L E L
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML- 136
H +IV ++ ++ + + +V E M + A D R+H Q Q++
Sbjct: 63 FDHSNIVRLEGVITRGNT-----MMIVTEYMSNG------ALDSFLRKHEGQLVAGQLMG 111
Query: 137 ------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT------- 183
+KY+ H+ L +L N++ K+ F + S+ T
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSP 171
Query: 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
V W APE + ++ A D+WS G + EV++
Sbjct: 172 VLWA---------APEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 56/252 (22%), Positives = 97/252 (38%), Gaps = 57/252 (22%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLR-LLRHPDI 84
++ +G G++G VC A T A+K + DV A VK R +L D
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVA-----HVKAERDILAEADN 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
+ ++ ++ ++Y V + + D+ ++ + +F++ ++ A++ +H
Sbjct: 61 EWVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL----------------ARVAFSDTPMTVFWT 187
HRD+KP NIL + + +K+ DFGL + + + W
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 188 D----------------------------YVATRWYRAPELCGSFFSKYTPAIDIWSIGC 219
D V T Y APE+ YT D WS+G
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGV 236
Query: 220 IFAEVLTGKPLF 231
I E+L G+P F
Sbjct: 237 ILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 58/264 (21%), Positives = 101/264 (38%), Gaps = 73/264 (27%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
++ +G G++G VC A T A+K + ++V L + H V+
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRK------------KDVLLRNQVAH---VKA 50
Query: 88 KRIMLPPSKRE--------FKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQM 135
+R +L + E F+D +Y V + + D+ ++ + +F++ ++
Sbjct: 51 ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAEL 110
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----------------RVAFSD 179
A++ +H HRD+KP NIL + + +K+ DFGL V
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 180 TPMTVFWTD----------------------------YVATRWYRAPELCGSFFSKYTPA 211
+ W D V T Y APE+ + YT
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQL 228
Query: 212 IDIWSIGCIFAEVLTGKPLFPGKS 235
D WS+G I E+L G+P F ++
Sbjct: 229 CDWWSVGVILYEMLVGQPPFLAQT 252
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 82/345 (23%), Positives = 130/345 (37%), Gaps = 90/345 (26%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRHP 82
+ ++ IG G++G VC T A+K + DV + A + E +L +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR-NQAAHVKAERDILAEADNE 61
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFEL-----MESDLHQVIKANDDLTREHHQFFLYQMLR 137
+V+ L S ++ ++Y V + M S L ++ +DL R F++ ++
Sbjct: 62 WVVK-----LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR----FYIAELTC 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL------------------ARVAFSD 179
A++ +H HRD+KP NIL + + +K+ DFGL R +
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 180 TPMTVFWTD----------------------YVATRWYRAPELCGSFFSKYTPAIDIWSI 217
D V T Y APE+ + YT D WS+
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSV 230
Query: 218 GCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP 277
G I E+L G+P F L TP+ ET V N + T +
Sbjct: 231 GVILYEMLVGQPPF--------------LADTPA-ETQLKVINWE-----TTLHIPSQA- 269
Query: 278 LFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFKGL 319
+ A L+ RL +DR A+E A P+FKG+
Sbjct: 270 ------KLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 8e-06
Identities = 36/119 (30%), Positives = 62/119 (52%), Gaps = 12/119 (10%)
Query: 112 DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDF 170
DL ++K L+ + + Q++ AL +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 171 GLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
GL ++ TP Y T Y +PE + G Y + D W++G + E+LTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 25/218 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLL 79
R + +++ +G++G + I E+V +K + D I +L+E LL L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVT-LLLQESCLLYGL 65
Query: 80 RHPDIVEIKR----------IMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHH 128
H +I+ I ++ P + K L E++ Q + T++
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS-----TQQLV 120
Query: 129 QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
+ Q+ + Y+H V H+D+ +N + + ++K+ D L+R F + +
Sbjct: 121 HMAI-QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+W L +S A D+WS G + E++T
Sbjct: 180 NRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 58/224 (25%), Positives = 87/224 (38%), Gaps = 60/224 (26%)
Query: 129 QFFLYQMLRALKYMHTANVYHRDLKPKNIL-ANANCKLKVCDFGLA---RVAFSDTPMTV 184
Q + Q+L AL +H+ + HRD+KP+NI+ + + K+ D G A RV + P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP--- 314
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPA----------------------IDIWSIGCIFA 222
+++ Y APE S TP+ DI+S G IF
Sbjct: 315 --KEFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY-LTEMRK----KPPVP 277
++ FP L +D I R K Y L RK +
Sbjct: 371 QM-----AFPN--------LRSD------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411
Query: 278 LFQKFPNVD---PLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
L + F +D LL+ ++ F + R +A+ ALA PYF
Sbjct: 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455
|
Length = 566 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 55/247 (22%), Positives = 96/247 (38%), Gaps = 50/247 (20%)
Query: 27 ILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+L +G G++G V + +VA+K + + D L E ++ H
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNH 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR--- 137
+IV + + R +++ ELM DL ++ N + +L
Sbjct: 69 QNIVRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 138 ----ALKYMHTANVYHRDLKPKNILANANCK-----LKVCDFGLARVAFSDTPMTVFWTD 188
KY+ + HRD+ +N L CK K+ DFG+AR ++
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCL--LTCKGPGRVAKIADFGMAR--------DIYRAS 173
Query: 189 Y--------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237
Y + +W PE L G F SK D+WS G + E+ + G +PG++
Sbjct: 174 YYRKGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
Query: 238 HQLDLIT 244
++ +T
Sbjct: 229 EVMEFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 41/224 (18%)
Query: 27 ILEVIGKGSYGVVCAAI--DTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+L +G+GS+G+V D GE +VA+K +++ + + I L E +++
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-ASLRERIEFLNEASVMKGFTC 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKA------NDDLTREHHQFFLYQ 134
+V R++ SK + VV ELM DL +++ N+ + Q
Sbjct: 69 HHVV---RLLGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 135 MLR----ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY- 189
M + Y++ HRDL +N + + +K+ DFG+ R ++ TDY
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYY 175
Query: 190 -------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW L F+ + D+WS G + E+ +
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 81/342 (23%), Positives = 131/342 (38%), Gaps = 64/342 (18%)
Query: 26 KILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR-EVKLLRLLRHP 82
++L VIG+G V A TGE V +++I ++ ++ + L+ E+ + +L HP
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRI-NLEACTNEMVTFLQGELHVSKLFNHP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRA 138
+IV + + + +++VV M DL D ++ + L +L+A
Sbjct: 60 NIVPYRATFIADN-----ELWVVTSFMAYGSAKDL-ICTHFMDGMSELAIAYILQGVLKA 113
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS------------DTPMTVFW 186
L Y+H HR +K +IL + + KV GL R S D P
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDG--KVYLSGL-RSNLSMINHGQRLRVVHDFPKYS-- 168
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
V + +PE+ Y DI+S+G E+ G P K + L+ L
Sbjct: 169 ---VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKL 223
Query: 247 LGT----------PSPETIAVVRNEKARKYLTEMR----------KKPPVPLFQKF-PNV 285
GT P+ E A L E + P + F P+
Sbjct: 224 NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHF 283
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
+ LQR +P RP+A L +FK +I+R S
Sbjct: 284 HHFVEQCLQR----NPDARPSASTLLNHSFFK---QIKRRAS 318
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 78/332 (23%), Positives = 131/332 (39%), Gaps = 70/332 (21%)
Query: 31 IGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR-EVKLLRLLRHPDIVEI 87
IG+G + V A T TG V ++ I D+ + ++ L+ EV L RHP+I+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKA------NDDLTREHHQFFLYQMLRALK 140
+ S ++V+ M + ++K ++ L L+ LR L
Sbjct: 65 WTVFTTGSW-----LWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLN 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGL------------ARVAFSDTPMTVFWTD 188
Y+H HR++K +IL + + + + GL A+V + D P F T
Sbjct: 116 YLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY-DFPQ--FSTS 170
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
+ W +PEL Y DI+S+G E+ TG+ P + ++ L+ L G
Sbjct: 171 VLP--WL-SPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRTQMLLQKLKG 225
Query: 249 TP-SPETIAVVRNEKAR----------------------KYLTEMRKKPPVPLFQKFPNV 285
P SP I E++R + +T R + P
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSS-----KTF 280
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
P L++ + DP+ RP+A L+ +FK
Sbjct: 281 SPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 48/220 (21%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 31 IGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G+GS+G+V I +VAIK +++ + + I L E +++ +V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVV 72
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKA-NDDLTREHHQFF--LYQMLR---- 137
+ ++ + + V+ ELM DL +++ ++ Q L +M++
Sbjct: 73 RLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 138 ---ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY----- 189
+ Y++ HRDL +N + + +K+ DFG+ R ++ TDY
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKGG 179
Query: 190 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW L F+ Y+ D+WS G + E+ T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 16/42 (38%), Positives = 28/42 (66%)
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
+ Q+L L+ +H + HRD+KP+N+L + ++K+ DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 28/203 (13%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
VI +G G G + +K+I+DV ++I E+ + L+HP+IV++
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDV-----NSIP-SSEIADMGKLQHPNIVKLIG 750
Query: 90 IMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH---TA 145
+ R K Y++ E +E +L +V++ +L+ E + + +AL+++H +
Sbjct: 751 LC-----RSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
V +L P+ I+ + + + L + +DT + + Y APE +
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI-------SSAYVAPETRET-- 852
Query: 206 SKYTPAIDIWSIGCIFAEVLTGK 228
T DI+ G I E+LTGK
Sbjct: 853 KDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 31 IGKGSYG-VVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
IG G +G V+ +++ +T +V +K++ V + + ++ L E + R L+H ++++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 89 RIMLPPSKREFKDIYVVFELME-SDLH---QVIKANDDLTREHH--QFFLYQMLRALKYM 142
E +V E DL + + + +T + Q ++ L ++
Sbjct: 62 GQC-----TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H N H DL +N L A+ +K+ D+GL+ + + +V RW APEL
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVD 175
Query: 203 SFFSKY-----TPAIDIWSIGCIFAEVL 225
T ++WS+G E+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 374 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.59 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.38 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.35 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.13 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.05 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.98 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.96 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.78 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.64 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.56 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.49 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.3 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.25 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.16 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.16 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.09 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 98.0 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.9 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.84 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.78 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.74 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.74 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.74 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.7 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.66 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.66 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.52 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.52 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.5 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.19 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.19 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.16 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.08 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.72 | |
| PLN02236 | 344 | choline kinase | 96.61 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.57 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.56 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.42 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.87 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.86 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.65 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.24 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.84 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.67 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.61 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 94.35 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.92 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-75 Score=506.91 Aligned_cols=343 Identities=57% Similarity=0.976 Sum_probs=321.8
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..+....+|..++.||+|+||.|+.|.++.+|+.||+|++...+.+...+++..||+.+|+.++|+||+.+.+++..+..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 45577788888999999999999999999999999999999889999999999999999999999999999999988777
Q ss_pred CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
+..+.+|+|+|+|+.+|.+.++++..+++.+++.+++||+.||+|+|+.+|+|||+||+|++++.++.+||+|||+|+..
T Consensus 96 ~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 96 DKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred cccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 78899999999999999999999988999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
... .....++.++.|+||+|||++... ..|+.+.||||+||||+||++|++.|.|.+..+++..|...+|+|+++.+.
T Consensus 176 ~~~-~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 176 DKF-FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccc-CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 655 455667899999999999998664 789999999999999999999999999999999999999999999999999
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcch
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (374)
.+.++.++.++..+...++.++...+|+.++.+.||+++||.+||.+|+|++|+|+|||+..+..++++|.+++....
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~-- 331 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS-- 331 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999988876543
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCccchh
Q 017301 337 EFERRRVTKDDIRELIYREILEYHPQLLK 365 (374)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (374)
++.. .+.++|++++|+|+.+|+|...+
T Consensus 332 -~~~~-~~~~~~r~~i~~e~~~~~~~~~~ 358 (359)
T KOG0660|consen 332 -FEHE-LTEEELRELIYKEILDFHPDVSK 358 (359)
T ss_pred -cccc-ccHHHHHHHHHHHHHhhCccccC
Confidence 3444 89999999999999999998654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-64 Score=430.39 Aligned_cols=290 Identities=37% Similarity=0.679 Sum_probs=251.4
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|+.+.++|+|+||+||+|+++.||+.||||++..+..+....+-.+|||++|++++|+|+|.++++| .....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 579999999999999999999999999999999987666666677789999999999999999999999 556679
Q ss_pred EEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
++|+|||+.++.+.+.... .++...++.+++|++.|+.|+|+++++||||||+|||++.+|.+||||||+|+......
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg- 155 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG- 155 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence 9999999998888887653 79999999999999999999999999999999999999999999999999999765422
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
..+++++.|+||+|||++.|. ..|+.++||||+||++.||++|.+.|+|.++.+++-.|.+.+|.-.+.-...+...
T Consensus 156 --d~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred --chhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 235789999999999998875 68999999999999999999999999999999999999999999888765544332
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.+-.-+.--....+.++...+|+++..+.||+++||+.||++|+|.+|+|.||||.++..
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 211111111122234556678999999999999999999999999999999999987654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-62 Score=410.70 Aligned_cols=288 Identities=41% Similarity=0.698 Sum_probs=251.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
.||...++||+|.||+||+|++..+|+.||||+++............+|||..|+.++|+||+.++++| .....+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 689999999999999999999999999999999986544444455788999999999999999999999 444569
Q ss_pred EEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
.||+||++.+|...++.+. .++..+++.++.++++||+|||++.|.||||||+|+|++.+|.+||+|||+|+...+...
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9999999999999998754 789999999999999999999999999999999999999999999999999998766543
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
.. ...+.|+||+|||++.|. ..|+..+||||.|||++||+.|.+.|.|.++.+|+..|...+|+|.++.|+.+..-
T Consensus 157 ~~---~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQ---THQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred cc---ccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 32 334899999999998885 78999999999999999999999999999999999999999999999998866532
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (374)
..|.+ +...+..+....|+..++++.||+.+||.+||.+|+|+.|+|+|+||++...+
T Consensus 233 --pdY~~-~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 233 --PDYVK-IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred --ccHHH-HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 22222 22333344455889999999999999999999999999999999999975543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-61 Score=447.93 Aligned_cols=338 Identities=89% Similarity=1.434 Sum_probs=301.5
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||+|+||.||+|++..++..||+|.+............+.+|+.+++.++||||+++++++...+......+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999875444445556788999999999999999999998766555556799
Q ss_pred EEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc
Q 017301 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (374)
Q Consensus 104 lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (374)
+||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999997643333222
Q ss_pred cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 017301 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (374)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (374)
.......||+.|+|||++.+....++.++|||||||++|+|++|++||.+.+...++..+....+.|....+..+.....
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 23345679999999999865335789999999999999999999999999998889999999999999998888888777
Q ss_pred HHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchhhhhccC
Q 017301 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRV 343 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
..++..+....+.+....++.+++.+.++|.+||+.||++|||++++|+||||+++......+...+.+..++.++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL 320 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence 78888877777777777788899999999999999999999999999999999999888888888899999999999999
Q ss_pred CHHHHHHHHHHHHHHhCc
Q 017301 344 TKDDIRELIYREILEYHP 361 (374)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~ 361 (374)
++++.++.++++++++||
T Consensus 321 ~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 321 TKEDVRELIYREILEYHP 338 (338)
T ss_pred CHHHHHHHHHHHHHhcCC
Confidence 999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-63 Score=445.00 Aligned_cols=292 Identities=38% Similarity=0.675 Sum_probs=253.4
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCc
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 96 (374)
...+.+||+++++||.|.||.||+|..+.+|..||||.+++.+....+. .-+||+..|++++ ||||+++.+++.+..
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~- 82 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDND- 82 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccC-
Confidence 3456689999999999999999999999999999999998766554333 4468999999999 999999999995543
Q ss_pred CCCCcEEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
.++|+|||||+.+|.++++.+ ..|++..++.|++||++||+|+|.+|+.|||+||+|||+..+..|||+|||+||.
T Consensus 83 ---~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 83 ---RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred ---ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence 379999999999999999875 4799999999999999999999999999999999999999888899999999997
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..+..+ ++.++.|+||+|||++... ..|+.+.||||+|||++|+.+-+++|+|.+..+++.+|..++|+|..+.|
T Consensus 160 v~SkpP----YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 160 VRSKPP----YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cccCCC----cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 665543 5788999999999998774 78999999999999999999999999999999999999999999998877
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.... ......--.+....+.++....++.++++.+||.+||.|||++||||.++|+||||+.-.
T Consensus 235 ~eg~-~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 235 PEGY-NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred hhHH-HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 6431 111111123445556667777888999999999999999999999999999999998643
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-61 Score=416.39 Aligned_cols=293 Identities=39% Similarity=0.614 Sum_probs=254.2
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..+.|+.+..|++|+||+||+|+|+.|++.||+|.++.......-....+|||++|.+++|||||.+-.++...+. .
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d 150 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---D 150 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---c
Confidence 3568999999999999999999999999999999998655444444567899999999999999999999865443 4
Q ss_pred cEEEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|+|||||+.||..++...+ +|...+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+++.
T Consensus 151 ~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 599999999999999998866 8999999999999999999999999999999999999999999999999999987665
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. .++..+.|.||+|||++.+. ..|+.++|+||+|||+.||+++.+.|.|.+..++++.|.+.+|+|+...|+.+.
T Consensus 231 ~k---~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 231 LK---PYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred cc---cCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 32 34677899999999999885 789999999999999999999999999999999999999999999999988776
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCC--ChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNV--DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~--s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.....+.+ .....+...+...|+.. +....+|+..+|.+||.+|.||.|+|.|.||.....
T Consensus 307 ~lp~~k~~-~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 307 ELPAVKKM-TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred ccchhhcc-ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 54433321 22333444445555554 599999999999999999999999999999998543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-61 Score=427.92 Aligned_cols=264 Identities=33% Similarity=0.557 Sum_probs=221.5
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh-----HHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
..+.|.+.+.||+|+||.|-+|.++.||+.||||++++..... .....+.+|+++|++++|||||+++++|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---- 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---- 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence 5678999999999999999999999999999999997543221 1223467999999999999999999999
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC---CCeEEeeec
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFG 171 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~---~~vkl~DFg 171 (374)
+.....|+||||++| +|.+.+..++.+.+...+.+++|++.||.|||++||+||||||+|||++.+ ..+||+|||
T Consensus 246 -~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 246 -EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred -ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 444557999999996 999999999999999999999999999999999999999999999999877 779999999
Q ss_pred ccccccCCCCcccccccccccccccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCCChhh-HHHHHHHhhCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGT 249 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~ 249 (374)
+|+..+.. .++.+.||||.|.|||++.+.... +..++|+|||||+||.+++|.+||.+..... ..++|.+
T Consensus 325 lAK~~g~~----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~---- 396 (475)
T KOG0615|consen 325 LAKVSGEG----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK---- 396 (475)
T ss_pred hhhccccc----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc----
Confidence 99876533 356788999999999998663233 4448999999999999999999998876544 2233322
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
....-....|..+|.++++||.+||..||++|||++++|+||||+...
T Consensus 397 -----------------------G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 397 -----------------------GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred -----------------------CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 111112234567899999999999999999999999999999998653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-60 Score=435.57 Aligned_cols=255 Identities=32% Similarity=0.567 Sum_probs=227.6
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.+|+.++.||+|||++||.+++..+|+.||+|++.+. .......+++.+||++.+.++|||||++++.| ++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 7899999999999999999999999999999999653 34556677899999999999999999999999 66678
Q ss_pred EEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|||.|+|. ++|..++++++.++|.+++++++||+.||.|||+.+|+|||||..|+|++++.+|||+|||+|.......
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999 5999999999999999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
.. ..+.||||.|.|||++.+ ...+..+||||+|||||.|+.|+|||...+-.+....|...
T Consensus 173 Er---k~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------------- 233 (592)
T KOG0575|consen 173 ER---KKTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------------- 233 (592)
T ss_pred cc---cceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--------------
Confidence 22 256799999999999987 78999999999999999999999999998877777666431
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.+.....+|.++++||.+||+.||.+|||++++|.|+||+.
T Consensus 234 -----------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 234 -----------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred -----------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 11222468999999999999999999999999999999954
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-60 Score=429.12 Aligned_cols=287 Identities=37% Similarity=0.629 Sum_probs=247.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.+.|+.+++||+|.||.||+|++..+|+.||+|++...........-..|||.+|++++||||+++.+++... ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 4679999999999999999999999999999999986555555666778999999999999999999999665 2246
Q ss_pred EEEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+|+|||+.||.-++.+.+ .|++.+++.++.||+.||+|||++||.|||||.+||||+.+|.+||+|||+|+.+....
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99999999999999998754 89999999999999999999999999999999999999999999999999999765544
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
.. .++..+.|.||+|||++.|. ..|+.++|+||.||||.||++|++.|.|.+..+|+..|.+++|.|.++.|....-
T Consensus 273 ~~--~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 273 SA--PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred Cc--ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 32 25777899999999999885 7899999999999999999999999999999999999999999999999873222
Q ss_pred HHHHHHHHHhcCCC--CCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 261 EKARKYLTEMRKKP--PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 261 ~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
+.+. .+.... ..-+.+.+..+++.+.+|+..||..||.+|.||.++|.|+||..
T Consensus 350 P~~~----~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 350 PHAT----IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred Cccc----ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 2111 111111 12233457789999999999999999999999999999999953
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-58 Score=404.23 Aligned_cols=260 Identities=27% Similarity=0.482 Sum_probs=221.9
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
+..+.++.||+|+.|+||+|+|+.|++.+|+|++.. ........++.+|+.+++.++||+||.+|++|+.... .+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eE
Confidence 467889999999999999999999999999999953 3444667789999999999999999999999965531 48
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+| +|.++++..++++|.....|+.++++||.|||+ .+|+||||||+|||++.+|.|||||||.+.....+
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999995 999999999999999999999999999999996 89999999999999999999999999999876554
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC--ChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--SVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
...+++||..|||||.+.+ ..|+.++||||||+.+.||.+|+.||... .....++.+......|++.
T Consensus 233 ----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~----- 301 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR----- 301 (364)
T ss_pred ----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC-----
Confidence 2366799999999999998 79999999999999999999999999875 2223333333332222221
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
+.. ..+|+++++||..||+.||.+|||+.|+|+|||++...
T Consensus 302 -------------------lP~--~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 302 -------------------LPE--GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred -------------------CCc--ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 111 14899999999999999999999999999999998654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-58 Score=400.26 Aligned_cols=321 Identities=35% Similarity=0.619 Sum_probs=256.7
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
-.|.-.+.+|+|+||+||.|....+++.||||++-.... --.+|+.+|+.+.||||+++..+|......+.-++
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 368889999999999999999999999999998743211 12379999999999999999999876654445678
Q ss_pred EEEEccCcccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC-CCeEEeeeccccccc
Q 017301 103 YVVFELMESDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAF 177 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~-~~vkl~DFg~a~~~~ 177 (374)
.+||||++.+|.+.++. +..++.-.++-+++||++||+|||+.||+||||||+|+|+|.+ |.+||||||.|+...
T Consensus 98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 89999999999999984 5689999999999999999999999999999999999999987 899999999999876
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.+.+. .++..|+.|+|||++.|. ..|+.+.||||.||+++||+-|++.|.|.+..+++..|.+.+|+|+.+.+..
T Consensus 178 ~~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 178 KGEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred cCCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 66554 467899999999999885 7899999999999999999999999999999999999999999999998877
Q ss_pred hcCHHHHHHHHHhcCCCCCCccc-cCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCC-CCCCCC-CCc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE-PSCQPI-SKL 334 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~-~~~~~~-~~~ 334 (374)
+....... ...+-...+... .....++++.+|+.++|+++|.+|.|+.++|.||||..+..+... +...++ .-+
T Consensus 253 mn~~y~~~---~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf 329 (364)
T KOG0658|consen 253 MNPNYTEF---KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLF 329 (364)
T ss_pred cCcccccc---cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCcc
Confidence 65442111 111112222222 346789999999999999999999999999999999988765322 222222 223
Q ss_pred chhhhhccCCHHHHHHHHHHHHH
Q 017301 335 EFEFERRRVTKDDIRELIYREIL 357 (374)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~ 357 (374)
+|.........+-+..++-.+..
T Consensus 330 ~f~~~e~~~~~~~~~~l~p~~~~ 352 (364)
T KOG0658|consen 330 NFKRAELGISPELVNVLIPEHLR 352 (364)
T ss_pred CchHHHhccchHHHHhhccHhhh
Confidence 34333344444444444444433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-57 Score=397.54 Aligned_cols=259 Identities=31% Similarity=0.523 Sum_probs=227.1
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
-..+.|++++.||+|+||+||.++.+.+++.+|+|++++..- ...+.....+|.++|..++||+||+++..| ++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----cc
Confidence 447899999999999999999999999999999999976432 224566788999999999999999999999 55
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
..++|+|+||+.| +|..++++.+.+++..++.++..|+.||.|||++||+||||||+|||++.+|.++|+|||+|+...
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 5669999999996 999999999999999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
..... ..+.|||+.|||||++.+ ..|+.++|.||||+++|+|++|.+||.+.+.....+.|...-
T Consensus 177 ~~~~~---t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---------- 241 (357)
T KOG0598|consen 177 KDGDA---TRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---------- 241 (357)
T ss_pred cCCCc---cccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc----------
Confidence 33222 245799999999999988 799999999999999999999999999998777766664311
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCC-CChHHHHHHHHhccCCCCCCC----CHHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRP----TAEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rp----t~~~lL~hp~~~~~ 319 (374)
....+. ++.++++||+++|+.||++|. ++.++-+||||.++
T Consensus 242 ---------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 242 ---------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred ---------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 011234 899999999999999999995 79999999999975
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-57 Score=396.89 Aligned_cols=293 Identities=39% Similarity=0.659 Sum_probs=249.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC-ccccceeecCCC-cCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPS-KREF 99 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~-~~~~ 99 (374)
...|..+++||+|+||+||+|+++.+|+.||+|++.-....+.......+|+.+|+.++|+| |+.+++++...+ ....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688899999999999999999999999999999755443344456789999999999999 999999997654 2334
Q ss_pred CcEEEEEccCcccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 100 KDIYVVFELMESDLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
..+++|+||+..+|..++.... .++...++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 5799999999999999998765 578889999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..-... ..+..++|.||+|||++.+. ..|+...||||+|||++||+++++.|.+.+..+++..|..++|+|..+.|
T Consensus 170 ~~ip~~---~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 170 FSIPMR---TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hcCCcc---cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 442222 24667899999999999885 57999999999999999999999999999999999999999999999988
Q ss_pred hhhcCHHHHHHHHHhcCCC-CCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 256 AVVRNEKARKYLTEMRKKP-PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
+.+..-..... ...... +.++....+..++.+.+++.+||+.+|.+|.||+.+|+||||....
T Consensus 246 p~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 246 PGVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 76543211111 222222 4455566677888999999999999999999999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-55 Score=401.38 Aligned_cols=262 Identities=30% Similarity=0.521 Sum_probs=226.8
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
.++.|++++.||.|+|++|++|+++.+++.||||++.+..-. ....+-+.+|-.+|.+| .||.|++++..| ++
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence 357899999999999999999999999999999998754321 12233466788889999 799999999999 55
Q ss_pred CCcEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...+|+|+||++ |+|.++|+.-+.|++..++.++.+|+.||+|||++|||||||||+|||++.+|++||+|||.|....
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 566999999999 6999999999999999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCc----------ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 178 SDTPM----------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 178 ~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
..... ......++||-.|.+||++.. ...++.+|+|+||||+|.|+.|.+||.+.+....+..|+++.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 32211 111245899999999999988 788999999999999999999999999999888888877532
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
- ...+++++.++|||+++|..||.+|+|+.+|-+||||.++.
T Consensus 304 y-------------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 304 Y-------------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred c-------------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 2 22356889999999999999999999999999999999753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-55 Score=385.26 Aligned_cols=261 Identities=32% Similarity=0.482 Sum_probs=222.8
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...+.|.+.+.||+|+||+||+|+++.++..||||.+.+........+.+..|+.+|+.++|||||.++++... .
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-----~ 81 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-----D 81 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-----C
Confidence 35689999999999999999999999999999999997655566677778899999999999999999999944 4
Q ss_pred CcEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC------CCeEEeeecc
Q 017301 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN------CKLKVCDFGL 172 (374)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~------~~vkl~DFg~ 172 (374)
+.+|+|||||. |||.+++.+.+.+++..++.++.||+.||++||+++|+||||||+|||++.. -.+||+|||+
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 56999999999 4999999999999999999999999999999999999999999999999875 4589999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
|+...... .....||+|.|||||++.. +.|+.++|+||+|+|+|+|++|++||...+..+.+..+.+.-
T Consensus 162 AR~L~~~~----~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~----- 230 (429)
T KOG0595|consen 162 ARFLQPGS----MAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN----- 230 (429)
T ss_pred hhhCCchh----HHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc-----
Confidence 98765332 3356799999999999976 789999999999999999999999999888766554332210
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
...+. ....+++...+|+...|+.+|..|.+..+-+.|+++..-
T Consensus 231 -------------------~~~~~----~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 231 -------------------EIVPV----LPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred -------------------cccCc----hhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 00000 012356677899999999999999999999999998753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-56 Score=378.19 Aligned_cols=256 Identities=32% Similarity=0.485 Sum_probs=215.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
-..|+++++||+|+||+||+|.+..+|..||.|.++-...+......+..|+.+|++++||||+++++.-+.. +...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~---~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE---DNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc---cchh
Confidence 3569999999999999999999999999999999986656666677889999999999999999999844332 2234
Q ss_pred EEEEEccCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhh--CC--ccccCCCCCceEecCCCCeEEeeecc
Q 017301 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHT--AN--VYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~--~~--i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
++||||+|+ |||.++++. ...++|..+++++.|++.||.++|+ .. |+||||||.||+++.+|.|||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 899999999 599999974 4579999999999999999999999 44 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
++...+.. .+..+++|||+||+||++.+ .+|+.+|||||+||++|||+.-++||.+.+-.+....|...--.|-+
T Consensus 175 ~r~l~s~~---tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 175 GRFLSSKT---TFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred HhHhcchh---HHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 99765543 33467899999999999988 89999999999999999999999999999766555555432111111
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
. ..+|..+..||..|+..||+.||+. +|++..+
T Consensus 250 ~-----------------------------~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di 282 (375)
T KOG0591|consen 250 D-----------------------------EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDI 282 (375)
T ss_pred H-----------------------------HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHH
Confidence 0 2468889999999999999999986 5555544
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=395.24 Aligned_cols=337 Identities=54% Similarity=0.987 Sum_probs=286.1
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
|...++|++.+.||+|++|+||+|.+..++..||+|.++...........+.+|+.+++.++|+||+++++++.......
T Consensus 1 ~~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred CccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 34678999999999999999999999999999999998754444444556778999999999999999999886655445
Q ss_pred CCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...+|+|+||+.++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 81 FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred cCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 56799999999999999999888999999999999999999999999999999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. .......++..|+|||.+.+. ..++.++|+|||||++|+|++|++||.+.+.......+....+.+.++.+...
T Consensus 161 ~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 161 KG---DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred Cc---ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 21 122345688899999987642 35888999999999999999999999999888888889999999988887777
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchhh
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~ 338 (374)
.......+................+.+++.+.+||++||+.||.+|||+.++|+||||..+......+..+. .+.+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~--~~~~~~ 314 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQT--PFSFDF 314 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCC--ccchhh
Confidence 777777776665554444444556789999999999999999999999999999999998877666665543 456777
Q ss_pred hhccCCHHHHHHHHHHHHHHhCc
Q 017301 339 ERRRVTKDDIRELIYREILEYHP 361 (374)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
+....+.+++++.++.|.+.+||
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 315 EEDALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hhhhcCHHHHHHHHHHHHhhcCC
Confidence 77779999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-53 Score=395.76 Aligned_cols=333 Identities=41% Similarity=0.798 Sum_probs=272.3
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 96 (374)
.+.+.++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 4567899999999999999999999999999999999987544443445567799999999999999999998864432
Q ss_pred CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
.....+|+++++++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 23456899999998899887764 46999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.+.++...
T Consensus 169 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 169 DDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred CCC------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 322 2345789999999998652 468899999999999999999999999998888888888888998888777
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcch
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (374)
.........+...+...........+...++.+.+||.+||+.||.+|||+.++|+||||.....+...+...+ ...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~---~~~ 318 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEP---YDE 318 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCc---ccc
Confidence 76666666666555444444444445667889999999999999999999999999999998766554443333 223
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCc
Q 017301 337 EFERRRVTKDDIRELIYREILEYHP 361 (374)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
.......+.+++++..+.+...+.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07878 319 SPENKERTIEEWKELTYEEVSSFKP 343 (343)
T ss_pred chhhhhccHHHHHHHHHHHHHhcCC
Confidence 3344566678899998888877665
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-54 Score=398.43 Aligned_cols=259 Identities=32% Similarity=0.519 Sum_probs=219.3
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC--C-hHHHHHHHHHHHHHHhCC-CCCccccceeecCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--H-ISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 95 (374)
...++|.+++.||+|+||+|+.|.+..++..||+|++.+... . ......+.+|+.+++.++ ||||+++++++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 456899999999999999999999999999999998765311 1 133456678999999999 99999999999544
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC-CCeEEeeeccc
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLA 173 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~-~~vkl~DFg~a 173 (374)
.++|+||||+.| +|++++...+++.|..++.+++||+.||+|||+.||+||||||+|||++.+ +++||+|||++
T Consensus 93 ----~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 93 ----TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred ----CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 449999999996 999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
.... .......+.+||+.|+|||++.+. ..| +.++||||+|++||.|++|+.||...+.......|.+
T Consensus 169 ~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~-~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------- 237 (370)
T KOG0583|consen 169 AISP---GEDGLLKTFCGSPAYAAPEVLSGK-GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------- 237 (370)
T ss_pred cccC---CCCCcccCCCCCcccCCHHHhCCC-CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-------
Confidence 8653 112345678999999999999883 215 4789999999999999999999998765544443321
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCC-ChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV-DPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
........+ |+++++||++||..||.+|+|+.+++.||||+.
T Consensus 238 ------------------------~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 ------------------------GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ------------------------CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 011112334 999999999999999999999999999999986
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-56 Score=370.48 Aligned_cols=262 Identities=30% Similarity=0.484 Sum_probs=227.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
-..+.|.+.+.||+|+|++|+++.+..+|+.+|+|++..........+.+.+|+++.+.++||||+++++.+ .+.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccc
Confidence 456789999999999999999999999999999999875444445677889999999999999999999988 555
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC---CCCeEEeeeccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARV 175 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~---~~~vkl~DFg~a~~ 175 (374)
...|+|+|++.| +|...+..+.-++|..+..+++||++||.|+|.+||+|||+||+|+++-. ...+||+|||+|..
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 678999999997 99888887778899999999999999999999999999999999999854 34599999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
... ....-...|||.|||||++.. .+|+.++||||.|+|||-|+.|.+||.+.+..+..+.|...
T Consensus 163 l~~----g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g--------- 227 (355)
T KOG0033|consen 163 VND----GEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG--------- 227 (355)
T ss_pred eCC----ccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc---------
Confidence 542 223456789999999999988 89999999999999999999999999998877776666532
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
...-....|+.+++++++||++||..||.+|+|+.++|+|||+.+-
T Consensus 228 ------------------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 228 ------------------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred ------------------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 1112223578999999999999999999999999999999999763
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-54 Score=400.24 Aligned_cols=282 Identities=38% Similarity=0.643 Sum_probs=233.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-C-----CCccccceeecCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-H-----PDIVEIKRIMLPP 94 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~i~~~~~~~~~~ 94 (374)
+..||.|++.||+|+||.|.+|.|..|++.||||++++. ..-..+...|+.+|..++ | -|+|+++++|...
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 345899999999999999999999999999999999853 344556678999999997 3 3899999999554
Q ss_pred CcCCCCcEEEEEccCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC--CCeEEeee
Q 017301 95 SKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--CKLKVCDF 170 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~--~~vkl~DF 170 (374)
+++|||+|.+..+|.++++.+. +++...++.++.||+.||.+||+.||||+||||+|||+..- ..||++||
T Consensus 261 -----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 261 -----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred -----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence 5699999999999999999875 68999999999999999999999999999999999999654 46999999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
|.|+..... ...++.++.|+|||++.| .+|+.+.||||||||++||++|.++|.|.+..+++..|+.++|.|
T Consensus 336 GSSc~~~q~------vytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 336 GSSCFESQR------VYTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred ccccccCCc------ceeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 999754332 237789999999999999 899999999999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCHHHHHHHHH----------------------------hcCCCCCC-----ccccCC-CCChHHHHHHHHh
Q 017301 251 SPETIAVVRNEKARKYLTE----------------------------MRKKPPVP-----LFQKFP-NVDPLALRLLQRL 296 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~-----~~~~~~-~~s~~~~~li~~~ 296 (374)
++..+...... ..+++. .......+ .....+ .....+.|||.+|
T Consensus 408 p~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~ 485 (586)
T KOG0667|consen 408 PPKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC 485 (586)
T ss_pred CHHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence 99887654422 111111 11111111 111122 2234578999999
Q ss_pred ccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 297 IAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 297 L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
|.+||.+|+|+.++|+||||.+..
T Consensus 486 L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 486 LEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred hccCchhcCCHHHHhcCccccccc
Confidence 999999999999999999999643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=366.76 Aligned_cols=254 Identities=26% Similarity=0.493 Sum_probs=223.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
-++|++++.||.|+||+|.+++++.+|..+|+|++++.. -.....+...+|.++|+.+.||+++++.+.+ .+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence 467999999999999999999999999999999987431 2334455678999999999999999999999 4556
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
++|+||||.+| .|+.++.+.+++++..++.++.||+.||+|||+++|++||+||+|||++.+|.+||+|||+|......
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 69999999996 99999999999999999999999999999999999999999999999999999999999999875443
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
+ .+.||||.|+|||++.. .+|+.++|.|||||++|||+.|.+||...+.....+.|...-
T Consensus 198 T------~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~------------ 257 (355)
T KOG0616|consen 198 T------WTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK------------ 257 (355)
T ss_pred E------EEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc------------
Confidence 2 45699999999999988 899999999999999999999999999998877666664311
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCC-----CCHHHHhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R-----pt~~~lL~hp~~~~~ 319 (374)
....+.+++.+++||+++|+.|-.+| ....++.+||||+++
T Consensus 258 -------------------v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 258 -------------------VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred -------------------ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 11124689999999999999999999 367899999999975
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-54 Score=400.71 Aligned_cols=264 Identities=28% Similarity=0.491 Sum_probs=229.6
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
...+-|++++.||.|+.|.|.+|.+..||+.+|||++.+. .........+.+||-+|+.+.|||+++++++| +.
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~ 83 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----EN 83 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----cc
Confidence 4457799999999999999999999999999999999765 22334455788999999999999999999999 55
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
..++|+|.||+.| .|++++...+++++.++.++++||+.|+.|||..+|+|||+||+|+|++.++++||+|||.|....
T Consensus 84 ~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 5679999999995 999999999999999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.+ ....+.||+|.|.|||++.|. ..-+.++||||+|||||.|+||+.||++.+....+.++..
T Consensus 164 ~g----klLeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~------------ 226 (786)
T KOG0588|consen 164 PG----KLLETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR------------ 226 (786)
T ss_pred CC----ccccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc------------
Confidence 43 245678999999999999883 3345689999999999999999999998776555544432
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIER 324 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~ 324 (374)
..++...++|+++++||++||..||.+|+|.++|+.|||+.+......
T Consensus 227 -------------------G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 227 -------------------GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred -------------------CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 233444679999999999999999999999999999999998765443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=396.52 Aligned_cols=256 Identities=34% Similarity=0.588 Sum_probs=229.7
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+......+...+.+|+++++.++||||+.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 689999999999999999999999999999999998878888888999999999999999999999999 666779
Q ss_pred EEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 103 YVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
|+|+|||.|+|..++...+.++|+.++.+..+++.||.|||+++|.|||+||+|||+..+|.+|++|||+|+....+.
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-- 154 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-- 154 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 017301 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (374)
...+..-|||.|||||++.+ ++|+..+|+||||||+|||.+|++||...+..+....|.
T Consensus 155 -~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~------------------ 213 (808)
T KOG0597|consen 155 -SVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL------------------ 213 (808)
T ss_pred -eeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh------------------
Confidence 33466789999999999988 899999999999999999999999998776554444433
Q ss_pred HHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.....+ .+.+|..+.+|++.+|..||.+|.|..+++.|||.++-
T Consensus 214 ---------~d~v~~----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 214 ---------KDPVKP----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ---------cCCCCC----cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 222111 23689999999999999999999999999999999863
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=372.01 Aligned_cols=335 Identities=36% Similarity=0.660 Sum_probs=283.0
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS- 95 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 95 (374)
..+.+..||.-+..+|.|+. .|..|.|..++++||+|++..++.+...+++..+|..++..++|+|+++++.+|.+..
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 45567899999999999999 8889999999999999999877777777889999999999999999999999997653
Q ss_pred cCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
..++..+|+|||+|..+|.+.+.. .++...++.|++|++.|++|||++||+||||||+||++..++.+|+.|||+|+.
T Consensus 90 l~~~~e~y~v~e~m~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhHHHHHHhhhhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 345678999999999999999983 588899999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
.... ...++++.|+.|+|||++.+ ..|...+||||+||++.||++|+..|+|.+..++..++...+|+|.+...
T Consensus 168 e~~~----~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 168 EDTD----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred cCcc----cccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 4332 34578899999999999988 56999999999999999999999999999999999999999999999887
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCC------------CCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFP------------NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (374)
...... .+.++....+.....+...+| .-+..+++|+.+||..||++|.|++++|+|||++ ++-..
T Consensus 242 ~qL~~~-~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~-vw~~~ 319 (369)
T KOG0665|consen 242 KQLQPT-VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK-VWYDP 319 (369)
T ss_pred HHhhHH-HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee-eeccc
Confidence 665433 233333222222222222222 2345789999999999999999999999999999 44444
Q ss_pred CCCCCCCCCCcchhhhhccCCHHHHHHHHHHHHHHhCcc
Q 017301 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362 (374)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (374)
.++..+++..++..++.+..|.++|+++||+|+.+|.+.
T Consensus 320 ~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~ 358 (369)
T KOG0665|consen 320 DEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEF 358 (369)
T ss_pred ccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhccc
Confidence 555555555566778889999999999999999999884
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-52 Score=390.43 Aligned_cols=329 Identities=36% Similarity=0.646 Sum_probs=259.2
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-CC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-RE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~ 98 (374)
...++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++..... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45689999999999999999999999999999999997655555556678899999999999999999998865432 33
Q ss_pred CCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...+|+||||++++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 456899999999999888864 488999999999999999999999999999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....+.|.++.+...
T Consensus 179 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 179 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred CC----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 21 1234578999999999987 67899999999999999999999999999999999999888998887765544
Q ss_pred cCHHHHHHHHHhcCCCCCCcc------------ccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLF------------QKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (374)
... ...+............. ......++.+++||.+||+.||.+|||+.++|+||||..+..+...+
T Consensus 253 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 331 (364)
T cd07875 253 QPT-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331 (364)
T ss_pred hHH-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence 322 22222221111111000 11122456789999999999999999999999999998766554433
Q ss_pred CCCCCCCcchhhhhccCCHHHHHHHHHHHHHH
Q 017301 327 SCQPISKLEFEFERRRVTKDDIRELIYREILE 358 (374)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (374)
...+ ...+...+.+..+.++|++.+++++.+
T Consensus 332 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd07875 332 APPP-KIPDKQLDEREHTIEEWKELIYKEVMD 362 (364)
T ss_pred CCCC-CCCCccchhhhccHHHHHHHHHHHHHc
Confidence 2222 111223455667778899999988754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-53 Score=382.64 Aligned_cols=285 Identities=36% Similarity=0.658 Sum_probs=234.2
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
+..++|++.+.||.|+||+||+|++..++..||+|+++..... .....+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 75 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT-----E 75 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----C
Confidence 4567899999999999999999999999999999998643221 223456789999999999999999999843 3
Q ss_pred CcEEEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+||||+.++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 76 RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 4689999999999999887654 579999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... ......+++.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+....+.|..+.+...
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 156 PTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred CCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 211 12345789999999987652 56889999999999999999999999999999999999999999988877654
Q ss_pred cCH-HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 259 RNE-KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 259 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
... ....+. .......+.....+.+++++++||++||++||.+|||++|+|+||||
T Consensus 232 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 232 TSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccchhhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 432 111111 11111222233345788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=388.99 Aligned_cols=265 Identities=29% Similarity=0.464 Sum_probs=225.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..+.|+++..||+|+||.||+|+.+.||+.+|+|++++... .......+..|-.+|....+|+||+++..| ++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 46789999999999999999999999999999999986543 334455688899999999999999999999 566
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.++||||||++| |+..++...+.+++..++.++.+++.||..||..|++||||||+|+||+..|++||+|||+|.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 779999999996 9999999999999999999999999999999999999999999999999999999999999953211
Q ss_pred C-------------------CCc-cc------------------------ccccccccccccccccccccCCCCCccchH
Q 017301 179 D-------------------TPM-TV------------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (374)
Q Consensus 179 ~-------------------~~~-~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 214 (374)
. .+. .. .....+|||.|+|||++.+ ..|+..+|.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDw 371 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDW 371 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccH
Confidence 0 000 00 0124589999999999998 789999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHH
Q 017301 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294 (374)
Q Consensus 215 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 294 (374)
||||||+|||+.|.+||.+.+..+....|...-.+ ... ..-..++++++|||.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------------l~f------P~~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------------LKF------PEEVDLSDEAKDLIT 424 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------------ccC------CCcCcccHHHHHHHH
Confidence 99999999999999999999988888777652111 000 001346799999999
Q ss_pred HhccCCCCCCC---CHHHHhcCCCCCcCc
Q 017301 295 RLIAFDPKDRP---TAEEALADPYFKGLA 320 (374)
Q Consensus 295 ~~L~~dp~~Rp---t~~~lL~hp~~~~~~ 320 (374)
+||. ||.+|. .++||-+||||+++.
T Consensus 425 rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 425 RLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 9999 999997 599999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-52 Score=385.78 Aligned_cols=334 Identities=50% Similarity=0.872 Sum_probs=272.7
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++.+.||+|++|+||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++........
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4568999999999999999999999999999999998642 222345567789999999999999999998876655555
Q ss_pred CcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
..+|+|+||+.++|.+.+.. ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 67999999999999888854 46999999999999999999999999999999999999999999999999999765433
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
...........|++.|+|||.+.+. ..++.++||||+||++|+|++|++||.+.+.......+...++.+.++.+....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 2222223445789999999986542 468899999999999999999999999998888888888999998888776666
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchhhh
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (374)
......++.........+.....+..++.+.++|.+||+.||.+|||+.++++||||+.+......+..++...++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF 318 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccc
Confidence 66666665554444444444445678999999999999999999999999999999999877666655544333344332
Q ss_pred hccCCHHHHHHHHHHHHH
Q 017301 340 RRRVTKDDIRELIYREIL 357 (374)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~ 357 (374)
++..++..++.|+.++.
T Consensus 319 -~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 319 -DDLPKEKLKELIFEEIM 335 (336)
T ss_pred -cccCHHHHHHHHHHHhc
Confidence 55668889999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-52 Score=390.22 Aligned_cols=330 Identities=42% Similarity=0.710 Sum_probs=260.5
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
.|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999999999999999999875544445566788999999999999999999999765433445799
Q ss_pred EEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc
Q 017301 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (374)
Q Consensus 104 lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (374)
+||||+.++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999976432221
Q ss_pred cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 017301 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (374)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (374)
.......+++.|+|||++.+. ..++.++||||+||++|+|++|+.||.+.+..+++..+....|.+..+.+..... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GA 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HH
Confidence 122345688999999988763 4578999999999999999999999999999999999999999998876554332 22
Q ss_pred HHHHHHhcCCCCC--CccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccC-------------------
Q 017301 264 RKYLTEMRKKPPV--PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI------------------- 322 (374)
Q Consensus 264 ~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~------------------- 322 (374)
...+.......+. .........++.+.+||.+||+.||.+|||+.++|+||||.+..-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYT 316 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCC
Confidence 2222221111111 0112234568899999999999999999999999999999873210
Q ss_pred -CCCCCCCCCCCcchhhhhccCCHHHHHHHHHHHHHHh
Q 017301 323 -EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEY 359 (374)
Q Consensus 323 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (374)
+.++. +...+.+..+....+..++++.++.++.+.
T Consensus 317 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (372)
T cd07853 317 SDFEPS--ANPPFDDEYEKNLTSVRQVKEELHQFILEQ 352 (372)
T ss_pred cccCCC--CCCCCCcccccccCCHHHHHHHHHHHHHHh
Confidence 11111 112334455556677788888888887765
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-52 Score=388.41 Aligned_cols=326 Identities=37% Similarity=0.657 Sum_probs=251.3
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-CC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-RE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~ 98 (374)
...++|++.+.||+|+||+||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++..... ..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45789999999999999999999999999999999997655555556678899999999999999999999865432 23
Q ss_pred CCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...+|+||||+++++.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 456899999999998888754 488999999999999999999999999999999999999999999999999975322
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....+.|..+.....
T Consensus 176 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 176 NF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred Cc----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 21 1234578999999999987 67899999999999999999999999999988888888888888887654433
Q ss_pred cCHHHHHHHHHhcCCCCCCcccc------------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQK------------FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (374)
.. ....+............... ....++.+++||.+||+.||++|||+.|+|+||||..+..+....
T Consensus 250 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~ 328 (359)
T cd07876 250 QP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAE 328 (359)
T ss_pred HH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccccc
Confidence 21 12222222111111111111 112467899999999999999999999999999998755443322
Q ss_pred CCCCCCCcchhhhhccCCHHHHHHHHHHH
Q 017301 327 SCQPISKLEFEFERRRVTKDDIRELIYRE 355 (374)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (374)
...+. ......+.+..+.+.+.+.+...
T Consensus 329 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 356 (359)
T cd07876 329 APPPQ-IYDAQLEEREHAIEEWKELIYKE 356 (359)
T ss_pred CCCcc-ccccccccccccHHHHHHHHHHH
Confidence 22221 11222245555666666666554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=364.20 Aligned_cols=295 Identities=38% Similarity=0.633 Sum_probs=243.0
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
+.-..|++++.||+|.||.||+|..+.++. .+|+|+++.............||+..++.++|||++.+..+++..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~- 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH- 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-
Confidence 445689999999999999999997665543 789999986544445556778999999999999999999999764
Q ss_pred cCCCCcEEEEEccCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC----CCeE
Q 017301 96 KREFKDIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN----CKLK 166 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~----~~vk 166 (374)
...+++++||++.+|+++++-+ ..++...++.|++||+.|+.|||++.|+||||||.|||+..+ |+||
T Consensus 100 ---d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 100 ---DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ---CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 3569999999999999999632 468999999999999999999999999999999999999888 8999
Q ss_pred EeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC---------hh
Q 017301 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS---------VV 237 (374)
Q Consensus 167 l~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~---------~~ 237 (374)
|+|||+|+.+...-..-......+.|.||+|||++.|. ..|+++.||||+|||+.||+|-.+.|.+.. ..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 99999999876654433344567889999999999885 789999999999999999999999997653 46
Q ss_pred hHHHHHHHhhCCCCHHHHhhhcC-HHHHHHHHHhcCCCCCC-----ccccCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 017301 238 HQLDLITDLLGTPSPETIAVVRN-EKARKYLTEMRKKPPVP-----LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (374)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL 311 (374)
+++..|..++|+|..+.|+.... +.....+...+.....+ .......-++.+.+|+.+||++||.+|.|++++|
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 78999999999999998886653 33333333333222211 1223344567799999999999999999999999
Q ss_pred cCCCCCcC
Q 017301 312 ADPYFKGL 319 (374)
Q Consensus 312 ~hp~~~~~ 319 (374)
+|+||+.-
T Consensus 336 eh~yF~~d 343 (438)
T KOG0666|consen 336 EHPYFTED 343 (438)
T ss_pred cccccccC
Confidence 99999864
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=382.89 Aligned_cols=327 Identities=36% Similarity=0.638 Sum_probs=253.3
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-CC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-RE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~ 98 (374)
...++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++..... ..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45689999999999999999999999999999999998655555566778899999999999999999999865432 33
Q ss_pred CCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
....|+||||+++++.+.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred cceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 456899999999999888864 488999999999999999999999999999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...++.+.++.+...
T Consensus 172 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 172 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cc----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 21 1234578999999999877 67899999999999999999999999999988888888888888887765544
Q ss_pred cCHHHHHHHHHhcCCCCCC------------ccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVP------------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (374)
... ...+........... ........+..+++||.+||+.||++|||+.|+|+||||..+..+....
T Consensus 246 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~~~~ 324 (355)
T cd07874 246 QPT-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVE 324 (355)
T ss_pred cHH-HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChhhcc
Confidence 322 222222211111000 0011123466789999999999999999999999999998664432222
Q ss_pred CCCCCCCcchhhhhccCCHHHHHHHHHHHH
Q 017301 327 SCQPISKLEFEFERRRVTKDDIRELIYREI 356 (374)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (374)
..+ ..........+..+.+++.+.++.++
T Consensus 325 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (355)
T cd07874 325 APP-PQIYDKQLDEREHTIEEWKELIYKEV 353 (355)
T ss_pred CCC-ccccccchhhhhccHHHHHHHHHHHh
Confidence 111 11122222344456677777777765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=380.96 Aligned_cols=334 Identities=43% Similarity=0.820 Sum_probs=282.2
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..+...++|++.+.||+|++|.||+|.+..++..||+|++............+.+|+.+++.++|||++++++++.....
T Consensus 9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 44567789999999999999999999999999999999987544344445667889999999999999999998755433
Q ss_pred -CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 -REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 -~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
.....+|+|+||++++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 89 ~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 89 LEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 34456899999998899998876 4699999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
.... .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+.+..+
T Consensus 168 ~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 168 TDDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccc------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 4322 2344688899999987552 36788999999999999999999999999888888888888898888888
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLE 335 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~ 335 (374)
..........++..+...........++..++.+.++|.+||+.||.+|||+.++++||||+.+...+..+.. ....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~---~~~~ 317 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVA---PPYD 317 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccccc---cccC
Confidence 8777777777776666555545555556779999999999999999999999999999999988766655542 2345
Q ss_pred hhhhhccCCHHHHHHHHHHHHHHhCc
Q 017301 336 FEFERRRVTKDDIRELIYREILEYHP 361 (374)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
..++....+.++|+++++.++.+|.|
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 318 QSFESRDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred cchhhhhcCHHHHHHHhHHHHHhccC
Confidence 67788899999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=381.36 Aligned_cols=330 Identities=50% Similarity=0.921 Sum_probs=277.8
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++.+.||+|++|.||+|.+..+|..||+|++............+.+|+.+|+.++||||+++++++.... ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCc
Confidence 458999999999999999999999999999999998765444445566778999999999999999999875543 3456
Q ss_pred cEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
.+|+||||+.++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred eEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 79999999999999999888889999999999999999999999999999999999999999999999999987543322
Q ss_pred Cc-ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 181 PM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 181 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. ........++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+....+..+....|.|+...+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred cCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 11 1112345789999999987653 458899999999999999999999999999888999999999999998887777
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchhhh
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (374)
.................+.....+..++.+.++|++||+.||.+|||+.+++.||||.+...+..++.+.+ .+++.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~ 318 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPP--PFDFDFE 318 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCC--CCCCChh
Confidence 77666666665555555555556778999999999999999999999999999999999888777766533 4667777
Q ss_pred hccCCHHHHHHHHHH
Q 017301 340 RRRVTKDDIRELIYR 354 (374)
Q Consensus 340 ~~~~~~~~~~~~~~~ 354 (374)
....+.+.+.+.|.+
T Consensus 319 ~~~~~~~~~~~~~~~ 333 (334)
T cd07855 319 AIELSREQLKEAIVK 333 (334)
T ss_pred hhhcChhhHHHHhhc
Confidence 777888888777654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=376.97 Aligned_cols=291 Identities=34% Similarity=0.576 Sum_probs=225.3
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
+|..++|++.+.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++. .
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~ 74 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIH-----T 74 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEe-----c
Confidence 46679999999999999999999999999999999998743222 22345678999999999999999999984 3
Q ss_pred CCcEEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
....|+||||+.++|.+++... +.+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 4568999999999999888764 578999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 256 (374)
... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.+... .+.+..+....+.+....+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 211 112345789999999987652 4588899999999999999999999987643 45666666667777665543
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccC--CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
......... ........+......+ ...++.+.+||.+||+.||.+|||+.++|+||||+++.
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 231 GVHSLPHFK-PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred chhhccccc-cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 322100000 0000000011111111 13567899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-51 Score=378.21 Aligned_cols=330 Identities=56% Similarity=0.968 Sum_probs=281.5
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||+|++|.||+|.+..++..||+|.+............+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999976544445566788999999999999999999998766544456799
Q ss_pred EEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc
Q 017301 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (374)
Q Consensus 104 lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (374)
+||||++++|.+++.....+++..++.++.||+.||++||+.||+||||||+||+++.++.++|+|||.+..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998654432111
Q ss_pred cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 017301 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (374)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (374)
.......+++.|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+..+....+....+.+.+..+........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 223445789999999998773 2789999999999999999999999999999999999999999999888777677777
Q ss_pred HHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchhhhhccC
Q 017301 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRV 343 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
..++.........+.....+.+++.+.++|.+||++||.+|||+.++|.||||+++.....++.......+ ..++....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 318 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDF-DFFDDDEL 318 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccc-cccchhhc
Confidence 77777766666666666777899999999999999999999999999999999998877666665544322 14577788
Q ss_pred CHHHHHHHHHHH
Q 017301 344 TKDDIRELIYRE 355 (374)
Q Consensus 344 ~~~~~~~~~~~~ 355 (374)
++++.+++|+.|
T Consensus 319 ~~~~~~~~~~~~ 330 (330)
T cd07834 319 TEEELKELIYEE 330 (330)
T ss_pred CHHHHhHHhhcC
Confidence 999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=372.03 Aligned_cols=284 Identities=36% Similarity=0.656 Sum_probs=224.2
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++.+.||+|+||+||+|+++.+++.||+|++............+.+|+.+++.++||||+++++++ .....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 479999999999999999999999999999999975444334456678999999999999999999998 344569
Q ss_pred EEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|+||||+++++.+.+.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99999999866565543 45799999999999999999999999999999999999999999999999999976433221
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC-
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN- 260 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 260 (374)
. ......|++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+..+....+....+..+...+.....
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 A--NYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred c--cccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 1 1234578999999999877 6789999999999999999999999999888777777777777666554332111
Q ss_pred HHHHHHHHHhcCCCCCCc-cccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 261 EKARKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
...... .......+... ......+|+.+.+||++||++||++|||++++|+||||
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGL-RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhccc-ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 100000 00000000000 01123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=372.40 Aligned_cols=284 Identities=35% Similarity=0.594 Sum_probs=228.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhC---CCCCccccceeecCCCcCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~ 98 (374)
++|++++.||+|+||+||+|.+.. ++..||+|.++...........+.+|+.+++.+ +||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 568899999875433333334556677777665 6999999999986544344
Q ss_pred CCcEEEEEccCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
...+++||||+.++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 5679999999999999999753 35899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.|.+..+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 3321 1234578999999999876 678999999999999999999999999999988888888888877765443
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
....-. -.........+.....+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 235 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhccc----chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 211000 00111222233334456789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=381.88 Aligned_cols=265 Identities=29% Similarity=0.497 Sum_probs=226.4
Q ss_pred ccccccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceee
Q 017301 12 DKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIM 91 (374)
Q Consensus 12 ~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 91 (374)
.+.++..-+....|....+||+|+.|.||.|....+++.||+|.+....+ ...+.+++|+.+|+..+|+|||++++.|
T Consensus 262 l~~v~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sy 339 (550)
T KOG0578|consen 262 LKRVVSQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSY 339 (550)
T ss_pred hheeccCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHh
Confidence 34455666777899999999999999999999999999999999975433 3345688999999999999999999999
Q ss_pred cCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeee
Q 017301 92 LPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (374)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DF 170 (374)
... ..+|+||||++| +|.+.+... .++|.++..|++.+++||+|||.+||+|||||.+|||++.+|.+||+||
T Consensus 340 lv~-----deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 340 LVG-----DELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred ccc-----ceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeee
Confidence 655 459999999996 877777654 5999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
|+|..+...... ....+|||+|||||++.. ..|+++.||||||+++.||+-|.+||-..+....+.+|.. .|+
T Consensus 414 GFcaqi~~~~~K---R~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~- 486 (550)
T KOG0578|consen 414 GFCAQISEEQSK---RSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT- 486 (550)
T ss_pred eeeeccccccCc---cccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCC-
Confidence 999876554432 356799999999999988 7899999999999999999999999988776555544422 111
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
+.......+|+.++||+.+||+.|+.+|+||.+||+||||+
T Consensus 487 --------------------------P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 487 --------------------------PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred --------------------------CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 22233457999999999999999999999999999999994
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-52 Score=368.74 Aligned_cols=263 Identities=29% Similarity=0.452 Sum_probs=212.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
..++..++.||+|+||.||++.+..+|..+|+|.+... +......+.+|+.+|++++|||||++++....... ..
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---ee
Confidence 56789999999999999999999999999999998643 22226678899999999999999999997533221 36
Q ss_pred EEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-CCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~-~~~vkl~DFg~a~~~~~ 178 (374)
+++.|||+.+ +|.+++...+ .+++..++.+.+||++||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 8999999995 9999999877 7999999999999999999999999999999999999999 79999999999976543
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC-ChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-SVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
............||+.|||||++... ...++++|||||||++.||+||.+||... .....+-.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~--------------- 234 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLL--------------- 234 (313)
T ss_pred ccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHH---------------
Confidence 11111223457899999999999841 23446999999999999999999999763 21111111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
+......| .....+|+.+++||.+|+..||.+||||+++|+|||.++.
T Consensus 235 ------------ig~~~~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 235 ------------IGREDSLP--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ------------HhccCCCC--CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 11111111 3345689999999999999999999999999999999764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=371.34 Aligned_cols=291 Identities=38% Similarity=0.671 Sum_probs=238.5
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
++..++|++.+.||+|+||+||+|+++.+++.||+|.++..... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 75 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT----- 75 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee-----
Confidence 34568899999999999999999999999999999998743222 223456789999999999999999999843
Q ss_pred CCcEEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
....|+||||++++|.+.+... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 76 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 3568999999999999888764 458999999999999999999999999999999999999999999999999987533
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+....+....+.+....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 156 VPTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred CCcc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 2221 12334688999999987653 4688999999999999999999999999999899999999999998887765
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.......... ......+.+.....+.+++++++||.+||+.||.+|||+.++|+||||+.+.
T Consensus 232 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 232 ISSNDEFKNY-NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hcchhhhhhh-hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 5433211111 1222223333344567899999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=364.99 Aligned_cols=274 Identities=29% Similarity=0.413 Sum_probs=225.3
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..+.|++...||.|..++||+|+...++..||||++.-+..+ .....+.+|+..|+.++||||++++..|...+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~----- 97 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS----- 97 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-----
Confidence 468999999999999999999999999999999999754333 33678899999999999999999999996554
Q ss_pred cEEEEEccCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 101 DIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
.+|+||.+|. |++.++++.. ..++|..+..|++++++||.|||.+|-||||||+.||||+.+|.|||+|||.+....
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 4999999999 5999999874 369999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCccccc-ccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMTVFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
......... ....||++|||||++...-..|+.++||||||++..||.+|+.||........+ ++++-+.|+.-...
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPPTLLTS 255 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCCCcccc
Confidence 433222222 677999999999997655578999999999999999999999999887765544 33333333211111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.. .......++..++.+|..||+.||.+||||+++|+|+||+....
T Consensus 256 ~~-------------------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 256 GL-------------------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred cC-------------------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 11 11112356778999999999999999999999999999997654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=330.48 Aligned_cols=279 Identities=39% Similarity=0.657 Sum_probs=241.6
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
.+|.-.++||+|.||+||+|+++.+++.||+|.++-...........++||.+|+.++|.||++++++. .....+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCcee
Confidence 357778999999999999999999999999999986655556666788999999999999999999998 444569
Q ss_pred EEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
.+|+|+|..+|..+..+ ++.++.+.++.++.|+++||.++|+.++.|||+||+|+|++.+|.+||+|||+|+..+-..
T Consensus 77 tlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 99999999999999986 6689999999999999999999999999999999999999999999999999998654321
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
..++..+.|.||++|.++.|. .-|+.+.|+||.|||+.|+.. |++.|++.+..+++..|...+|.|+.+.|+.+.
T Consensus 156 --rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t- 231 (292)
T KOG0662|consen 156 --RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT- 231 (292)
T ss_pred --EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc-
Confidence 234556789999999998874 679999999999999999987 899999999999999999999999998887543
Q ss_pred HHHHHHHHHhcCCCCCC-------ccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVP-------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~-------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
++.+..+.+ +.+..|.++...+||++++|.-+|.+|++|+.+|+||||...
T Consensus 232 --------~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 232 --------KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred --------cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 222333222 233456778889999999999999999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=381.80 Aligned_cols=282 Identities=27% Similarity=0.358 Sum_probs=221.1
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++++.||+|+||.||+|.+..+++.||+|... ...+.+|+.+|+.++||||+++++++.. ....
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~ 158 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFT 158 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCee
Confidence 57999999999999999999999999999999743 2245789999999999999999999843 3458
Q ss_pred EEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 103 YVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
++|+|++.++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999964322211
Q ss_pred ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-------hhhHHHHHHHhhCCCCHHHH
Q 017301 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-------VVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~ 255 (374)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ...++..+....|.++.+..
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred -cccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 11234679999999999977 679999999999999999999997765432 34566667776776554322
Q ss_pred hhhcCHHHHHHH-HHhcCCCC----CCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccC
Q 017301 256 AVVRNEKARKYL-TEMRKKPP----VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (374)
Q Consensus 256 ~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (374)
... ........ ........ .+.......++.++.+||.+||++||.+|||+.++|+||||+.+..+
T Consensus 315 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 315 IDA-QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred cch-hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 111 11111111 11111111 11111122457789999999999999999999999999999876543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=387.41 Aligned_cols=287 Identities=35% Similarity=0.595 Sum_probs=227.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc---C
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK---R 97 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~ 97 (374)
..++|++++.||+|+||+||+|.+..+++.||+|++.... ....+|+.+|+.++||||+++++++..... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3468999999999999999999999999999999885321 123479999999999999999998754322 2
Q ss_pred CCCcEEEEEccCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC-CeEEeeecc
Q 017301 98 EFKDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGL 172 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~-~vkl~DFg~ 172 (374)
....+++||||+++++.+++. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 223578999999998887775 345799999999999999999999999999999999999998765 699999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
|+....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|..
T Consensus 218 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred chhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 976433221 1345789999999987652 46899999999999999999999999999999999999999999887
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccC-CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
+.+...... .... ......+......+ ...++++.+||.+||++||.+|||+.++|+||||..+..
T Consensus 293 ~~~~~~~~~-~~~~--~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 293 DQLKEMNPN-YADI--KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHhchh-hhcc--cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 765432211 0000 00000111111112 246789999999999999999999999999999988654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=370.16 Aligned_cols=334 Identities=40% Similarity=0.750 Sum_probs=275.2
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
+.+...++|++++.||+|++|+||+|.+..++..||+|.+............+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 34567899999999999999999999999999999999986544444445567899999999999999999999865432
Q ss_pred -CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 -REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 -~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
......++|||+++++|.+++.. ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 89 ~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 89 LDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 22345799999998899888865 5699999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..... ....+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+.......+.+..+.+..+..
T Consensus 168 ~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 168 TDSEM------TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccCc------cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 43221 234678899999988652 35788999999999999999999999998887777777777777777766
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLE 335 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~ 335 (374)
..........+...+....+.......+.+++.+.++|.+||+.||.+|||+.+++.||||+.....+..+...+ +.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~---~~ 317 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP---YD 317 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCC---cc
Confidence 666666666666655544444444455678999999999999999999999999999999998766555444333 45
Q ss_pred hhhhhccCCHHHHHHHHHHHHHHhCc
Q 017301 336 FEFERRRVTKDDIRELIYREILEYHP 361 (374)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
..++....+-++|+.+.+-|+++|+|
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 318 DSFDEVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred ccHHhhccchHHHHHHHHHHHHhcCC
Confidence 56778888899999999999999986
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=373.20 Aligned_cols=327 Identities=38% Similarity=0.670 Sum_probs=257.8
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-C
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-R 97 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~ 97 (374)
+...++|++.+.||+|+||+||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++..... .
T Consensus 12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 345789999999999999999999999999999999987554444555677889999999999999999999865432 3
Q ss_pred CCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
+....|+||||+.++|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.++...
T Consensus 92 ~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 44568999999999999988764 8999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...++.|.++....
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 170 TSFM----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred CCCC----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 3221 233468899999999877 6789999999999999999999999999998888888988999988776554
Q ss_pred hcCHHHHHHHHHhcCCCCCCcccc-------------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQK-------------FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIER 324 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~ 324 (374)
.... ...+..........+.... ....++.+++||.+||+.||.+|||+.++|.||||+.+.....
T Consensus 244 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~ 322 (353)
T cd07850 244 LQPT-VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE 322 (353)
T ss_pred hhhh-hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence 3322 1222221111111111111 1134667899999999999999999999999999987665433
Q ss_pred CCCCCCCCCcchhhhhccCCHHHHHHHHHHH
Q 017301 325 EPSCQPISKLEFEFERRRVTKDDIRELIYRE 355 (374)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (374)
.... .....+...+.+..+.++|++.++.+
T Consensus 323 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 323 VEAP-PPAPYDHSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred CCCC-CCCccccccccccccHHHHHHHHHhh
Confidence 3222 22233445567788889999988876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=369.37 Aligned_cols=268 Identities=26% Similarity=0.426 Sum_probs=217.8
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc------------CChHHHHHHHHHHHHHHhCCCCCcccc
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF------------EHISDAIRILREVKLLRLLRHPDIVEI 87 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~~E~~~l~~l~h~~i~~~ 87 (374)
..-++|++++.||+|.||.|.+|++..+++.||||++.+.. ......+++.+||.+|+++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34579999999999999999999999999999999996421 111223578899999999999999999
Q ss_pred ceeecCCCcCCCCcEEEEEccCcccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeE
Q 017301 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLK 166 (374)
Q Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vk 166 (374)
+++.-++ ....+|||+|||...-..+....++ +++.+++.+++.++.||+|||.+||+||||||+|+|++.+|+||
T Consensus 174 iEvLDDP---~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDP---ESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCc---ccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 9998543 4467999999999533333434444 99999999999999999999999999999999999999999999
Q ss_pred EeeecccccccCC--CCccccccccccccccccccccccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 017301 167 VCDFGLARVAFSD--TPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242 (374)
Q Consensus 167 l~DFg~a~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 242 (374)
|+|||.+...... ......+....|||.|+|||.+.+. ....+.+.||||+||+||.|+.|+.||.+....+...+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999998754222 2223334567899999999988652 13456789999999999999999999999887766666
Q ss_pred HHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
|....- .....+.+.+.++|||.+||+.||++|++..++..|||...-
T Consensus 331 Ivn~pL-----------------------------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 331 IVNDPL-----------------------------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HhcCcc-----------------------------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 543100 012234678999999999999999999999999999998754
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=366.20 Aligned_cols=283 Identities=35% Similarity=0.598 Sum_probs=226.3
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC---CCCCccccceeecCCCcCCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+|++++.||+|+||+||+|.++.+++.||+|.++...........+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875332222223445676666655 799999999998665444456
Q ss_pred cEEEEEccCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 101 DIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.+++|||++.++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 78999999999999988764 3589999999999999999999999999999999999999999999999999976432
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... .....||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccc----CCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 211 134568999999999877 67899999999999999999999999999888888888887777765544321
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
..... .......+.+.....+.++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 235 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPR----GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccc----cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 10000 0011122223334456788899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-52 Score=349.79 Aligned_cols=266 Identities=28% Similarity=0.468 Sum_probs=223.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc------CChHHHHHHHHHHHHHHhCC-CCCccccceeec
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF------EHISDAIRILREVKLLRLLR-HPDIVEIKRIML 92 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 92 (374)
+....|.-.+.||+|..++|.++.++.+|..+|+|++.... ......+...+|+.+|+++. ||+|+.+.++|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34567888999999999999999999999999999986321 11222345668999999985 999999999995
Q ss_pred CCCcCCCCcEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeec
Q 017301 93 PPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (374)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg 171 (374)
.+ ..+++|+|.|+ |.|++++.+.-.+++.+.+.|++|+++|+.|||.++|+|||+||+|||++++.++||+|||
T Consensus 94 s~-----sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 SD-----AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred Cc-----chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 44 45899999999 7999999999899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccccccccccccccc----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
+|+...... .....||||+|+|||.+.. ....|+..+|+||+|+|||.|+.|.+||......-.+..|+..-
T Consensus 169 Fa~~l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk 244 (411)
T KOG0599|consen 169 FACQLEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK 244 (411)
T ss_pred eeeccCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence 998764443 2456799999999998743 12568999999999999999999999998876655555554321
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
..--.+.|.++|..++|||.+||+.||.+|.|++++|.||||.++..
T Consensus 245 ---------------------------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 245 ---------------------------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred ---------------------------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 11122346789999999999999999999999999999999977543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=366.25 Aligned_cols=253 Identities=24% Similarity=0.395 Sum_probs=213.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCe
Confidence 479999999999999999999999999999999864321 2234456788999999999999999998873 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.+ +|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999985 999999988899999999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 23469999999999877 67899999999999999999999999887654443333210
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
.. .....+++.+++||++||+.||.+||+ ++++++||||+.+
T Consensus 214 ------------~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 214 ------------KL-----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred ------------Cc-----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 00 111346889999999999999999995 9999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=367.12 Aligned_cols=334 Identities=40% Similarity=0.742 Sum_probs=267.9
Q ss_pred ccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 16 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
...+...++|.+.+.||+|++|.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 8 KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred hhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 34456678999999999999999999999999999999998754433334456789999999999999999999986443
Q ss_pred c-CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 96 K-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 96 ~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
. ......|+|+||+..+|...+. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 88 SGDEFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred cCCCCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 2 2335679999999988877653 368999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
..... .....+++.|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+.+....+..+....+.+.+..
T Consensus 166 ~~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 166 HADAE------MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCCCC------CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 53221 1344678899999987652 4578899999999999999999999999988888888888888888887
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKL 334 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~ 334 (374)
...........+...............++..++.+.+||.+||+.||.+|||+.++|.||||..+...+..+...+ +
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~ 315 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---Y 315 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---c
Confidence 7666655555554443333333334445678899999999999999999999999999999999876544443222 3
Q ss_pred chhhhhccCCHHHHHHHHHHHHHHhCc
Q 017301 335 EFEFERRRVTKDDIRELIYREILEYHP 361 (374)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
....+......+++..-+|+|+.++.|
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (342)
T cd07879 316 DDSLENEKLSVDEWKKHIYKEVKSFSP 342 (342)
T ss_pred cchhhhhhCCHHHHHHHhhhhhhccCC
Confidence 334445566678999999999887765
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=364.64 Aligned_cols=332 Identities=42% Similarity=0.808 Sum_probs=271.6
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-C
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-R 97 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~ 97 (374)
+...++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.++++++||||+++++++..... .
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 456699999999999999999999999999999999987644444445667889999999999999999998854322 2
Q ss_pred CCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
.....|+++++++++|.+++... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhcccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 33568999999988998887654 69999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. .....+++.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+.+.....
T Consensus 172 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 172 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cc------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 21 1334688999999987552 4688899999999999999999999998888888888888888888888777
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchh
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (374)
........++..+...............++.+.+||.+||+.||.+|||+.++|.||||+++..++..+...+ .+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~~---~~~~ 321 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQS 321 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCCC---ccCc
Confidence 7666666665555444333333334467889999999999999999999999999999998877666654332 4445
Q ss_pred hhhccCCHHHHHHHHHHHHHHhCc
Q 017301 338 FERRRVTKDDIRELIYREILEYHP 361 (374)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
+..+..-.+++....|+|+-+|.|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 322 FESRDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred chhcccCHHHHHHHHHHHHHhcCC
Confidence 555566668999999999888765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=370.74 Aligned_cols=264 Identities=31% Similarity=0.510 Sum_probs=226.2
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHHHHHHHhCC-CCCccccceeecCCC
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-SDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 95 (374)
.......|++.+.||+|.||+||+|+++.+|+.+|+|++.+..... .....+.+|+.+|++++ ||||+.++++|
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~---- 105 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF---- 105 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence 3456678999999999999999999999999999999997643322 24567889999999998 99999999999
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC----CCeEEeee
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN----CKLKVCDF 170 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~----~~vkl~DF 170 (374)
+....+++|||+|.| .|.+.+... .+++..+..++.|++.|++|||+.||+||||||+|+|+... +.+|++||
T Consensus 106 -e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 106 -EDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred -EcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 444569999999995 999999877 49999999999999999999999999999999999998543 57999999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
|+|..... .......+||+.|+|||++.. .+|+..+||||+|+++|.|++|.+||.+.+.......+..
T Consensus 184 Gla~~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~----- 252 (382)
T KOG0032|consen 184 GLAKFIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR----- 252 (382)
T ss_pred CCceEccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc-----
Confidence 99987654 223467899999999999987 7899999999999999999999999999886655543322
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
....-....|+.+|..++++|+.||..||.+|+|+.++|+|||+++..
T Consensus 253 ----------------------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 253 ----------------------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred ----------------------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 111223355788999999999999999999999999999999998753
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=383.79 Aligned_cols=284 Identities=27% Similarity=0.425 Sum_probs=222.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCC------CCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH------PDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~ 95 (374)
.++|++++.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| .+++.+++++..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-- 202 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-- 202 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc--
Confidence 478999999999999999999999999999999986421 122334567777776654 457777777743
Q ss_pred cCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCC-----------
Q 017301 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANC----------- 163 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~----------- 163 (374)
+..++|+|||+++++|.+++...+.+++..++.|+.||+.||+|||+ .||+||||||+|||++.++
T Consensus 203 --~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 203 --ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred --CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 23468999999999999999888899999999999999999999998 5999999999999998765
Q ss_pred -----CeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 017301 164 -----KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238 (374)
Q Consensus 164 -----~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 238 (374)
.+||+|||.+...... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~------~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS------RTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCccc------cccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4999999987542211 234579999999999987 689999999999999999999999999999999
Q ss_pred HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCcc---------ccC--CCCChHHHHHHHHhccCCCCCCCCH
Q 017301 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF---------QKF--PNVDPLALRLLQRLIAFDPKDRPTA 307 (374)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~--~~~s~~~~~li~~~L~~dp~~Rpt~ 307 (374)
.+..+.+.+|.++..+...........++.......+.... ... ...++.+.|||.+||++||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 99999999998877665443333333333222111110000 000 0124678899999999999999999
Q ss_pred HHHhcCCCCCcCc
Q 017301 308 EEALADPYFKGLA 320 (374)
Q Consensus 308 ~~lL~hp~~~~~~ 320 (374)
+|+|+||||....
T Consensus 433 ~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 433 RQMTTHPYVLKYY 445 (467)
T ss_pred HHHhcCccccccC
Confidence 9999999998754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=369.73 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=214.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.+.|++.+.||+|+||.||+|.++.+++.||+|+++... ........+.+|+.+++.++||||+++++++. ...
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence 478999999999999999999999999999999986432 12233456789999999999999999999984 345
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|+||||+.+ +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 69999999985 99999998889999999999999999999999999999999999999999999999999999754332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
. ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 172 ~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-------------- 229 (329)
T PTZ00263 172 T------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-------------- 229 (329)
T ss_pred c------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Confidence 1 23479999999999987 6789999999999999999999999987665433322211
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
... .....+++.+.+||.+||+.||.+||+ ++++++||||++.
T Consensus 230 ------------~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 230 ------------GRL-----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred ------------CCc-----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 000 011247888999999999999999997 7999999999874
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=376.91 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=220.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 99 (374)
.+.|+++++||+|+||+|++|..+.+++.+|||++++..- ...+.+..+.|-+++...+ ||.+++++..| +..
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT~ 441 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QTK 441 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----ccC
Confidence 3689999999999999999999999999999999986542 3345567788888888775 99999999999 555
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.++|+||||+.| + .-.+...+.+++..++.++..++.||+|||++|||+||||.+|||+|.+|.+||+|||+|+-.-.
T Consensus 442 ~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 679999999997 6 44445567899999999999999999999999999999999999999999999999999975332
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... ..+++||||.|+|||++.+ ..|+.++|.|||||+||+|+.|..||.+.+..+..+.|..-
T Consensus 521 ~g~---~TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------------ 583 (694)
T KOG0694|consen 521 QGD---RTSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------------ 583 (694)
T ss_pred CCC---ccccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Confidence 222 2367899999999999998 89999999999999999999999999999998888777531
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
. ......+|.++.++++++|..||++|.- +.+|..||||+.+
T Consensus 584 --------------~-----~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 584 --------------E-----VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred --------------C-----CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 0 1112368999999999999999999974 6899999999975
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-50 Score=368.79 Aligned_cols=250 Identities=26% Similarity=0.458 Sum_probs=209.4
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEc
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e 107 (374)
+.||+|+||.||+|.+..+|+.||+|+++.... .......+.+|+.+++.++||||+++++++. ....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----cCCEEEEEEe
Confidence 469999999999999999999999999875322 2234456778999999999999999999984 4456999999
Q ss_pred cCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccc
Q 017301 108 LMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (374)
Q Consensus 108 ~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (374)
|+.+ +|.+.+..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cc
Confidence 9986 9999999888999999999999999999999999999999999999999999999999999874322211 12
Q ss_pred ccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 017301 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (374)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (374)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 34579999999999977 6789999999999999999999999987665433332211
Q ss_pred HHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
.. ......+++.+.+||++||+.||++|| ++.++++||||.++
T Consensus 210 -----~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 210 -----EE-----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -----CC-----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 00 011235789999999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=357.32 Aligned_cols=255 Identities=28% Similarity=0.502 Sum_probs=222.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
.-.||++.+.||+|.||.|-+|.+..+|+.||||-+++. .....+...+.+||.+|..++||||+.++++| +..
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENk 125 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENK 125 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCC
Confidence 357999999999999999999999999999999998754 33445666889999999999999999999999 555
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+.|||||..+ .|.+++...+.+++.+++.+++||..|+.|+|.++++|||||.+|||++.|+++||+|||++-.+..
T Consensus 126 dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 569999999995 9999999999999999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
..+..++||+|.|.+||++.|. ..-++.+|.||||++||.|+.|..||+|.+....+.+|......
T Consensus 206 ----~kfLqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr--------- 271 (668)
T KOG0611|consen 206 ----KKFLQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR--------- 271 (668)
T ss_pred ----ccHHHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc---------
Confidence 2356789999999999999883 23467899999999999999999999999877666655432111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
-|.-+..+.-||+.||..||++|.|++++-+|=|++
T Consensus 272 -----------------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 272 -----------------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -----------------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 134567789999999999999999999999998875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=361.82 Aligned_cols=281 Identities=35% Similarity=0.604 Sum_probs=213.9
Q ss_pred eceeeccCCeeEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEE
Q 017301 28 LEVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
+++||+|+||+||+|.++ .+++.||+|.+..... ...+.+|+.+|+.++||||+++++++.... ...+|++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEE
Confidence 568999999999999965 4678999999864322 234668999999999999999999885432 3468999
Q ss_pred EccCcccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe----cCCCCeEEeeecc
Q 017301 106 FELMESDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDFGL 172 (374)
Q Consensus 106 ~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~----~~~~~vkl~DFg~ 172 (374)
|||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999998887632 258999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh---------hhHHHHH
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---------VHQLDLI 243 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~---------~~~~~~i 243 (374)
|+................||+.|+|||++.+. ..++.++||||+||++|+|++|++||.+... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 97654332222223456789999999988662 4588999999999999999999999976542 3567778
Q ss_pred HHhhCCCCHHHHhhhcCH-HHHHHHHHhcCCCCC--C----ccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 244 TDLLGTPSPETIAVVRNE-KARKYLTEMRKKPPV--P----LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--~----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
....+.|....+...... ............... . ........+..+.+||.+||++||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 888888877665543211 111111111110000 0 001112346679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=359.35 Aligned_cols=291 Identities=37% Similarity=0.642 Sum_probs=231.3
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
++..++|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++. .
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~ 75 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIH-----T 75 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEe-----c
Confidence 35568999999999999999999999999999999998643222 22345678999999999999999999984 3
Q ss_pred CCcEEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
....|+||||+.++|.+++... ..+++..++.++.|++.||+|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 76 EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 4568999999999999988764 468999999999999999999999999999999999999999999999999987533
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+....+....+.+....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 156 IPTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 2211 11334678899999987653 4578899999999999999999999999998888888888888887665543
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
......... ...............+.+++.+.+||.+||+.||.+|||++++|+||||+.+.
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 232 ILSNEEFKS-YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hhccccccc-cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 221110000 00000000111122346788999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=333.78 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=224.0
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
......+.|++++.||+|-||.||.|+.+.++..||+|++.++ ........++.+|+.+-..++||||+++++.|.+.
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~- 94 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS- 94 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-
Confidence 3455678999999999999999999999999999999998643 22334455788999999999999999999999554
Q ss_pred cCCCCcEEEEEccCc-ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecc
Q 017301 96 KREFKDIYVVFELME-SDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~--~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
..+|+++||.. |++...+. ...++++..+..++.|++.|+.|+|.++++||||||+|+|++..+.+|++|||.
T Consensus 95 ----~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 95 ----KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred ----ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCc
Confidence 45999999999 59999998 567899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
+.....+ .....|||..|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+....|.+.--.
T Consensus 171 sV~~p~~-----kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~--- 240 (281)
T KOG0580|consen 171 SVHAPSN-----KRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK--- 240 (281)
T ss_pred eeecCCC-----CceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc---
Confidence 8754322 2256799999999999988 78999999999999999999999999988866666555432111
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
..+.++..+.|||.+||..+|.+|.+..|++.|||+..
T Consensus 241 ----------------------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 ----------------------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ----------------------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 11468999999999999999999999999999999864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=359.48 Aligned_cols=327 Identities=47% Similarity=0.816 Sum_probs=262.2
Q ss_pred CeeEeceeeccCCeeEEEEEECCC--CcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+|++.+.||+|+||.||+|.+..+ +..||+|.+............+.+|+.+++.+ .||||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999888 89999999875444434455678899999999 5999999998764322 2335
Q ss_pred cEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
.+|+++++++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999997543322
Q ss_pred Cc-ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 181 PM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 181 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. ........|++.|+|||.+.+. ..++.++|+||+||++|+|++|.+||.+.+....+..+....+.+..+.+....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 1112345789999999987552 468899999999999999999999999999888999999999998887776666
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchhhh
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (374)
.......................+..+..+.+|+.+||+.||.+|||+.+++.|||++.+..+...+.|.......|+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~- 317 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES- 317 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc-
Confidence 6555555555444444444455667889999999999999999999999999999999988777777776544333321
Q ss_pred hccCCHHHHHHHHHHH
Q 017301 340 RRRVTKDDIRELIYRE 355 (374)
Q Consensus 340 ~~~~~~~~~~~~~~~~ 355 (374)
.-+-++++..|.++
T Consensus 318 --~~~~~~~~~~~~~~ 331 (332)
T cd07857 318 --EDSMEELRDMIIEE 331 (332)
T ss_pred --cccHHHHHHHHhhc
Confidence 12344555555443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=362.93 Aligned_cols=330 Identities=44% Similarity=0.771 Sum_probs=263.5
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 99 (374)
+.++|++.+.||+|+||.||+|.+..++..+|+|++............+.+|+.+++++ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence 46789999999999999999999999999999999865444444455677899999999 999999999988442 22
Q ss_pred CcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
...|+||||+.++|.+++..+ .+++...+.++.|++.||+|||++||+|+||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 458999999999999999876 7899999999999999999999999999999999999999999999999999765433
Q ss_pred CCc--ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 180 TPM--TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 180 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
... ........|++.|+|||++.+. ..++.++|+|||||++|+|++|+.||.+....+....+....+.+..+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred cccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 211 1122345789999999987552 4678899999999999999999999999988888888888888888776666
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchh
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (374)
.........+...............+.++..+.++|.+||+.||++|||+.++++||||+.+.....++.........+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCcc
Confidence 55554445555444444444455566789999999999999999999999999999999988665555443332222222
Q ss_pred hhhccCCHHHHHHHHHHHH
Q 017301 338 FERRRVTKDDIRELIYREI 356 (374)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~ 356 (374)
+.+++...+-+..+|+|+
T Consensus 320 -~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07852 320 -DNVKLSVAEYRNKLYEEI 337 (337)
T ss_pred -ccceeeHHHHHhhhhhcC
Confidence 455666666677777653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=366.11 Aligned_cols=261 Identities=26% Similarity=0.470 Sum_probs=217.1
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++. ...+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 479999999999999999999999999999999874322 2233456788999999999999999999984 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.| +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999985 9999999888899999999999999999999999999999999999999999999999999975433
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------- 217 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL---------- 217 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----------
Confidence 1234579999999999987 688999999999999999999999998877655444332210000
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
. .+ ........+++.+.+||.+||..+|.+|||+.++++||||...
T Consensus 218 -----------~-~~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 218 -----------Q-RP-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred -----------c-CC-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 0 00 0000113578999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=367.49 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=211.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++++.||+|+||+||+|.+..+++.||+|+++.... .......+.+|+.++..++||||+++++.+. +...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-----~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-----DKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCe
Confidence 479999999999999999999999999999999864321 2233446778999999999999999999984 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.| +|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999985 999999988899999999999999999999999999999999999999999999999999987532211
Q ss_pred Cc--------------------------------ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 017301 181 PM--------------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (374)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~ 228 (374)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 000124579999999999977 67999999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCC---CCC
Q 017301 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK---DRP 305 (374)
Q Consensus 229 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~---~Rp 305 (374)
.||.+.+..+....+...... . .......+++.+++||.+|+. +|. .||
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~------------------------~---~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKET------------------------L---IFPPEVPISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcCc------------------------c---cCCCcCCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 999887765544443321000 0 001113478899999999876 444 458
Q ss_pred CHHHHhcCCCCCcC
Q 017301 306 TAEEALADPYFKGL 319 (374)
Q Consensus 306 t~~~lL~hp~~~~~ 319 (374)
+++++++||||+++
T Consensus 286 ~~~ei~~hp~f~~~ 299 (363)
T cd05628 286 GVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHhCCCCCCCC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=343.69 Aligned_cols=274 Identities=31% Similarity=0.471 Sum_probs=222.8
Q ss_pred cccCCCCCeeE-eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCC
Q 017301 17 TEYGDANRYKI-LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (374)
Q Consensus 17 ~~~~~~~~Y~~-~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 94 (374)
+++.+.+.|++ -++||-|-.|.|..|.++.|++.+|+|++. +..+..+|+...-.. .|||||.++++|...
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-------DSPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-------cCHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 77888899988 567999999999999999999999999874 234566888876655 599999999998543
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC---CCCeEEe
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVC 168 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~---~~~vkl~ 168 (374)
.....++.+|||.|+| .|+..++.++. ++|.++..|++||..||.|||+.+|.||||||+|+|... |..+||+
T Consensus 128 -~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 128 -YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred -ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 3556789999999996 99999998775 999999999999999999999999999999999999865 4569999
Q ss_pred eecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 017301 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (374)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 248 (374)
|||+|+.... .....+.|.||+|.|||+++. ..|+..+|+||+||++|.|+.|.+||+.......
T Consensus 207 DfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--------- 271 (400)
T KOG0604|consen 207 DFGFAKETQE----PGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--------- 271 (400)
T ss_pred ccccccccCC----CccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCccC---------
Confidence 9999975432 233466789999999999987 7899999999999999999999999988764221
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCC
Q 017301 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~ 327 (374)
++.+... +......-..+.|..+|.+++|+|+.+|..+|++|.|+.++++|||+.+.......+.
T Consensus 272 --spgMk~r------------I~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl 336 (400)
T KOG0604|consen 272 --SPGMKRR------------IRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL 336 (400)
T ss_pred --ChhHHhH------------hhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence 1111111 1111111112345678999999999999999999999999999999998765554443
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=366.18 Aligned_cols=256 Identities=23% Similarity=0.383 Sum_probs=213.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCC-cEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
..+.|++.+.||+|+||.||+|.+..++ ..||+|++.... ........+.+|+.+++.++||||+++++++. +
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----D 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----e
Confidence 4568999999999999999999876655 689999986422 12234456788999999999999999999994 3
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...+|+||||+.+ +|.+++..++.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 4569999999975 999999998899999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 183 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~------------ 242 (340)
T PTZ00426 183 TR------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE------------ 242 (340)
T ss_pred CC------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc------------
Confidence 22 134579999999999977 6789999999999999999999999988765433333221
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcCc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (374)
.. ....+.+++.+.++|++||+.||.+|+ |++++++||||+++.
T Consensus 243 ---------------~~----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 243 ---------------GI----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred ---------------CC----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 00 011245788999999999999999995 999999999998753
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=368.44 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=213.4
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++++.||+|+||+||+|++..+|+.||+|++.... ........+.+|+.+++.++||||+++++.+. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-----DENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCe
Confidence 47999999999999999999999999999999997432 12233456778999999999999999999984 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.+ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999985 999999988899999999999999999999999999999999999999999999999999986532211
Q ss_pred Ccc-----------------------------------cccccccccccccccccccccCCCCCccchHHHHHHHHHHHH
Q 017301 181 PMT-----------------------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (374)
Q Consensus 181 ~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll 225 (374)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 000 01113469999999999877 67899999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC
Q 017301 226 TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305 (374)
Q Consensus 226 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp 305 (374)
+|.+||.+.+.......+... ..... ......+++.+.+||.+||. +|.+|+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~------------------------~~~~~---~~~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINW------------------------KETLQ---FPDEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcC------------------------CCccC---CCCCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 999999887654433332210 00000 01112578999999999997 999999
Q ss_pred C---HHHHhcCCCCCcC
Q 017301 306 T---AEEALADPYFKGL 319 (374)
Q Consensus 306 t---~~~lL~hp~~~~~ 319 (374)
+ +.++|+||||++.
T Consensus 286 ~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 286 GNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 8 9999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-51 Score=362.77 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=221.7
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
.....|+.++.||+|+||.||+|.+..+++.||+|++.-. ......+.+.+|+.+|.+++++||.++|+.|+....
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~--- 85 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK--- 85 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc---
Confidence 3456888899999999999999999999999999999743 333556778899999999999999999999976654
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
++++||||.| ++.+.++..+.+.+..+..++++++.|+.|||+.+.+|||||+.|||+..+|.+||+|||.+.....
T Consensus 86 --LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 86 --LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred --HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec
Confidence 8999999996 9999999988889999999999999999999999999999999999999999999999999976544
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... ...+++|||.|||||++.+ ..|+.++||||||++.+||++|.+|+....+...+..|
T Consensus 164 ~~~---rr~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI--------------- 223 (467)
T KOG0201|consen 164 TVK---RRKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI--------------- 223 (467)
T ss_pred hhh---ccccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec---------------
Confidence 332 2267899999999999987 79999999999999999999999999887764332221
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.+..|-.+. ..+|+.+++||..||+.||+.||||.++|.|+|++.
T Consensus 224 ------------pk~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 224 ------------PKSAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ------------cCCCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 111111111 267899999999999999999999999999999986
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=360.77 Aligned_cols=248 Identities=31% Similarity=0.483 Sum_probs=207.4
Q ss_pred eeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccC
Q 017301 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (374)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 109 (374)
||+|+||+||+|.+..+++.||+|+++... ........+.+|+.+++.++||||+++++.+. ....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 799999999999999999999999986432 22234456788999999999999999999884 345689999999
Q ss_pred cc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccccc
Q 017301 110 ES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (374)
Q Consensus 110 ~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~ 188 (374)
.+ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 86 9999999888999999999999999999999999999999999999999999999999999875322221 1234
Q ss_pred ccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHH
Q 017301 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLT 268 (374)
Q Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (374)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 579999999999987 6789999999999999999999999987665433322211
Q ss_pred HhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC---CHHHHhcCCCCCcC
Q 017301 269 EMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP---TAEEALADPYFKGL 319 (374)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~~lL~hp~~~~~ 319 (374)
.. ......+++.+.+||.+||+.||.+|| ++.++|+||||...
T Consensus 208 ----~~----~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 ----EP----LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ----CC----CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 00 111245789999999999999999997 58999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=355.09 Aligned_cols=322 Identities=46% Similarity=0.845 Sum_probs=267.9
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
+...++|++++.||.|+||.||+|.+..+++.||+|.+............+.+|+.+++.++|||++++++++...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 81 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP---- 81 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----
Confidence 5567899999999999999999999999999999998865443334456677899999999999999999988532
Q ss_pred CCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
....|+++||++++|.+++.. .++++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred CCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 235899999998899888864 4688999999999999999999999999999999999999999999999999874322
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
. .....+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+.......+.+.++.++.+.....
T Consensus 161 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 Q------MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C------cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 1 1234678889999987542 46889999999999999999999999999888888888888999988877666
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchhh
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~ 338 (374)
.......+........+.+.....+.+++.+.++|++||+.+|++|||+.+++.||||.....+..++. ..++++|.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~--~~~~~~~~~ 311 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPV--AEEKFDWSF 311 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccC--chhhcCCch
Confidence 555555555555555555555566778999999999999999999999999999999988776655544 234788889
Q ss_pred hhccCCHHHHHHHHHH
Q 017301 339 ERRRVTKDDIRELIYR 354 (374)
Q Consensus 339 ~~~~~~~~~~~~~~~~ 354 (374)
+...+..+.|+-..|.
T Consensus 312 ~~~~~~~~~~~~~~~~ 327 (328)
T cd07856 312 NDADLPVDTWKVMMYS 327 (328)
T ss_pred hcccCCHHHHHHHhcC
Confidence 9999999999877765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=355.04 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=210.0
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
.|++.+.||+|+||+||+|.+..+|+.||+|.+..... .......+.+|+.+++.++|++++++++.+. ....+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence 38899999999999999999999999999999864322 2223345778999999999999999999984 34568
Q ss_pred EEEEccCcc-cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 103 YVVFELMES-DLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
++||||+.+ +|.+.+.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999985 88877754 336899999999999999999999999999999999999999999999999999764322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~------------- 216 (285)
T cd05631 156 E----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR------------- 216 (285)
T ss_pred C----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-------------
Confidence 1 1234578999999999987 68999999999999999999999999876543222111110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcCc
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~~ 320 (374)
+.. ........+++.+.+||++||+.||.+||| ++++++||||.++.
T Consensus 217 ----------~~~----~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 217 ----------VKE----DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ----------hhc----ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 100 111123467899999999999999999997 99999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=347.32 Aligned_cols=268 Identities=26% Similarity=0.395 Sum_probs=224.1
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
...-..+.|++++.||.|.-|+||+|+.+.++..+|+|++.+... ......++..|-.||..+.||.++.+|..+
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f---- 146 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF---- 146 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee----
Confidence 334445789999999999999999999999999999999976433 234455778899999999999999999999
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecc
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
+.....|+|||||.| +|..++++. +.+++..++.++..++.||+|||-.|||+|||||+||||.++|.|.|+||.+
T Consensus 147 -et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDL 225 (459)
T KOG0610|consen 147 -ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDL 225 (459)
T ss_pred -eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccc
Confidence 556679999999996 999998764 5799999999999999999999999999999999999999999999999999
Q ss_pred cccccC-------C---------------------------C-------------------Ccccccccccccccccccc
Q 017301 173 ARVAFS-------D---------------------------T-------------------PMTVFWTDYVATRWYRAPE 199 (374)
Q Consensus 173 a~~~~~-------~---------------------------~-------------------~~~~~~~~~~gt~~y~aPE 199 (374)
+..... . . +.......++||-.|.|||
T Consensus 226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE 305 (459)
T KOG0610|consen 226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE 305 (459)
T ss_pred cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence 743210 0 0 0001123468999999999
Q ss_pred cccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCcc
Q 017301 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF 279 (374)
Q Consensus 200 ~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (374)
++.| ...+.++|.|+|||++|||+.|..||.|.+..+.+..|+. .+. ..
T Consensus 306 vI~G--~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~---~~l--------------------------~F 354 (459)
T KOG0610|consen 306 VIRG--EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG---QPL--------------------------KF 354 (459)
T ss_pred eeec--CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc---CCC--------------------------cC
Confidence 9999 7889999999999999999999999999998777665542 111 01
Q ss_pred ccCCCCChHHHHHHHHhccCCCCCCCC----HHHHhcCCCCCcCc
Q 017301 280 QKFPNVDPLALRLLQRLIAFDPKDRPT----AEEALADPYFKGLA 320 (374)
Q Consensus 280 ~~~~~~s~~~~~li~~~L~~dp~~Rpt----~~~lL~hp~~~~~~ 320 (374)
...+.++..++|||+++|.+||.+|.. |.+|-+||||+++.
T Consensus 355 p~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 355 PEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred CCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence 112467799999999999999999998 99999999999864
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=367.73 Aligned_cols=263 Identities=22% Similarity=0.358 Sum_probs=211.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
..|++++.||+|+||+||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++.+. +..+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~ 75 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDN 75 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCE
Confidence 36899999999999999999999999999999986432 22334556889999999999999999999994 3456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.| +|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999985 999999988889999999999999999999999999999999999999999999999999975321100
Q ss_pred Cc--------------------------------------------ccccccccccccccccccccccCCCCCccchHHH
Q 017301 181 PM--------------------------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (374)
Q Consensus 181 ~~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwS 216 (374)
.. .......+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceee
Confidence 00 000123579999999999877 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHh
Q 017301 217 IGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296 (374)
Q Consensus 217 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 296 (374)
|||++|+|++|..||...+.......+..... . ........+++++.+||.+|
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------------------~---~~~~~~~~~s~~~~dli~~l 286 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWEN------------------------T---LHIPPQVKLSPEAVDLITKL 286 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc------------------------c---cCCCCCCCCCHHHHHHHHHH
Confidence 99999999999999987765433322211000 0 00111235789999999996
Q ss_pred cc--CCCCCCCCHHHHhcCCCCCcC
Q 017301 297 IA--FDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 297 L~--~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
+. .+|..|+|+.++++||||+++
T Consensus 287 l~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 287 CCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred ccCcccccCCCCHHHHhcCcccCCC
Confidence 65 455559999999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=360.78 Aligned_cols=250 Identities=24% Similarity=0.452 Sum_probs=208.5
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEc
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e 107 (374)
+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++.+. ....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEe
Confidence 469999999999999999999999999875322 2234556788999999999999999999884 4456999999
Q ss_pred cCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccc
Q 017301 108 LMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (374)
Q Consensus 108 ~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (374)
|+.+ +|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cc
Confidence 9985 9999998888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred ccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 017301 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (374)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (374)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 34579999999999877 6789999999999999999999999987665433322210
Q ss_pred HHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
.. ......+++.+.+||++||+.||.+|+ ++.++++||||.+.
T Consensus 210 -----~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 210 -----ED-----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -----CC-----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 011245789999999999999999997 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=349.92 Aligned_cols=282 Identities=37% Similarity=0.622 Sum_probs=225.5
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
.|++++.||+|++|+||+|.+..++..||+|+++...........+.+|+.+++.++|||++++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 4899999999999999999999999999999987543333334567789999999999999999999843 35689
Q ss_pred EEEccCcccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 104 VVFELMESDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 104 lv~e~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+||||+.++|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999998888653 468999999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
.......+++.|+|||++.+. ..++.++|+|||||++|+|++|++||.+.+.......+....+.+....+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---ccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 112334678899999987653 4578899999999999999999999999887777777766667666555543222
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
. ..+..................+++++.+||++||+.||.+|||+.++++||||
T Consensus 232 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 L--PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred h--HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 1 12222222212222223345689999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=365.70 Aligned_cols=262 Identities=30% Similarity=0.494 Sum_probs=215.9
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++++.||+|+||+||+|.+..+++.||+|+++.... .......+.+|+.++..++||||+++++++. +..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence 479999999999999999999999999999999874322 1134456788999999999999999999883 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.+ +|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999985 999999988889999999999999999999999999999999999999999999999999997643322
Q ss_pred C--------------------------cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 017301 181 P--------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (374)
Q Consensus 181 ~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 234 (374)
. .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 0 0011234579999999999987 68899999999999999999999999887
Q ss_pred ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-HHHHhcC
Q 017301 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-AEEALAD 313 (374)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~~lL~h 313 (374)
+.......+.... .... ......+++.+.+||.+||. ||.+||+ +.++|+|
T Consensus 234 ~~~~~~~~i~~~~------------------------~~~~---~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWK------------------------ESLR---FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccC------------------------Cccc---CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 7544433332110 0000 11123478999999999998 9999999 9999999
Q ss_pred CCCCcC
Q 017301 314 PYFKGL 319 (374)
Q Consensus 314 p~~~~~ 319 (374)
|||+++
T Consensus 286 p~~~~~ 291 (350)
T cd05573 286 PFFKGI 291 (350)
T ss_pred CCcCCC
Confidence 999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=359.54 Aligned_cols=251 Identities=25% Similarity=0.455 Sum_probs=208.9
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEc
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e 107 (374)
+.||+|+||.||+|.+..+|..||+|+++.... .......+.+|+.+++.++||||+++++.+.. ...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence 469999999999999999999999999875322 22344567789999999999999999999843 356899999
Q ss_pred cCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccc
Q 017301 108 LMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (374)
Q Consensus 108 ~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (374)
|+.+ +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cc
Confidence 9985 9999998888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred ccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 017301 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (374)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (374)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------- 209 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Confidence 34579999999999877 6789999999999999999999999987765443332211
Q ss_pred HHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcCc
Q 017301 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (374)
.. ......+++.+.+||.+||+.||.+|+ ++.++++||||.+..
T Consensus 210 -----~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 210 -----EE-----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred -----CC-----CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 00 011235789999999999999999998 999999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=339.14 Aligned_cols=306 Identities=32% Similarity=0.523 Sum_probs=250.9
Q ss_pred ccccccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceee
Q 017301 12 DKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIM 91 (374)
Q Consensus 12 ~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 91 (374)
+..+++--..++.|+-+.+||+|.||.||+|+.+.+|+.||+|++--......-....++|+.+|..++|+|++.+++++
T Consensus 6 ~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 6 DSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred hcccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence 34445666778999999999999999999999999999999997643333334445678999999999999999999988
Q ss_pred cCCC---cCCCCcEEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEE
Q 017301 92 LPPS---KREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (374)
Q Consensus 92 ~~~~---~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl 167 (374)
-... ......+|+||++|+.+|.-++... .+++..+++.++.+++.||.|+|++.|+|||+||.|+||+.+|.+||
T Consensus 86 ~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 86 RTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred hhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe
Confidence 5432 2344569999999999999999876 58999999999999999999999999999999999999999999999
Q ss_pred eeecccccccCCCCc-ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 017301 168 CDFGLARVAFSDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (374)
Q Consensus 168 ~DFg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 246 (374)
+|||+|+........ ...++..+.|.||++||.+.|. ..|+++.|||+.|||+.+|.+|.+.+.+.+...++..|..+
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 999999765433222 2224556789999999998885 78999999999999999999999999999999999999999
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHH--hcCCCCCCccccCC--CCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 247 LGTPSPETIAVVRNEKARKYLTE--MRKKPPVPLFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
+|.-.++.|+.+.+-...+.++. +.+........... .-++++.||+.+||..||.+|++++++|+|.||..
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 99999999998877655554421 11111111111111 13668999999999999999999999999999964
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=368.62 Aligned_cols=262 Identities=25% Similarity=0.407 Sum_probs=211.0
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++++.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++. +..+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence 47999999999999999999999999999999986422 12233456788999999999999999999994 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.| +|.+++...+.+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999985 999999988889999999999999999999999999999999999999999999999999986321100
Q ss_pred Cc------------c--------------------------------cccccccccccccccccccccCCCCCccchHHH
Q 017301 181 PM------------T--------------------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (374)
Q Consensus 181 ~~------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwS 216 (374)
.. . ......+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 00012469999999999877 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHh
Q 017301 217 IGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296 (374)
Q Consensus 217 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 296 (374)
|||++|+|++|.+||.+.+..+....+.... .... ......+++.+.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------------~~~~---~p~~~~~s~~~~dli~~l 286 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWR------------------------ETLY---FPDDIHLSVEAEDLIRRL 286 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccC------------------------CccC---CCCCCCCCHHHHHHHHHH
Confidence 9999999999999998876554443332110 0000 011234788999999999
Q ss_pred ccCCCCCC---CCHHHHhcCCCCCcC
Q 017301 297 IAFDPKDR---PTAEEALADPYFKGL 319 (374)
Q Consensus 297 L~~dp~~R---pt~~~lL~hp~~~~~ 319 (374)
|. +|.+| +|+.++++||||++.
T Consensus 287 L~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 98 77765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=367.57 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=212.0
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.+|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++.+. +...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCE
Confidence 369999999999999999999999999999999864321 2234456788999999999999999999994 3456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.+ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999985 999999888889999999999999999999999999999999999999999999999999975321100
Q ss_pred C--------------------------------------------cccccccccccccccccccccccCCCCCccchHHH
Q 017301 181 P--------------------------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (374)
Q Consensus 181 ~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwS 216 (374)
. ........+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 0000123479999999999987 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHh
Q 017301 217 IGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296 (374)
Q Consensus 217 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 296 (374)
|||++|+|++|++||.+.+..+....+... ...........+++.+.++|.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~---------------------------~~~~~~p~~~~~s~~~~~li~~l 286 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINW---------------------------QTSLHIPPQAKLSPEASDLIIKL 286 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHcc---------------------------CCCcCCCCcccCCHHHHHHHHHH
Confidence 999999999999999887654333222210 00000111246789999999998
Q ss_pred ccCCCCCCCC---HHHHhcCCCCCcC
Q 017301 297 IAFDPKDRPT---AEEALADPYFKGL 319 (374)
Q Consensus 297 L~~dp~~Rpt---~~~lL~hp~~~~~ 319 (374)
+ .||.+|++ ++++++||||+.+
T Consensus 287 ~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred c-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 7 59999997 9999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=351.91 Aligned_cols=281 Identities=38% Similarity=0.613 Sum_probs=222.1
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||+|++|.||+|.+..+|+.||+|.++...........+.+|+.+++.++|||++++++++. +...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence 699999999999999999999999999999998653333233345678999999999999999999984 345689
Q ss_pred EEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 104 VVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 104 lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
+|+||++++|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999988875 56799999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCC-CCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
......+++.|+|||.+.+. ..++.++|||||||++|+|++|..| |.+.+....+..+.+..+.+....+......
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12334678899999987652 4578899999999999999998766 5666667777777777777766554322111
Q ss_pred HHHHHHHHhcCCCC-CCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 262 KARKYLTEMRKKPP-VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 262 ~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.... ....... ....+..+.+++.+.+||.+||+.||.+|||++++|.||||
T Consensus 232 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYK---PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccc---ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0000 0000000 01122345688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=367.59 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=211.7
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
+.|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+|+.++||||+++++.+. +...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCE
Confidence 479999999999999999999999999999999864221 1223456778999999999999999999984 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.+ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999985 999999988889999999999999999999999999999999999999999999999999975321000
Q ss_pred C----------------------------------------cccccccccccccccccccccccCCCCCccchHHHHHHH
Q 017301 181 P----------------------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (374)
Q Consensus 181 ~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~i 220 (374)
. ........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123479999999999987 678999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCC
Q 017301 221 FAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300 (374)
Q Consensus 221 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 300 (374)
+|+|++|+.||.+.+..+....+... ...........+++.+.++|.+|+ .+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~---------------------------~~~~~~~~~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINW---------------------------ETTLHIPSQAKLSREASDLILRLC-CG 285 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhcc---------------------------CccccCCCCCCCCHHHHHHHHHHh-cC
Confidence 99999999999887654433222110 000011112457899999999987 59
Q ss_pred CCCCC---CHHHHhcCCCCCcC
Q 017301 301 PKDRP---TAEEALADPYFKGL 319 (374)
Q Consensus 301 p~~Rp---t~~~lL~hp~~~~~ 319 (374)
|.+|+ |+.++++||||+++
T Consensus 286 p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 286 AEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred HhhcCCCCCHHHHhCCCCcCCC
Confidence 99999 99999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=357.26 Aligned_cols=251 Identities=24% Similarity=0.413 Sum_probs=207.7
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||+||+|.++.+++.||+|++.+... .......+.+|..++..+ +||||+++++++. ....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-----~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-----TPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-----cCCEEEEEE
Confidence 469999999999999999999999999874321 223345567888888876 6999999999984 445699999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 99985 9999998888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------------------- 210 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-------------------- 210 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234579999999999877 6789999999999999999999999988775544433321
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH------HHHhcCCCCCcCc
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGLA 320 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~~lL~hp~~~~~~ 320 (374)
.. ......+++.+.+||++||+.||.+||++ +++++||||..+.
T Consensus 211 -------~~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 211 -------DE----VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred -------CC----CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 00 01123478899999999999999999998 9999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=356.07 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=210.6
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCC-CccccceeecCCCcCCCCc
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHP-DIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~~~~ 101 (374)
.|++++.||+|+||.||+|.+..+++.||+|++..... .......+..|..++..++|+ +|+.+++.+. ....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence 48999999999999999999999999999999875322 223445677899999999765 5778888873 3356
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.+ +|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999985 999999888889999999999999999999999999999999999999999999999999986432211
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 1 1234579999999999987 67899999999999999999999999887655444333210
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH-----HHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~~lL~hp~~~~~ 319 (374)
. ......+++.+.++|.+||..||.+|+++ .++++||||+.+
T Consensus 217 -------------~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 217 -------------N----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred -------------C----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 01123578899999999999999999976 899999999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=353.19 Aligned_cols=279 Identities=24% Similarity=0.378 Sum_probs=217.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||.||+|.+..++..+|+|++.... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCE
Confidence 478999999999999999999999999999999987532 23345578899999999999999999999843 346
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+++||||+.+ +|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 8999999996 9999999888899999999999999999999986 6999999999999999999999999998754322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH----H
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET----I 255 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~----~ 255 (374)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.... ++.+.... .
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccccccccCCc
Confidence 1 234578999999999987 6789999999999999999999999987665433222 22111000 0
Q ss_pred h-------------------hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 256 A-------------------VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 256 ~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
. .............+....... .....+++++++||.+||++||++|||+.++|+||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 0 000001111122221111110 0112478899999999999999999999999999999
Q ss_pred CcC
Q 017301 317 KGL 319 (374)
Q Consensus 317 ~~~ 319 (374)
+..
T Consensus 305 ~~~ 307 (331)
T cd06649 305 KRS 307 (331)
T ss_pred hhc
Confidence 754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=350.93 Aligned_cols=293 Identities=42% Similarity=0.649 Sum_probs=232.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++.+.||+|+||.||+|.+..+|+.||+|.++...........+.+|+.+++.++|+|++++++++.... ..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CC
Confidence 357899999999999999999999999999999998643333222334568999999999999999999985432 24
Q ss_pred cEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+++||||+.++|.+++.. ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 5899999999999888876 357899999999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. ......+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+....+....
T Consensus 162 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AK---PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cC---CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 21 11233567889999987652 467899999999999999999999999999999999999888888776654332
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.......+. ............++..++.+.+||.+||++||.+|||+.++|.||||+...-
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 238 DLPLVGKFT-LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred ccccccccc-ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 211100000 0111111111223456889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=358.82 Aligned_cols=259 Identities=29% Similarity=0.461 Sum_probs=228.2
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|..++++|+|+||.+++++++..+..+|+|.+.-............+|+.+++++.||||+.+.+.|...+ .
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~ 77 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----Q 77 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----c
Confidence 357899999999999999999999999999999999866556566667889999999999999999999994332 3
Q ss_pred cEEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 101 DIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
.++|||+||+| ++.+.++..+ .++++.+..++.|++.||.|||+++|.|||||+.||+++.++.|||+|||+|+...
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 49999999996 9999997643 68999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
... ....+.+|||.|+.||++.+ .+|+.++|||||||++|||++-+++|.+.+....+..|......|-+
T Consensus 158 ~~~---~~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp----- 227 (426)
T KOG0589|consen 158 PED---SLASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP----- 227 (426)
T ss_pred Cch---hhhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-----
Confidence 543 23367799999999999998 89999999999999999999999999999887777777654433332
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
...+.+++.||+.||+.+|..||++.++|.+|.+..
T Consensus 228 -------------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 228 -------------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred -------------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 357889999999999999999999999999998764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=358.94 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=213.7
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|.+.+.||+|+||+||+|.+..+|+.||+|+++.... .......+.+|+.+++.++||||+++++++. ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCe
Confidence 479999999999999999999999999999999975322 2233456778999999999999999999884 3456
Q ss_pred EEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+|+||||+.+ +|.+++... +.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 8999999985 999999876 68999999999999999999999999999999999999999999999999999765332
Q ss_pred CCccccccccccccccccccccccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
... ......||+.|+|||++... ...++.++|||||||++|+|++|..||...+.......+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--------- 224 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--------- 224 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---------
Confidence 211 12334789999999998631 156788999999999999999999999877654443333211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.........+.+++.+.+||++||+ ||.+|||++++++||||..+
T Consensus 225 ------------------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 225 ------------------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred ------------------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 0000111224678999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-48 Score=360.85 Aligned_cols=264 Identities=25% Similarity=0.362 Sum_probs=213.1
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++.+.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++. ..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-----~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-----DD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 4578999999999999999999999999999999986422 12233345678999999999999999999884 44
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+|+||||+.| +|.+++... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 569999999985 999888654 689999999999999999999999999999999999999999999999999975432
Q ss_pred CCCccccccccccccccccccccccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
... ......+||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~----------- 261 (370)
T cd05596 195 NGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD----------- 261 (370)
T ss_pred CCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------
Confidence 211 112345799999999988652 13488899999999999999999999988765443333221
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (374)
............+|..+.+||++||+.+|.+ |+|++++++||||++.
T Consensus 262 ----------------~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 262 ----------------HKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred ----------------CCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 0000011122357899999999999999988 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=344.83 Aligned_cols=285 Identities=40% Similarity=0.702 Sum_probs=231.4
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.++|||++++++++.. ....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 6999999999999999999999999999999987544334445678899999999999999999999844 45689
Q ss_pred EEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 104 VVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 104 lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
+||||++++|.+++.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999996699999865 45789999999999999999999999999999999999999999999999999876543321
Q ss_pred ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 017301 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (374)
.......++..|+|||.+.+. ..++.++||||+||++|+|++|.+||.+.+....+..+....+.+.+..+.......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 112345789999999987652 457889999999999999999999999988888888888888888776554432211
Q ss_pred HHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
....+ ........+....+++.+..+.+||++||+.||.+|||++++|+||||.
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKI-TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhcc-cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 11000 0111111222334567789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=358.00 Aligned_cols=250 Identities=26% Similarity=0.464 Sum_probs=207.6
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEc
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e 107 (374)
+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++.+. ....+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-----~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----cCCEEEEEEe
Confidence 469999999999999999999999999975322 2233456778999999999999999999884 3456999999
Q ss_pred cCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 108 LMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 108 ~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
|+.+ +|...+...+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 9986 999999888889999999999999999999997 7999999999999999999999999999864322211 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------- 210 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234579999999999877 6789999999999999999999999987765433332211
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
.. ......+++.+.+||.+||+.||.+|+ ++.++++||||.+.
T Consensus 211 ------~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 211 ------EE-----IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred ------CC-----CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 00 011235789999999999999999997 99999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=354.35 Aligned_cols=251 Identities=29% Similarity=0.494 Sum_probs=207.0
Q ss_pred eceeeccCCeeEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 28 LEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++.||+|+||.||+|.+. .+++.||+|+++... ........+.+|+.+|+.++||||+++++.+.. ...+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeE
Confidence 468999999999999864 578899999987432 122233456789999999999999999999843 3568
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|+||||+.+ +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999996 9999999888899999999999999999999999999999999999999999999999999864322211
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~---------------- 214 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK---------------- 214 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Confidence 1234579999999999877 6788999999999999999999999988765443333221
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
.. ....+.+++.+.+||.+||+.||++|| ++.++++||||+..
T Consensus 215 ----------~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 215 ----------GK-----LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------CC-----CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 112245788999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=354.20 Aligned_cols=253 Identities=26% Similarity=0.442 Sum_probs=206.7
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHH---HhCCCCCccccceeecCCCcCCCC
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLL---RLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l---~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
|++++.||+|+||+||+|.+..+++.||+|+++... ........+.+|+.++ +.++||||+++++++. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 789999999999999999999999999999997432 1222344566666655 4567999999999984 345
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
++|+||||+.+ +|...+.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 69999999996 88877754 57999999999999999999999999999999999999999999999999998643222
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. .....+|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------- 215 (324)
T cd05589 155 GD---RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------------- 215 (324)
T ss_pred CC---cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Confidence 11 1234679999999999887 6789999999999999999999999988765544433221
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
... .....+++.+.++|.+||+.||.+|| ++.++++||||+++
T Consensus 216 -------------~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 216 -------------DEV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred -------------CCC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 000 11235789999999999999999999 79999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=343.80 Aligned_cols=282 Identities=38% Similarity=0.623 Sum_probs=227.3
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
.|++++.||.|++|.||+|.+..++..||+|.+............+.+|+.++++++||||+++++++. +....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 488999999999999999999999999999998754333334456788999999999999999999984 345689
Q ss_pred EEEccCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 104 VVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 104 lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
+||||+.++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 9999999899988865 35689999999999999999999999999999999999999999999999999875432211
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
......+++.|+|||.+.+. ..++.++|+|||||++|+|+||..||.+.+..+....+....+.+....+.....
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS- 230 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH-
Confidence 11233578899999987652 3468899999999999999999999999888888888888888777655443221
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
...+................+.+++.++++|.+||+.||.+|||+.++|.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 231 -LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred -HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 112222222222222333345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=356.35 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=208.5
Q ss_pred CeeEeceeeccCCeeEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 97 (374)
.|++++.||+|+||+||+|++. .+++.||+|++.+.. ........+.+|+.+++.++ ||+|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ----- 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-----
Confidence 4899999999999999999864 578999999986432 12233456778999999995 999999999883
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....+|+||||+.+ +|.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 44568999999996 99999988888999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+.
T Consensus 156 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~------------ 220 (332)
T cd05614 156 LSEEKE--RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS------------ 220 (332)
T ss_pred cccCCC--ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH------------
Confidence 332211 12345799999999998752 357889999999999999999999997543221111111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
..+.... ....+.+++.+.+||.+||+.||++|| +++++++||||+..
T Consensus 221 -----------~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 221 -----------RRILKCD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred -----------HHHhcCC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 1111111 011245789999999999999999999 88999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=354.45 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=207.5
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||.||+|.+..+++.||+|++..... .......+..|..++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence 469999999999999999999999999875321 223344567788888866 79999999999943 45689999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+++ +|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 99986 9999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-------------------- 210 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999877 6789999999999999999999999988776544433321
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-------CHHHHhcCCCCCcC
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-------TAEEALADPYFKGL 319 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-------t~~~lL~hp~~~~~ 319 (374)
... .....+++.+.+||.+||+.||++|| ++.++++||||..+
T Consensus 211 ------~~~-----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 211 ------DDV-----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred ------CCC-----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 000 01134688999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=345.81 Aligned_cols=281 Identities=33% Similarity=0.579 Sum_probs=223.9
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC--CCC----ccccceeecCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--HPD----IVEIKRIMLPP 94 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~----i~~~~~~~~~~ 94 (374)
..+||++++.+|+|.||.|-.+.|..++..||+|+++.. . ...+..+-|+++|.++. -|+ ++.+.++|
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--- 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-D--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--- 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-H--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh---
Confidence 378999999999999999999999999999999998742 1 22234556999999994 222 44444555
Q ss_pred CcCCCCcEEEEEccCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-----------
Q 017301 95 SKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA----------- 161 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~----------- 161 (374)
+-.+++|||+|.++.++.+++..++ +++...++.+.+||++++++||+++++|.||||+|||+..
T Consensus 161 --dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 161 --DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred --hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 4557799999999999999999876 7899999999999999999999999999999999999621
Q ss_pred ---------CCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 017301 162 ---------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (374)
Q Consensus 162 ---------~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~ 232 (374)
+..|+++|||.|+...... +..+.|+.|+|||++.+ -+++.++||||+||||+|+.+|..+|+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceecc
Confidence 2348999999998654432 45578999999999999 689999999999999999999999999
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhc---------------CCCCCCccccCCCCC---hHHHHHHH
Q 017301 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR---------------KKPPVPLFQKFPNVD---PLALRLLQ 294 (374)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~s---~~~~~li~ 294 (374)
+.++.+++.+|...+|..+...+...+ ..+++.... .+.+.++.......+ ..+.|||+
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 999999999999999976666655442 223332221 011222222222222 24789999
Q ss_pred HhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 295 RLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 295 ~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
+||.+||.+|+|+.|+|.||||+.+.
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhcCC
Confidence 99999999999999999999998753
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=351.70 Aligned_cols=297 Identities=40% Similarity=0.679 Sum_probs=227.7
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC--
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR-- 97 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-- 97 (374)
+..++|++.+.||.|+||+||+|.+..+|..||+|++..... .....+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 567999999999999999999999999999999999864322 3445677899999999999999999887554321
Q ss_pred -------CCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-CCCeEEee
Q 017301 98 -------EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCD 169 (374)
Q Consensus 98 -------~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~-~~~vkl~D 169 (374)
+....|+||||++++|.+.+.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 2246899999999999888864 46899999999999999999999999999999999999975 55689999
Q ss_pred ecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
||.+.................++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99987543222111112334678899999986542 46888999999999999999999999988877666666555444
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
+.++......+. ..............+.....+.++..+.+||.+||+.||.+|||+.++|.||||+.+..
T Consensus 238 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~ 308 (342)
T cd07854 238 VREEDRNELLNV-IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC 308 (342)
T ss_pred CChHHhhhhhhh-hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence 444332222111 11111111112222333345678899999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=350.36 Aligned_cols=281 Identities=36% Similarity=0.590 Sum_probs=211.2
Q ss_pred eceeeccCCeeEEEEEECC--CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEE
Q 017301 28 LEVIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
+.+||+|+||+||+|.+.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.... ...+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEE
Confidence 4689999999999998654 56899999886432 2234678999999999999999999985432 3468999
Q ss_pred EccCcccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe----cCCCCeEEeeecc
Q 017301 106 FELMESDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDFGL 172 (374)
Q Consensus 106 ~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~----~~~~~vkl~DFg~ 172 (374)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999998887532 258899999999999999999999999999999999999 5567899999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh---------hhHHHHH
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---------VHQLDLI 243 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~---------~~~~~~i 243 (374)
++................||+.|+|||++.+. ..++.++|||||||++|+|+||.+||..... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98654432222223445789999999988652 4588999999999999999999999975432 3456667
Q ss_pred HHhhCCCCHHHHhhhcCH-HHHHHHHHhcCCCC--C----CccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 244 TDLLGTPSPETIAVVRNE-KARKYLTEMRKKPP--V----PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~----~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
...++.+....+...... .............. . .........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 777787776655443211 00111000000000 0 0001112346678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=352.06 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=204.5
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||.||+|.++.+|+.||+|+++.... ..........|..++... +||||+++++.+. ...++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence 479999999999999999999999999875321 112334556788887754 8999999999984 445699999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NR 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---Cc
Confidence 99986 999999888889999999999999999999999999999999999999999999999999986432211 11
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------------------- 210 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------------------- 210 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 244679999999999987 6789999999999999999999999987765433332211
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH-HHHhcCCCCCcC
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-EEALADPYFKGL 319 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-~~lL~hp~~~~~ 319 (374)
..+ .....++..+.+||++||+.||++||++ +++++||||...
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 211 -------DTP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred -------CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 000 1112478899999999999999999998 589999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=359.16 Aligned_cols=264 Identities=26% Similarity=0.368 Sum_probs=211.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++. ..
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-----DD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cC
Confidence 4578999999999999999999999999999999986422 22233445778999999999999999999984 44
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+|+||||+.+ +|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 569999999985 999988654 689999999999999999999999999999999999999999999999999976432
Q ss_pred CCCcccccccccccccccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
... ......+||+.|+|||++.+.. ..++.++|+|||||++|+|++|+.||.+.+.......+......
T Consensus 195 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~------- 265 (370)
T cd05621 195 TGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS------- 265 (370)
T ss_pred CCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc-------
Confidence 211 1123557999999999986521 23788999999999999999999999887654444333221000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (374)
........++..++++|.+||..++.+ |+|+.++++||||+..
T Consensus 266 --------------------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 266 --------------------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred --------------------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 001112357889999999999865543 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=359.63 Aligned_cols=262 Identities=25% Similarity=0.413 Sum_probs=212.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
+.|++++.||+|+||+||+|.+..+++.||+|+++... ........+.+|+.++..++||+|+++++.+. ...+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 46999999999999999999999999999999986432 12233456778999999999999999999984 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.| +|.+++...+.+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999985 999999988899999999999999999999999999999999999999999999999999986432211
Q ss_pred Cc--------------------------------ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 017301 181 PM--------------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (374)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~ 228 (374)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 000123579999999999987 68999999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC---
Q 017301 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP--- 305 (374)
Q Consensus 229 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp--- 305 (374)
+||.+.+.......+.... ... .......+++.+++||.+|+. ||.+|+
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~------------------------~~~---~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 234 PPFCSETPQETYRKVMNWK------------------------ETL---VFPPEVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCCHHHHHHHHHcCC------------------------Cce---ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 9998877554443332100 000 001112478899999999874 999998
Q ss_pred CHHHHhcCCCCCcC
Q 017301 306 TAEEALADPYFKGL 319 (374)
Q Consensus 306 t~~~lL~hp~~~~~ 319 (374)
++.++++||||+++
T Consensus 286 ~~~ei~~hp~f~~~ 299 (360)
T cd05627 286 GVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHhcCCCCCCC
Confidence 58999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=344.77 Aligned_cols=286 Identities=43% Similarity=0.661 Sum_probs=229.9
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC---hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+..|+.+++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 589999999999999999999999999999999754332 2334456789999999999999999999944 45
Q ss_pred cEEEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|+||||+.++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 689999999779999998776 7999999999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. ......+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+....+....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR---KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc---cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 11334568889999987542 467889999999999999999999999888777777777777766655443222
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
... .+ .......+.+....+...+..+.++|.+||++||++|||+.++|.||||++...
T Consensus 232 ~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 232 SLP--DY-VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred ccc--cc-ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 111 11 011111222333445667889999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=351.51 Aligned_cols=255 Identities=23% Similarity=0.396 Sum_probs=210.6
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCc
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.|.+++.||+|+||.||+|.+..+++.||+|++.+... ..........|..++..+ .|++|+.+++++. ....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCE
Confidence 48899999999999999999999999999999875322 222334566788888777 4889999998883 3456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.+ +|.+.+...+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999985 999999888889999999999999999999999999999999999999999999999999987532221
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1234579999999999987 67999999999999999999999999887765444433210
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
.. .....+++.+.+|+.+||+.||.+|++ ..++++||||+.+
T Consensus 217 ------------~~-----~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 217 ------------NV-----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred ------------CC-----CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 00 112357899999999999999999998 4899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=350.53 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=204.0
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||+||+|.+..+++.||+|+++.... ..........|..++... +||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 469999999999999999999999999875321 122334455677777654 7999999999984 345699999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.| +|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GK 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Cc
Confidence 99985 999999888899999999999999999999999999999999999999999999999999997533222 12
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------------------- 210 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999887 6789999999999999999999999988765444333211
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH-HHHhcCCCCCcC
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-EEALADPYFKGL 319 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-~~lL~hp~~~~~ 319 (374)
..+ .....+++.+.+||.+||+.||.+||++ .++++||||...
T Consensus 211 -------~~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 211 -------DRP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred -------CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 000 1113478899999999999999999986 588899999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=352.95 Aligned_cols=250 Identities=27% Similarity=0.463 Sum_probs=205.0
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHH-HHHhCCCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|.. +++.++||||+++++.+. ....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence 469999999999999999999999999864321 2223344555655 467789999999999884 345689999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|..++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 99996 9999999888999999999999999999999999999999999999999999999999999864322211 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------------------- 210 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------------------- 210 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999877 6789999999999999999999999988765443332211
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCCCCCcC
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (374)
. .....+.+++.+.++|++||+.||.+||++ .++++||||...
T Consensus 211 -------~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 211 -------K----PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred -------C----CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 0 011235678999999999999999999998 699999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=342.89 Aligned_cols=282 Identities=39% Similarity=0.698 Sum_probs=218.1
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++.+.||+|++|.||+|.++.+++.||+|++............+.+|+.+++.++|||++++++.+. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 5799999999999999999999999999999998643322233345778999999999999999999984 34568
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
++||||+++ .|..++.....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999997 5555555666799999999999999999999999999999999999999999999999999976533221
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
......++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+..+....+....+...+.........
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 11234678899999987652 45788999999999999999999999988877666666555444333211111000
Q ss_pred HHHHHHHHhcCCC---CCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 262 KARKYLTEMRKKP---PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 262 ~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
. +........ ..+....++.++..+.+||.+||+.||++|||+.+++.||||
T Consensus 232 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 Q---FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred c---ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 000000000 011112245678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=350.53 Aligned_cols=250 Identities=24% Similarity=0.430 Sum_probs=206.9
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||+||+|.+..++..||+|+++... ........+.+|..+++.+ +||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 46999999999999999999999999987432 1223344567888898887 6999999999984 345699999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|...+...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 99985 9999998888999999999999999999999999999999999999999999999999999864322111 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------------- 210 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234578999999999987 6789999999999999999999999987765443332211
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH-----HHHhcCCCCCcC
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGL 319 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~~lL~hp~~~~~ 319 (374)
... .....+++.+.+||++||+.||.+|||+ .++++||||+..
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 211 -------DEV----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred -------CCC----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 1123578899999999999999999999 999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=345.43 Aligned_cols=297 Identities=34% Similarity=0.532 Sum_probs=228.6
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 96 (374)
-....++|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 3455678999999999999999999999999999999986443333333456689999999999999999998865432
Q ss_pred --CCCCcEEEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccc
Q 017301 97 --REFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 97 --~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
......++||||++++|.+.+.... .+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 87 YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 2335679999999999988887653 7899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc-ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 174 RVAFSDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 174 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
......... ........++..|+|||.+.+. ..++.++|+||||+++|+|++|++||.+.+.......+....+..++
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 754332211 1112344678889999987652 45788999999999999999999999999888888888888877766
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccc--cCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQ--KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
+.++............ ........... .....++.+.+||.+||+.||.+|||++++|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 6544332211111000 00000000000 011246778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=350.20 Aligned_cols=264 Identities=25% Similarity=0.419 Sum_probs=210.4
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++++.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+.+++.++|+||+++++++. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCe
Confidence 47999999999999999999999999999999986421 12233445778999999999999999999984 4456
Q ss_pred EEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+|+||||+.| +|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999985 99999976 457999999999999999999999999999999999999999999999999998654332
Q ss_pred CCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
... ......||+.|+|||++.+. ...++.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~---------- 223 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC----------
Confidence 211 11234699999999998631 145788999999999999999999999887654443333210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (374)
..........+.+++.+++||++||..++.+ |+++.++++||||.++
T Consensus 224 ----------------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 224 ----------------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ----------------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 0111111223458899999999999765444 7899999999999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=331.13 Aligned_cols=289 Identities=42% Similarity=0.722 Sum_probs=244.9
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
..+--+.||.|+||+||.+.|..+|+.||+|++...+++....+++.+|+.+|..++|.|++..+++.......-+..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34456789999999999999999999999999987777777788999999999999999999999999887766677899
Q ss_pred EEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc
Q 017301 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (374)
Q Consensus 104 lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (374)
+++|.+..+|..++.+-..++.+.++-+++||++||+|||+.||.||||||.|+|++.|+.+||||||+|+....+. .
T Consensus 134 V~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~--~ 211 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD--R 211 (449)
T ss_pred HHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh--h
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998754332 2
Q ss_pred cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 017301 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (374)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (374)
..++..+.|.+|+|||++.|. ..|+.+.||||.|||+.||+..+.+|...+..++++.|.+++|+|+.+.+..--...
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA- 289 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA- 289 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh-
Confidence 234555788999999999885 789999999999999999999999999999999999999999999988765432221
Q ss_pred HHHHHHhcCCCC-CCccccCC------CCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 264 RKYLTEMRKKPP-VPLFQKFP------NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 264 ~~~~~~~~~~~~-~~~~~~~~------~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
-.++.+... .+..+..- ....+..+++.+||.+||++|.+..+++.|+|+...
T Consensus 290 ---k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 290 ---KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred ---HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 112222221 11111111 234467899999999999999999999999998753
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=353.89 Aligned_cols=251 Identities=28% Similarity=0.469 Sum_probs=207.9
Q ss_pred eceeeccCCeeEEEEEE---CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEE
Q 017301 28 LEVIGKGSYGVVCAAID---THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l 104 (374)
++.||+|+||.||++.+ ..+|+.||+|++............+.+|+.++++++||||+++++++. ....+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEE
Confidence 36799999999999986 357899999999754333334456778999999999999999999984 3456899
Q ss_pred EEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc
Q 017301 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (374)
Q Consensus 105 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (374)
||||+.+ +|.+.+.....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 9999985 9999998888899999999999999999999999999999999999999999999999999875433211
Q ss_pred cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 017301 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (374)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (374)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 154 -~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~------------------ 212 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK------------------ 212 (318)
T ss_pred -ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc------------------
Confidence 1234579999999999877 6788999999999999999999999988765444333221
Q ss_pred HHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
.. ......+++.+.+||++||+.||.+||| +.+++.||||..+
T Consensus 213 --------~~-----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 213 --------AK-----LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred --------CC-----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 00 0112357889999999999999999999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=358.53 Aligned_cols=282 Identities=23% Similarity=0.299 Sum_probs=216.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
...+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||+++++++. .
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~-----~ 157 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYR-----W 157 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEe-----e
Confidence 3457999999999999999999754 45678999987532 13457999999999999999999883 3
Q ss_pred CCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...+|+|||++.++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 158 ~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 158 KSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred CCEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 45689999999999999998778899999999999999999999999999999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh---hhHHHHHHHhhCCCCHHHH
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---VHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~ 255 (374)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ...+..+.+.++..+.+..
T Consensus 238 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 238 HPDT-PQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cccc-ccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 2221 12234579999999999977 6789999999999999999999999977653 3445555555544332221
Q ss_pred hhhcCHHHHHHHHHhcC--CCCCCcccc--CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 256 AVVRNEKARKYLTEMRK--KPPVPLFQK--FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.. ........+..... ..+...... ...++..+.++|.+||..||++|||+.++|+||||..
T Consensus 315 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 315 QN-GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred Cc-cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 11 11111111111111 000111011 1245778999999999999999999999999999975
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=341.50 Aligned_cols=258 Identities=34% Similarity=0.592 Sum_probs=212.3
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l 104 (374)
|++++.||+|+||+||+|.+..+++.||+|++..............+|+.+++.++||||+++++++.. ...+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999998654443444445679999999999999999999954 456899
Q ss_pred EEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc
Q 017301 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (374)
Q Consensus 105 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (374)
|||++.+ +|.+++...+.+++..+..++.|++.||++||++||+|+||||+||+++.++.++|+|||.+...... .
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---N 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST---T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c
Confidence 9999998 99999997788999999999999999999999999999999999999999999999999998753111 1
Q ss_pred ccccccccccccccccccc-ccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 017301 184 VFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (374)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (374)
.......+++.|+|||++. + ..++.++|+||||+++|+|++|..||......+....+............
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS------- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-------
Confidence 2234567899999999987 5 67899999999999999999999999987544444443332221111100
Q ss_pred HHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
. .....++.+.++|.+||+.||++|||+.++++||||
T Consensus 224 --------~---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 224 --------Q---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp --------T---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred --------c---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0 001123789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=350.58 Aligned_cols=259 Identities=23% Similarity=0.398 Sum_probs=204.7
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||.||+|.+..+++.||+|+++.... .......+.+|..+++.+ +||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEE
Confidence 469999999999999999999999999975332 223345677899999888 6999999999984 345689999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 99986 9999998888999999999999999999999999999999999999999999999999999864222111 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||......+ .+... . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~------~--~~~ 212 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQN------T--EDY 212 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------ccccc------c--hHH
Confidence 234579999999999987 678999999999999999999999996432110 00000 0 000
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC------HHHHhcCCCCCcC
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGL 319 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt------~~~lL~hp~~~~~ 319 (374)
....+.... ......+++.+.+||.+||+.||.+|+| ++++++||||..+
T Consensus 213 ~~~~~~~~~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 213 LFQVILEKQ----IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHHHcCC----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 001111111 1112457889999999999999999987 7899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=348.33 Aligned_cols=259 Identities=29% Similarity=0.486 Sum_probs=225.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+.+-|.+.+.||+|.|.+|.+|++..+|..||||++.+..........+..|+++|+..+|||||++|++. ....
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccc
Confidence 56789999999999999999999999999999999987655555555788999999999999999999999 5556
Q ss_pred cEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe-cCCCCeEEeeeccccccc
Q 017301 101 DIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA-NANCKLKVCDFGLARVAF 177 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~-~~~~~vkl~DFg~a~~~~ 177 (374)
.+|+|+|+-.+ +|+++|-.+ ..+.+..+++++.||+.|+.|+|...+|||||||+|+.+ ..-|-|||.|||++-.+.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 69999999985 999998764 479999999999999999999999999999999999965 556899999999986554
Q ss_pred CCCCcccccccccccccccccccccccCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
... .....||+..|-|||++.| ..|+ +++||||||||||-|++|++||...++.+.+.+|++-..
T Consensus 171 PG~----kL~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-------- 236 (864)
T KOG4717|consen 171 PGK----KLTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-------- 236 (864)
T ss_pred Ccc----hhhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--------
Confidence 432 3467799999999999988 5555 578999999999999999999999998888888765211
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.....+|.+++|||..||..||.+|.|.++|.+|+|++....
T Consensus 237 -----------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 237 -----------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred -----------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 222467899999999999999999999999999999997654
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=344.50 Aligned_cols=287 Identities=41% Similarity=0.671 Sum_probs=230.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.+.|++.+.||.|++|.||+|.+..+++.+|+|.++...........+.+|+.+++.++||||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence 36799999999999999999999999999999998754333333345678999999999999999999885432 256
Q ss_pred EEEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
.|+||||+.++|.+++.... .+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999999999999887654 58999999999999999999999999999999999999999999999999987654332
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ......+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||...+..+....+....+.|.+..+.....
T Consensus 161 ~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 K---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 1 12334678899999988652 3468899999999999999999999999998888888888888888776654322
Q ss_pred HHHHHHHHHhcCCCCCCccccCCC--CChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPN--VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
-..... ..............++. +++.+.++|++||+.||++|||+.|+|.||||
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 111000 01111111122233444 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=365.01 Aligned_cols=271 Identities=26% Similarity=0.350 Sum_probs=220.6
Q ss_pred ccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 16 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
.+.....++|++.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.++..++|+|++++++.+....
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34445568999999999999999999999999999999999765445555667889999999999999999988775432
Q ss_pred c---CCCCcEEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEE
Q 017301 96 K---REFKDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (374)
Q Consensus 96 ~---~~~~~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl 167 (374)
. .....+++||||+.+ +|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence 1 112347899999995 99998865 346899999999999999999999999999999999999999999999
Q ss_pred eeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
+|||+++........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 185 ~DFGls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-- 259 (496)
T PTZ00283 185 GDFGFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-- 259 (496)
T ss_pred EecccCeeccccccc-cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--
Confidence 999999764332211 11234579999999999987 6799999999999999999999999987765443332211
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
... ....+.+++.+.+|+.+||+.||.+|||+.++|+|||++..
T Consensus 260 -------------------------~~~---~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 260 -------------------------GRY---DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred -------------------------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 000 11234678999999999999999999999999999998764
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=348.06 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=204.6
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHh-CCCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRL-LRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||+||+|.+..+++.||+|+++.... ..........|..++.. ++||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence 469999999999999999999999999875321 11233445677888776 489999999999843 35699999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 99985 9999998888899999999999999999999999999999999999999999999999999864322111 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
.....||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------------------- 210 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 234579999999999877 6789999999999999999999999987765433332211
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHH-HHhcCCCCCcCc
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKGLA 320 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~-~lL~hp~~~~~~ 320 (374)
..+ .....++..+.+||.+||+.||.+||++. ++++||||+.+.
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 211 -------DNP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred -------CCC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 000 01124788899999999999999999996 899999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=342.00 Aligned_cols=287 Identities=38% Similarity=0.682 Sum_probs=223.2
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
++..++|++.+.||+|++|+||+|.++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++. .
T Consensus 1 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 74 (291)
T cd07844 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIH-----T 74 (291)
T ss_pred CCCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEe-----c
Confidence 35568999999999999999999999999999999998643222 12234668999999999999999999984 3
Q ss_pred CCcEEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
....|+||||+.++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++...
T Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 75 KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 4568999999999999988764 468999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.... ......++..|+|||++.+. ..++.++||||+||++|+|++|+.||.+.. ..++...+.+..+.+.++.+.
T Consensus 155 ~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 155 VPSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CCCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 2111 11223567889999987652 457889999999999999999999998766 566677777777777766554
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCC--hHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVD--PLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
......... ........+.+.....+.++ ..+.++|.+||+.||++|||+.++|+||||
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 231 GVSSNPEFK-PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhccccc-cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 322110000 00000111111222233455 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=341.64 Aligned_cols=288 Identities=37% Similarity=0.627 Sum_probs=226.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++.+.||+|+||.||+|.+..+++.||+|.++...........+.+|+.+++.++ ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998654333333456788999999995 699999999986554334445
Q ss_pred EEEEEccCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-CCCeEEeeeccccc
Q 017301 102 IYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARV 175 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~-~~~vkl~DFg~a~~ 175 (374)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||.+..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999998888653 35799999999999999999999999999999999999998 88999999999875
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
....... .....+++.|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+.......+...++.+....+
T Consensus 161 ~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVKS---YTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCccc---cCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 4322111 1233578899999987542 45789999999999999999999999998888777777777777765544
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
........ ... .....+.......+.+++.+.+||.+||+.||.+|||+.++|.||||+
T Consensus 237 ~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRD--WHE-FPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccc--hhh-cCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 32211110 000 111111122223456889999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=347.11 Aligned_cols=255 Identities=23% Similarity=0.400 Sum_probs=209.3
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCc
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.|...+.||+|+||+||+|.++.+|+.||+|++.+... .......+..|..++..+. |++|+++++.+. ....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-----TVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe-----cCCE
Confidence 47889999999999999999999999999999874321 2233445678888888886 567778888873 3356
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.+ +|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999985 999999888899999999999999999999999999999999999999999999999999987532221
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ......||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.......+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1234569999999999877 67899999999999999999999999887654443333210
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
. ......+++.+.+++.+||+.||.+|++ ..++++||||+.+
T Consensus 217 ------------~-----~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 217 ------------N-----VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ------------C-----CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 0 0112357889999999999999999997 5799999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=354.14 Aligned_cols=264 Identities=25% Similarity=0.357 Sum_probs=211.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++.+.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+++.++||||+++++.+. ..
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cC
Confidence 3489999999999999999999999999999999986422 12233445778999999999999999999984 44
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+|+||||+.| +|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 569999999985 899888654 589999999999999999999999999999999999999999999999999976432
Q ss_pred CCCcccccccccccccccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
... ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---------- 262 (371)
T cd05622 195 EGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH---------- 262 (371)
T ss_pred CCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------
Confidence 211 1123457999999999986521 23788999999999999999999999887654443333211
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (374)
.........+.++..+++||.+||..++.+ |++++++++||||++.
T Consensus 263 -----------------~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 263 -----------------KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred -----------------CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 000011123468999999999999844433 7899999999999873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=346.16 Aligned_cols=255 Identities=29% Similarity=0.401 Sum_probs=209.3
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcE-EEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.......+.+.||+|+||+||+|..+ |.. ||+|++............+.+|+.+|.+++||||+.+++++..+..
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-- 113 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-- 113 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC--
Confidence 33556677788999999999999654 666 9999998655544457789999999999999999999999965431
Q ss_pred CCcEEEEEccCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCC-ccccCCCCCceEecCCC-CeEEeeeccc
Q 017301 99 FKDIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNILANANC-KLKVCDFGLA 173 (374)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~-i~H~dikp~Nil~~~~~-~vkl~DFg~a 173 (374)
.++|||||+. |+|.+++.. ...++...+..++.+|+.|+.|||+++ ||||||||+|||++.++ ++||+|||++
T Consensus 114 --~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 114 --SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred --ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 5899999999 599999987 578999999999999999999999999 99999999999999998 9999999999
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
+...... ...+...||+.|||||++.+....|+.++||||||+++|||+||..||.+.........+.....+|.
T Consensus 192 r~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~-- 266 (362)
T KOG0192|consen 192 REKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP-- 266 (362)
T ss_pred eeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC--
Confidence 8654321 11233689999999999984126899999999999999999999999999887433333321111111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. ....++.+.+|+..||+.||.+||+..+++.
T Consensus 267 ----------------------~-----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 ----------------------I-----PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ----------------------C-----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 1 1237888999999999999999999999876
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=349.15 Aligned_cols=258 Identities=23% Similarity=0.414 Sum_probs=203.8
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||+||+|.+..+++.||+|++++... .......+.+|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 479999999999999999999999999975432 223445677899888776 79999999999843 45689999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|...+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 99995 9999998888999999999999999999999999999999999999999999999999999874322111 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ +. .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------~~---------~~~~~ 211 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----------PD---------QNTED 211 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcCC----------cc---------cccHH
Confidence 234579999999999987 6789999999999999999999999953211000 00 00000
Q ss_pred H-HHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC------HHHHhcCCCCCcC
Q 017301 266 Y-LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGL 319 (374)
Q Consensus 266 ~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt------~~~lL~hp~~~~~ 319 (374)
. ........ ......++..+.+||++||+.||.+||| +.++++||||+..
T Consensus 212 ~~~~~i~~~~----~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 212 YLFQVILEKQ----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHhcCC----CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 0 01111110 1122457889999999999999999998 5899999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=350.70 Aligned_cols=279 Identities=24% Similarity=0.345 Sum_probs=208.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
...|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++||||+++++++.. ...
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEe-----CCe
Confidence 35699999999999999999999999999999975421 23468999999999999999999844 345
Q ss_pred EEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
.++|||++.++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred eEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 899999999999998865 4579999999999999999999999999999999999999999999999999987432221
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCC-CCCCCCCh---------hhHHHHHHHhhCCC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSV---------VHQLDLITDLLGTP 250 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~-~pf~~~~~---------~~~~~~i~~~~~~~ 250 (374)
......||+.|+|||++.+ ..++.++|||||||++|+|+++. ++|..... ...+..+...++..
T Consensus 212 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 212 ----AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred ----ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 1234569999999999987 67899999999999999999854 55544321 12222333333332
Q ss_pred CHHHHhhhcCHHHHHHHHHhcC-CCCCCcc--ccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 251 SPETIAVVRNEKARKYLTEMRK-KPPVPLF--QKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
+..............++..... ..+.... .....++..+.+||.+||+.||.+|||+.|+|+||||+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 2221111111111222211111 0111000 0112567888999999999999999999999999999863
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=339.86 Aligned_cols=285 Identities=37% Similarity=0.677 Sum_probs=219.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++ ......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 479999999999999999999999999999999865433333445677899999999999999999998 344568
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|+||||+.+ .|..+......+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999997 566666556679999999999999999999999999999999999999999999999999987543322
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
.......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+....+....+.............
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred --cccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 122345688999999988652 45788999999999999999999999888766666665555444332211111000
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
...............+.....+.++..+.+|+.+||+.||++|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000000000000111222356789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=341.20 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=202.1
Q ss_pred eeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccC
Q 017301 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (374)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 109 (374)
||+|+||+||+|.+..+++.||+|.+..... .......+..|+.+++.++||||+++.+++. ....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCC
Confidence 7999999999999999999999999864322 2223356678999999999999999999884 345689999999
Q ss_pred cc-cHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccc
Q 017301 110 ES-DLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (374)
Q Consensus 110 ~~-~L~~~l~----~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (374)
.+ +|.+.+. .+..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--- 152 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--- 152 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---
Confidence 85 8887774 245689999999999999999999999999999999999999999999999999875433221
Q ss_pred ccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 017301 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (374)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (374)
......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...........+.
T Consensus 153 ~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~-------------------- 210 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-------------------- 210 (280)
T ss_pred cccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH--------------------
Confidence 1234578999999999987 678999999999999999999999997654321111110
Q ss_pred HHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
..... ......+.+++.+.+++.+||+.||++|| |++++++||||+++
T Consensus 211 ---~~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 211 ---QRILN----DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred ---Hhhcc----cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 00100 01112245789999999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=359.33 Aligned_cols=281 Identities=25% Similarity=0.321 Sum_probs=209.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
...|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+|+.++|+||+++++++.. ...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCE
Confidence 558999999999999999999999999999999642 1234689999999999999999998843 345
Q ss_pred EEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
.++|||++.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 235 ~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 235 TCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 8999999999999988764 469999999999999999999999999999999999999999999999999997643322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCC-CCCCCh------hhHHHHHHHhhCCCCHH
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSV------VHQLDLITDLLGTPSPE 253 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~p-f~~~~~------~~~~~~i~~~~~~~~~~ 253 (374)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..+ |..... ..++..+....+....+
T Consensus 315 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 315 ST-PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cc-ccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 11 11234579999999999987 6789999999999999999998754 433211 22333333332221111
Q ss_pred HHhhhcCHHHHHHHHHh----cCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 254 TIAVVRNEKARKYLTEM----RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
............+.... ......+....+..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 10000001111111110 001111112233457788999999999999999999999999999964
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=340.92 Aligned_cols=287 Identities=39% Similarity=0.669 Sum_probs=227.9
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++.+.||+|++|+||+|.+..+|+.||+|.+............+.+|+.+++.++|||++++++.+. ...+.
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 6899999999999999999999999999999998654333333456778999999999999999999984 34569
Q ss_pred EEEEccCcccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-CCCeEEeeecccccccCC
Q 017301 103 YVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~-~~~vkl~DFg~a~~~~~~ 179 (374)
|+||||++++|.+.+..... +++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999999999988876543 578889999999999999999999999999999999985 457999999999754332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. ......+++.|+|||.+.+. ..++.++|+||+||++|+|++|++||.+.+..+.+..+....+.|....+....
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR---TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc---ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 11 11334678899999987652 467889999999999999999999999888877777777777777666554322
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
. ...+................+.+++.+.++|.+||+.||++||++.++|.||||.++.
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 233 S--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred c--chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 1 1111111111122222233467889999999999999999999999999999998764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=337.66 Aligned_cols=281 Identities=40% Similarity=0.664 Sum_probs=227.8
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l 104 (374)
|++.+.||.|++|+||+|.+..+|..||+|++............+.+|+.+++.++|||++++++++.. ....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence 678999999999999999999999999999987543333334567789999999999999999999843 356899
Q ss_pred EEccCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 105 VFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 105 v~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
+|||++++|.+++.... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+........
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999889999998765 789999999999999999999999999999999999999999999999999865432211
Q ss_pred ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 017301 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (374)
......++..|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+.......+....++|....+.... .
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 229 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT--S 229 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh--h
Confidence 11233568889999987652 457889999999999999999999999988877777777777888776554321 1
Q ss_pred HHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
...+................+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 122222222222223334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=350.31 Aligned_cols=250 Identities=28% Similarity=0.480 Sum_probs=204.2
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHH-HHHhCCCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|.. +++.++||||+++++.+. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence 469999999999999999999999999864321 2223344555655 467789999999999884 445689999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|...+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 99986 9999998888999999999999999999999999999999999999999999999999999864322211 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-------------------- 210 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-------------------- 210 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999977 6789999999999999999999999987765433322211
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCCCCCcC
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (374)
. .....+..+..+.++|++||+.||.+||++ .+++.||||...
T Consensus 211 -------~----~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 211 -------K----PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred -------C----CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0 011234678899999999999999999976 599999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=340.48 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=209.0
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
.|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+. ....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence 48999999999999999999999999999999864322 1222345678999999999999999999884 33569
Q ss_pred EEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 103 YVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
|+||||+.+ +|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999985 888877543 46899999999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. .....|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+..
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~-------------- 215 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-------------- 215 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH--------------
Confidence 11 123478999999999877 6789999999999999999999999987654322222111
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
.+... .....+.+++.+.+||.+||+.||.+|| +++++++||||...
T Consensus 216 ---------~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 216 ---------RVKED----QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ---------Hhhhc----ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 01100 0111245788999999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=334.14 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=211.1
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC---hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
+.|++.+.||+|++|.||.|.+..++..||+|.+...... ......+.+|+.++++++||||+++++++. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence 5799999999999999999999999999999998643222 123456788999999999999999999994 33
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+|+|+||+.+ +|.+.+...+.+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+.....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 479999999986 9999998888899999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
............++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT------------- 221 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-------------
Confidence 2221111134567889999999987 5689999999999999999999999976544322211110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.. ........++..+.++|.+||..+|.+|||+.++|+||||
T Consensus 222 --------------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 222 --------------QP--TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------cC--CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 00 0011223578899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=346.06 Aligned_cols=283 Identities=23% Similarity=0.366 Sum_probs=215.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.++||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCE
Confidence 478999999999999999999999999999999887532 23345578899999999999999999999944 356
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+|+||||+.+ +|.+++...+.+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999985 9999999888899999999999999999999985 7999999999999999999999999998654322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHH-hhCCCCHHHHh--
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD-LLGTPSPETIA-- 256 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~-- 256 (374)
. .....|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||......+....+.. ..+.+......
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1 133468999999999977 6789999999999999999999999987654333221110 00111000000
Q ss_pred ---------hhc----C-HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 257 ---------VVR----N-EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ---------~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
... . .........+........ .....+.++.+||.+||+.||++|||+.+++.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 0 000011111111111000 012367889999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=347.85 Aligned_cols=250 Identities=27% Similarity=0.448 Sum_probs=203.8
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHH-HHHhCCCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||+||+|++..+++.||+|++..... .......+.+|.. +++.++||||+++++++. ....+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence 469999999999999999999999999864321 1122234444544 567889999999999984 445689999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 99996 9999998888899999999999999999999999999999999999999999999999999874322211 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-------------------- 210 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--------------------
Confidence 234579999999999887 6789999999999999999999999988765444333221
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHH----HHhcCCCCCcC
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE----EALADPYFKGL 319 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~----~lL~hp~~~~~ 319 (374)
. .....+.+++.+.++|.+||+.||.+|+++. ++++|+||...
T Consensus 211 -------~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 211 -------K----PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred -------C----CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 0 0112356889999999999999999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=342.39 Aligned_cols=294 Identities=37% Similarity=0.626 Sum_probs=229.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc---C
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK---R 97 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~ 97 (374)
..++|++.+.||+|++|.||+|.+..+++.+|+|.+............+.+|+.+++.++||||+++++.+..... .
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 3689999999999999999999999999999999986433322223456789999999999999999998765432 2
Q ss_pred CCCcEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....+|+||||+.+++...+.. ...+++..++.++.|+++||.|||++||+|+||||+||+++.++.++|+|||+++..
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 3456899999999988888765 347999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCcc--------cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 017301 177 FSDTPMT--------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (374)
Q Consensus 177 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 248 (374)
....... .......+++.|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+.......+....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 3322111 112334678889999987652 4588899999999999999999999999998888888888888
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.+.+..+........... .......+......+..+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 777655443211110000 0001111112222345677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=338.00 Aligned_cols=281 Identities=38% Similarity=0.681 Sum_probs=224.9
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||.|++|.||+|.+..+|..||+|+++..... .....+.+|+.+++.++|||++++++.+.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEE
Confidence 589999999999999999999999999999998753322 223456789999999999999999999843 35689
Q ss_pred EEEccCcccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 104 VVFELMESDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 104 lv~e~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+||||+.++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+.......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 99999999999988764 368999999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ......++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+..+....+......|....+.....
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 11334578899999987552 4578899999999999999999999999988888888888887777765543331
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
. ..+................+..++.+.++|.+||+.||.+|||+.++++||||
T Consensus 231 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 L--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred C--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1 11111111111111122234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=346.58 Aligned_cols=264 Identities=26% Similarity=0.411 Sum_probs=210.4
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++.+.||+|+||+||++.++.+++.||+|++.+.. ........+.+|+.++..++|++|+++++.+. ....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCE
Confidence 47999999999999999999999999999999986421 12223345778999999999999999999984 4456
Q ss_pred EEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999985 99999977 467899999999999999999999999999999999999999999999999998654322
Q ss_pred CCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.. ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---------- 223 (332)
T cd05623 156 GT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (332)
T ss_pred Cc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC----------
Confidence 11 112335799999999988531 246888999999999999999999999887655444333210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (374)
............+++.+.+||++||..++.+ |++++++++||||.++
T Consensus 224 ----------------~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 224 ----------------KERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ----------------CccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 0001111223467899999999999765544 6899999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=336.34 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=217.4
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
.-|.++.+||+|+||.||+|.++.+|..+|+|.+.. ..+...+.+||.++++++.|++|++|+.|+..+ .+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DL 103 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DL 103 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ce
Confidence 457899999999999999999999999999998753 356778899999999999999999999997654 39
Q ss_pred EEEEccCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 103 YVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
|||||||+ |++.+++.. ++++++.++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|.......
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999999 699999875 5689999999999999999999999999999999999999999999999999997653332
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. .....+|||.|||||++.. ..|+..+||||||+...||..|++||.+-.....+..|
T Consensus 184 A---KRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----------------- 241 (502)
T KOG0574|consen 184 A---KRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----------------- 241 (502)
T ss_pred H---hhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-----------------
Confidence 2 2356789999999999987 78999999999999999999999999876654333221
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
...|.+-.......|.++.|+|++||-..|++|.||.++++|||+++..
T Consensus 242 -----------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 242 -----------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred -----------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 1111112222234688899999999999999999999999999998743
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=349.91 Aligned_cols=259 Identities=24% Similarity=0.313 Sum_probs=203.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.+.|+.++.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++++ .....
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence 467899999999999999999999999999999986432 223445788999999999999999999998 34456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.+ +|.+ ....++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 8999999996 6643 2345778889999999999999999999999999999999999999999999997643321
Q ss_pred Cccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
. ......||..|+|||++... ....+.++|||||||++|+|++|+.||......+....+..
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~------------ 287 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------------ 287 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH------------
Confidence 1 12345799999999987431 12345689999999999999999999974332211111110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
..... .......+++.+.+||.+||+.||++|||+.++|+||||....
T Consensus 288 ------------~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 288 ------------ICMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred ------------HhccC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 00000 0112246788999999999999999999999999999998753
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=345.37 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=202.7
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHH-HHHhCCCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||+||+|++..+++.||+|++.+... .......+.+|.. +++.++||||+++++.+. ....+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence 479999999999999999999999999864321 1222334555554 578899999999999884 345689999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+++ +|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 99996 9999998888899999999999999999999999999999999999999999999999999874322211 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234579999999999877 6789999999999999999999999988764433322211
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCCCCCcC
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (374)
.. ....+..+..+.++|.+||+.||.+||++ .++++||||..+
T Consensus 211 -------~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 211 -------KP----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred -------CC----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 00 11124578889999999999999999875 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=371.49 Aligned_cols=270 Identities=26% Similarity=0.398 Sum_probs=216.9
Q ss_pred cccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 017301 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (374)
Q Consensus 15 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 94 (374)
+.+.-...++|++++.||+|+||+||+|.+..++..||+|++............+..|+.+|+.++||||++++++|...
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 34445566899999999999999999999999999999999875544555566788999999999999999999988643
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhC-------CccccCCCCCceEecC-
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTA-------NVYHRDLKPKNILANA- 161 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~-------~i~H~dikp~Nil~~~- 161 (374)
. ...+||||||+.+ +|.+++.. .+.+++..++.|+.||+.||.|||+. +|+||||||+|||++.
T Consensus 85 ~---~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 85 A---NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred C---CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 2 2468999999995 99998865 35799999999999999999999985 4999999999999964
Q ss_pred ----------------CCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHH
Q 017301 162 ----------------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (374)
Q Consensus 162 ----------------~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll 225 (374)
.+.+||+|||++........ .....||+.|+|||++.+....++.++|||||||+||+|+
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 23489999999975433221 2345799999999998653356889999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC
Q 017301 226 TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305 (374)
Q Consensus 226 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp 305 (374)
+|..||...+....+... +..... ...+..++.+.+||..||+.+|.+||
T Consensus 238 TGk~PF~~~~~~~qli~~--------------------------lk~~p~----lpi~~~S~eL~dLI~~~L~~dPeeRP 287 (1021)
T PTZ00266 238 SGKTPFHKANNFSQLISE--------------------------LKRGPD----LPIKGKSKELNILIKNLLNLSAKERP 287 (1021)
T ss_pred HCCCCCCcCCcHHHHHHH--------------------------HhcCCC----CCcCCCCHHHHHHHHHHhcCChhHCc
Confidence 999999765543222111 111111 11235688999999999999999999
Q ss_pred CHHHHhcCCCCCcCcc
Q 017301 306 TAEEALADPYFKGLAK 321 (374)
Q Consensus 306 t~~~lL~hp~~~~~~~ 321 (374)
|+.|+|.|||+..+..
T Consensus 288 Sa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 288 SALQCLGYQIIKNVGP 303 (1021)
T ss_pred CHHHHhccHHHhhcCC
Confidence 9999999999986543
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=337.49 Aligned_cols=286 Identities=40% Similarity=0.690 Sum_probs=222.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++.+.||+|++|.||+|.+..+++.||+|.++...........+.+|+.+++.++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 47999999999999999999999999999999987544444445678899999999999999999999944 3468
Q ss_pred EEEEccCcccHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMESDLHQV-IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~~L~~~-l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|+||||+++++.+. ......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99999999855554 44556799999999999999999999999999999999999999999999999999876544332
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
.......++..|+|||++.+. ..++.++|+||||+++|+|++|++||.+.+..+.+..+....+...+.........
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 122345788999999998772 27889999999999999999999999988877777777666666555433222111
Q ss_pred HHHHHHHHhcCCCCCCccccCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
....-...............++. +++.+.+||++||..||++|||+++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000000000000001111233 48899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=349.71 Aligned_cols=250 Identities=25% Similarity=0.414 Sum_probs=201.3
Q ss_pred eeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhC---CCCCccccceeecCCCcCCCCcEEEEE
Q 017301 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
||+|+||+||+|++..+++.||+|++.... ...........|..++... .||||+.+++.+. ....+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-----~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-----TDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-----cCCeEEEEE
Confidence 799999999999999999999999986422 1222333455677777665 6999999999984 445689999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 99985 9999998888999999999999999999999999999999999999999999999999999865322211 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~-------------------- 211 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-------------------- 211 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc--------------------
Confidence 2345799999999988652 4588999999999999999999999988765433322211
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC----CHHHHhcCCCCCcC
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP----TAEEALADPYFKGL 319 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp----t~~~lL~hp~~~~~ 319 (374)
.....+ ...+++.+.+||++||+.||.+|| ++.++++||||...
T Consensus 212 ------~~~~~~----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 212 ------GKVRFP----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred ------CCCCCC----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 000000 124688999999999999999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=344.54 Aligned_cols=264 Identities=25% Similarity=0.393 Sum_probs=210.7
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++.+.||+|+||+||+|++..+++.||+|++.+.. ........+.+|+.++..++|++|+.+++.+. ....
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 57999999999999999999999999999999986421 12223445778999999999999999999984 4456
Q ss_pred EEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.|+||||+.| +|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999985 99999987 467999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccccccccccccccccccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
... ......||+.|+|||++.+.. ..++.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---------- 223 (331)
T cd05624 156 GTV--QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (331)
T ss_pred Cce--eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC----------
Confidence 211 112356999999999876421 35788999999999999999999999877654433332210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (374)
....+.......+++.+++||.+||..++.+ |++++++++||||++.
T Consensus 224 ----------------~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 224 ----------------EERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred ----------------CCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 0011112223457899999999999976654 5799999999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=333.71 Aligned_cols=280 Identities=39% Similarity=0.726 Sum_probs=220.3
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCcEE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
|++++.||+|++|.||+|.+..+++.||+|.++....... .....+|+.+++++. |+|++++++++.... ...++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEE
Confidence 7889999999999999999999999999999875433222 233457899998885 999999999985431 24689
Q ss_pred EEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 104 VVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 104 lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
+||||+.+++.+.+... ..+++..+..++.|++.||+|||+.|++||||+|+||+++. +.+||+|||.+........
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999998888764 57899999999999999999999999999999999999999 9999999999976533222
Q ss_pred ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 017301 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (374)
.....+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+..+....+....+.+............
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1234678999999976442 457889999999999999999999999998888888888888877765532221111
Q ss_pred HHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
...+ ..............+.++..+.+||.+||+.||++|||+.++|+||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 000000011112234678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=339.56 Aligned_cols=288 Identities=37% Similarity=0.620 Sum_probs=218.6
Q ss_pred CeeEeceeeccCCeeEEEEEECC--CCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+|.+.+.||+|++|.||+|.+.. ++..||+|.+.... ........+.+|+.+++.++||||+++++.+.... ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA---DK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC---Cc
Confidence 68999999999999999999988 89999999987532 11223345678999999999999999999996542 25
Q ss_pred cEEEEEccCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC----CCCeEEeeec
Q 017301 101 DIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA----NCKLKVCDFG 171 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~----~~~vkl~DFg 171 (374)
.+|+||||+++++.+.+... ..+++..++.++.|++.||+|||+.||+||||||+||+++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 69999999999888877532 26899999999999999999999999999999999999999 8999999999
Q ss_pred ccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh---------hHHHH
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV---------HQLDL 242 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------~~~~~ 242 (374)
++.................+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 997654332211222345788999999987652 45788999999999999999999999876543 24555
Q ss_pred HHHhhCCCCHHHHhhhcC-HHHHHHHHHhcCCCCCC------ccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 017301 243 ITDLLGTPSPETIAVVRN-EKARKYLTEMRKKPPVP------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (374)
Q Consensus 243 i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~ 315 (374)
+...++.+.+..+..... .......+.... ...+ ........+..+.++|.+||++||++|||+.+++.|||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKT-KTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccC-CCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 566666665544432111 111111111110 0000 00111256788999999999999999999999999999
Q ss_pred C
Q 017301 316 F 316 (374)
Q Consensus 316 ~ 316 (374)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=343.17 Aligned_cols=258 Identities=21% Similarity=0.385 Sum_probs=204.5
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||+||+|.+..+++.||+|+++.... .......+.+|+.++..+ .||+|+.+++.+. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence 479999999999999999999999999975422 223345677899998888 5999999999984 345699999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---T 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---c
Confidence 99985 9999998888899999999999999999999999999999999999999999999999999874322111 1
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~---------~-----------~~~ 210 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN---------T-----------EDY 210 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc---------c-----------HHH
Confidence 234579999999999877 688999999999999999999999996432110000 0 000
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC------HHHHhcCCCCCcCc
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGLA 320 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt------~~~lL~hp~~~~~~ 320 (374)
........ + ......++..+.++|.+||+.||.+|++ ..++++||||+.+.
T Consensus 211 ~~~~~~~~-~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 211 LFQVILEK-P---IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHHHhC-C---CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 00111111 1 1112357889999999999999999998 57999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.90 Aligned_cols=258 Identities=24% Similarity=0.312 Sum_probs=211.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCC-CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
...|.+.+.||+|++|.||+|.+..+ +..||+|.+.. ........+.+|+.+|+.++||||+++++.+. ...
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~ 138 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDD 138 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECC
Confidence 34599999999999999999998887 78899997643 23344456778999999999999999999984 345
Q ss_pred cEEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 101 DIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
++|+||||+.+ +|.+++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 69999999985 99887753 44689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
....... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 219 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~--------- 286 (478)
T PTZ00267 219 YSDSVSL-DVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG--------- 286 (478)
T ss_pred cCCcccc-ccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Confidence 5332211 11244579999999999877 67999999999999999999999999877654443332210
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.. ......+++.+.+||.+||+.||++|||+.++|.|+|++.+
T Consensus 287 ------------------~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 287 ------------------KY---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred ------------------CC---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 00 01123578899999999999999999999999999998753
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=327.99 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=222.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
-+.|..+++||+|.||.|-+++.+.+++.+|+|++++..-- ..+...-+.|-++|+.++||.+..+.-.| +...
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCc
Confidence 46788999999999999999999999999999999865432 23344567899999999999999998888 4445
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
++|+||||+.| .|.-++.+...++++.++.+...|+.||.|||+++|+.||+|.+|+|++.+|.+||+|||+|+-....
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 69999999996 99999999889999999999999999999999999999999999999999999999999999753322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
....+.+||||.|+|||++.. ..|+.++|.|.+||++|||++|+.||.+.+....+..|..--
T Consensus 322 ---g~t~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed------------ 384 (516)
T KOG0690|consen 322 ---GDTTKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED------------ 384 (516)
T ss_pred ---cceeccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh------------
Confidence 223467899999999999988 789999999999999999999999999998877776664210
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
......++++++.|+..+|..||.+|. .|.++..|+||.++
T Consensus 385 -------------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 385 -------------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred -------------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 011236899999999999999999997 59999999999875
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=332.00 Aligned_cols=285 Identities=37% Similarity=0.610 Sum_probs=217.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
+..+.|++.+.||+|+||.||+|.+..+|..||+|.+...... .....+.+|+.+++.++|+||+++++++. ..
T Consensus 2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~ 75 (291)
T cd07870 2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIH-----TK 75 (291)
T ss_pred CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cC
Confidence 4457899999999999999999999999999999998643221 22335678999999999999999999984 33
Q ss_pred CcEEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+||||+.+++.+.+... ..+++..++.++.|++.||+|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 76 ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 468999999998888877653 4678899999999999999999999999999999999999999999999999875332
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... .....+++.|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.+. .+.+..+....+.|.+.....
T Consensus 156 ~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PSQT---YSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCCC---CCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 2111 1234578899999988652 4578899999999999999999999976553 455666666677666554332
Q ss_pred hcCHHHHHHHHH-hcCCCCCCccccCC--CCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 258 VRNEKARKYLTE-MRKKPPVPLFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 258 ~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.... ..+... .....+......+. ..++.+.+++.+||..||.+|||+.+++.||||
T Consensus 232 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 232 VSKL--PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhc--ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 2110 000000 00000111111111 136788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=341.34 Aligned_cols=293 Identities=39% Similarity=0.583 Sum_probs=230.9
Q ss_pred cCCCCCeeE-eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChH------------HHHHHHHHHHHHHhCCCCCcc
Q 017301 19 YGDANRYKI-LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS------------DAIRILREVKLLRLLRHPDIV 85 (374)
Q Consensus 19 ~~~~~~Y~~-~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~i~ 85 (374)
+...+||.. .+.||+|+||+||+|.+..+++.||+|++........ ....+.+|+.+++.++||||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 456789965 5779999999999999999999999999864322110 012467899999999999999
Q ss_pred ccceeecCCCcCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCe
Q 017301 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (374)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~v 165 (374)
++++++.. ....|+||||+.++|.+++.....+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+
T Consensus 84 ~~~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 84 GLVDVYVE-----GDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeEEEec-----CCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 99999843 3568999999999999999988889999999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCC-----------CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 017301 166 KVCDFGLARVAFSDT-----------PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (374)
Q Consensus 166 kl~DFg~a~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 234 (374)
+|+|||.+....... ..........+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999987644111 001112234568889999988653 45788999999999999999999999999
Q ss_pred ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 017301 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (374)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp 314 (374)
+..+.+..+....+.|....+....... .+ .......+.......+..+..+.++|.+||+.||++|||++++|.||
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLP--LY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcc--cc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 9888888888888887765443221100 00 00111111222233456788999999999999999999999999999
Q ss_pred CCCcCc
Q 017301 315 YFKGLA 320 (374)
Q Consensus 315 ~~~~~~ 320 (374)
||+...
T Consensus 315 ~~~~~~ 320 (335)
T PTZ00024 315 YFKSDP 320 (335)
T ss_pred ccCCCC
Confidence 998754
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=334.15 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=207.2
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
.|++.+.||+|+||+||+|.+..+++.||+|.+...... ......+.+|+.+++.++|++++.+++.+.. ...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEE
Confidence 478899999999999999999999999999998643222 2233456789999999999999999998843 3568
Q ss_pred EEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 103 YVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
|+||||+.+ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999985 898888643 35899999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. .....|++.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+...........
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~--------------- 214 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------------- 214 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---------------
Confidence 11 123478999999999977 678999999999999999999999997654221111110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
........ .....+++.+.+|+.+||+.||.+||| ++++++||||+.+
T Consensus 215 -----~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 215 -----RLVKEVQE-------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -----hhhhhhhh-------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 00000000 112357889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=332.25 Aligned_cols=281 Identities=43% Similarity=0.721 Sum_probs=231.4
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l 104 (374)
|++.+.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++|+|++++++++... ...++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 6788999999999999999999999999999976543334455677899999999999999999998443 56899
Q ss_pred EEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc
Q 017301 105 VFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (374)
Q Consensus 105 v~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (374)
|||+++++|.+++... ..+++..+..++.|++.||++||++||+||||+|+||+++.++.++|+|||.+........
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5799999999999999999999999999999999999999999999999999876433221
Q ss_pred cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 017301 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (374)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (374)
......++..|+|||.+.+. ..++.++|+|||||++++|++|++||.+.+....+..+....+.+.+..+.......
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12334567889999988662 378899999999999999999999999999888888888888888877665443322
Q ss_pred HHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.+-..............++.++..+.++|.+||..||++|||+.+++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 -DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred -cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111112222222234456678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=331.86 Aligned_cols=282 Identities=47% Similarity=0.761 Sum_probs=230.6
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l 104 (374)
|++.+.||+|++|.||+|.+..+++.+++|.+............+.+|+.+++.++|+|++++++++... ...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 6788999999999999999999999999999875544434456788899999999999999999998443 56899
Q ss_pred EEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc
Q 017301 105 VFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (374)
Q Consensus 105 v~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (374)
|+||+++++.+.+... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 9999999998888764 589999999999999999999999999999999999999999999999999987654432
Q ss_pred cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 017301 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (374)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (374)
.......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||.+.+..+.+..+...++.+.+..+........
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 112335688899999988762 3788999999999999999999999999998888888888888877766554433111
Q ss_pred HHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
..................+.++..++++|.+||+.||.+||++.+++.||||
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 232 -NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred -hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1111122222222233445688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=324.40 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=209.4
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
.|++++.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.++|+|++++++.+.. ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 4899999999999999999999999999999987544444555678899999999999999999887732 224589
Q ss_pred EEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 104 VVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
++|||+.+ +|.+++... ..+++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999985 899988763 468999999999999999999999999999999999999999999999999987653322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ......+++.|+|||++.+ ..++.++|+|||||++++|++|+.||...+.......+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------------- 216 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------------
Confidence 1 1234568899999999877 6788999999999999999999999987654333222111
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
... ......+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 217 -----------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 -----------GKL----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------cCC----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 01123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=340.72 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=205.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 100 (374)
+..|+++++||+||.+.||++... ....||+|++.....+......+.+|+..|.+++ |.+|++++++-.. ++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----DG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----Cc
Confidence 578999999999999999999753 3456777776655556677788999999999996 9999999998854 45
Q ss_pred cEEEEEccCcccHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMESDLHQVIKANDDL-TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~~l-~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|+||||-+.||..++...... +.-.++.+..|++.||.++|..||||.||||.|+|+- .|.+||+|||.|..+..+
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 69999999989999999886543 3358889999999999999999999999999999975 568999999999876554
Q ss_pred CCcccccccccccccccccccccccC---------CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFF---------SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~---------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
+ ++......+||+.|||||.+.... ...++++||||||||||+|+.|++||..-. +.+..+..+ -.|
T Consensus 513 T-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI-~~P 588 (677)
T KOG0596|consen 513 T-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAI-TDP 588 (677)
T ss_pred c-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhh-cCC
Confidence 3 345557789999999999875421 136789999999999999999999995321 111111110 001
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCh--HHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP--LALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
...-.||.+++ ++.++++.||.+||.+|||+.++|+|||++.
T Consensus 589 --------------------------~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 589 --------------------------NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred --------------------------CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 01112344443 3899999999999999999999999999975
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=333.72 Aligned_cols=283 Identities=25% Similarity=0.387 Sum_probs=214.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++.+.||+|+||.||+|.+..++..+|+|.++... .......+.+|+.++++++||||+++++.+.. ...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEE
Confidence 46999999999999999999999999999999987432 23344568899999999999999999999943 4569
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
|+||||+.+ +|.+++...+.+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999986 999999988889999999999999999999998 599999999999999999999999999986542221
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH-----
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI----- 255 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~----- 255 (374)
.....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+............
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 134578899999999876 56889999999999999999999999776543322211111000000000
Q ss_pred ----hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 256 ----AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 256 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
...................+ + ......+++.+.+||.+||..||++|||+.++++||||.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPP-P-KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCC-c-cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 00000001111111111111 0 011123688899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=334.52 Aligned_cols=291 Identities=38% Similarity=0.627 Sum_probs=227.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-----c
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-----K 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~ 96 (374)
.++|++.+.||+|++|.||+|.++.+|+.||+|.++...........+.+|+.+++.++|||++++++++.... .
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 47899999999999999999999999999999998754333333346678999999999999999999886543 1
Q ss_pred CCCCcEEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
.....+|+|+||+++++...+... ..+++..+..++.|++.||+|||+.||+|+||||+||+++.++.+||+|||.+..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 123479999999999888888764 4689999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
....... ......++..|+|||.+.+. ..++.++|||||||++++|++|++||...+....+..+....+.+.+..+
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 166 YNSEESR--PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccCCccc--ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 5433221 11233567789999987542 45788999999999999999999999998888888888888887776654
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
+.............. ..........+..+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPK-KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccc-cccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 332211100000000 000011112344578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=320.05 Aligned_cols=275 Identities=26% Similarity=0.415 Sum_probs=220.3
Q ss_pred eeE-eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCcE
Q 017301 25 YKI-LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 25 Y~~-~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
|++ .+.||+|+|+.|-.|....+|..||||++.+... -...++.+|++++.+++ |+||+.++++| ++....
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~F 151 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRF 151 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceE
Confidence 444 5789999999999999999999999999986532 34557889999999996 99999999999 566679
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC---CCeEEeeecccccccC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARVAFS 178 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~---~~vkl~DFg~a~~~~~ 178 (374)
|+|||-|.| .|...|..+..+++.++.+++..|+.||.|||.+||.|||+||+|||.... ..|||+||.++.....
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 999999996 999999999999999999999999999999999999999999999997654 3489999998865432
Q ss_pred CCC----cccccccccccccccccccc---cccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 179 DTP----MTVFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 179 ~~~----~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
+.+ ......+.+|+..|||||+. .+....|+.++|.||||+|+|.|++|.+||.|.-..+-
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC------------ 299 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC------------ 299 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC------------
Confidence 221 22334567889999999975 34446799999999999999999999999987643110
Q ss_pred HHHHhhhcCHH----HHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccC
Q 017301 252 PETIAVVRNEK----ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (374)
Q Consensus 252 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (374)
.+.+.+. -...++.+......-....|..+|.+++|||+.+|..|+.+|.++.++|+|||++.....
T Consensus 300 ----GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 300 ----GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred ----CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 0000000 112334444444433345577899999999999999999999999999999999986543
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=326.60 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=207.6
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..|++.+.||+|++|.||+|.+..++..||+|.+..... .......+.+|+.+++.++||||+++++.+.... .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA---E 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC---C
Confidence 578999999999999999999999999999998864322 2233456788999999999999999999875422 2
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+++++||+.+ +|.+.+...+.+++...+.++.|++.||+|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 468999999985 9999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
............++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...........+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~------------- 223 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT------------- 223 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-------------
Confidence 2111111233468889999999877 6788999999999999999999999976543322211110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
.... ......+++.+.++| +||..+|++|||++++++||||+
T Consensus 224 --------------~~~~--~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 224 --------------QPTN--PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --------------CCCC--CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0000 011124677889999 57778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=331.02 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=199.3
Q ss_pred eeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccC
Q 017301 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (374)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 109 (374)
||+|+||+||+|.++.+|+.||+|.+...... ......+..|+.+++.++||||+++++.+. ...++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-----SKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-----cCCeEEEEEecC
Confidence 79999999999999999999999998642221 122334567999999999999999999883 445689999999
Q ss_pred cc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccc
Q 017301 110 ES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (374)
Q Consensus 110 ~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (374)
.| +|.+.+.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++........ .
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----I 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----e
Confidence 85 8988876543 588999999999999999999999999999999999999999999999999875433211 1
Q ss_pred ccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 017301 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (374)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (374)
....|++.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.........+.
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~---------------------- 207 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK---------------------- 207 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH----------------------
Confidence 33468999999999877 569999999999999999999999997643211111100
Q ss_pred HHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCCCCCcC
Q 017301 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (374)
....... .......+++.+++||.+||+.||.+|||+ ++++.||||+.+
T Consensus 208 -~~~~~~~---~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 208 -RRTLEDE---VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred -HHhhccc---cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 0000000 001123578999999999999999999999 778899999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=340.17 Aligned_cols=287 Identities=21% Similarity=0.309 Sum_probs=207.0
Q ss_pred Eeceeecc--CCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEE
Q 017301 27 ILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 27 ~~~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l 104 (374)
++++||+| ++++||++.++.+|+.||+|.+............+.+|+.+++.++||||+++++++... ...|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 57889999 679999999999999999999975544444555677899999999999999999998443 45899
Q ss_pred EEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 105 VFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 105 v~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
||||+.+ +|.+++..+ ..+++..++.++.|++.||+|||++||+||||||+||+++.++.++++||+.+........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999985 999998653 4689999999999999999999999999999999999999999999999986543221111
Q ss_pred c----ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC------
Q 017301 182 M----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS------ 251 (374)
Q Consensus 182 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------ 251 (374)
. ........++..|+|||++.+....++.++|||||||++|+|++|..||.............. +...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCcccccccc
Confidence 0 001122356778999999875334689999999999999999999999987654433222211 1100
Q ss_pred ---HHHHhhhcCHH-HH-HHHHHhc--CCCC----CCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 252 ---PETIAVVRNEK-AR-KYLTEMR--KKPP----VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 252 ---~~~~~~~~~~~-~~-~~~~~~~--~~~~----~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
++......... .. ....... ...+ .........+++.+.+||.+||+.||++|||++++|+||||+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00000000000 00 0000000 0000 000111234678899999999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=330.07 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=209.3
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
.|+..+.||+|+||+||+|.+..+++.||+|.+..... .......+.+|+.+++.++|+|++.+.+.+. .....
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEE
Confidence 47889999999999999999999999999999864322 2223345678999999999999999998884 34568
Q ss_pred EEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 103 YVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
|+||||+.+ +|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999996 888887643 36999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. .....|+..|+|||++.+ ..++.++|+||+||++|+|++|..||.+.........+...
T Consensus 156 ~~----~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~------------- 216 (285)
T cd05632 156 ES----IRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR------------- 216 (285)
T ss_pred Cc----ccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-------------
Confidence 11 134578999999999877 67899999999999999999999999876543332222110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
.... .....+.+++.+.+|+..||+.||.+||| +.+++.|+||+..
T Consensus 217 ----------~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 217 ----------VLET----EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ----------hhcc----ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 0000 01112457888999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=330.50 Aligned_cols=285 Identities=40% Similarity=0.665 Sum_probs=226.7
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l 104 (374)
|++.+.||+|++|.||+|.+..+++.+|+|.+............+.+|+.+++.++|||++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 78899999999999999999999999999999865433344456788999999999999999999985431 256999
Q ss_pred EEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc
Q 017301 105 VFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (374)
Q Consensus 105 v~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (374)
||||++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9999999999998765 5799999999999999999999999999999999999999999999999999976544321
Q ss_pred cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 017301 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (374)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (374)
.......++..|+|||.+.+. ..++.++|||||||++|+|++|..||...+.......+....+.+....+........
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 112334578889999977652 4678999999999999999999999999988888888888877777665543322111
Q ss_pred HHHHHHhcCCCCCCccccCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 264 RKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
...... ....+......+.. .++.+.++|++||+.||.+|||+.+++.||||
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKP-KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccc-cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 000000 00000011122233 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=344.59 Aligned_cols=267 Identities=28% Similarity=0.492 Sum_probs=223.8
Q ss_pred ccccccCCCCCeeE--eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceee
Q 017301 14 DFFTEYGDANRYKI--LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIM 91 (374)
Q Consensus 14 ~~~~~~~~~~~Y~~--~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 91 (374)
++....++..-|++ -+.||+|.||+||-|.++.+|+.||||++.+..........+.+|+.||+.+.||.||.+...+
T Consensus 553 qiqe~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ 632 (888)
T KOG4236|consen 553 QIQENVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF 632 (888)
T ss_pred hhhhhhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee
Confidence 33444455556665 5789999999999999999999999999987665556667889999999999999999999998
Q ss_pred cCCCcCCCCcEEEEEccCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC---CCeE
Q 017301 92 LPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLK 166 (374)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~---~~vk 166 (374)
. ....+++|||-+.|++.+.+.+ .+++++...+.++.||+.||.|||.++|+|+||||+|||+... -++|
T Consensus 633 E-----T~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvK 707 (888)
T KOG4236|consen 633 E-----TPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVK 707 (888)
T ss_pred c-----CCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCcee
Confidence 4 4455999999999999998865 4689999999999999999999999999999999999999654 3599
Q ss_pred EeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 017301 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (374)
Q Consensus 167 l~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 246 (374)
|||||+|+++++.+- ....+|||.|+|||++.. ..|...-|+||.|+|+|.-++|..||+...+.+ ++|++.
T Consensus 708 lCDFGfARiIgEksF----RrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNA 779 (888)
T KOG4236|consen 708 LCDFGFARIIGEKSF----RRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNA 779 (888)
T ss_pred eccccceeecchhhh----hhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchh--HHhhcc
Confidence 999999999876543 356789999999999988 789999999999999999999999998665322 222211
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
...-....|..+++.+.|||..+|+..-.+|.|.+..|.|||+++..
T Consensus 780 ---------------------------aFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 780 ---------------------------AFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred ---------------------------ccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 11111123567999999999999999999999999999999999754
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=322.30 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=210.7
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
.|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++|||++++++.+.. ....|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-----KGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-----CCEEE
Confidence 4889999999999999999999999999999987544445566678899999999999999999999844 35689
Q ss_pred EEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 104 VVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+||||+.+ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999985 999998764 578999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ......|++.|+|||++.+ ..++.++|+|||||++++|++|..||...+.......+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--------------- 215 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1234468899999999877 6788999999999999999999999987764333222211
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
... ......++..+.++|.+||+.+|++||++.+++.|||+
T Consensus 216 ------------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 ------------GVF---PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------------CCC---CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 000 01112567889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=333.55 Aligned_cols=262 Identities=27% Similarity=0.439 Sum_probs=213.1
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++.+.||+|++|+||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++.+. ....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence 4799999999999999999999999999999998754332 234557889999999999999999999983 4456
Q ss_pred EEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.|+||||+.+ +|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 8999999986 999998754 5789999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcc--------------------------cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 017301 179 DTPMT--------------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (374)
Q Consensus 179 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~ 232 (374)
..... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 21100 01123468889999999877 678999999999999999999999998
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC----HH
Q 017301 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT----AE 308 (374)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt----~~ 308 (374)
+.+.......+.. .... ......+++.+.++|.+||..||++||| ++
T Consensus 234 ~~~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 234 GSNRDETFSNILK--------------------------KEVT---FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCchHHHHHHHhc--------------------------CCcc---CCCccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 7765433322210 0000 0111236889999999999999999999 99
Q ss_pred HHhcCCCCCcCc
Q 017301 309 EALADPYFKGLA 320 (374)
Q Consensus 309 ~lL~hp~~~~~~ 320 (374)
++|+||||++..
T Consensus 285 ~ll~~~~~~~~~ 296 (316)
T cd05574 285 EIKQHPFFRGVN 296 (316)
T ss_pred HHHcCchhhcCC
Confidence 999999998753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=329.57 Aligned_cols=254 Identities=25% Similarity=0.467 Sum_probs=213.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++.+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+.++++++||||+++++.+. ....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence 47999999999999999999999999999999986432 12234557889999999999999999999984 3456
Q ss_pred EEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|.||+++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 899999996 599999998889999999999999999999999999999999999999999999999999998765333
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
.....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 212 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------------- 212 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 133468899999999876 5788899999999999999999999987664322222210
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcCc
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (374)
... .....+++.+.++|.+||..||.+|+ +++++++||||+.+.
T Consensus 213 -----------~~~-----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 213 -----------GKV-----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -----------CCc-----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 000 11234688999999999999999999 999999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=327.20 Aligned_cols=282 Identities=37% Similarity=0.621 Sum_probs=222.0
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC---CCCCccccceeecCCCcCCCCc
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
|++.+.||+|++|.||+|.++.+++.||+|.++...........+.+|+.+++++ +|||++++++.+..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999998999999999975443333344566788777666 5999999999997654434456
Q ss_pred EEEEEccCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
++++||++.++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 89999999999999887643 5899999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. .....++..|+|||++.+ ..++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 123457888999999877 678899999999999999999999999988887777777666555443322111
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
...... .............+.+++.+.++|.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSS----FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhh----cccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 100000 11111112223334667889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=338.05 Aligned_cols=254 Identities=26% Similarity=0.451 Sum_probs=198.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 95 (374)
.++|++++.||+|+||.||+|.+ ..+++.||+|+++.. ........+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 36899999999999999999975 245578999998743 2233455788999999999 899999999988432
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhC------------------------------------------------------
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKAN------------------------------------------------------ 120 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~------------------------------------------------------ 120 (374)
...+++||||+.+ +|.+++...
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 2358999999995 999988653
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccccccccc
Q 017301 121 --------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192 (374)
Q Consensus 121 --------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt 192 (374)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .......++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~ 239 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLP 239 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCC
Confidence 23778888999999999999999999999999999999999999999999999754322111 111223456
Q ss_pred ccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhc
Q 017301 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR 271 (374)
Q Consensus 193 ~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (374)
+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+... +.
T Consensus 240 ~~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~--------------------------~~ 291 (338)
T cd05102 240 LKWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR--------------------------LK 291 (338)
T ss_pred ccccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH--------------------------Hh
Confidence 78999999877 678999999999999999997 99999875432221111 00
Q ss_pred CCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 272 KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 272 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.... .......++.+.+|+.+||+.||.+|||+.++++
T Consensus 292 ~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 292 DGTR---MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred cCCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000 0112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=326.49 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=208.8
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++.+.. .
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~ 78 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----R 78 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----C
Confidence 34568999999999999999999999999999999986432 2334567789999999999999999999843 3
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+|+||||+++ +|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 568999999996 9999998888999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccccccccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
... ......|++.|+|||.+.. ....++.++|+|||||++|+|++|..||...........+..
T Consensus 159 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~------------ 223 (267)
T cd06645 159 TIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK------------ 223 (267)
T ss_pred ccc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc------------
Confidence 211 1234578999999998742 124688899999999999999999999865543222111100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~ 315 (374)
....+ +.......++..+.++|.+||+.||++|||++++++|||
T Consensus 224 -------------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 -------------SNFQP-PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -------------cCCCC-CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00000 001111246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=327.25 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=210.9
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++.+.||.|++|.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+|++++++.+.. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeE
Confidence 47999999999999999999999999999999986432 22344567899999999999999999998843 3568
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|+|+||+.+ +|.+++... .+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999986 999998875 789999999999999999999999999999999999999999999999999976543321
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+..
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------------- 212 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK---------------- 212 (274)
T ss_pred ---ccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----------------
Confidence 1234568889999999877 5689999999999999999999999976653322221111
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..+... ....+++.+.+++.+||..||++|||++++++||||+..
T Consensus 213 -----------~~~~~~--~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 213 -----------NNPPSL--EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred -----------cCCCCC--cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 000000 011268889999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=324.25 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=208.3
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh-------HHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-------SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
+|.+...||+|++|.||+|.+..++..+|+|.+....... .....+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 5788999999999999999999999999999886432221 123467789999999999999999999843
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
....++||||+.+ +|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.++.
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 3568999999986 9999998888899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCc---ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 176 AFSDTPM---TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 176 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
....... ........|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-------
Confidence 5422111 111123458889999999877 6788899999999999999999999987654322211110
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
. ........++..+.++|++||+.||.+|||+.++++||||
T Consensus 227 --------------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 --------------------N---ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred --------------------c---CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0 0001123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=326.97 Aligned_cols=263 Identities=23% Similarity=0.385 Sum_probs=210.9
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...+.|++++.||.|+||.||+|.+..++..+|+|.+... .......+.+|+.+++.++|||++++++.+.. .
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 81 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----D 81 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----C
Confidence 3457899999999999999999999999999999998643 33455678889999999999999999999843 3
Q ss_pred CcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...|+||||+.+ +|..++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+....
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 468999999996 77777654 4578999999999999999999999999999999999999999999999999886532
Q ss_pred CCCCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
.... ......+++.|+|||++.+. ...++.++|+|||||++|+|++|.+||...+.......+.. .
T Consensus 162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~----- 230 (292)
T cd06644 162 KTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---S----- 230 (292)
T ss_pred cccc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---C-----
Confidence 2211 11344688899999987531 14578899999999999999999999977654322211110 0
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
. .+.......++..+.++|.+||+.||++||++.++++||||..+.
T Consensus 231 -------------------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 231 -------------------E-PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred -------------------C-CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 001111235678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=328.29 Aligned_cols=263 Identities=27% Similarity=0.464 Sum_probs=213.5
Q ss_pred ccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 16 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
..-.+...+|++.+.||+|++|.||+|.+..++..||+|.+..... .....+.+|+.+++.++|||++++++.+..
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-- 88 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV-- 88 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEe--
Confidence 3444566899999999999999999999999999999999864332 334567899999999999999999998854
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
..+.|+||||+.+ +|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||.+.
T Consensus 89 ---~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 89 ---GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred ---CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccch
Confidence 3468999999986 89998865 468999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
....... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 165 ~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~--------- 230 (296)
T cd06654 165 QITPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--------- 230 (296)
T ss_pred hcccccc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc---------
Confidence 5432211 1133468899999999877 6788999999999999999999999977654322211110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
. ..+.......+++.+.++|.+||..||.+|||+.++++||||...
T Consensus 231 -----------------~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 231 -----------------N--GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred -----------------C--CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 0 001111124577889999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=326.15 Aligned_cols=261 Identities=23% Similarity=0.407 Sum_probs=208.3
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC-
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE- 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~- 98 (374)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.+ +|||++++++.+.......
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 3578999999999999999999999999999999986432 2234577899999988 6999999999986543222
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...+|+||||+.+ +|.+++... ..+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 3568999999985 999988863 3689999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
...... ......|++.|+|||++.+. ...++.++|+||+||++|+|++|..||...........+.
T Consensus 161 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~-------- 229 (272)
T cd06637 161 LDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-------- 229 (272)
T ss_pred cccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh--------
Confidence 432211 12345789999999987531 2468889999999999999999999997654322211110
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
... ........++..+.+|+.+||..||.+|||+.+++.||||
T Consensus 230 -------------------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 230 -------------------RNP--APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------------cCC--CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 000 0001123567899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=327.98 Aligned_cols=260 Identities=24% Similarity=0.422 Sum_probs=209.2
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++++.||+|+||+||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+.. ...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeE
Confidence 47899999999999999999999999999999886432 23344578899999999999999999998844 3568
Q ss_pred EEEEccCcc-cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 103 YVVFELMES-DLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~---~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
|+||||+.+ +|.+++... ..+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||.+....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999996 888888763 378999999999999999999997 599999999999999999999999999986543
Q ss_pred CCCCccccccccccccccccccccccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
.... ....+++.|+|||.+.+. ...++.++|+|||||++|+|++|..||...........+...
T Consensus 155 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~------- 222 (286)
T cd06622 155 ASLA-----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI------- 222 (286)
T ss_pred CCcc-----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH-------
Confidence 2211 234688899999987542 124688999999999999999999999765433222221111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.... .....+.+++.+.+||.+||+.+|++||++.++++||||....
T Consensus 223 -----------------~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 223 -----------------VDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred -----------------hhcC---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 1111 1112345789999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=366.21 Aligned_cols=264 Identities=26% Similarity=0.392 Sum_probs=223.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.+.|.+++.||+|+||.|.+++++.+++.||+|++++... .......|..|-.+|...+.+-|+.++-+| ++..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 4789999999999999999999999999999999976322 223445677888999988999999999999 6667
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
++|+||||+.| ||..++...+++++..++.++..|+.||.-||+.|.|||||||+|||++..|++||+|||.|-....+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 89999999996 99999999889999999999999999999999999999999999999999999999999998765433
Q ss_pred CCcccccccccccccccccccccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
. ....+..+|||.|.|||++.. ..+.|++.+|.||+||++|||+.|..||+..+-.+....|++.-
T Consensus 229 G--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk--------- 297 (1317)
T KOG0612|consen 229 G--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK--------- 297 (1317)
T ss_pred C--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh---------
Confidence 3 233456789999999999842 12579999999999999999999999999988777777765420
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCcCc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGLA 320 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~~lL~hp~~~~~~ 320 (374)
... .+. .-..+|+.+++||+++|. +|+.|.. ++++-+||||.++.
T Consensus 298 ---------------~~l--~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 298 ---------------ESL--SFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred ---------------hhc--CCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 001 111 113589999999999997 6889998 99999999999864
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=345.38 Aligned_cols=273 Identities=27% Similarity=0.396 Sum_probs=224.0
Q ss_pred hhhhhhhcccccccc---CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCC
Q 017301 5 QTKKELKDKDFFTEY---GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR 80 (374)
Q Consensus 5 ~~~~~~~~~~~~~~~---~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~ 80 (374)
..+-.||++++..-+ +.-..|.-++.||.|+||-||-|++..+.+.||||++..... .......+++|+..|++++
T Consensus 5 ~r~GslKDPeiA~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~ 84 (948)
T KOG0577|consen 5 GRPGSLKDPEIADLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR 84 (948)
T ss_pred CCCCCCCCchHHHHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc
Confidence 444466666654444 444678999999999999999999999999999999975443 3445668999999999999
Q ss_pred CCCccccceeecCCCcCCCCcEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe
Q 017301 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (374)
Q Consensus 81 h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~ 159 (374)
|||.+.+.++|+-.. ..|+|||||-|+-.+++.- .+++.+.++..|+.+.+.||+|||+.+.||||||..|||+
T Consensus 85 HPntieYkgCyLre~-----TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL 159 (948)
T KOG0577|consen 85 HPNTIEYKGCYLREH-----TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL 159 (948)
T ss_pred CCCcccccceeeccc-----hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe
Confidence 999999999996543 3699999999988887764 3589999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeecccccccCCCCcccccccccccccccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 017301 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238 (374)
Q Consensus 160 ~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 238 (374)
++.|.|||+|||.|.+... ..+++|||+|||||++.. ..+.|+-++||||||++..+|...+||+-+.+...
T Consensus 160 se~g~VKLaDFGSAsi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS 232 (948)
T KOG0577|consen 160 SEPGLVKLADFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 232 (948)
T ss_pred cCCCeeeeccccchhhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH
Confidence 9999999999999976432 246799999999998754 23679999999999999999999999987766543
Q ss_pred HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.+--|.. +..|. -.-+..|..++.|+..||+.-|.+|||++++|.|+|+..
T Consensus 233 ALYHIAQ--------------------------NesPt---Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 233 ALYHIAQ--------------------------NESPT---LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHh--------------------------cCCCC---CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 3322211 11111 012457889999999999999999999999999999864
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=329.17 Aligned_cols=264 Identities=28% Similarity=0.465 Sum_probs=213.5
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
+..+..++|++++.||+|++|.||+|.+..+++.||+|.+..... .....+.+|+.+++.++|||++++++.+..
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--- 87 (297)
T cd06656 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV--- 87 (297)
T ss_pred ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 334556899999999999999999999999999999999864322 334567889999999999999999999843
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
....|+||||+++ +|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+..
T Consensus 88 --~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 88 --GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred --CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceE
Confidence 4568999999986 89888865 4589999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 165 ~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~---------- 229 (297)
T cd06656 165 ITPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------- 229 (297)
T ss_pred ccCCcc---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc----------
Confidence 432221 1133468889999999877 6788999999999999999999999977653222111100
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
...+.......+++.+.+||.+||..||++|||+.++|+||||+....
T Consensus 230 ------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 230 ------------------NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred ------------------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 000111112356788999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=329.04 Aligned_cols=287 Identities=29% Similarity=0.479 Sum_probs=224.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-----C---CCccccceeecC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----H---PDIVEIKRIMLP 93 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~i~~~~~~~~~ 93 (374)
.+||.+.++||+|.|+|||+|.|....+.||+|+++.. + -..+..+.||.+|++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-q--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-Q--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-h--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 38999999999999999999999999999999998742 2 22345678999999884 2 369999999866
Q ss_pred CCcCCCCcEEEEEccCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCC--------
Q 017301 94 PSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANAN-------- 162 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~-------- 162 (374)
.+ ..+.++|+|+|+++.+|+.+|... ..++...++.|++|++.||.|||+. ||||.||||+|||+..+
T Consensus 154 sG-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 154 SG-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred cC-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence 55 567899999999999999999875 4799999999999999999999986 99999999999994111
Q ss_pred --------------------------------------------------------------------------------
Q 017301 163 -------------------------------------------------------------------------------- 162 (374)
Q Consensus 163 -------------------------------------------------------------------------------- 162 (374)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------CC
Q 017301 163 ------------------------------------------------------------------------------CK 164 (374)
Q Consensus 163 ------------------------------------------------------------------------------~~ 164 (374)
.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 01
Q ss_pred eEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC------hhh
Q 017301 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------VVH 238 (374)
Q Consensus 165 vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~------~~~ 238 (374)
|||+|||-|+.... .++..+.|+.|+|||++.| ..|+..+||||++|++|||+||..+|...+ +.+
T Consensus 393 vKIaDlGNACW~~k------hFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 393 VKIADLGNACWVHK------HFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred EEEeeccchhhhhh------hhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 34444444432111 1233467899999999999 899999999999999999999999997654 567
Q ss_pred HHHHHHHhhCCCCHHHHhhhcCHHHHHHH------HHhcCCCCCCccccC---CCCC----hHHHHHHHHhccCCCCCCC
Q 017301 239 QLDLITDLLGTPSPETIAVVRNEKARKYL------TEMRKKPPVPLFQKF---PNVD----PLALRLLQRLIAFDPKDRP 305 (374)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~---~~~s----~~~~~li~~~L~~dp~~Rp 305 (374)
++..|+.++|..+.......+.. +.|+ .++.+-.+.++.... -.+| .++.+||.-||+++|++||
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~S--RdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~ 542 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYS--RDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP 542 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcch--HhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence 99999999999988776554433 2333 233333333332211 1223 4578999999999999999
Q ss_pred CHHHHhcCCCCCcCccC
Q 017301 306 TAEEALADPYFKGLAKI 322 (374)
Q Consensus 306 t~~~lL~hp~~~~~~~~ 322 (374)
||.++|+|||+..+..+
T Consensus 543 tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 543 TAAQCLKHPWLNPVAGP 559 (590)
T ss_pred cHHHHhcCccccCCCCC
Confidence 99999999999987654
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=326.64 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=211.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||.|++|+||+|.+..++..+|+|.+.. ........+.+|+.+++.++|||++++++.+.. ...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCe
Confidence 4689999999999999999999988999999999863 233455678899999999999999999999844 346
Q ss_pred EEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.|+||||+++ +|.+++... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 8999999996 898888764 47999999999999999999999999999999999999999999999999988654322
Q ss_pred CCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.. ......+++.|+|||.+... ...++.++|+|||||++|+|++|++||.+.+.......+..
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 222 (280)
T cd06611 157 LQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK----------- 222 (280)
T ss_pred cc---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-----------
Confidence 21 11345688999999987421 14578899999999999999999999987654332222111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.. .+.......++..+.++|.+||+.||.+|||+.++|+||||...
T Consensus 223 ----------------~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 223 ----------------SE-PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ----------------CC-CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 00 00111123578899999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=305.09 Aligned_cols=289 Identities=30% Similarity=0.592 Sum_probs=230.3
Q ss_pred ccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCC
Q 017301 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPP 94 (374)
Q Consensus 16 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 94 (374)
.-.||..+.|++++++|+|-||.||.|++..+++.++||+++. -..+.+.+|+.+|+.++ ||||++++++..++
T Consensus 31 ~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 31 VIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred eeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 3468899999999999999999999999999999999999874 34567889999999997 99999999999765
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC-CCeEEeeecc
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGL 172 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~-~~vkl~DFg~ 172 (374)
.. ....+|+|+... +...+.. .++..+++.++++++.||.|+||.||.|||+||.|++++.. -.++|+|+|+
T Consensus 106 ~S---ktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 106 ES---KTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred cc---cCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecch
Confidence 33 456899999996 6666654 48889999999999999999999999999999999999875 4599999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCC-CCCCCCChhhHHHHHHHhhCCCC
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
|...-..... .-.+.++.|.-||++... +.|+.+-|+|||||+|+.|+..+ +.|.|.++.+++..|.+++|+..
T Consensus 180 AEFYHp~~eY----nVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 180 AEFYHPGKEY----NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred HhhcCCCcee----eeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 9876544332 345678889999998775 67999999999999999999976 55689999999999999999865
Q ss_pred HHH-HhhhcCHHHHHHHHHhcCCCCCCcccc-----CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 252 PET-IAVVRNEKARKYLTEMRKKPPVPLFQK-----FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 252 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
-.. +....-...+++-.-+......++... -.-.++++.||+.++|.+|-.+|+||.+++.||||..+.
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 432 222222111222111111111111111 012579999999999999999999999999999998654
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=326.65 Aligned_cols=259 Identities=29% Similarity=0.498 Sum_probs=212.4
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
...+|++.+.||.|++|+||+|.+..+++.||+|.+.... ......+.+|+.+++.++|||++++++.+.. ..
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 89 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLV-----GD 89 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEec-----Cc
Confidence 4468999999999999999999999999999999986432 2334567889999999999999999999843 35
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|+|+||+.+ +|.+++... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 68999999986 888877654 6899999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus 169 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~------------- 230 (296)
T cd06655 169 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN------------- 230 (296)
T ss_pred cc---cCCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Confidence 21 1133468889999999876 67889999999999999999999999887654333222110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
..+.......+++.+.++|.+||..||.+|||+.+++.||||+...
T Consensus 231 ---------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 231 ---------------GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ---------------CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 0011112245788999999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=321.20 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=208.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
+..|++.+.||+|+||.||.|.+..++..||+|.+.... ........+.+|+.+++.+.||||+++++.+....
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 77 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM--- 77 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---
Confidence 367999999999999999999999999999999885322 12234557888999999999999999999874322
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...++++|||+.+ +|.+++.+.+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.++...
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 2458899999985 999999887889999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.............++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~-------- 224 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQ-------- 224 (265)
T ss_pred cccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cC--------
Confidence 21111111233468889999999877 678999999999999999999999997654332221111 00
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
... ....+.++..+.++|.+|+. +|.+|||++++++|||+.
T Consensus 225 ----------------~~~--~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 225 ----------------PTN--PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----------------CCC--CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 000 01123567789999999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=323.93 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=207.3
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
+..++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++.+.. .
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~ 78 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----R 78 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----C
Confidence 34578999999999999999999999999999999986432 2234467789999999999999999999843 3
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+|+||||+++ +|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 468999999995 9999998888899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCcccccccccccccccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
... ......+++.|+|||.+.+ ....++.++|+||+||++|+|++|..||...+.......+..
T Consensus 159 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~------------ 223 (267)
T cd06646 159 TIA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK------------ 223 (267)
T ss_pred ccc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec------------
Confidence 211 1133468889999998743 124578899999999999999999999965442211111000
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~ 315 (374)
.....+.......++..+.+||++||+.||++|||++++|+|+|
T Consensus 224 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 --------------SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --------------CCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00000001112346889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=340.56 Aligned_cols=261 Identities=26% Similarity=0.447 Sum_probs=225.8
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...+-|.+.+.||+|.|+.|.+|++..++..||||.+++...+......+.+|+++|+.++||||++++.+. ...
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~ 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETE 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eec
Confidence 446789999999999999999999999999999999998776666666789999999999999999999999 444
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+|+||||+.+ .+++++..+++..+..++.++.|++.|++|||+++|+|||||++|||++.+.++||+|||++.....
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence 569999999985 9999999999999999999999999999999999999999999999999999999999999987653
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
. ....++||++.|.|||++.+. ...++.+|+||+|+++|.|+.|..||.+.+-...
T Consensus 208 ~----~~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L------------------- 263 (596)
T KOG0586|consen 208 G----LMLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL------------------- 263 (596)
T ss_pred c----ccccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccc-------------------
Confidence 3 234678999999999999885 4677899999999999999999999998763221
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
+...-.......-.++.++.+||+++|-.+|.+|++.+++..|.|......
T Consensus 264 ------------r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 264 ------------RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred ------------cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 111111222223357889999999999999999999999999999876543
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=318.56 Aligned_cols=253 Identities=27% Similarity=0.464 Sum_probs=212.6
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++++.||.|+||.||.+.+..+++.+++|.+............+.+|+.++++++|+||+++++.+.. ...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 6999999999999999999999999999999987554444556678899999999999999999999944 35689
Q ss_pred EEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 104 VVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
++|||+.+ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999985 999999775 468999999999999999999999999999999999999999999999999997653332
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..+....+..
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--------------- 215 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1234568999999999877 5678899999999999999999999987665443333221
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
... ....+.++..+.++|.+||+.||.+|||+.++|+|||+
T Consensus 216 ------------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 216 ------------GNY---TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------CCC---CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 000 01114578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=319.98 Aligned_cols=253 Identities=26% Similarity=0.445 Sum_probs=209.6
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||+|+||.||.+.+..+|+.||+|.+............+.+|+.+++.++||||+++++.+ ......|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 69999999999999999999999999999999865433344556788999999999999999999998 3445689
Q ss_pred EEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 104 VVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+||||+.+ +|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999985 9999887643 57899999999999999999999999999999999999999999999999987543322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ......|++.|+|||++.+ ..++.++|+|||||++++|++|..||...+..+....+..
T Consensus 156 ~---~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08218 156 E---LARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--------------- 215 (256)
T ss_pred h---hhhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc---------------
Confidence 1 1123457888999999877 6788899999999999999999999977655443322211
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
... .......+..+.++|.+||+.+|++||++.++|.||||
T Consensus 216 -----------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 216 -----------GSY----PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------CCC----CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 000 01123568889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=320.02 Aligned_cols=257 Identities=25% Similarity=0.407 Sum_probs=207.0
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC----ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE----HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+..... .......+.+|+.+++.++|+||+++++.+. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence 588999999999999999976 4788999998864321 1223456788999999999999999999984 33
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+|+||+.+ +|.+++.+...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 569999999986 9999998888899999999999999999999999999999999999999999999999999875422
Q ss_pred CC---CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 179 DT---PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 179 ~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
.. ..........++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------- 222 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---------- 222 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh----------
Confidence 11 11112234568899999999877 6788999999999999999999999976543222111110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
... ........++..+.++|++||+.+|.+|||+.++|+||||
T Consensus 223 ----------------~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 223 ----------------HRG--LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------ccC--CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000 0111224578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=323.57 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=208.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +|||++++++++...+.....
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 578999999999999999999999999999999986421 2234567899999988 799999999998755433445
Q ss_pred cEEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 101 DIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
..|+||||+.+ +|.+++.. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 78999999986 89888753 45789999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCcccccccccccccccccccccccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
....... .....|+..|+|||.+.... ..++.++|+|||||++|+|++|++||...+....+..+..
T Consensus 178 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------- 247 (291)
T cd06639 178 LTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR------- 247 (291)
T ss_pred ccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc-------
Confidence 4332211 12346888999999875421 2368899999999999999999999987654332222110
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
... +........+..+.+||.+||+.||++|||+.++++||||+
T Consensus 248 --------------------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 --------------------NPP-PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------------------CCC-CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000 00011134667899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=319.04 Aligned_cols=255 Identities=32% Similarity=0.507 Sum_probs=211.6
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||.|++|.||+|.+..++..||+|.+............+.+|+.+++.++|||++++++.+... .....|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 58999999999999999999999999999999875544555566788999999999999999999987543 234689
Q ss_pred EEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhh-----hCCccccCCCCCceEecCCCCeEEeeeccc
Q 017301 104 VVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMH-----TANVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH-----~~~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
++|||+.+ +|.+++.. ...+++..+..++.||+.||+||| +.+++|+||+|+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 99999985 99998875 357899999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
........ ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+..
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 224 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-------- 224 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc--------
Confidence 76543321 1234568999999999877 5688999999999999999999999987764332222111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.. ........+..+.+++.+||+.+|++|||+.++|+|||+
T Consensus 225 -------------------~~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 225 -------------------GK---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -------------------CC---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 00 011123577899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=320.34 Aligned_cols=262 Identities=27% Similarity=0.426 Sum_probs=210.9
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++++.||.|++|+||+|....++..+|+|++....... ....+.+|+.+++.++|+|++++++.+.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEE
Confidence 47999999999999999999998899999999986433332 55678899999999999999999998843 4568
Q ss_pred EEEEccCcc-cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 103 YVVFELMES-DLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~---~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
|+|||++.+ +|.+++... ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999986 999998764 4589999999999999999999999999999999999999999999999999876544
Q ss_pred CCCcc-cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMT-VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
..... .......|+..|+|||.+... ..++.++|+|||||++++|++|..||...+.......... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~~~------ 224 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---NDP------ 224 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---CCC------
Confidence 32221 112344688999999988763 3688899999999999999999999976654322222111 000
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
........+..+++.+.+++.+||..||++|||+.+++.||||
T Consensus 225 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 225 ----------------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ----------------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0001111134678899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=322.32 Aligned_cols=261 Identities=24% Similarity=0.420 Sum_probs=208.8
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC----hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
+|+..+.||+|++|.||+|.+..+++.||+|++...... ......+.+|+.+++.++|+|++++++++. +.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 488899999999999999999999999999998643211 123457889999999999999999999984 44
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC-CeEEeeeccccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~-~vkl~DFg~a~~~~ 177 (374)
.+.++||||+.+ +|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 568999999996 9999998888899999999999999999999999999999999999998776 59999999987654
Q ss_pred CCCCcc-cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMT-VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
...... .......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...........+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------- 222 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK----------- 222 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH-----------
Confidence 321111 11123468889999999876 6788999999999999999999999975543222221111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
..... ........+++.+.+++.+||..||++|||+.++++||||+
T Consensus 223 -------------~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 223 -------------IASAT--TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred -------------HhccC--CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00000 00111235788999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=343.26 Aligned_cols=264 Identities=24% Similarity=0.407 Sum_probs=216.9
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
....+.+.|+..||.|+||.||+|.++.++-..|.|++.. ......+.++-||.||..+.||+|+++++.|+..
T Consensus 28 lnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e---- 101 (1187)
T KOG0579|consen 28 LNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE---- 101 (1187)
T ss_pred CCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc----
Confidence 3444677899999999999999999999999999998853 3446677889999999999999999999999655
Q ss_pred CCcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
+.+||+.|+|+| -...++.. ...+.+.++..+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+...
T Consensus 102 -nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 102 -NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred -CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc
Confidence 449999999997 45555443 457999999999999999999999999999999999999999999999999987543
Q ss_pred cCCCCcccccccccccccccccccccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
.... .....++|||+|||||+... ...+|+.++||||||++|.+|.-+.+|-...+....+-.|.+ ..+|.
T Consensus 181 ~~t~---qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPT 254 (1187)
T KOG0579|consen 181 KSTR---QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPT 254 (1187)
T ss_pred hhHH---hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCc
Confidence 2222 22357899999999998632 126899999999999999999999999988777655544432 11111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.-.....+..+.|++.+||..||..||++.++|.||||++..
T Consensus 255 -------------------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 255 -------------------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred -------------------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 111235678899999999999999999999999999998653
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=325.31 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=210.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
+.|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+. ....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 469999999999999999999999999999999864322 1233456778999999999999999999883 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.| +|.+++...+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||.++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 8999999986 999999888889999999999999999999999999999999999999999999999999986421111
Q ss_pred Cc------------ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 017301 181 PM------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (374)
Q Consensus 181 ~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 248 (374)
.. ........++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~-- 231 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-- 231 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--
Confidence 00 001112457888999999876 67899999999999999999999999876543322222110
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCcC
Q 017301 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGL 319 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~~lL~hp~~~~~ 319 (374)
....+ .....+++.+.++|.+||+.||++||| +.++|+||||...
T Consensus 232 ------------------------~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 232 ------------------------DIEWP--EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ------------------------ccCCC--CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 00000 111257888999999999999999998 8999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=321.50 Aligned_cols=254 Identities=28% Similarity=0.489 Sum_probs=210.5
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|++++++++||||+++++.+ .+..+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 58999999999999999999999999999999875332 224456788999999999999999999988 444569
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|+|+||+.| +|.+.+.....+++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 999999986 999999887789999999999999999999999999999999999999999999999999987643322
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.... ..+.
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~----------------- 211 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIR----------------- 211 (258)
T ss_pred ---cccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHH-----------------
Confidence 1233468889999999877 5689999999999999999999999987663211 1110
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH--HHHhcCCCC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA--EEALADPYF 316 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~--~~lL~hp~~ 316 (374)
..... ......+.+++.+.++|.+||+.||.+||++ .++++||||
T Consensus 212 ------~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 212 ------AKQET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ------HHhcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 00110 0111224567899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=318.73 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=209.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||.|++|.||+|.+..+++.+|+|++.... ......+.+|+.+++.++|||++++++.+.. ...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCE
Confidence 478999999999999999999999999999999987432 2345678899999999999999999998843 456
Q ss_pred EEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+|++|||+++ +|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 8999999996 899988776 78999999999999999999999999999999999999999999999999998754332
Q ss_pred CCccccccccccccccccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. ......++..|+|||.+.+. ...++.++|+|||||++|+|++|.+||.+.+.......+......
T Consensus 155 ~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~--------- 222 (262)
T cd06613 155 IA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP--------- 222 (262)
T ss_pred hh---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------
Confidence 11 11334688899999998651 126888999999999999999999999876644333222110000
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~ 315 (374)
..........+..+.++|++||..||..|||+.+++.|+|
T Consensus 223 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 223 -----------------PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -----------------CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0000111245678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=324.01 Aligned_cols=262 Identities=24% Similarity=0.417 Sum_probs=208.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCc-C
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK-R 97 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-~ 97 (374)
...++|++.+.||.|+||.||+|.+..+++.+|+|++... ......+..|+.+++.+ +|+|++++++.+..... .
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3458999999999999999999999999999999988542 23344677899999988 69999999999864322 2
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
....+|++|||+++ +|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 34678999999986 999988753 358888999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
....... ......|++.|+|||.+... ...++.++|+|||||++|+|++|..||...........+.
T Consensus 170 ~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~------- 239 (282)
T cd06636 170 QLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP------- 239 (282)
T ss_pred hhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh-------
Confidence 5432211 12345689999999987521 2468889999999999999999999997654322221110
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
... ........++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 240 --------------------~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 --------------------RNP--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------hCC--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000 0001123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=323.25 Aligned_cols=258 Identities=23% Similarity=0.385 Sum_probs=203.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++++.||+|++|.||+|.+..+++.||+|.+.... .......+.+|+.++++++||||+++++.+.. ....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEE
Confidence 36889999999999999999999999999999986432 23344568899999999999999999999844 3458
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
++||||+++ +|..+ ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999999997 65433 357899999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
.....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.......... ..
T Consensus 150 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~---------~~--------- 205 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL---------MP--------- 205 (279)
T ss_pred ----ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc---------ch---------
Confidence 234578999999999877 678999999999999999999999996533211000 00
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
...........+ ........++.+.++|.+||+.||.+||+++++++||||...
T Consensus 206 --~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 206 --LQLLQCIVDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred --HHHHHHHhccCC--CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 000000110000 001123467889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=322.51 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=206.7
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l 104 (374)
|++.+.||+|+||.||+|.+..++..+++|.+... .......+.+|+.+++.++|||++++++.+.. ....|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEE
Confidence 78899999999999999999999999999998642 23445678889999999999999999999854 345899
Q ss_pred EEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 105 VFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 105 v~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
|+||+.+ +|..++.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 9999996 77777654 45799999999999999999999999999999999999999999999999999865432211
Q ss_pred ccccccccccccccccccccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 183 TVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
......+++.|+|||++.. ....++.++|+||+||++|+|++|.+||...+.......+...
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------------- 223 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------------- 223 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-------------
Confidence 1234568899999998742 1145788999999999999999999999876543332222110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.. +.......++..+.+||.+||+.||.+|||+.++++||||+.
T Consensus 224 -------------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 224 -------------EP--PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred -------------CC--CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 00 001112346789999999999999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=316.45 Aligned_cols=261 Identities=29% Similarity=0.451 Sum_probs=211.6
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
||++.+.||+|++|.||+|.+..+++.||+|.++...........+.+|+.+++.++|+||+++++... ....++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence 699999999999999999999999999999998765444446678889999999999999999999873 335689
Q ss_pred EEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 104 VVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
+|+||+.+ +|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999985 99999988878999999999999999999999999999999999999999999999999998765433322
Q ss_pred ccc-cccccccccccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 183 TVF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 183 ~~~-~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
... .....+++.|+|||++.+.. ..++.++||||+||++|+|++|+.||...+..........
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~--------------- 220 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--------------- 220 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh---------------
Confidence 111 22356788999999987631 2378899999999999999999999976542211111100
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
. ...+.......+++.+.++|.+||+.||.+|||+.+++.|||+
T Consensus 221 -----------~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 221 -----------A-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----------c-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0011111223458889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=316.90 Aligned_cols=252 Identities=28% Similarity=0.472 Sum_probs=208.3
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||+|++|.||+|.+..++..+|+|.+............+.+|+.+++.++|||++++++.+. .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence 699999999999999999999999999999998754444455667889999999999999999999884 335689
Q ss_pred EEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC-CeEEeeecccccccCC
Q 017301 104 VVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSD 179 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~-~vkl~DFg~a~~~~~~ 179 (374)
+||||+.+ +|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999986 999999764 3589999999999999999999999999999999999998654 5799999999765433
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+..
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-------------- 215 (256)
T cd08220 156 SK----AYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------------- 215 (256)
T ss_pred cc----ccccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------------
Confidence 22 123468889999999877 6788999999999999999999999987664333222211
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.. .......+++.+.+++.+||+.||++|||+.++++||||
T Consensus 216 -------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 216 -------------GT---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -------------cC---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00 001123478899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.16 Aligned_cols=288 Identities=23% Similarity=0.291 Sum_probs=202.8
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCC-cEEEEEEec---------------CccCChHHHHHHHHHHHHHHhCCCCCc
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIH---------------DVFEHISDAIRILREVKLLRLLRHPDI 84 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~---------------~~~~~~~~~~~~~~E~~~l~~l~h~~i 84 (374)
..++|++++.||+|+||+||+|..+... ...+.|.+. ...........+.+|+.+|+.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998765332 222222110 011122234467899999999999999
Q ss_pred cccceeecCCCcCCCCcEEEEEccCcccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe
Q 017301 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND-----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (374)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~ 159 (374)
+++++++. .....|+|++++.++|.+++.... ......++.++.||+.||+|||++||+||||||+|||+
T Consensus 226 v~l~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl 300 (501)
T PHA03210 226 LKIEEILR-----SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300 (501)
T ss_pred CcEeEEEE-----ECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 99999984 335589999999999888875432 33466788899999999999999999999999999999
Q ss_pred cCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCC-CCCC--Ch
Q 017301 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGK--SV 236 (374)
Q Consensus 160 ~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~p-f~~~--~~ 236 (374)
+.++.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..+ |... ..
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 9999999999999976533221 11234579999999999987 6799999999999999999998754 4322 23
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcC-CCCCCccc--cCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK-KPPVPLFQ--KFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..++..+...++.+..+. .. .......++....- ..+..... ....++..+.++|.+||++||.+|||+.|+|+|
T Consensus 377 ~~~~~~~~~~~~~~~~~~-p~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEF-PD-PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHHhcccChhhc-CC-cHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 334444444444332221 00 00111122211100 00000000 012367788999999999999999999999999
Q ss_pred CCCCcC
Q 017301 314 PYFKGL 319 (374)
Q Consensus 314 p~~~~~ 319 (374)
|||...
T Consensus 455 p~f~~~ 460 (501)
T PHA03210 455 PLFSAE 460 (501)
T ss_pred hhhhcC
Confidence 999764
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=321.56 Aligned_cols=257 Identities=28% Similarity=0.479 Sum_probs=209.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++.+.||+|++|.||+|.++.+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+... ...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEE
Confidence 468899999999999999999999999999999875433 24456788999999999999999999998443 568
Q ss_pred EEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 103 YVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
++++||+.+ +|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 999999995 999999876 789999999999999999999999 99999999999999999999999999998654322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--hhHHHHHHHhhCCCCHHHHhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+. ......
T Consensus 155 ~~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------------- 212 (265)
T cd06605 155 LA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL--------------- 212 (265)
T ss_pred Hh-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHH---------------
Confidence 11 12568889999999877 6789999999999999999999999976531 001111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
+.......... .... +++.+.++|.+||..||++|||+.+++.||||+.+
T Consensus 213 ---------~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 213 ---------LQYIVNEPPPR---LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ---------HHHHhcCCCCC---CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 11111111100 0111 78889999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=321.87 Aligned_cols=280 Identities=41% Similarity=0.723 Sum_probs=222.8
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCcEE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
|++.+.||+|++|+||+|....+++.||+|.+...... .......+|+..++.++ |||++++++++.. ....|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEE
Confidence 78899999999999999999989999999998754332 22334557999999999 9999999999844 45689
Q ss_pred EEEccCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 104 VVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 104 lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
+||||++++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 999999889999998764 789999999999999999999999999999999999999999999999999875433221
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
.....++..|+|||++.+. ..++.++|+||||+++++|++|.+||.+.+..+....+...++.+....+......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 2345688899999987542 45788999999999999999999999999988888888888888776543321100
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
. ...-.......+......++..++.+.++|++||+.||.+|||+.+++.||||
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 A-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred h-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 00000011111111122234457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=319.99 Aligned_cols=261 Identities=28% Similarity=0.466 Sum_probs=209.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCc-CCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK-REF 99 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-~~~ 99 (374)
.++|++.+.||.|++|.||+|.++.+++.+++|++.... .....+.+|+.+++.+ .|+||+++++.+..... ...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 489999999999999999999999999999999986432 2345688999999998 69999999999876543 345
Q ss_pred CcEEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 100 KDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
..+|+||||+.+ +|.+++.. +..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 678999999996 88888764 3578999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
....... ......|++.|+|||++... ...++.++|||||||++|+|++|.+||...+.......+..
T Consensus 162 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 232 (275)
T cd06608 162 QLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR------ 232 (275)
T ss_pred ecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc------
Confidence 5433221 12345688999999987431 13577899999999999999999999976544332222111
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
... +.......++..+.+||.+||..||.+|||+.++++|||+
T Consensus 233 ---------------------~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 ---------------------NPP-PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------------------cCC-CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000 0011112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=318.47 Aligned_cols=262 Identities=26% Similarity=0.461 Sum_probs=207.2
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC--------hHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--------ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
+|.+.+.||.|++|.||+|.+..+|+.+|+|.++..... ....+.+.+|+.+++.++|||++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 689999999999999999999999999999987532111 112345778999999999999999999883
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
....+++||||+.+ +|.+++...+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 34568999999985 999999888889999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
....... ........++..|+|||.+.+....++.++|+||||+++|+|++|..||...+.......+..
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 226 (272)
T cd06629 157 KSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN--------- 226 (272)
T ss_pred ccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---------
Confidence 5332111 111233457889999999876323478899999999999999999999975543222111100
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
............+.++..+.++|.+||..||++|||++++|+|||+
T Consensus 227 ----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 227 ----------------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0000001112234678999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=300.26 Aligned_cols=265 Identities=24% Similarity=0.354 Sum_probs=207.8
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
-..+||++.+.||+|||+-||++.+..++..||+|++.... ..+.+..++|+...++++|||++++++.......+..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34689999999999999999999999999999999997543 4677788999999999999999999998876655555
Q ss_pred CcEEEEEccCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEecCCCCeEEeeecc
Q 017301 100 KDIYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
...||+++|.. |+|.+.+... ..+++.++..|+.+|++||++||+.. .+||||||.|||++..+.++|+|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 67999999998 6899998752 36899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccc------ccccccccccccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 017301 173 ARVAFSDTPMTV------FWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (374)
Q Consensus 173 a~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 245 (374)
++...-....+. .+.....|..|+|||++.- .....+.++|||||||+||.|+.|..||...-.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------- 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------- 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence 875432111110 1122356888999998743 125688899999999999999999999953210
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.-|.-. +.-..+.-....-..+|..+.+||+.||+.||.+||++.+++.+
T Consensus 247 ~GgSla------------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 247 QGGSLA------------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cCCeEE------------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 000000 00000000001112378999999999999999999999999874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=321.44 Aligned_cols=246 Identities=20% Similarity=0.236 Sum_probs=199.9
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccCChH-HHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEc
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e 107 (374)
..||+|++|.||+|.. +|+.||+|.++....... ....+.+|+.+|++++||||+++++++.... .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5699999999999976 689999999975433222 2456789999999999999999999985521 22346899999
Q ss_pred cCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 108 LMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 108 ~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
|+.+ +|.+++...+.+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 9996 9999999888899999999999999999999985 99999999999999999999999999987543221
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....|+..|+|||++.+....++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~----------------- 239 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN----------------- 239 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-----------------
Confidence 23468899999999866435789999999999999999999999987765444333221100
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. ......++.+.+|+.+||+.||++|||+.++++
T Consensus 240 -------~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 240 -------SL-----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------CC-----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 00 011257889999999999999999999999986
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=321.17 Aligned_cols=258 Identities=25% Similarity=0.450 Sum_probs=202.0
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHH-HHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKL-LRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
+.|++.+.||+|+||.||+|.+..+|+.||+|.++....... ...+..|+.. ++...|||++++++.+.. ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCc
Confidence 479999999999999999999999999999999875433322 3345556665 666789999999999843 345
Q ss_pred EEEEEccCcccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 102 IYVVFELMESDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
+|++|||++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+...
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 899999999988877754 34689999999999999999999997 9999999999999999999999999998754
Q ss_pred cCCCCccccccccccccccccccccccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHhhCCCCHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQLDLITDLLGTPSPE 253 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~ 253 (374)
..... .....++..|+|||.+.+. ...++.++|+|||||++|+|++|..||..... .+.+....
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 221 (283)
T cd06617 155 VDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------- 221 (283)
T ss_pred ccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH---------
Confidence 32211 1234688899999987541 13578899999999999999999999964321 11111110
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
...... .....+|..+.++|.+||..+|++|||+.+++.||||...
T Consensus 222 ------------------~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 222 ------------------EEPSPQ--LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ------------------hcCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 000000 0012468899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=317.88 Aligned_cols=253 Identities=30% Similarity=0.523 Sum_probs=208.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|++|.||+|.+..++..+|+|.+... .....+.+|+.+++.++|||++++++.+... ..
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~ 72 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TD 72 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----Cc
Confidence 37899999999999999999999988999999998643 2256788999999999999999999998543 56
Q ss_pred EEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+|+++||+.+ +|.+++.. ...+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 8999999996 99999875 457899999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. ......++..|+|||++.+ ..++.++||||+||++|+|++|+.||...+.......+.
T Consensus 153 ~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~--------------- 212 (256)
T cd06612 153 MA---KRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP--------------- 212 (256)
T ss_pred cc---ccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---------------
Confidence 21 1123457889999999877 678999999999999999999999997655432211110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.. ..........++..+.++|.+||+.||++|||+.++|.||||
T Consensus 213 ------------~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 213 ------------NK-PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ------------cC-CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00 001111123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=347.26 Aligned_cols=255 Identities=24% Similarity=0.416 Sum_probs=205.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCcccccee-ecCCCcCC-
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRI-MLPPSKRE- 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~-~~~~~~~~- 98 (374)
..+++|.+.|.+|||+.||+|.+...|..||+|++-.. +......+.+||.+|+.|+ |+|||.+++. ........
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 35778999999999999999999988899999988643 5566677889999999997 9999999994 33332222
Q ss_pred CCcEEEEEccCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEecCCCCeEEeeeccc
Q 017301 99 FKDIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
.-.+.|.||||. |+|.++|.. ...|++.++.+|++++++||++||..+ |||||||-+|||++.+|..||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 356899999999 599999984 346999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccc---cc---ccccccccccccccc---cccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 017301 174 RVAFSDTPMTV---FW---TDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (374)
Q Consensus 174 ~~~~~~~~~~~---~~---~~~~gt~~y~aPE~~---~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 244 (374)
+-......... .. -....|+.|+|||++ .+ .+++.++|||+|||+||-||....||.+.....+++.
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg--~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng-- 269 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSG--LPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNG-- 269 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcC--CCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEec--
Confidence 64322211110 00 123578999999976 34 6799999999999999999999999987643222110
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
. -....++.++..+.+||+.||+.||++||++.|++.+
T Consensus 270 -----------------------------~--Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 270 -----------------------------N--YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred -----------------------------c--ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 0 0112346789999999999999999999999999874
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=325.37 Aligned_cols=261 Identities=28% Similarity=0.507 Sum_probs=210.6
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
+..+.|.....||.|+||.||++.+..++..||+|.+... .......+.+|+.+++.++|||++++++.+.. .
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~ 91 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----G 91 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----C
Confidence 3346677788899999999999999999999999998642 23345568899999999999999999999843 3
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+||||+.+ +|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 92 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 92 DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred CeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 568999999986 78777754 5689999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... ......|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+.....
T Consensus 171 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---------- 235 (292)
T cd06658 171 EVP---KRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP---------- 235 (292)
T ss_pred ccc---cCceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------
Confidence 221 1133568899999999876 6788999999999999999999999987665433322211000
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
+........+..+.+++.+||..||.+|||++++++||||.....
T Consensus 236 ------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 236 ------------------PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred ------------------CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 000112346888999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=321.45 Aligned_cols=262 Identities=24% Similarity=0.426 Sum_probs=207.4
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++++.||+|+||+||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +|||++++++.+........
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 5689999999999999999999999999999999876421 2234567899999999 69999999998865444455
Q ss_pred CcEEEEEccCcc-cHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 100 KDIYVVFELMES-DLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~----~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
...++||||+++ +|.+++. ....+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 679999999986 8888765 33568999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
....... ......|++.|+|||++... ...++.++||||+||++|+|++|..||...+....+..+.
T Consensus 173 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~------- 242 (286)
T cd06638 173 QLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP------- 242 (286)
T ss_pred ecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc-------
Confidence 5432211 12334689999999987531 1457889999999999999999999997655322221110
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.... +........+..+.+||.+||+.||++|||+.++|+|+||
T Consensus 243 --------------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 243 --------------------RNPP-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------------------ccCC-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0000 0000112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=314.91 Aligned_cols=254 Identities=29% Similarity=0.482 Sum_probs=208.1
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+|+..+.||+|++|+||+|.+..++..|++|.+..... .......+.+|+.+++.++|+|++++++.+. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 68889999999999999999988999999999864321 2234557889999999999999999999883 335
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|+++||+++ +|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||.+......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 68999999986 99999988888999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
. ......++..|+|||.+... ..++.++|+|||||++|+|++|+.||...........+..
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-------------- 216 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR-------------- 216 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--------------
Confidence 2 12345688999999988662 2388999999999999999999999976553222211110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.. ......+.+++.+.+++.+||+.+|.+|||+.++|.|||+
T Consensus 217 -------------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 217 -------------SK--ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -------------cc--cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00 0111224578899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.11 Aligned_cols=263 Identities=27% Similarity=0.463 Sum_probs=220.5
Q ss_pred ccccCCCCCe-eEeceeeccCCeeEEEEEECCCCcEEEEEEec--CccCChHHHHHHHHHHHHHHhCCCCCccccceeec
Q 017301 16 FTEYGDANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIML 92 (374)
Q Consensus 16 ~~~~~~~~~Y-~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 92 (374)
+-..+..+|| +...+||+|+|-+||+|.|..+|..||.-.++ +.........++..|+.+|+.|+||||+++++.|.
T Consensus 32 ~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 32 FVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV 111 (632)
T ss_pred ccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence 4445666788 56788999999999999999999999987654 33455566788999999999999999999999997
Q ss_pred CCCcCCCCcEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEecCC-CCeEEe
Q 017301 93 PPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANAN-CKLKVC 168 (374)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~~~-~~vkl~ 168 (374)
+... ..+-+|+|.+. |+|..++++.++++...++.|++||++||.|||++. |+|||||-+||+|+.+ |.|||+
T Consensus 112 d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 112 DTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred cCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence 7643 56899999999 699999999999999999999999999999999995 9999999999999876 899999
Q ss_pred eecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 017301 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (374)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 248 (374)
|+|+|+....... ...+|||.|||||++.. .|+..+||||||+++.||+|+..||....+..++-+-+ ..
T Consensus 189 DLGLAtl~r~s~a-----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV--~S 258 (632)
T KOG0584|consen 189 DLGLATLLRKSHA-----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV--TS 258 (632)
T ss_pred chhHHHHhhcccc-----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH--Hc
Confidence 9999987655443 34689999999999864 79999999999999999999999998887665553221 11
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.-.|..+. .--++++++||.+||.. ...|||+.++|.||||..
T Consensus 259 GiKP~sl~--------------------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 259 GIKPAALS--------------------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred CCCHHHhh--------------------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 11111111 11267899999999999 899999999999999986
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=319.29 Aligned_cols=259 Identities=29% Similarity=0.526 Sum_probs=210.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
...|...+.||+|++|.||+|.+..++..+|+|+++.. .......+.+|+.+++.++|||++++++.+.. ..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~ 90 (285)
T cd06648 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDE 90 (285)
T ss_pred hHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCe
Confidence 34666778999999999999999999999999988532 22334567899999999999999999998843 345
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
.++++||+.+ +|.+++.. .++++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||.+.......
T Consensus 91 ~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred EEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 8999999986 99998877 678999999999999999999999999999999999999999999999999886543322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
.. .....|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+...
T Consensus 170 ~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-------------- 230 (285)
T cd06648 170 PR---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-------------- 230 (285)
T ss_pred cc---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc--------------
Confidence 21 123468899999999876 57889999999999999999999999776543333222110
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
. .+.......++..+.++|.+||+.||++|||+.++++||||+....
T Consensus 231 -------------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 231 -------------L-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred -------------C-CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 0 0111112347789999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=315.19 Aligned_cols=259 Identities=30% Similarity=0.471 Sum_probs=213.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
+.|++.+.||+|++|.||+|.+..+++.||+|++...... .....+.+|+..+..++|+|++++++.+... ...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeE
Confidence 4689999999999999999999999999999998754332 4456788999999999999999999998443 568
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
++||||+.+ +|.+++.....+++..+..++.|++.|++|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999995 999999988889999999999999999999999 999999999999999999999999999987654332
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
.. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.............
T Consensus 155 ~~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---------------- 213 (264)
T cd06623 155 DQ---CNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---------------- 213 (264)
T ss_pred Cc---ccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH----------------
Confidence 21 124467889999999877 678899999999999999999999997764211111111
Q ss_pred HHHHHHHHHhcCCCCCCccccCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.+..... ...... ++..+.++|.+||..+|++|||+.++++|||++..
T Consensus 214 --------~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 214 --------AICDGPP---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred --------HHhcCCC---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 1111110 111223 78899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=303.55 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=208.2
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCcE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
..+.+..||+|+.|+||+++.+.+|...|||.+.+. .+..+.++++..+.++.... +|+||+.+++|..+.. +
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d-----V 166 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD-----V 166 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-----H
Confidence 345678899999999999999999999999999764 34456678888888776654 9999999999976643 7
Q ss_pred EEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
++.||.|..-+..+++. .++++|..+-.+...++.||.||.++ ||+|||+||+|||++..|++||||||.+.....+.
T Consensus 167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 89999998644444443 34799999999999999999999877 89999999999999999999999999997654432
Q ss_pred Cccccccccccccccccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHhhCCCCHHHHhhh
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
. .+...|.+.|||||.+.-. ...|+.++||||||+.++||.||..||.+.+. .+.+..+.+
T Consensus 247 A----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln------------- 309 (391)
T KOG0983|consen 247 A----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN------------- 309 (391)
T ss_pred c----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-------------
Confidence 2 2445799999999988543 35799999999999999999999999998653 222222211
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
..| +....-.++|+.+++|+..||+.|+.+||...++|+|||+....
T Consensus 310 --------------~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 310 --------------EEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred --------------cCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 111 11111234899999999999999999999999999999987653
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=322.39 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=210.0
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
.....+|++.+.||+|++|+||+|.+..+++.||+|++.... ........+.+|+.+++.++|||++++++++...
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--- 87 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--- 87 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC---
Confidence 455578999999999999999999999999999999986432 2334445688999999999999999999998543
Q ss_pred CCCcEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
...|+||||+.|++.+.+.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 88 --~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 88 --HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred --CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 45899999999998888764 457899999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCcccccccccccccccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
... ....+++.|+|||++.+ ....++.++||||||+++|+|++|.+||.+.+.......+..
T Consensus 166 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---------- 228 (307)
T cd06607 166 SPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---------- 228 (307)
T ss_pred CCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc----------
Confidence 221 23467889999998743 125688899999999999999999999977654332211110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
...+. ......+..+.++|.+||+.||++|||+.+++.||||..
T Consensus 229 ----------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 229 ----------------NDSPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ----------------CCCCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00000 001235778999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=312.11 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=209.2
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..|.+.+.||+|++|.||+|.+..++..||+|.+.... ........+.+|+.+++.++|+||+++++.+.... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 57999999999999999999999999999999875321 12234457889999999999999999999874432 2
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+++++||+.+ +|.+.+...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 458999999986 9999998878899999999999999999999999999999999999999999999999999976433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
............++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........+..+ ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~------- 226 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPT------- 226 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCC-------
Confidence 2111111234568899999999877 56889999999999999999999999765443322211 11110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.......+++.+.++|.+||+ +|..|||+.++++|||.
T Consensus 227 -------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 -------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 011234578899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=320.48 Aligned_cols=259 Identities=21% Similarity=0.322 Sum_probs=198.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECC----------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCcc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTH----------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 85 (374)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4789999999999999999997532 34479999987532 234455788999999999999999
Q ss_pred ccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHhhhC
Q 017301 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-------------------DLTREHHQFFLYQMLRALKYMHTA 145 (374)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~-------------------~l~~~~~~~i~~qi~~al~~LH~~ 145 (374)
++++++... ...++||||+.+ +|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999998543 458999999985 9999886532 367788999999999999999999
Q ss_pred CccccCCCCCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHH
Q 017301 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (374)
Q Consensus 146 ~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll 225 (374)
||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999998754322211 11122345778999999876 67899999999999999998
Q ss_pred h--CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCC
Q 017301 226 T--GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303 (374)
Q Consensus 226 t--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 303 (374)
+ +..||.+.+..+.+..+.... . ...........+.++..+.+|+.+||+.||.+
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~--------------------~---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFF--------------------R---DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHh--------------------h---hccccccccCCCCCCHHHHHHHHHHccCCchh
Confidence 7 557887765544333221110 0 00000011122457889999999999999999
Q ss_pred CCCHHHHhc
Q 017301 304 RPTAEEALA 312 (374)
Q Consensus 304 Rpt~~~lL~ 312 (374)
|||+.++.+
T Consensus 292 RPs~~~i~~ 300 (304)
T cd05096 292 RPSFSDIHA 300 (304)
T ss_pred CcCHHHHHH
Confidence 999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=317.87 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=196.4
Q ss_pred eeeccCCeeEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHHHHHHH---hCCCCCccccceeecCCCcCCCCcEEEE
Q 017301 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-SDAIRILREVKLLR---LLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~---~l~h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
.||+|+||.||+|.+..+++.+|+|.+....... .......+|..+++ ...|||++.+++.+.. .+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 4899999999999999999999999986533221 22223344444333 3479999999998843 3458999
Q ss_pred EccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccc
Q 017301 106 FELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (374)
Q Consensus 106 ~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (374)
|||+.+ +|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 152 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence 999996 9999998888899999999999999999999999999999999999999999999999999865432211
Q ss_pred ccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 017301 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (374)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (374)
....|++.|+|||.+.+. ..++.++|+||+||++|+|++|..||.......... +..
T Consensus 153 --~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~------------------- 209 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDR------------------- 209 (279)
T ss_pred --cCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHH-------------------
Confidence 234689999999987532 468899999999999999999999997653221110 000
Q ss_pred HHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcCc
Q 017301 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (374)
.... ......+.+++.+.++|.+||+.||.+|| |+.++++||||+++.
T Consensus 210 -----~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 210 -----MTLT---VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred -----Hhhc---CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 0000 00112345788999999999999999999 699999999998853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=337.89 Aligned_cols=252 Identities=30% Similarity=0.463 Sum_probs=206.3
Q ss_pred eeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccC
Q 017301 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (374)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 109 (374)
+||+|.||+||.|+|..+...+|||.+.. ........+..||...++++|.|||+++|.+ .+.+++-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecC
Confidence 59999999999999999999999999853 2334556788999999999999999999998 4556788999999
Q ss_pred cc-cHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-CCCeEEeeecccccccCCCCccc
Q 017301 110 ES-DLHQVIKAN-DDL--TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTV 184 (374)
Q Consensus 110 ~~-~L~~~l~~~-~~l--~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~-~~~vkl~DFg~a~~~~~~~~~~~ 184 (374)
+| +|.+++.+. +++ .+..+..+.+||++||+|||++.|||||||-+|+|++. .|.+||+|||-++....-. .
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin---P 731 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN---P 731 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC---c
Confidence 96 999999764 666 88899999999999999999999999999999999976 5889999999987643322 2
Q ss_pred ccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 017301 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (374)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (374)
...++.||..|||||++......|+.++|||||||++.||.||+|||......+.. |.+
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFk------------------- 790 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFK------------------- 790 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhh-------------------
Confidence 33567899999999999876688999999999999999999999999754432211 100
Q ss_pred HHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
-.+-+. .......+|.+++.+|.+|+.+||.+||+|.++|..||++.-
T Consensus 791 ---VGmyKv----HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 791 ---VGMYKV----HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ---hcceec----CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 000000 001123567889999999999999999999999999999864
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=314.65 Aligned_cols=249 Identities=25% Similarity=0.414 Sum_probs=204.3
Q ss_pred eeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccC
Q 017301 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (374)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 109 (374)
||.|++|.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+. ....+|+|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 6999999999999999999999999865332 2234567889999999999999999999884 335689999999
Q ss_pred cc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccccc
Q 017301 110 ES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (374)
Q Consensus 110 ~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~ 188 (374)
.+ +|.+++.....+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence 85 999999888889999999999999999999999999999999999999999999999999997653332 1123
Q ss_pred ccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--hhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 017301 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (374)
Q Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (374)
..+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||..... ......+..
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 208 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--------------------- 208 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc---------------------
Confidence 468889999999876 5788999999999999999999999987652 111111110
Q ss_pred HHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
..... ......++.+.++|.+||+.||++||| ++++++||||+++
T Consensus 209 ---~~~~~-----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 209 ---GNGKL-----EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred ---cCCCC-----CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 00000 111234788999999999999999999 9999999999865
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=314.47 Aligned_cols=251 Identities=19% Similarity=0.269 Sum_probs=200.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.++|++.+.||+|+||.||+|..+ ..+..||+|.++.... ......+.+|+..++.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITR----- 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----
Confidence 467999999999999999999765 4456899999875422 2344568899999999999999999999843
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....++||||+++ +|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 3458999999996 888888764 57899999999999999999999999999999999999999999999999987543
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ......++..|+|||.+.+ ..++.++|||||||++|++++ |..||.+.+..+....+...
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~--------- 224 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG--------- 224 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---------
Confidence 221110 0112235678999999877 678999999999999999775 99999877654443332211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. ....+.++..+.+++.+||+.+|.+|||++++++
T Consensus 225 ------------------~~---~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 225 ------------------FR---LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------------CC---CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 00 0112457888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=312.21 Aligned_cols=253 Identities=28% Similarity=0.476 Sum_probs=206.9
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||+|++|.||+|.+..+|..+|+|.+............+.+|+.+++.++|+|++++++.+.. ....|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence 6899999999999999999999999999999986533233344567799999999999999999998843 35689
Q ss_pred EEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC-eEEeeecccccccCC
Q 017301 104 VVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-LKVCDFGLARVAFSD 179 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~-vkl~DFg~a~~~~~~ 179 (374)
+|+||+.+ +|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999986 9999887643 5799999999999999999999999999999999999998865 699999998765332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. ......|++.|+|||.+.+ ..++.++|+|||||++++|++|..||...+.......+..
T Consensus 156 ~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 ME---LAYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred cc---cccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 21 1123468889999998876 5788999999999999999999999977654332221110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
. ......+.++..+.++|.+||..+|++|||+.+++.||||
T Consensus 217 ------------~----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 ------------G----YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------------c----cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 0111234578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=319.63 Aligned_cols=262 Identities=26% Similarity=0.449 Sum_probs=204.0
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 101 (374)
+.|+..+.||+|+||.||++.+..++..||+|.+...... .....+.+|+.++.++. ||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----Cc
Confidence 4577788999999999999999999999999998743322 44556789999999996 99999999988543 45
Q ss_pred EEEEEccCcccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 102 IYVVFELMESDLHQVIK-----ANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
.+++|||+.+++.++.. ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 79999999876655432 235799999999999999999999975 999999999999999999999999999875
Q ss_pred ccCCCCcccccccccccccccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
...... .....|++.|+|||++.+.. ..++.++||||+||++|+|++|..||..... ....+.....
T Consensus 158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~------ 225 (288)
T cd06616 158 LVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVK------ 225 (288)
T ss_pred hccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcC------
Confidence 433211 12336888999999986621 2688999999999999999999999976541 1111111110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
...+.........++..+.+||.+||+.||++|||+++++.||||+..
T Consensus 226 -----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 226 -----------------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred -----------------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 001100111123578899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=316.15 Aligned_cols=256 Identities=30% Similarity=0.544 Sum_probs=210.9
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 100 (374)
++|.+.+.||+|++|.||+|.+..++..||+|++.... ........+.+|+.+++.++ ||||+++++++. ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-----DEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc-----CCc
Confidence 47999999999999999999999999999999987532 22333456788999999998 999999999884 335
Q ss_pred cEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
..++|||++. ++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 6899999996 599999998888999999999999999999999999999999999999999999999999998764432
Q ss_pred CCc-----------------ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 017301 180 TPM-----------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242 (374)
Q Consensus 180 ~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 242 (374)
... ........++..|+|||...+ ..++.++|+||||++++++++|+.||...+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 211 011233467889999998876 5688899999999999999999999987764322222
Q ss_pred HHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCCCC
Q 017301 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYF 316 (374)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~~lL~hp~~ 316 (374)
+.. . .......+++.+.+||.+||+.||.+|||+ +++|+||||
T Consensus 234 ~~~------------------------~-------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILK------------------------L-------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHh------------------------c-------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 110 0 011123568899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=328.34 Aligned_cols=247 Identities=28% Similarity=0.411 Sum_probs=204.0
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
..+++++.||+|-||.||.|... ....||+|.++... -....+.+|+++|++|+|++||++++++.. ...+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCce
Confidence 35588999999999999999764 23489999987532 234567799999999999999999999943 3359
Q ss_pred EEEEccCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 103 YVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
|||||||. |+|.+++.. +..+.......++.||++|++||+++++|||||-..||||+++..+||+|||+|+....+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999 799999997 457899999999999999999999999999999999999999999999999999943322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.-. ...+.--...|.|||.+.. ..++.+||||||||+|+||+| |+.|+.+.+..+.+..+.+...-|.
T Consensus 357 ~Y~--~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~------- 425 (468)
T KOG0197|consen 357 EYT--ASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR------- 425 (468)
T ss_pred cee--ecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC-------
Confidence 111 1111122345999999977 789999999999999999999 8999999998888777655332222
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.+.+|+.+-+++..|+..+|++|||.+.+..
T Consensus 426 -----------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 426 -----------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred -----------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 2468999999999999999999999997643
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=310.10 Aligned_cols=253 Identities=31% Similarity=0.505 Sum_probs=212.1
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||+|++|.||+|.+..++..||+|++............+.+|+++++.++|||++++.+.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 68999999999999999999999999999999976554445666788999999999999999999998543 5689
Q ss_pred EEEccCcc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 104 VVFELMES-DLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
+|+|++++ +|.+.+... ..+++..+..++.+++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999986 999998763 6799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. .......|++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.........
T Consensus 156 ~~---~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------------- 216 (258)
T cd08215 156 TV---DLAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-------------- 216 (258)
T ss_pred Cc---ceecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh--------------
Confidence 32 12234578899999998876 668899999999999999999999997765433222211
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
..... ......+..+.+++.+||..+|++|||+.++|+||||
T Consensus 217 -------------~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 217 -------------KGQYP---PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------------cCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 11111 1122577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=314.83 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=206.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++.++||||+++++.+.... ...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeE
Confidence 479999999999999999999999999999999874322 244567889999999999999999999885432 2468
Q ss_pred EEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 103 YVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
|+||||+++ +|.+++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999986 88887653 3468999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--hhHHHHHHHhhCCCCHHHH
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 255 (374)
.... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ....+...
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------- 218 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS----------- 218 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH-----------
Confidence 2221 23457888999999877 6789999999999999999999999976532 00111110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCcc---ccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLF---QKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.+......... ..-...++.+.++|.+||+.||.+|||+.+++.||||+..
T Consensus 219 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 219 -------------YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred -------------HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 01110000000 0011346789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=316.97 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=209.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
...|+.++.||.|+||.||+|.+..++..||+|++... ........+.+|+.+++.++|||++++++.+.. ...
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTK 76 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCE
Confidence 46788999999999999999999999999999998643 223445678899999999999999999999843 456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
.|+||||+++ +|.+++.. +++++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999986 89988865 568999999999999999999999999999999999999999999999999997543322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 156 ~---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~---------------- 214 (277)
T cd06640 156 I---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP---------------- 214 (277)
T ss_pred c---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh----------------
Confidence 1 1123467888999999876 678899999999999999999999998765432221110
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
... .......++..+.++|.+||+.+|++|||+.++++||||...
T Consensus 215 -----------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 215 -----------KNN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred -----------cCC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 000 011123467789999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=317.16 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=203.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
++|++.+.||+|++|.||+|.+...+ ..||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---- 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK---- 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC----
Confidence 57899999999999999999876555 689999886432 23345568899999999999999999999843
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~ 160 (374)
....|++|||+.+ +|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++
T Consensus 80 -~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 80 -EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 3458999999985 999999764 4578899999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 017301 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (374)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 239 (374)
.++.++|+|||++........ ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999875432211 111233456788999998876 678999999999999999998 9999987765443
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
...+.. ... ......+++.+.+|+.+||+.||.+|||+.+++++
T Consensus 236 ~~~i~~---------------------------~~~---~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRS---------------------------RQL---LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCc---CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 332211 110 01124678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=317.74 Aligned_cols=266 Identities=26% Similarity=0.394 Sum_probs=210.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++++.||+|++|+||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++.+... ...
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence 67999999999999999999999999999999886432 233456788999999999999999999998543 568
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
|+||||+.+ +|.+++...+.+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999996 899998888889999999999999999999997 599999999999999999999999999886432221
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ....|+..|+|||++.+ ..++.++|+|||||++|+|++|..||........... . .
T Consensus 159 ~-----~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--------~--------~ 215 (284)
T cd06620 159 A-----DTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--------D--------P 215 (284)
T ss_pred c-----CccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--------h--------h
Confidence 1 23468999999999876 5788999999999999999999999986553211000 0 0
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..............+... ....++..+.+||.+||+.||++|||+.++++||||...
T Consensus 216 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 216 MGILDLLQQIVQEPPPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hHHHHHHHHHhhccCCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000111111111111000 011367789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=320.11 Aligned_cols=260 Identities=28% Similarity=0.527 Sum_probs=210.1
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
+...-|.....||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++|||++++++.+.. .
T Consensus 18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~ 90 (297)
T cd06659 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----G 90 (297)
T ss_pred cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee-----C
Confidence 344556677789999999999999999999999999864322 234567889999999999999999998843 3
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+||||+.+ +|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 91 ~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 91 EELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 568999999996 88877654 5689999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 231 (297)
T cd06659 170 DVP---KRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD------------- 231 (297)
T ss_pred ccc---cccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 221 1134568899999999877 6789999999999999999999999987654433322210
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
. ..........+++.+.++|.+||+.+|.+|||+.++++||||....
T Consensus 232 --------------~-~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 232 --------------S-PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred --------------c-CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 0 0111122345788899999999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=316.69 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=202.3
Q ss_pred eeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccC
Q 017301 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (374)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 109 (374)
||+|+||+||+|.+..+|+.||+|.+...... ......+.+|+.+++.++|||++++++++. .....|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence 69999999999999999999999998643221 223445678999999999999999999983 345689999999
Q ss_pred cc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccc
Q 017301 110 ES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (374)
Q Consensus 110 ~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (374)
.+ +|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+....... ..
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KI 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----cc
Confidence 95 9999987765 79999999999999999999999999999999999999999999999999987543211 11
Q ss_pred ccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 017301 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (374)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (374)
....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...........+..
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 208 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------------------- 208 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---------------------
Confidence 33467888999999877 5688999999999999999999999976543211111100
Q ss_pred HHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcCc
Q 017301 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (374)
.... ......+.+++.+.++|.+||+.||.+|| ++.++++||||..+.
T Consensus 209 --~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 209 --RTLE----MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred --cccc----ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 0000 01112245789999999999999999999 999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=320.26 Aligned_cols=256 Identities=28% Similarity=0.391 Sum_probs=207.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
...|+..+.||+|++|.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++.+.. ...
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTK 76 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCc
Confidence 3568889999999999999999999999999999864322 2345578899999999999999999999843 345
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
.|+||||+++ +|.+++.. +.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred eEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 8999999996 88888764 568999999999999999999999999999999999999999999999999987543321
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~----------------- 213 (277)
T cd06642 156 I---KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI----------------- 213 (277)
T ss_pred h---hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-----------------
Confidence 1 1123467889999999877 67889999999999999999999999765432221110
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..... .......+..+.++|.+||+.+|++|||+.++++||||..+
T Consensus 214 ----------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 214 ----------PKNSP---PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ----------hcCCC---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 00000 01112467789999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=318.32 Aligned_cols=260 Identities=28% Similarity=0.491 Sum_probs=210.7
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
+..++|++.+.||+|+||+||++.+..++..||+|.+... .......+.+|+.+++.++|||++++++.+.. .
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~ 88 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLV-----G 88 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeee-----C
Confidence 3458999999999999999999999889999999998632 22334567899999999999999999999844 3
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+|+||+.+ +|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 458999999986 999888654 588999999999999999999999999999999999999999999999998865433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... ......+++.|+|||.+.+ ..++.++|+|||||++|++++|..||...+.......+..
T Consensus 168 ~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~------------- 229 (293)
T cd06647 168 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------- 229 (293)
T ss_pred ccc---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-------------
Confidence 221 1233468889999999876 6788999999999999999999999987654322211100
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
...+.......++..+.++|++||..+|++|||+.+++.||||+...
T Consensus 230 ---------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 230 ---------------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ---------------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 00011111234678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=329.52 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=197.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 95 (374)
.++|++++.||+|+||.||+|++..+| ..||+|+++.... ......+.+|+.+++.+ +|+||+++++.+..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 468999999999999999999865443 5799999875432 23455688999999999 89999999999843
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhC------------------------------------------------------
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKAN------------------------------------------------------ 120 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~------------------------------------------------------ 120 (374)
...+|+||||+.+ +|.+++...
T Consensus 114 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 114 ---GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ---CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 3458999999995 999888532
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccc
Q 017301 121 ----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (374)
Q Consensus 121 ----------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (374)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~- 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV- 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee-
Confidence 247888899999999999999999999999999999999999999999999997543322111
Q ss_pred ccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 017301 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (374)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (374)
......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~------------------ 329 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK------------------ 329 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH------------------
Confidence 1112235567999999876 679999999999999999997 9999976543222211110
Q ss_pred HHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.... . ......++.+.+++.+||+.||.+|||+.++++
T Consensus 330 --------~~~~-~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 330 --------RGYQ-M--SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred --------cccC-c--cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 0 011246789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=307.35 Aligned_cols=253 Identities=31% Similarity=0.504 Sum_probs=212.1
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.++++++|||++++++.+.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 5899999999999999999999999999999997654444556678899999999999999999999843 35689
Q ss_pred EEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 104 VVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
++||++++ +|.+++.....+++..+..++.|++.||.+||++||+||||+|+||+++.++.++|+|||.+.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999986 99999988888999999999999999999999999999999999999999999999999999765443321
Q ss_pred ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 017301 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (374)
.....++..|+|||...+ ..++.++|+||+|+++|+|++|..||...+.......+.
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 212 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------------------ 212 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------------------
Confidence 233468889999999877 458899999999999999999999997655322211110
Q ss_pred HHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.. ......+.+++.+.+++.+||..+|++|||+.+++.||||
T Consensus 213 --------~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 213 --------QD----DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred --------cc----CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 00 0011224578899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=310.13 Aligned_cols=249 Identities=29% Similarity=0.443 Sum_probs=204.1
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||+|+||.||++.+..++..+|+|.++... .......+.+|+.+++.++|||++++++.+ .....+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEE
Confidence 5899999999999999999999999999999986432 234456778899999999999999999998 3445699
Q ss_pred EEEccCcc-cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 104 VVFELMES-DLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+.......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999985 99988865 3468999999999999999999999999999999999999999999999999987543322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--------------- 214 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------------- 214 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc---------------
Confidence 1 1234568899999999877 6789999999999999999999999987654333222211
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
... ......++..+.+||.+||+.||++|||+.++++-
T Consensus 215 ------------~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 ------------GSY---KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------------CCC---CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000 01123467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=322.42 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=214.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.+.|..-++||+|+||.||.+.-+.||+.+|+|.+.+.... .......++|-.+|...+.+.||.+--+| +...
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCC
Confidence 46788999999999999999999999999999988643222 23344577899999999999999998888 4445
Q ss_pred cEEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 101 DIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
.+|+|+..|+| ||.-+|.+.+ .+++..+..++.+|+.||++||+.+||+||+||+|||+|+.|+|+|+|.|+|..+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 69999999996 9998887765 89999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
...+ ....+||.+|||||++.+ ..|+.+.|.|||||++|+|+.|+.||...........+.
T Consensus 339 ~g~~----~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd------------- 399 (591)
T KOG0986|consen 339 EGKP----IRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD------------- 399 (591)
T ss_pred CCCc----cccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH-------------
Confidence 5443 245589999999999988 679999999999999999999999997654322111111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
+.... ........+|+++++|.+.+|+.||.+|. .++++-+||||+.+
T Consensus 400 -----------rr~~~---~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 400 -----------RRTLE---DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred -----------HHHhc---chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 11111 11122246899999999999999999997 68899999999975
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=328.60 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=197.1
Q ss_pred CCeeEeceeeccCCeeEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 96 (374)
++|++++.||+|+||+||+|.+ ..++..||+|+++... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--- 110 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTV--- 110 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence 5899999999999999999964 3466789999987432 223455788999999999 89999999999844
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCC------------------------------------------------------
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAND------------------------------------------------------ 121 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~------------------------------------------------------ 121 (374)
....++||||+.+ +|.+++....
T Consensus 111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 3458999999995 9998886432
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 122 ---------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 122 ---------------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 46788899999999999999999999999999999999999999999999997543322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+...........
T Consensus 269 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~--------------- 330 (375)
T cd05104 269 NYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI--------------- 330 (375)
T ss_pred ccc-ccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH---------------
Confidence 111 1112234567999999877 679999999999999999998 889997654322211110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
. .... .......+..+.+||.+||+.||++|||+.++++.
T Consensus 331 --------~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 331 --------K---EGYR---MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --------H---hCcc---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 0000 00112357789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=314.68 Aligned_cols=257 Identities=31% Similarity=0.493 Sum_probs=207.0
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC---CCCccccceeecCCCcCCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~~~ 100 (374)
.|++.+.||+|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.++ |||++++++.+.. ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CC
Confidence 58889999999999999999999999999999864322 234456778999999986 9999999998843 34
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
..|+||||+.+ +|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 68999999986 898888654 7899999999999999999999999999999999999999999999999998765443
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. ......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.+.......+
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---------------- 214 (277)
T cd06917 155 SS---KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---------------- 214 (277)
T ss_pred cc---ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc----------------
Confidence 21 12344688999999987542 45788999999999999999999999765432221111
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
....+... ....++..+.+++.+||+.||++|||+.+++.||||++..
T Consensus 215 -----------~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 215 -----------PKSKPPRL--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -----------ccCCCCCC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00000000 0112678899999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=309.94 Aligned_cols=251 Identities=29% Similarity=0.428 Sum_probs=198.6
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEc
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e 107 (374)
...||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++|+||+++++.+.. ....++|+|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NGFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CCEEEEEEe
Confidence 35799999999999999999999999988643 23455678899999999999999999999843 356899999
Q ss_pred cCcc-cHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-CCCeEEeeecccccccCCCCc
Q 017301 108 LMES-DLHQVIKAN-DDL--TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 108 ~~~~-~L~~~l~~~-~~l--~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~-~~~vkl~DFg~a~~~~~~~~~ 182 (374)
|+.+ +|.+++... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||.+........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 9985 999998764 445 88889999999999999999999999999999999976 67899999999875432221
Q ss_pred ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 017301 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (374)
......+++.|+|||.+.+....++.++|+||+|+++|+|++|..||............
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~------------------- 223 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK------------------- 223 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-------------------
Confidence 12234578899999998653345888999999999999999999999654321110000
Q ss_pred HHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
...... .......+++.+.+++.+||+.+|.+|||+.+++.||||
T Consensus 224 -----~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 224 -----VGMFKI----HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----hhhhcc----CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 000000 001123578889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=310.41 Aligned_cols=248 Identities=23% Similarity=0.426 Sum_probs=201.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
..|.+.+.||+|++|.||+|.+..++..||+|.+... ......+.+|+.+++.++|||++++++++. ....+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCc
Confidence 5689999999999999999999999999999998642 233456889999999999999999999984 33458
Q ss_pred EEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 103 YVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+++|||+.+ +|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999985 999998764 35899999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 158 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~------------- 220 (263)
T cd05052 158 TYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------- 220 (263)
T ss_pred eeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------------
Confidence 2111 112234567999998876 678899999999999999998 9999987664433222211
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... ......+++.+.++|.+||+.||++|||+.++++
T Consensus 221 --------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 221 --------------GYR---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred --------------CCC---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000 0112457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=310.62 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=199.0
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHH-HhCCCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||.|++|.||+|.+..+++.||+|++...... ......+..|..++ ...+|+|++++++.+. ....+|+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 5799999999999999999999999998643221 12223344555443 4458999999999984 345689999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 99986 9999998888899999999999999999999999999999999999999999999999999865322
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
.....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 207 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-------------------- 207 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------------------
Confidence 123468889999999877 5588999999999999999999999987665433322211
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCcC
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGL 319 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~~lL~hp~~~~~ 319 (374)
............+++.+.++|.+||+.||++||| ++|+|+||||+.+
T Consensus 208 -------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 208 -------RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred -------cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 0000011112357899999999999999999995 5799999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=312.84 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=196.2
Q ss_pred eeeccCCeeEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHH---HHHHHhCCCCCccccceeecCCCcCCCCcEEEE
Q 017301 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-SDAIRILRE---VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E---~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
.||+|+||.||+|.+..+++.||+|.+....... ........| +..++...||+++.+++.+. ....+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence 4899999999999999999999999986432221 111223333 33455567999999999884 34568999
Q ss_pred EccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccc
Q 017301 106 FELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (374)
Q Consensus 106 ~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (374)
|||+.| +|.+++...+.+++..++.++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++........
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 999986 9999998888899999999999999999999999999999999999999999999999999865432211
Q ss_pred ccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 017301 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (374)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (374)
....|+..|+|||.+.+. ..++.++|+||+||++|+|++|+.||.+...........
T Consensus 153 --~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-------------------- 209 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------------------- 209 (278)
T ss_pred --cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH--------------------
Confidence 234689999999998642 458899999999999999999999997763221111000
Q ss_pred HHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
.. ... ........++.+.++|.+||..||.+|| ++.++++||||+..
T Consensus 210 ----~~-~~~---~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 210 ----MT-LTM---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred ----Hh-hcc---CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 00 000 0111234688999999999999999999 99999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=311.01 Aligned_cols=253 Identities=32% Similarity=0.506 Sum_probs=205.2
Q ss_pred eeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccC
Q 017301 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (374)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 109 (374)
||+|++|.||+|.+..+|+.+|+|++..... .......+.+|+.+++.++|||++++++.+. .....|+++||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence 6899999999999999999999999864322 2234557889999999999999999998883 445689999999
Q ss_pred cc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc-----c
Q 017301 110 ES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM-----T 183 (374)
Q Consensus 110 ~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~-----~ 183 (374)
.+ +|.+++.+.+.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 86 99999988778999999999999999999999999999999999999999999999999998754332110 1
Q ss_pred cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 017301 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (374)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (374)
.......++..|+|||...+ ..++.++|+||||+++|+|++|..||...........+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------ 215 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------------ 215 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Confidence 11233467889999999877 5688899999999999999999999987664433322211
Q ss_pred HHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH---HHHhcCCCCCcC
Q 017301 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEALADPYFKGL 319 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~---~~lL~hp~~~~~ 319 (374)
..... .....+++.+.+++.+||+.+|++|||+ .++|+||||+.+
T Consensus 216 --------~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 216 --------GKIEW---PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred --------CCcCC---CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 00000 0011258899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=323.58 Aligned_cols=288 Identities=19% Similarity=0.229 Sum_probs=204.6
Q ss_pred ceeecc--CCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
..||+| +||+||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence 456766 99999999999999999999987554444555678899999999999999999999944 44589999
Q ss_pred ccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc
Q 017301 107 ELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (374)
Q Consensus 107 e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (374)
||+.+ ++.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++++||+.+..........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99995 999988764 358999999999999999999999999999999999999999999999998654322111100
Q ss_pred -cc---cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH--H--
Q 017301 184 -VF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET--I-- 255 (374)
Q Consensus 184 -~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~--~-- 255 (374)
.. .....++..|+|||++.+....++.++||||+||++|+|++|..||.+.................+... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 00 011234567999999876334578999999999999999999999988765443322221111000000 0
Q ss_pred --hhhcCHH--HH-HHHHHhcC-----CCC--CCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 256 --AVVRNEK--AR-KYLTEMRK-----KPP--VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 256 --~~~~~~~--~~-~~~~~~~~-----~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
....+.. .. ........ ... .-........++.+.+||++||+.||++|||+.++|+||||.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0000000 00 00000000 000 0000112246778999999999999999999999999999987643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=308.21 Aligned_cols=245 Identities=22% Similarity=0.331 Sum_probs=197.1
Q ss_pred eeeccCCeeEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEc
Q 017301 30 VIGKGSYGVVCAAID--THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (374)
Q Consensus 30 ~lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e 107 (374)
.||+|+||.||+|.. ..++..+|+|+++...........+.+|+.+++.+.||||+++++.+.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 689999999999964 4577899999987554444556678899999999999999999988732 34699999
Q ss_pred cCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccc
Q 017301 108 LMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (374)
Q Consensus 108 ~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (374)
|+.+ +|.+++.....+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||.+.............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9995 899999888889999999999999999999999999999999999999999999999999997654332211111
Q ss_pred ccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+.......+..
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-------------------- 213 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-------------------- 213 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC--------------------
Confidence 22234578999998866 678889999999999999998 9999987655433332211
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... ....+.+++.+.+||.+||+.||.+|||+++|..
T Consensus 214 -------~~~---~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 214 -------GER---MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -------CCC---CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 000 0112457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=312.66 Aligned_cols=259 Identities=22% Similarity=0.378 Sum_probs=202.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
.++|++.+.||+|+||.||+|..+. .+..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-- 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 5789999999999999999997542 34589999886432 233445678899999999999999999998433
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCe
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~----------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~v 165 (374)
...|+||||+.+ +|.+++... ...+...+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 82 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 ---QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred ---CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 458999999984 999999752 234667888999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 017301 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (374)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 244 (374)
+|+|||+++......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred EECcCCcccccccccccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999987543322111 1122245677999999876 678999999999999999998 788997765443332221
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc------CCCCCc
Q 017301 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA------DPYFKG 318 (374)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~------hp~~~~ 318 (374)
. .. ........++.+.+++.+||+.||++|||+.++++ ||||++
T Consensus 236 ~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 236 D---------------------------GG---YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred c---------------------------CC---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 1 00 00111245788999999999999999999999988 999986
Q ss_pred C
Q 017301 319 L 319 (374)
Q Consensus 319 ~ 319 (374)
+
T Consensus 286 ~ 286 (288)
T cd05061 286 V 286 (288)
T ss_pred C
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=344.69 Aligned_cols=256 Identities=26% Similarity=0.369 Sum_probs=201.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|+++++||+|+||+||+|.+..+|+.||+|++..... ......++.+|+.+++.++||||+++++++. +...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 789999999999999999999999999999999975432 2334557889999999999999999999984 3456
Q ss_pred EEEEEccCcc-cHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEee
Q 017301 102 IYVVFELMES-DLHQVIKAN-----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-----------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~D 169 (374)
.|+||||++| +|.+++... ..++...+..++.||+.||+|||++||+||||||+||+++.++.++|+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 8999999996 999988641 2355677889999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCc---------------ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 017301 170 FGLARVAFSDTPM---------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (374)
Q Consensus 170 Fg~a~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 234 (374)
||+++........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999765211100 000123469999999999877 67899999999999999999999999775
Q ss_pred ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
........ ..... + .....+..+++.+.+++.+||+.||++|++..+.|.+
T Consensus 235 ~~~ki~~~--~~i~~-------------------------P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYR--DVILS-------------------------P-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhh--hhccC-------------------------h-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43221110 00000 0 0001124678899999999999999999887666653
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=306.27 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=208.9
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||+|++|.||++.+..+++.+|+|.+............+.+|+.+++.++|+||+++++.+... ...|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 58999999999999999999999999999999875444445556778899999999999999999988443 5689
Q ss_pred EEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 104 VVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
+||||+++ +|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||.+.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 99999986 99988866 35689999999999999999999999999999999999999999999999999976544
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||...+.......+..
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------- 215 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 31 123468889999999877 6788999999999999999999999987664332221110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
... .......+..+.+++.+||+.+|.+|||+.++++||++
T Consensus 216 --------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 --------------GKY---PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------------CCC---CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 000 01112567889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=311.54 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=195.4
Q ss_pred CCeeEecee--eccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCC
Q 017301 23 NRYKILEVI--GKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 23 ~~Y~~~~~l--g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 99 (374)
+.|++.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.....+ +|||++++++.+...
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~----- 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL----- 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC-----
Confidence 456666665 99999999999999999999999986432111 122222222 699999999999443
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC-CeEEeeeccccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~-~vkl~DFg~a~~~~ 177 (374)
...|+||||+.+ +|.+++..+..+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||.+....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 468999999985 9999998888899999999999999999999999999999999999999998 99999999987543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. ....++..|+|||++.+ ..++.++|+||+||++|+|++|..||........-
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~----------------- 215 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD----------------- 215 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-----------------
Confidence 22 22358889999999977 67899999999999999999999999755422100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-HHHHhcCCCCCc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-AEEALADPYFKG 318 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~~lL~hp~~~~ 318 (374)
........ . ......+.+++.+.+||.+||+.||.+||+ ++++|+||||.+
T Consensus 216 -----~~~~~~~~-~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 216 -----LESLLKRQ-Q----KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred -----HHHHHHhh-c----ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 00000111 0 111223468999999999999999999996 599999999963
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=313.17 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=202.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.++.... ......+.+|+++++.++||||+++++.+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence 3579999999999999999998743 467899999875322 23456788999999999999999999998443
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAND--------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~--------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~ 161 (374)
...++||||+.+ +|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 81 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 ---DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ---CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 568999999985 9999997643 4788999999999999999999999999999999999999
Q ss_pred CCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHH
Q 017301 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (374)
Q Consensus 162 ~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 240 (374)
++.+||+|||.+......... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred CCeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999998754322111 11123346788999999877 678999999999999999998 99999876654433
Q ss_pred HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..+.. ... .......+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQ---------------------------GRL---LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33221 000 0112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=316.15 Aligned_cols=259 Identities=26% Similarity=0.386 Sum_probs=209.3
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
....+.|...+.||+|++|+||+|.+..++..||+|++..... .......+.+|+.+++.++|||++++++++..
T Consensus 17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 92 (313)
T cd06633 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK---- 92 (313)
T ss_pred CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe----
Confidence 3444568888999999999999999999999999999864322 23344567889999999999999999999844
Q ss_pred CCCcEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....|+||||+.+++.+.+.. ..++++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...
T Consensus 93 -~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 93 -EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred -CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 355899999999988888865 457899999999999999999999999999999999999999999999999988532
Q ss_pred cCCCCcccccccccccccccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
.. .....|+..|+|||.+.. ....++.++|+|||||++|+|++|.+||...+.......+..
T Consensus 172 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---------- 234 (313)
T cd06633 172 SP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---------- 234 (313)
T ss_pred CC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----------
Confidence 11 123468889999998742 114688899999999999999999999987664333322211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
...+ ....+.++..+.+|+.+||+.+|.+|||+.+++.||||+.
T Consensus 235 ----------------~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 235 ----------------NDSP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ----------------cCCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 0000 0112346778999999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=305.79 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=212.3
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||+|++|.||+|.+..++..|++|++............+.+|+.++++++||||+++++.+.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 588999999999999999999999999999998765444455677889999999999999999999985442 25689
Q ss_pred EEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 104 VVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
+++|++.+ +|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999965 99999988889999999999999999999999999999999999999999999999999999765444321
Q ss_pred ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 017301 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (374)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ...+..
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~----------------- 215 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYK----------------- 215 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHh-----------------
Confidence 01133468889999999877 55889999999999999999999999876511 111111
Q ss_pred HHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
... ...........+..+.++|.+||+.||++|||+.++++||||
T Consensus 216 -------~~~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 216 -------IGS--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -------ccc--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000 001111223458899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=314.02 Aligned_cols=261 Identities=32% Similarity=0.530 Sum_probs=214.9
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
..+..+.|++...||.|++|.||+|.+..++..||+|++..... ....+.+|+..++.++|+|++++++.+...
T Consensus 14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 87 (286)
T cd06614 14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG--- 87 (286)
T ss_pred CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC---
Confidence 34566789999999999999999999998999999999874322 455678999999999999999999998543
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...|+|+||+++ +|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 88 --DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred --CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 458999999995 9999998876 899999999999999999999999999999999999999999999999998865
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 166 ~~~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~---------- 230 (286)
T cd06614 166 LTKEKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT---------- 230 (286)
T ss_pred hccchh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence 432211 1123457888999999877 6789999999999999999999999987655433222211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
... +.......++..+.++|.+||+.+|.+|||+.++|.||||+..
T Consensus 231 -----------------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 231 -----------------KGI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred -----------------cCC-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 000 0111123477889999999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=328.08 Aligned_cols=255 Identities=23% Similarity=0.296 Sum_probs=206.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.+...++..||+|+||+||+|++. -.||||+++.........+.|.+|+.++++-+|.||+=+.|++..+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~------ 461 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP------ 461 (678)
T ss_pred HHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc------
Confidence 456688999999999999999764 46999999877777788889999999999999999999999995543
Q ss_pred EEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+.||+-+|+| +|..++.-. .+|.....+.|+.||++|+.|||.++|||||||..||++.++++|||+|||++..-.--
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 4999999999 999998753 47889999999999999999999999999999999999999999999999999753222
Q ss_pred CCcccccccccccccccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. ........|...|||||++.. ...+|++.+|||||||++|||++|..||...+...++-++-...+.|.
T Consensus 542 ~g-~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd------- 613 (678)
T KOG0193|consen 542 SG-EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD------- 613 (678)
T ss_pred cc-ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc-------
Confidence 11 111234467788999998853 236799999999999999999999999995554433322221111111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
......+.+.++++|+..||.+++++||+..+||.
T Consensus 614 -------------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 -------------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -------------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 11223456779999999999999999999999987
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=321.00 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=199.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 95 (374)
.++|++++.||.|+||.||+|.+. .+++.||+|+++... .......+.+|+.+++++ +|+||+++++.+...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 368999999999999999999743 345789999987432 233445678899999999 799999999988533
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhC------------------------------------------------------
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKAN------------------------------------------------------ 120 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~------------------------------------------------------ 120 (374)
...++++|||+.+ +|.+++...
T Consensus 84 ---~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 84 ---GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ---CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 2468999999996 998888542
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccccccccccc
Q 017301 121 -------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193 (374)
Q Consensus 121 -------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~ 193 (374)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++........ .......++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCc
Confidence 25788999999999999999999999999999999999999999999999999764332211 1112334567
Q ss_pred cccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcC
Q 017301 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK 272 (374)
Q Consensus 194 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (374)
.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+... +..
T Consensus 240 ~y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~--------------------------~~~ 291 (337)
T cd05054 240 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR--------------------------LKE 291 (337)
T ss_pred cccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH--------------------------Hhc
Confidence 8999999877 689999999999999999998 99999764432221111 000
Q ss_pred CCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
... .......++.+.+++.+||+.+|++|||+.++++|
T Consensus 292 ~~~---~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 292 GTR---MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred cCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 00113467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=319.72 Aligned_cols=282 Identities=22% Similarity=0.259 Sum_probs=202.5
Q ss_pred eEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEE
Q 017301 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
++++.+|. +|.||.+++..+++.||+|+++...........+.+|+.+++.++||||+++++++.. ....|++
T Consensus 5 ~i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~ 77 (314)
T cd08216 5 LIGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVV 77 (314)
T ss_pred hhhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEE
Confidence 34444444 4556666667799999999997654444566788999999999999999999999844 3458999
Q ss_pred EccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 106 FELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 106 ~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
|||+.+ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+.........
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 999995 898988753 46899999999999999999999999999999999999999999999999988654322110
Q ss_pred ----ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 183 ----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 183 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
........++..|+|||++.+....++.++|+||+||++|+|++|..||...+....... ...+..... +...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~-~~~~ 234 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCL-LDKS 234 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccCccc-cccC
Confidence 111133457788999999866334688999999999999999999999987654433211 111111100 0000
Q ss_pred cCHHHHHHHHHhcC---------CCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 259 RNEKARKYLTEMRK---------KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 259 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
. .......... ............++..+.+|+.+||+.||++|||++++|+||||+++.
T Consensus 235 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 235 T---YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred c---hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0 0000000000 000000011123567889999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=308.62 Aligned_cols=256 Identities=22% Similarity=0.360 Sum_probs=201.2
Q ss_pred eeEeceeeccCCeeEEEEEECCCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-CCCCc
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFKD 101 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~ 101 (374)
|.+++.||+|+||.||+|.+..++. .+|+|.++...........+.+|+.+++.++||||+++++.+..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999877765 69999887654455566778899999999999999999998754322 22346
Q ss_pred EEEEEccCcc-cHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 102 IYVVFELMES-DLHQVIKA------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~------~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.+++|||+.+ +|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 7999999985 99888742 2347899999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
......... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--------- 228 (272)
T cd05075 161 KIYNGDYYR-QGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR--------- 228 (272)
T ss_pred ccCccccee-cCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---------
Confidence 653322111 1122345678999999877 678999999999999999999 889998765433222221
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.... ....+.++..+.++|.+||+.||++|||+.+++++
T Consensus 229 ------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 229 ------------------QGNR---LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ------------------cCCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1000 01124577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=308.84 Aligned_cols=256 Identities=22% Similarity=0.345 Sum_probs=202.6
Q ss_pred eeEeceeeccCCeeEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-CCCC
Q 017301 25 YKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFK 100 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~ 100 (374)
|++++.||+|+||.||+|.... ++..||+|.++...........+.+|+.+++.++|||++++++.+..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6789999999999999998754 34789999987654445556678899999999999999999998865443 3345
Q ss_pred cEEEEEccCcc-cHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccc
Q 017301 101 DIYVVFELMES-DLHQVIKAN------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
..+++|||+.+ +|..++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 68999999995 998888532 36899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
+......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH------- 230 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 7643322111 1112234667999999876 678999999999999999999 8899977654433322211
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.. ........++.+.+++.+||+.||++|||+.+++.+
T Consensus 231 --------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 231 --------------------GN---RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --------------------CC---CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 011224578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=309.94 Aligned_cols=253 Identities=21% Similarity=0.384 Sum_probs=199.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
.++|++.+.||+|++|.||+|.+. .++..||+|++... ........+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~---- 79 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 468999999999999999999864 24568999988642 22344556889999999999999999999983
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCe
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAND----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~----------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~v 165 (374)
.....++||||+.+ +|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 34568999999985 9999987532 35678889999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 017301 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (374)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 244 (374)
+|+|||+++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 159 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred EECCCCCccccCCcceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999987543322111 1112345778999999877 678999999999999999999 789998766543332221
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
. .. ........++.+.+++.+||+.||++|||+.+++++
T Consensus 236 ~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 E---------------------------GG---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred c---------------------------CC---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 00 001113467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=314.69 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=208.9
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
+....|+..+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++|||++++++++...
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 97 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE---- 97 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC----
Confidence 44456899999999999999999999999999999986432 2334455788999999999999999999998443
Q ss_pred CCcEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...|+||||+.|++.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus 98 -~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 98 -HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred -CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 45899999999988888764 4578999999999999999999999999999999999999999999999999886432
Q ss_pred CCCCcccccccccccccccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.. ....+++.|+|||.+.. ....++.++|+||+||++|+|++|..||.+.+.......+....
T Consensus 177 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--------- 240 (317)
T cd06635 177 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--------- 240 (317)
T ss_pred Cc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcc---------
Confidence 21 23468889999998742 12468889999999999999999999997765433332222100
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.+ .......++.+.+||.+||+.+|.+|||+.++++|+|+..
T Consensus 241 -----------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 241 -----------------SP---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----------------CC---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 00 0011346778999999999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=313.20 Aligned_cols=257 Identities=29% Similarity=0.526 Sum_probs=207.9
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
..|....+||+|++|.||++....++..||+|++... .......+.+|+.+++.++|+|++++++.+.. ..+.
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 92 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDEL 92 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEE
Confidence 4455567899999999999999999999999988532 22345568899999999999999999999843 4568
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|+||||+.+ +|.+++. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 93 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 93 WVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 999999997 7877664 45689999999999999999999999999999999999999999999999998865433221
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+...
T Consensus 172 ---~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~--------------- 231 (292)
T cd06657 172 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------- 231 (292)
T ss_pred ---cccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh---------------
Confidence 1133568899999998876 67889999999999999999999999876654333222110
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.+ ........+++.+.+++.+||+.||.+|||+.++|.||||....
T Consensus 232 ------------~~-~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 232 ------------LP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ------------CC-cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 00 01111245788899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=309.99 Aligned_cols=252 Identities=21% Similarity=0.379 Sum_probs=200.1
Q ss_pred CCeeEeceeeccCCeeEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
++|++.+.||+|++|.||+|.+.. ++..||+|.+... ........+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--- 81 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence 679999999999999999999877 7789999987643 2233345688899999999999999999988443
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC---CeE
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAND-------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLK 166 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~-------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~---~vk 166 (374)
...++||||+.| +|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++ .+|
T Consensus 82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 447999999975 9999997653 488999999999999999999999999999999999998765 599
Q ss_pred EeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHH
Q 017301 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD 245 (374)
Q Consensus 167 l~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~ 245 (374)
|+|||+++........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 160 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eccCccccccCCccce-ecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999765222111 11112234567999999876 679999999999999999997 9999987765433322211
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
. .. ......++..+.+++.+||+.||++|||+.++++|
T Consensus 237 ~---------------------------~~---~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 G---------------------------GR---LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------Cc---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 00 01124578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=302.80 Aligned_cols=251 Identities=29% Similarity=0.515 Sum_probs=207.4
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
.|++.+.||+|++|.||+|.+..++..+++|++..... .....+.+|+.+++.++|+|++++++.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence 48889999999999999999998999999999875332 3456788999999999999999999998443 4589
Q ss_pred EEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 104 VVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
+++||+++ +|.+++... ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 99999995 999998876 5799999999999999999999999999999999999999999999999999876544321
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 211 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---------------- 211 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------------
Confidence 234468889999999877 5688899999999999999999999987654333222211
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~ 315 (374)
...+.......++..+.++|.+||+.||++|||+.++|.|||
T Consensus 212 ------------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 ------------NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------------cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000000011124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=307.82 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=201.2
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++.+.||+|+||.||+|++..+++.||+|.++... ........+.+|+.+++.++|||++++++.+.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 68999999999999999999999999999999886422 233445568899999999999999999998843 346
Q ss_pred EEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 102 IYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
.++|+||+++ +|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 8999999996 88887753 345899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||....... ....
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~------------- 217 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLC------------- 217 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHH-------------
Confidence 33221 1123468889999999877 568899999999999999999999996543210 0000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..+......+ ......+..+.++|.+||+.+|++|||+.++++
T Consensus 218 -----------~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 218 -----------QKIEQCDYPP--LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred -----------HHHhcCCCCC--CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 0111000000 001246778999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=306.67 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=202.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.++|++.+.||+|+||+||+|....+ ...||+|.++... .......+.+|+.+++.++||||+++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK----- 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----
Confidence 46799999999999999999988654 4589999886432 23345568899999999999999999998843
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....++||||+.+ +|.+++... +.+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 3458999999986 999998764 47899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+......
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------ 227 (266)
T cd05033 157 EDSEAT-YTTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL------ 227 (266)
T ss_pred cccccc-eeccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 421111 11112234577999999877 678999999999999999998 99999776544333322211000
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
......++.+.+|+.+||+.+|++|||+.+++++
T Consensus 228 ------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 228 ------------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0113567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=304.50 Aligned_cols=245 Identities=22% Similarity=0.374 Sum_probs=193.4
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEcc
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 108 (374)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++.. ....|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEee
Confidence 46999999999999999999999999876432 23345578899999999999999999999843 3458999999
Q ss_pred Ccc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccc
Q 017301 109 MES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (374)
Q Consensus 109 ~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (374)
+.+ +|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+.......... ..
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-cC
Confidence 986 9999987644 68999999999999999999999999999999999999999999999999986533211100 00
Q ss_pred ccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+.......+..
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------------------- 211 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------------------- 211 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc--------------------
Confidence 11123456999999877 678999999999999999998 8899976544322221111
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.... ......+..+.+|+.+||+.||++|||+.++++
T Consensus 212 -------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 212 -------GVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 112346788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=311.38 Aligned_cols=263 Identities=23% Similarity=0.388 Sum_probs=207.7
Q ss_pred CeeEeceeeccCCeeEEEEEEC---CCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 97 (374)
.|++.+.||.|+||.||.|.+. .+|..||+|++..... .......+.+|+.+++.+ +|+||+++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----- 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-----
Confidence 4889999999999999999875 4789999999864321 223345677899999999 5999999998883
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....+|+||||+.+ +|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 34568999999996 99999988888999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
...... ......|+..|+|||.+.+....++.++||||||+++|+|++|..||...........+.
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~------------ 221 (290)
T cd05613 156 HEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS------------ 221 (290)
T ss_pred cccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHH------------
Confidence 332111 112456889999999987543457889999999999999999999996543221111111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcCc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (374)
..+....+ ...+.+++.+.+++++||+.||++|| ++.+++.||||+...
T Consensus 222 -----------~~~~~~~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 222 -----------RRILKSEP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred -----------HHhhccCC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 11111100 11234788899999999999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=309.20 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=207.6
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
+-|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+. .....
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 77 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKL 77 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeE
Confidence 45788999999999999999999999999999876432 2234457889999999999999999999984 34568
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|+||||+++ +|.+++.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 999999996 88888764 468999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
.......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+.
T Consensus 156 --~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06641 156 --IKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP----------------- 214 (277)
T ss_pred --hhhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-----------------
Confidence 11233468889999999876 677889999999999999999999997655332222110
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
... .......++..+.++|.+||+.+|.+||++.++++||||...
T Consensus 215 ----------~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 215 ----------KNN---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ----------cCC---CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 000 001123467889999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=305.51 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=198.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|+||.||+|..+ ++..+|+|.+.... .....+.+|+.+++.++||||+++++++. ....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 73 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKP 73 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCC
Confidence 367999999999999999999765 45689999876432 22346788999999999999999999984 3355
Q ss_pred EEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.++||||+.+ +|.+++... +.+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||.++.....
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 8999999985 999988753 46899999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||...+..+....+.....
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~---------- 219 (256)
T cd05114 154 EYT--SSSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR---------- 219 (256)
T ss_pred cee--ccCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------
Confidence 111 1122235567999999876 678999999999999999999 8999987765544443322100
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. ......+..+.+++.+||+.||++|||+.++++
T Consensus 220 ---------------~-----~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 220 ---------------L-----YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ---------------C-----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 001235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=344.67 Aligned_cols=264 Identities=32% Similarity=0.466 Sum_probs=201.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-------
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS------- 95 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------- 95 (374)
..|+.++.||+||||.||+|+++-+|+.||||++.-.. ......++.+|+.+|.+++|||||+++..|....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 45688999999999999999999999999999997554 4456678899999999999999999988772110
Q ss_pred ----------------------------------------------c---------------------------------
Q 017301 96 ----------------------------------------------K--------------------------------- 96 (374)
Q Consensus 96 ----------------------------------------------~--------------------------------- 96 (374)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred ---------------------CC-------CCcEEEEEccCcccHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHhhhCC
Q 017301 97 ---------------------RE-------FKDIYVVFELMESDLHQVIKANDDL--TREHHQFFLYQMLRALKYMHTAN 146 (374)
Q Consensus 97 ---------------------~~-------~~~~~lv~e~~~~~L~~~l~~~~~l--~~~~~~~i~~qi~~al~~LH~~~ 146 (374)
.+ ...+||-||||+.++.+.+-..+.+ ....+++++++|++||+|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 00 0248999999998665555555545 47889999999999999999999
Q ss_pred ccccCCCCCceEecCCCCeEEeeeccccccc---C------------CCCcccccccccccccccccccccccC-CCCCc
Q 017301 147 VYHRDLKPKNILANANCKLKVCDFGLARVAF---S------------DTPMTVFWTDYVATRWYRAPELCGSFF-SKYTP 210 (374)
Q Consensus 147 i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~---~------------~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~ 210 (374)
||||||||.||+++.++.|||+|||+|+... . ........+..+||-.|+|||++.+.. ..|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998621 0 011122346679999999999998742 26999
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCcc-ccCCCCChHH
Q 017301 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF-QKFPNVDPLA 289 (374)
Q Consensus 211 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~ 289 (374)
++||||||+||+||+ .||..... ....+ ..++ ....+.. ..+.+--+..
T Consensus 798 KiDmYSLGIVlFEM~---yPF~TsME--Ra~iL------------------------~~LR-~g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEML---YPFGTSME--RASIL------------------------TNLR-KGSIPEPADFFDPEHPEE 847 (1351)
T ss_pred hhhhHHHHHHHHHHh---ccCCchHH--HHHHH------------------------Hhcc-cCCCCCCcccccccchHH
Confidence 999999999999998 45755432 11111 2222 1111111 1122223456
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 290 LRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 290 ~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
..+|++||+.||.+||||.|+|++.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 7899999999999999999999999985
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=314.68 Aligned_cols=252 Identities=21% Similarity=0.357 Sum_probs=200.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
..+|++.+.||+|+||+||+|.+..++. .||+|+++.. ........+.+|+.+++.++||||+++++.+...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 3679999999999999999998766665 4899998643 2234455788999999999999999999998543
Q ss_pred CCCcEEEEEccCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
..++++||+. |+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 2579999988 5999999874 3688999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
........ ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (316)
T cd05108 159 LGADEKEY-HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------- 226 (316)
T ss_pred ccCCCcce-eccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC---------
Confidence 54322211 1122234667999999877 678999999999999999998 9999987654332211110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.... ...+..+..+.+++.+||..||.+|||+.+++.+
T Consensus 227 ----------------~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 227 ----------------GERL-----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ----------------CCCC-----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000 1123567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=327.26 Aligned_cols=244 Identities=30% Similarity=0.445 Sum_probs=201.4
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh-CCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL-LRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~~ 99 (374)
....|++...+|.|+||.|-.+.+..+++..++|++.+.. ....+|+.++.. -+|||++++++++ .+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~ 388 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVY-----EDG 388 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeeccee-----cCC
Confidence 4678899999999999999999999999999999997541 123356655444 4799999999999 566
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe-cCCCCeEEeeeccccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA-NANCKLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~-~~~~~vkl~DFg~a~~~~ 177 (374)
.++|+|||.+.| .+.+-+.....+. ..+..|+.+|+.|+.|||++|++|||+||+|||+ +..++++|+|||+++...
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 779999999997 6666666655455 7888899999999999999999999999999999 688999999999997643
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. ....+-|..|.|||++.. ..|+.++|+||||++||+|++|+.||...... ..+...++.+..
T Consensus 468 ~~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~----- 531 (612)
T KOG0603|consen 468 RS------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF----- 531 (612)
T ss_pred hh------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc-----
Confidence 33 234477889999999986 89999999999999999999999999876654 112221221110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
-..+|..+++||++||++||.+||++.+++.||||
T Consensus 532 ------------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 ------------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------------------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 03689999999999999999999999999999999
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=356.96 Aligned_cols=264 Identities=27% Similarity=0.382 Sum_probs=219.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.-|..-...||.|.||.||.|.+..+|...|+|.++-..........+.+|..+|..++|||+++++++-.+.. .
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----k 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----K 1308 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----H
Confidence 34666788999999999999999999999999988644444455667789999999999999999999986543 3
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
++|.||||.| +|.+.+...+-.++...+.+..|++.|++|||+.|||||||||+||+++.+|.+|++|||.|.....+.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 8999999995 999999988888888899999999999999999999999999999999999999999999998765554
Q ss_pred -CcccccccccccccccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 181 -PMTVFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 181 -~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
..........||+.|||||++.+.. .....++|||||||+..||+||+.||...++.-++---
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~--------------- 1453 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH--------------- 1453 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH---------------
Confidence 3334557789999999999997643 45677999999999999999999999876654332111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
-.....++. ...+|++.+|+|.+||..||++|.++.|+|+|-|-+.-
T Consensus 1454 ---------V~~gh~Pq~-----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1454 ---------VAAGHKPQI-----PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ---------HhccCCCCC-----chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 111112211 13489999999999999999999999999999987643
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=304.79 Aligned_cols=246 Identities=25% Similarity=0.419 Sum_probs=202.4
Q ss_pred ceeeccCCeeEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
+.||+|+||.||+|.+... +..||+|.++...... ....+.+|+..++.++|+|++++++++.. ...+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEE
Confidence 4699999999999998866 8999999997544332 45678899999999999999999999854 4568999
Q ss_pred EccCc-ccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 106 FELME-SDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 106 ~e~~~-~~L~~~l~~~---------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
|||+. ++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99996 5999999875 7899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
...... ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 222 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------- 222 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 544321 111234457888999999877 578999999999999999999 6999988765443333221
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.. .......+++.+.+++.+||+.||++|||+.+++++
T Consensus 223 ------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 ------------------GY---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------------CC---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00 011124568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=305.37 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=199.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|+++++||+|++|.||+|.+. ++..||+|.+... ......+.+|+.+++.++|+||+++++.+. ....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCC
Confidence 468999999999999999999864 5677999987642 223557889999999999999999999884 3455
Q ss_pred EEEEEccCcc-cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.+++|||+.+ +|.+++.. ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||.+.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 8999999985 99999865 34688999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.........+...
T Consensus 156 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----------- 220 (261)
T cd05072 156 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG----------- 220 (261)
T ss_pred Ccee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----------
Confidence 2211 1122345678999999876 678899999999999999998 99999876544333222110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. ......++..+.+++.+||..||++|||++++++
T Consensus 221 ----------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 221 ----------------YR---MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ----------------CC---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 1112457889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=312.49 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=208.1
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...+|+..+.||+|++|.||+|++..++..+|+|.+.... ........+.+|+.+++.++|+|++++++++...
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----- 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----
Confidence 5567999999999999999999999999999999986422 2333445678899999999999999999998543
Q ss_pred CcEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...++||||+.+++.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 45899999999988887754 45689999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccccccccccccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
. ....+++.|+|||.+.+. ...++.++|||||||++|+|++|..||...+.......+..
T Consensus 168 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------ 228 (308)
T cd06634 168 A-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------ 228 (308)
T ss_pred c-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh------------
Confidence 1 234688899999987431 14578899999999999999999999976543322221110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
...+ .......+..+.+||++||+.+|.+|||+.+++.|||+...
T Consensus 229 --------------~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 229 --------------NESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred --------------cCCC---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0000 00113567889999999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=309.91 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=200.2
Q ss_pred CCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
+.|.+.+.||+|+||+||++.+. .++..+|+|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 78 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE---- 78 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 67999999999999999999853 34567999988643 23445578899999999999999999999843
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAND-------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC 163 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~-------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~ 163 (374)
....++||||+.+ +|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 79 -GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred -CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 3568999999985 9999987543 489999999999999999999999999999999999999999
Q ss_pred CeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHH
Q 017301 164 KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDL 242 (374)
Q Consensus 164 ~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 242 (374)
.++|+|||.++........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....
T Consensus 158 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred cEEeccCCccccccCCcee-ecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999998754332211 11123345778999999877 678999999999999999998 8999987665443332
Q ss_pred HHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
+.. ... .......+..+.+|+.+||+.||.+|||+.+++.
T Consensus 235 i~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 235 ITQ---------------------------GRV---LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHc---------------------------CCc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 211 000 0111346788999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=304.22 Aligned_cols=245 Identities=20% Similarity=0.318 Sum_probs=195.9
Q ss_pred ceeeccCCeeEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
++||+|+||.||+|....++ ..+|+|.+...... .....+.+|+.+++.+.|||++++++++.. ...++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence 47999999999999876554 78999998754333 445678899999999999999999997632 347999
Q ss_pred EccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccc
Q 017301 106 FELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (374)
Q Consensus 106 ~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (374)
|||+.+ +|.+++.....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||.++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999985 9999999888899999999999999999999999999999999999999999999999999976533322111
Q ss_pred ccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 017301 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (374)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (374)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~----------------- 214 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG----------------- 214 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----------------
Confidence 1111223457999998876 678999999999999999998 99999776644333222110
Q ss_pred HHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. ......+++.+.++|.+||+.||++|||+.++++
T Consensus 215 ----------~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 215 ----------ER---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----------Cc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0122457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=303.75 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=198.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++.+.||+|++|.||+|.+. +++.||+|.++.... ....+.+|+.+++.++|||++++++++. .....
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPI 76 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCe
Confidence 67999999999999999999865 457899999864322 2456788999999999999999999884 33458
Q ss_pred EEEEccCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
|+||||+. ++|.+++.... .+++..+..++.|++.||.+||++|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999996 59999997654 6899999999999999999999999999999999999999999999999999765422
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.... ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+.......+..
T Consensus 157 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------- 219 (261)
T cd05068 157 IYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ------------- 219 (261)
T ss_pred cccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------------
Confidence 1111 111223457999999877 678999999999999999999 9999987664433332211
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.... ......+..+.+++.+||+.||.+||++.++++
T Consensus 220 --------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 220 --------------GYRM---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --------------CCCC---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0000 112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=305.44 Aligned_cols=253 Identities=27% Similarity=0.391 Sum_probs=201.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.++|++.+.||+|+||.||+|.+..++. .+|+|.++... .......+.+|+.+++.++||||+++++.+. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----K 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence 4689999999999999999998865543 79999886432 2344567889999999999999999999984 3
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....|+||||+++ +|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 3458999999985 999999765 46899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..............++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+.+..+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-------- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC--------
Confidence 332211111112233567999999876 678999999999999999886 999998766544333322110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. .....+++.+.+++.+||+.+|.+|||+.++++
T Consensus 227 -------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 227 -------------------RL---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------------cC---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 00 112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=308.43 Aligned_cols=252 Identities=21% Similarity=0.371 Sum_probs=199.9
Q ss_pred CCeeEeceeeccCCeeEEEEEE----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAID----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
..|++.+.||+|+||+||+|.. ..++..||+|.+... ........+.+|+.+++.++||||+++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ----- 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----
Confidence 5689999999999999999985 345678999998743 223344578889999999999999999999843
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN-----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~-----------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~ 160 (374)
....|+||||+.+ +|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 3458999999985 999988532 2478888999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 017301 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (374)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 239 (374)
.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCccee-cccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999997643322111 1123345677999999876 678999999999999999998 9999987654333
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
...+.. ... ......+++.+.+++.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRK---------------------------RQL---LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 322211 000 01123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=310.27 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=197.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 99 (374)
++|++.+.||+|+||.||+|.+..++. .+++|.++. .........+.+|+.++.++ +||||+++++.+.. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----R 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----C
Confidence 679999999999999999999877765 468887763 22334456788999999999 79999999999843 3
Q ss_pred CcEEEEEccCcc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC
Q 017301 100 KDIYVVFELMES-DLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~ 162 (374)
..+|+||||+.+ +|.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 458999999984 9999997532 47889999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHH
Q 017301 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (374)
Q Consensus 163 ~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~ 241 (374)
+.+||+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999863221111 111223456999999876 678999999999999999997 999998776543332
Q ss_pred HHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.+.. ... ......+++.+.+||.+||+.||.+|||++++++.
T Consensus 230 ~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLPQ---------------------------GYR---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHhc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2211 000 01123578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=312.82 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=196.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcE--EEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
.+.|++.+.||+|+||.||+|.++.++.. +|+|.++.. ........+.+|+.++.++ +||||+++++++. .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~ 79 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----H 79 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----C
Confidence 36899999999999999999998877764 577766532 2234455778899999999 8999999999984 3
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~ 161 (374)
....|+||||+.+ +|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 4568999999985 9999987532 5789999999999999999999999999999999999999
Q ss_pred CCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHH
Q 017301 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (374)
Q Consensus 162 ~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 240 (374)
++.+||+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|+| |..||.+.+..+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred CCcEEeCccccCcccchhhh----cccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 99999999999863211110 111234567999998876 678999999999999999998 99999766543322
Q ss_pred HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..+. .... .......++.+.+||.+||+.+|++|||+.++|++
T Consensus 234 ~~~~---------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 234 EKLP---------------------------QGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHh---------------------------cCCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2110 0000 01112467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=339.70 Aligned_cols=148 Identities=24% Similarity=0.431 Sum_probs=132.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.++|+++++||+|+||+||+|.+..+++.||+|+++... ........+.+|+.+++.++||||+++++++ ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 478999999999999999999999999999999987432 2334456788999999999999999999888 3445
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
++|+||||+.| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 69999999975 999999888889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=303.08 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=197.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.++||+|++|.||+|.+..+ ..||+|++..... ....+.+|+.+++.++||||+++++.+.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC------CC
Confidence 47899999999999999999988655 4699999874322 23467889999999999999999887622 34
Q ss_pred EEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.|+||||+.+ +|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 6999999995 999999763 3588999999999999999999999999999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......++..|+|||...+ ..++.++|+|||||++|+|++ |..||.+.........+..
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~------------ 218 (262)
T cd05071 155 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------ 218 (262)
T ss_pred cccc--cccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc------------
Confidence 2211 1122346678999998876 678999999999999999999 8899987654433322211
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.... .....++..+.+|+.+||+.||++|||+.++++
T Consensus 219 ---------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 219 ---------------GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ---------------CCCC---CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0000 112357888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=303.20 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=197.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|++|+||.|.... +..+|+|.+..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCC
Confidence 4679999999999999999997643 45699998864322 23467889999999999999999999843 345
Q ss_pred EEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.|+||||+.+ +|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||.++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 7999999985 899998764 46899999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05113 154 EYT--SSVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG------------ 217 (256)
T ss_pred cee--ecCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC------------
Confidence 211 1112335667999999876 578999999999999999998 99999776543333222110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
... ......++.+.+++.+||+.||.+|||+.+++.+
T Consensus 218 ---------------~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 218 ---------------LRL---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------------CCC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 000 0112357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.95 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=198.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPP 94 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 94 (374)
..++|++++.||+|+||.||+|.+... +..||+|+++... .......+.+|+.+|+.+. ||||+++++++.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~-- 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACT-- 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--
Confidence 357899999999999999999986433 3479999986432 2344567889999999996 999999999994
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHhC-----------------------------------------------------
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKAN----------------------------------------------------- 120 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~~----------------------------------------------------- 120 (374)
+...+|+|||||.+ +|.+++..+
T Consensus 112 ---~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 112 ---KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred ---cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 34568999999985 998887542
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCce
Q 017301 121 -------------------------------------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (374)
Q Consensus 121 -------------------------------------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Ni 157 (374)
..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2377888899999999999999999999999999999
Q ss_pred EecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 017301 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (374)
Q Consensus 158 l~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 236 (374)
|++.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999999999999999764332211 11123356778999999877 678999999999999999997 8899976543
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
....... +..... ......++..+.+++.+||+.||++|||+.++.+
T Consensus 346 ~~~~~~~--------------------------~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 346 DSTFYNK--------------------------IKSGYR---MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hHHHHHH--------------------------HhcCCC---CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 2211110 001000 0112357888999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=303.98 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=200.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.+.|+..+.||+|++|.||+|.+..++. .+|+|.++... .......+.+|+.+++.++|||++++.+++. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----K 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----c
Confidence 4578999999999999999999876654 79999886432 2344567889999999999999999999984 3
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....|+||||+++ +|.+++... +.+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 3458999999996 999998764 57899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...............+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~------- 228 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR------- 228 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC-------
Confidence 332221111111223457999999876 678999999999999999997 9999977665443333321100
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. ......+..+.+++.+||+.||++||++.++++
T Consensus 229 ------------------~-----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 229 ------------------L-----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------------------C-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 011246788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=308.63 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=202.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCC----------------cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCcc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTG----------------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 85 (374)
.++|++++.||+|+||.||+|.+..++ ..||+|.+..... ......+.+|+++++.++|||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence 368999999999999999999876544 5689999874322 24456788999999999999999
Q ss_pred ccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 017301 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (374)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~-----------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dik 153 (374)
++++++... ...+++||++.+ +|.+++.... .+++..+..++.|++.||+|||+.|++|+|||
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 83 RLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred EEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 999998433 468999999985 9999987765 68999999999999999999999999999999
Q ss_pred CCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh--CCCCC
Q 017301 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLF 231 (374)
Q Consensus 154 p~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt--g~~pf 231 (374)
|+||+++.++.++|+|||.++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 99999999999999999998754332211 11123356778999999876 578999999999999999998 67888
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 017301 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (374)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL 311 (374)
...+..+.+........ ...........+..+..+.+++.+||+.||.+|||+.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 235 EHLTDQQVIENAGHFFR-----------------------DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred CCcChHHHHHHHHhccc-----------------------cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 76654443332221100 0000011112245678999999999999999999999996
Q ss_pred c
Q 017301 312 A 312 (374)
Q Consensus 312 ~ 312 (374)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=303.25 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=197.7
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
.+|++.+.||+|++|.||+|.+. ++..+|+|++..... ....+.+|+.+++.++||||+++++.+. .....
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCce
Confidence 56899999999999999999875 567899998864322 2335778999999999999999999884 33458
Q ss_pred EEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 103 YVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
|+||||+++ +|.+++..+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.++......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 999999985 999998764 468999999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+..
T Consensus 155 ~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------------- 216 (256)
T cd05059 155 YTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-------------- 216 (256)
T ss_pred ccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc--------------
Confidence 111 111223457999999877 678999999999999999999 8999987654433322211
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
... .......++.+.+++.+||+.+|++|||+.++++.
T Consensus 217 -------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 217 -------------GYR---LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -------------CCc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 000 01123478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=305.04 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=201.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
..|++++.||.|++|.||+|.+.. +..+|+|.+... .......+.+|+.+++.++||||+++++.+. .....
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 77 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV 77 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence 468999999999999999999877 889999998643 2233556788999999999999999999884 33458
Q ss_pred EEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 103 YVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
++||||+.+ +|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999986 999999753 46899999999999999999999999999999999999999999999999999754322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+..+....+.....
T Consensus 158 ~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 222 (261)
T cd05148 158 VYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR---------- 222 (261)
T ss_pred ccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc----------
Confidence 111 123345678999999876 678899999999999999998 8999987765444333221000
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.......++.+.+++.+||+.||.+|||+.++++
T Consensus 223 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 223 --------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0112457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=302.08 Aligned_cols=253 Identities=29% Similarity=0.457 Sum_probs=201.6
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++.+.||+|++|.||+|.+..+|+.||+|.++.. .........+.+|+.+++.++|+|++++++.+... ..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 6899999999999999999999999999999988642 22233456788999999999999999999998543 45
Q ss_pred EEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 102 IYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
.++||||+.+ +|.+++.. ...+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 8999999995 99988864 345899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...... ...
T Consensus 157 ~~~~~---~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~--------------- 215 (267)
T cd08224 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYS--------------- 215 (267)
T ss_pred cCCCc---ccceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHH---------------
Confidence 33221 1133468889999999876 67899999999999999999999999654311 000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
...........+. ..+.++..+.++|.+||..+|++|||+.++++
T Consensus 216 ---------~~~~~~~~~~~~~--~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 216 ---------LCKKIEKCDYPPL--PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---------HHhhhhcCCCCCC--ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0011111000000 01256778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=304.45 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=199.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
..+|++.+.||+|+||+||+|.+..++. .||+|+++... .......+.+|+.+++.++||||+++++.+...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---
Confidence 4689999999999999999999777766 48999886432 334455788999999999999999999988532
Q ss_pred CCCcEEEEEccCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
..++++|++. |+|.+++..+ +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 82 ---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 ---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred ---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 3689999998 5999999764 5689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
....... .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (279)
T cd05109 159 LDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK--------- 226 (279)
T ss_pred cccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---------
Confidence 5332211 11122234677999999876 678999999999999999998 8999976554322221111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... ....+..++.+.+++.+||+.||++|||+.+++.
T Consensus 227 ------------------~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 227 ------------------GER---LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ------------------CCc---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 0112457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=302.91 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=197.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|++|.||+|.+. .+..+|+|.+...... ...+.+|+.+++.++|+|++++++.+.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE------EP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC------CC
Confidence 468999999999999999999765 5667999998753322 3457899999999999999999988732 23
Q ss_pred EEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.|++|||+.+ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.+.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 7999999985 999998763 3589999999999999999999999999999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||.+.+..+....+...
T Consensus 155 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05070 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----------- 219 (260)
T ss_pred ccccc--ccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 22111 112235567999998876 678899999999999999999 89999876654433332210
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... ......+..+.+|+.+||..||++|||+.++++
T Consensus 220 ----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 220 ----------------YRM---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ----------------CCC---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 000 112356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.43 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=200.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 95 (374)
.++|++.+.||+|+||.||+|.+...+ ..+|+|.+.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 378999999999999999999876443 689999887532 234455688999999999 79999999999843
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceE
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKA----------------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL 158 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~----------------~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil 158 (374)
...++++|||+.+ +|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 88 ---~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 88 ---EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred ---CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 3458999999985 99999864 246889999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChh
Q 017301 159 ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237 (374)
Q Consensus 159 ~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~ 237 (374)
++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999997643322111 1122234567999999876 678999999999999999997 99999876644
Q ss_pred hHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
+....+.. .. ........+..+.+|+.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKE---------------------------GY---RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHc---------------------------CC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 33322211 00 001123567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=307.81 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=204.4
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 99 (374)
..+.|++.+.||+|++|+||+|.+..+++.||+|.++..... .....+.+|+.++... .||||+++++.+.. .
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~ 86 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----D 86 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec-----C
Confidence 347899999999999999999999999999999998754322 2344566777766666 49999999999843 4
Q ss_pred CcEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...|+||||+++++.+++.. ...+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||.+....
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 46899999999888877765 4578999999999999999999997 599999999999999999999999999987543
Q ss_pred CCCCcccccccccccccccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChh-hHHHHHHHhhCCCCHHH
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLGTPSPET 254 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 254 (374)
.... .....++..|+|||.+.+.. ..++.++|+||||+++|+|++|+.||...... +.+..+
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----------- 231 (296)
T cd06618 167 DSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI----------- 231 (296)
T ss_pred CCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH-----------
Confidence 2221 12235778899999986531 34788999999999999999999999653321 111111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
..... +.......++..+.+||.+||+.||.+|||+.+++.||||....
T Consensus 232 ---------------~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 232 ---------------LQEEP--PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred ---------------hcCCC--CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 00000 00011124678899999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=307.60 Aligned_cols=252 Identities=20% Similarity=0.322 Sum_probs=199.7
Q ss_pred CCeeEeceeeccCCeeEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
.+|++.+.||+|+||.||+|.+..+ +..||+|+++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--- 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--- 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC---
Confidence 4688999999999999999987543 5789999987432 223345678899999999999999999998433
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~ 160 (374)
...++++||+.+ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 81 --~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 81 --QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred --CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 458999999985 898888532 2478888999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 017301 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (374)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 239 (374)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCCceEecccccccccccchhe-eeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999998754332211 11123346778999999876 678999999999999999998 8889987665444
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
...+... .. ......++..+.+|+.+||+.+|.+|||+.++++.
T Consensus 236 ~~~i~~~---------------------------~~---~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 236 IEMIRNR---------------------------QV---LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHcC---------------------------Cc---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 4333211 00 01123578889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=304.69 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=201.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++.+.||+|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++||||+++++.+.. ...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 57999999999999999999999999999999876432 233344578899999999999999999999843 346
Q ss_pred EEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 102 IYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
.+++|||+.+ +|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 8999999996 89888863 346899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+..... ..
T Consensus 157 ~~~~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~--------------- 215 (267)
T cd08229 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YS--------------- 215 (267)
T ss_pred ccCCc---ccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchH-HH---------------
Confidence 33221 1133468899999999876 678899999999999999999999997543210 00
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
...........+ ......++.+.++|.+||+.||.+|||+.++++
T Consensus 216 ---------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 216 ---------LCKKIEQCDYPP--LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ---------HhhhhhcCCCCC--CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 001111100000 011346789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=306.53 Aligned_cols=258 Identities=22% Similarity=0.358 Sum_probs=198.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCC--------------CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHT--------------GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 88 (374)
++|++.+.||+|+||.||+|.+..+ ...||+|.++... .......+.+|+++++.++|||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 6899999999999999999987543 2358999987532 234455788999999999999999999
Q ss_pred eeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q 017301 89 RIMLPPSKREFKDIYVVFELMES-DLHQVIKAND------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPK 155 (374)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~ 155 (374)
+.+.. ....++||||+.+ +|.+++.... .+++..+..++.|++.||+|||++|++|+||||+
T Consensus 84 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 84 GVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred EEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 99843 3458999999996 9999886532 3688889999999999999999999999999999
Q ss_pred ceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh--CCCCCCC
Q 017301 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPG 233 (374)
Q Consensus 156 Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt--g~~pf~~ 233 (374)
||+++.++.+||+|||++......... .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||..
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999998754322111 11122345678999999876 678999999999999999998 6688877
Q ss_pred CChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 234 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.+..+.+..+.... ...... ......+..++.+.+|+.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~--------------------~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFF--------------------RNQGRQ---IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhh--------------------hhcccc---ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66544433322110 000000 001122356789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=304.23 Aligned_cols=252 Identities=21% Similarity=0.361 Sum_probs=200.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
.++|++.+.||+|+||.||+|.++..+ ..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--- 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST--- 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC---
Confidence 468999999999999999999876443 789999986432 23445567899999999999999999999844
Q ss_pred CCCCcEEEEEccCc-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCe
Q 017301 97 REFKDIYVVFELME-SDLHQVIKAND----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (374)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~----------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~v 165 (374)
....|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus 81 --~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 --GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 355899999998 59999986532 36788899999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 017301 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (374)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 244 (374)
||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999998754332211 11123356788999999876 678999999999999999998 999998766443332221
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... ........+..+.++|.+||+.+|++|||+.++++
T Consensus 236 ---------------------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 ---------------------------DGG---HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ---------------------------cCC---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 00112345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=299.14 Aligned_cols=245 Identities=30% Similarity=0.486 Sum_probs=202.8
Q ss_pred eeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccC
Q 017301 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (374)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 109 (374)
||.|++|.||+|.+..+++.+|+|.+..... .......+.+|+.+++.++|||++++++.+ .....+|+|||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6999999999999998999999999865322 223455788999999999999999999988 3445689999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccccc
Q 017301 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (374)
Q Consensus 110 ~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~ 188 (374)
. ++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 6 59999999888899999999999999999999999999999999999999999999999999876543321 1234
Q ss_pred ccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHH
Q 017301 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLT 268 (374)
Q Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (374)
..++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.......+..
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------------- 207 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------------------- 207 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------------
Confidence 568889999999877 5678899999999999999999999977654222222110
Q ss_pred HhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH---HHHhcCCCC
Q 017301 269 EMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEALADPYF 316 (374)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~---~~lL~hp~~ 316 (374)
. ........+..+.++|++||..||++|||+ .++++||||
T Consensus 208 ---~-----~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 ---D-----PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---C-----CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0 011123457889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.63 Aligned_cols=257 Identities=24% Similarity=0.417 Sum_probs=216.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 99 (374)
...|..+.+||+|+||.|.+|..+.+.+.+|||++++..- ...+.+--+.|-++|... +-|.++.++..| +..
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhh
Confidence 4578889999999999999999999999999999976432 112233344577777665 478889998888 445
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+|+||||+.| +|...++.-+++-+..+..++..|+-||-+||++||++||||.+|||++.+|.+||+|||.+.....
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 569999999996 9999999999999999999999999999999999999999999999999999999999999975333
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
...+ ..++||||.|+|||++.- ++|+.++|.||+|++||||+.|.+||.+.+..+....|...-
T Consensus 503 ~~~T---TkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn----------- 566 (683)
T KOG0696|consen 503 DGVT---TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN----------- 566 (683)
T ss_pred CCcc---eeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-----------
Confidence 3222 357899999999999876 899999999999999999999999999999888777765311
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
......+|.++.++.+..|...|.+|.. -.++-.||||+.+
T Consensus 567 --------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 567 --------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred --------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 1122468999999999999999999964 4688899999975
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=309.48 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=198.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 93 (374)
.++|.+++.||+|+||.||+|.+.. +...+|+|.++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 4789999999999999999998643 23479999987532 234455688899999999 79999999999843
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~N 156 (374)
....|+||||+.+ +|.+++.... .+++..+..++.|++.||+|||+.|++||||||+|
T Consensus 96 -----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 96 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 3458999999985 9999997642 47889999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 017301 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (374)
Q Consensus 157 il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 235 (374)
|+++.++.+||+|||.++........ .......+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999998754321111 00111234567999999877 678999999999999999998 889997655
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..+....+. .... .......+..+.+||.+||..+|.+|||+.+++++
T Consensus 248 ~~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLK---------------------------EGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHH---------------------------cCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 433222211 0000 01123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=300.92 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=199.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|++|+||+|.+. .+..||+|.+..... ....+.+|+.+++.++|||++++++++.. ...
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCc
Confidence 478999999999999999999875 557899999874322 23567889999999999999999998843 345
Q ss_pred EEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.++|||++.+ +|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 8999999985 9999997643 689999999999999999999999999999999999999999999999999876433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......++..|+|||.+.+ ..++.++|+||+||++|+|++ |+.||.+.+.......+......
T Consensus 156 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 223 (261)
T cd05034 156 DEYT--AREGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------- 223 (261)
T ss_pred hhhh--hhhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 2111 1112234567999999877 678999999999999999998 99999877654444333211100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
......+..+.+++.+||+.||++|||++++++
T Consensus 224 ----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 ----------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 111345788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=306.13 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=199.6
Q ss_pred CCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
++|.+.+.||+|+||.||+|.+. .++..+++|.+... .......+.+|+.+++.++||||+++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 78 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGD---- 78 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc----
Confidence 57999999999999999999753 34567999987632 23344568899999999999999999999843
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~ 160 (374)
....++||||+.+ +|.+++..++ .+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 79 -GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 3458999999985 9999997542 378999999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 017301 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (374)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 239 (374)
.++.++|+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred cCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999975433221 111233456788999999877 678999999999999999999 9999977665443
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
...+.. ... .......+..+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQ---------------------------GRV---LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhC---------------------------CCC---CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 322211 000 0112346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=301.86 Aligned_cols=252 Identities=28% Similarity=0.476 Sum_probs=200.6
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
||.+.+.||+|++|+||+|.+..++..+++|+++... ........+.+|+.+++.++|||++++++.+... .
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence 6999999999999999999998887777777765321 1223344567899999999999999999988443 4
Q ss_pred cEEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 101 DIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
..++||||+.+ +|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 58999999986 88887753 457899999999999999999999999999999999999975 5699999999876
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ......|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+. ..
T Consensus 155 ~~~~~~---~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~---~~------ 220 (260)
T cd08222 155 LMGSCD---LATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV---EG------ 220 (260)
T ss_pred cCCCcc---cccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---cC------
Confidence 433221 1233467889999998866 678889999999999999999999997655332222111 00
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
........++..+.++|.+||+.||++||++.++++||||
T Consensus 221 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 221 ---------------------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ---------------------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0001123567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=304.95 Aligned_cols=268 Identities=23% Similarity=0.325 Sum_probs=198.7
Q ss_pred CCe-eEeceeeccCCeeEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 23 NRY-KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 23 ~~Y-~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
+|| ++++.||+|+||+||++. ...++..||+|.++... .......+.+|+.+++.++||||+++++.+...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--- 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 566 999999999999998764 34578899999987532 223445678999999999999999999987432
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....+|+||||+.+ +|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 22458999999996 898888764 5999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ...+ ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~---~~~~~~---- 226 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEM---IGPKQG---- 226 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhh---hccccc----
Confidence 332211111122345667999999876 67889999999999999999999998654321 1001 000000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
............. ... .......+..+.+++.+||+.||++|||++++++
T Consensus 227 ~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 227 QMTVVRLIELLER---GMR---LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ccchhhhhhhhhc---CCC---CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000001111110 000 0112457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=301.13 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=200.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.+.|++.+.||+|+||.||+|.++.+++ .||+|.++... .......+.+|+.+++.++||||+++++.+. .
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~ 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----K 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----C
Confidence 3568999999999999999999887665 69999986532 3344567889999999999999999999984 3
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....++||||+++ +|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 3458999999986 899888763 56899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCccccccccc--ccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 177 FSDTPMTVFWTDYV--ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 177 ~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
.............. .+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~------ 228 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY------ 228 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC------
Confidence 33221111111111 2457999999876 678999999999999999886 999998766543333221110
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. .....++..+.+++.+||+.+|.+|||+.+++.
T Consensus 229 ---------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 229 ---------------------RL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ---------------------cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 112356788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=315.36 Aligned_cols=282 Identities=31% Similarity=0.503 Sum_probs=226.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCC------CCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH------PDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~ 95 (374)
.++|.+....|+|=||+|.+|.+...|..||||++... ....+.=++|+.+|++|+. -|+++++..|.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~--- 504 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK--- 504 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh---
Confidence 67999999999999999999999999999999999742 2333445689999999962 37888888884
Q ss_pred cCCCCcEEEEEccCcccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC-CCeEEeeec
Q 017301 96 KREFKDIYVVFELMESDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFG 171 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~-~~vkl~DFg 171 (374)
..+++|||+|.+.-+|.++++.-+ .+....++.++.|++.||..|..+||+|.||||+|||+++. ..+||||||
T Consensus 505 --hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 505 --HKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred --hcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 446799999999999999998754 68899999999999999999999999999999999999876 458999999
Q ss_pred ccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
.|.....+. .+.+..+..|+|||++.| .+|+...|+||.||+||||.||...|+|.++.+++...+.+-|..+
T Consensus 583 SA~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 583 SASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 997654433 355678888999999999 7999999999999999999999999999999999999999999988
Q ss_pred HHHHhhhcCHH--HHHHHH----------------HhcCCCCC-Cccc------cCC----CCChHHHHHHHHhccCCCC
Q 017301 252 PETIAVVRNEK--ARKYLT----------------EMRKKPPV-PLFQ------KFP----NVDPLALRLLQRLIAFDPK 302 (374)
Q Consensus 252 ~~~~~~~~~~~--~~~~~~----------------~~~~~~~~-~~~~------~~~----~~s~~~~~li~~~L~~dp~ 302 (374)
..++....... +...+. -+....|. .+.+ .++ .+-..+++|+.+||..||.
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 88776543211 000000 00000110 0000 011 1223578999999999999
Q ss_pred CCCCHHHHhcCCCCCc
Q 017301 303 DRPTAEEALADPYFKG 318 (374)
Q Consensus 303 ~Rpt~~~lL~hp~~~~ 318 (374)
+|.|..|+|.||||+.
T Consensus 736 KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 736 KRITVNQALKHPFITE 751 (752)
T ss_pred hcCCHHHHhcCCcccC
Confidence 9999999999999974
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=305.45 Aligned_cols=263 Identities=23% Similarity=0.370 Sum_probs=205.0
Q ss_pred CeeEeceeeccCCeeEEEEEEC---CCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 97 (374)
.|++.+.||+|++|.||+|.+. .++..||+|.++.... .......+.+|+.+++.+ +|||++++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~----- 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ----- 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee-----
Confidence 4889999999999999999864 4678999999864321 123345677899999999 5999999998883
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....+|+||||+.+ +|.+++.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 33568999999985 99999988788999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
...... ......|+..|+|||.+.+.....+.++|+||||+++|+|++|..||...........+.
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------------ 221 (288)
T cd05583 156 LAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS------------ 221 (288)
T ss_pred cccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH------------
Confidence 332211 112346888999999986632347889999999999999999999996543211111110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCcCc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGLA 320 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~~lL~hp~~~~~~ 320 (374)
....... ......+++.+.++|.+||+.||++||| +.++|+||||+.+.
T Consensus 222 -----------~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 222 -----------RRILKSK----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred -----------HHHHccC----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 0000000 1112347888999999999999999998 56789999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=303.69 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=199.0
Q ss_pred CCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
.+|++.++||+|+||.||+|... .++..+|+|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--- 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC---
Confidence 57889999999999999999642 35678999987642 334456788999999999999999999988443
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAND---------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~---------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~ 161 (374)
...+++|||+.+ +|.+++...+ .+++..+..++.|++.||+|||+.|++||||||+||+++.
T Consensus 80 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 --RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred --CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 458999999985 9999987643 4788999999999999999999999999999999999999
Q ss_pred CCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHH
Q 017301 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (374)
Q Consensus 162 ~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 240 (374)
++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred CCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 999999999998754322111 11122345678999998877 678999999999999999998 89999776554333
Q ss_pred HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..+... .. ......+++.+.+||.+||+.||.+|||+.+++.
T Consensus 235 ~~~~~~---------------------------~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECITQG---------------------------RE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHcC---------------------------cc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 222110 00 0112357889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=298.45 Aligned_cols=243 Identities=25% Similarity=0.414 Sum_probs=196.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
..+|++.+.||+|++|.||+|.. .|..||+|.++.. .....+.+|+.+++.++|+|++++++++... ...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~ 74 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 74 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCc
Confidence 35799999999999999999965 4788999988642 2345678999999999999999999876432 245
Q ss_pred EEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.|+||||+++ +|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 8999999985 9999997654 478999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.+
T Consensus 155 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05082 155 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 214 (256)
T ss_pred cC------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------
Confidence 21 12234567999999877 678999999999999999997 9999976554332222211
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... ....+.+++.+.+++.+||+.||++|||+.++++
T Consensus 215 ---------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 215 ---------------GYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ---------------CCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 0112457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=298.90 Aligned_cols=244 Identities=21% Similarity=0.325 Sum_probs=191.7
Q ss_pred eeeccCCeeEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEc
Q 017301 30 VIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (374)
Q Consensus 30 ~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e 107 (374)
.||+|+||.||+|... ..+..||+|++.... .......+.+|+.+++.++||||+++++++.. ...++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence 4899999999999765 445679999886432 23444568899999999999999999998732 34799999
Q ss_pred cCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 108 LMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 108 ~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
|+++ +|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++............
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9985 99998875 457899999999999999999999999999999999999999999999999998754332211111
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (374)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------------- 213 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ------------------- 213 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-------------------
Confidence 112233567999998876 678999999999999999996 9999987665433322211
Q ss_pred HHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... ....+..++++.++|.+||..||++||++.++.+
T Consensus 214 --------~~~---~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 214 --------GKR---LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred --------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 0112456889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=305.45 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=199.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 95 (374)
.++|.+.+.||+|+||.||+|.+ ..++..||+|.++... .......+.+|+.+++++ +||||+++++.+...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-
Confidence 35899999999999999999975 3345689999887532 233455788999999999 799999999998443
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecc
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
...|+||||+.+ +|.+++.... .+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||.
T Consensus 112 ----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 ----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 458999999984 9999997643 389999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
+......... .......++..|+|||.+.+ ..++.++||||+||++|+|++ |..||.+...........
T Consensus 188 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~------- 257 (302)
T cd05055 188 ARDIMNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI------- 257 (302)
T ss_pred cccccCCCce-eecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH-------
Confidence 9754332211 11122345778999998877 678999999999999999998 999997655332221110
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..... .......++.+.+++.+||+.+|++|||+.++++
T Consensus 258 -------------------~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 258 -------------------KEGYR---MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -------------------HcCCc---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00000 0112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=304.30 Aligned_cols=270 Identities=23% Similarity=0.374 Sum_probs=202.5
Q ss_pred CCeeEeceeeccCCeeEEEEEE----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAID----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.-|++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.++|||++++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--- 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---
Confidence 3578999999999999999973 4678899999986432 2344557889999999999999999999885432
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....++||||+.| +|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 2458999999985 9999987653 6899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..............++..|+|||.+.+ ..++.++|||||||++|+|++++.|+..... ...+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~-- 230 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQM-- 230 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccc--
Confidence 433221111223456778999999876 6789999999999999999998876543211 1111111111100
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
........+..... ......++..+.+|+.+||+.||++|||+.+++++
T Consensus 231 -----~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 231 -----TVTRLVRVLEEGKR---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred -----cHHHHHHHHHcCcc---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 01111111111111 11234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=298.65 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=196.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|.+.+.||+|++|.||+|.+..+ ..+|+|.+.... .....+.+|+.+++.++|||++++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CC
Confidence 37899999999999999999987655 469999876432 223467789999999999999999888732 34
Q ss_pred EEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.|+||||+.+ +|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 6999999985 9999997643 478999999999999999999999999999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......++..|+|||...+ ..++.++|+|||||++|+|++ |..||.+....+....+...
T Consensus 155 ~~~~--~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05069 155 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG----------- 219 (260)
T ss_pred Cccc--ccCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 2211 1122345677999998876 678999999999999999999 89999876654333322110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. .......+..+.+++++||..||.+|||++++++
T Consensus 220 ----------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 220 ----------------YR---MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ----------------CC---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 0112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=298.17 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=197.0
Q ss_pred ceeeccCCeeEEEEEECC-CCc--EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTH-TGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
+.||+|++|+||+|.+.. .++ .||+|.+...... .....+.+|+.++++++||||+++++.+.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence 468999999999999765 333 6999998754333 456678899999999999999999999844 458999
Q ss_pred EccCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 106 FELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 106 ~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
|||+. ++|.+.+.... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++.........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99997 49999998764 6899999999999999999999999999999999999999999999999999765432221
Q ss_pred ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------------- 215 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK---------------- 215 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----------------
Confidence 111123456778999999877 678999999999999999998 9999987665443333221
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.... .......+..+.+++.+||+.+|++|||+.++++
T Consensus 216 --------~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 216 --------EGER-----LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred --------cCCc-----CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0000 0111346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=299.46 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=198.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.+.|+++++||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++.++|+|++++++++.. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CC
Confidence 468999999999999999999864 567899999874332 23567889999999999999999988622 34
Q ss_pred EEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.|++||++.+ +|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 7999999985 999988653 3689999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |+.||.+.+..+....+....
T Consensus 155 ~~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 220 (260)
T cd05067 155 NEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY---------- 220 (260)
T ss_pred CCcc--cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC----------
Confidence 2111 1122345678999999876 678899999999999999999 999998776544333221110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. ......+..+.++|.+||+.+|++|||++++++
T Consensus 221 -----------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 221 -----------------RM---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------------CC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 112346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.31 Aligned_cols=243 Identities=26% Similarity=0.432 Sum_probs=198.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.+.|++.+.||.|++|.||+|.. .|+.||+|.+..... ....+.+|+.+++.++|+|++++++.+.. ...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCC
Confidence 46889999999999999999976 488999999875422 45678899999999999999999999854 345
Q ss_pred EEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.|+||||+++ +|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 8999999995 9999998765 689999999999999999999999999999999999999999999999999976522
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+.
T Consensus 155 ~~------~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------------- 213 (256)
T cd05039 155 GQ------DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE------------- 213 (256)
T ss_pred cc------ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------------
Confidence 21 12234567999998876 678889999999999999997 999997665433222111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.... .......++.+.++|.+||..+|++|||+.+++.
T Consensus 214 --------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 214 --------------KGYR---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --------------cCCC---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 0112356889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=301.56 Aligned_cols=270 Identities=22% Similarity=0.387 Sum_probs=200.4
Q ss_pred CCCeeEeceeeccCCeeEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
..+|++++.||+|+||+||+|. +..++..||+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-- 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC--
Confidence 3589999999999999999997 4567889999998643 3344567889999999999999999999875432
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...+++||||+.+ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 79 -~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 79 -RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred -CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 2458999999985 999999764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...............++..|+|||.+.+ ..++.++|+|||||++|+|++|..++...... .. ...+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~----~~~~~~~~~-- 228 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FM----RMMGNDKQG-- 228 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hh----hhccccccc--
Confidence 5332221111112233456999999876 67899999999999999999998776443211 11 111110000
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..........+..... ......++..+.+||.+||+.+|++|||+.+++.
T Consensus 229 ----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 229 ----QMIVYHLIELLKNNGR---LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ----ccchHHHHHHHhcCCc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0000111111111111 1123467889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=301.95 Aligned_cols=248 Identities=28% Similarity=0.444 Sum_probs=195.1
Q ss_pred eEeceeeccCCeeEEEEEEC----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 26 KILEVIGKGSYGVVCAAIDT----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++.+.||.|+||.||+|... ..+..|+||.++. .........+.+|++.+++++||||+++++++... ..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc-----cc
Confidence 57889999999999999987 4567899999964 33444577899999999999999999999999633 33
Q ss_pred EEEEEccCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.++|+||+. |+|.+++... ..+++.....++.||+.||.|||+++++|++|+|+||+++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999998 5999999987 6899999999999999999999999999999999999999999999999999976522
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... .......+...|+|||.+.+ ..++.++||||||+++|||++ |..||.+.+..+....+....
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~---------- 222 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ---------- 222 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE----------
T ss_pred cccc-cccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 2211 12233456778999999877 568999999999999999999 789998776554443332110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. ......++..+.++|..||..||.+|||+.++++
T Consensus 223 -----------------~---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 -----------------R---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -----------------E---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -----------------c---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 0112357889999999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.55 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=198.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 93 (374)
.++|++++.||+|+||.||+|.+. ..+..+|+|.++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 379999999999999999999763 234579999887432 234455788999999999 59999999999843
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~N 156 (374)
...+|+||||+.+ +|.+++... ..+++..+..++.|++.||.|||++|++||||||+|
T Consensus 90 -----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 90 -----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 3458999999985 999999653 347889999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 017301 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (374)
Q Consensus 157 il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 235 (374)
|+++.++.+||+|||.++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999997543221111 0111234467999999877 678999999999999999999 889997765
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..+....+.. ... ......++..+.+|+.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLRE---------------------------GHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 4433332211 000 0112456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=303.74 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=196.1
Q ss_pred CeeEeceeeccCCeeEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+. .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----Q 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----c
Confidence 48899999999999999998753 23578888876432 2334567889999999999999999999884 3
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN------------------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dik 153 (374)
....++++||+.+ +|.+++... ..+++..+..++.|++.||+|||++|++|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 3458999999995 999887642 247888999999999999999999999999999
Q ss_pred CCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 017301 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (374)
Q Consensus 154 p~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~ 232 (374)
|+||+++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++++|++ |..||.
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999998754322211 11122345678999998876 678999999999999999998 999998
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
+.........+... .. ......++..+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 232 GIAPERLFNLLKTG---------------------------YR---MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCHHHHHHHHhCC---------------------------CC---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 76543322221110 00 0112356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=301.41 Aligned_cols=266 Identities=16% Similarity=0.190 Sum_probs=195.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCC---CcEEEEEEecCccCChHHH---------HHHHHHHHHHHhCCCCCccccc
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDA---------IRILREVKLLRLLRHPDIVEIK 88 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~---------~~~~~E~~~l~~l~h~~i~~~~ 88 (374)
..++|++.+.||+|+||+||+|.+..+ +..+|+|+........... .....++..+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 347999999999999999999998777 6678888643221111111 1122344455667899999999
Q ss_pred eeecCCCcCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEe
Q 017301 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (374)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~ 168 (374)
+....... .....+++++++..++.+.+......++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+
T Consensus 90 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRC-RMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecC-CceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 87643321 12245789998888888888776667889999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCcc----cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 017301 169 DFGLARVAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (374)
Q Consensus 169 DFg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 244 (374)
|||+|+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...........
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999997653222110 11123469999999999887 679999999999999999999999998774322111110
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
+ ..+...+.... ...+..++.+.++++.|++.+|++||++.++++
T Consensus 247 ~------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 K------------------CDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred H------------------HHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 01111111111 012456788999999999999999999999874
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.05 Aligned_cols=253 Identities=24% Similarity=0.395 Sum_probs=199.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 93 (374)
.++|++.+.||+|+||.||+|... ..+..||+|.+.... .......+.+|+.+++.+ +||||+++++.+..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 578999999999999999999753 234579999886432 234456788999999999 79999999999843
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~N 156 (374)
....|+||||+.+ +|.+++... ..++...+..++.||+.||.|||++|++||||||+|
T Consensus 93 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 93 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 3468999999985 999998753 246788899999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 017301 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (374)
Q Consensus 157 il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 235 (374)
|+++.++.+||+|||.++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999765332211 11122345678999999877 678999999999999999998 788997765
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..+....+.. ... ......++..+.+||.+||+.+|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKE---------------------------GHR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 4433332211 000 01123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=300.21 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=196.0
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
++|++++.||+|+||+||+|....++. .+++|.+... ........+..|+..++.++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~----- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG----- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----
Confidence 678999999999999999999877776 4677776432 122334567788889999999999999998732
Q ss_pred CCcEEEEEccCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
...++++||+. |+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.++..
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 23688999998 5999999764 57899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+.+
T Consensus 160 ~~~~~-~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---------- 226 (279)
T cd05111 160 YPDDK-KYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK---------- 226 (279)
T ss_pred cCCCc-ccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----------
Confidence 33221 111233456778999999876 678999999999999999998 9999987654322221110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
....+ .....+..+.+++.+||..||.+|||+.++++
T Consensus 227 -----------------~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 227 -----------------GERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00000 11234667899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.10 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=196.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 95 (374)
.++|++++.||+|+||+||+|.+ ..+++.||+|+++.... ......+.+|+.++..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 36899999999999999999984 35678999999874322 23445688999999999 689999999987432
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhC------------------------------------------------------
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKAN------------------------------------------------------ 120 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~------------------------------------------------------ 120 (374)
...+++||||+.+ +|.+++...
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 84 ---GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ---CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 2458999999995 999888642
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccccc
Q 017301 121 -------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187 (374)
Q Consensus 121 -------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~ 187 (374)
..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcC
Confidence 13677788899999999999999999999999999999999999999999998754322111 1111
Q ss_pred cccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 017301 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (374)
Q Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (374)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+..........
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----------------------- 294 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----------------------- 294 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-----------------------
Confidence 2345677999999876 678999999999999999997 89999765432111110
Q ss_pred HHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
+...... ......++.+.+++..||+.||.+|||+.++++|
T Consensus 295 ---~~~~~~~---~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 295 ---LKEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ---HhccCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000000 0112357789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=302.16 Aligned_cols=258 Identities=22% Similarity=0.369 Sum_probs=196.6
Q ss_pred CCeeEeceeeccCCeeEEEEEECC----------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTH----------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 86 (374)
++|++.+.||+|+||+||+|.+.. ++..||+|++.... .......+.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 679999999999999999986432 34579999986432 2334557889999999999999999
Q ss_pred cceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q 017301 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (374)
Q Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~-----------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp 154 (374)
+++.+... ...|+||||+.+ +|.+++.... .+++..+..++.|++.||+|||+.|++|+||||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 84 LLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred EEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 99998443 448999999985 9999987643 366788999999999999999999999999999
Q ss_pred CceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh--CCCCCC
Q 017301 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFP 232 (374)
Q Consensus 155 ~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt--g~~pf~ 232 (374)
+||+++.++.++|+|||+++......... ......++..|+|||...+ ..++.++|+|||||++|+|++ |..||.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999987543322111 1112234677999998766 678999999999999999998 678887
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..+..+....... +....... ......+.+++.+.+|+.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~--------------------~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 236 QLSDEQVIENTGE--------------------FFRDQGRQ---VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccChHHHHHHHHH--------------------HHhhcccc---ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6654333221110 11100000 011112356788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=295.39 Aligned_cols=248 Identities=29% Similarity=0.471 Sum_probs=201.1
Q ss_pred eeEeceeeccCCeeEEEEEECCCC----cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+++.+.||.|+||.||+|.+..++ ..||+|.+..... ......+..|+.+++.++|+|++++++.+... .
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----E 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----C
Confidence 467889999999999999998766 8999999864322 22556788999999999999999999998543 4
Q ss_pred cEEEEEccCcc-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 101 DIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
..|++||++.+ +|.+++..... +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 58999999986 99999987554 9999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
....... ....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+.......+..
T Consensus 155 ~~~~~~~--~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~----------- 219 (258)
T smart00219 155 DDDYYKK--KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK----------- 219 (258)
T ss_pred ccccccc--ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 3321111 12236788999998865 678999999999999999998 8899987655443333221
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... .......+..+.+++.+||+.||++|||+.++++
T Consensus 220 ----------------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 220 ----------------GYR---LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ----------------CCC---CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 000 0112347889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=296.70 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=199.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
..+|++.+.||+|+||.||+|.+... ...||+|...... .......+.+|+.+++.++|||++++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----
Confidence 35699999999999999999987544 3579999876432 23445678899999999999999999998743
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
...|+||||+.+ +|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 236899999985 9999998744 5899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~---------- 223 (270)
T cd05056 158 EDESYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN---------- 223 (270)
T ss_pred ccccce--ecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc----------
Confidence 332111 1122234567999998876 678899999999999999986 9999987765443322211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
... ....+.+++.+.++|.+||..+|++|||+.+++..
T Consensus 224 -----------------~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 224 -----------------GER---LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred -----------------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 01234678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=306.66 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=198.6
Q ss_pred CCeeEeceeeccCCeeEEEEEECCC-------CcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHT-------GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 94 (374)
.+|++++.||+|+||.||+|.+... +..||+|.++.. ........+.+|+.+++++ +||||+++++.+..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 4799999999999999999986432 236899987643 2234456788999999999 79999999999843
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCce
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Ni 157 (374)
...++++|||+.+ +|.+++.... .++...+..++.|++.||.|||++|++||||||+||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 90 ----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 3458999999985 9999987532 477888899999999999999999999999999999
Q ss_pred EecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 017301 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (374)
Q Consensus 158 l~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 236 (374)
+++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYK-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceecccccccc-cccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999997543321111 1122234567999999877 678999999999999999998 8899987664
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.+....+.. ... .......+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 243 ~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKE---------------------------GHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHc---------------------------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 433322211 000 01123567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=301.00 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=198.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
.++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++|||++++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV--- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC---
Confidence 367999999999999999999874 367899999987432 23344568889999999999999999998843
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAND----------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~----------------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dik 153 (374)
....|+||||+.+ +|.+++.... .+++..+..++.|++.||.|||++|++|||||
T Consensus 80 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 80 --GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred --CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 3458999999995 9999986432 46788899999999999999999999999999
Q ss_pred CCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 017301 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (374)
Q Consensus 154 p~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~ 232 (374)
|+||+++.++.++|+|||.+.......... .......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999987543322111 0122234667999998876 678999999999999999997 888987
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
+.+..+....+.. ... .......+..+.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 GMAHEEVIYYVRD---------------------------GNV---LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCHHHHHHHHhc---------------------------CCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6654433222111 000 0112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=298.13 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=200.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
.++|++++.||+|+||+||+|.++.+|. .+|+|...... .......+.+|+.+++.++|||++++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 4789999999999999999999876665 68999876432 23445678899999999999999999999854
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...++||||+.+ +|.+++..+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||.++.
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 357999999985 999998774 4689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
........ ......++..|+|||.+.. ..++.++|+|||||++|++++ |..||.+....+....+..
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 226 (279)
T cd05057 159 LDVDEKEY-HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK--------- 226 (279)
T ss_pred ccCcccce-ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC---------
Confidence 54322111 1112224567999998866 678899999999999999998 9999987664433322211
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... .......+..+.+++.+||..||..|||+.++++
T Consensus 227 ------------------~~~---~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 227 ------------------GER---LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 0112346778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=313.81 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=223.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
...+++..||-|+||.|=++.-......+|+|++++.. -.....+.+..|-++|..++.|.||++|..| .+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence 35677889999999999999776665569999887532 2334556788999999999999999999999 66678
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|++||-|-| .++..+..++.|.+..++.++..+++|++|||++||++|||||+|++++.+|-+||.|||+|+......
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999998875 999999999999999999999999999999999999999999999999999999999999999877665
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
.+ -++||||.|.|||++.+ ...+.++|.||||+++|||++|.+||++.++....+.|.+.+..-
T Consensus 575 KT----wTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---------- 638 (732)
T KOG0614|consen 575 KT----WTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---------- 638 (732)
T ss_pred ce----eeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------
Confidence 43 46799999999999988 788999999999999999999999999999988888876643211
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
.....++..+.+||+++...+|.+|.. +.+|-.|.||.+.
T Consensus 639 -------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 639 -------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred -------------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 112357888999999999999999985 8999999999874
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=293.58 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=198.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
..+|++.+.||+|++|.||+|.+. .+..+|+|.+...... ...+.+|+++++.++|||++++++.+.. ...
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTE-----RSP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEcc-----CCc
Confidence 468999999999999999999875 4678999988643222 3457789999999999999999999843 345
Q ss_pred EEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.++||||+.+ +|.+++... +.+++..+..++.|++.|+++||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 8999999986 899888764 46899999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...........+..
T Consensus 154 ~~~~--~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 216 (256)
T cd05112 154 QYTS--STGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA------------- 216 (256)
T ss_pred cccc--cCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-------------
Confidence 1111 122335568999999876 678899999999999999998 9999987664433332211
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
... . ......+..+.+|+.+||+.+|++|||+.+++++
T Consensus 217 --------------~~~-~--~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 217 --------------GFR-L--YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred --------------CCC-C--CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 000 0 0012357889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=293.54 Aligned_cols=244 Identities=26% Similarity=0.406 Sum_probs=193.7
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEcc
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 108 (374)
++||.|++|.||+|.+.. ++.||+|.+...... .....+.+|+++++.++||||+++++.+.. ....++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEc
Confidence 479999999999999877 999999988754332 345678899999999999999999998843 3458999999
Q ss_pred Ccc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccc
Q 017301 109 MES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (374)
Q Consensus 109 ~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (374)
+.+ +|.+++.. ...+++..+..++.+++.||+|||++|++||||+|+||+++.++.++|+|||.+.......... ..
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-SD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-cc
Confidence 985 89999865 3468999999999999999999999999999999999999999999999999987543211110 00
Q ss_pred ccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.........+....
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~------------------ 212 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY------------------ 212 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC------------------
Confidence 11233566999999876 678999999999999999999 889997765433222211100
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. .......+..+.+++.+||+.+|.+|||+.++++
T Consensus 213 ---------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 213 ---------R---MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ---------C---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 0111346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=311.88 Aligned_cols=238 Identities=25% Similarity=0.361 Sum_probs=196.7
Q ss_pred eEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEE
Q 017301 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
.-++-||+|+.|-||+|+- .++.||||+++. .-..+|..|++|+||||+.+.++|.. ..++|||
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtq-----sPcyCIi 190 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQ-----SPCYCII 190 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecC-----CceeEEe
Confidence 3467899999999999954 588999998752 12258889999999999999999944 4458999
Q ss_pred EccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccc
Q 017301 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (374)
Q Consensus 106 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (374)
||||. |.|.++++....+.......+..+|+.|+.|||.++|||||||.-||||+.+..|||+|||-++.....+.
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--- 267 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--- 267 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhh---
Confidence 99999 69999999999999999999999999999999999999999999999999999999999998875433211
Q ss_pred ccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 017301 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (374)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (374)
.-.++||..|||||++.+ .+.+.++|||||||+||||+||..||.+-+...++ -..|....
T Consensus 268 -kMSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wGVGsNsL------------ 328 (904)
T KOG4721|consen 268 -KMSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WGVGSNSL------------ 328 (904)
T ss_pred -hhhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccchheeE----EeccCCcc------------
Confidence 235789999999999988 89999999999999999999999999765532221 11111110
Q ss_pred HHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 017301 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp 314 (374)
.. .....+++.++-||++||+-.|..||++.++|.|-
T Consensus 329 --------~L-----pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 329 --------HL-----PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred --------cc-----cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 00 11235677888999999999999999999999993
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=293.72 Aligned_cols=228 Identities=26% Similarity=0.367 Sum_probs=184.7
Q ss_pred cCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccCcc-c
Q 017301 34 GSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-D 112 (374)
Q Consensus 34 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 112 (374)
|.+|.||+|+++.+++.||+|.+.... ...+|...+....|||++++++.+. .....|+||||+.+ +
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCC
Confidence 889999999999999999999986431 1223444455567999999999884 34568999999996 9
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccccccccc
Q 017301 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192 (374)
Q Consensus 113 L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt 192 (374)
|.+++.....+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++|||.+....... ....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcC
Confidence 99999887789999999999999999999999999999999999999999999999999876443221 233567
Q ss_pred ccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcC
Q 017301 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK 272 (374)
Q Consensus 193 ~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (374)
..|+|||.+.+ ..++.++|+||+||++|+|++|..||...... + ..
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~---------------------------~~ 191 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I---------------------------NT 191 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c---------------------------cc
Confidence 78999999876 67889999999999999999999887543210 0 00
Q ss_pred CCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH-----HHHhcCCCC
Q 017301 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYF 316 (374)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~~lL~hp~~ 316 (374)
.. .....+.+++.+.++|.+||+.||++|||+ +++++||||
T Consensus 192 ~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 HT---TLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cc---ccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00 001123578899999999999999999996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=321.38 Aligned_cols=278 Identities=20% Similarity=0.252 Sum_probs=183.4
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCC----CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHT----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS- 95 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 95 (374)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+..... .+....+ .++...+.++..+...+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 457899999999999999999999988 99999998763211 1111111 122222333333333332211
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDD--------------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~--------------------l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp 154 (374)
......+++|+||+++ +|.+++..... ..+..+..++.||+.||+|||+.||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 1345678999999995 89988875421 12344678999999999999999999999999
Q ss_pred CceEecC-CCCeEEeeecccccccCCCCcccccccccccccccccccccccC--------------------CCCCccch
Q 017301 155 KNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 213 (374)
Q Consensus 155 ~Nil~~~-~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------~~~~~~~D 213 (374)
+|||++. ++.+||+|||+|+....... ......++|+.|+|||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 57899999999975432221 1224567899999999653211 12345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCC---ccccCCCCChHHH
Q 017301 214 IWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP---LFQKFPNVDPLAL 290 (374)
Q Consensus 214 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~~~ 290 (374)
|||+||+||+|+++..++ .+....+..+....+.....+... ........ ........+..++
T Consensus 362 VwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKL------------VEPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred cHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHh------------hccccchhhhhhhhhccccchHHH
Confidence 999999999999866443 333333333332222221111110 00000000 0111122345678
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 291 RLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 291 ~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
+||.+||+.||.+|||+.++|+||||++..
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence 999999999999999999999999998754
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=292.94 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=197.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+... ......+.+|+.+++.++|+|++++++.+.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 74 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CC
Confidence 578999999999999999999754 5567999987642 2234568889999999999999999998843 34
Q ss_pred EEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.|++|||+.+ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 7999999985 999999763 3578889999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......++..|+|||++.+ ..++.++|+|||||++|++++ |..||.+.+..+....+..
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~------------ 218 (260)
T cd05073 155 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER------------ 218 (260)
T ss_pred CCcc--cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC------------
Confidence 2111 1122345677999999876 678999999999999999998 9999987665433322211
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. ........+..+.+++.+||+.||++|||+.++++
T Consensus 219 ---------------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 219 ---------------GY---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ---------------CC---CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00 00112457889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=296.90 Aligned_cols=254 Identities=20% Similarity=0.327 Sum_probs=201.4
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECC----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTH----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+++.++|||++++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 35789999999999999999999875 3578999988643 3445566788999999999999999999987543
Q ss_pred CCCCcEEEEEccCc-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEE
Q 017301 97 REFKDIYVVFELME-SDLHQVIKAN--------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (374)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~--------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl 167 (374)
....+++++|+. ++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||
T Consensus 81 --~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 --GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred --CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 234799999998 5999998653 35889999999999999999999999999999999999999999999
Q ss_pred eeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHh
Q 017301 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDL 246 (374)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 246 (374)
+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|++++ |+.||...+..+....+..
T Consensus 159 ~d~g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~- 234 (280)
T cd05043 159 TDNALSRDLFPMDYH-CLGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD- 234 (280)
T ss_pred CCCCCcccccCCceE-EeCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-
Confidence 999999754332211 11122345667999999876 678999999999999999999 9999987654332221110
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.... .....+++.+.+++.+||+.||++|||+.++++
T Consensus 235 --------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 --------------------------GYRL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------------------------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 112346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=295.64 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=199.6
Q ss_pred CCeeEeceeeccCCeeEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
++|++++.||+|+||.||+|+.+. ..+.|++|.+... ........+.+|+.+++.++|||++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCR----- 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----
Confidence 679999999999999999999654 3467999987642 22224557889999999999999999999883
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEE
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAND---------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~---------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl 167 (374)
+....|+||||+.+ +|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 33458999999984 9999998765 6899999999999999999999999999999999999999999999
Q ss_pred eeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHh
Q 017301 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDL 246 (374)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 246 (374)
+|||++....... ........++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+..
T Consensus 159 ~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~- 233 (275)
T cd05046 159 SLLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA- 233 (275)
T ss_pred cccccccccCccc--ccccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc-
Confidence 9999986432221 111233456778999998876 567889999999999999998 7889976544322221110
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.... ......++..+.+++.+||+.||.+|||+.+++++
T Consensus 234 -------------------------~~~~---~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 234 -------------------------GKLE---LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------------------CCcC---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0000 01123577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=311.28 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=198.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 95 (374)
.++|.+++.||+|+||.||+|++. .++..||+|+++.... ......+.+|+.+|..+. ||||+++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~- 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG- 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence 367899999999999999999853 3556899999975422 233456889999999997 99999999998443
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCC-----------------------------------------------------
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKAND----------------------------------------------------- 121 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~----------------------------------------------------- 121 (374)
..+++||||+.+ +|.+++..++
T Consensus 114 ----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 114 ----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred ----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 458999999995 9999986432
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 017301 122 ---------------------------------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (374)
Q Consensus 122 ---------------------------------------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~N 156 (374)
.+++..+..++.||+.||+|||+.||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 25667788899999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 017301 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (374)
Q Consensus 157 il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 235 (374)
||++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999997543222111 1122356788999999877 678999999999999999998 889997654
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..+....... .... ......++..+.+|+.+||..+|.+||++++++..
T Consensus 347 ~~~~~~~~~~--------------------------~~~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 347 MNEQFYNAIK--------------------------RGYR---MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred chHHHHHHHH--------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3322211110 0000 01123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=290.27 Aligned_cols=243 Identities=24% Similarity=0.411 Sum_probs=192.4
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEcc
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 108 (374)
+.||+|+||.||+|... ++..+|+|.++.... ......+.+|+.+++.++||||+++++.+.. ....++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEEC
Confidence 46899999999999854 688999999875432 2334468899999999999999999999843 3458999999
Q ss_pred Ccc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccc
Q 017301 109 MES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (374)
Q Consensus 109 ~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (374)
+.+ +|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 985 999988753 467999999999999999999999999999999999999999999999999986532221110 0
Q ss_pred ccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 017301 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (374)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (374)
....++..|+|||++.+ ..++.++||||||+++|++++ |..||.+.........+..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-------------------- 209 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-------------------- 209 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc--------------------
Confidence 11234567999999876 678899999999999999998 9999987654332222111
Q ss_pred HHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... ......++..+.+++.+||+.+|++|||+.++++
T Consensus 210 -------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 210 -------GYR---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -------CCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 000 0112457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=296.15 Aligned_cols=242 Identities=25% Similarity=0.369 Sum_probs=189.9
Q ss_pred ceeeccCCeeEEEEEECCCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCcEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
+.||+|+||.||+|.+..++. .+++|.++.. ........+.+|+.++..+ +||||+++++.+.. ....|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEE
Confidence 368999999999999887775 4688877632 2234455788999999999 79999999999843 3458999
Q ss_pred EccCcc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEe
Q 017301 106 FELMES-DLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (374)
Q Consensus 106 ~e~~~~-~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~ 168 (374)
|||+.+ +|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 999984 9999987542 47889999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhh
Q 017301 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 247 (374)
|||++....... .......+..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus 155 dfgl~~~~~~~~----~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--- 225 (270)
T cd05047 155 DFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 225 (270)
T ss_pred CCCCccccchhh----hccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh---
Confidence 999985321111 0111234567999999876 678999999999999999997 999997765433222211
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.... .......+..+.+|+.+||+.||.+|||+.++++
T Consensus 226 ------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 226 ------------------------QGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------------------CCCC---CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 1000 0112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=293.30 Aligned_cols=240 Identities=26% Similarity=0.434 Sum_probs=194.7
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++.+.||+|+||.||++. .+++.||+|.++.. .....+.+|+.+++.++|||++++++.+... ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------Cc
Confidence 579999999999999999984 57889999998643 2335678899999999999999999988432 26
Q ss_pred EEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 103 YVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
++||||+.+ +|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 999999985 9999997643 5789999999999999999999999999999999999999999999999998753221
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |++||...+..+....+.+
T Consensus 154 ~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 212 (254)
T cd05083 154 V------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK------------- 212 (254)
T ss_pred C------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------------
Confidence 1 12234567999998876 678899999999999999997 9999987654332222111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... ......+++.+.+++.+||+.+|.+|||+++++.
T Consensus 213 --------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 213 --------------GYR---MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --------------CCC---CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 0112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=289.75 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=208.2
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHH-HhCCCCCccccceeecCCCcCCCCcE
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
..+-+..||.|+||+|++..++.+|+..|||.++.... ..+..+++.|.... +.-++||||+++++.+..+ ..
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-----dc 138 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-----DC 138 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-----ce
Confidence 44557789999999999999999999999999975433 45666788888864 4557999999999996543 47
Q ss_pred EEEEccCcccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 103 YVVFELMESDLHQVIK-----ANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
|+.||+|.-++..+.+ ....++|..+-.|....+.||.||... +|+||||||+|||++..|.|||||||.+...
T Consensus 139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 9999999977655543 345799999999999999999999876 8999999999999999999999999999765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh-CCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL-GTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~ 255 (374)
..+.. .+...|...|||||.+......|+.+||+||||++|||+.||..|+.+.+. .++++..+. |-|+ ..
T Consensus 219 v~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp-~l- 290 (361)
T KOG1006|consen 219 VDSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPP-IL- 290 (361)
T ss_pred HHHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCC-ee-
Confidence 44322 234478999999999876545699999999999999999999999987654 222222211 1111 00
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.....--.++..++.+|.-||..|-..||...+++.+||++....
T Consensus 291 ---------------------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 291 ---------------------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred ---------------------cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 001111247889999999999999999999999999999986543
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=295.39 Aligned_cols=256 Identities=22% Similarity=0.354 Sum_probs=199.3
Q ss_pred eeEeceeeccCCeeEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC-CC
Q 017301 25 YKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE-FK 100 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~-~~ 100 (374)
|++.+.||+|+||.||+|... .++..||+|++............+.+|+++++.++|||++++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 35789999999765555556677889999999999999999999886543222 22
Q ss_pred cEEEEEccCc-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccc
Q 017301 101 DIYVVFELME-SDLHQVIKAN------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
..+++++|+. ++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578999998 4888777432 24788999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
+......... ......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05074 161 KKIYSGDYYR-QGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK------- 230 (273)
T ss_pred ccccCCccee-cCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------
Confidence 7643322111 1112345577999998876 678889999999999999999 8899977654332222111
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
... ....+..++.+.+++.+||+.+|++|||+.+++.+
T Consensus 231 --------------------~~~---~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 231 --------------------GNR---LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --------------------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 01113567899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=306.23 Aligned_cols=264 Identities=26% Similarity=0.431 Sum_probs=194.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
+.|.-...||+|+||.||+|.-. +|..||||.+....... ...|.+|+.++.+++|||+++++|+|...+. +.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~ 147 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR 147 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence 56777789999999999999764 44899999886543321 4459999999999999999999999954431 48
Q ss_pred EEEEccCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCC---ccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTAN---VYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~---i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
+||+||+. |+|.+.+.... .++|....+|+.++++||+|||+.. |+||||||+|||+|.+...||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999999 69999998765 8999999999999999999999964 999999999999999999999999999654
Q ss_pred cCCCCcccccccc-cccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
... ... .... .||.+|+|||++.. +..+.++||||||++|.||+||+.+............. .. .+
T Consensus 228 ~~~-~~~--~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~-~w-------~~ 294 (361)
T KOG1187|consen 228 PEG-DTS--VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV-EW-------AK 294 (361)
T ss_pred Ccc-ccc--eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH-HH-------HH
Confidence 331 111 1122 79999999999876 67899999999999999999999888754311111100 00 00
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCC--CCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.........+ +.+..-.. ..++ ..-..+..+...|++.+|..||++.+++.
T Consensus 295 ~~~~~~~~~e----iiD~~l~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 295 PLLEEGKLRE----IVDPRLKE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHCcchhh----eeCCCccC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111111111 11111000 0011 01123567889999999999999999854
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=297.69 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=198.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
.++|+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++.+...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 3678899999999999999999877776 57888876432 223344678899999999999999999988532
Q ss_pred CCCcEEEEEccCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 98 EFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
..++++||+. |+|.+++.... .+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 ---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 2579999998 59999987654 689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK--------- 226 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC---------
Confidence 4332211 11123345678999999876 678999999999999999997 8999977653322221110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.... ...+..+..+.+++.+||..||++|||+.++++.
T Consensus 227 ------------------~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 227 ------------------GERL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ------------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 1123467789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=291.74 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=186.7
Q ss_pred ceeeccCCeeEEEEEECC--CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||.||+|.... ....+|+|.+... ........+.+|+.+++.++||||+++++.+.. ....|+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEE
Confidence 469999999999996432 4457888877543 223344567889999999999999999999843 34589999
Q ss_pred ccCcc-cHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 107 ELMES-DLHQVIKAND-----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~-----~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
||+.+ +|.+++.... ..++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 99985 9999987643 24677889999999999999999999999999999999999999999999986432221
Q ss_pred Cccccccccccccccccccccccc-----CCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
... ......++..|+|||++... ...++.++|||||||++|+|++ |..||......+.+........
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~------ 227 (269)
T cd05042 155 YYI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD------ 227 (269)
T ss_pred hee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC------
Confidence 110 11223456779999986431 1357889999999999999999 7889977654433322211000
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
...+.......+++...+++..|+ .||++|||++++++
T Consensus 228 -------------------~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 228 -------------------IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -------------------ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 001111122357788899999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=290.88 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=188.8
Q ss_pred ceeeccCCeeEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
+.||+|+||.||+|.+.. .+..||+|.+... ........+.+|+.+++.++|||++++++.+...+ ...++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEE
Confidence 468999999999998643 3457999987532 23344567889999999999999999999775322 347899
Q ss_pred EccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc
Q 017301 106 FELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (374)
Q Consensus 106 ~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (374)
|||+.+ +|.+++... ...++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+++.........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999985 999998764 356778888999999999999999999999999999999999999999999987543221100
Q ss_pred -cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 184 -VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 184 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
.......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~----------------- 216 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----------------- 216 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-----------------
Confidence 01122345678999998876 678999999999999999999 567776654332221111
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..... .....+++.+.+++.+||+.+|++|||+.+++..
T Consensus 217 ----------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 217 ----------QGRRL---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred ----------cCCCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00000 0012357889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=309.67 Aligned_cols=263 Identities=24% Similarity=0.417 Sum_probs=212.0
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.-|..++.||-|+||.|.+++...|...||+|.+.+. .........+..|-.||..-..+-||+++-.| ++..+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence 5688999999999999999999999999999988643 22233444567799999999999999999999 55567
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||+.| ++-.++-+.+-|.|..++.++..+..|+++.|..|+|||||||+|||||.+|.+||.|||+|+-.....
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999996 999999999999999999999999999999999999999999999999999999999999997543211
Q ss_pred Ccc---------------------------------------cccccccccccccccccccccCCCCCccchHHHHHHHH
Q 017301 181 PMT---------------------------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221 (374)
Q Consensus 181 ~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il 221 (374)
... ......+||+.|+|||++.. ..|+..+|.||.||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHH
Confidence 100 00123589999999999988 7899999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCC
Q 017301 222 AEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301 (374)
Q Consensus 222 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp 301 (374)
|+|+.|++||-..+..+....+.+ ++.++. ...-.++|+++.+||.++.. ++
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~n-----------------w~~~l~----------~~~~~~ls~e~~~li~kLc~-sa 913 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVIN-----------------WRNFLH----------IPYQGNLSKEALDLIQKLCC-SA 913 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeee-----------------hhhccc----------cccccccCHHHHHHHHHHhc-Ch
Confidence 999999999987664332222111 111111 11124689999999998765 67
Q ss_pred CCCC---CHHHHhcCCCCCcCc
Q 017301 302 KDRP---TAEEALADPYFKGLA 320 (374)
Q Consensus 302 ~~Rp---t~~~lL~hp~~~~~~ 320 (374)
+.|. -++++-+||||+++.
T Consensus 914 d~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 914 DSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred hhhhcccchhhhhcCccccccc
Confidence 8886 478899999999853
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=294.58 Aligned_cols=238 Identities=18% Similarity=0.273 Sum_probs=185.2
Q ss_pred ceeeccCCeeEEEEEECCCCc-------EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 29 EVIGKGSYGVVCAAIDTHTGE-------KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
+.||+|+||.||+|.+...+. .+|+|.+... .......+.+|+.+++.++|||++++++.+... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence 469999999999998865544 4888876532 223445678899999999999999999998543 44
Q ss_pred EEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC--------eEEeeec
Q 017301 102 IYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--------LKVCDFG 171 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~--------vkl~DFg 171 (374)
.++||||+.+ +|.+++..++ .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 7999999985 8999997654 5899999999999999999999999999999999999987764 6999999
Q ss_pred ccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCC-CCCCCCChhhHHHHHHHhhCCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
.+...... ....+++.|+|||.+.+. ..++.++|||||||++|+|++|. +||...+........
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------- 218 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------- 218 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------
Confidence 88643221 234578889999998652 45788999999999999999984 666554332211100
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.... ......+..+.+||.+||+.||++|||++++++.
T Consensus 219 --------------------~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 219 --------------------EDRH-----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred --------------------Hccc-----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0000 0112356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=291.81 Aligned_cols=238 Identities=21% Similarity=0.289 Sum_probs=183.7
Q ss_pred ceeeccCCeeEEEEEECC------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 29 EVIGKGSYGVVCAAIDTH------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
+.||+|+||.||+|.... ....|++|++... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 468999999999997432 2336888987642 223445678899999999999999999998543
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC-------eEE
Q 017301 97 REFKDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-------LKV 167 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~-------vkl 167 (374)
...++||||+++ +|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +++
T Consensus 77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 346999999996 77777765 356899999999999999999999999999999999999987664 899
Q ss_pred eeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHH-hCCCCCCCCChhhHHHHHHHh
Q 017301 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKSVVHQLDLITDL 246 (374)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~~~i~~~ 246 (374)
+|||.+...... ....++..|+|||.+.+. ..++.++|||||||++|+|+ +|..||......+....
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---- 221 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---- 221 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH----
Confidence 999988654221 233578889999987632 56889999999999999998 58888876543221100
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.. . ........++.+.+||.+||+.||.+|||+.+++.+
T Consensus 222 --------------------~~---~-----~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 222 --------------------YE---G-----QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --------------------Hh---c-----CccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00 0 001112345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=290.04 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=187.2
Q ss_pred ceeeccCCeeEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++.+.. ....++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEE
Confidence 46899999999999754 4567899998865432 2334568889999999999999999998843 34589999
Q ss_pred ccCcc-cHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 107 ELMES-DLHQVIKAND-----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~-----~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
||+.+ +|.+++.... ..++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||.+.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 99994 9999986532 45677888999999999999999999999999999999999999999999986532221
Q ss_pred CcccccccccccccccccccccccC-----CCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
. ........++..|+|||++.+.. ..++.++|+|||||++|+|++ |..||......+.......
T Consensus 155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 224 (269)
T cd05087 155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--------- 224 (269)
T ss_pred e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---------
Confidence 1 11112345778899999885421 135789999999999999996 9999976654332211110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
...... +........++.+.++++.|+ .+|++|||+++++.
T Consensus 225 --------------~~~~~~--~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 225 --------------EQQLKL--PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------------cccCCC--CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000000 111111246778899999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.20 Aligned_cols=269 Identities=23% Similarity=0.394 Sum_probs=201.7
Q ss_pred CCeeEeceeeccCCeeEEEEEEC----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDT----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
..|++.+.||+|+||.||+|... .++..+|+|.+...... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~--- 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG--- 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC---
Confidence 57889999999999999999854 34789999998754332 34567889999999999999999999874422
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....++||||+.+ +|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 3568999999985 9999997654 6899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..............++..|+|||.+.+ ..++.++|+|||||++++|++|..||....... ....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~---- 228 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQG---- 228 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----ccccccccc----
Confidence 432221111112344566999998876 578899999999999999999999886543211 001111000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..........+...... ......+..+.+|+.+||+.+|.+|||+.++++
T Consensus 229 ---~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 229 ---QMIVTRLLELLKEGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ---cccHHHHHHHHHcCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00011111111111111 112346688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=291.21 Aligned_cols=250 Identities=28% Similarity=0.463 Sum_probs=198.3
Q ss_pred CeeEeceeeccCCeeEEEEEECC-CCcEEEEEEecCcc--------CChHHHHHHHHHHHHHHh-CCCCCccccceeecC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVF--------EHISDAIRILREVKLLRL-LRHPDIVEIKRIMLP 93 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~ 93 (374)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.++.. ++|||++++++.+.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 48899999999999999999887 78899999875321 122334557788888865 78999999999984
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCCCeEE
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKV 167 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~~vkl 167 (374)
.....+++|||+.+ +|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 34568999999986 88887743 3478999999999999999999996 68999999999999999999999
Q ss_pred eeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
+|||.+....... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.......+...
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~- 228 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA- 228 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhc-
Confidence 9999997643322 2234568889999999876 67899999999999999999999999766543332222110
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
...+. .....++.+.++|.+||+.||++|||+.++.++
T Consensus 229 --------------------------~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 229 --------------------------VYEPL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred --------------------------cCCcC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 00000 012467889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=314.92 Aligned_cols=267 Identities=25% Similarity=0.429 Sum_probs=221.2
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCc
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 96 (374)
--+..+.+++...||.|.+|.||++.++.+++.+|+|+...... ..+.+..|+++|+.. .|||++.+++++.....
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 33556899999999999999999999999999999999875433 333456789999887 49999999999987766
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
...+.+|||||||+| +.-++++. ..++.|..+.+|++.++.|+.+||.+.++|||||-+|||++.+|.|||+|||.+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 677889999999995 88888875 457999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
........ .....+|||.|||||++... ...|+..+|+||||++..||.-|.+|+-+......+..| ...|
T Consensus 171 aQldsT~g---rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNP 244 (953)
T KOG0587|consen 171 AQLDSTVG---RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNP 244 (953)
T ss_pred eeeecccc---cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCC
Confidence 76544332 23567899999999998542 245888999999999999999999999888765443222 2222
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
++. ...+...+..+.++|..||..|..+||+..++|.|||++.
T Consensus 245 PPk-------------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 245 PPK-------------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred Ccc-------------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 222 2223467888999999999999999999999999999873
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=292.95 Aligned_cols=237 Identities=19% Similarity=0.258 Sum_probs=182.8
Q ss_pred eeeccCCeeEEEEEECC------------------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCcc
Q 017301 30 VIGKGSYGVVCAAIDTH------------------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85 (374)
Q Consensus 30 ~lg~G~~g~V~~a~~~~------------------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 85 (374)
.||+|+||.||+|.... ....||+|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 69999999999997432 1246888987532 223345678899999999999999
Q ss_pred ccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC
Q 017301 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC 163 (374)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~ 163 (374)
++++++... ...++||||+++ +|..++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++..+
T Consensus 80 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 999998543 457999999996 88888765 45789999999999999999999999999999999999997643
Q ss_pred -------CeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHH-hCCCCCCCCC
Q 017301 164 -------KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKS 235 (374)
Q Consensus 164 -------~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll-tg~~pf~~~~ 235 (374)
.+|++|||.+...... ....++..|+|||.+.+. ..++.++|||||||++|+|+ +|..||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999987543221 123577889999988653 56899999999999999985 6899997654
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..+..... .. ... .....++.+.++|.+||+.+|++|||+.++|++
T Consensus 227 ~~~~~~~~------------------------~~---~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERFY------------------------EK---KHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHHH------------------------Hh---ccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 32221110 00 000 012345679999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=300.51 Aligned_cols=278 Identities=27% Similarity=0.430 Sum_probs=218.8
Q ss_pred ccccccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCc--c---CChHHHHHHHHHHHHHHhCCCCCccc
Q 017301 12 DKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV--F---EHISDAIRILREVKLLRLLRHPDIVE 86 (374)
Q Consensus 12 ~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~---~~~~~~~~~~~E~~~l~~l~h~~i~~ 86 (374)
+..|.+.-...+||-++..||+|||+.||+|.|....+.||+|+-+-. . ......+...+|..|.+.+.||.||+
T Consensus 452 nSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 452 NSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred hhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 346777778889999999999999999999999999999999975421 1 11222345679999999999999999
Q ss_pred cceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEecC--
Q 017301 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANA-- 161 (374)
Q Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~~-- 161 (374)
+|+++.-.. ..+|-|+|||+| +|.-+++.+.-+++.+++.|+.||+.||.||.+.. |+|-||||.|||+-.
T Consensus 532 lYDyfslDt----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 532 LYDYFSLDT----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeeeeecc----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 999995443 347999999999 89999999999999999999999999999999874 999999999999843
Q ss_pred -CCCeEEeeecccccccCCCCcc----cccccccccccccccccc--cccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 017301 162 -NCKLKVCDFGLARVAFSDTPMT----VFWTDYVATRWYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (374)
Q Consensus 162 -~~~vkl~DFg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~--~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 234 (374)
-|.+||.|||++.+....+... ...+...||.||++||-+ .......+.++||||+|||+|.++.|+.||...
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 4779999999999876544321 122456799999999954 222356888999999999999999999999765
Q ss_pred ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 017301 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (374)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp 314 (374)
.....+-.-..++ +.... .+..-|-+++++.+||++||++.-++|....++-.||
T Consensus 688 qsQQdILqeNTIl------------------------kAtEV-qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dp 742 (775)
T KOG1151|consen 688 QSQQDILQENTIL------------------------KATEV-QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDP 742 (775)
T ss_pred hhHHHHHhhhchh------------------------cceec-cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCc
Confidence 4322111100000 00000 1112256899999999999999999999999999999
Q ss_pred CCCc
Q 017301 315 YFKG 318 (374)
Q Consensus 315 ~~~~ 318 (374)
||..
T Consensus 743 yllP 746 (775)
T KOG1151|consen 743 YLLP 746 (775)
T ss_pred cccc
Confidence 9964
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=288.71 Aligned_cols=236 Identities=19% Similarity=0.280 Sum_probs=186.2
Q ss_pred ceeeccCCeeEEEEEECCCC----------cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 29 EVIGKGSYGVVCAAIDTHTG----------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998776 357888765322 115678899999999999999999998854
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC-------CeEEee
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-------KLKVCD 169 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~-------~vkl~D 169 (374)
...++||||+.+ +|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 236999999995 9999998765 789999999999999999999999999999999999999887 799999
Q ss_pred ecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhC
Q 017301 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248 (374)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 248 (374)
||++...... ....++..|+|||++.+....++.++|+|||||++|+|++ |..||...+........
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~----- 219 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY----- 219 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-----
Confidence 9998754331 2235677899999987632378899999999999999999 57888665422111110
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. .....+ ...+..+.++|.+||..+|.+|||+.++++
T Consensus 220 -------------------~-~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 220 -------------------Q-DQHRLP-------MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -------------------h-cCCCCC-------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 000000 112368899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=290.76 Aligned_cols=245 Identities=27% Similarity=0.397 Sum_probs=191.5
Q ss_pred ceeeccCCeeEEEEEECCCC------cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 29 EVIGKGSYGVVCAAIDTHTG------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
+.||+|+||.||+|.+...+ ..+|+|.+..... ......+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCe
Confidence 46999999999999876443 6899998764321 23355688899999999999999999998543 458
Q ss_pred EEEEccCcc-cHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC-----CeEEee
Q 017301 103 YVVFELMES-DLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-----KLKVCD 169 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~-------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~-----~vkl~D 169 (374)
++||||+.+ +|.+++... ..+++..+..++.|++.||+|||+++++|+||||+||+++.++ .++|+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 999999985 999998642 3478899999999999999999999999999999999999887 899999
Q ss_pred ecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhC
Q 017301 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248 (374)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 248 (374)
||++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--- 228 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA--- 228 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc---
Confidence 99987543221111 1122345678999999877 678999999999999999998 9999987654433222110
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. ........++..+.++|.+||+.+|.+|||++++++
T Consensus 229 ------------------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 229 ------------------------G---GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------------------C---CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 000112356788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=283.29 Aligned_cols=251 Identities=22% Similarity=0.268 Sum_probs=185.6
Q ss_pred ceeeccCCeeEEEEEECCC--CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||+||+|..... ...+++|.+... ........+.+|+.+++.++||||+++++.+.. ....|+||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~ 74 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVF 74 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEE
Confidence 3699999999999975433 345677776532 223345678899999999999999999999853 34589999
Q ss_pred ccCcc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 107 ELMES-DLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 107 e~~~~-~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
||+.+ +|.+++... ...++..++.++.|++.||+|||+++++||||||+|||++.++.++|+|||++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 99995 999998754 2456777889999999999999999999999999999999999999999998854222111
Q ss_pred ccccccccccccccccccccccc-----CCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
........++..|+|||++... ...++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--------- 224 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD--------- 224 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh---------
Confidence 0111344678899999987531 1245789999999999999997 57788766554433322110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..... ........+++.+.+++..|+ .+|++|||+.+++.
T Consensus 225 --------------~~~~~--~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 225 --------------QQVKL--FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred --------------ccccc--CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 00000 001112347788999999999 68999999999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=301.99 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=201.7
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCc---E-EEEEEecCc-cCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGE---K-VAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~---~-vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
+-.+.++||+|+||.||+|.-+..+. . ||+|..+.. .........+++|.++|++++||||++++|+.....
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--- 234 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--- 234 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC---
Confidence 34566999999999999999765422 3 899988752 245566778999999999999999999999995543
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
-+++|||+|.| +|.++++.++ .++..+...++.+++.||+|||+++++||||-..|+|++.++.+||+|||+++..
T Consensus 235 --Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 235 --PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred --ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 48999999996 9999999987 4999999999999999999999999999999999999999998999999998754
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHH-hhCCCCHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD-LLGTPSPET 254 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~ 254 (374)
..-.... ...--...|+|||.+.. ..|+.++||||+||++||+.+ |..||.+....+....+.. ....+.
T Consensus 313 ~~~~~~~---~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~--- 384 (474)
T KOG0194|consen 313 SQYVMKK---FLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI--- 384 (474)
T ss_pred cceeecc---ccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC---
Confidence 2111100 01123457999999987 689999999999999999999 7889999987765555522 111111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
....+..+..++.+|+..||++|||+.++.+
T Consensus 385 ---------------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 385 ---------------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ---------------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 1245677888999999999999999999876
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=312.26 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=206.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
...-+..+.||+|+||+||+|+-. .....||||.++.. .......+|.+|+..|..++|||||+++|++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC----- 558 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVC----- 558 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----
Confidence 345678899999999999999743 23457999999853 3334567899999999999999999999999
Q ss_pred CCCCcEEEEEccCc-ccHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC
Q 017301 97 REFKDIYVVFELME-SDLHQVIKAND--------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (374)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~--------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~ 161 (374)
.+++-+|+|+|||. |||.+++..+. +++..+...|+.||+.|+.||-++.+|||||-..|+||.+
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE 638 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence 44556999999999 79999996432 2888999999999999999999999999999999999999
Q ss_pred CCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHH
Q 017301 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (374)
Q Consensus 162 ~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 240 (374)
+..|||+|||+++...+..-... .....-...|||||.+.- +.++.+|||||+||+|||+.+ |..||.+.++.+.+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~-~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKV-RGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred ceEEEecccccchhhhhhhhhcc-cCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 99999999999987654321111 011234567999998876 789999999999999999999 89999999988887
Q ss_pred HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 017301 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (374)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~l 310 (374)
+.+... ...+...+.++++.+|+..||+.+|.+|||+.||
T Consensus 716 e~i~~g------------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 716 ECIRAG------------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHHHcC------------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 776431 1112235789999999999999999999999998
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=281.57 Aligned_cols=263 Identities=22% Similarity=0.417 Sum_probs=211.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-SDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 99 (374)
-+.|.++++||+|+|..|.+++.+++.+.+|+|++++..-+. .+..-+..|-.+..+- +||.++-++..|.+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte----- 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE----- 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc-----
Confidence 468999999999999999999999999999999998754332 3344466677777665 699999999999544
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+++|.||++| +|.-.+++..++++++++.+...|+.||.|||+.||+.||+|.+|+|++..|.+||.|+|.++....
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 459999999996 9999999999999999999999999999999999999999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.... .+++||||.|.|||++.+ ..|+.++|.|+||++++||+.|+.||.--. ..+++
T Consensus 404 ~gd~---tstfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdivg-------------m~n~d----- 460 (593)
T KOG0695|consen 404 PGDT---TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIVG-------------MDNPD----- 460 (593)
T ss_pred CCcc---cccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcceec-------------CCCcc-----
Confidence 3322 367899999999999999 789999999999999999999999995211 00000
Q ss_pred cCHHHHHHHHH--hcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC------CHHHHhcCCCCCcC
Q 017301 259 RNEKARKYLTE--MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP------TAEEALADPYFKGL 319 (374)
Q Consensus 259 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp------t~~~lL~hp~~~~~ 319 (374)
..-+.|+-+ +.++.. ....+|-.+..+++..|+.||.+|. ...++-.|+||+.+
T Consensus 461 --~ntedylfqvilekqir-----iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 461 --MNTEDYLFQVILEKQIR-----IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred --cchhHHHHHHHhhhccc-----ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 000111111 111111 1235677788999999999999996 47899999999965
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=308.29 Aligned_cols=211 Identities=29% Similarity=0.444 Sum_probs=176.3
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-cCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~ 98 (374)
+...-...-+.||+||||.||+++++.+|+.||||.++... .....+...+|+++|++++|||||+++++-.+.. .-.
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 33455677899999999999999999999999999998644 3455667789999999999999999988864332 111
Q ss_pred CCcEEEEEccCcc-cHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec--CCCC--eEEeee
Q 017301 99 FKDIYVVFELMES-DLHQVIKA---NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANCK--LKVCDF 170 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~---~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~--~~~~--vkl~DF 170 (374)
...-.+|||||.| +|...+.+ ...+++.+...++..+..|+.|||++||+||||||.||++- .+|+ -||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 2346899999995 99999975 34799999999999999999999999999999999999863 3454 699999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 236 (374)
|.|+....++ .+.+.+||+.|.+||++.. ...|+..+|.|||||++|+++||..||.....
T Consensus 169 G~Arel~d~s----~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 169 GAARELDDNS----LFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccccCCCCC----eeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 9998765544 4577899999999999874 26899999999999999999999999966543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.47 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=206.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
...-++.+.||+|+||.||.|.-.... ..||+|.+.+ .........|++|..+|+.++||||++++|+++...
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~-~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~- 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR-LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG- 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc-cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC-
Confidence 356688999999999999999865332 3599998875 344567778999999999999999999999998743
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEe
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~-------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~ 168 (374)
..+|++|||.| ||..++... ..++..+...++.+|++|+.||+++++|||||...|+|++....|||+
T Consensus 769 ----~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 769 ----PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred ----CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 37999999995 999999875 368899999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhh
Q 017301 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 247 (374)
|||+|+.+....-.... ....-...|||||.+.. +.++.++|||||||++||++| |..||.+.++.+.+......-
T Consensus 845 DFGlArDiy~~~yyr~~-~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKH-GEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred ccchhHhhhhchheecc-CccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 99999954333211110 01122346999999987 789999999999999999999 889999998876665332210
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
--...+.++..+.+|+.+||+.+|++||++..|++
T Consensus 922 ------------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 ------------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ------------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 01123568888999999999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=293.43 Aligned_cols=277 Identities=16% Similarity=0.240 Sum_probs=187.1
Q ss_pred CCCCeeEeceeeccCCeeEEEEEEC----------------CCCcEEEEEEecCccCChH------------HHHHHHHH
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDT----------------HTGEKVAIKKIHDVFEHIS------------DAIRILRE 72 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~----------------~~~~~vaiK~~~~~~~~~~------------~~~~~~~E 72 (374)
..++|++.++||+|+||+||+|... ..++.||||.+........ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3678999999999999999999742 3456899999864221100 01123346
Q ss_pred HHHHHhCCCCCc-----cccceeecCCC---cCCCCcEEEEEccCcc-cHHHHHHhC-----------------------
Q 017301 73 VKLLRLLRHPDI-----VEIKRIMLPPS---KREFKDIYVVFELMES-DLHQVIKAN----------------------- 120 (374)
Q Consensus 73 ~~~l~~l~h~~i-----~~~~~~~~~~~---~~~~~~~~lv~e~~~~-~L~~~l~~~----------------------- 120 (374)
+.++.+++|.++ +++++++.... .......++||||+.+ +|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766554 55666654321 1123468999999995 898888632
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccc
Q 017301 121 -DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199 (374)
Q Consensus 121 -~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 199 (374)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChh
Confidence 123567788999999999999999999999999999999999999999999996543322111 11223578999999
Q ss_pred cccccCC------------------CCC--ccchHHHHHHHHHHHHhCCC-CCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 200 LCGSFFS------------------KYT--PAIDIWSIGCIFAEVLTGKP-LFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 200 ~~~~~~~------------------~~~--~~~DiwSlG~il~~lltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.+..... .|+ .+.||||+||++|+|++|.. ||.+....+.. + . ..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~--~-~-----------~~ 446 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE--L-R-----------QY 446 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH--H-h-----------hc
Confidence 8754211 122 24799999999999999874 77543211100 0 0 00
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCC---CCCCCHHHHhcCCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP---KDRPTAEEALADPYFK 317 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp---~~Rpt~~~lL~hp~~~ 317 (374)
.+ .... ...... .......+...++.++||+.+||..+| .+|+|++|+|+||||.
T Consensus 447 ~~-~~~~-~r~~~~--~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 447 DN-DLNR-WRMYKG--QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred cc-hHHH-HHhhcc--cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 00 0000 000100 111223456789999999999999876 6899999999999995
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=269.65 Aligned_cols=242 Identities=39% Similarity=0.658 Sum_probs=197.0
Q ss_pred CCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccCcc-cH
Q 017301 35 SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DL 113 (374)
Q Consensus 35 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L 113 (374)
+||.||+|.+..+++.+|+|++........ ...+.+|+..++.++|+|++++++.+... ...++++|++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCH
Confidence 589999999998999999999875433221 56788999999999999999999998543 458999999997 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccccccccccc
Q 017301 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193 (374)
Q Consensus 114 ~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~ 193 (374)
.+++.....++...+..++.+++.++.+||+.|++|+||+|.||+++.++.++|+|||.+....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9999887778999999999999999999999999999999999999999999999999997654432 123456888
Q ss_pred cccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC-ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcC
Q 017301 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK 272 (374)
Q Consensus 194 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (374)
.|+|||.+.+ ..++.++|+||+|+++++|++|..||... +.......+. .
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---------------------------~ 201 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---------------------------K 201 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---------------------------c
Confidence 9999999876 67888999999999999999999999773 2222211111 0
Q ss_pred CCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
...........++..+.+++.+||..||++||++.++++||||
T Consensus 202 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 202 -PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -cCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0001111111277889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=289.44 Aligned_cols=245 Identities=26% Similarity=0.435 Sum_probs=197.7
Q ss_pred eEeceeeccCCeeEEEEEECCC----CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 26 KILEVIGKGSYGVVCAAIDTHT----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++.++||.|-||.||.|.-..- .-.||||..+.... ....+.|+.|..+|+.+.||||++++|++... -
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P 464 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P 464 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence 4567899999999999985432 23689998876443 34477899999999999999999999999543 3
Q ss_pred EEEEEccCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+|||||++. |.|..+++.++ .++......+++||+.||+|||+.+++||||-..|||+.....|||+|||+++.....
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 799999999 79999998765 6888899999999999999999999999999999999999999999999999875443
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.-.. .+...-..-|||||-+.- ..++.++|||.|||.+||++. |..||.+-.+.+.+..+.+...
T Consensus 545 ~yYk--aS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR---------- 610 (974)
T KOG4257|consen 545 AYYK--ASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER---------- 610 (974)
T ss_pred chhh--ccccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC----------
Confidence 2111 011122345999998865 678999999999999999887 8999998776555433322111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL 311 (374)
....+++++.+..|+.+||.+||.+||+..++.
T Consensus 611 --------------------lP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 611 --------------------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred --------------------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 122468999999999999999999999876654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=304.13 Aligned_cols=248 Identities=29% Similarity=0.425 Sum_probs=190.1
Q ss_pred eceeeccCCeeE-EEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCcEEEE
Q 017301 28 LEVIGKGSYGVV-CAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 28 ~~~lg~G~~g~V-~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
.+.+|.|+.|+| |+|. -.|+.||||.+-. .....+.+|+..|+.. .||||+++++.- .+.+..||.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 567899998765 9995 4688999998742 3344677999999988 599999998887 455679999
Q ss_pred EccCcccHHHHHHhCC-C---CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC---C--CCeEEeeecccccc
Q 017301 106 FELMESDLHQVIKAND-D---LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---N--CKLKVCDFGLARVA 176 (374)
Q Consensus 106 ~e~~~~~L~~~l~~~~-~---l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~---~--~~vkl~DFg~a~~~ 176 (374)
.|.|..+|.+++.... . ...-..+.++.|++.||++||+.+|+||||||+||||+. + .+++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9999999999998741 1 111445788999999999999999999999999999976 3 46899999999876
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
......-.......||.+|+|||++.. ..-+.++|||||||++|+.++| ..||...-.. + ..|..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~-~NIl~---------- 727 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-Q-ANILT---------- 727 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchHHh-h-hhhhc----------
Confidence 555443333566789999999999987 4556799999999999999996 7999654321 0 00100
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
... .....-+.....+.|||.+||++||..||+|.++|.||+|-..
T Consensus 728 -----------------~~~-~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 728 -----------------GNY-TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred -----------------Ccc-ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 000 0001111112289999999999999999999999999999754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=276.78 Aligned_cols=288 Identities=28% Similarity=0.427 Sum_probs=212.6
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 95 (374)
...+.|.++++||.|+|++||+|.+.. ..+.||+|.+... ....++.+|+++|..+. +.||+++.+.+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~---- 104 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF---- 104 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh----
Confidence 345789999999999999999999887 7889999988643 33446889999999995 89999999998
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC-CCeEEeeeccc
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLA 173 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~-~~vkl~DFg~a 173 (374)
....++.+|+||++. +..++... ++..+++.+++.++.||+++|.+||+||||||+|+|.+.. ++-.|+|||+|
T Consensus 105 -rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 105 -RNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred -ccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 455669999999997 66666654 6789999999999999999999999999999999999865 66899999999
Q ss_pred ccccCC--------------CC-----------------c----------ccccccccccccccccccccccCCCCCccc
Q 017301 174 RVAFSD--------------TP-----------------M----------TVFWTDYVATRWYRAPELCGSFFSKYTPAI 212 (374)
Q Consensus 174 ~~~~~~--------------~~-----------------~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 212 (374)
...... .+ . ........||++|+|||++... ..-++++
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~Qttai 259 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAI 259 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCcc
Confidence 721100 00 0 0001235799999999998763 5678899
Q ss_pred hHHHHHHHHHHHHhCCCCC-CCCChhhHHHHHHHhhCCCCHHHHhhhcC-------------HHHHHHHHHh-----cCC
Q 017301 213 DIWSIGCIFAEVLTGKPLF-PGKSVVHQLDLITDLLGTPSPETIAVVRN-------------EKARKYLTEM-----RKK 273 (374)
Q Consensus 213 DiwSlG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~-----~~~ 273 (374)
||||.|+|+..+++++.|| ...++...+..+...+|...-........ ......+..+ .+.
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999998776 55566666666666666433222111000 1111111111 111
Q ss_pred CC--CCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 274 PP--VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 274 ~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.. ..........+..+.||+.+||..||.+|.||+++|.||||....
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 11 011111223456899999999999999999999999999998543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=295.56 Aligned_cols=263 Identities=25% Similarity=0.406 Sum_probs=220.6
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
+..++|+++..+|+|.||.||+|+|+.+++..|+|+++-. ......-+..|+-+++.++||||+.+++.|....
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~d---- 85 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD---- 85 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhc----
Confidence 6678999999999999999999999999999999999743 2234556778999999999999999999996554
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.+|++||||+| +|.+...-.+++++.++.+.++..++|++|||+.|-+|||||-.||+++..|.+|++|||.+..+..
T Consensus 86 -klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 86 -KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred -CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 48999999996 8999888889999999999999999999999999999999999999999999999999999876654
Q ss_pred CCCcccccccccccccccccccc-cccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ..+++||++|||||+. .+..+.|...+|+|++|+...|+-.-.+|-........+.++.+-...|+.-
T Consensus 165 ti~K---rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l---- 237 (829)
T KOG0576|consen 165 TIAK---RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL---- 237 (829)
T ss_pred hhhh---hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc----
Confidence 4333 3678999999999974 2223679999999999999999988888876666655555554432222210
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
..-...++.+.+|++.+|..+|++|||++.+|+|||..+
T Consensus 238 ----------------------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 238 ----------------------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ----------------------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 111346788999999999999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=292.84 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=218.0
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
+..-+|.++||.|.||.|++|+-+..|+ .||||.++. ....+....|+.|..||-++.||||+++.+++. .
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT-----k 701 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT-----K 701 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe-----c
Confidence 3445789999999999999999887664 799999984 344566678999999999999999999999994 3
Q ss_pred CCcEEEEEccCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
..-+.||+|||+ |+|..++..+ +.|+.-+...+++.|+.|++||-+.|.|||||-..|||++.+...|++|||+++..
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 345899999999 6999999765 57888899999999999999999999999999999999999999999999999976
Q ss_pred cCCCCcccccccccc--cccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 177 FSDTPMTVFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 177 ~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
..+.+.. .+...| ...|.|||.+.- ..++.+|||||+|++|||.++ |..||.+.++.+.+..|.....-|+|
T Consensus 782 edd~~~~--ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP- 856 (996)
T KOG0196|consen 782 EDDPEAA--YTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP- 856 (996)
T ss_pred ccCCCcc--ccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-
Confidence 5544222 222222 356999999876 789999999999999999877 99999999999998888776555553
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc--CCCCCcC
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKGL 319 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~--hp~~~~~ 319 (374)
.+++..+..|+..||++|..+||+..||++ |..+++.
T Consensus 857 -----------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 857 -----------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred -----------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 468889999999999999999999999998 3555543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=246.44 Aligned_cols=209 Identities=25% Similarity=0.433 Sum_probs=171.3
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCcEE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
...+..||+|+||.|-+.++..+|...|+|.+..... ....++.++|+.+..+. .+|+++.+++.++. ...+|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-----egdvw 121 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-----EGDVW 121 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-----cccEE
Confidence 3456789999999999999999999999999976544 34556778888875544 69999999998844 34599
Q ss_pred EEEccCcccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 104 VVFELMESDLHQVI----KANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 104 lv~e~~~~~L~~~l----~~~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
+.||.|..+|..+. +.++.++|..+-+|+..++.||.|||++ .++|||+||+|||++.+|+||+||||.+.....
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99999998776544 5677899999999999999999999998 899999999999999999999999999976544
Q ss_pred CCCccccccccccccccccccccccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCC-ChhhHHHHH
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-SVVHQLDLI 243 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i 243 (374)
+... +-..|...|||||.+... ...|+-++||||||+.++||.+++.||... +..+++.++
T Consensus 202 SiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 202 SIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred hhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 4322 224688889999987542 247999999999999999999999999754 334444433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=276.66 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=203.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++..++++||+|-||.|.+|.- ..+..||+|.++.... ......|.+|+++|.+|+||||++++++|.... -+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----ch
Confidence 4668899999999999999964 3468999999985433 234568999999999999999999999996544 38
Q ss_pred EEEEccCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
++|+||++ |+|.+++..+. .........|+.||+.|++||.+.+++||||.+.|+|++.++++||+|||.++...+.
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999 79999998873 3344566779999999999999999999999999999999999999999999854433
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh--CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.-... --..+-...|||||.+.. +.++.++|+|++|+++||+++ ...||...++.+..+....++..+...
T Consensus 691 ~yy~v-qgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~---- 763 (807)
T KOG1094|consen 691 DYYRV-QGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ---- 763 (807)
T ss_pred Cceee-ecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc----
Confidence 22111 012234567999998766 689999999999999999877 568998887766665544433333221
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
......+-++..+.+|+-.|+..|-.+|||.+++-.
T Consensus 764 -------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 764 -------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 111223456778899999999999999999999843
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=280.42 Aligned_cols=201 Identities=24% Similarity=0.398 Sum_probs=174.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHH------HHHHHHHHHHHHhCC---CCCccccceeec
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD------AIRILREVKLLRLLR---HPDIVEIKRIML 92 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~---h~~i~~~~~~~~ 92 (374)
-..|+.++.+|+|+||.|++|.++.....|++|.+.++.--... .-.+-.||+||..++ |+||++++++|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF- 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF- 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-
Confidence 35699999999999999999999999999999998754211111 112446999999997 99999999999
Q ss_pred CCCcCCCCcEEEEEccCc-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeee
Q 017301 93 PPSKREFKDIYVVFELME-S-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (374)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DF 170 (374)
++..++||+||.-+ | +|++++.....++|.+++.|++|++.|+++||+.||+|||||-+|+.++.+|-+||+||
T Consensus 639 ----Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 639 ----EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred ----ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 66677999999988 5 99999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~ 233 (374)
|.|....+ ..+..++||..|.|||+++|. ...+..-|||+||++||.++....||++
T Consensus 715 gsaa~~ks-----gpfd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTKS-----GPFDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhcC-----CCcceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99865433 234667999999999999884 4567789999999999999999999864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=280.90 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=207.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCC-Cc--EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHT-GE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.++.++.+.||+|+||+|++|..+.. |+ .||||.++...... ....|++|+.+|.+++|+|++++|+++.+..
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~qp--- 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQP--- 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccch---
Confidence 45667889999999999999987643 33 79999997543332 5668999999999999999999999997632
Q ss_pred CCcEEEEEccCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 99 FKDIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
+.+|||++. |+|++.+.. ...|.......++.||+.|+.||.++++|||||-..|+|+-..-.|||+|||+.+.
T Consensus 185 ---~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 ---AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred ---hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence 689999999 699999876 34688888999999999999999999999999999999998888999999999997
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
...+..........--...|+|||.+.. ..++.++|+|++||++|||+| |..||.|....+++..|-+..
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e------- 332 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE------- 332 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-------
Confidence 7665433211111223345999999987 789999999999999999999 789999998877766553211
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
.. ...+.++..+.+++..||..+|.+|||+..|.+.-++
T Consensus 333 ------------------rL-----pRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 333 ------------------RL-----PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ------------------cC-----CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 11 1224678899999999999999999999998654333
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=273.86 Aligned_cols=247 Identities=23% Similarity=0.413 Sum_probs=202.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
...++..+||.|.||.||.+..++-.-.||||.++. +.-..+.|++|..+|+.++|||+|+++++|... .-+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPF 338 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPF 338 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCe
Confidence 345778899999999999999999999999999873 234566899999999999999999999999544 348
Q ss_pred EEEEccCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
|||+|||. |+|.+++...+ .++.-...+++.||..|+.||..+++|||||-..|+|+.++..||++|||+++....+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999998 79999998754 4666677888899999999999999999999999999999999999999999987655
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
+-+.. ...--..-|.|||-+.- ..++.++|||+|||+|||+.| |..||.+-+-.+...++.+...
T Consensus 419 TYTAH--AGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR---------- 484 (1157)
T KOG4278|consen 419 TYTAH--AGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR---------- 484 (1157)
T ss_pred ceecc--cCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc----------
Confidence 43221 11122345999997754 678999999999999999999 8899999876655554433111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL 311 (374)
. ....++++.+.+|++.||+|.|.+||++.++-
T Consensus 485 -------------M-------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 485 -------------M-------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred -------------c-------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 0 11246899999999999999999999998873
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=308.40 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=183.7
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
..|...+.||+|+||.||+|.+..++..||+|.+...... ..+|+..+++++||||+++++++... ...
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSE-----KGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcC-----CCC
Confidence 3466678899999999999999999999999998643211 12468889999999999999999543 447
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh---hCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH---TANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH---~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
|+||||+++ +|.+++.. +++..+..++.|++.|++||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 759 ~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 999999985 99999963 889999999999999999999 6699999999999999998887775 665543211
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh-HHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~ 257 (374)
. ....+|+.|+|||++.+ ..++.++||||+||++|||+||+.||....... .+.......
T Consensus 835 ~-------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---------- 895 (968)
T PLN00113 835 D-------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC---------- 895 (968)
T ss_pred C-------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHh----------
Confidence 1 22368899999999877 679999999999999999999999995432110 000000000
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.........+ +................+.+++.+||+.||++|||+.++++.
T Consensus 896 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 896 YSDCHLDMWI----DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cCccchhhee----CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000000000 000000000000112356789999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=260.19 Aligned_cols=267 Identities=23% Similarity=0.334 Sum_probs=192.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--CCCCCccccceeecCCCcCCCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL--LRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
...++.+.||+|.||.||+| .-.++.||||++.. .....+.+|-++.+. ++|+||++++++-...+. ...
T Consensus 210 ~pl~l~eli~~Grfg~V~Ka--qL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKA--QLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehh--hccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-ccc
Confidence 45578899999999999999 45679999999852 445567777777665 479999999887644332 245
Q ss_pred cEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC---------CccccCCCCCceEecCCCCeEEeee
Q 017301 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA---------NVYHRDLKPKNILANANCKLKVCDF 170 (374)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~---------~i~H~dikp~Nil~~~~~~vkl~DF 170 (374)
.++||++|.+ |+|.++++.+ .+++....+++..+++||+|||+- .|+|||||..|||+..|++..|+||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 7899999998 7999999886 589999999999999999999963 4999999999999999999999999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCC-----ccchHHHHHHHHHHHHhCCCCCC-CCChhhHHHHHH
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAEVLTGKPLFP-GKSVVHQLDLIT 244 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-----~~~DiwSlG~il~~lltg~~pf~-~~~~~~~~~~i~ 244 (374)
|+|.......+.. .....+||..|||||++.+. .... .+.||||+|.+||||++...-+. +....-++---.
T Consensus 361 GLAl~~~p~~~~~-d~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 361 GLALRLEPGKPQG-DTHGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ceeEEecCCCCCc-chhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 9998765443332 23347899999999999763 2222 36899999999999999775553 222221221111
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCC--CChHHHHHHHHhccCCCCCCCCHHHH
Q 017301 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN--VDPLALRLLQRLIAFDPKDRPTAEEA 310 (374)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~li~~~L~~dp~~Rpt~~~l 310 (374)
.+-..|+-+. ...++-+-+.++..+ ..|.. .-..+++.+..|++.||+-|.||.=+
T Consensus 439 evG~hPt~e~--------mq~~VV~kK~RP~~p--~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 439 EVGNHPTLEE--------MQELVVRKKQRPKIP--DAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HhcCCCCHHH--------HHHHHHhhccCCCCh--hhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 2222333222 112222111111111 11222 23467899999999999999998644
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=253.71 Aligned_cols=263 Identities=23% Similarity=0.279 Sum_probs=189.8
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHH--HHHHHHhCCCCCccccceeecCCC
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR--EVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~--E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
+..+..+.++.+.||+|.||.||+|.. .|+.||||++... +.....+ ||..-..++|+||+.++++-....
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc--cCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 345577899999999999999999955 5999999999642 2223334 444455579999999988865544
Q ss_pred cCCCCcEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC--------CccccCCCCCceEecCCCCeE
Q 017301 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA--------NVYHRDLKPKNILANANCKLK 166 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~i~H~dikp~Nil~~~~~~vk 166 (374)
....++|||++|-+ |+|++++.+ ..++.+.+.+++..++.||+|||.. .|.|||||..|||+..+|..-
T Consensus 279 -gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 279 -GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred -CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 45678999999999 799999998 5799999999999999999999953 399999999999999999999
Q ss_pred EeeecccccccCCC-CcccccccccccccccccccccccCCC----CCccchHHHHHHHHHHHHhC----------CCCC
Q 017301 167 VCDFGLARVAFSDT-PMTVFWTDYVATRWYRAPELCGSFFSK----YTPAIDIWSIGCIFAEVLTG----------KPLF 231 (374)
Q Consensus 167 l~DFg~a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~DiwSlG~il~~lltg----------~~pf 231 (374)
|+|+|+|....+.. .........+||-.|||||++...-.. --..+||||||.++||++.. .+||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99999998765543 223444677999999999998652110 11258999999999998862 2666
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCcc-ccCCCCC--hHHHHHHHHhccCCCCCCCCHH
Q 017301 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF-QKFPNVD--PLALRLLQRLIAFDPKDRPTAE 308 (374)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s--~~~~~li~~~L~~dp~~Rpt~~ 308 (374)
.+--+. ++.+++-.+-+..+..+|.. ..|...+ ..+..+++.||..||.-|.||-
T Consensus 437 yd~Vp~----------------------DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltAL 494 (513)
T KOG2052|consen 437 YDVVPS----------------------DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTAL 494 (513)
T ss_pred ccCCCC----------------------CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHH
Confidence 543221 11111111111111111111 1122211 1345789999999999999987
Q ss_pred HHh
Q 017301 309 EAL 311 (374)
Q Consensus 309 ~lL 311 (374)
.+-
T Consensus 495 riK 497 (513)
T KOG2052|consen 495 RIK 497 (513)
T ss_pred HHH
Confidence 663
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=271.79 Aligned_cols=247 Identities=27% Similarity=0.457 Sum_probs=196.3
Q ss_pred eEeceeeccCCeeEEEEEEC----C---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcC
Q 017301 26 KILEVIGKGSYGVVCAAIDT----H---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~----~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 97 (374)
++.+.||+|+||.|++|.-. . ....||+|.++..... .+...+..|+.+|+.+ .|+|++.+++++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 67779999999999999733 1 1457999998865544 6677899999999999 59999999999954
Q ss_pred CCCcEEEEEccCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec
Q 017301 98 EFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (374)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~ 160 (374)
...+++|+||+. |+|.+++..+. .++..+...+.+||+.|++||++.+++||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 456899999999 69999998765 388899999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCcccccccccc--cccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC-h
Q 017301 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS-V 236 (374)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~-~ 236 (374)
.+..+||+|||+|+.......... ....+ ...|||||.+.. ..|+.++||||+|++|||+.+ |..||.+-. .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999986443322211 11122 234999999987 789999999999999999999 789998743 2
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.+.... ++... + ......+++++.++++.|++.+|++||+..++..
T Consensus 529 ~~l~~~------------------------l~~G~-r-----~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEF------------------------LKEGN-R-----MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHH------------------------HhcCC-C-----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 222111 11100 0 0112356889999999999999999999999876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=231.35 Aligned_cols=212 Identities=37% Similarity=0.624 Sum_probs=180.6
Q ss_pred eeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccCc
Q 017301 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME 110 (374)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~ 110 (374)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++++++++.+... ...++++|++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence 689999999999998889999999987532221 346788999999999999999999998543 45899999999
Q ss_pred -ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-CCCeEEeeecccccccCCCCcccccc
Q 017301 111 -SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWT 187 (374)
Q Consensus 111 -~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~-~~~vkl~DFg~a~~~~~~~~~~~~~~ 187 (374)
++|.+++... ..++...+..++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 5999999876 57899999999999999999999999999999999999999 89999999999976533321 123
Q ss_pred cccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHH
Q 017301 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267 (374)
Q Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 267 (374)
...+...|++||.+... ..++.++|+||+|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 34578889999988662 2778899999999999999
Q ss_pred HHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 017301 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp 314 (374)
..+.+++.+|++.||++|||+.++++|+
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1356799999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=237.02 Aligned_cols=263 Identities=27% Similarity=0.422 Sum_probs=201.5
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCc
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 96 (374)
.....+.|.+.+.||+|.||.+-+|+|+.++..+|+|.+..+ ......|.+|...--.|+ |.||+..+++-+...
T Consensus 19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~- 94 (378)
T KOG1345|consen 19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS- 94 (378)
T ss_pred ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC-
Confidence 345567899999999999999999999999999999998754 345667889988755664 999999888765433
Q ss_pred CCCCcEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC--CCCeEEeeeccc
Q 017301 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLA 173 (374)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~--~~~vkl~DFg~a 173 (374)
+.+.+++||++ |+|..-+..+ .+.|...+.++.|++.|+.|+|++++||||||.+||||-. ..+|||||||.+
T Consensus 95 ---d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 95 ---DAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred ---ceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccc
Confidence 45789999999 6999888775 4899999999999999999999999999999999999833 357999999998
Q ss_pred ccccCCCCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
+..+..-.. .--+..|.+||++... .-...+.+|+|.||+++|.++||.+||.....
T Consensus 171 ~k~g~tV~~------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-------------- 230 (378)
T KOG1345|consen 171 RKVGTTVKY------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-------------- 230 (378)
T ss_pred cccCceehh------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc--------------
Confidence 754332221 1234568899976321 12367789999999999999999999974321
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCC---CCHHHHhcCCCCC
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFK 317 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---pt~~~lL~hp~~~ 317 (374)
.++.+.++........+ .....|..+|+.+..+.++-|..+|.+| -++......-|..
T Consensus 231 --------~d~~Y~~~~~w~~rk~~-~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 231 --------MDKPYWEWEQWLKRKNP-ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred --------cCchHHHHHHHhcccCc-cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 22333344444433333 3334567789999999999999999999 5555555555654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=260.68 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=201.0
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..+..++||+|+||+||+|...-.|+ +||+|++.. .........+++|.-+|.++.|||++++++++....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---- 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST---- 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch----
Confidence 44567889999999999999765554 789998864 344455667899999999999999999999996553
Q ss_pred CcEEEEEccCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
+-||++|++ |.|.++++.+ +.+.......|+.||++|+.|||.++++||||-..|||+..-..+|+.|||+|+...
T Consensus 772 --~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 772 --LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred --HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 679999999 5999999864 478999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... .....-...+-|||-|.+.. ..|+.++||||+||.+||++| |..|+.+....++-+.+.+
T Consensus 850 ~d~~e-y~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----------- 915 (1177)
T KOG1025|consen 850 PDEKE-YSAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----------- 915 (1177)
T ss_pred ccccc-ccccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-----------
Confidence 44322 11112223445888888776 789999999999999999999 8999988876544433321
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
- .+. +..|..+-++.-++.+||..|++.||+++++..
T Consensus 916 -------------g-eRL-----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 916 -------------G-ERL-----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -------------c-ccC-----CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 1 111 223677889999999999999999999998866
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=282.22 Aligned_cols=208 Identities=15% Similarity=0.175 Sum_probs=147.1
Q ss_pred hCCC-CCccccceeecCCCc--CCCCcEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 017301 78 LLRH-PDIVEIKRIMLPPSK--REFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (374)
Q Consensus 78 ~l~h-~~i~~~~~~~~~~~~--~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dik 153 (374)
.++| +||.++++.+..... .....++.++|+++++|.+++.. ...+++.+++.+++||+.||+|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 577777777632221 12245788999998999999975 3469999999999999999999999999999999
Q ss_pred CCceEecCCCC-------------------eEEeeecccccccCCCC-------------cccccccccccccccccccc
Q 017301 154 PKNILANANCK-------------------LKVCDFGLARVAFSDTP-------------MTVFWTDYVATRWYRAPELC 201 (374)
Q Consensus 154 p~Nil~~~~~~-------------------vkl~DFg~a~~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~ 201 (374)
|+|||++..+. +|++|||+++....... ........+||++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999965444 55555555543111000 00001124689999999998
Q ss_pred cccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCcccc
Q 017301 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK 281 (374)
Q Consensus 202 ~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (374)
.+ ..|+.++|||||||+||||++|.+|+..... .+..+... . .+ ..
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~-----------------------~---~~----~~ 233 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR-----------------------V---LP----PQ 233 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh-----------------------h---cC----hh
Confidence 87 6799999999999999999999888753211 11111000 0 00 00
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 282 FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 282 ~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.....+...+++.+||+.||.+|||+.++|+||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 01123456789999999999999999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-31 Score=229.29 Aligned_cols=199 Identities=38% Similarity=0.681 Sum_probs=171.6
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l 104 (374)
|.+.+.||+|++|.||+|.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+... ...++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEE
Confidence 67889999999999999999988999999998754332 2456788999999999999999999988433 45899
Q ss_pred EEccCcc-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 105 VFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 105 v~e~~~~-~L~~~l~~~~~-l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
++|++.+ +|.+++..... +++..+..++.+++.++.+||+.|++|+||+|.||+++.++.++|+|||.+.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999997 99999988766 899999999999999999999999999999999999999999999999999765443211
Q ss_pred ccccccccccccccccccc-cccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 017301 183 TVFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~ 233 (374)
......++..|++||.+ .. ..++.++|+||||+++++|++|+.||..
T Consensus 155 --~~~~~~~~~~~~~pe~~~~~--~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLLGG--KGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhcCC--CCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12345678889999988 43 6778899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=259.57 Aligned_cols=269 Identities=26% Similarity=0.335 Sum_probs=204.9
Q ss_pred CCe-eEeceeeccCCeeEEEEEECCCCcEEEEEEec----CccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 23 NRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 23 ~~Y-~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
..| .-...+|.|++|.|+.+......+.++.|.+. ...........+..|+.+-..+.|||++..+..+.....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~- 395 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG- 395 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-
Confidence 446 55788999999988888887777777777654 211111222236678888888999999888777754332
Q ss_pred CCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
.+-+||||.++|+..+.+.+.++..++..++.||+.||+|+|+.||.|||+||+|+++..+|.+||+|||.+....
T Consensus 396 ----~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 396 ----ILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred ----chhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 3344999999999999998889999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCc-ccccccccccccccccccccccCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCChhhHHH-HHHHhhCCCCHHH
Q 017301 178 SDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD-LITDLLGTPSPET 254 (374)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwSlG~il~~lltg~~pf~~~~~~~~~~-~i~~~~~~~~~~~ 254 (374)
..... .......+|+..|+|||++.+ ..|++ ..||||.|+++..|.+|+.||......+... ...
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~---------- 539 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN---------- 539 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----------
Confidence 44332 234467789999999999987 56666 5799999999999999999997654332210 000
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
..............+..++...+.+|.+||++||.+|.|+++|++.+||+.+..
T Consensus 540 -------------~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 540 -------------YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred -------------cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 000001111112223346777899999999999999999999999999997654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=214.90 Aligned_cols=165 Identities=22% Similarity=0.266 Sum_probs=127.0
Q ss_pred ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccccccc
Q 017301 111 SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189 (374)
Q Consensus 111 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~ 189 (374)
|+|.+++..+ ..+++..++.++.|++.||+|||+.+ ||+|||++.++.+|+ ||.+...... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 6889999874 46999999999999999999999999 999999999999999 9998764332 12
Q ss_pred cccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh-HHHHHHHhhCCCCHHHHhhhcCHHHHHHHH
Q 017301 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLT 268 (374)
Q Consensus 190 ~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (374)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+..+..
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~----------------------- 119 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN----------------------- 119 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH-----------------------
Confidence 68899999999987 689999999999999999999999997654321 1111111
Q ss_pred HhcCCCCCCccccCCCCCh--HHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 269 EMRKKPPVPLFQKFPNVDP--LALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~--~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
......+.. ......++. .+.++|.+||+.||.+|||+.+++.|+|+.
T Consensus 120 ~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 120 GMPADDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhccCCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 000000000 000112233 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=213.21 Aligned_cols=253 Identities=18% Similarity=0.294 Sum_probs=193.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..|+++...+-+|.||.||.|..+.. .+.|.+|.++.. ...-....++.|--.+....|||+..+.++....
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-- 359 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-- 359 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec--
Confidence 56788899999999999999975532 345666766532 2223344677888889999999999999998643
Q ss_pred CCCCcEEEEEccCc-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEE
Q 017301 97 REFKDIYVVFELME-SDLHQVIKAN--------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (374)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~--------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl 167 (374)
....++++.+++ |+|..++... ..++..+...++.|++.|++|||+.|++|.||-..|.+|++..+|||
T Consensus 360 --~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 360 --YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred --cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 234678888888 7999998721 24666777788999999999999999999999999999999999999
Q ss_pred eeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHh
Q 017301 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDL 246 (374)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 246 (374)
+|=.+++......-. ..-..--....|||||.+.. ..|+.++|+||||++||||+| |..|+..-++.+....+.+.
T Consensus 438 tDsaLSRDLFP~DYh-cLGDnEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYH-CLGDNENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred ccchhccccCccccc-ccCCCCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 999998865433211 11111123445999999987 789999999999999999999 88999777665544433221
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. +. ...-++++++..++.-||..+|++||+.+|+..
T Consensus 515 y-------------------------Rl-----aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 Y-------------------------RL-----AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred c-------------------------ee-----cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 0 01 112378999999999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=218.95 Aligned_cols=170 Identities=20% Similarity=0.206 Sum_probs=130.3
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECC-CCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 94 (374)
....++|++.+.||+|+||+||+|.++. ++..||+|++..... .......+.+|+.+|+.++|+|+++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456889999999999999999999876 677889998753211 223455688999999999999998633222
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC-CCCceEecCCCCeEEeeecc
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDL-KPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~di-kp~Nil~~~~~~vkl~DFg~ 172 (374)
...|+||||+.| +|. .+... . ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+
T Consensus 91 -----~~~~LVmE~~~G~~L~-~~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLH-LARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred -----CCcEEEEEccCCCCHH-HhCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 236999999997 675 22211 1 1467899999999999999999999 99999999999999999999
Q ss_pred cccccCCCCccc-----ccccccccccccccccccc
Q 017301 173 ARVAFSDTPMTV-----FWTDYVATRWYRAPELCGS 203 (374)
Q Consensus 173 a~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~ 203 (374)
|+.......... ......+++.|+|||.+..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 986544322111 1134568888999998754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-26 Score=210.99 Aligned_cols=256 Identities=20% Similarity=0.214 Sum_probs=187.3
Q ss_pred CeeEeceeeccCCeeEEEEEECCCC-cEEEEEEecCccCChHHHHHHHHHHHHHHhCCC----CCccccceeecCCCcCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLRH----PDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~~i~~~~~~~~~~~~~~ 98 (374)
+|++.+.||+|+||.||.|.+..++ ..+|+|+.......... .+..|..++..+.. +++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 8999999999999999999988775 68899987643222111 45568888887762 57777776663 23
Q ss_pred CCcEEEEEccCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC-----CCeEEeeec
Q 017301 99 FKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-----CKLKVCDFG 171 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~-----~~vkl~DFg 171 (374)
...-|+||+.++.+|.++.... +.++...+..|+.|++.+|++||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 3457999999999999988654 589999999999999999999999999999999999999765 359999999
Q ss_pred ccc--cccCCCC-----cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 017301 172 LAR--VAFSDTP-----MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (374)
Q Consensus 172 ~a~--~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 244 (374)
+|+ ....... .........||..|+++....+ ...+++.|+||++.++.+++.|..||.+.........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 3222211 1111134569999999999988 788999999999999999999999997765433222221
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
... ...... . .....+..+..+...+-..+...+|....+...
T Consensus 251 ~~~--------------------~~~~~~---~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDP--------------------RKLLTD---R---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHh--------------------hhhccc---c---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 100 000000 0 112234566667776667888888887777553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-26 Score=207.13 Aligned_cols=265 Identities=34% Similarity=0.521 Sum_probs=203.4
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChH-HHHHHHHHHHHHHhCCCC-CccccceeecCCCcCCCCcE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-DAIRILREVKLLRLLRHP-DIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~~~~~ 102 (374)
|.+...||.|+||.||.+.+. ..+++|.+........ ....+.+|+.++..+.|+ +++++.+.+... ...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence 889999999999999999887 8899999876544443 566788999999999988 799999999332 337
Q ss_pred EEEEccCcc-cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC-CeEEeeeccccccc
Q 017301 103 YVVFELMES-DLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~-~vkl~DFg~a~~~~ 177 (374)
+++++++.+ ++.+.+.... .++......++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999996 8887777664 799999999999999999999999999999999999999998 69999999997543
Q ss_pred CCCCcc---cccccccccccccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCh---hhHHHHHHHhhCCC
Q 017301 178 SDTPMT---VFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---VHQLDLITDLLGTP 250 (374)
Q Consensus 178 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~ 250 (374)
...... .......||..|+|||.+.+.. ..++...|+||+|++++++++|..||..... .............+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 332211 1235678999999999987631 3678899999999999999999999877653 12222211111111
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccC-CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.......... ......+.+++..++..+|..|.+..+...++|....
T Consensus 234 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 ----------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ----------------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000000 1123578899999999999999999999998776654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=197.10 Aligned_cols=241 Identities=21% Similarity=0.279 Sum_probs=187.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 99 (374)
++-.|+++++||.|+||+.+.|.+.-+++.||||.-. ....+.++..|++..+.|. .++|...+-+- +++
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP----rkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG 96 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP----RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEG 96 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecc----ccCCcchHHHHHHHHHHHcCCCCCCceeeec-----ccc
Confidence 4568999999999999999999999999999999642 2245667778888888885 67887765444 555
Q ss_pred CcEEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC-----CeEEeeeccc
Q 017301 100 KDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-----KLKVCDFGLA 173 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~-----~vkl~DFg~a 173 (374)
.+-.||+|+++.+|.+++.-. .+|+...+..++.|++.-++++|++.+|.|||||+|+||...+ .|-++|||+|
T Consensus 97 ~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 97 KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 667899999999888888754 4799999999999999999999999999999999999997644 3899999999
Q ss_pred ccccCCCCcc----cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh---HHHHHHHh
Q 017301 174 RVAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH---QLDLITDL 246 (374)
Q Consensus 174 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~---~~~~i~~~ 246 (374)
+.+....... .......||..||+=.-..| ..-+.+.|+-|||-++++++.|..||.|..... ..+.|-..
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 8765443221 11245679999999988877 667889999999999999999999998865443 44444443
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcC
Q 017301 247 LGTPSPETIAVVRNEKARKYLTEMRK 272 (374)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (374)
....+.+.++..-...+..|+...+.
T Consensus 255 Kr~T~i~~Lc~g~P~efa~Yl~yvR~ 280 (449)
T KOG1165|consen 255 KRSTPIEVLCEGFPEEFATYLRYVRR 280 (449)
T ss_pred cccCCHHHHHhcCHHHHHHHHHHHHh
Confidence 44445555555444555555555443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=191.27 Aligned_cols=245 Identities=24% Similarity=0.292 Sum_probs=182.9
Q ss_pred ccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCC-CCccccceeecCC
Q 017301 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPP 94 (374)
Q Consensus 16 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~ 94 (374)
..+.-+.++|+++++||+|+||-+|.|....+|..||||+-+.... ...+..|..+.+.+++ ..|..+..+.
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~--- 80 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYG--- 80 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhc---
Confidence 3445678999999999999999999999999999999998653322 2245678888888864 4555555444
Q ss_pred CcCCCCcEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC---CCeEEeee
Q 017301 95 SKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDF 170 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~---~~vkl~DF 170 (374)
.+..+-.+|||.++.+|.+++.- +..++...+..++-|++.-++|+|..+++||||||+|+|..-+ .++.|+||
T Consensus 81 --~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 81 --TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred --cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEec
Confidence 34455689999999888888863 4468999999999999999999999999999999999997543 45999999
Q ss_pred cccccccCCCCcc----cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH---HH
Q 017301 171 GLARVAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD---LI 243 (374)
Q Consensus 171 g~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~---~i 243 (374)
|+|+......... .......||..|.+-....+ ..-+.+.|+-|+|.+|..+..|..||.+-......+ .|
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 9998754432211 11234679999999888776 456789999999999999999999999876544433 33
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhc
Q 017301 244 TDLLGTPSPETIAVVRNEKARKYLTEMR 271 (374)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (374)
....-..+.+.++..-..++..++...+
T Consensus 237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R 264 (341)
T KOG1163|consen 237 SEKKMSTPIEVLCKGFPAEFAMYLNYCR 264 (341)
T ss_pred HHhhcCCCHHHHhCCCcHHHHHHHHHHh
Confidence 3333344455555444444444444433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-27 Score=220.57 Aligned_cols=240 Identities=25% Similarity=0.395 Sum_probs=193.7
Q ss_pred eeeccCCeeEEEEEE---CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCcEEEE
Q 017301 30 VIGKGSYGVVCAAID---THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 30 ~lg~G~~g~V~~a~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~lv 105 (374)
.+|.|+||.|++++. ...|..+|+|+.++.............|-.++...+ ||.+++++..+. ....+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq-----t~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ-----TDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec-----cccchhHh
Confidence 379999999998863 245678999988754333232224445777888876 999999999984 44558999
Q ss_pred EccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccc
Q 017301 106 FELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (374)
Q Consensus 106 ~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (374)
+++..| +|...+.....+.+...+.+...++-|++++|+.||+|||+|++||+++.+|.+++.|||+++.......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999996 9999999888999999999999999999999999999999999999999999999999999986544322
Q ss_pred ccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 017301 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (374)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (374)
.|||..|||||++.+ ...++|.||+|+++|+|+||..||.+ +....|.+..-
T Consensus 153 ----~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~---------------- 204 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL---------------- 204 (612)
T ss_pred ----cccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc----------------
Confidence 289999999999863 57789999999999999999999987 23333322100
Q ss_pred HHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcCc
Q 017301 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~~ 320 (374)
.....++..+++++..|+..+|..|.- +.++++|++|+.+.
T Consensus 205 ---------------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 205 ---------------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred ---------------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence 111346788999999999999999974 58999999998753
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=225.30 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=184.4
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.|...+.||++.|=.|.+|.+. .-.|++|++-+... ......+.+.|++ ....++||.+++..+.. ....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~-----t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV-----TDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--CceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH-----hhHH
Confidence 7888999999999999999764 33599999865432 3344555666777 66678999999887763 3344
Q ss_pred EEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc--CC
Q 017301 102 IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF--SD 179 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~--~~ 179 (374)
.|+|-+|...+|.+-+..++-+..-+.+-|+.||+.||.-+|..||+|||||.+|||++.-+-+-|+||..-+... .+
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 6999999999999999988888889999999999999999999999999999999999998889999998765322 11
Q ss_pred CC--ccccccccccccccccccccccc---------CCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhh
Q 017301 180 TP--MTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 180 ~~--~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 247 (374)
.+ ...++.+...--.|.|||.+... ....+++-||||+||+++||++ |++||.-.. +-.. ..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aY--r~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAY--RS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhH--hc
Confidence 11 11222222233459999976331 1126778999999999999998 799994211 1000 00
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
| ......+.++.+. +...+.||..|++.||++|.+|++.|+.
T Consensus 250 ~----------~~~~~e~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 G----------NADDPEQLLEKIE--------------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred c----------CccCHHHHHHhCc--------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 0011112222221 3368899999999999999999999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=222.75 Aligned_cols=231 Identities=25% Similarity=0.376 Sum_probs=174.1
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
........|..++.|..|+||-||.++|+.+.+++|+|+-+. . .+ |+ ||..+.+.
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-----~---li------lR-----nilt~a~n------ 131 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-----N---LI------LR-----NILTFAGN------ 131 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhccccc-----c---hh------hh-----ccccccCC------
Confidence 455667889999999999999999999999999999964321 1 11 11 12222111
Q ss_pred CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
.++| ||=...++.-+.++-.. +.+++|||+.||+|||+||+|++|+.-|.+|+.|||++...
T Consensus 132 -----pfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 132 -----PFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred -----ccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhh
Confidence 1233 55555666656666543 78999999999999999999999999999999999999765
Q ss_pred cCCCCccc------------ccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 017301 177 FSDTPMTV------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (374)
Q Consensus 177 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 244 (374)
........ .....+|||.|+|||++.. +.|+..+|.|++|+|+|+.+-|..||.+++..+.+..+.
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 43222211 1134589999999999987 789999999999999999999999999998877665544
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCC---CCHHHHhcCCCCCcCc
Q 017301 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFKGLA 320 (374)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---pt~~~lL~hp~~~~~~ 320 (374)
.-... +.+.-...+++++++|.++|+.+|..| +.+-++-+|+||+.+.
T Consensus 272 sd~i~----------------------------wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 272 SDDIE----------------------------WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred hhhcc----------------------------ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 31110 011123578899999999999999999 4688889999998753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=194.48 Aligned_cols=241 Identities=20% Similarity=0.266 Sum_probs=151.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCC----------CCCccccceee
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR----------HPDIVEIKRIM 91 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~----------h~~i~~~~~~~ 91 (374)
..+..++.||.|+++.||.+.|..||+.+|+|++..... .....+.+.+|.-....+. |-.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 356778999999999999999999999999999863332 2234445555554443322 22333333333
Q ss_pred cCCCc-------CCCC-----cEEEEEccCcccHHHHHHh---CCCC----CHHHHHHHHHHHHHHHHHhhhCCccccCC
Q 017301 92 LPPSK-------REFK-----DIYVVFELMESDLHQVIKA---NDDL----TREHHQFFLYQMLRALKYMHTANVYHRDL 152 (374)
Q Consensus 92 ~~~~~-------~~~~-----~~~lv~e~~~~~L~~~l~~---~~~l----~~~~~~~i~~qi~~al~~LH~~~i~H~di 152 (374)
...+. .+.. +.+++|+-+.+||.+++.. .... .......+..|+++.+++||+.|++|+||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 21110 0011 3478999998888887642 2222 22223445689999999999999999999
Q ss_pred CCCceEecCCCCeEEeeecccccccCCCCccccccccccccccccccccccc------CCCCCccchHHHHHHHHHHHHh
Q 017301 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLT 226 (374)
Q Consensus 153 kp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwSlG~il~~llt 226 (374)
+|+|++++.+|.++|+||+.....+.... ....+..|.+||..... ...++.+.|.|+||+++|.|.+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999998765433211 12345779999976331 1357889999999999999999
Q ss_pred CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCC
Q 017301 227 GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304 (374)
Q Consensus 227 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 304 (374)
|+.||.......... ..+.... +++..+++||++||+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~----------------------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPE----------------------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSG----------------------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccccc----------------------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999997654321100 0111222 678899999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=190.28 Aligned_cols=177 Identities=11% Similarity=0.110 Sum_probs=134.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHH-HH------HHHHHHHHHhCCCCCccccceeecCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IR------ILREVKLLRLLRHPDIVEIKRIMLPP 94 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~-~~------~~~E~~~l~~l~h~~i~~~~~~~~~~ 94 (374)
.++|++++.||.|+||.||++.+ ++..+|+|+++......... .. +.+|++.+.++.|++|..+.+.+...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 68999999999999999999754 46789999997544333221 22 57899999999999999998886543
Q ss_pred CcC---CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeee
Q 017301 95 SKR---EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (374)
Q Consensus 95 ~~~---~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DF 170 (374)
... .....++||||++| +|.++.. +++ ....+++.+|..||+.|++|||+||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 211 12457999999998 8877632 333 3466999999999999999999999999999998 999999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt 226 (374)
|.++........ ..+... ..|+.++|+||||+.+..+..
T Consensus 179 g~~~~~~e~~a~---------------d~~vle--r~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 179 SGKRCTAQRKAK---------------DRIDLE--RHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CCcccccchhhH---------------HHHHHH--hHhcccccccceeEeehHHHH
Confidence 988643221110 002233 457789999999999987753
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=186.04 Aligned_cols=140 Identities=19% Similarity=0.219 Sum_probs=109.1
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHH------------------------HHHHHHHHHHHHhCCCCC
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD------------------------AIRILREVKLLRLLRHPD 83 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~~ 83 (374)
.+.||+|++|.||+|.+. +|+.||+|+++........ .....+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 568999999999999986 8999999999743211100 112345999999998887
Q ss_pred ccccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-hhCCccccCCCCCceEecC
Q 017301 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLKPKNILANA 161 (374)
Q Consensus 84 i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~L-H~~~i~H~dikp~Nil~~~ 161 (374)
+....... .. ..+|||||++| ++.........+++..+..++.|++.+|.++ |+.||+||||||+|||++
T Consensus 81 v~~p~~~~-~~------~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPIL-LK------SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEE-ec------CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 74433322 11 13899999997 5555444556899999999999999999999 799999999999999998
Q ss_pred CCCeEEeeecccccc
Q 017301 162 NCKLKVCDFGLARVA 176 (374)
Q Consensus 162 ~~~vkl~DFg~a~~~ 176 (374)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=179.03 Aligned_cols=141 Identities=21% Similarity=0.186 Sum_probs=111.1
Q ss_pred EeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh----------------------HH--HHHHHHHHHHHHhCCCC
Q 017301 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----------------------SD--AIRILREVKLLRLLRHP 82 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----------------------~~--~~~~~~E~~~l~~l~h~ 82 (374)
+.+.||+|++|.||+|.+. +|+.||+|+++...... .. .....+|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999987542110 00 12245789999999999
Q ss_pred CccccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEec
Q 017301 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILAN 160 (374)
Q Consensus 83 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~ 160 (374)
++.....+... ..|+||||++| ++.........++...+..++.|++.++.++|+ .||+||||||+||+++
T Consensus 80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 87554444321 13899999997 344333344578889999999999999999999 9999999999999999
Q ss_pred CCCCeEEeeecccccc
Q 017301 161 ANCKLKVCDFGLARVA 176 (374)
Q Consensus 161 ~~~~vkl~DFg~a~~~ 176 (374)
++.++|+|||+|+..
T Consensus 153 -~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DGKPYIIDVSQAVEL 167 (190)
T ss_pred -CCCEEEEEcccceec
Confidence 789999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=186.73 Aligned_cols=199 Identities=25% Similarity=0.356 Sum_probs=142.0
Q ss_pred CCCCccccceeecCC----------------------CcCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHH
Q 017301 80 RHPDIVEIKRIMLPP----------------------SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLR 137 (374)
Q Consensus 80 ~h~~i~~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~ 137 (374)
+||||+++..+|.+. ...+...+|+||..+..+|.+++-.+. .+.....-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-RSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-CchHHHHHHHHHHHH
Confidence 599999999887432 123445799999999999999998764 567778889999999
Q ss_pred HHHHhhhCCccccCCCCCceEec--CCC--CeEEeeecccccccCC---CCcccccccccccccccccccccccCCC---
Q 017301 138 ALKYMHTANVYHRDLKPKNILAN--ANC--KLKVCDFGLARVAFSD---TPMTVFWTDYVATRWYRAPELCGSFFSK--- 207 (374)
Q Consensus 138 al~~LH~~~i~H~dikp~Nil~~--~~~--~vkl~DFg~a~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~--- 207 (374)
|+.|||..||.|||+|.+|||+. +++ .++++|||+|-..... -+.....-+..|.-.-||||+...-.++
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 99999999999999999999974 443 3789999998532221 1111111234577779999987542111
Q ss_pred -CCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCC
Q 017301 208 -YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD 286 (374)
Q Consensus 208 -~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 286 (374)
--.++|.|+.|-+.||+++...||++...... + .+.|-+ ..+......++
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------------~---------~r~Yqe-------~qLPalp~~vp 483 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------------D---------TRTYQE-------SQLPALPSRVP 483 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchhee-------------c---------hhhhhh-------hhCCCCcccCC
Confidence 11278999999999999999999987432100 0 000100 11112234578
Q ss_pred hHHHHHHHHhccCCCCCCCCHH
Q 017301 287 PLALRLLQRLIAFDPKDRPTAE 308 (374)
Q Consensus 287 ~~~~~li~~~L~~dp~~Rpt~~ 308 (374)
+.+++|+..+|+.||++|+++.
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hHHHHHHHHHhcCCccccCCcc
Confidence 8999999999999999999844
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=170.63 Aligned_cols=192 Identities=15% Similarity=0.053 Sum_probs=137.6
Q ss_pred eEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChH--HHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCcE
Q 017301 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS--DAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
-+...|++|+||+|+.+.. .+..++.+.+........ ....+.+|+++|+++. |++++++++.. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 3678899999999998854 677888776653322111 1225789999999996 57788887752 25
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC-CCCceEecCCCCeEEeeecccccccCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDL-KPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~di-kp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
|++|||+.| +|.+.... ....++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 74 ~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred EEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999999998 66544321 12357889999999999999999999 7999999999999999999997543322
Q ss_pred Cccc-c---------cccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 017301 181 PMTV-F---------WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235 (374)
Q Consensus 181 ~~~~-~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 235 (374)
.... . ..-...++.|++|+...-....--.+.+.++.|+.+|.++|++.++.+.+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 1000 0 00123577888888543221222246788899999999999998876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=176.03 Aligned_cols=241 Identities=15% Similarity=0.209 Sum_probs=183.8
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l 104 (374)
..++-+|.....|..|+++. .|..+++|++....-.......|..|.-.|+-++||||+.+++.+. ...++.+
T Consensus 192 lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-----sppnlv~ 264 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-----SPPNLVI 264 (448)
T ss_pred hhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-----CCCCceE
Confidence 34567789999999999954 5778888988754445555667889999999999999999999994 3456899
Q ss_pred EEccCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEecCCCCeEEe--eeccccccc
Q 017301 105 VFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVC--DFGLARVAF 177 (374)
Q Consensus 105 v~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~~~~~vkl~--DFg~a~~~~ 177 (374)
+..||+ |+|.+.+.... ..+..++.+++..+++|++|||+.. |.---+....++++++.+.+|. |--++.
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--- 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--- 341 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---
Confidence 999999 69999998654 4577889999999999999999985 4445688889999998776553 322221
Q ss_pred CCCCcccccccccccccccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
........|.|++||.+.... ...-.++|+|||+++++||.|...||...++.+.--++.
T Consensus 342 -------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------ 402 (448)
T KOG0195|consen 342 -------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------ 402 (448)
T ss_pred -------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------------
Confidence 112345678899999886521 223347899999999999999999998877654322211
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL 311 (374)
++.++ ....|+++..+..|+.-|++.||.+||..+.++
T Consensus 403 ----------leglr-------v~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 403 ----------LEGLR-------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------hcccc-------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 11111 133578999999999999999999999987664
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=165.03 Aligned_cols=136 Identities=21% Similarity=0.237 Sum_probs=105.9
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-----CCCCccccceeecCCCcCCCCcE
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-----RHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
.+.||+|++|.||. ++.++.. +||++..... .....+.+|+.+++.+ .||||+++++++.+.. +.+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 56899999999995 6777666 6998864222 2345688999999999 5799999999996643 12333
Q ss_pred E-EEEccCc---ccHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHhhhCCccccCCCCCceEecCC----CCeEEeeeccc
Q 017301 103 Y-VVFELME---SDLHQVIKANDDLTREHHQFFLYQMLRAL-KYMHTANVYHRDLKPKNILANAN----CKLKVCDFGLA 173 (374)
Q Consensus 103 ~-lv~e~~~---~~L~~~l~~~~~l~~~~~~~i~~qi~~al-~~LH~~~i~H~dikp~Nil~~~~----~~vkl~DFg~a 173 (374)
+ +|+||++ ++|.++++.. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899955 4999999764 46665 46688888888 89999999999999999999743 37999995533
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=171.30 Aligned_cols=145 Identities=17% Similarity=0.145 Sum_probs=112.0
Q ss_pred CCeeEeceeeccCCeeEEEEE-ECCCCcEEEEEEecCccCCh--------------------H--HHHHHHHHHHHHHhC
Q 017301 23 NRYKILEVIGKGSYGVVCAAI-DTHTGEKVAIKKIHDVFEHI--------------------S--DAIRILREVKLLRLL 79 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~-~~~~~~~vaiK~~~~~~~~~--------------------~--~~~~~~~E~~~l~~l 79 (374)
.-|.+.+.||+|++|.||+|. +..+|+.||+|+++...... . ....+.+|+.+++.+
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357899999999999999998 67799999999987432100 0 112356899999999
Q ss_pred CCCCccccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCC-ccccCCCCCce
Q 017301 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNI 157 (374)
Q Consensus 80 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~-i~H~dikp~Ni 157 (374)
.+.+ +.+..++... ..++||||++| ++.........+....+..++.|++.+|++||+.| |+||||||+||
T Consensus 108 ~~~~-i~~p~~~~~~------~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI 180 (237)
T smart00090 108 YEAG-VPVPKPIAWR------RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI 180 (237)
T ss_pred HhcC-CCCCeeeEec------CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence 7533 3322333111 24899999998 66655545556677778899999999999999999 99999999999
Q ss_pred EecCCCCeEEeeeccccc
Q 017301 158 LANANCKLKVCDFGLARV 175 (374)
Q Consensus 158 l~~~~~~vkl~DFg~a~~ 175 (374)
+++ ++.++|+|||.|..
T Consensus 181 li~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEE-CCCEEEEEChhhhc
Confidence 999 88999999998864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=194.50 Aligned_cols=193 Identities=24% Similarity=0.315 Sum_probs=152.0
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC---CCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~ 98 (374)
...|.|-+.||+|+||.||+|.+.. |+.||+|+=+...... +.==.+++.+|+ -+.|+.+..++...+.
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-- 768 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNA-- 768 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCCc--
Confidence 4689999999999999999999877 9999999866432211 111112333333 3455555555543332
Q ss_pred CCcEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-------CCCeEEeee
Q 017301 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-------NCKLKVCDF 170 (374)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~-------~~~vkl~DF 170 (374)
.++|+||.+ |+|.+++..++.+++..+..+..|++..|++||..||||+||||+|+|+.. .--++|+||
T Consensus 769 ---S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 769 ---SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred ---ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 589999999 799999999999999999999999999999999999999999999999843 223899999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~ 228 (374)
|.+....--.+. ..+...++|-.+-.+|...| .+++..+|.|.|+-+++.|+.|+
T Consensus 846 G~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCC-cEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 999654322222 23466788999999999998 89999999999999999999997
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-21 Score=178.54 Aligned_cols=181 Identities=29% Similarity=0.456 Sum_probs=134.5
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
..++||.|++|.. +|.+++..+. ..+....+.++.|++.|+.| +|.+|+|+||.||+...+..+||+|||+..
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 3468999999995 9999997543 46778889999999999999 999999999999999999999999999987
Q ss_pred cccCCC---CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 175 VAFSDT---PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 175 ~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
...... +.....+...||.+||+||.+.+ ..|+.++||||||++|+|++. +|..... ....
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~---~f~T~~e--r~~t--------- 468 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLI---QFSTQFE--RIAT--------- 468 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHH---HhccHHH--HHHh---------
Confidence 654433 11223456789999999999998 789999999999999999997 2221110 0000
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
+..+++.. ..+.+..-.+.-.+|+.+||...|.+||++...--|+|.
T Consensus 469 ---------------~~d~r~g~---ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 469 ---------------LTDIRDGI---IPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ---------------hhhhhcCC---CChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 00111100 000111223556789999999999999988777777764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-22 Score=195.20 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=206.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 99 (374)
...|.+.+.||+|+++.|-.+.... ....+|.|.+............+..|..+-+.++ |+|++.+++.. ...
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence 5678999999999999998887643 3446777766544333344555666888877787 99999999988 344
Q ss_pred CcEEEEEccCcc-cHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHhh-hCCccccCCCCCceEecCCC-CeEEeeecccc
Q 017301 100 KDIYVVFELMES-DLHQVI-KAND-DLTREHHQFFLYQMLRALKYMH-TANVYHRDLKPKNILANANC-KLKVCDFGLAR 174 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l-~~~~-~l~~~~~~~i~~qi~~al~~LH-~~~i~H~dikp~Nil~~~~~-~vkl~DFg~a~ 174 (374)
...++++++..| ++..-+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 557999999886 888888 5554 6788899999999999999999 99999999999999999999 99999999998
Q ss_pred cccCCCCcccccccccc-cccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 175 VAFSDTPMTVFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
...............+| ++.|+|||...+. ....+..|+||+|+++..+++|..|+.........
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------------- 239 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------------- 239 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccccc-------------
Confidence 76652233333456788 9999999998763 35577899999999999999999999765432210
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
+....... .......+..++....+++.++|..+|..|.+.+++-.+||+..
T Consensus 240 ------------~~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 240 ------------YSSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ------------ceeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00001110 11123346678999999999999999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=158.93 Aligned_cols=136 Identities=22% Similarity=0.295 Sum_probs=110.0
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh------HHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI------SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++.||+|++|.||+|.. .|..+++|+........ .....+.+|+.++..+.|+++.....++... ..
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~ 73 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----EN 73 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CC
Confidence 36799999999999976 67889999865332211 1223577899999999999987776665332 34
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
.+++|||++| +|.+.+..... ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 6899999987 89988875432 7888999999999999999999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-19 Score=151.78 Aligned_cols=137 Identities=21% Similarity=0.198 Sum_probs=105.0
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh--------------------HHHHHHHHHHHHHHhCCCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--------------------SDAIRILREVKLLRLLRHPD 83 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~~ 83 (374)
.|.+.+.||+|++|.||+|... +|+.||+|++....... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999874 79999999875322110 01123567888998887774
Q ss_pred c--cccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec
Q 017301 84 I--VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (374)
Q Consensus 84 i--~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~ 160 (374)
+ +..++. ...++||||+.| +|...... .....++.+++.++.++|+.||+||||||+||+++
T Consensus 95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceeec---------CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 3 332221 224899999997 66554321 34667889999999999999999999999999999
Q ss_pred CCCCeEEeeecccccc
Q 017301 161 ANCKLKVCDFGLARVA 176 (374)
Q Consensus 161 ~~~~vkl~DFg~a~~~ 176 (374)
.++.++|+|||.+...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=152.93 Aligned_cols=131 Identities=27% Similarity=0.371 Sum_probs=102.1
Q ss_pred eeeccCCeeEEEEEECCCCcEEEEEEecCcc-CC-----hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EH-----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
.||+|++|.||+|. .++..+++|...... .. .....++.+|+.+++.+.|+++.......... ...+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 48999999999997 467889999865321 11 11234677899999999888755444443222 2358
Q ss_pred EEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 104 VVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 104 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
+||||++| +|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999987 88887755321 7899999999999999999999999999999 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.3e-19 Score=165.25 Aligned_cols=211 Identities=24% Similarity=0.323 Sum_probs=153.3
Q ss_pred HHhCCCCCccccceeecCCCcCCCCcEEEEEccCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCc-cccCC
Q 017301 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANV-YHRDL 152 (374)
Q Consensus 76 l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i-~H~di 152 (374)
|+.+.|.|+.++++.+.+. ..+++|.+||. |+|.+.+.. .-.++.-....+++.|+.|++|||..-| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4567899999999999766 45899999999 699999987 4478888889999999999999999865 99999
Q ss_pred CCCceEecCCCCeEEeeecccccccCCCCccccccccccccccccccccccc--CC---CCCccchHHHHHHHHHHHHhC
Q 017301 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF--FS---KYTPAIDIWSIGCIFAEVLTG 227 (374)
Q Consensus 153 kp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~---~~~~~~DiwSlG~il~~lltg 227 (374)
+..|.+++....+||+|||+........ .........-...|.|||++.+. .. ..+.+.|+||+|++++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccc-cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999987653211 11111112234559999998652 11 256789999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH
Q 017301 228 KPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307 (374)
Q Consensus 228 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~ 307 (374)
..||...........+.. .++........|.........+.+..+++.|+..+|..||++
T Consensus 155 ~~~~~~~~~~~~~~eii~--------------------~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIIL--------------------RVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred cCccccccccCChHHHHH--------------------HHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 999976432211111110 011111111222222122455678999999999999999999
Q ss_pred HHHhc
Q 017301 308 EEALA 312 (374)
Q Consensus 308 ~~lL~ 312 (374)
+++-.
T Consensus 215 ~~i~~ 219 (484)
T KOG1023|consen 215 EQIRS 219 (484)
T ss_pred HHHHh
Confidence 98854
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-18 Score=144.15 Aligned_cols=137 Identities=23% Similarity=0.264 Sum_probs=96.4
Q ss_pred EeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHH----------------------HHHHHHHHHhCCCCC-
Q 017301 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR----------------------ILREVKLLRLLRHPD- 83 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~~- 83 (374)
+.+.||+|++|+||+|.+. +++.||+|++............ ...|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999876 8999999998643222111111 134566666554332
Q ss_pred -ccccceeecCCCcCCCCcEEEEEccCcc-cHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEe
Q 017301 84 -IVEIKRIMLPPSKREFKDIYVVFELMES-DLH-QVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILA 159 (374)
Q Consensus 84 -i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~-~~l~~~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~ 159 (374)
+.+.++. ...++||||+++ .+. ..+.... .. ..+..++.+++.++.++|+ .||+|+||||+||++
T Consensus 80 ~~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 80 PVPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV 148 (187)
T ss_pred CCCceEec---------CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence 2333222 124899999997 221 1121111 11 6788899999999999999 999999999999999
Q ss_pred cCCCCeEEeeecccccc
Q 017301 160 NANCKLKVCDFGLARVA 176 (374)
Q Consensus 160 ~~~~~vkl~DFg~a~~~ 176 (374)
+ ++.++|+|||.+...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 889999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-18 Score=166.04 Aligned_cols=137 Identities=23% Similarity=0.310 Sum_probs=106.0
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEec-CccCC-----hHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEH-----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~-~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..|...+.||+|+||+||++... +..+++|+.. +.... ......+.+|+.+++.++|++++.........
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 34566899999999999999764 3445555432 11111 12234678999999999999988766555332
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...++||||++| +|.+++. ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 409 ---~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 409 ---EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ---CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 235899999997 8888875 356789999999999999999999999999999 577899999999864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.8e-17 Score=140.97 Aligned_cols=140 Identities=21% Similarity=0.267 Sum_probs=102.9
Q ss_pred eceee-ccCCeeEEEEEECCCCcEEEEEEecCcc------C-----ChHHHHHHHHHHHHHHhCCCCCc--cccceeecC
Q 017301 28 LEVIG-KGSYGVVCAAIDTHTGEKVAIKKIHDVF------E-----HISDAIRILREVKLLRLLRHPDI--VEIKRIMLP 93 (374)
Q Consensus 28 ~~~lg-~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~-----~~~~~~~~~~E~~~l~~l~h~~i--~~~~~~~~~ 93 (374)
...|| .|+.|+||.+.. .+..+|+|.+.... . ......++.+|+.++..+.|+++ +..+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 34576 788888888855 37889999875311 0 11233467889999999998875 555555332
Q ss_pred CCcCCCCcEEEEEccCcc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeec
Q 017301 94 PSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg 171 (374)
.. ......++|||+++| +|.+++.. ..+++. .+.+|+.+|.+||++||+||||||.|||++.++.++|+|||
T Consensus 114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 114 RH-GLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred ec-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 21 111224699999995 88888765 345554 36789999999999999999999999999999999999999
Q ss_pred cccc
Q 017301 172 LARV 175 (374)
Q Consensus 172 ~a~~ 175 (374)
.++.
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-17 Score=156.50 Aligned_cols=258 Identities=25% Similarity=0.227 Sum_probs=197.4
Q ss_pred CCCeeEeceeec--cCCeeEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGK--GSYGVVCAAID--THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~--G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 96 (374)
..++.+...+|+ |.+|.||.+.. ..++..+|+|.-+...........-.+|+...+.++ |++.++.+..+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~----- 187 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW----- 187 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----
Confidence 456778889999 99999999988 888999999985544443333444456777666664 99999977777
Q ss_pred CCCCcEEEEEccCcccHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHhhhCCccccCCCCCceEecCC-CCeEEeee
Q 017301 97 REFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLR----ALKYMHTANVYHRDLKPKNILANAN-CKLKVCDF 170 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~----al~~LH~~~i~H~dikp~Nil~~~~-~~vkl~DF 170 (374)
.+....|+-+|+|+.+|.++...... ++...++.++.+... ||.++|+.+++|-|+||.||+...+ ...+++||
T Consensus 188 e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 188 EGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred ccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 55566899999999999888887554 889999999999999 9999999999999999999999999 78999999
Q ss_pred cccccccCCCCccccc--ccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC--ChhhHHHHHHHh
Q 017301 171 GLARVAFSDTPMTVFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--SVVHQLDLITDL 246 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~--~~~~~~~~i~~~ 246 (374)
|+...+.......... ....|...|++||+..+ -++.++|++|+|.++.+-.+|..++... +...++..+.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-- 342 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-- 342 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--
Confidence 9988765544222111 22256777999999876 5788999999999999999987655443 2111111000
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
-..+.....+..+...+..|++.+|..|++++.+++|+++...
T Consensus 343 ------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 343 ------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 0001122456666779999999999999999999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.5e-16 Score=127.33 Aligned_cols=131 Identities=22% Similarity=0.229 Sum_probs=105.6
Q ss_pred EeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCC--CCccccceeecCCCcCCCCcEEE
Q 017301 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH--PDIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~l 104 (374)
+++.||+|+++.||++... +..+++|....... ...+.+|+..++.+++ .++++++..... .+..++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES-----DGWSYL 70 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEE
Confidence 4678999999999999864 37899998864322 4467789999999976 478887776632 245899
Q ss_pred EEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC---CccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA---NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 105 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~---~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
+|||+.| .+..+ +......++.+++.+++.||.. +++|+|++|+||+++..+.++++|||.++.
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999987 44333 5566777899999999999985 799999999999999988999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.8e-15 Score=140.25 Aligned_cols=184 Identities=23% Similarity=0.332 Sum_probs=134.8
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEE
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l 104 (374)
|.+ ...+-++.+..-.|..+.++.+|.+.+.+.... .....+.+-+..|+.++||||+++++.+ +...++||
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~yl 86 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYL 86 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEE
Confidence 444 444444444333466678899999998875322 3344567788899999999999999998 55567999
Q ss_pred EEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh-hCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc
Q 017301 105 VFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH-TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (374)
Q Consensus 105 v~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH-~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (374)
|+|.+.. |..+++. ++...+...++||+.||.||| +++++|++|.-+.|+++..|..||++|..+.........
T Consensus 87 vTErV~P-l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~- 161 (690)
T KOG1243|consen 87 VTERVRP-LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP- 161 (690)
T ss_pred Eeecccc-HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-
Confidence 9998873 4445554 336788889999999999997 668999999999999999999999999988654332221
Q ss_pred cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 017301 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227 (374)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg 227 (374)
......-..|..|+.+.. -+-..|.|.|||++++++.|
T Consensus 162 --~~~~~~~~s~~~P~~~~~----s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 --AKSLYLIESFDDPEEIDP----SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cccchhhhcccChhhcCc----cccchhhhhHHHHHHHHhCc
Confidence 011122223677776533 12467999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4e-16 Score=154.10 Aligned_cols=265 Identities=23% Similarity=0.262 Sum_probs=190.8
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
-.+.+.+.+-+-+|++|.++.+.-..+|...+.|+...... ..........+-+++-...+|.++.....+ ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 35667788899999999999998888887777776532111 001112222232333233345555443332 223
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...+|+++|+++ +|...+...+..+.+-++..+..+..++++||+..+.|+|++|.|++...++..++.|||.......
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 458999999986 9999999888888888899999999999999999999999999999999999999999984322110
Q ss_pred CCC---c-------------------------ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 017301 179 DTP---M-------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (374)
Q Consensus 179 ~~~---~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~p 230 (374)
-.+ . ........||+.|.+||...+ ...+.++|.|+.|+++++.++|.+|
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCC
Confidence 000 0 000123468999999999988 6778899999999999999999999
Q ss_pred CCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHH--
Q 017301 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-- 308 (374)
Q Consensus 231 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~-- 308 (374)
|+.......+..|.+ ... ++.......+..+.+++..+|..+|.+|..+.
T Consensus 1035 ~na~tpq~~f~ni~~--------------------------~~~--~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~ 1086 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILN--------------------------RDI--PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGA 1086 (1205)
T ss_pred CCCcchhhhhhcccc--------------------------CCC--CCCCCccccChhhhhhhhhhhccCchhccCcccc
Confidence 988876544433221 011 11112234688899999999999999999887
Q ss_pred -HHhcCCCCCcCc
Q 017301 309 -EALADPYFKGLA 320 (374)
Q Consensus 309 -~lL~hp~~~~~~ 320 (374)
++-.||||+...
T Consensus 1087 ~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1087 AEVKGHPFFQDVD 1099 (1205)
T ss_pred cccccCCccCCCC
Confidence 888999998754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.8e-16 Score=136.89 Aligned_cols=248 Identities=19% Similarity=0.198 Sum_probs=162.8
Q ss_pred eEEEEEECCCCcEEEEEEecCcc-CChH-HHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccCc-ccHH
Q 017301 38 VVCAAIDTHTGEKVAIKKIHDVF-EHIS-DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLH 114 (374)
Q Consensus 38 ~V~~a~~~~~~~~vaiK~~~~~~-~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 114 (374)
.||++.+...|..|+...++... .+.. .......-...|-++-|.|+++++.++.+....+...+.++.||+. |++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 45666666666666654443111 1111 1112222334455667999999999997766666778999999999 5998
Q ss_pred HHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEecCCCCeEEeeecccccccCC-CCcccccc
Q 017301 115 QVIKA----NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSD-TPMTVFWT 187 (374)
Q Consensus 115 ~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~-~~~~~~~~ 187 (374)
+++++ ...+.....++|+-||+.||.|||+.. |+|+++..+.|++..+|.+|++--......... .......+
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence 88875 336888999999999999999999995 999999999999999998888632221111000 00011112
Q ss_pred cccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCC-CCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 017301 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP-LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (374)
Q Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (374)
...+-++|.|||.-.- ...+.++|||++|....+|..|.. +-++.+....-..+.+.
T Consensus 241 ~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~-------------------- 298 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV-------------------- 298 (458)
T ss_pred ccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh--------------------
Confidence 2346688999996433 456678999999999999988763 22222211110001000
Q ss_pred HHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.+.--++.-++++.+||+..|..||++.++|.||.+-++..
T Consensus 299 --------------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 299 --------------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS 339 (458)
T ss_pred --------------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence 00011223467899999999999999999999998766543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.3e-14 Score=119.40 Aligned_cols=139 Identities=19% Similarity=0.206 Sum_probs=99.9
Q ss_pred eceeeccCCeeEEEEEECC------CCcEEEEEEecCcc----------------C----ChHHHHH----HHHHHHHHH
Q 017301 28 LEVIGKGSYGVVCAAIDTH------TGEKVAIKKIHDVF----------------E----HISDAIR----ILREVKLLR 77 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~------~~~~vaiK~~~~~~----------------~----~~~~~~~----~~~E~~~l~ 77 (374)
...||.|--+.||.|.... .+..+|+|+.+... . ....... ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999997653 35799999875210 0 0111222 348999999
Q ss_pred hCCC--CCccccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-hhCCccccCCC
Q 017301 78 LLRH--PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLK 153 (374)
Q Consensus 78 ~l~h--~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~L-H~~~i~H~dik 153 (374)
++.. -+++..+.+. . -+|||||+++ .+..-......+++.....+..+++.+|..| |..|++|+|++
T Consensus 82 rl~~~Gv~vP~pi~~~---~------~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---K------HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---C------CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9853 4555555431 1 3899999986 3322222223456667788899999999998 89999999999
Q ss_pred CCceEecCCCCeEEeeecccccc
Q 017301 154 PKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 154 p~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
|.||++. ++.+.|+|||.|...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 467999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.8e-14 Score=138.72 Aligned_cols=142 Identities=20% Similarity=0.300 Sum_probs=94.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC----------------------------h----HHHH---
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----------------------------I----SDAI--- 67 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----------------------------~----~~~~--- 67 (374)
..|.. +.||+|++|.||+|+.+.+|+.||||+.+..... . ....
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 7899999999999999888999999998743100 0 0011
Q ss_pred ---HHHHHHHHHHhCC----CCCccccceeecCCCcCCCCcEEEEEccCcc-cHHHH--HHhCC----CCCHHHHHHHHH
Q 017301 68 ---RILREVKLLRLLR----HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQV--IKAND----DLTREHHQFFLY 133 (374)
Q Consensus 68 ---~~~~E~~~l~~l~----h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~--l~~~~----~l~~~~~~~i~~ 133 (374)
.+.+|...+.++. +.+.+.+-.++.+. ...-++||||+.| .+.+. +...+ .+.+..+..++.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 1333444444432 33334444444221 1235899999998 77653 33333 244455555556
Q ss_pred HHHHHHHHhhhCCccccCCCCCceEecCCC----CeEEeeecccccc
Q 017301 134 QMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDFGLARVA 176 (374)
Q Consensus 134 qi~~al~~LH~~~i~H~dikp~Nil~~~~~----~vkl~DFg~a~~~ 176 (374)
|++ ..|++|+|+||.||+++.+| +++++|||.+...
T Consensus 275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 655 58999999999999999988 9999999998654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.5e-13 Score=130.91 Aligned_cols=141 Identities=19% Similarity=0.260 Sum_probs=93.9
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChH--------------------------------------HHHHH
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS--------------------------------------DAIRI 69 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~--------------------------------------~~~~~ 69 (374)
.+.||+|++|.||+|+. .+|+.||||+.+......- ....+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 35799999999999986 4799999999864211000 00023
Q ss_pred HHHHHHHHhC----CCCCccccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHh
Q 017301 70 LREVKLLRLL----RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLR-ALKYM 142 (374)
Q Consensus 70 ~~E~~~l~~l----~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~-al~~L 142 (374)
.+|...+..+ ++.+-+.+-.++...+ ..-++||||++| +|.+..... ... ....++..++. .+..+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH
Confidence 3455555444 2333333333442211 225899999997 777665432 122 23345556655 46789
Q ss_pred hhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 143 H~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
|..|++|+|+||.||+++.+++++++|||++...
T Consensus 274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.6e-14 Score=115.57 Aligned_cols=126 Identities=19% Similarity=0.193 Sum_probs=91.9
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCcc-ccceeecCCCcCCCCcEEEEE
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV-EIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~~~~~~lv~ 106 (374)
++.|+.|.++.||++... +..|++|....... ....+.+|+.+++.+.+.+++ +++... . ..-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~------~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD-P------ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe-C------CCCeEEE
Confidence 467899999999999754 78899998754321 122456788998888655544 333332 1 1137999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCc-----cccCCCCCceEecCCCCeEEeeecccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV-----YHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i-----~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
|+++| ++.+. ......++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99998 54432 01123467899999999999985 9999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.8e-14 Score=133.46 Aligned_cols=252 Identities=22% Similarity=0.225 Sum_probs=179.5
Q ss_pred CCCCeeEeceeeccCCeeEEEEEEC-CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
...+|..+..||.|.++.|+.+..+ .++..|++|...+..........-..|+.+...+ .|.+++..+..|. .
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-----~ 337 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-----Q 337 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-----c
Confidence 3467889999999999999988755 6778999998876555444444455677776666 4899998888873 4
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC-CCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~-~~vkl~DFg~a~~~ 176 (374)
..+.|+--|||.+ ++...+.....+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..+++|||.++..
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 4457899999985 544444444468889999999999999999999999999999999999886 77899999988632
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.-... ....++..|...|++... ..+..+.|++|||.-+.+.++|.+.-........+
T Consensus 418 ~~~~~-----~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i---------------- 475 (524)
T KOG0601|consen 418 AFSSG-----VFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI---------------- 475 (524)
T ss_pred ceecc-----cccccccccccchhhccc-cccccccccccccccccccccCcccCcccccceee----------------
Confidence 11111 011123334234544432 67888999999999999999987433222111000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
........+.....+..+.+.++..|+..||.+.++..|.=|.
T Consensus 476 ------------------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 ------------------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ------------------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0011111234456778899999999999999999998887654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.1e-11 Score=100.38 Aligned_cols=142 Identities=22% Similarity=0.292 Sum_probs=104.3
Q ss_pred EeceeeccCCeeEEEEEECCCCcEEEEEEec-Ccc-----CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVF-----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~-~~~-----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.+..|.+|+-+.|+++ ..+|+..+||.-- +.. ...-...+..+|.+.|.++.--.|....-++.+...
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~---- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG---- 84 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence 6778999999999999 4579998888642 111 122234456789999988865555444344433322
Q ss_pred cEEEEEccCcc--cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC---eEEeeeccc
Q 017301 101 DIYVVFELMES--DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLA 173 (374)
Q Consensus 101 ~~~lv~e~~~~--~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~---vkl~DFg~a 173 (374)
-.|+|||++| ++.+++.+.. .........++..|-+.|.-||.++|+|+||..+||++..++. +.++|||++
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 3799999998 8888887532 2333344788999999999999999999999999999876653 589999998
Q ss_pred cc
Q 017301 174 RV 175 (374)
Q Consensus 174 ~~ 175 (374)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.1e-11 Score=112.96 Aligned_cols=215 Identities=17% Similarity=0.204 Sum_probs=154.4
Q ss_pred CCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccCcc--c
Q 017301 35 SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES--D 112 (374)
Q Consensus 35 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~--~ 112 (374)
...+.|+|....+|..|++|.++...... ......-+...+++.|+|+|++.+++.... -....+++|++|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCch
Confidence 45688999999999999999995321110 111223567788999999999999998443 344669999999985 7
Q ss_pred HHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 113 LHQVIKA---------------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 113 L~~~l~~---------------~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
|.++.-. +...+++.+|.++.||..||.++|+.|...+-|.|.+|+++.+.+++|..-|......
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 8776632 2357889999999999999999999999999999999999999889998777654432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCC-CCCCChhhH-HHHHHHhhCCCCHHHH
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQ-LDLITDLLGTPSPETI 255 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~ 255 (374)
.+. . +-+.+ -.+-|.=.||.+++.|.||+.- +........ +..|
T Consensus 445 ~d~---------------~--~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------ 490 (655)
T KOG3741|consen 445 EDP---------------T--EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------ 490 (655)
T ss_pred CCC---------------C--cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------
Confidence 221 0 11111 2357999999999999999632 111111100 1111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.+.+|.+++++|.-+...++.+ -++.+++.|
T Consensus 491 --------------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 --------------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --------------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1356778888888888888876 678888775
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1e-11 Score=101.03 Aligned_cols=132 Identities=21% Similarity=0.309 Sum_probs=93.9
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEec-CccCChH-----HHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHIS-----DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~-~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
..+++|+-+.++.+.. -|..+++|.-. +.-.... ...+..+|..++..+.--.|....-+..++. ..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~-----~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD-----NG 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CC
Confidence 4678999999999843 45567777643 2222222 2234667999998886444443333332222 24
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
.|+|||.+| .|.+.+... ...++..+-.-+.-||.+||+|+|+.++||++..++ +.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 799999999 667677665 245677788888899999999999999999998775 99999999863
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-10 Score=104.94 Aligned_cols=259 Identities=17% Similarity=0.153 Sum_probs=161.6
Q ss_pred eEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh-CCCCCcccccee---ecCCCcCCCCc
Q 017301 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL-LRHPDIVEIKRI---MLPPSKREFKD 101 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~---~~~~~~~~~~~ 101 (374)
..++.||+|+-+.+|..-. -+ ..+.|+++....... .+ .+..|.. -.||-+-.-+.. .+.+. +....
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~-d~VAKIYh~Pppa~~--aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VR-DQVAKIYHAPPPAAQ--AQ---KVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch--hh-chhheeecCCCchHH--HH---HHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 4578899999999997732 22 345688876433211 11 1222222 345543321110 01111 22334
Q ss_pred EEEEEccCcc--cHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccc
Q 017301 102 IYVVFELMES--DLHQVIK------ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 102 ~~lv~e~~~~--~L~~~l~------~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
+.++|..+.| .+..++. +.....++...+..+.|+.+.+.||..|-+-+|+.++|+|+++++.|.|+|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 8899999886 5555553 2235788999999999999999999999999999999999999999999984433
Q ss_pred ccccCCCCccccccccccccccccccccc-ccC--CCCCccchHHHHHHHHHHHHhC-CCCCCCCChhhHHHHHHHhhCC
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCG-SFF--SKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~--~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
.+... .......+|.+.|.+||.-. +.. -.-+...|-|.||+++|+++.| +.||.|-.. ....
T Consensus 165 qi~~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~---------~~~a 231 (637)
T COG4248 165 QINAN----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL---------ISDA 231 (637)
T ss_pred eeccC----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc---------cCCC
Confidence 22211 22334567999999999643 110 2345678999999999999997 899987431 1112
Q ss_pred CCHH--HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccC--CCCCCCCHHH
Q 017301 250 PSPE--TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF--DPKDRPTAEE 309 (374)
Q Consensus 250 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dp~~Rpt~~~ 309 (374)
|.+- .+........ -+.-....+.+..-.+.-+++++..|..+|+.. ++.-|||++.
T Consensus 232 p~p~E~~Ia~g~f~ya---~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 232 PNPLETDIAHGRFAYA---SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred CCcchhhhhcceeeec---hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 2211 1111111111 112222333333444556889999999999864 3568998653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.1e-12 Score=122.34 Aligned_cols=155 Identities=23% Similarity=0.306 Sum_probs=112.7
Q ss_pred HHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeecccccccCCCCccccc------ccccccccccccccccccCCCC
Q 017301 136 LRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW------TDYVATRWYRAPELCGSFFSKY 208 (374)
Q Consensus 136 ~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~ 208 (374)
+.|+.|+|.. ++||++|.|++|.++.++.+||+.|+++............. ........|.|||++.+ ...
T Consensus 109 ~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--~~~ 186 (700)
T KOG2137|consen 109 ADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--TTN 186 (700)
T ss_pred cchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--ccc
Confidence 3899999976 99999999999999999999999999986544422211000 01123456999999988 678
Q ss_pred CccchHHHHHHHHHHHH-hCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCh
Q 017301 209 TPAIDIWSIGCIFAEVL-TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP 287 (374)
Q Consensus 209 ~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 287 (374)
+.++|+||+||++|.+. .|...+...........-. ............++++
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~---------------------------~~~~~~~~~~s~~~p~ 239 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR---------------------------NLLNAGAFGYSNNLPS 239 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhh---------------------------cccccccccccccCcH
Confidence 89999999999999999 5666665543221111000 0000111122257899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 288 ~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
++++=+.++|..++..||++..++..|||.+.
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 99999999999999999999999999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.1e-10 Score=101.82 Aligned_cols=142 Identities=14% Similarity=0.093 Sum_probs=96.1
Q ss_pred eeccCCeeEEEEEECCCCcEEEEEEecCccCCh---------HHHHHHHHHHHHHHhCCCCCcccc--ceeecCCCcCCC
Q 017301 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---------SDAIRILREVKLLRLLRHPDIVEI--KRIMLPPSKREF 99 (374)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~--~~~~~~~~~~~~ 99 (374)
+-......|.++. ..|+.|.+|......... .....+.+|...+..+..-+|... +.+.........
T Consensus 30 v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 30 FRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3333334455653 457789999764321110 001136789888888854444333 333322111113
Q ss_pred CcEEEEEccCcc--cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-------CCCeEEe
Q 017301 100 KDIYVVFELMES--DLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-------NCKLKVC 168 (374)
Q Consensus 100 ~~~~lv~e~~~~--~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~-------~~~vkl~ 168 (374)
..-++|||++++ +|.+++.. ....+......++.+++..+.-||.+||+|+|++|.|||++. ++.+.|+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 456899999997 78888764 345567778899999999999999999999999999999975 4679999
Q ss_pred eecccc
Q 017301 169 DFGLAR 174 (374)
Q Consensus 169 DFg~a~ 174 (374)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999775
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=9.5e-11 Score=101.82 Aligned_cols=142 Identities=18% Similarity=0.264 Sum_probs=100.3
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.|+.|..+.||++... .|..+++|........ .....+.+|..+++.+.+.+ +.+++....... ..+..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEE
Confidence 56899999999999764 3688999987543221 12345778999999987533 455555543211 123468999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------------
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT----------------------------------------- 144 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~----------------------------------------- 144 (374)
|+++| ++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99997 55544321 346666777777777777777774
Q ss_pred ---------------CCccccCCCCCceEecC--CCCeEEeeeccccc
Q 017301 145 ---------------ANVYHRDLKPKNILANA--NCKLKVCDFGLARV 175 (374)
Q Consensus 145 ---------------~~i~H~dikp~Nil~~~--~~~vkl~DFg~a~~ 175 (374)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23599999999999998 56689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-10 Score=96.81 Aligned_cols=126 Identities=26% Similarity=0.304 Sum_probs=81.9
Q ss_pred eEEEEEECCCCcEEEEEEecCc----------------c--------CChHHHHHHHHHHHHHHhCCCC--Cccccceee
Q 017301 38 VVCAAIDTHTGEKVAIKKIHDV----------------F--------EHISDAIRILREVKLLRLLRHP--DIVEIKRIM 91 (374)
Q Consensus 38 ~V~~a~~~~~~~~vaiK~~~~~----------------~--------~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~ 91 (374)
.||.|.. ..|..+|+|+.+.. . ..........+|++.|..+..- ++++.+.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888875 46779999987520 0 0011123467899999999755 455555443
Q ss_pred cCCCcCCCCcEEEEEccCc--c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-hhhCCccccCCCCCceEecCCCCeEE
Q 017301 92 LPPSKREFKDIYVVFELME--S-DLHQVIKANDDLTREHHQFFLYQMLRALKY-MHTANVYHRDLKPKNILANANCKLKV 167 (374)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~--~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~-LH~~~i~H~dikp~Nil~~~~~~vkl 167 (374)
. -+|||||++ | .+..+.... ++......++.+++..+.. +|+.||+|+|+.+.||+++.+ .+.+
T Consensus 80 ---~------~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---R------NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---T------TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE
T ss_pred ---C------CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEE
Confidence 1 279999999 7 443333221 2245567788888886555 689999999999999999988 8999
Q ss_pred eeecccccc
Q 017301 168 CDFGLARVA 176 (374)
Q Consensus 168 ~DFg~a~~~ 176 (374)
+|||.|...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999998653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.2e-10 Score=95.56 Aligned_cols=109 Identities=25% Similarity=0.345 Sum_probs=84.9
Q ss_pred HHHHHHHHHHHHhCCCCCc--cccceeecCCCcCCCCcEEEEEccCcc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 017301 66 AIRILREVKLLRLLRHPDI--VEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQMLRALKY 141 (374)
Q Consensus 66 ~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~~~~~~~~~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qi~~al~~ 141 (374)
..+..+|...+..+..-+| ++.+.+...... .....++|+|++++ +|.+++......+......++.+++..++-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 3467788888887754333 344444432221 12456899999996 799999875557778889999999999999
Q ss_pred hhhCCccccCCCCCceEecCCC---CeEEeeeccccc
Q 017301 142 MHTANVYHRDLKPKNILANANC---KLKVCDFGLARV 175 (374)
Q Consensus 142 LH~~~i~H~dikp~Nil~~~~~---~vkl~DFg~a~~ 175 (374)
||++||+|+|++|.|||++.++ .+.++||+.++.
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.7e-09 Score=93.37 Aligned_cols=136 Identities=26% Similarity=0.245 Sum_probs=100.8
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecC------------------ccCC--hHHHHHHHHHHHHHHhCCCC--
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD------------------VFEH--ISDAIRILREVKLLRLLRHP-- 82 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~------------------~~~~--~~~~~~~~~E~~~l~~l~h~-- 82 (374)
+.++.+||-|--|.||.|.+. .|.++|+|.=+- .... .-......+|..+|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 467899999999999999865 789999995320 0000 11233567899999988643
Q ss_pred CccccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC
Q 017301 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (374)
Q Consensus 83 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~ 161 (374)
.+++.++. +.-++|||+++| .|...- +.......++..|++-+..+-..|++|+|+++-||+++.
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 44444332 234899999998 443322 235566777888888888888999999999999999999
Q ss_pred CCCeEEeeeccccc
Q 017301 162 NCKLKVCDFGLARV 175 (374)
Q Consensus 162 ~~~vkl~DFg~a~~ 175 (374)
+|.+.++||-.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999998753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.2e-08 Score=86.09 Aligned_cols=142 Identities=18% Similarity=0.155 Sum_probs=101.5
Q ss_pred eeccCCeeEEEEEECCCCcEEEEEEecC----ccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCcCCCCcEEE
Q 017301 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHD----VFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~----~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~l 104 (374)
-|+||-|-|+.... .|..+-+|.-.. ..........+.+|+..++.+..-+ +++.. ++-.......-.-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 36788888988743 345688886541 1111224557889999998886433 33333 111111122345689
Q ss_pred EEccCcc--cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC--eEEeeeccccc
Q 017301 105 VFELMES--DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--LKVCDFGLARV 175 (374)
Q Consensus 105 v~e~~~~--~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~--vkl~DFg~a~~ 175 (374)
|+|-++| +|.+++... .+.+......++.+++.+++-||+.|+.|+|+-+.||+++.++. +.++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998885 898888663 35577778899999999999999999999999999999987777 99999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.8e-09 Score=87.53 Aligned_cols=143 Identities=20% Similarity=0.250 Sum_probs=90.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHH-HHH------HHHHHHHHHhCCCCCcccc---ceee
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD-AIR------ILREVKLLRLLRHPDIVEI---KRIM 91 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~-~~~------~~~E~~~l~~l~h~~i~~~---~~~~ 91 (374)
.++|++.+.+.......|.+. ...|..+++|........... ... ..+++..+..+...++..+ +-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 578888888888777666666 467889999987642211111 111 2234444444433333322 2222
Q ss_pred cCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeee
Q 017301 92 LPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (374)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DF 170 (374)
.-....-....+++|||++| .|.+... +++ .+.-.+.+++.-||+.|+.|+|.+|.|++++.++ ++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 21121222345689999998 6655432 222 2445677889999999999999999999998665 999999
Q ss_pred ccccc
Q 017301 171 GLARV 175 (374)
Q Consensus 171 g~a~~ 175 (374)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.8e-08 Score=82.39 Aligned_cols=138 Identities=19% Similarity=0.172 Sum_probs=96.9
Q ss_pred EeceeeccCCeeEEEEEECCCCcEEEEEEecCccC--------------------ChHHH--HHHHHHHHHHHhCC--CC
Q 017301 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--------------------HISDA--IRILREVKLLRLLR--HP 82 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------------------~~~~~--~~~~~E~~~l~~l~--h~ 82 (374)
+...|+.|--+.||+|.. .++..+|+|+++.... +.... .-..+|+..|+++. +-
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 345788899999999964 5688999999862110 11111 12457888888875 44
Q ss_pred CccccceeecCCCcCCCCcEEEEEccCccc--HHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEe
Q 017301 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILA 159 (374)
Q Consensus 83 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~--L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~ 159 (374)
.+.+.+.+. +-.||||+++.. -.-.++.- ++...++..+..++++.+.-|-. .|+||+||+.=|||+
T Consensus 131 rvP~Pi~~~---------~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 131 RVPEPIAFR---------NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred CCCCceeec---------CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 445555444 237999999853 11112111 23334788889999999998877 899999999999999
Q ss_pred cCCCCeEEeeecccccc
Q 017301 160 NANCKLKVCDFGLARVA 176 (374)
Q Consensus 160 ~~~~~vkl~DFg~a~~~ 176 (374)
. ++.+.++|||.|...
T Consensus 201 ~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 201 H-DGEPYIIDVSQAVTI 216 (268)
T ss_pred E-CCeEEEEECcccccc
Confidence 9 778999999998654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.8e-07 Score=93.74 Aligned_cols=205 Identities=16% Similarity=0.202 Sum_probs=138.9
Q ss_pred HHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 017301 69 ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147 (374)
Q Consensus 69 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i 147 (374)
...|+..+....|+|++.++.+-...-... ..+.+..++|.. ++...+..-+..+....+.+..++++|++++|+...
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 345666778889999999988775443221 235566778886 899999998899999999999999999999999965
Q ss_pred cccCCCCC---ceEecCCCCeEEe--eecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHH
Q 017301 148 YHRDLKPK---NILANANCKLKVC--DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 222 (374)
Q Consensus 148 ~H~dikp~---Nil~~~~~~vkl~--DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ 222 (374)
.|.-+..+ +--.+..+.+..+ ||+.......... ......+..+.|||.............|+|.+|..+.
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~----~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK----SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCccc----chhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 55544443 3334445556655 7777654322211 1222345557788877653233344579999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCh-HHHHHHHHhccCCC
Q 017301 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP-LALRLLQRLIAFDP 301 (374)
Q Consensus 223 ~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dp 301 (374)
.+..|..+-.... .+.. ..+..+. ...+.+.+|+.-++
T Consensus 384 ~~~~~~~i~~~~~------~~~~-----------------------------------~l~~~~~~~~~d~~~~~~~~~~ 422 (1351)
T KOG1035|consen 384 QLSQGEDISEKSA------VPVS-----------------------------------LLDVLSTSELLDALPKCLDEDS 422 (1351)
T ss_pred hhhhcCccccccc------chhh-----------------------------------hhccccchhhhhhhhhhcchhh
Confidence 9998764321110 0000 0111122 67789999999999
Q ss_pred CCCCCHHHHhcCCCCCcC
Q 017301 302 KDRPTAEEALADPYFKGL 319 (374)
Q Consensus 302 ~~Rpt~~~lL~hp~~~~~ 319 (374)
++|+++.+++.|+|.+..
T Consensus 423 ~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 423 EERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhccchhhhhhchhcccc
Confidence 999999999999998753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.56 E-value=9.9e-07 Score=76.75 Aligned_cols=132 Identities=17% Similarity=0.175 Sum_probs=77.6
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCc--cccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI--VEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-.+ .+.+.+.. .....++||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~-----~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVE-----DGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEe-----cCCeeeeee
Confidence 56899999999984 25578889875322 23346789999988864333 45555542 223367899
Q ss_pred ccCcc-c-HHHHH---------------------HhC--CCCCHHHH-HHHHHH----------HHHH-HHHhh--h--C
Q 017301 107 ELMES-D-LHQVI---------------------KAN--DDLTREHH-QFFLYQ----------MLRA-LKYMH--T--A 145 (374)
Q Consensus 107 e~~~~-~-L~~~l---------------------~~~--~~l~~~~~-~~i~~q----------i~~a-l~~LH--~--~ 145 (374)
|+++| + +...+ +.- ...+.... ..+..+ +... ..+|. . .
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 99998 3 11111 000 01111110 001000 0111 11121 1 2
Q ss_pred CccccCCCCCceEecCCCCeEEeeecccc
Q 017301 146 NVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 146 ~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.++|+|+.|.||+++.++ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 468999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.3e-08 Score=97.00 Aligned_cols=246 Identities=15% Similarity=0.130 Sum_probs=165.3
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC-ccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~~ 99 (374)
...-|....-+++|+++.+++.+...+...+ .+++... ....-++++|.+++||| .+..++.+ +.+
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E 306 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDY-----DGE 306 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccC-----Ccc
Confidence 3456778888999999999999877666555 6665422 23445788999999999 44433333 566
Q ss_pred CcEEEEEccCccc--HHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 100 KDIYVVFELMESD--LHQVIK-ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 100 ~~~~lv~e~~~~~--L~~~l~-~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
.+.+++++++.+. ....+. +.-.+.+-+...+.+.-+++++++|+.--+|+| ||+..+ +..+..||+.+...
T Consensus 307 ~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 307 DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc
Confidence 7789999999853 322221 112345556667788889999999999878998 777655 57999999988654
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.... ......+++.++|||+... ..+....|+||+|.--.++.-|-+|-...... .. ..|..+
T Consensus 382 ~~~~----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~----~~g~~p----- 444 (829)
T KOG0576|consen 382 TRTM----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--LP----MIGNGP----- 444 (829)
T ss_pred Cccc----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCCCccc--cC----CCCCCC-----
Confidence 3332 1245679999999998877 68888999999999877887777766442110 00 000000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHH-HHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA-LRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~-~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
........ ...++.. .++...|+..-|..|++...++-|.+|.+-
T Consensus 445 -----~s~~L~~~-------------~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 445 -----NSPMLTDK-------------SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred -----Cccccchh-------------hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 00000000 0011111 147778999999999999999999999864
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.1e-06 Score=84.73 Aligned_cols=139 Identities=21% Similarity=0.336 Sum_probs=86.8
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccC----------------------------ChH----------HHHHHH
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE----------------------------HIS----------DAIRIL 70 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----------------------------~~~----------~~~~~~ 70 (374)
..|+.++-|.||+|+-+ +|+.||||+.+.... -.. ..-.+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67999999999999865 599999998762110 000 011233
Q ss_pred HHHHHHHhCC----CCCccccceeecCCCcCCCCcEEEEEccCcc-cHHHH--HHhCCCCCHHHHHHHHHHHHHH-HHHh
Q 017301 71 REVKLLRLLR----HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQV--IKANDDLTREHHQFFLYQMLRA-LKYM 142 (374)
Q Consensus 71 ~E~~~l~~l~----h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~--l~~~~~l~~~~~~~i~~qi~~a-l~~L 142 (374)
+|...+.+++ ...-+.+-.++...+ ..-.++|||+.| .+.+. +++ ..++...+ ...++++ +..+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~ 281 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQL 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHH
Confidence 4555554442 222233334443221 224899999998 66665 444 33443222 2222222 2223
Q ss_pred hhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 143 H~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
=..|++|.|.+|.||+++.+|++.+.|||.....
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 3479999999999999999999999999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.4e-06 Score=76.03 Aligned_cols=139 Identities=18% Similarity=0.228 Sum_probs=78.8
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCcCCCCcEEEE
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~lv 105 (374)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+.... +.+++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 5679999999999997654 58999987532 34556778888888885332 44555433221 222347999
Q ss_pred EccCcc-cHHH----------------HH---HhC----CCCCHHH------HHHH---------------HHHHHH-HH
Q 017301 106 FELMES-DLHQ----------------VI---KAN----DDLTREH------HQFF---------------LYQMLR-AL 139 (374)
Q Consensus 106 ~e~~~~-~L~~----------------~l---~~~----~~l~~~~------~~~i---------------~~qi~~-al 139 (374)
|+++.| .+.. .+ ... ..+.... ...+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999997 5555 11 111 1111100 0000 011111 22
Q ss_pred HHhh-------hCCccccCCCCCceEec-CCCCeEEeeecccc
Q 017301 140 KYMH-------TANVYHRDLKPKNILAN-ANCKLKVCDFGLAR 174 (374)
Q Consensus 140 ~~LH-------~~~i~H~dikp~Nil~~-~~~~vkl~DFg~a~ 174 (374)
..++ ...++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 24699999999999999 56666799999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.5e-06 Score=70.67 Aligned_cols=132 Identities=17% Similarity=0.229 Sum_probs=92.7
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
..-.+.+.|++|..|.||++.. .|..+|+|+-+.+ .....+..|.++|..++--++.+=+-.+ +..
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~ 87 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFY--------GED 87 (201)
T ss_pred hhhhhhhhhhcccccEEEEeec--cCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEe--------chh
Confidence 3346688899999999999964 4779999986543 2334567899999988876665533333 113
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC-CCceEecCCCCeEEeeeccccc
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLK-PKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dik-p~Nil~~~~~~vkl~DFg~a~~ 175 (374)
.+.|||+.| .|.+..... . +.-+..+++.---|-..||-|+.|+ |...++-.++.+.|+||..|+.
T Consensus 88 ~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 567999998 776555321 1 2334556666666778899999998 5555555555899999999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.30 E-value=9.2e-06 Score=71.70 Aligned_cols=73 Identities=12% Similarity=0.064 Sum_probs=45.7
Q ss_pred eeeccCC-eeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCcEEEEEc
Q 017301 30 VIGKGSY-GVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFE 107 (374)
Q Consensus 30 ~lg~G~~-g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~lv~e 107 (374)
.|..|.+ ..||++.. .+..+++|...... ...+.+|+.+++.+. +--+.+++...... ...++|||
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e 72 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLTS 72 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEEE
Confidence 3455555 78899954 34688888765321 234567888888774 33344555554222 34689999
Q ss_pred cCcc-cHH
Q 017301 108 LMES-DLH 114 (374)
Q Consensus 108 ~~~~-~L~ 114 (374)
+++| ++.
T Consensus 73 ~i~G~~l~ 80 (244)
T cd05150 73 AVPGVPAA 80 (244)
T ss_pred eeCCccHh
Confidence 9987 444
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.25 E-value=4.5e-06 Score=70.10 Aligned_cols=132 Identities=27% Similarity=0.310 Sum_probs=91.9
Q ss_pred CCeeEeceeeccCC-eeEEEEEECCCCcEEEEEEecC---c--------cCC-h-------HHHHHHHHHHHHHHhCC--
Q 017301 23 NRYKILEVIGKGSY-GVVCAAIDTHTGEKVAIKKIHD---V--------FEH-I-------SDAIRILREVKLLRLLR-- 80 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~-g~V~~a~~~~~~~~vaiK~~~~---~--------~~~-~-------~~~~~~~~E~~~l~~l~-- 80 (374)
..++.++.||.|.- |.||++. ..|+.||+|++.. . ... . .....|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 9999995 5688999999431 0 000 0 11235667777666554
Q ss_pred -CCCc--cccceeecCCC-------------cCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh
Q 017301 81 -HPDI--VEIKRIMLPPS-------------KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144 (374)
Q Consensus 81 -h~~i--~~~~~~~~~~~-------------~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~ 144 (374)
+.++ +++++++.-.. ........||.||+...- .++ ..-+.++++-+..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~----~~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQ----IRDIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccc----hhHHHHHHHHHHHHHH
Confidence 5566 88888874331 011223578888877532 122 2235678888889999
Q ss_pred CCccccCCCCCceEecCCCCeEEeeeccc
Q 017301 145 ANVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 145 ~~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
.||+-+|+++.|.. .-||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999998 3489999964
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.7e-05 Score=69.61 Aligned_cols=30 Identities=33% Similarity=0.468 Sum_probs=25.2
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 145 ~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.+++|+|+.|.||+++.++..-|+||+.|.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 358999999999999876545699999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.1e-05 Score=74.66 Aligned_cols=140 Identities=21% Similarity=0.289 Sum_probs=85.9
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh-----------------------------------HHHHHHHHH
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-----------------------------------SDAIRILRE 72 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----------------------------------~~~~~~~~E 72 (374)
-+.||..+.|.|++|+-+. |+.||||+-+...... ...-.+.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 4679999999999998765 9999999876321111 001123334
Q ss_pred HHHHHhC----CCCC---ccccceeecCCCcCCCCcEEEEEccCcc---cHHHHHHhCCCCCHHHHHHHHHHHHHHHH-H
Q 017301 73 VKLLRLL----RHPD---IVEIKRIMLPPSKREFKDIYVVFELMES---DLHQVIKANDDLTREHHQFFLYQMLRALK-Y 141 (374)
Q Consensus 73 ~~~l~~l----~h~~---i~~~~~~~~~~~~~~~~~~~lv~e~~~~---~L~~~l~~~~~l~~~~~~~i~~qi~~al~-~ 141 (374)
.+...++ .|-+ -+.+-.++.+-+ ..-.|+||||+| +=.+.+.+.+ ++.. .+...+.++.. -
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~---~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKRG-ISPH---DILNKLVEAYLEQ 316 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHcC-CCHH---HHHHHHHHHHHHH
Confidence 4433332 3444 122333333221 124899999997 2235555554 4444 33344444333 2
Q ss_pred hhhCCccccCCCCCceEecC----CCCeEEeeecccccc
Q 017301 142 MHTANVYHRDLKPKNILANA----NCKLKVCDFGLARVA 176 (374)
Q Consensus 142 LH~~~i~H~dikp~Nil~~~----~~~vkl~DFg~a~~~ 176 (374)
+=..|++|+|=+|.||++.. ++.+.+.|||+....
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 33568999999999999984 678999999998654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.16 E-value=5.1e-05 Score=64.25 Aligned_cols=129 Identities=19% Similarity=0.244 Sum_probs=87.7
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCcc--------------CChHHHHHHHHHHHHHHhCC------CCCcccc
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--------------EHISDAIRILREVKLLRLLR------HPDIVEI 87 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------h~~i~~~ 87 (374)
...||+|+.=.||.- .......||+..... ..........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999888865 344566789887543 11122345556666555554 7899999
Q ss_pred ceeecCCCcCCCCcEEEEEccCc---c----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec
Q 017301 88 KRIMLPPSKREFKDIYVVFELME---S----DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (374)
Q Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~---~----~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~ 160 (374)
+|...++ ....+|+|.+. | +|.+++... .++. . +...+-+-..+|-+.+|+.+|++|.||++.
T Consensus 83 ~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETN-----LGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecC-----CceEEEEEEEECCCCCcCccHHHHHHcC-CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEE
Confidence 9999544 44788888754 2 688888554 4555 3 333444455688899999999999999985
Q ss_pred CCC----CeEEee
Q 017301 161 ANC----KLKVCD 169 (374)
Q Consensus 161 ~~~----~vkl~D 169 (374)
.+. .++|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 432 477877
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.3e-05 Score=78.55 Aligned_cols=83 Identities=18% Similarity=0.247 Sum_probs=54.4
Q ss_pred EeceeeccCCeeEEEEEECCCC--cEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCc--cccceeecCCCcCCCCc
Q 017301 27 ILEVIGKGSYGVVCAAIDTHTG--EKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDI--VEIKRIMLPPSKREFKD 101 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--~~~~~~~~~~~~~~~~~ 101 (374)
.+..|+.|.+..+|+......+ ..+++|+..... .......+.+|+.+|+.+. |+++ .+++..+.+.+ ..+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~--v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS--VIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC--cCCC
Confidence 3677899999999998754332 467777653221 1122346779999999995 6665 55555553321 2234
Q ss_pred EEEEEccCccc
Q 017301 102 IYVVFELMESD 112 (374)
Q Consensus 102 ~~lv~e~~~~~ 112 (374)
.|+|||+++|.
T Consensus 119 ~flVME~v~G~ 129 (822)
T PLN02876 119 AFYIMEYLEGR 129 (822)
T ss_pred ceEEEEecCCc
Confidence 68999999873
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=4e-05 Score=72.32 Aligned_cols=177 Identities=23% Similarity=0.372 Sum_probs=116.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh
Q 017301 64 SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143 (374)
Q Consensus 64 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH 143 (374)
....+++-..++++.+.|+|...++++.-. ......+|||+++.++.+.+..+. +-... +.
T Consensus 24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~----~~~r~IVV~e~~~~Sled~~~~~~-l~~~s-------~~------- 84 (725)
T KOG1093|consen 24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRG----KHERVIVVMEHYTMSLEDILKTGN-LKDES-------LL------- 84 (725)
T ss_pred CcHHHHhhhhHHHHhhcCccceeeEeeecC----ccceEEEEehhhccchHHHHHhcc-cchhh-------hc-------
Confidence 345567788899999999999988777632 223489999999999999998764 21111 11
Q ss_pred hCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHH
Q 017301 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223 (374)
Q Consensus 144 ~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ 223 (374)
..|+.|- |+ +..+| .++.. | | .+.++++||||+|.++.+
T Consensus 85 ~~~~~~~-----~~-------~~~td-~~~t~-------------------~--~-------~~~~pKsdVwsl~~i~~e 123 (725)
T KOG1093|consen 85 AHGVLHL-----NI-------IYITD-HFLTK-------------------Y--P-------SPIGPKSDVWSLGFIILE 123 (725)
T ss_pred cccccee-----hh-------hhccc-ccccc-------------------C--C-------CCCCcchhhhhHHHHHHH
Confidence 2222221 22 22333 11100 0 1 122359999999999999
Q ss_pred HHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCC
Q 017301 224 VLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303 (374)
Q Consensus 224 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 303 (374)
+..|...+......+....+.+....+-....-.. .. .+. -.++...+.+..+|+-..|..
T Consensus 124 l~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~-e~----~~~--------------~~~d~~~~~~~~~c~~~~~~i 184 (725)
T KOG1093|consen 124 LYLGISLEAELTESEYLEILLKYYTDDQELLSTAM-EH----LIQ--------------LLADKKRLPLLKKCLWLEPII 184 (725)
T ss_pred HHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHH-HH----HHH--------------HhhhHhHHHHhccCCcccccc
Confidence 99999999888877777777665444332211100 00 000 134666788999999999999
Q ss_pred CCCHHHHhcCCCCCcC
Q 017301 304 RPTAEEALADPYFKGL 319 (374)
Q Consensus 304 Rpt~~~lL~hp~~~~~ 319 (374)
||...++..++-|..+
T Consensus 185 r~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 185 RPLPMELSKRCSFTEV 200 (725)
T ss_pred ccchhHHhcCccHHHH
Confidence 9999999999999865
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.90 E-value=4.9e-06 Score=86.98 Aligned_cols=156 Identities=18% Similarity=0.126 Sum_probs=113.9
Q ss_pred HHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEEccCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHh
Q 017301 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYM 142 (374)
Q Consensus 68 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~L 142 (374)
....|..-++...|+++.....-..+.. ....|.+++++. |.+++.+-++ ..+.+.-+.....+.+.+..-+
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~---s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSE---STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCC---ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence 3445555666678999887766654432 234689999998 5898888653 2334444444444547777776
Q ss_pred hhC-C----ccccCCCCCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHH
Q 017301 143 HTA-N----VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217 (374)
Q Consensus 143 H~~-~----i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSl 217 (374)
|+. + -+|+++|+-|.+|..+.+++++++|+.++.... ........+++.|++|++... ..++.++|+|+.
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~---~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV---LSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRR 1426 (2724)
T ss_pred hhcccCCccchhhhhhhhccceecCCcccccccccccccCch---HhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHH
Confidence 654 2 689999999999999999999999999843221 223344578889999998876 678888999999
Q ss_pred HHHHHHHHhCCCCC
Q 017301 218 GCIFAEVLTGKPLF 231 (374)
Q Consensus 218 G~il~~lltg~~pf 231 (374)
|+.+|....|..+|
T Consensus 1427 s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHhcccHHH
Confidence 99999999988777
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00018 Score=62.95 Aligned_cols=72 Identities=11% Similarity=0.222 Sum_probs=44.5
Q ss_pred eceeeccCCeeEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCcc-ccceeecCCCcCCCCcEEEE
Q 017301 28 LEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV-EIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~~~~~~lv 105 (374)
++.|..|-...+|++.... .+..|++|+..... .......+|+.+++.+...++. +++... .. .++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---ELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---cceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEE
Confidence 4568888888999996432 35788899765321 1112334788888888544443 333322 11 479
Q ss_pred EccCcc
Q 017301 106 FELMES 111 (374)
Q Consensus 106 ~e~~~~ 111 (374)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999887
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.78 E-value=8e-05 Score=62.71 Aligned_cols=97 Identities=22% Similarity=0.233 Sum_probs=76.3
Q ss_pred HHHHHHHHhCCC-CCccccceeecCCCcCCCCcEEEEEccCcc-cHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHhhh
Q 017301 70 LREVKLLRLLRH-PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQV---IKANDDLTREHHQFFLYQMLRALKYMHT 144 (374)
Q Consensus 70 ~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~---l~~~~~l~~~~~~~i~~qi~~al~~LH~ 144 (374)
..|.-+|+.+.+ +++++++|.+ . -.+|.||.+. ++... +..-...++.....|+.++++.+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 358888888875 6999999998 1 2678898884 44321 1111235899999999999999999987
Q ss_pred C---CccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 145 A---NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 145 ~---~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
. .+.-.|++|+|+-++.+|++|++|...+..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 3 488889999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00026 Score=64.76 Aligned_cols=150 Identities=15% Similarity=0.130 Sum_probs=82.4
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCC-
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPP- 94 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~- 94 (374)
.|+. +...-++.++.|....+|++.. ++..+++|+.+... ....+..|+.++..+...+ +.+++......
T Consensus 18 ~y~~-~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~ 90 (307)
T TIGR00938 18 GYDL-GELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQ 90 (307)
T ss_pred hcCC-CCceeccccCCccccceEEEEe--CCCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCe
Confidence 3444 3455577788888889999853 34468889875421 1223445677777764322 33333321000
Q ss_pred CcCCCCcEEEEEccCcc-cH-----H------HHH---Hh-CCCC--------CHHH-----HH----------HHHHHH
Q 017301 95 SKREFKDIYVVFELMES-DL-----H------QVI---KA-NDDL--------TREH-----HQ----------FFLYQM 135 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L-----~------~~l---~~-~~~l--------~~~~-----~~----------~i~~qi 135 (374)
-....+..++++++++| .+ . ..+ +. ...+ .... .. .....+
T Consensus 91 ~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l 170 (307)
T TIGR00938 91 LSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAEL 170 (307)
T ss_pred ehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHH
Confidence 00112457899999886 21 1 111 10 0011 0000 00 001122
Q ss_pred HHHHHHhh-------hCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 136 LRALKYMH-------TANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 136 ~~al~~LH-------~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
...++++. ..+++|+|+++.||+++.++.+.++||+.+.
T Consensus 171 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 171 DKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 33444443 2589999999999999988767899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00034 Score=63.71 Aligned_cols=141 Identities=21% Similarity=0.255 Sum_probs=98.3
Q ss_pred eEeceeeccCCeeEEEEEECCCCcEEEEEEecCc----------------c------CChHHH--HHHHHHHHHHHhCCC
Q 017301 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV----------------F------EHISDA--IRILREVKLLRLLRH 81 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----------------~------~~~~~~--~~~~~E~~~l~~l~h 81 (374)
.+-.+|..|--+.||.|.. ..|..+|||+++.+ + .+.... .-..+|++.|+++..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4567888999999999964 57888999988621 0 011111 124578888988877
Q ss_pred CCccccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-hhCCccccCCCCCceEe
Q 017301 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLKPKNILA 159 (374)
Q Consensus 82 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~L-H~~~i~H~dikp~Nil~ 159 (374)
..|...--+.+-. -.|||+++++ ....=....-.++...+..+-.+++.-+.-| |.++.||.||+-=|+|+
T Consensus 226 aGIP~PePIlLk~-------hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 226 AGIPCPEPILLKN-------HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY 298 (520)
T ss_pred cCCCCCCceeeec-------ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence 6655443333322 2799999985 2222222234577778888888888888877 56699999999999998
Q ss_pred cCCCCeEEeeeccccc
Q 017301 160 NANCKLKVCDFGLARV 175 (374)
Q Consensus 160 ~~~~~vkl~DFg~a~~ 175 (374)
. +|.+-++|-+.+.-
T Consensus 299 h-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 H-DGKLYIIDVSQSVE 313 (520)
T ss_pred E-CCEEEEEEcccccc
Confidence 6 45799999988754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0002 Score=63.73 Aligned_cols=132 Identities=17% Similarity=0.244 Sum_probs=74.4
Q ss_pred eeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCcc-ccceeecCCCcCCCCcEEEEEcc
Q 017301 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV-EIKRIMLPPSKREFKDIYVVFEL 108 (374)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~~~~~~lv~e~ 108 (374)
.+..|-...+|+.. .++..+++|......... .....+|..+++.+....+. +++... . -++||||
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEe
Confidence 45678888999885 457788888754321110 01345788888888644332 333222 1 2689999
Q ss_pred Ccc-cHH--------------HHHH---hC----CCCCH-HHHHHHHHHH---------HHHHHHhhh--------CCcc
Q 017301 109 MES-DLH--------------QVIK---AN----DDLTR-EHHQFFLYQM---------LRALKYMHT--------ANVY 148 (374)
Q Consensus 109 ~~~-~L~--------------~~l~---~~----~~l~~-~~~~~i~~qi---------~~al~~LH~--------~~i~ 148 (374)
++| .+. +.+. +. .+++. ..+..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 887 321 1111 11 11111 1122221111 111222211 2589
Q ss_pred ccCCCCCceEecCCCCeEEeeeccccc
Q 017301 149 HRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 149 H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
|+|+.|.||+++.++ +.|+||..|..
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999999877 89999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00068 Score=61.63 Aligned_cols=78 Identities=15% Similarity=0.126 Sum_probs=52.2
Q ss_pred eEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCC---CCccccceeecCCCcCCCCcE
Q 017301 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH---PDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~i~~~~~~~~~~~~~~~~~~ 102 (374)
.-.+.||.|..+.||.... ++..+++|..+. . .....+.+|...|+.+.- ..+.++++++.... ..+.-
T Consensus 17 ~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~-~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~ 88 (297)
T PRK10593 17 SRVECISEQPYAALWALYD--SQGNPMPLMARS-F---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPD 88 (297)
T ss_pred heeeecCCccceeEEEEEc--CCCCEEEEEecc-c---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCe
Confidence 4467899999999999843 233577787532 1 122467789999988853 35667776654321 12347
Q ss_pred EEEEccCcc
Q 017301 103 YVVFELMES 111 (374)
Q Consensus 103 ~lv~e~~~~ 111 (374)
++|||+++|
T Consensus 89 ~LVmE~i~G 97 (297)
T PRK10593 89 VLLLERLRG 97 (297)
T ss_pred EEEEeccCC
Confidence 999999886
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0012 Score=62.13 Aligned_cols=77 Identities=19% Similarity=0.176 Sum_probs=50.2
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCcc----CC-hHHHHHHHHHHHHHHhCC---CCCccccceeecCCCcCCC
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----EH-ISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~-~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~~ 99 (374)
.+.||.|....||++.+...++.++||.-.... .. .-...+...|...|+.+. ..++++++.+- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~----- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E----- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C-----
Confidence 567999999999999886444689999753111 10 123446667888888763 23455555542 1
Q ss_pred CcEEEEEccCcc
Q 017301 100 KDIYVVFELMES 111 (374)
Q Consensus 100 ~~~~lv~e~~~~ 111 (374)
...++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 225899999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00026 Score=64.38 Aligned_cols=143 Identities=15% Similarity=0.052 Sum_probs=79.8
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCC-CcCCCCc
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPP-SKREFKD 101 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~-~~~~~~~ 101 (374)
..-++.|..|....+|++.. .+..+++|+... .....+..|+.++..+.+.+ +.+++...... -....+.
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hhheecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 33466788888889999853 445788998753 12234556777777774333 33333221000 0011235
Q ss_pred EEEEEccCcc-cHH-----------HHH---Hh-CCCC----------CH--HHHH--------HHHHHHHHHHHHhhh-
Q 017301 102 IYVVFELMES-DLH-----------QVI---KA-NDDL----------TR--EHHQ--------FFLYQMLRALKYMHT- 144 (374)
Q Consensus 102 ~~lv~e~~~~-~L~-----------~~l---~~-~~~l----------~~--~~~~--------~i~~qi~~al~~LH~- 144 (374)
.++|+++++| .+. ..+ +. ...+ .+ .... .....+..++.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 6899999986 321 111 00 0000 00 0000 011112333444442
Q ss_pred ------CCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 145 ------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 145 ------~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988767899999774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.66 E-value=5.1e-05 Score=67.75 Aligned_cols=137 Identities=18% Similarity=0.185 Sum_probs=96.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecC-------------------ccC-ChHHHHHHHHHHHHHHhCC-C
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD-------------------VFE-HISDAIRILREVKLLRLLR-H 81 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~-------------------~~~-~~~~~~~~~~E~~~l~~l~-h 81 (374)
.-|.++++||-|--+-||.+-+ ..|++.++|.-.- ... -.-......+|+..|+.+. |
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 3567899999999999999975 4688888884310 000 0011224567888888885 3
Q ss_pred CC-ccccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe
Q 017301 82 PD-IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (374)
Q Consensus 82 ~~-i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~ 159 (374)
.. +++.++. +.-++|||++.| .|.+.-+- ..+..+...+..-+.-|...|+||+|..-=||++
T Consensus 171 gfpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 171 GFPVPKPIDH---------NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCCCcccc---------cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEE
Confidence 22 2222222 235899999998 66655432 2334566677777888999999999999999999
Q ss_pred cCCCCeEEeeeccccc
Q 017301 160 NANCKLKVCDFGLARV 175 (374)
Q Consensus 160 ~~~~~vkl~DFg~a~~ 175 (374)
..++.++++||-.+..
T Consensus 236 ~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVS 251 (465)
T ss_pred ecCCCEEEeechHhhc
Confidence 9999999999987753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00065 Score=61.96 Aligned_cols=29 Identities=38% Similarity=0.406 Sum_probs=26.1
Q ss_pred CccccCCCCCceEecCC----CCeEEeeecccc
Q 017301 146 NVYHRDLKPKNILANAN----CKLKVCDFGLAR 174 (374)
Q Consensus 146 ~i~H~dikp~Nil~~~~----~~vkl~DFg~a~ 174 (374)
+++|+|+.|.||+++.+ +.+.++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999885 789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0027 Score=58.39 Aligned_cols=30 Identities=30% Similarity=0.296 Sum_probs=25.6
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 145 ~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.|+||+|+.|.||+++.+...-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999866545799999874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.001 Score=59.80 Aligned_cols=30 Identities=30% Similarity=0.552 Sum_probs=25.3
Q ss_pred CccccCCCCCceEecCCCCe-EEeeeccccc
Q 017301 146 NVYHRDLKPKNILANANCKL-KVCDFGLARV 175 (374)
Q Consensus 146 ~i~H~dikp~Nil~~~~~~v-kl~DFg~a~~ 175 (374)
.++|+|++|.||+++.++++ -|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 48999999999999975664 5999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0032 Score=58.78 Aligned_cols=88 Identities=22% Similarity=0.206 Sum_probs=53.9
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecC----ccCChHHHHHHHHHHHHHHhCC--CCCccccceeecCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD----VFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSK 96 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~----~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~ 96 (374)
...+ .+.||.|.-..||++.+...++.|+||.-.. ...-.-...+..-|...|+... .|..++-+-.+ +
T Consensus 30 ~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D--- 104 (409)
T PRK12396 30 KGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-D--- 104 (409)
T ss_pred ccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-C---
Confidence 3443 7789999999999998754467899996431 1122234556667888888764 45444322222 1
Q ss_pred CCCCcEEEEEccCcc--cHHHHH
Q 017301 97 REFKDIYVVFELMES--DLHQVI 117 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~--~L~~~l 117 (374)
.....+|||+++. .|.+.+
T Consensus 105 --~e~~~~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 105 --SVMNCCVMEDLSDHTILRTAL 125 (409)
T ss_pred --cHHhhHHHHhCcccHHHHHHH
Confidence 1224788998863 455544
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0068 Score=55.93 Aligned_cols=82 Identities=15% Similarity=0.035 Sum_probs=49.2
Q ss_pred eeeccCCeeEEEEEECCCCcEEEEEEecC-----ccCChHHHHHHHHHHHHHHhCC--CCCccccceeecCCCcCCCCcE
Q 017301 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHD-----VFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~-----~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
.||.|....||++.+...++.|+||.-.. .....-...+..-|...|+... .|..++-+-.+ + ....
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D-----~e~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-D-----TEMA 75 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-c-----cccc
Confidence 57999999999998754446899996431 1111233445567888887763 45433322222 1 1224
Q ss_pred EEEEccCcc--cHHHHH
Q 017301 103 YVVFELMES--DLHQVI 117 (374)
Q Consensus 103 ~lv~e~~~~--~L~~~l 117 (374)
.+|||+++. .|...+
T Consensus 76 ~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 76 VTVMEDLSHHKIARKGL 92 (370)
T ss_pred eehHhhCccchHHHHHH
Confidence 699999863 454444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0078 Score=54.73 Aligned_cols=145 Identities=18% Similarity=0.203 Sum_probs=80.2
Q ss_pred eEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCcCCCCcEE
Q 017301 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~ 103 (374)
.++..+..|..-.+|...+. ++.+++. ...............+|+.+++.+.--. +...++.+.... -...|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~pf 101 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTPF 101 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCce
Confidence 45555555555555666443 7778877 2222333455666778888888775322 233333332221 24579
Q ss_pred EEEccCcc-cHHH------------------HHHh-------C-------CCCCHHHHHHHHHH--------------HH
Q 017301 104 VVFELMES-DLHQ------------------VIKA-------N-------DDLTREHHQFFLYQ--------------ML 136 (374)
Q Consensus 104 lv~e~~~~-~L~~------------------~l~~-------~-------~~l~~~~~~~i~~q--------------i~ 136 (374)
.||++++| .+.+ .+.. . +.+...++..+..+ +.
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 99999987 2211 1110 0 00011111111111 11
Q ss_pred HHHHHhhhC--------CccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 137 RALKYMHTA--------NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 137 ~al~~LH~~--------~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
.-..+|+.+ .++|+|+++.|++++.++.+=+.||+.+...
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 123333322 4799999999999999988999999998753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0095 Score=54.48 Aligned_cols=29 Identities=28% Similarity=0.384 Sum_probs=25.4
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 145 ~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 578999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.02 Score=52.39 Aligned_cols=30 Identities=17% Similarity=0.118 Sum_probs=27.5
Q ss_pred CccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 146 NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 146 ~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
++||+|+.+.|+|++.++.+-++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999998999999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.018 Score=53.57 Aligned_cols=138 Identities=13% Similarity=0.106 Sum_probs=76.0
Q ss_pred eeEeceeeccCCeeEEEEEECC----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCcc-ccceeecCCCcCCC
Q 017301 25 YKILEVIGKGSYGVVCAAIDTH----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV-EIKRIMLPPSKREF 99 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~~ 99 (374)
..-+..|..|-.-.+|++.... .++.|++|+..... .......+|..+++.+..-++. ++++.+ ..
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~-----~~- 108 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRF-----PN- 108 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEE-----CC-
Confidence 3345566668888999986322 34689999875421 1112235688888888644443 444444 11
Q ss_pred CcEEEEEccCcc-cHH-----------H---HH---HhCC------CCCHHHHHHHHHHH-----------------HHH
Q 017301 100 KDIYVVFELMES-DLH-----------Q---VI---KAND------DLTREHHQFFLYQM-----------------LRA 138 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~-----------~---~l---~~~~------~l~~~~~~~i~~qi-----------------~~a 138 (374)
..|.+|++| ++. . .+ ++.. ......+..++.++ ...
T Consensus 109 ---g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~ 185 (344)
T PLN02236 109 ---GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDE 185 (344)
T ss_pred ---ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHH
Confidence 146777765 321 1 11 1100 11122233332221 111
Q ss_pred HHH----h----hhCCccccCCCCCceEecC-CCCeEEeeecccc
Q 017301 139 LKY----M----HTANVYHRDLKPKNILANA-NCKLKVCDFGLAR 174 (374)
Q Consensus 139 l~~----L----H~~~i~H~dikp~Nil~~~-~~~vkl~DFg~a~ 174 (374)
+.. + +...++|+|+++.|||++. ++.+.++||..|.
T Consensus 186 ~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 186 INLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 111 1 1235899999999999986 4679999999875
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.041 Score=51.84 Aligned_cols=76 Identities=14% Similarity=0.154 Sum_probs=48.1
Q ss_pred EeceeeccCCeeEEEEEECCCCcEEEEEEecCccC--C---hHHHHHHHHHHHHHHhCC---CCCccccceeecCCCcCC
Q 017301 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--H---ISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~---~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~ 98 (374)
..+.||.|....||+..+. +..++||.-..... . .-...+...|...|+.+. ...+++++.+..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----- 108 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----- 108 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC-----
Confidence 4778999999999999763 45799997541111 0 012334455677776653 2366666666531
Q ss_pred CCcEEEEEccCcc
Q 017301 99 FKDIYVVFELMES 111 (374)
Q Consensus 99 ~~~~~lv~e~~~~ 111 (374)
.-+++||++++
T Consensus 109 --~~vlvME~L~~ 119 (418)
T PLN02756 109 --MALIGMRYLEP 119 (418)
T ss_pred --CCEEEEeecCC
Confidence 24788999965
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.019 Score=53.00 Aligned_cols=28 Identities=32% Similarity=0.433 Sum_probs=24.9
Q ss_pred ccccCCCCCceEecC-CCCeEEeeecccc
Q 017301 147 VYHRDLKPKNILANA-NCKLKVCDFGLAR 174 (374)
Q Consensus 147 i~H~dikp~Nil~~~-~~~vkl~DFg~a~ 174 (374)
++|+|+.+.|||++. ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 4789999999874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.0086 Score=54.73 Aligned_cols=75 Identities=21% Similarity=0.348 Sum_probs=59.2
Q ss_pred CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
.+..+.|++|++-++++.-.- --...++..++++.+..++-+..+ ..-|||+...||||+ +|+|.|+||-+++.
T Consensus 296 de~~y~yl~~kdhgt~is~ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 296 DETLYLYLHFKDHGTPISIIK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CCceEEEEEEecCCceeeeee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 344678999998887553222 134677888888888887777665 789999999999999 99999999999985
Q ss_pred c
Q 017301 176 A 176 (374)
Q Consensus 176 ~ 176 (374)
.
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 3
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.085 Score=49.69 Aligned_cols=29 Identities=31% Similarity=0.315 Sum_probs=24.2
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 145 ~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
...+|.|+.+.||+.+.+ .+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence 457999999999997654 59999998764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.043 Score=51.10 Aligned_cols=59 Identities=19% Similarity=0.167 Sum_probs=41.3
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-hhhCCccccCCCCCceEecC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY-MHTANVYHRDLKPKNILANA 161 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~-LH~~~i~H~dikp~Nil~~~ 161 (374)
..++-+|..| ++..+++.. ..++...+.+..--..|+-- |--.+++|.|++|.||++-.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 4567777778 787777654 34565666666666666543 34458999999999999844
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.097 Score=47.21 Aligned_cols=74 Identities=15% Similarity=0.123 Sum_probs=43.6
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC---CCCccccceeecCCCcCCCCc
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~ 101 (374)
-+-.+.|+.|....+|+.. .+++.+.+|+-.. .....+..|..-|+.+. --.+++.+.+....+ .
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-----~ 86 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-----D 86 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-----C
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-----C
Confidence 3456789999999999985 7788999998642 22335667888887773 334556666553322 2
Q ss_pred EEEEEccCc
Q 017301 102 IYVVFELME 110 (374)
Q Consensus 102 ~~lv~e~~~ 110 (374)
-|+|||+++
T Consensus 87 ~fLlle~l~ 95 (288)
T PF03881_consen 87 AFLLLEFLE 95 (288)
T ss_dssp CEEEEE---
T ss_pred ceEEEEeec
Confidence 499999976
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.72 Score=42.51 Aligned_cols=28 Identities=32% Similarity=0.323 Sum_probs=23.8
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 145 ~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.+++|+|+.+.|||++ + .+.++||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4789999999999995 4 57899999774
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.022 Score=47.56 Aligned_cols=28 Identities=25% Similarity=0.382 Sum_probs=25.2
Q ss_pred ccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 147 VYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 147 i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
.+|+|+.|.||+++.++ ++++||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998887 99999998854
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.063 Score=47.93 Aligned_cols=45 Identities=29% Similarity=0.357 Sum_probs=34.5
Q ss_pred HHHHHHHHHHHhhhC--CccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 131 FLYQMLRALKYMHTA--NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 131 i~~qi~~al~~LH~~--~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
.+..+-.++.-.+.. -++|+|+.|+|++.++.+.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344444455544444 589999999999999989999999998754
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.3 Score=46.97 Aligned_cols=28 Identities=32% Similarity=0.660 Sum_probs=23.9
Q ss_pred CccccCCCCCceEecCCCCeEEeeecccc
Q 017301 146 NVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 146 ~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.++|.|+.+.|||.+.++ ++|+||..|.
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeecccc
Confidence 479999999999987654 9999998764
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.048 Score=49.23 Aligned_cols=135 Identities=21% Similarity=0.256 Sum_probs=89.0
Q ss_pred EeceeeccCCeeEEEEEE-------C---CCCcEEEEEEecCcc----------------------CChHHHHH--HHHH
Q 017301 27 ILEVIGKGSYGVVCAAID-------T---HTGEKVAIKKIHDVF----------------------EHISDAIR--ILRE 72 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~-------~---~~~~~vaiK~~~~~~----------------------~~~~~~~~--~~~E 72 (374)
|-.+|..|--+.|+-|.- . -....+|||+++... ++...... ..+|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 456788888888888742 1 133568999875211 11122222 2345
Q ss_pred HHHHHhCC-----CCCccccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-hhC
Q 017301 73 VKLLRLLR-----HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM-HTA 145 (374)
Q Consensus 73 ~~~l~~l~-----h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~L-H~~ 145 (374)
+..|.++. +|-+|.+.. -.|||-+++. .+..=-..+-.++..+.+..-.|+..++.-| |.+
T Consensus 336 mhNL~RMq~~GlpcP~vV~lkk------------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec 403 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLKK------------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKEC 403 (531)
T ss_pred HHHHHHHHhcCCCCCceeeeec------------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhh
Confidence 55555553 455444322 2689999884 2221112233588899999999999998877 677
Q ss_pred CccccCCCCCceEecCCCCeEEeeecccc
Q 017301 146 NVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 146 ~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
-++|-|++--|+|...+ ++.++|-..+.
T Consensus 404 ~LVHADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 404 LLVHADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred heeecchhhhhheecCC-ceEEEechhcc
Confidence 89999999999999877 89999988764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.92 E-value=0.66 Score=40.08 Aligned_cols=72 Identities=15% Similarity=0.141 Sum_probs=43.4
Q ss_pred EeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC---ccccceeecCCCcCCCCcEE
Q 017301 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD---IVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~---i~~~~~~~~~~~~~~~~~~~ 103 (374)
-.+.+..|.--..|...+ ....+.+|+-. ......+..|+.-|+.+.-.| +.+.+.+- ....+.|
T Consensus 20 er~~v~gG~inea~~v~d--g~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G-----~~~~~sy 87 (286)
T COG3001 20 EREEVSGGDINEAWRLRD--GTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVG-----ASRDHSY 87 (286)
T ss_pred cccccCCccccceeEeec--CCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEec-----CCCCeeE
Confidence 344555555555555533 23478888632 234456777888887775444 44444443 3446789
Q ss_pred EEEccCc
Q 017301 104 VVFELME 110 (374)
Q Consensus 104 lv~e~~~ 110 (374)
+||||++
T Consensus 88 lVle~L~ 94 (286)
T COG3001 88 LVLEYLP 94 (286)
T ss_pred EEEeecc
Confidence 9999987
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 374 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-89 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-89 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-82 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-82 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-82 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-82 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-82 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-82 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-82 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-82 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-82 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-82 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-82 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-82 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-82 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-81 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-81 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-81 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-81 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-81 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-80 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-80 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-80 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-80 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-79 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-77 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-77 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-76 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-76 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-74 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-74 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-74 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-74 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-74 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-74 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-74 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-74 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-74 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-74 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-74 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-74 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-74 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-74 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-74 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-74 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-74 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-74 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-74 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-74 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-74 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-74 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-74 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-74 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-74 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-74 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-74 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-74 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-74 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-74 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-74 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-74 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-74 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-74 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-74 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-74 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-74 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-74 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-74 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-74 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-74 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-74 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-73 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-73 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-73 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-73 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-73 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-73 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-73 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-73 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-73 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-73 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-73 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-73 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-73 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-73 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-73 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-72 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-72 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-71 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-71 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-70 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-66 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-66 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-66 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-66 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-62 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-57 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-57 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-56 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-56 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-56 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-55 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-55 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-55 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-55 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-55 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-55 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-55 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-55 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-55 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-55 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-54 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-54 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-54 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-54 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-54 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-54 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-54 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-54 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-54 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-54 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-54 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-54 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-54 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-53 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-53 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-53 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-53 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-53 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-53 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-53 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-52 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-52 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-48 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-48 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-47 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-45 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-44 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-44 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-43 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-43 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-43 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-43 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-43 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-43 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-43 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-43 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-43 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-43 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-43 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-43 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-43 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-43 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-43 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-43 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-43 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-43 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-43 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-43 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-43 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-43 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-43 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-43 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-43 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-43 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-43 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-43 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-43 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-42 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-42 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-42 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-42 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-42 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-42 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-42 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-42 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-42 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-42 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-41 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-40 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-39 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-39 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-39 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-39 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-39 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-39 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-39 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-39 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-39 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-39 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-39 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-39 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-39 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-38 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-38 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-38 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-38 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-38 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-38 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-38 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-38 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-38 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-38 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-38 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-38 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-38 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-38 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-38 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-38 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-38 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-38 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-37 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-36 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-36 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-36 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-36 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-34 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-29 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-28 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-28 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-27 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-26 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-26 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-26 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-25 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-25 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-25 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-25 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-24 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-24 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-23 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-23 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-23 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-23 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-23 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-23 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-23 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-23 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-23 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-23 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-23 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-22 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-22 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-22 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-22 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-21 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-21 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-21 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-21 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-21 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-21 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-21 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-20 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-20 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-20 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-19 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-19 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-18 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-17 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-17 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-17 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-17 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-14 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-14 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-13 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-13 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 9e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 5e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 7e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-08 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 8e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-08 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 549 bits (1416), Expect = 0.0
Identities = 156/362 (43%), Positives = 219/362 (60%), Gaps = 5/362 (1%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
+ + RY L IG+G+YG+VC+A D +VAIKKI FE
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFE 64
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND 121
H + R LRE+K+L RH +I+ I I+ P+ + KD+Y+V +LME+DL++++K
Sbjct: 65 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH 124
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
L+ +H +FLYQ+LR LKY+H+ANV HRDLKP N+L N C LK+CDFGLARVA D
Sbjct: 125 -LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
T F T+YVATRWYRAPE+ + YT +IDIWS+GCI AE+L+ +P+FPGK + QL+
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301
I +LG+PS E + + N KAR YL + K VP + FPN D AL LL +++ F+P
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 302
Query: 302 KDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
R E+ALA PY + EP + +F+ E + K+ ++ELI+ E + P
Sbjct: 303 HKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQP 360
Query: 362 QL 363
Sbjct: 361 GY 362
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 550 bits (1420), Expect = 0.0
Identities = 132/422 (31%), Positives = 212/422 (50%), Gaps = 52/422 (12%)
Query: 1 MQQDQTKKELKDKDFFTEYGDAN---RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH 57
M ++ +F + + Y I +IG+GSYG V A D +T + VAIKK++
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 58 DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI 117
+FE + D RILRE+ +L L+ I+ + +++P +F ++Y+V E+ +SDL ++
Sbjct: 61 RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF 120
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
K LT EH + LY +L ++H + + HRDLKP N L N +C +KVCDFGLAR
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 178 SDTPMTV-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218
S+ + T +V TRWYRAPEL YT +IDIWS G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTG 239
Query: 219 CIFAEVLTG-----------KPLFPG-----------------KSVVHQLDLITDLLGTP 250
CIFAE+L PLFPG KS QL++I +++GTP
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
+ + + + + KY+ + P+ L QK+P++ + LL+ ++ F+P R T ++A
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA 359
Query: 311 LADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYING 370
L PY K + K + E L F+ + +++ +R + +E+ +HP+L+ +
Sbjct: 360 LDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFT 418
Query: 371 TE 372
Sbjct: 419 IH 420
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 547 bits (1411), Expect = 0.0
Identities = 148/351 (42%), Positives = 220/351 (62%), Gaps = 13/351 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
Y ++ +++ ++G+G+YGVVC+A TGE VAIKKI + F+ A+R LRE+K+L
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKIL 63
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQML 136
+ +H +I+ I I P S F ++Y++ ELM++DLH+VI L+ +H Q+F+YQ L
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTL 122
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD-------TPMTVFWTDY 189
RA+K +H +NV HRDLKP N+L N+NC LKVCDFGLAR+ T ++
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
VATRWYRAPE+ + +KY+ A+D+WS GCI AE+ +P+FPG+ HQL LI ++GT
Sbjct: 183 VATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 250 PSPE-TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
P + + + + +AR+Y+ + P PL + FP V+P + LLQR++ FDP R TA+
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 309 EALADPYFKGLAKIEREPSCQPISKLEFEF--ERRRVTKDDIRELIYREIL 357
EAL PY + EP +PI FEF + +T D+++LI+ EI
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 528 bits (1363), Expect = 0.0
Identities = 120/368 (32%), Positives = 183/368 (49%), Gaps = 21/368 (5%)
Query: 5 QTKKELKDKDFF-TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD----- 58
Q K E +D + + Y + I GSYG VCA +D+ G VAIK++ +
Sbjct: 3 QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDG 61
Query: 59 ----VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLH 114
+ R+LRE++LL HP+I+ ++ I + + +Y+V ELM +DL
Sbjct: 62 RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 115 QVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
QVI ++ +H Q+F+Y +L L +H A V HRDL P NIL N + +CDF LA
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R +D T YV RWYRAPEL F +T +D+WS GC+ AE+ K LF G
Sbjct: 182 REDTADANK----THYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR-KKPPVPLFQKFPNVDPLALRL 292
+ +QL+ I +++GTP E + + + AR YL P P DP+AL L
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL 296
Query: 293 LQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELI 352
+ +++ F+P+ R + E+AL PYF+ L F F+ D+ ++
Sbjct: 297 IAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE---RFHFDESVTDVYDMHKIF 353
Query: 353 YREILEYH 360
E+ ++
Sbjct: 354 TAEVERFN 361
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 527 bits (1360), Expect = 0.0
Identities = 136/385 (35%), Positives = 213/385 (55%), Gaps = 43/385 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP 82
+Y++++ +GKG+YG+V +ID TGE VA+KKI D F++ +DA R RE+ +L L H
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV + ++ + +D+Y+VF+ ME+DLH VI+AN L H Q+ +YQ+++ +KY+
Sbjct: 70 NIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYL 125
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARV------------------AFSDTPMTV 184
H+ + HRD+KP NIL NA C +KV DFGL+R +
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG S ++QL+ I
Sbjct: 186 ILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF----------------PNVDP 287
++ PS E + +++ A+ + +++K + K + +
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDD 347
AL LL +L+ F+P R +A +AL P+ EP+C I + + + + DD
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDD 362
Query: 348 IRELIYREILEYHPQLLKDYINGTE 372
R L+Y EI +L+ + +
Sbjct: 363 YRNLVYSEISRRKRELISNKHQNVQ 387
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 526 bits (1356), Expect = 0.0
Identities = 132/341 (38%), Positives = 203/341 (59%), Gaps = 12/341 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y+ L+ +G G+YG VC+A+D TG KVAIKK++ F+ A R RE++LL+ +RH
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 83 DIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+++ + + P + +F D Y+V M +DL +++K L + QF +YQML+ L+Y
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 143
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H A + HRDLKP N+ N +C+LK+ DFGLAR A S+ T YV TRWYRAPE+
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVI 197
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +YT +DIWS+GCI AE++TGK LF G + QL I + GTP E + ++++
Sbjct: 198 LNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
+A+ Y+ + + N PLA+ LL++++ D + R TA EALA PYF+ L
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316
Query: 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
E EP Q + F+ T D+ + + Y+E+L + P
Sbjct: 317 TEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKEVLSFKPP 354
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 528 bits (1362), Expect = 0.0
Identities = 145/417 (34%), Positives = 207/417 (49%), Gaps = 57/417 (13%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
Q +K +++ +RY+I +IG GSYG VC A D VAIKKI VFE
Sbjct: 32 QHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND 121
+ D RILRE+ +L L H +V++ I++P +F ++YVV E+ +SD ++ +
Sbjct: 92 DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV 151
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA----- 176
LT H + LY +L +KY+H+A + HRDLKP N L N +C +KVCDFGLAR
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 177 -------------------FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217
+ T +V TRWYRAPEL YT AID+WSI
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSI 270
Query: 218 GCIFAEVLT-----------GKPLFPGKSVV--------------------HQLDLITDL 246
GCIFAE+L PLFPG S QL++I ++
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
LGTPS E I + E A++Y+ K+ L ++FP A+ LL+R++ F+P R T
Sbjct: 331 LGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390
Query: 307 AEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363
E LA P+FK + E E + +L F + + + +R +EI YHP++
Sbjct: 391 INECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 522 bits (1347), Expect = 0.0
Identities = 131/340 (38%), Positives = 195/340 (57%), Gaps = 12/340 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y +G G+YG VC+AID +GEKVAIKK+ F+ A R RE+ LL+ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 83 DIVEIKRIMLPPSK-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+++ + + P S R F D Y+V M++DL +++ + E Q+ +YQML+ LKY
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+A V HRDLKP N+ N +C+LK+ DFGLAR A ++ T YV TRWYRAPE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVI 195
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
S+ Y +DIWS+GCI AE+LTGK LF GK + QL I + G P E + + ++
Sbjct: 196 LSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
A+ Y+ + + P Q FP P A LL++++ D R TA +AL P+F+
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314
Query: 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E E Q + E ++T D+ ++ IY+EI+ + P
Sbjct: 315 PEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 520 bits (1342), Expect = 0.0
Identities = 142/372 (38%), Positives = 210/372 (56%), Gaps = 18/372 (4%)
Query: 1 MQQDQTKKELKDKDFF------TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK 54
M + F+ T + RY+ L +G G+YG VCAA DT TG +VA+K
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 55 KIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDL 113
K+ F+ I A R RE++LL+ ++H +++ + + P E F D+Y+V LM +DL
Sbjct: 61 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
+ ++K LT +H QF +YQ+LR LKY+H+A++ HRDLKP N+ N +C+LK+ DFGLA
Sbjct: 121 NNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R T YVATRWYRAPE+ ++ Y +DIWS+GCI AE+LTG+ LFPG
Sbjct: 180 RHTAD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLL 293
+ QL LI L+GTP E + + +E AR Y+ + + P + F +PLA+ LL
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 294 QRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIY 353
++++ D R TA +ALA YF + EP P + E R + D+ + L Y
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSLESRDLLIDEWKSLTY 349
Query: 354 REILEYHPQLLK 365
E++ + P L
Sbjct: 350 DEVISFVPPPLD 361
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 510 bits (1314), Expect = 0.0
Identities = 127/391 (32%), Positives = 200/391 (51%), Gaps = 29/391 (7%)
Query: 1 MQQDQTKKELKDKDFFT-EYGDAN-----RYKILEVIGKGSYGVVCAAIDTHTGEKVAIK 54
+ K D F++ E GD+ RY+ L+ IG G+ G+VCAA D VAIK
Sbjct: 34 AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 55 KIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDL 113
K+ F++ + A R RE+ L++ + H +I+ + + P E F+D+Y+V ELM+++L
Sbjct: 94 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 153
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
QVI+ +L E + LYQML +K++H+A + HRDLKP NI+ ++C LK+ DFGLA
Sbjct: 154 CQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R A + T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG
Sbjct: 212 RTAGTSF----MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV-------- 285
+ + Q + + + LGTP PE + + R Y+ K + + FP+
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 286 ----DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERR 341
A LL +++ DP R + ++AL PY P + + + R
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDKQLDER 383
Query: 342 RVTKDDIRELIYREILEYHPQLLKDYINGTE 372
T ++ +ELIY+E++ + + G
Sbjct: 384 EHTIEEWKELIYKEVMNSEEKTKNGVVKGQP 414
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 502 bits (1294), Expect = e-179
Identities = 122/353 (34%), Positives = 188/353 (53%), Gaps = 23/353 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
RY+ L+ IG G+ G+VCAA D VAIKK+ F++ + A R RE+ L++ + H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 83 DIVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+I+ + + P S EF+D+Y+V ELM+++L QVI+ +L E + LYQML +K+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKH 142
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ ++C LK+ DFGLAR A + T YV TR+YRAPE+
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVI 198
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y +DIWS+GCI E++ G LFPG + Q + + + LGTP PE + +
Sbjct: 199 LGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-QP 255
Query: 262 KARKYLTEMRKKPPVPLFQKFPNV------------DPLALRLLQRLIAFDPKDRPTAEE 309
R Y+ K + FP+V A LL +++ D R + +E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315
Query: 310 ALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
AL PY + P + + + R T ++ +ELIY+E+++
Sbjct: 316 ALQHPYINVWYDPSEAEAP-PPKIPDKQLDEREHTIEEWKELIYKEVMDLEHH 367
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 491 bits (1266), Expect = e-176
Identities = 119/315 (37%), Positives = 174/315 (55%), Gaps = 15/315 (4%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+RY L+ +G G G+V +A+D ++VAIKKI V LRE+K++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 82 PDIVEIKRIMLPPSKR---------EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL 132
+IV++ I+ P + E +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
YQ+LR LKY+H+ANV HRDLKP N+ N + LK+ DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T+WYR+P L S + YT AID+W+ GCIFAE+LTGK LF G + Q+ LI + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
E + + Y+ +P PL Q P + A+ L++++ F P DR TAEEAL
Sbjct: 246 EEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 312 ADPYFKGLAKIEREP 326
+ PY + EP
Sbjct: 305 SHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 457 bits (1178), Expect = e-162
Identities = 107/350 (30%), Positives = 172/350 (49%), Gaps = 27/350 (7%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+R+++ + G+G++G V + TG VAIKK+ + R L+ ++ L +L H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHH 78
Query: 82 PDIVEIKRIMLPPSKREFKDIY--VVFELMESDLHQVIK----ANDDLTREHHQFFLYQM 135
P+IV+++ +R+ +DIY VV E + LH+ + + FL+Q+
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 136 LRALKYMH--TANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
+R++ +H + NV HRD+KP N+L N A+ LK+CDFG A+ P Y+ +
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV----AYICS 194
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
R+YRAPEL YT A+DIWS+GCIFAE++ G+P+F G + QL I +LG PS
Sbjct: 195 RYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKF----PNVDPLALRLLQRLIAFDPKDRPTAE 308
E + + L +P F A LL L+ + P++R
Sbjct: 254 EVLRKLNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310
Query: 309 EALADPYFKGLAKIERE-PSCQPISKLEFEFERR--RVTKDDIRELIYRE 355
EAL PYF L + P+ + + + F F V + + + R+
Sbjct: 311 EALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-147
Identities = 98/392 (25%), Positives = 180/392 (45%), Gaps = 66/392 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+ +Y + + +G GS+G+VC D +G++ A+KK+ D RE+ ++++L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 82 PDIVEIKRIM---------------------------------LPPSKREFKDIYVVFEL 108
+I+++ + + + K + V+ E
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 109 MESDLHQVI----KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-C 163
+ LH+V+ ++ + ++YQ+ RA+ ++H+ + HRD+KP+N+L N+
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 164 KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA 222
LK+CDFG A+ P Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F
Sbjct: 180 TLKLCDFGSAKKLIPSEPSV----AYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG 233
Query: 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF 282
E++ GKPLF G++ + QL I ++GTP+ E + + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWRKIL 290
Query: 283 PNVDP-LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC----------QPI 331
P P LA+ LL++++ ++P R EA+A P+F L Q I
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
Query: 332 SKL-EFEFERRRVTKDDIRELIYREILEYHPQ 362
+L F + ++ I + + +
Sbjct: 351 PQLFNFSPYELSIIPGNVLNRILPKNFSPNYK 382
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-146
Identities = 114/360 (31%), Positives = 187/360 (51%), Gaps = 30/360 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y +VIG GS+GVV A + E VAIKK+ D RE++++R+++HP
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVL------QDKRFKNRELQIMRIVKHP 92
Query: 83 DIVEIKRIMLPPS-KREFKDIYVVFELMESDLHQVI----KANDDLTREHHQFFLYQMLR 137
++V++K K++ + +V E + +++ K + + ++YQ+LR
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 138 ALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
+L Y+H+ + HRD+KP+N+L + LK+ DFG A++ + P Y+ +R+YR
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV----SYICSRYYR 208
Query: 197 APELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APEL G+ + YT IDIWS GC+ AE++ G+PLFPG+S + QL I +LGTPS E I
Sbjct: 209 APELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ + P P + F P P A+ L+ RL+ + P R TA EAL P
Sbjct: 267 KTMNPNYMEHKF---PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323
Query: 315 YFKGLAKIE-REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEV 373
+F L E R P+ + + L F + + + +R + ++ H + + G +V
Sbjct: 324 FFDELRTGEARMPNGRELPPL-FNWTKE---ELSVRPDLISRLVPQHAE-AELLSRGIDV 378
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 413 bits (1063), Expect = e-144
Identities = 108/339 (31%), Positives = 169/339 (49%), Gaps = 25/339 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 108
Query: 84 IVEIKRIMLPPS-KREFKDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRA 138
IV ++ K++ + +V + + +++V + A L + + ++YQ+ R+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 139 LKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H+ + HRD+KP+N+L + + LK+CDFG A+ P Y+ +R+YRA
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV----SYICSRYYRA 224
Query: 198 PELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PEL G+ + YT +ID+WS GC+ AE+L G+P+FPG S V QL I +LGTP+ E I
Sbjct: 225 PELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ + P + F P P A+ L RL+ + P R T EA A +
Sbjct: 283 EMNPNYTEFKF---PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 316 FKGLAKIE-REPSCQPISKL-EFEFERRRVTKDDIRELI 352
F L + P+ + L F + LI
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 378
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 374 bits (962), Expect = e-130
Identities = 91/318 (28%), Positives = 155/318 (48%), Gaps = 24/318 (7%)
Query: 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK 74
E+G+ + Y+++ +G+G Y V AI+ EKV +K + V +I RE+K
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIK 82
Query: 75 LLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
+L LR P+I+ + I+ P V + +D Q+ + LT +F++Y
Sbjct: 83 ILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMY 137
Query: 134 QMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
++L+AL Y H+ + HRD+KP N++ + + KL++ D+GLA V VA+
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV----RVAS 193
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPS 251
R+++ PEL + Y ++D+WS+GC+ A ++ K P F G QL I +LGT
Sbjct: 194 RYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 252 PET-IAVVRNEKARKYLTEMRKKPPVPLFQKFPN-----VDPLALRLLQRLIAFDPKDRP 305
I E ++ + + + + V P AL L +L+ +D + R
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
Query: 306 TAEEALADPYFKGLAKIE 323
TA EA+ PYF + K +
Sbjct: 313 TAREAMEHPYFYTVVKDQ 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-123
Identities = 109/307 (35%), Positives = 167/307 (54%), Gaps = 12/307 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y+ + IG+GSYGVV + TG+ VAIKK + + LRE+++L+ L+HP
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKY 141
++V + + R + +++VFE + + + + + +Q L+A+ +
Sbjct: 63 NLVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
H N HRD+KP+NIL + +K+CDFG AR + P + D VATRWYR+PE L
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELL 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G ++Y P +D+W+IGC+FAE+L+G PL+PGKS V QL LI LG P V
Sbjct: 175 VGD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320
+ + + PL KFPN+ AL LL+ + DP +R T E+ L PYF+ +
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292
Query: 321 KIEREPS 327
+IE
Sbjct: 293 EIEDLAK 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 340 bits (874), Expect = e-116
Identities = 99/297 (33%), Positives = 161/297 (54%), Gaps = 12/297 (4%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y+ L ++G+GSYG+V + TG VAIKK + + +RE+KLL+ LRH
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKY 141
++V + + ++ K Y+VFE ++ + ++ + L + Q +L+Q++ + +
Sbjct: 85 NLVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H+ N+ HRD+KP+NIL + + +K+CDFG AR + P V+ D VATRWYRAPEL
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELL 196
Query: 202 -GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G KY A+D+W+IGC+ E+ G+PLFPG S + QL I LG P +
Sbjct: 197 VGD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ K PL +++P + + + L ++ + DP RP E L +F+
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-104
Identities = 115/301 (38%), Positives = 159/301 (52%), Gaps = 18/301 (5%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRI--LREVKLLRL 78
A RY+ L+ +G+G + V A D +T + VAIKKI D I LRE+KLL+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLR 137
L HP+I+ + S I +VF+ ME+DL +IK N LT H + ++ L+
Sbjct: 69 LSHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L+Y+H + HRDLKP N+L + N LK+ DFGLA+ +F P + T V TRWYRA
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRA 180
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE L G+ Y +D+W++GCI AE+L P PG S + QL I + LGTP+ E
Sbjct: 181 PELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ Y + P +PL F L L+Q L F+P R TA +AL YF
Sbjct: 239 DMC--SLPDY-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295
Query: 317 K 317
Sbjct: 296 S 296
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-104
Identities = 101/303 (33%), Positives = 146/303 (48%), Gaps = 18/303 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRI--LREVKLLRLL 79
+RY+ + IG G+YG V A D H+G VA+K + + I +REV LLR L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 80 R---HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQ 134
HP++V + + + +VFE ++ DL + L E + + Q
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
LR L ++H + HRDLKP+NIL + +K+ DFGLAR +S M T V T W
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSY-QMA--LTPVVVTLW 184
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
YRAPE+ S Y +D+WS+GCIFAE+ KPLF G S QL I DL+G P +
Sbjct: 185 YRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ + P P+ P ++ +LL ++ F+P R +A AL
Sbjct: 243 WPRD--VSLPRG--AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298
Query: 315 YFK 317
Y
Sbjct: 299 YLH 301
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-103
Identities = 119/325 (36%), Positives = 174/325 (53%), Gaps = 24/325 (7%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
++ G +Y+ LE +G+G+YGVV A D+ G VA+K+I +
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR--LDAE 58
Query: 64 SDAIRI--LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-N 120
+ I +RE+ LL+ L HP+IV + ++ + +VFE ME DL +V+
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENK 113
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L + +LYQ+LR + + H + HRDLKP+N+L N++ LK+ DFGLAR AF
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI- 171
Query: 181 PMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239
P+ + T V T WYRAP+ L GS KY+ ++DIWSIGCIFAE++TGKPLFPG + Q
Sbjct: 172 PVRSY-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228
Query: 240 LDLITDLLGTPSPET---IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
L I +LGTP+P + + K R + + P P + LL +
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIPGFCQEGIDLLSNM 284
Query: 297 IAFDPKDRPTAEEALADPYFKGLAK 321
+ FDP R +A +A+ PYFK L
Sbjct: 285 LCFDPNKRISARDAMNHPYFKDLDP 309
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 305 bits (785), Expect = e-103
Identities = 114/299 (38%), Positives = 165/299 (55%), Gaps = 19/299 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
+Y LE IG+G+YGVV A + GE A+KKI E + I +RE+ +L+ L+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR--LEKEDEGIPSTTIREISILKELK 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV++ ++ + + +VFE ++ DL +++ L + FL Q+L +
Sbjct: 59 HSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H V HRDLKP+N+L N +LK+ DFGLAR AF P+ + T + T WYRAP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPD 170
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L GS KY+ IDIWS+GCIFAE++ G PLFPG S QL I +LGTP+ + V
Sbjct: 171 VLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ KY P+P +D + LL +++ DP R TA++AL YFK
Sbjct: 229 T--ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-103
Identities = 113/331 (34%), Positives = 169/331 (51%), Gaps = 28/331 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
Y L+ +G+G+Y V T VA+K+I E + +REV LL+ L+
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV + I+ + +VFE ++ DL Q + + + + + FL+Q+LR L
Sbjct: 59 HANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H V HRDLKP+N+L N +LK+ DFGLAR A S P + + V T WYR P+
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPD 170
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET---I 255
L GS + Y+ ID+W +GCIF E+ TG+PLFPG +V QL I +LGTP+ ET I
Sbjct: 171 ILLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
K Y K L P +D LL +L+ F+ ++R +AE+A+ P+
Sbjct: 229 LSNEEFKTYNY----PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 316 FKGL----AKIEREPSCQPISKLEFEFERRR 342
F L K+ S + +++ + E
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQKEASL 315
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-103
Identities = 115/302 (38%), Positives = 166/302 (54%), Gaps = 19/302 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
+Y+ LE IG+G+YG V A + T E VA+K++ + + + LRE+ LL+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELK 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV + ++ K + +VFE + DL + + N DL E + FL+Q+L+ L
Sbjct: 60 HKNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H+ NV HRDLKP+N+L N N +LK+ +FGLAR AF P+ + + V T WYR P+
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPD 171
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG V QL I LLGTP+ E
Sbjct: 172 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ K Y L P ++ LLQ L+ +P R +AEEAL PYF
Sbjct: 230 MT--KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
Query: 318 GL 319
Sbjct: 288 DF 289
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 304 bits (782), Expect = e-102
Identities = 112/306 (36%), Positives = 167/306 (54%), Gaps = 23/306 (7%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
+RY+ + +G+G+YG V AIDT T E VAIK+I EH + + +REV LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
H +I+E+K ++ + ++++FE E+DL + + N D++ + FLYQ++ +
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 141 YMHTANVYHRDLKPKNILANANCK-----LKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ H+ HRDLKP+N+L + + LK+ DFGLAR AF P+ F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
R PE L GS Y+ ++DIWSI CI+AE+L PLFPG S + QL I ++LG P T
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALAD 313
V + K L + +D L LL ++ DP R +A+ AL
Sbjct: 262 WPGV--TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319
Query: 314 PYFKGL 319
PYF
Sbjct: 320 PYFSHN 325
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = e-102
Identities = 103/322 (31%), Positives = 161/322 (50%), Gaps = 26/322 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLL 79
+Y+ + IG+G+YG V A D + G VA+K++ + + + + +REV +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 80 R---HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQ 134
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+LR L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR +S M T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSF-QMA--LTSVVVTLW 184
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
YRAPE+ S Y +D+WS+GCIFAE+ KPLF G S V QL I D++G P E
Sbjct: 185 YRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ K P+ + ++D L LL + + F+P R +A AL+ P
Sbjct: 243 WPRD--VALPRQ--AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 315 YFKGLAKIEREPSCQPISKLEF 336
YF+ L C+
Sbjct: 299 YFQDL------ERCKENLDSHL 314
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = e-101
Identities = 112/338 (33%), Positives = 165/338 (48%), Gaps = 24/338 (7%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRL 78
+ ++Y+ L IG+G++G V A TG+KVA+KK+ E+ + I LRE+K+L+L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQL 72
Query: 79 LRHPDIVEIKRIM---LPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQ 134
L+H ++V + I P R IY+VF+ E DL ++ T + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY---VA 191
+L L Y+H + HRD+K N+L + LK+ DFGLAR AFS Y V
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVV 190
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
T WYR PE L G Y P ID+W GCI AE+ T P+ G + HQL LI+ L G+
Sbjct: 191 TLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 251 SPET-IAVVRNEKARKYLTEMRKKPPVPLFQKFPNV--DPLALRLLQRLIAFDPKDRPTA 307
+PE V E K E+ K + + DP AL L+ +L+ DP R +
Sbjct: 249 TPEVWPNVDNYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306
Query: 308 EEALADPYFKGL---AKIEREPSCQPISKLEFEFERRR 342
++AL +F + ++ S S E+ RR
Sbjct: 307 DDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = e-100
Identities = 113/312 (36%), Positives = 174/312 (55%), Gaps = 29/312 (9%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHI-SDAIRILREVKLLRLL 79
++++K LE +G G+Y V ++ TG VA+K++ D E S AIR E+ L++ L
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKEL 60
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN------DDLTREHHQFFLY 133
+H +IV + ++ +K + +VFE M++DL + + + L ++F +
Sbjct: 61 KHENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+L+ L + H + HRDLKP+N+L N +LK+ DFGLAR AF P+ F + V T
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTL 172
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
WYRAP+ L GS Y+ +IDIWS GCI AE++TGKPLFPG + QL LI D++GTP+
Sbjct: 173 WYRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKF-----PNVDPLALRLLQRLIAFDPKDRPTA 307
V K KY ++++PP L Q +D + L L+ +P R +A
Sbjct: 231 SLWPSV--TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288
Query: 308 EEALADPYFKGL 319
++AL P+F
Sbjct: 289 KQALHHPWFAEY 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 1e-86
Identities = 105/368 (28%), Positives = 170/368 (46%), Gaps = 58/368 (15%)
Query: 22 ANRYKIL-EVIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
+ ++ +G+G+YG V A D + A+K+I IS + RE+ LLR
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLRE 74
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF-------- 130
L+HP+++ ++++ L + + ++++F+ E DL +IK +
Sbjct: 75 LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 131 -FLYQMLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVF 185
LYQ+L + Y+H V HRDLKP NIL ++K+ D G AR F+ P+
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNS-PLKPL 189
Query: 186 --WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------- 235
V T WYRAPE L G+ YT AIDIW+IGCIFAE+LT +P+F +
Sbjct: 190 ADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 236 --VVHQLDLITDLLGTPS----------PETIAVVRNEKARKYLTEMRKKPPVPLFQKFP 283
QLD I +++G P+ PE ++++ + Y + +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY---TNCSLIKYMEKHKV 304
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQP-ISKLEFEFERRR 342
D A LLQ+L+ DP R T+E+A+ DPYF E + + + +R
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL-----EDPLPTSDVFAGCQIPYPKRE 359
Query: 343 VTKDDIRE 350
++ +
Sbjct: 360 FLTEEEPD 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 3e-72
Identities = 90/373 (24%), Positives = 146/373 (39%), Gaps = 65/373 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR-LLRHP 82
+ +V+G G+ G + VA+K+I +D REV+LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKY 141
+++ ++++ + Y+ EL + L + ++ D L Q L +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 142 MHTANVYHRDLKPKNIL-----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
+H+ N+ HRDLKP NIL A+ K + DFGL + + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE L T +DI+S GC+F V++ GKS+ Q +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------------- 239
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ + + D +A L++++IA DP+ RP+A+ L P+
Sbjct: 240 -------------ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 316 FKGLAK-----------IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE------ 358
F L K IE+E PI K + E R V K D RE I +
Sbjct: 287 FWSLEKQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRKFR 345
Query: 359 -YHPQLLKDYING 370
Y ++D +
Sbjct: 346 TYKGGSVRDLLRA 358
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-66
Identities = 47/343 (13%), Positives = 90/343 (26%), Gaps = 61/343 (17%)
Query: 15 FFTEYGDANR-YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILRE 72
+ R K++E + G VV D E A+K S+ R+
Sbjct: 53 VDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEA 112
Query: 73 VKLLRLLRHPDIVE---------------------IKRIMLPPSKREFKDIYVVFELMES 111
L E ++ + ++
Sbjct: 113 TFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV 172
Query: 112 DLHQVIKANDDLTREHH-------QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK 164
DL + D + Q++R + + + H P N+ + +
Sbjct: 173 DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR 232
Query: 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
L + D + P + Y E + + +T A++ W +G V
Sbjct: 233 LMLGDVSALWKVGTRGPASSV------PVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284
F + + L P ++ F
Sbjct: 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDS----------------------LAFGSCTP 324
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
+ L+ R + FD + R EA+ P F +++ E S
Sbjct: 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL---QLQNEIS 364
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-64
Identities = 93/344 (27%), Positives = 151/344 (43%), Gaps = 48/344 (13%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
+ D A RY++L+VIGKGS+G V A D + VA+K + + +
Sbjct: 83 DQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAA 141
Query: 69 ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--LTR 125
E+++L LR D ++ F++ I + FEL+ +L+++IK N +
Sbjct: 142 E--EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199
Query: 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMT 183
+ F + +L+ L +H + H DLKP+NIL +KV DFG + + +
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVY 257
Query: 184 VFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
Y+ +R+YRAPE + G+ +Y ID+WS+GCI AE+LTG PL PG+ QL
Sbjct: 258 T----YIQSRFYRAPEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
Query: 243 ITDLLGTPSPETI---------------------------AVVRNEKARKYLTEMRKKPP 275
+ +LLG PS + + +VV N +
Sbjct: 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370
Query: 276 VPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAEEALADPYFKG 318
D L++ + +DP R T +AL P+ +
Sbjct: 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-61
Identities = 70/358 (19%), Positives = 136/358 (37%), Gaps = 69/358 (19%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
+ F + G N + ++ +G G++G V + A+K + ++ + + + +
Sbjct: 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAK 79
Query: 69 ILREVKLLRLLRHPD-----IVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD 122
I E +L+ +++ D IV+ + D + ++FE + L+++I N+
Sbjct: 80 I--EADILKKIQNDDINNNNIVKYHGKF------MYYDHMCLIFEPLGPSLYEIITRNNY 131
Query: 123 --LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---------------------- 158
E + + ++L+AL Y+ ++ H DLKP+NIL
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 159 ---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDI 214
+ +K+ DFG A F + TR YRAPE + + + D+
Sbjct: 192 QIYRTKSTGIKLIDFGCA--TFKSDYHG----SIINTRQYRAPEVILNL---GWDVSSDM 242
Query: 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL------- 267
WS GC+ AE+ TG LF + L ++ ++ + KY+
Sbjct: 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKL 302
Query: 268 ------TEMRKKPPVPLFQKFPNV--DPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + V + L L ++ DP RP+ E L + +
Sbjct: 303 AWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-61
Identities = 72/327 (22%), Positives = 113/327 (34%), Gaps = 47/327 (14%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
++ F + Y IL+ IG G V ++ + AIK ++
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 65
Query: 62 HISDAIRILREVKLLRLLRHP--DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA 119
E+ L L+ I+ + + IY+V E DL+ +K
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKK 120
Query: 120 NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179
+ + + ML A+ +H + H DLKP N L + LK+ DFG+A D
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179
Query: 180 TPMTVFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
T V + V T Y PE G SK +P D+WS+GCI + GK
Sbjct: 180 TTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290
F I+ + + + P +
Sbjct: 239 FQQII-----------------NQISKLHAIIDPNH------EIEFP-----DIPEKDLQ 270
Query: 291 RLLQRLIAFDPKDRPTAEEALADPYFK 317
+L+ + DPK R + E LA PY +
Sbjct: 271 DVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 6e-61
Identities = 93/354 (26%), Positives = 154/354 (43%), Gaps = 57/354 (16%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI--HDVFEHISDA 66
+ D+ + G+ +RY+I +IGKGS+G V A D E VAIK I F + +
Sbjct: 40 DNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-- 97
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--L 123
EV+LL L+ D I+ F++ + +VFE++ +L+ +++ + +
Sbjct: 98 ---QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV 154
Query: 124 TREHHQFFLYQMLRALKYMHT--ANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSD 179
+ + F QM AL ++ T ++ H DLKP+NIL +K+ DFG +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLG 212
Query: 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239
+ Y+ +R+YR+PE+ Y AID+WS+GCI E+ TG+PLF G + V Q
Sbjct: 213 QRIY----QYIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 240 LDLITDLLGTPSPETI--------------------------AVVRNEKARKYLTEMRKK 273
++ I ++LG P + + L +
Sbjct: 267 MNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGV 326
Query: 274 PPVPLFQKFPN------VDPLALR-LLQRLIAFDPKDRPTAEEALADPYFKGLA 320
+ D L + L+ R++ +DPK R AL +FK A
Sbjct: 327 ETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-61
Identities = 94/355 (26%), Positives = 145/355 (40%), Gaps = 49/355 (13%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAI 67
K+ GD RY+I+ +G+G++G V +D G +VA+K I +V +A
Sbjct: 5 KEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAA 63
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--LT 124
R+ E+ +L+ ++ D +L F + + FEL+ + + +K N+
Sbjct: 64 RL--EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYP 121
Query: 125 REHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL-------------------ANANCKL 165
H + YQ+ AL+++H + H DLKP+NIL + N +
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
+V DFG A F T VATR YR PE+ + D+WSIGCI E
Sbjct: 182 RVADFGSA--TFDHEHHT----TIVATRHYRPPEVI--LELGWAQPCDVWSIGCILFEYY 233
Query: 226 TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK-------------ARKYLTEMRK 272
G LF L ++ +LG I R +K + +
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
KP + L++R++ FDP R T EAL P+F GL ER
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFH 348
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-59
Identities = 92/338 (27%), Positives = 144/338 (42%), Gaps = 51/338 (15%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ RY+I++ +G+G++G V ID G VA+K + +V + +A R E+++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 81 HPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLR 137
D R + E I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 138 ALKYMHTANVYHRDLKPKNIL-------------------ANANCKLKVCDFGLARVAFS 178
++ ++H+ + H DLKP+NIL N +KV DFG A +
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYD 187
Query: 179 DTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
D + V+TR YRAPE + ++ D+WSIGCI E G +FP
Sbjct: 188 DEHHS----TLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 238 HQLDLITDLLGTPSPETIAVVRNEK--------------ARKYLTEMRKKPPVPLFQKFP 283
L ++ +LG I R K A +Y++ KP
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSR-ACKPLKEFMLSQD 299
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
L+Q+++ +DP R T EAL P+F L K
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-58
Identities = 71/331 (21%), Positives = 116/331 (35%), Gaps = 47/331 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y IL+ IG G V ++ + AIK ++ E+ L L+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 83 --DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
I+ + + IY+V E DL+ +K + + + ML A+
Sbjct: 68 SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+H + H DLKP N L + LK+ DFG+A DT V + V T Y PE
Sbjct: 123 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEA 180
Query: 201 ---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
G SK +P D+WS+GCI + GK F
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------- 224
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
I+ + + + P + +L+ + DPK R + E L
Sbjct: 225 -NQISKLHAIIDPNH------EIEFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELL 272
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
A PY + + + ++++ +
Sbjct: 273 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-57
Identities = 70/331 (21%), Positives = 115/331 (34%), Gaps = 47/331 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y IL+ IG G V ++ + AIK ++ E+ L L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 83 --DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
I+ + + IY+V E DL+ +K + + + ML A+
Sbjct: 115 SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+H + H DLKP N L + LK+ DFG+A DT V + V Y PE
Sbjct: 170 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMPPEA 227
Query: 201 ---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
G SK +P D+WS+GCI + GK F
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------- 271
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
I+ + + + P + +L+ + DPK R + E L
Sbjct: 272 -NQISKLHAIIDPNH------EIEFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELL 319
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
A PY + + + ++++ +
Sbjct: 320 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 350
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-57
Identities = 72/296 (24%), Positives = 104/296 (35%), Gaps = 46/296 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHP 82
++ L +G GSYG V G A+K+ F D R L EV ++ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKY 141
V +++ + E +Y+ EL L Q +A E +L L AL +
Sbjct: 118 CCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ + H D+KP NI + K+ DFGL + V Y APEL
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPELL 228
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y A D++S+G EV L G QL
Sbjct: 229 Q---GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL--------------------- 264
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ P +L ++ DPK R TAE LA P +
Sbjct: 265 --------RQGYLPPEFTAGLS---SELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-56
Identities = 75/338 (22%), Positives = 130/338 (38%), Gaps = 55/338 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
RY ++ +G G + V A D VA+K + + ++A E+KLL+ +
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVN 73
Query: 81 HPDIVEIKRIMLPPSKREFKD-----------IYVVFELMESDLHQVIKANDD--LTREH 127
D + + M + D + +VFE++ +L +IK + + +
Sbjct: 74 DADNTK-EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 132
Query: 128 HQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCK------LKVCDFGLARVAFSDT 180
+ Q+L L YMH + H D+KP+N+L +K+ D G A + D
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190
Query: 181 PMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--- 236
T+ + TR YR+PE L G + + DIWS C+ E++TG LF
Sbjct: 191 HY----TNSIQTREYRSPEVLLG---APWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243
Query: 237 ---VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-- 291
+ I +LLG + + R + + + +P D L +
Sbjct: 244 TKDDDHIAQIIELLGELPSYLLR--NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 301
Query: 292 -----------LLQRLIAFDPKDRPTAEEALADPYFKG 318
L ++ DP+ R A + P+ K
Sbjct: 302 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 9e-56
Identities = 88/310 (28%), Positives = 134/310 (43%), Gaps = 55/310 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH------DVFEHISDAIRILREVKLLR 77
Y + + +G G+ G V A + T +KVAI+ I A+ + E+++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
L HP I++IK + +D Y+V ELME +L + N L + + YQML
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 137 RALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
A++Y+H + HRDLKP+N+L +C +K+ DFG +++ + M T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM----RTLCGTP 305
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT-- 249
Y APE L + Y A+D WS+G I L+G P F L D I G
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TSGKYN 363
Query: 250 -PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
+ V AL L+++L+ DPK R T E
Sbjct: 364 FIPEV----------------------------WAEVSEKALDLVKKLLVVDPKARFTTE 395
Query: 309 EALADPYFKG 318
EAL P+ +
Sbjct: 396 EALRHPWLQD 405
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-55
Identities = 79/347 (22%), Positives = 134/347 (38%), Gaps = 49/347 (14%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
+ + +Y L+ IG+GS+G T G + IK+I+
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN--IS 60
Query: 62 HISDAIR--ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK 118
+S R REV +L ++HP+IV+ + S E +Y+V + E DL + I
Sbjct: 61 RMSSKEREESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRIN 115
Query: 119 -ANDDLTREHH-QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
L +E + Q+ ALK++H + HRD+K +NI + +++ DFG+ARV
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
S + + T +Y +PE+C + Y DIW++GC+ E+ T K F S+
Sbjct: 176 NSTVELA---RACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQR 295
+ + I P+ LR L+ +
Sbjct: 231 KNLVLKI---------------------------ISGSFPPV----SLHYSYDLRSLVSQ 259
Query: 296 LIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
L +P+DRP+ L + + P F +
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFG 306
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-55
Identities = 56/314 (17%), Positives = 108/314 (34%), Gaps = 24/314 (7%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ + + +++G+G+ V TG+ AIK + + +RE ++L+ L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHK 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---DDLTREHHQFFLYQMLRA 138
+IV++ I + R ++ E L+ V++ L L ++
Sbjct: 68 NIVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 139 LKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ ++ + HR++KP NI+ + K+ DFG AR D T
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEE 180
Query: 195 YRAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
Y P++ KY +D+WSIG F TG F + + +
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
T P + + P + L +L ++ D + +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLS--RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 309 EALADPYFKGLAKI 322
+ A+
Sbjct: 299 QFFAETSDILHRGN 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-55
Identities = 82/312 (26%), Positives = 126/312 (40%), Gaps = 62/312 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
Y++L IG GSYG G+ + K++ + +++A + ++ EV LLR L+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELK 63
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF-------- 131
HP+IV ++ R +Y+V E E DL VI + Q+
Sbjct: 64 HPNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKG----TKERQYLDEEFVLRV 116
Query: 132 LYQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
+ Q+ ALK H + V HRDLKP N+ + +K+ DFGLAR+ DT
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--- 173
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
+V T +Y +PE Y DIWS+GC+ E+ P F S
Sbjct: 174 KTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---------- 221
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRP 305
E +R K F++ P L ++ R++ RP
Sbjct: 222 -----KELAGKIREGK----------------FRRIPYRYSDELNEIITRMLNLKDYHRP 260
Query: 306 TAEEALADPYFK 317
+ EE L +P
Sbjct: 261 SVEEILENPLIL 272
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-55
Identities = 71/323 (21%), Positives = 117/323 (36%), Gaps = 65/323 (20%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+K +E+IG G +G V A G+ IK++ + + REVK L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 82 PDIVE-----------IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA--NDDLTREH 127
+IV + S+ + K +++ E + L Q I+ + L +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
Q+ + + Y+H+ + +RDLKP NI ++K+ DFGL +D T
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDL 246
T Y +PE S Y +D++++G I AE+L F L
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL------ 231
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
+ + D LLQ+L++ P+DRP
Sbjct: 232 -------------------------RDGIIS-----DIFDKKEKTLLQKLLSKKPEDRPN 261
Query: 307 AEEALADPYFKGLAK--IEREPS 327
E L + ER +
Sbjct: 262 TSEILRTLTVWKKSPEKNERHTA 284
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-55
Identities = 70/324 (21%), Positives = 122/324 (37%), Gaps = 55/324 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++ ++ +G+G +GVV A + AIK+I + +++REVK L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 83 DIV-------EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF---F 131
IV E +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT---------PM 182
Q+ A++++H+ + HRDLKP NI + +KV DFGL D P
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
T V T+ Y +PE + Y+ +DI+S+G I E+L P
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQM-------- 231
Query: 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK 302
E + + + + K+ PP+ P ++Q +++ P
Sbjct: 232 ----------ERVRTLTDVRNLKF-------PPLF-----TQKYPCEYVMVQDMLSPSPM 269
Query: 303 DRPTAEEALADPYFKGLAKIEREP 326
+RP A + + F+ L +
Sbjct: 270 ERPEAINIIENAVFEDLDFPGKTV 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-55
Identities = 75/323 (23%), Positives = 124/323 (38%), Gaps = 54/323 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A+ ++ + V+G+G++G V A + AIKKI E +S IL EV LL L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNH 61
Query: 82 PDIVEIK--------RIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHH-QFF 131
+V + + ++ +++ E E L+ +I + + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW----- 186
Q+L AL Y+H+ + HRDLKP NI + + +K+ DFGLA+ +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 187 ------TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
T + T Y A E+ Y ID++S+G IF E++ P G V+ L
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+ R N + ++++ LI D
Sbjct: 239 KKL---------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271
Query: 301 PKDRPTAEEALADPYFKGLAKIE 323
P RP A L + + E
Sbjct: 272 PNKRPGARTLLNSGWLPVKHQDE 294
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-54
Identities = 89/319 (27%), Positives = 135/319 (42%), Gaps = 55/319 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH------DVFEHISDAIRILREVKLLR 77
Y + + +G G+ G V A + T +KVAIK I A+ + E+++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
L HP I++IK + +D Y+V ELME +L + N L + + YQML
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 137 RALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
A++Y+H + HRDLKP+N+L +C +K+ DFG +++ + T T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGE---TSLMRTLCGTP 180
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT-- 249
Y APE L + Y A+D WS+G I L+G P F L D I G
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TSGKYN 238
Query: 250 -PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
+ V AL L+++L+ DPK R T E
Sbjct: 239 FIPEV----------------------------WAEVSEKALDLVKKLLVVDPKARFTTE 270
Query: 309 EALADPYFKGLAKIEREPS 327
EAL P+ + +
Sbjct: 271 EALRHPWLQDEDMKRKFQD 289
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-53
Identities = 65/351 (18%), Positives = 126/351 (35%), Gaps = 31/351 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ + + +++G+G+ V TG+ AIK + + +RE ++L+ L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHK 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---DDLTREHHQFFLYQMLRA 138
+IV++ I + R ++ E L+ V++ L L ++
Sbjct: 68 NIVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 139 LKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ ++ + HR++KP NI+ + K+ DFG AR D T
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEE 180
Query: 195 YRAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD--L 246
Y P++ KY +D+WSIG F TG F + + +
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 247 LGTPSPETIAVVRNEKAR-KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
G PS V + E + +M + + L +L ++ D +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-----RGLQVLLTPVLANILEADQEKCW 295
Query: 306 TAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
++ A+ + S Q ++ + T EL+Y++
Sbjct: 296 GFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYN-TATIFHELVYKQT 345
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 7e-53
Identities = 72/304 (23%), Positives = 124/304 (40%), Gaps = 53/304 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
++I + IG+G + V A G VA+KK+ +F+ + R ++E+ LL+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLN 90
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF-------- 131
HP++++ S E ++ +V EL ++ DL ++IK ++ +
Sbjct: 91 HPNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHF----KKQKRLIPERTVWKY 141
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
Q+ AL++MH+ V HRD+KP N+ A +K+ D GL R S T V
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVG 198
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T +Y +PE + Y DIWS+GC+ E+ + F G +
Sbjct: 199 TPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY------------ 244
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
++ + + Y PP+P + L + DP+ RP
Sbjct: 245 ----SLCKKIEQCDY-------PPLPSDHYSEELRQLVNMCINP----DPEKRPDVTYVY 289
Query: 312 ADPY 315
Sbjct: 290 DVAK 293
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-51
Identities = 81/320 (25%), Positives = 137/320 (42%), Gaps = 50/320 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+RYK V+GKGS+G V D TG++ A+K I + +D +LREV+LL+ L H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
P+I+++ F+D Y+V E+ +L I + + + Q+L
Sbjct: 86 PNIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 138 ALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ YMH + HRDLKP+N+L + + +++ DFGL+ + M D + T +
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM----KDKIGTAY 193
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ Y D+WS G I +L+G P F G + L +
Sbjct: 194 YIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV----------- 239
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ KY + V A L+++++ + P R +A +AL
Sbjct: 240 -------EKGKY--TFELPQ-------WKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283
Query: 315 YFKGLAKIEREPSCQPISKL 334
+ + K + +
Sbjct: 284 WIQTYTKEQISVDVPSLDNA 303
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-51
Identities = 91/337 (27%), Positives = 143/337 (42%), Gaps = 51/337 (15%)
Query: 5 QTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS 64
++ + + A RY I+ ++GKGS+G V D T ++ A+K I+
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 65 DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKAN 120
D ILREV+LL+ L HP+I+++ I +D Y+V EL +L I
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAF 177
+ + Q+ + YMH N+ HRDLKP+NIL +C +K+ DFGL+
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 178 SDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+T M D + T +Y APE L G Y D+WS G I +L+G P F GK+
Sbjct: 176 QNTKM----KDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
L + + KY + + A L++++
Sbjct: 228 YDILKRV------------------ETGKY--AFDLPQ-------WRTISDDAKDLIRKM 260
Query: 297 IAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISK 333
+ F P R TA + L P+ + + S P +
Sbjct: 261 LTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-51
Identities = 83/318 (26%), Positives = 136/318 (42%), Gaps = 49/318 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y+ ++ +G G+YG V D T + AIK I S ++L EV +L+LL HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+I+++ F+D Y+V E + +L I + Q+L
Sbjct: 97 NIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 139 LKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ Y+H N+ HRDLKP+N+L + +K+ DFGL+ V + M + + T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM----KERLGTAYY 204
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ KY D+WSIG I +L G P F G++ L +
Sbjct: 205 IAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV------------ 249
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ KY + NV A L+++++ FD + R +A++AL P+
Sbjct: 250 ------EKGKY--TFDSPE-------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294
Query: 316 FKGLAKIEREPSCQPISK 333
K + + P
Sbjct: 295 IKEMCSKKESGIELPSLA 312
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-50
Identities = 82/340 (24%), Positives = 128/340 (37%), Gaps = 63/340 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
RY +GKG + D T E A K + + ++ E+ + R L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 102 HVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---------TPMTVFWTDYVAT 192
+H V HRDLK N+ N + ++K+ DFGLA D TP +Y+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 208
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 209 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------K 247
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEAL 311
ET K +Y P ++P+A L+Q+++ DP RPT E L
Sbjct: 248 ETY---LRIKKNEY--------------SIPKHINPVAASLIQKMLQTDPTARPTINELL 290
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
D +F R P F + + + L
Sbjct: 291 NDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 3e-50
Identities = 75/360 (20%), Positives = 132/360 (36%), Gaps = 74/360 (20%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR-LLRH 81
N +++G GS G V + G VA+K++ F I L E+KLL H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDH 68
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMESDLHQVIKANDDLTREHHQF-------F 131
P+++ +Y+ EL +L ++++ +
Sbjct: 69 PNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNIL-------------ANANCKLKVCDFGLAR-VAF 177
L Q+ + ++H+ + HRDLKP+NIL N ++ + DFGL + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 178 SDTPMTVFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+ + T +RAPEL + T +IDI+S+GC+F +L+ GK F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
+ + + + + ++ A
Sbjct: 241 GD-------------------------KYSRESNIIRGIFSLDEMK-CLHDRSLIAEATD 274
Query: 292 LLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
L+ ++I DP RPTA + L P F +K + +S E E R + +
Sbjct: 275 LISQMIDHDPLKRPTAMKVLRHPLFWPKSK--KLEFLLKVSD-RLEIENRDPPSALLMKF 331
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-50
Identities = 69/321 (21%), Positives = 125/321 (38%), Gaps = 42/321 (13%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
+ Q + + + R+ K IG+GS+ V +DT T +VA ++ D
Sbjct: 4 RNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK 63
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA 119
S+ R E ++L+ L+HP+IV K + K I +V ELM S L +K
Sbjct: 64 LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKR 122
Query: 120 NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANA-NCKLKVCDFGLARVA 176
+ + + + Q+L+ L+++HT + HRDLK NI +K+ D GLA +
Sbjct: 123 FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+ V T + APE+ KY ++D+++ G E+ T + +
Sbjct: 183 RASFAKAVIGTPE----FM-APEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
Q+ Y P + P +++
Sbjct: 235 AAQI-------------------------YRRVTSGVKPASFDK---VAIPEVKEIIEGC 266
Query: 297 IAFDPKDRPTAEEALADPYFK 317
I + +R + ++ L +F+
Sbjct: 267 IRQNKDERYSIKDLLNHAFFQ 287
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 4e-50
Identities = 89/321 (27%), Positives = 141/321 (43%), Gaps = 51/321 (15%)
Query: 11 KDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL 70
++ + + A RY I+ ++GKGS+G V D T ++ A+K I+ D IL
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 71 REVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQ 129
REV+LL+ L HP+I+++ I+ + Y+V EL +L I +
Sbjct: 70 REVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFW 186
+ Q+ + YMH N+ HRDLKP+NIL +C +K+ DFGL+ +T M
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---- 180
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
D + T +Y APE L G Y D+WS G I +L+G P F GK+ L +
Sbjct: 181 KDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-- 234
Query: 246 LLGT---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK 302
G P+ + + A L+++++ F P
Sbjct: 235 ETGKYAFDLPQ----------------------------WRTISDDAKDLIRKMLTFHPS 266
Query: 303 DRPTAEEALADPYFKGLAKIE 323
R TA + L P+ + + E
Sbjct: 267 LRITATQCLEHPWIQKYSSEE 287
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-49
Identities = 78/306 (25%), Positives = 122/306 (39%), Gaps = 63/306 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
RY +GKG + D T E A K + + ++ E+ + R L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 76 HVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---------TPMTVFWTDYVAT 192
+H V HRDLK N+ N + ++K+ DFGLA D TP +Y+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 182
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 183 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------K 221
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDRPTAEEAL 311
ET K +Y P +++P+A L+Q+++ DP RPT E L
Sbjct: 222 ETY---LRIKKNEY--------------SIPKHINPVAASLIQKMLQTDPTARPTINELL 264
Query: 312 ADPYFK 317
D +F
Sbjct: 265 NDEFFT 270
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-49
Identities = 78/343 (22%), Positives = 132/343 (38%), Gaps = 22/343 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+++ E +G G +G V I TGE+VAIK+ + R E+++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73
Query: 84 IVEIKRIMLPPSKREFKD-IYVVFELMES-DLHQVIKANDD---LTREHHQFFLYQMLRA 138
+V + + K D + E E DL + + ++ L + L + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 139 LKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L+Y+H + HRDLKP+NI+ + K+ D G A+ T F V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF----VGTLQY 189
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APEL KYT +D WS G + E +TG F Q
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV----REKSNEH 243
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
VV ++ P L + R LQ ++ + + R T +
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHL---SGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
F+ L I ++ + VT+++ + + + +
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQ 343
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-49
Identities = 78/349 (22%), Positives = 126/349 (36%), Gaps = 85/349 (24%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI---HDVFEHISDAIRILREVKLLRLL 79
+Y + IG+GSYGVV AI+ T AIK + + D RI EV+L++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQF-------- 130
HP+I + + + + I +V EL L + D +
Sbjct: 86 HHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 131 --------------------------------FLYQMLRALKYMHTANVYHRDLKPKNIL 158
+ Q+ AL Y+H + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 159 --ANANCKLKVCDFGLARVAFSDTPMTVF-WTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
N + ++K+ DFGL++ + + T T ++ APE+ + Y P D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 216 SIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPETIAVVRNEKARKYLTEMRK 272
S G + +L G FPG + + + L +P
Sbjct: 261 SAGVLLHLLLMGAVPFPGVNDADTISQV--LNKKLCFENPN------------------- 299
Query: 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
+ + PLA LL L+ + +R A AL P+ +
Sbjct: 300 ---------YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-49
Identities = 81/331 (24%), Positives = 130/331 (39%), Gaps = 62/331 (18%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-----------HDVFEHISDAIRILR 71
Y + +G G+YG V + + + AIK I D I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREH 127
E+ LL+ L HP+I+++ + F+D Y+V E E +L + I
Sbjct: 96 EISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTV 184
+ Q+L + Y+H N+ HRD+KP+NIL N+ +K+ DFGL+ D +
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-- 205
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
D + T +Y APE L KY D+WS G I +L G P F G++ + +
Sbjct: 206 --RDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
+ KY + N+ A L++ ++ +D
Sbjct: 260 ------------------EKGKY--YFDFND-------WKNISDEAKELIKLMLTYDYNK 292
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKL 334
R TAEEAL + K A + + +
Sbjct: 293 RCTAEEALNSRWIKKYANNINKSDQKTLCGA 323
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-49
Identities = 81/300 (27%), Positives = 126/300 (42%), Gaps = 47/300 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y + IG+GS+G V A+ T + A KKI + D R +E+++++ L HP+
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHPN 67
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+ + + DIY+V EL +L + + + +L A+ Y
Sbjct: 68 IIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H NV HRDLKP+N L + + LK+ DFGLA M V T +Y +P+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM----RTKVGTPYYVSPQ 178
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L G Y P D WS G + +L G P F + + I
Sbjct: 179 VLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--------------- 219
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ + +K + NV P A L++RL+ PK R T+ +AL +F+
Sbjct: 220 ---REGTF--TFPEKD-------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-48
Identities = 82/315 (26%), Positives = 136/315 (43%), Gaps = 50/315 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y + E +GKG++ VV + TG + A K I+ D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+IV + + +E Y+VF+L+ +L + I A + + + Q+L ++ Y
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 142 MHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
H+ + HR+LKP+N+L +K+ DFGLA +D + W + T Y +P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VND---SEAWHGFAGTPGYLSP 176
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPET 254
E L Y+ +DIW+ G I +L G P F + I G PSPE
Sbjct: 177 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPE- 230
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ V P A L+ ++ +PK R TA++AL P
Sbjct: 231 ---------------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263
Query: 315 YFKGLAKIEREPSCQ 329
+ ++ Q
Sbjct: 264 WICNRERVASAIHRQ 278
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-48
Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 49/299 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
++I +GKG +G V A + + +A+K + E ++ REV++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
P+I+ + ++ +Y++ E +++ ++ + ++ ++ AL
Sbjct: 69 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT-DYVATRWYRAPE 199
Y H+ V HRD+KP+N+L + +LK+ DFG + A S + T DY+ PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE 177
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + +D+WS+G + E L GKP F + I
Sbjct: 178 MIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---------------- 219
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
++ FP+ V A L+ RL+ +P RP E L P+
Sbjct: 220 --SRVEF--------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-47
Identities = 79/320 (24%), Positives = 130/320 (40%), Gaps = 55/320 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-------HDVFEHISDAIRILREVKL 75
Y+ E++G+G VV I T ++ A+K I E L+EV +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 76 LRLL-RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLY 133
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+L + +H N+ HRDLKP+NIL + + +K+ DFG + + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTP 187
Query: 194 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
Y APE + S Y +D+WS G I +L G P F + + L +I + G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGN 245
Query: 250 ---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
SPE + + L+ R + P+ R T
Sbjct: 246 YQFGSPE----------------------------WDDYSDTVKDLVSRFLVVQPQKRYT 277
Query: 307 AEEALADPYFKGLAKIEREP 326
AEEALA P+F+ E
Sbjct: 278 AEEALAHPFFQQYVVEEVRH 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 2e-47
Identities = 52/335 (15%), Positives = 97/335 (28%), Gaps = 73/335 (21%)
Query: 22 ANRYKIL---EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLR 77
R + L V+G+ A D TGE + + S+AI ++ EV LR
Sbjct: 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 78 LLR----------------------HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQ 115
LLR P ++ R+ L + ++ M+S+L
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 116 VIKANDDLTREHHQ-------FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEVL 225
F A A + + T A D W++G +
Sbjct: 254 GFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 226 TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV 285
+ + + I R +P
Sbjct: 312 CADLPNTDDAALGGSEWI--------------------------FRSCKNIP-------- 337
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320
LL+ + + +DR +A+ P ++ L
Sbjct: 338 -QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-47
Identities = 85/327 (25%), Positives = 139/327 (42%), Gaps = 50/327 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y + E +GKG++ VV + TG + A K I+ D ++ RE ++ R L+HP+
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV + + +E Y+VF+L+ +L + I A + + + Q+L ++ Y
Sbjct: 90 IVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H+ + HR+LKP+N+L +K+ DFGLA +D + W + T Y +PE
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VND---SEAWHGFAGTPGYLSPE 200
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPETI 255
L Y+ +DIW+ G I +L G P F + I G PSPE
Sbjct: 201 VLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPE-- 253
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ V P A L+ ++ +PK R TA++AL P+
Sbjct: 254 --------------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRR 342
++ Q +F RR
Sbjct: 288 ICNRERVASAIHRQDTVDCLKKFNARR 314
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-47
Identities = 62/303 (20%), Positives = 105/303 (34%), Gaps = 43/303 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y ++ +G+G + V H G A+K+I E D RE + RL HP+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQ-QDREEAQREADMHRLFNHPN 87
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRA 138
I+ + L + + +++ + L I+ + LT + + L + R
Sbjct: 88 ILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP------MTVFWTDYVAT 192
L+ +H HRDLKP NIL + + D G A W T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 193 RWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
YRAPEL D+WS+GC+ ++ G+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV----------------- 249
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+K ++ + +P + +LL ++ DP RP L
Sbjct: 250 --------FQKGDSVALAVQNQLSIPQSPRHS---SALWQLLNSMMTVDPHQRPHIPLLL 298
Query: 312 ADP 314
+
Sbjct: 299 SQL 301
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-47
Identities = 52/335 (15%), Positives = 102/335 (30%), Gaps = 81/335 (24%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR-EVKLLRLLR-- 80
V+G+ A D TGE + + S+AI+ ++ EV LRLLR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 81 --------------------HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
P ++ R+ L + ++ M+S+L +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 121 DDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
+ H Q++R L +H + H L+P +I+ + + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAEV 224
+ +V +R + PEL + T + D W++G + +
Sbjct: 254 VRDGARVVSSV-------SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284
+ + + I R +P
Sbjct: 307 WCADLPITKDAALGGSEWI--------------------------FRSCKNIP------- 333
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
LL+ + + +DR +A+ P ++ L
Sbjct: 334 --QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-47
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 49/313 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+ + I +GKG +G V A + +A+K + E ++ RE+++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
P+I+ + + IY++ E +L++ ++ + + F+ ++ AL
Sbjct: 74 PNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT-DYVATRWYRAPE 199
Y H V HRD+KP+N+L +LK+ DFG + A S T+ T DY+ PE
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPE 182
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + +D+W G + E L G P F S I
Sbjct: 183 MIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI---------------- 224
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
KFP + + L+ +L+ + P R + + P+ K
Sbjct: 225 --VNVDL--------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268
Query: 319 LAKIEREPSCQPI 331
++ P Q
Sbjct: 269 NSRRVLPPVYQST 281
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-46
Identities = 82/327 (25%), Positives = 134/327 (40%), Gaps = 49/327 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y++ E +GKG++ VV + G++ A I+ D ++ RE ++ RLL+HP+
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV + + E Y++F+L+ +L + I A + + + Q+L A+ +
Sbjct: 72 IVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H V HR+LKP+N+L +K+ DFGLA + W + T Y +PE
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGYLSPE 183
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPETI 255
L Y +D+W+ G I +L G P F + I G PSPE
Sbjct: 184 VLRK---DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPE-- 236
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ V P A L+ +++ +P R TA EAL P+
Sbjct: 237 --------------------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRR 342
+ + Q +F RR
Sbjct: 271 ISHRSTVASCMHRQETVDCLKKFNARR 297
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-46
Identities = 75/317 (23%), Positives = 124/317 (39%), Gaps = 53/317 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y++ E +G G + +V TG++ A K I I REV +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+RHP+I+ + I D+ ++ EL+ +L + + LT + FL Q+L
Sbjct: 65 IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 138 ALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+H+ + H DLKP+NI+ N ++K+ DFG+A + T
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI----FGTP 175
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---P 250
+ APE+ + D+WSIG I +L+G F G++ L I
Sbjct: 176 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--SAVNYDFD 231
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
F N LA ++RL+ DPK R T ++
Sbjct: 232 EEY----------------------------FSNTSELAKDFIRRLLVKDPKRRMTIAQS 263
Query: 311 LADPYFKGLAKIEREPS 327
L + K + +
Sbjct: 264 LEHSWIKAIRRRNVRGE 280
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-46
Identities = 73/308 (23%), Positives = 130/308 (42%), Gaps = 64/308 (20%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+K+ ++GKGS+ V A HTG +VAIK I R+ EVK+ L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRAL 139
P I+E+ + +Y+V E+ + ++++ +K + + F++Q++ +
Sbjct: 71 PSILELYNYFEDSNY-----VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---------TPMTVFWTDYV 190
Y+H+ + HRDL N+L N +K+ DFGLA TP +Y+
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP------NYI 179
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
+PE+ S + D+WS+GC+F +L G+P F +V + L+ +
Sbjct: 180 ------SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------- 224
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEE 309
Y + P+ + A L+ +L+ +P DR +
Sbjct: 225 -----------VLADY--------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSS 259
Query: 310 ALADPYFK 317
L P+
Sbjct: 260 VLDHPFMS 267
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-46
Identities = 75/358 (20%), Positives = 136/358 (37%), Gaps = 62/358 (17%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV 59
++ E K + Y++ +V+G G G V TG+K A+K +
Sbjct: 12 LEVLFQGPEPKKYAVT------DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL--- 62
Query: 60 FEHISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVI 117
D+ + +EV + P IV I + + + + ++ E ME +L I
Sbjct: 63 ----YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRI 117
Query: 118 KANDDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKV 167
+ R F + + A++++H+ N+ HRD+KP+N+L + LK+
Sbjct: 118 QE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227
DFG A+ + + T +Y APE+ G KY + D+WS+G I +L G
Sbjct: 173 TDFGFAKE-TTQNAL----QTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCG 225
Query: 228 KPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP 287
P F T + + R + +Y + V
Sbjct: 226 FPPFYSN--------------TGQAISPGMKRRIRLGQY--GFPNPE-------WSEVSE 262
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
A +L++ L+ DP +R T + + P+ + + P E + V +
Sbjct: 263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKE 320
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 8e-46
Identities = 76/310 (24%), Positives = 128/310 (41%), Gaps = 54/310 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------HDVFEHISDAIRILREVKLL 76
+Y +VIG+G VV + TG + A+K + + RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 77 RLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQ 134
R + HP I+ + +++VF+LM +L + L+ + + +
Sbjct: 154 RQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS 208
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+L A+ ++H N+ HRDLKP+NIL + N ++++ DFG + + + T
Sbjct: 209 LLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL----RELCGTPG 264
Query: 195 YRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT- 249
Y APE L S Y +D+W+ G I +L G P F + + L +I + G
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--MEGQY 322
Query: 250 --PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
SPE + + L+ RL+ DP+ R TA
Sbjct: 323 QFSSPE----------------------------WDDRSSTVKDLISRLLQVDPEARLTA 354
Query: 308 EEALADPYFK 317
E+AL P+F+
Sbjct: 355 EQALQHPFFE 364
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-45
Identities = 60/325 (18%), Positives = 101/325 (31%), Gaps = 71/325 (21%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL-RLLR 80
+ LE IG G +G V + G AIK+ D LREV L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTR---EHH-QFFLYQM 135
H +V + E + + E L I N + E + L Q+
Sbjct: 70 HSHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 136 LRALKYMHTANVYHRDLKPKNIL-------------------ANANCKLKVCDFGLARVA 176
R L+Y+H+ ++ H D+KP NI A+ K+ D G
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+P + A E+ ++ + P DI+++ +PL
Sbjct: 185 --SSPQVE-----EGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
H++ R+ + Q LL+ +
Sbjct: 237 WHEI------------------------------RQGRLPRIPQVLS---QEFTELLKVM 263
Query: 297 IAFDPKDRPTAEEALADPYFKGLAK 321
I DP+ RP+A + ++
Sbjct: 264 IHPDPERRPSAMALVKHSVLLSASR 288
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 80/337 (23%), Positives = 133/337 (39%), Gaps = 63/337 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI---HDVFEHISDAIRILREVKLLRLLR 80
Y++ EVIGKG + VV I+ TG++ A+K + + RE + +L+
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLY------ 133
HP IVE+ +Y+VFE M+ +DL ++ + F+Y
Sbjct: 85 HPHIVELLETY-----SSDGMLYMVFEFMDGADLC------FEIVKRADAGFVYSEAVAS 133
Query: 134 ----QMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFW 186
Q+L AL+Y H N+ HRD+KP +L + +K+ FG+A +
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV---A 190
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
V T + APE + Y +D+W G I +L+G F G
Sbjct: 191 GGRVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYG------------ 235
Query: 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
+ KY +M + + ++ A L++R++ DP +R
Sbjct: 236 -------TKERLFEGIIKGKY--KMNPRQ-------WSHISESAKDLVRRMLMLDPAERI 279
Query: 306 TAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
T EAL P+ K + + + +F RR
Sbjct: 280 TVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-45
Identities = 76/316 (24%), Positives = 136/316 (43%), Gaps = 51/316 (16%)
Query: 11 KDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL 70
++ + + + + +G G++G V + +G + IK I + +I
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQVPMEQIE 68
Query: 71 REVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD----LTR 125
E+++L+ L HP+I++I + ++ ++Y+V E E +L + I + L+
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPM 182
+ + QM+ AL Y H+ +V H+DLKP+NIL + + +K+ DFGLA + SD
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 183 TVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
T+ T Y APE T DIWS G + +LTG F G S+
Sbjct: 184 ----TNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301
++ + + P A+ LL++++ DP
Sbjct: 236 KA------------------TYKEPNYA----------VECRPLTPQAVDLLKQMLTKDP 267
Query: 302 KDRPTAEEALADPYFK 317
+ RP+A + L +FK
Sbjct: 268 ERRPSAAQVLHHEWFK 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-45
Identities = 71/325 (21%), Positives = 122/325 (37%), Gaps = 53/325 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y I E +G G + +V + TG + A K I I REV +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+ H +++ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 138 ALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+HT + H DLKP+NI+ +K+ DFGLA T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI----FGTP 182
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---P 250
+ APE+ + D+WSIG I +L+G F G + L I +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--TSVSYDFD 238
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
F + LA +++L+ + + R T +EA
Sbjct: 239 EEF----------------------------FSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 311 LADPYFKGLAKIEREPSCQPISKLE 335
L P+ + + + + LE
Sbjct: 271 LRHPWITPVDNQQAMVRRESVVNLE 295
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-45
Identities = 73/325 (22%), Positives = 122/325 (37%), Gaps = 53/325 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y I E +G G + +V + TG + A K I I REV +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+ HP+I+ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 138 ALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+HT + H DLKP+NI+ +K+ DFGLA T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI----FGTP 182
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---P 250
+ APE+ + D+WSIG I +L+G F G + L I +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--TAVSYDFD 238
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
F LA +++L+ + + R T +EA
Sbjct: 239 EEF----------------------------FSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 311 LADPYFKGLAKIEREPSCQPISKLE 335
L P+ + + + + LE
Sbjct: 271 LRHPWITPVDTQQAMVRRESVVNLE 295
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-45
Identities = 78/339 (23%), Positives = 152/339 (44%), Gaps = 54/339 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y++L+ IGKG++ V A TG +VAIK I + + ++ REV+++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV++ ++ K +Y++ E ++ + A+ + + + Q++ A++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLK +N+L +A+ +K+ DFG + + F Y APEL
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF----CGAPPYAAPEL-- 184
Query: 203 SFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
F KY P +D+WS+G I +++G F G++
Sbjct: 185 --FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------------------ 218
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK-G 318
L E+R++ ++ + LL+R + +P R T E+ + D + G
Sbjct: 219 -------LKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
Query: 319 LAKIEREPSCQPISKLEFEF-----ERRRVTKDDIRELI 352
+ E +P +P + + ++++I+E +
Sbjct: 272 HEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL 310
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-45
Identities = 62/321 (19%), Positives = 129/321 (40%), Gaps = 62/321 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------------------------HD 58
N+Y + + IGKGSYGVV A + + A+K +
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 59 VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI 117
+ ++ +E+ +L+ L HP++V++ ++ P++ +Y+VFEL+ + +V
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVP 129
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
L+ + +F+ +++ ++Y+H + HRD+KP N+L + +K+ DFG++
Sbjct: 130 T-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--NE 186
Query: 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+ V T + APE ++ A+D+W++G + G+ F + +
Sbjct: 187 FKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
+ I + P P++ L+ R+
Sbjct: 246 MCLHSKI--------------------------KSQALEFP---DQPDIAEDLKDLITRM 276
Query: 297 IAFDPKDRPTAEEALADPYFK 317
+ +P+ R E P+
Sbjct: 277 LDKNPESRIVVPEIKLHPWVT 297
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-45
Identities = 77/347 (22%), Positives = 132/347 (38%), Gaps = 62/347 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y E +G G + VV + TG + A K I I REV +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 79 LRHPDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQ 134
++HP+++ + + +++ + ++ EL+ +L + + LT E FL Q
Sbjct: 71 IQHPNVITLHEV--------YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 135 MLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
+L + Y+H+ + H DLKP+NI+ ++K+ DFGLA
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI----F 178
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT- 249
T + APE+ + D+WSIG I +L+G F G + L +
Sbjct: 179 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--SAVNY 234
Query: 250 --PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
F N LA ++RL+ DPK R T
Sbjct: 235 EFEDEY----------------------------FSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 308 EEALADPYFKGL---AKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
+++L P+ K + R+ S + K + R++ L
Sbjct: 267 QDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGL 313
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 9e-45
Identities = 83/375 (22%), Positives = 139/375 (37%), Gaps = 71/375 (18%)
Query: 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
++K +Y +V+G G G V + T EK A+K + D +
Sbjct: 53 QIKKNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPK 100
Query: 69 ILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTRE 126
REV+L R + P IV I + K + +V E ++ +L +
Sbjct: 101 ARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELF------SRIQDR 153
Query: 127 HHQFF--------LYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARV 175
Q F + + A++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+
Sbjct: 154 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213
Query: 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
S + T T +Y APE+ G KY + D+WS+G I +L G P F
Sbjct: 214 TTSHNSL----TTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267
Query: 236 VVHQLDLITD--LLGT---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290
+ + +G P+PE + V
Sbjct: 268 GLAISPGMKTRIRMGQYEFPNPE----------------------------WSEVSEEVK 299
Query: 291 RLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRE 350
L++ L+ +P R T E + P+ K+ + P E + V ++
Sbjct: 300 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSA 359
Query: 351 LIYREILEYHPQLLK 365
L + ++ K
Sbjct: 360 LATMRVDYEQIKIKK 374
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-44
Identities = 69/306 (22%), Positives = 129/306 (42%), Gaps = 40/306 (13%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+ +++ +G+G+YG V A++ T E VA+K I D+ + I +E+ + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+V+ + Y+ E +L I+ + + Q F +Q++ + Y+
Sbjct: 67 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LK+ DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +D+WS G + +L G+ + S D +
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEY--------------- 218
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF-KGLA 320
+ + P + +D L LL +++ +P R T + D ++ K L
Sbjct: 219 --SDWKEKKTYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
Query: 321 KIEREP 326
K + P
Sbjct: 271 KGAKRP 276
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 68/362 (18%), Positives = 122/362 (33%), Gaps = 100/362 (27%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++ ++ +G+G +GVV A + AIK+I + +++REVK L L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 64
Query: 83 DIV-------------------------------------------------EIKRIMLP 93
IV
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 94 PSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQ---FFLYQMLRALKYMHTAN 146
+ ++ M+ +L + L H Q+ A++++H+
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARV---------AFSDTPMTVFWTDYVATRWYRA 197
+ HRDLKP NI + +KV DFGL + P T V T+ Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE + Y+ +DI+S+G I E+L E + +
Sbjct: 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFS--------------------TQMERVRI 282
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + + K+ P + F P ++Q +++ P +RP A + + + F+
Sbjct: 283 ITDVRNLKF-------PLL-----FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
Query: 318 GL 319
L
Sbjct: 331 NL 332
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 76/345 (22%), Positives = 136/345 (39%), Gaps = 51/345 (14%)
Query: 10 LKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI 69
+KD F+ Y + + +G+GS+ + + + + A+K I E
Sbjct: 1 MKDSPFYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA-----NT 52
Query: 70 LREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLT 124
+E+ L+L HP+IV++ + F D ++V EL+ +L + IK +
Sbjct: 53 QKEITALKLCEGHPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFS 104
Query: 125 REHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTP 181
+ + +++ A+ +MH V HRDLKP+N+L N N ++K+ DFG AR+ D
Sbjct: 105 ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 182 MTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
T Y APE L + Y + D+WS+G I +L+G+ F
Sbjct: 165 P---LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC 218
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+++ + I K + + + NV A L+Q L+ D
Sbjct: 219 TSAVEIM-----KKI------KKGDF--SFEGEA-------WKNVSQEAKDLIQGLLTVD 258
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
P R + + + +++ P P K
Sbjct: 259 PNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVK 303
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 78/306 (25%), Positives = 126/306 (41%), Gaps = 55/306 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+++ +G+G+ +V T + A+K + + D + E+ +L L HP+
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHPN 109
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+++K I P++ I +V EL+ +L I + + Q+L A+ Y+
Sbjct: 110 IIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYL 164
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H + HRDLKP+N+L + LK+ DFGL+++ M T Y APE
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM----KTVCGTPGYCAPE 220
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT---PSPET 254
L G Y P +D+WS+G I +L G F + + I L SP
Sbjct: 221 ILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI--LNCEYYFISPW- 274
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ V A L+++LI DPK R T +AL P
Sbjct: 275 ---------------------------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307
Query: 315 YFKGLA 320
+ G A
Sbjct: 308 WVTGKA 313
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 54/340 (15%), Positives = 117/340 (34%), Gaps = 56/340 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---------------DVFEHISDAI 67
N Y+I+ + +G + + + A+KK D S
Sbjct: 31 NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTRE 126
E++++ +++ + + I+ ++Y+++E ME+ + + + L +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 127 HHQ--------FFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
+ + +L + Y+H N+ HRD+KP NIL + N ++K+ DFG +
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 178 SDTPMTVFWT-DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
T +++ PE + S +DIWS+G + F K
Sbjct: 204 DKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKAR---KYLTEMRKKPPVPLFQKFPNVDPLALRLL 293
+ E +R + + + + L
Sbjct: 258 L--------------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303
Query: 294 QRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISK 333
+ + +P +R T+E+AL + + + + K
Sbjct: 304 KLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 70/315 (22%), Positives = 130/315 (41%), Gaps = 40/315 (12%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+ +++ +G+G+YG V A++ T E VA+K I D+ + I +E+ + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+V+ + Y+ E +L I+ + + Q F +Q++ + Y+
Sbjct: 67 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LK+ DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +D+WS G + +L G+ + S D +
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEY--------------- 218
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF-KGLA 320
+ + P + +D L LL +++ +P R T + D ++ K L
Sbjct: 219 --SDWKEKKTYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
Query: 321 KIEREPSCQPISKLE 335
K + P E
Sbjct: 271 KGAKRPRVTSGGVSE 285
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-43
Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 38/313 (12%)
Query: 24 RYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-H 81
Y++ +V+G+G++ V I+ T ++ A+K I HI + REV++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF--REVEMLYQCQGH 70
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+++E+ F++ Y+VFE M + I + +
Sbjct: 71 RNVLELIEF--------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 138 ALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARV----AFSDTPMTVFWTDYV 190
AL ++H + HRDLKP+NIL N +K+CDF L T
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 191 ATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
+ Y APE+ S Y D+WS+G I +L+G P F G+ +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
+ + KY E K + ++ A L+ +L+ D K R +A
Sbjct: 243 PACQNMLFESI---QEGKY--EFPDKD-------WAHISCAAKDLISKLLVRDAKQRLSA 290
Query: 308 EEALADPYFKGLA 320
+ L P+ +G A
Sbjct: 291 AQVLQHPWVQGCA 303
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-43
Identities = 73/336 (21%), Positives = 130/336 (38%), Gaps = 62/336 (18%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y ILE +G G++GVV ++ TG K I+ + D + E+ ++ L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLTREHHQF-------F 131
++ + F+D + ++ E + +L D + E ++ +
Sbjct: 109 KLINLHDA--------FEDKYEMVLILEFLSGGELF------DRIAAEDYKMSEAEVINY 154
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
+ Q LK+MH ++ H D+KP+NI+ +K+ DFGLA D + V
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---- 210
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
AT + APE+ D+W+IG + +L+G F G+
Sbjct: 211 TATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGED-------------- 254
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
ET+ V+ + E F +V P A ++ L+ +P+ R T +
Sbjct: 255 -DLETLQNVK--RCDWEFDE----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 301
Query: 310 ALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
AL P+ KG + + +
Sbjct: 302 ALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-43
Identities = 70/310 (22%), Positives = 118/310 (38%), Gaps = 48/310 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G+GS+G V D TG + A+KK+ E E+ L
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVACAGLS 108
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRA 138
P IV + + RE + + EL+E S L Q+IK L + ++L Q L
Sbjct: 109 SPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLGQALEG 162
Query: 139 LKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLA-RVAFSDTPMTVFWTDYVA-TRWY 195
L+Y+HT + H D+K N+L +++ + +CDFG A + ++ DY+ T +
Sbjct: 163 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ +DIWS C+ +L G + + L + P P
Sbjct: 223 MAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQ---YFRGPLCLKIASEPPP--- 274
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+P P+ PL + +Q + +P R +A E
Sbjct: 275 -----------------IREIP-----PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
Query: 316 FKGLAKIERE 325
+
Sbjct: 313 KALQEVGGLK 322
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-42
Identities = 60/319 (18%), Positives = 127/319 (39%), Gaps = 54/319 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI--HDVFEHISDAIRILREVKLLRLLRH 81
+Y + +++G+GSYG V +D+ T + A+K + + + + +E++LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME---SDLHQVIKANDDLTREHHQFFLYQMLRA 138
+++++ ++ K + +Y+V E ++ + + H +F Q++
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF-CQLIDG 121
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW---- 194
L+Y+H+ + H+D+KP N+L LK+ G+A + F D
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA------LHPFAADDTCRTSQGSP 175
Query: 195 -YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
++ PE+ + ++ +DIWS G + TG F G +
Sbjct: 176 AFQPPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN----------------- 217
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ ++ + + + P LL+ ++ ++P R + +
Sbjct: 218 --------------IYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
Query: 313 DPYF-KGLAKIEREPSCQP 330
+F K E P
Sbjct: 264 HSWFRKKHPPAEAPVPIPP 282
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 73/327 (22%), Positives = 132/327 (40%), Gaps = 50/327 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y I E +G G++GVV + TG A K + H SD + +E++ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-SDL-HQVIKANDDLTREHHQFFLYQMLR 137
+V + F+D + +++E M +L +V ++ ++ + ++ Q+ +
Sbjct: 215 TLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 138 ALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L +MH N H DLKP+NI+ + +LK+ DFGL + V T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT----TGTAEF 322
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ D+WS+G + +L+G F G++ ET+
Sbjct: 323 AAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---------------DDETL 365
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
V K+ + M F + +++L+ DP R T +AL P+
Sbjct: 366 RNV---KSCDW--NMDDSA-------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRR 342
R+ + +
Sbjct: 414 LTPGNAPGRDSQIPSSRYTKIRDSIKT 440
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 78/315 (24%), Positives = 127/315 (40%), Gaps = 55/315 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + V+GKG+YG+V A D ++AIK+I + S + E+ L + L+
Sbjct: 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLK 77
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQML 136
H +IV+ S E I + E + S L + + F+ Q+L
Sbjct: 78 HKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 137 RALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPM------TVFWTDY 189
LKY+H + HRD+K N+L N + LK+ DFG ++ P T+ +
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM-- 190
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
APE+ Y A DIWS+GC E+ TGKP F ++L
Sbjct: 191 -------APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF------YELG-------- 229
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
E A + + + P +P ++ A + + DP R A +
Sbjct: 230 ---EPQAAMF------KVGMFKVHPEIP-----ESMSAEAKAFILKCFEPDPDKRACAND 275
Query: 310 ALADPYFKGLAKIER 324
L D + K +K ++
Sbjct: 276 LLVDEFLKVSSKKKK 290
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-42
Identities = 62/307 (20%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y I E +G+G +G+V ++T + + K + + +E+ +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNIARHR 61
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-SDLH-QVIKANDDLTREHHQFFLYQMLR 137
+I+ + F+ + ++FE + D+ ++ + +L +++Q+
Sbjct: 62 NILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 138 ALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL+++H+ N+ H D++P+NI+ + +K+ +FG AR + Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL----FTAPEY 169
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE + A D+WS+G + +L+G F + T+ +
Sbjct: 170 YAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAE---------TN------QQI 211
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
I + +Y ++ F + A+ + RL+ + K R TA EAL P
Sbjct: 212 IENI---MNAEY--TFDEEA-------FKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259
Query: 315 YFKGLAK 321
+ K +
Sbjct: 260 WLKQKIE 266
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-42
Identities = 75/324 (23%), Positives = 123/324 (37%), Gaps = 62/324 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHP 82
Y++ E IG GSY V I T + A+K I E++ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+I+ +K + + D +YVV ELM+ +L I + L+ + +
Sbjct: 77 NIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 139 LKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
++Y+H V HRDLKP NIL + +++CDFG A+ ++ T
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE---NGLLMTPCYTAN 185
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD-LLGT--- 249
+ APE L Y A DIWS+G + +LTG F +++ G
Sbjct: 186 FVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ +V A L+ +++ DP R TA
Sbjct: 243 SGGY----------------------------WNSVSDTAKDLVSKMLHVDPHQRLTAAL 274
Query: 310 ALADPYFKGLAKIEREPSCQPISK 333
L P+ ++ + + +
Sbjct: 275 VLRHPWIVHWDQLPQYQLNRQDAP 298
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 66/331 (19%), Positives = 123/331 (37%), Gaps = 58/331 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP 82
R ++ V+ +G + V A D +G + A+K++ + I++EV ++ L HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME---SDLHQVI---KANDDLTREHHQFFLYQML 136
+IV+ + L E L + + ++ L+ + YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 137 RALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA--- 191
RA+++MH + HRDLK +N+L + +K+CDFG A +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 192 ------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
T YR PE+ +S DIW++GCI + + F + +
Sbjct: 207 EITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
+V KY PP + L++ ++ +P++
Sbjct: 260 ------------RIVN----GKY-----SIPP------HDTQYTVFHSLIRAMLQVNPEE 292
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKL 334
R + E + + +A PI++L
Sbjct: 293 RLSIAEVVHQL--QEIAAARNVNPKSPITEL 321
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 45/297 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
Y + + +G G++G V TG KVA+K ++ + +I RE++ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I+++ +++ P+ ++V E + +L I + + + Q+L A+ Y
Sbjct: 72 HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H V HRDLKP+N+L +A+ K+ DFGL+ + + + Y APE+
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----CGSPNYAAPEVI 182
Query: 202 GSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
Y P +DIWS G I +L G F +
Sbjct: 183 SG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEH------------------------- 215
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KK +F ++ LL ++ DP R T ++ +FK
Sbjct: 216 ------VPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-41
Identities = 76/360 (21%), Positives = 126/360 (35%), Gaps = 90/360 (25%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH 62
++ ++K +Y +V+G G G V + T EK A+K +
Sbjct: 3 HVKSGLQIKKNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKML------ 51
Query: 63 ISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN 120
D + REV+L R + P IV I + K + +V E ++ +L I+
Sbjct: 52 -QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD- 108
Query: 121 DDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDF 170
R F + + A++Y+H+ N+ HRD+KP+N+L N LK+ DF
Sbjct: 109 ----RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
G A E G KY + D+WS+G I +L G P
Sbjct: 165 GF------------------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPP 197
Query: 231 FPGKSVVHQLDLITD--LLGT---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV 285
F + + +G P+PE + V
Sbjct: 198 FYSNHGLAISPGMKTRIRMGQYEFPNPE----------------------------WSEV 229
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
L++ L+ +P R T E + P+ K+ + P E + V +
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKE 289
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-41
Identities = 74/327 (22%), Positives = 121/327 (37%), Gaps = 62/327 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLL 79
Y++ ++GKG +G V A +VAIK I + +SD++ EV LL +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 80 R----HPDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLY 133
HP ++ + +V E DL I L + F
Sbjct: 92 GAGGGHPGVIRLLDWFETQEG-----FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
Q++ A+++ H+ V HRD+K +NIL + K+ DFG + D P T F T
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDF----DGT 201
Query: 193 RWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
R Y PE +Y +WS+G + +++ G F +
Sbjct: 202 RVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------------- 245
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+ + P +V P L++R +A P RP+ EE L
Sbjct: 246 ------------------LEAELHFP-----AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282
Query: 312 ADPYFK-GLAKIEREPSCQPISKLEFE 337
DP+ + + PS + L +
Sbjct: 283 LDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-41
Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
Y I E +G+GS+G V A T +KVA+K I + + +R+ RE+ L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+++ ++ P DI +V E +L I +T + + F Q++ A++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLKP+N+L + N +K+ DFGL+ + + + Y APE+
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS----CGSPNYAAPEVIN 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y P +D+WS G + +L G+ F +
Sbjct: 181 G--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-------------------------- 212
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KK ++ + P A L++R+I DP R T +E DP+F
Sbjct: 213 -----IPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 69/305 (22%), Positives = 117/305 (38%), Gaps = 59/305 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLL 79
+Y++ ++G G +G V + I VAIK + + + + R+ EV LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 80 RH--PDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQM 135
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 136 LRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
L A+++ H V HRD+K +NIL + N +LK+ DFG + DT T F TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDF----DGTRV 213
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y PE + +Y + +WS+G + +++ G F +
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------------- 255
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+R + V L++ +A P DRPT EE
Sbjct: 256 ----------------IRGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 314 PYFKG 318
P+ +
Sbjct: 295 PWMQD 299
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 68/360 (18%), Positives = 128/360 (35%), Gaps = 68/360 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------HDVFEHISDAIRILREVKLLR 77
+Y + +G G++G V A+D ++V +K I D + ++ E+ +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQM 135
+ H +I+++ I +V E S DL I + L + Q+
Sbjct: 85 RVEHANIIKVLDIFENQGF-----FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ A+ Y+ ++ HRD+K +NI+ + +K+ DFG A F T Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF----CGTIEY 195
Query: 196 RAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE+ + Y P +++WS+G ++ + F
Sbjct: 196 CAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCE--------------------- 232
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ PP V + L+ L+ P+ R T E+ + DP
Sbjct: 233 ---LEETVEAAI------HPP-------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEVL 374
+ QP++ ++ +E ++ LE + L D E+
Sbjct: 277 WVT-----------QPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELC 325
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 67/309 (21%), Positives = 120/309 (38%), Gaps = 58/309 (18%)
Query: 23 NRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
N Y + + +G+G + VV I TG++ A K + IL E+ +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 82 -PDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVI--KANDDLTREHHQFFLYQ 134
P ++ + + +++ I ++ E ++ + + + ++ + Q
Sbjct: 88 CPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 135 MLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
+L + Y+H N+ H DLKP+NIL +K+ DFG++R + +
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI----MG 195
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT-- 249
T Y APE+ + T A D+W+IG I +LT F G+ I
Sbjct: 196 TPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI--SQVNVD 251
Query: 250 -PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
F +V LA +Q L+ +P+ RPTAE
Sbjct: 252 YSEET----------------------------FSSVSQLATDFIQSLLVKNPEKRPTAE 283
Query: 309 EALADPYFK 317
L+ + +
Sbjct: 284 ICLSHSWLQ 292
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 83/343 (24%), Positives = 132/343 (38%), Gaps = 52/343 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY ++ IG G++GV D T E VA+K I D + RE+ R LRHP+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDE-NVQREIINHRSLRHPN 77
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV K ++L P+ + ++ E +L++ I + + +FF Q+L + Y
Sbjct: 78 IVRFKEVILTPTH-----LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 143 HTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
H+ + HRDLK +N L + +LK+CDFG ++ + + V T Y APE+
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 188
Query: 201 CGSFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
+Y D+WS G +L G F
Sbjct: 189 ----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY----------------- 227
Query: 258 VRNEKARKYLTE-MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
RK + + K +P + P L+ R+ DP R + E +F
Sbjct: 228 ------RKTIQRILSVKYSIP---DDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278
Query: 317 -KGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
K L S E E + + D I ++I +
Sbjct: 279 LKNLPADLMNESNTGSQFQEPEQPMQSL--DTIMQIISEATIP 319
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-40
Identities = 89/347 (25%), Positives = 143/347 (41%), Gaps = 63/347 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D ++ EV+G+G++GVVC A + VAIK+I E A E++ L +
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIES--ESERKAFI--VELRQLSRVN 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTREHHQFFLYQML 136
HP+IV++ L P + +V E E L+ V+ + T H + Q
Sbjct: 60 HPNIVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 137 RALKYMHTAN---VYHRDLKPKNILANANCK-LKVCDFGLARVAFSDTPMTVFWTDYVAT 192
+ + Y+H+ + HRDLKP N+L A LK+CDFG A T M T+ +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHM----TNNKGS 166
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
+ APE+ S Y+ D++S G I EV+T + F +G P+
Sbjct: 167 AAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDE-------------IGGPAF 211
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ V N +PP+ N+ L+ R + DP RP+ EE +
Sbjct: 212 RIMWAVHN----------GTRPPLI-----KNLPKPIESLMTRCWSKDPSQRPSMEEIV- 255
Query: 313 DPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEY 359
K + + R L++ + +D R Y + E+
Sbjct: 256 ----KIMTHLMRYFPGADE-PLQYPCQHSLPPGEDGRVEPYVDFAEF 297
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-40
Identities = 75/315 (23%), Positives = 132/315 (41%), Gaps = 54/315 (17%)
Query: 23 NRYKI--LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ Y + E++G G +G V +T TG K+A K I + D + E+ ++ L
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLD 144
Query: 81 HPDIVEIKRIMLPPSKREF---KDIYVVFELME-SDLH-QVIKANDDLTREHHQFFLYQM 135
H +++++ F DI +V E ++ +L ++I + +LT F+ Q+
Sbjct: 145 HANLIQLYDA--------FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 136 LRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+++MH + H DLKP+NIL ++K+ DFGLAR + V T
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN----FGTP 252
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
+ APE + F + D+WS+G I +L+G F G D
Sbjct: 253 EFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGD---------ND------A 294
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
ET+ + R L + ++F ++ A + +L+ + R +A EAL
Sbjct: 295 ETLNNIL--ACRWDLED----------EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342
Query: 313 DPYFKGLAKIEREPS 327
P+ R +
Sbjct: 343 HPWLSDHKLHSRLSA 357
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 68/298 (22%), Positives = 109/298 (36%), Gaps = 54/298 (18%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-----REVKLLRLLR 80
+ + IGKG +G+V VAIK + + REV ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI-KANDDLTREHHQFFLYQMLRA 138
HP+IV++ +M P +V E + DL+ + + + +
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 139 LKYMHTAN--VYHRDLKPKNIL-----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
++YM N + HRDL+ NI NA KV DFGL++ + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSVSGLLGN---- 189
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
+W APE G+ YT D +S I +LTG+ F S
Sbjct: 190 FQW-MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------------- 235
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ I ++R E R P +P + P +++ + DPK RP
Sbjct: 236 IKFINMIREEGLR---------PTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSY 279
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-38
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 45/297 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
Y + + +G G++G V TG KVA+K ++ + +I RE++ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I+++ +++ P DI++V E + +L I N L + + Q+L + Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H V HRDLKP+N+L +A+ K+ DFGL+ + + + Y APE+
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----CGSPNYAAPEVI 187
Query: 202 GSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
Y P +DIWS G I +L G F
Sbjct: 188 SG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDH------------------------- 220
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KK +F ++P + LL+ ++ DP R T ++ +FK
Sbjct: 221 ------VPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-38
Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 38/287 (13%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ + IG GS+G V G+ VA+K ++ EV +LR RH +I+
Sbjct: 27 TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALKYMH 143
P + +V + E S L+ + A++ + Q R + Y+H
Sbjct: 84 LFMGYSTAP------QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
++ HRDLK NI + + +K+ DFGLA S + + + + APE +
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ Y+ D+++ G + E++TG+ + + I +V
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI--------------NNRDQIIEMV---- 238
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
R L V N RL+ + +RP+
Sbjct: 239 GRGSL--SPDLSKVR-----SNCPKRMKRLMAECLKKKRDERPSFPR 278
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-38
Identities = 77/339 (22%), Positives = 134/339 (39%), Gaps = 33/339 (9%)
Query: 4 DQTKKELKDKDFFTEYG---DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
+Q +K L+ + + ++ + +G G+ GVV +G +A K IH +
Sbjct: 11 EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LE 69
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKA 119
+ +I+RE+++L P IV +I + E M+ L QV+K
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKK 124
Query: 120 NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178
+ + +++ L Y+ + HRD+KP NIL N+ ++K+CDFG++
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LI 183
Query: 179 DTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
D+ F V TR Y +PE L G + Y+ DIWS+G E+ G+ P
Sbjct: 184 DSMANSF----VGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF---QKFPNVDPLALRLLQ 294
+ + + ET R M +PP+ +F N P L
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
Query: 295 RLIAF----------DPKDRPTAEEALADPYFKGLAKIE 323
+ F +P +R ++ + + K E
Sbjct: 297 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-38
Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 47/287 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
I E IG GS+G V A G VA+K + + H LREV +++ LRHP+IV
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD---LTREHHQFFLYQMLRALKY 141
+ P + +V E + L++++ + L Y + + + Y
Sbjct: 98 LFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 142 MHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H N + HR+LK N+L + +KVCDFGL+R+ S + T + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPE 209
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ D++S G I E+ T + + ++ ++ AV
Sbjct: 210 VLRD--EPSNEKSDVYSFGVILWELATLQQPWGN---LNPAQVV-----------AAVGF 253
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
K+ +P N++P +++ +P RP+
Sbjct: 254 K----------CKRLEIP-----RNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-38
Identities = 66/314 (21%), Positives = 119/314 (37%), Gaps = 53/314 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+I E+IGKG +G V GE VAI+ I ++ REV R RH ++V
Sbjct: 36 EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 86 E-IKRIMLPPSKREFKDIYVVFELME-SDLHQVI-KANDDLTREHHQFFLYQMLRALKYM 142
+ M PP + ++ L + L+ V+ A L + ++++ + Y+
Sbjct: 93 LFMGACMSPP------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR--APEL 200
H + H+DLK KN+ + N K+ + DFGL ++ + W APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 201 -------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
++ D++++G I+ E+ + F + P+
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ---------------PAEA 250
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
I + KP + + +L AF+ ++RPT + +
Sbjct: 251 IIWQMGT----------GMKPNLSQ----IGMGKEISDILLFCWAFEQEERPTFTKLMD- 295
Query: 314 PYFKGLAKIEREPS 327
+ L K R S
Sbjct: 296 -MLEKLPKRNRRLS 308
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 71/385 (18%), Positives = 132/385 (34%), Gaps = 53/385 (13%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVF 60
+ L + + + Y++L VIGKG V A TGE V +++I ++
Sbjct: 5 HHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLE 63
Query: 61 EHISDAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQ 115
++ + + E+ + +L HP+IV + + ++ ++VV M DL
Sbjct: 64 ACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-----LWVVTSFMAYGSAKDLIC 118
Query: 116 VIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
D + + L +L+AL Y+H HR +K +IL + + K+ +
Sbjct: 119 THF-MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177
Query: 176 AFSD----TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP-- 229
S + F V + +PE+ Y DI+S+G E+ G
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 230 --------LF----------PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR 271
L S + +L + + ++ +
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 272 KKPPV-----PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326
P P F F V+ + LQR +P RP+A L +FK + + E
Sbjct: 298 PSHPYHRTFSPHFHHF--VE----QCLQR----NPDARPSASTLLNHSFFKQIKRRASEA 347
Query: 327 SCQPISKLEFEFERRRVTKDDIREL 351
+ + + D +
Sbjct: 348 LPELLRPVTPITNFEGSQSQDHSGI 372
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 60/296 (20%), Positives = 102/296 (34%), Gaps = 48/296 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
EV+GKG +G TGE + +K++ E L+EVK++R L HP+++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF--LKEVKVMRCLEHPNVL 70
Query: 86 E-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYM 142
+ I + + + E ++ L +IK+ D F + + Y+
Sbjct: 71 KFIGVLYKDK------RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ N+ HRDL N L N + V DFGLAR+ + + + G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 203 SF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
+ Y +D++S G + E++ P P
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD--------------YLPRTM 230
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ P PN P + R DP+ RP+ +
Sbjct: 231 DFGLNVRGFLD---------RYCP-----PNCPPSFFPITVRCCDLDPEKRPSFVK 272
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 75/298 (25%), Positives = 118/298 (39%), Gaps = 58/298 (19%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIR-ILREVKLLRLLRHPD 83
+ E+IG G +G V A G++VA+K D E IS I + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+ ++ + L + +V E L++V+ + + + Q+ R + Y+
Sbjct: 68 IIALRGVCLKEPN-----LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYL 121
Query: 143 HTANVY---HRDLKPKNIL--------ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
H + HRDLK NIL +N LK+ DFGLAR T M+
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA---- 177
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
W APE+ + S ++ D+WS G + E+LTG+ F G
Sbjct: 178 YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID---------------G 219
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
V K P+P +L++ DP RP+
Sbjct: 220 LAVAYGVAMNKLA---------LPIP-----STCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-37
Identities = 84/374 (22%), Positives = 141/374 (37%), Gaps = 91/374 (24%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
RY ++ +G G + V + D + VA+K + EH ++ E++LL+ +R+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRN 92
Query: 82 PDIVEIKRIMLPPSKREFKD-------IYVVFELMESDLHQVIKANDD--LTREHHQFFL 132
D + R M+ +FK I +VFE++ L + I ++ L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 133 YQMLRALKYMHT-ANVYHRDLKPKNILANAN----------------------------- 162
Q+L+ L Y+HT + H D+KP+NIL + N
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 163 --------------------CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
K+K+ D G A + T TR YR+ E+
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQ----TRQYRSLEVL- 265
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------VVHQLDLITDLLGTPSPETIA 256
S Y DIWS C+ E+ TG LF S + LI +LLG + I
Sbjct: 266 -IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 257 VVRNEKARKY------LTEMRKKPPVPLFQ------KFPNVD-PLALRLLQRLIAFDPKD 303
+ ++++ L + K P LF+ ++ + L ++ P+
Sbjct: 325 --AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382
Query: 304 RPTAEEALADPYFK 317
R TA E L P+
Sbjct: 383 RATAAECLRHPWLN 396
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 82/303 (27%), Positives = 129/303 (42%), Gaps = 54/303 (17%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLR 80
RYKI++ +G G V A DT KVAIK I + + R REV L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 81 HPDIVEIKRIMLPPSKREFKDI-------YVVFELME-SDLHQVIKANDDLTREHHQFFL 132
H +IV + D+ Y+V E +E L + I+++ L+ + F
Sbjct: 70 HQNIVSMI------------DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFT 117
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV-A 191
Q+L +K+ H + HRD+KP+NIL ++N LK+ DFG+A+ A S+T +T T++V
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQ--TNHVLG 174
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T Y +PE DI+SIG + E+L G+P F G +
Sbjct: 175 TVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNG----------------ET 216
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEA 310
+IA+ ++ P ++ ++ R D +R T +E
Sbjct: 217 AVSIAIKH----------IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266
Query: 311 LAD 313
D
Sbjct: 267 KDD 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 48/289 (16%), Positives = 93/289 (32%), Gaps = 52/289 (17%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
L + + G + G + +K + + E LR+ HP+++
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 86 EIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALKY 141
+ PP+ ++ M L+ V+ + + Q F M R + +
Sbjct: 71 PVLGACQSPPAPH----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 142 MHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM-TVFWTDYVATRWYRAP 198
+HT + L ++++ + + ++ + S M W AP
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWV---------AP 177
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E L + D+WS + E++T + F S + E
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIGMK 222
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
V E R P +P P + P +L++ + DP RP
Sbjct: 223 VALEGLR---------PTIP-----PGISPHVSKLMKICMNEDPAKRPK 257
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-37
Identities = 72/299 (24%), Positives = 118/299 (39%), Gaps = 52/299 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLRHP 82
Y++ ++G+G G V A DT VA+K + + R+ RE + L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 83 DIV------EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQM 135
+V EI + YV L+ DL +++ L + Q+
Sbjct: 95 HVVPIHDFGEIDGQL-----------YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQI 143
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL H A HRD+KP+NIL +A+ + DFG+A A +D +T V T +Y
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGN-TVGTLYY 201
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE S T DI+++ C+ E LTG P + G + +
Sbjct: 202 MAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQG-------------------DQL 240
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-PTAEEALAD 313
+V ++ + P + ++ R +A +P+DR T + A
Sbjct: 241 SV-----MGAHINQ----AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 66/313 (21%), Positives = 113/313 (36%), Gaps = 47/313 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVK-LLRL 78
+ N + L +G G+ G V TG +A+K++ + RIL ++ +L+
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMDLDVVLKS 80
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE-HHQFFLYQMLR 137
P IV+ + + D+++ ELM + ++ K E +++
Sbjct: 81 HDCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 138 ALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL Y+ V HRD+KP NIL + ++K+CDFG++ Y
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSAGCAAYM 191
Query: 197 APE---LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSP 252
APE Y D+WS+G E+ TG+ P K+ L + P
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---EEPP 248
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ + FQ F L + D + RP + L
Sbjct: 249 ------LLPGHMGFSGD---------FQSFVK------DCLTK----DHRKRPKYNKLLE 283
Query: 313 DPYFKGLAKIERE 325
+ K +E +
Sbjct: 284 HSFIKRYETLEVD 296
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 85/375 (22%), Positives = 144/375 (38%), Gaps = 70/375 (18%)
Query: 1 MQQDQTKKELKDKDFFTEYGDAN---RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH 57
M LKD D + + + L IG GS+G V A D E VAIKK+
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 58 DVFEHISDAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQV 116
+ ++ + I++EV+ L+ LRHP+ ++ + L ++V E +
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDL 143
Query: 117 IKANDDLTREHH-QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-- 173
++ + +E + L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 174 ---RVAFSDTPMTVFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA-EVLTGK 228
+F TP +W APE+ +Y +D+WS+G I E+ K
Sbjct: 204 MAPANSFVGTP---YWM---------APEVILAMDEGQYDGKVDVWSLG-ITCIELAERK 250
Query: 229 -PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP 287
PLF N A L + + P Q +
Sbjct: 251 PPLF----------------------------NMNAMSALYHIAQNES-PALQS-GHWSE 280
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDD 347
+ + P+DRPT+E L + +P + + +R + +
Sbjct: 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVL---------RERPPTVIMDLIQRTKDAVRE 331
Query: 348 IRELIYREILEYHPQ 362
+ L YR++ + Q
Sbjct: 332 LDNLQYRKMKKILFQ 346
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-36
Identities = 85/383 (22%), Positives = 140/383 (36%), Gaps = 88/383 (22%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI---H 57
M D + L + D A ++++E++G G+YG V TG+ AIK +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 58 DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELME----SD 112
D E I I +L++ H +I + + D +++V E +D
Sbjct: 62 DEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
L + K N L E + ++LR L ++H V HRD+K +N+L N ++K+ DFG+
Sbjct: 117 LIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 173 A---------RVAFSDTPMTVFWTDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCI 220
+ R F TP +W APE C + Y D+WS+G I
Sbjct: 176 SAQLDRTVGRRNTFIGTP---YWM---------APEVIACDENPDATYDFKSDLWSLG-I 222
Query: 221 FA-EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV--- 276
A E+ G P + L LI R P
Sbjct: 223 TAIEMAEGAPPLCDMHPMRALFLIP--------------------------RNPAPRLKS 256
Query: 277 ----PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPIS 332
FQ F + L++ + RP E+ + P+ + Q
Sbjct: 257 KKWSKKFQSF-----IESCLVK-----NHSQRPATEQLMKHPFIRDQPNER-----QVRI 301
Query: 333 KLEFEFERRRVTKDDIRELIYRE 355
+L+ +R + + + E Y
Sbjct: 302 QLKDHIDRTKKKRGEKDETEYEY 324
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-36
Identities = 80/320 (25%), Positives = 121/320 (37%), Gaps = 39/320 (12%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
++++ IGKG YG V GEKVA+K + R E+ L+RH +I+
Sbjct: 40 QMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFT--TEEASWFR-ETEIYQTVLMRHENIL 94
Query: 86 E-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I + +Y++ + E+ L+ +K+ L + Y + L ++H
Sbjct: 95 GFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLH 151
Query: 144 TANVY--------HRDLKPKNILANANCKLKVCDFGLARVAFSDT-PMTVFWTDYVATRW 194
T HRDLK KNIL N + D GLA SDT + + V T+
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 195 YRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
Y PE L S + + D++S G I EV G +QL + P
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQLPYHDLVPSDP 270
Query: 251 SPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
S E + +V +K R P P +L+ A +P R TA
Sbjct: 271 SYEDMREIVCIKKLR---------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 310 ALADPYFKGLAKIEREPSCQ 329
K LAK+ +
Sbjct: 322 VK-----KTLAKMSESQDIK 336
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 79/304 (25%), Positives = 129/304 (42%), Gaps = 51/304 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLR 80
++RY++ E++G G V A D VA+K + R RE + L
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 81 HPDIVEI--------KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFF 131
HP IV + LP Y+V E ++ L ++ +T +
Sbjct: 71 HPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV- 190
+ +AL + H + HRD+KP NI+ +A +KV DFG+AR A +D+ +V T V
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAAVI 180
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
T Y +PE D++S+GC+ EVLTG+P F G S
Sbjct: 181 GTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------------- 223
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEE 309
++V A +++ E P+P + + ++ + +A +P++R TA E
Sbjct: 224 ---PVSV-----AYQHVRE----DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271
Query: 310 ALAD 313
AD
Sbjct: 272 MRAD 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 79/328 (24%), Positives = 139/328 (42%), Gaps = 64/328 (19%)
Query: 1 MQQDQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV 59
+ +Q K L+ + GD IG+GS G+VC A + H+G +VA+K +
Sbjct: 25 VTHEQFKAALRM---VVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD-- 79
Query: 60 FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK 118
+ EV ++R +H ++VE+ + L + ++V+ E ++ L ++
Sbjct: 80 LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-----LWVLMEFLQGGALTDIVS 134
Query: 119 ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----- 173
L E +L+AL Y+H V HRD+K +IL + ++K+ DFG
Sbjct: 135 QVR-LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193
Query: 174 ----RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
R + TP +W APE+ S Y +DIWS+G + E++ G+P
Sbjct: 194 DVPKRKSLVGTP---YWM---------APEVISR--SLYATEVDIWSLGIMVIEMVDGEP 239
Query: 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA 289
+ ++ + + +R PP P + V P+
Sbjct: 240 PY---------------------------FSDSPVQAMKRLRDSPP-PKLKNSHKVSPVL 271
Query: 290 LRLLQRLIAFDPKDRPTAEEALADPYFK 317
L+R++ DP++R TA+E L P+
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFLL 299
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 70/311 (22%), Positives = 128/311 (41%), Gaps = 46/311 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLL 79
A+ + + +G+G+YGVV +G+ +A+K+I + R+L ++ +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTV 63
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELM----ESDLHQVIKANDDLTREHHQFFLYQM 135
P V + D+++ ELM + QVI + + +
Sbjct: 64 DCPFTVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 136 LRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
++AL+++H+ +V HRD+KP N+L NA ++K+CDFG++ D + +
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID----AGCKP 174
Query: 195 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
Y APE Y+ DIWS+G E+ + FP S + ++ PSP
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSP 232
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ L + F F + + L++ + K+RPT E +
Sbjct: 233 Q-------------LPADKFSAE---FVDFTS------QCLKK----NSKERPTYPELMQ 266
Query: 313 DPYFKGLAKIE 323
P+F
Sbjct: 267 HPFFTLHESKG 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 73/307 (23%), Positives = 122/307 (39%), Gaps = 46/307 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLL 79
A K L IG+G+YG V + +G+ +A+K+I + ++L ++ ++R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSS 78
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELM----ESDLHQVIKANDDLTREHH-QFFLYQ 134
P IV+ + D ++ ELM + V DD+ E
Sbjct: 79 DCPYIVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 135 MLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
++AL ++ + HRD+KP NIL + + +K+CDFG++ ++ T R
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRDAGCR 189
Query: 194 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTP 250
Y APE + Y D+WS+G E+ TG+ P SV QL +
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK---GD 246
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
P+ + N + R++ F F N L + D RP +E
Sbjct: 247 PPQ----LSNSEEREFSPS---------FINFVN------LCLTK----DESKRPKYKEL 283
Query: 311 LADPYFK 317
L P+
Sbjct: 284 LKHPFIL 290
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 75/325 (23%), Positives = 132/325 (40%), Gaps = 64/325 (19%)
Query: 4 DQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH 62
++ ++L+ GD +Y E IG+G+ G V A+D TG++VAI++++ +
Sbjct: 3 EEILEKLRS---IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQ 57
Query: 63 ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND 121
I+ E+ ++R ++P+IV L + ++VV E + L V+
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE-----LWVVMEYLAGGSLTDVVTETC 112
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-------- 173
+ + L+AL+++H+ V HRD+K NIL + +K+ DFG
Sbjct: 113 -MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 174 -RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
R TP +W APE+ Y P +DIWS+G + E++ G+P +
Sbjct: 172 KRSTMVGTP---YWM---------APEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPY- 216
Query: 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRL 292
NE + L + P Q + +
Sbjct: 217 --------------------------LNENPLRALYLIATNGT-PELQNPEKLSAIFRDF 249
Query: 293 LQRLIAFDPKDRPTAEEALADPYFK 317
L R + D + R +A+E L + K
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 67/312 (21%), Positives = 113/312 (36%), Gaps = 59/312 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
A +Y++ I G G + A+D + G V +K + + + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP IV+I + + Y+V E + L + L +L ++L AL
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y+H+ + + DLKP+NI+ +LK+ D G + T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYL------YGTPGFQAPE 247
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + T A DI+++G A + P G+ V P
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LP--------- 285
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEALADPYFKG 318
P+ + + + L R + DP+ R TAEE A
Sbjct: 286 --------------EDDPVLKTYDSYGRLLRRAIDP----DPRQRFTTAEEMSAQ----- 322
Query: 319 LAKIEREPSCQP 330
L + RE Q
Sbjct: 323 LTGVLREVVAQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 73/324 (22%), Positives = 119/324 (36%), Gaps = 47/324 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ E IGKG +G V GE+VA+K R E+ +LRH +I+
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLRHENIL 99
Query: 86 -----EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ K +++V + E L + +T E L
Sbjct: 100 GFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGL 152
Query: 140 KYMHTA--------NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW-TDYV 190
++H + HRDLK KNIL N + D GLA S T V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 191 ATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
T+ Y APE L S K+ + DI+++G +F E+ + G +QL +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLV 271
Query: 247 LGTPSPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
PS E + VV +K R P +P + + ++++ + R
Sbjct: 272 PSDPSVEEMRKVVCEQKLR---------PNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
Query: 306 TAEEALADPYFKGLAKIEREPSCQ 329
TA K L+++ ++ +
Sbjct: 323 TALRIK-----KTLSQLSQQEGIK 341
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 76/308 (24%), Positives = 132/308 (42%), Gaps = 39/308 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + Y++ EVIG G+ VV AA EKVAIK+I ++ + + +L+E++ +
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCH 71
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDD-----LTREHHQFF 131
HP+IV + + +++V +L+ D+ + I A + L
Sbjct: 72 HPNIVSYYTSFVVKDE-----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDY 189
L ++L L+Y+H HRD+K NIL + +++ DFG++ D +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
V T + APE+ Y DIWS G E+ TG + + ++ L
Sbjct: 187 VGTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLMLTLQN 242
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
P V++++ K F+K ++L L + DP+ RPTA E
Sbjct: 243 DPPSLETGVQDKEMLKKYG--------KSFRKM-----ISLCLQK-----DPEKRPTAAE 284
Query: 310 ALADPYFK 317
L +F+
Sbjct: 285 LLRHKFFQ 292
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 37/277 (13%), Positives = 81/277 (29%), Gaps = 49/277 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+ + ++G+G++ V A D +K +K + + + ++
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMER 120
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIK-----ANDDLTREHHQ 129
L+ ++ L + +V EL L I + +
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNG-----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNIL-----------ANANCKLKVCDFGLARVAFS 178
F +ML ++ +H + H D+KP N + + + L + D G +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 179 DTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
T+F T ++ E L + ID + + +L G +
Sbjct: 236 FPKGTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
Query: 238 HQL---------------DLITDLLGTPSPETIAVVR 259
+ +L P + +
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLD 328
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 84/341 (24%), Positives = 128/341 (37%), Gaps = 82/341 (24%)
Query: 1 MQQDQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV 59
M + L D + LE IGKGS+G V ID T + VAIK I D+
Sbjct: 1 MAHSPVQSGLPGMQNLKA--DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DL 57
Query: 60 FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQ 115
E + I +E+ +L P + + L +K ++++ E + DL +
Sbjct: 58 EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-----LWIIMEYLGGGSALDLLE 112
Query: 116 VIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-- 173
L L ++L+ L Y+H+ HRD+K N+L + + ++K+ DFG+A
Sbjct: 113 ----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 168
Query: 174 -------RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
R F TP FW APE+ S Y DIWS+G E+
Sbjct: 169 LTDTQIKRNTFVGTP---FWM---------APEVIKQ--SAYDSKADIWSLGITAIELAR 214
Query: 227 GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV------PLFQ 280
G+P + L LI + PP +
Sbjct: 215 GEPPHSELHPMKVLFLIP--------------------------KNNPPTLEGNYSKPLK 248
Query: 281 KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
+F V+ L + +P RPTA+E L + AK
Sbjct: 249 EF--VE----ACLNK----EPSFRPTAKELLKHKFILRNAK 279
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-34
Identities = 81/331 (24%), Positives = 134/331 (40%), Gaps = 69/331 (20%)
Query: 2 QQDQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
++ +++LK D + + +LE +G+GSYG V AI TG+ VAIK++ V
Sbjct: 7 LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVE 65
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQV 116
+ + I++E+ +++ P +V+ + +++V E SD+ ++
Sbjct: 66 SDLQE---IIKEISIMQQCDSPHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRL 117
Query: 117 IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA--- 173
N LT + L L+ L+Y+H HRD+K NIL N K+ DFG+A
Sbjct: 118 R--NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 174 ------RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EVLT 226
R TP FW APE+ Y DIWS+G I A E+
Sbjct: 176 TDTMAKRNTVIGTP---FWM---------APEVIQE--IGYNCVADIWSLG-ITAIEMAE 220
Query: 227 GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD 286
GKP P + + + + PP P F+K
Sbjct: 221 GKP--P-------------------------YADIHPMRAIFMIPTNPP-PTFRKPELWS 252
Query: 287 PLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+++ + P+ R TA + L P+ +
Sbjct: 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 71/318 (22%), Positives = 114/318 (35%), Gaps = 47/318 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+LE +GKG YG V + GE VA+K R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 86 -----EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
++ ++++ E L+ ++ L + + L
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 140 KYMHTANVY--------HRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYV 190
++H HRDLK KNIL N + + D GLA + + S + V V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 191 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
T+ Y APE L + +DIW+ G + EV G ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVV 237
Query: 247 LGTPSPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
PS E + VV ++ R P +P +L++ +P R
Sbjct: 238 PNDPSFEDMRKVVCVDQQR---------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 306 TAEEALADPYFKGLAKIE 323
TA K L KI+
Sbjct: 289 TALRIK-----KTLTKID 301
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 68/335 (20%), Positives = 124/335 (37%), Gaps = 69/335 (20%)
Query: 7 KKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA 66
+K + + + ++I+ +G G++G V A + TG A K I + +
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEEL 60
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDD 122
+ E+++L HP IV++ K ++++ E + +++ +
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAI--MLELDRG 113
Query: 123 LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA--------- 173
LT Q QML AL ++H+ + HRDLK N+L +++ DFG++
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-EVLTGK- 228
R +F TP +W APE+ K Y DIWS+G I E+ +
Sbjct: 174 RDSFIGTP---YWM---------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 220
Query: 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPL 288
P + L ++ K P P
Sbjct: 221 PHH----------------------------ELNPMRVLLKIAKSDP-PTLLTPSKWSVE 251
Query: 289 ALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
L+ + +P+ RP+A + L P+ + +
Sbjct: 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 66/307 (21%), Positives = 127/307 (41%), Gaps = 55/307 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + + + RE ++ L HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHP 90
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
V++ F+D +Y ++ +L + I+ +F+ +++ A
Sbjct: 91 FFVKLYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+Y+H + HRDLKP+NIL N + +++ DFG A+V ++ + +V T Y +P
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSP 201
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
EL + D+W++GCI +++ G P F + I
Sbjct: 202 ELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--------------- 244
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALA 312
++ + P P A L+++L+ D R A
Sbjct: 245 -----------IKLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 288
Query: 313 DPYFKGL 319
P+F+ +
Sbjct: 289 HPFFESV 295
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 71/325 (21%), Positives = 120/325 (36%), Gaps = 49/325 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ ++LEV +G +G V A E VA+K + + EV L ++
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMK 76
Query: 81 HPDIVE-IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRA 138
H +I++ I S D++++ E L +KAN ++ M R
Sbjct: 77 HENILQFIGAEKRGTSVD--VDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARG 133
Query: 139 LKYMHTANVY----------HRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
L Y+H HRD+K KN+L N + DFGLA F
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHG 192
Query: 189 YVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
V TR Y APE+ +F ID++++G + E+ + G + L +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 246 LLGTPSPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP-LALRLLQRLIAF---- 299
+ PS E + VV ++K R P + + +L I
Sbjct: 253 IGQHPSLEDMQEVVVHKKKR---------PVLR-----DYWQKHAGMAMLCETIEECWDH 298
Query: 300 DPKDRPTAEEALADPYFKGLAKIER 324
D + R +A + + +++R
Sbjct: 299 DAEARLSAGCVG-----ERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 78/343 (22%), Positives = 132/343 (38%), Gaps = 54/343 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D + K+LE+IG+G YG V + VA+K + + + L+
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKG--SLDERPVAVKVF---SFANRQNFINEKNIYRVPLME 65
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
H +I + + +V E + L + + + + + R L
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGL 124
Query: 140 KYMHTANVY---------HRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY- 189
Y+HT HRDL +N+L + + DFGL+ + + D
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 190 ----VATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVV-H 238
V T Y APE L G+ +D++++G I+ E+ LFPG+SV +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 239 QLDLITDLLGTPSPET-IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297
Q+ T++ P+ E +V EK R P P + + LA+R L+ I
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQR---------PKFP---EAWKENSLAVRSLKETI 292
Query: 298 ----AFDPKDRPTAEEALADPYFKGLAKI----EREPSCQPIS 332
D + R TA+ A + +A++ ER S P +
Sbjct: 293 EDCWDQDAEARLTAQXAE-----ERMAELMMIWERNKSVSPTA 330
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 70/328 (21%), Positives = 135/328 (41%), Gaps = 63/328 (19%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
+++ F +IL IGKGS+G VC T + A+K ++ +
Sbjct: 4 PVFDENEDVNFDHF----------EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK--Q 51
Query: 62 HI--SDAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLH 114
+ +R + +E+++++ L HP +V + F+D +++V +L+ DL
Sbjct: 52 KCVERNEVRNVFKELQIMQGLEHPFLVNLWY--------SFQDEEDMFMVVDLLLGGDLR 103
Query: 115 QVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174
++ N E + F+ +++ AL Y+ + HRD+KP NIL + + + + DF +A
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163
Query: 175 VAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ +T +T T+ Y APE + Y+ A+D WS+G E+L G+ +
Sbjct: 164 MLPRETQITTM----AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRL 292
R+ + K + + V +P + L
Sbjct: 220 -------------------------RSSTSSKEIVHTFETTVV----TYPSAWSQEMVSL 250
Query: 293 LQRLIAFDPKDR-PTAEEALADPYFKGL 319
L++L+ +P R + PY +
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 68/301 (22%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAA----IDTHTGEKVAIKKI-HDVFEHISDAIRILREVKL 75
+ K L+ +GKG++G V + +TGE VA+KK+ H EH+ D RE+++
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---FEREIEI 64
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
L+ L+H +IV+ K + +R ++ ++ E + L ++ + + + +
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
Q+ + ++Y+ T HRDL +NIL ++K+ DFGL +V D +
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF------FKVKE 175
Query: 193 ------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
WY APE SK++ A D+WS G + E+ T + KS + + +
Sbjct: 176 PGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMI 228
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRP 305
+ + + L + P P+ P + ++ + RP
Sbjct: 229 GNDKQGQ----MIVFHLIELLKNNGRLPR-------PDGCPDEIYMIMTECWNNNVNQRP 277
Query: 306 T 306
+
Sbjct: 278 S 278
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 69/301 (22%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAA----IDTHTGEKVAIKKI-HDVFEHISDAIRILREVKL 75
+ K L+ +GKG++G V + +TGE VA+KK+ H EH+ D RE+++
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---FEREIEI 95
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
L+ L+H +IV+ K + +R ++ ++ E + L ++ + + + +
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
Q+ + ++Y+ T HRDL +NIL ++K+ DFGL +V D Y
Sbjct: 153 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY------YKVKE 206
Query: 193 ------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
WY APE SK++ A D+WS G + E+ T + KS + + +
Sbjct: 207 PGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMI 259
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRP 305
+ + + L + P P+ P + ++ + RP
Sbjct: 260 GNDKQGQ----MIVFHLIELLKNNGRLPR-------PDGCPDEIYMIMTECWNNNVNQRP 308
Query: 306 T 306
+
Sbjct: 309 S 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 71/297 (23%), Positives = 128/297 (43%), Gaps = 47/297 (15%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL 79
K + +G+G +G V +TGE+VA+K K HI+D + +E+++LR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNL 80
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLR 137
H +IV+ K I ++ I ++ E + S L + + N + + + + Q+ +
Sbjct: 81 YHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
+ Y+ + HRDL +N+L + ++K+ DFGL + +D Y
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVKDDRDS 191
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
WY APE SK+ A D+WS G E+LT S + L ++G
Sbjct: 192 PVFWY-APE--CLMQSKFYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPT 243
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPT 306
+ + + L E ++ P P P + +L+++ F P +R +
Sbjct: 244 HGQ----MTVTRLVNTLKEGKRLPC-------PPNCPDEVYQLMRKCWEFQPSNRTS 289
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 9e-27
Identities = 71/332 (21%), Positives = 118/332 (35%), Gaps = 67/332 (20%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---- 57
+ + L DF + +IG+G +G V TG+ A+K +
Sbjct: 178 KNVELNIHLTMNDF----------SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227
Query: 58 ---DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DL 113
+ +L V P IV + P K + + +LM DL
Sbjct: 228 KMKQGETLALNERIMLSLVSTGD---CPFIVCMSYAFHTPDK-----LSFILDLMNGGDL 279
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
H + + + +F+ +++ L++MH V +RDLKP NIL + + +++ D GLA
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
P V T Y APE+ Y + D +S+GC+ ++L G F
Sbjct: 340 CDFSKKKPHA-----SVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRL 292
K + + M V + P + P L
Sbjct: 394 -------------------------HKTKDKHEIDRMTLTMAV----ELPDSFSPELRSL 424
Query: 293 LQRLIAFDPKDR-----PTAEEALADPYFKGL 319
L+ L+ D R A+E P+F+ L
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 55/235 (23%), Positives = 104/235 (44%), Gaps = 33/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 67
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLR 137
HP++V++ + ++ Y++ E M +L ++ + +++ + Q+
Sbjct: 68 HPNLVQLLGVC---TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
A++Y+ N HRDL +N L N +KV DFGL+R+ DT Y A
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKF 174
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 175 PIKWT-APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 33/234 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D + ++ IG G +G+V + KVAIK I E + E +++ L
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIR---EGAMSEEDFIEEAEVMMKLS 61
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
HP +V++ + L E I +V E ME L ++ E +
Sbjct: 62 HPKLVQLYGVCL-----EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ Y+ A V HRDL +N L N +KV DFG+ R D Y ++
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFP 168
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W +PE FS+Y+ D+WS G + EV + GK + +S VV +
Sbjct: 169 VKWA-SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ K+L+ IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 72
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLR 137
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF---WTDYVATRW 194
A++Y+ N HRDL +N+L + + KV DFGL + A S WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
APE K++ D+WS G + E+ + G+ +P VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-26
Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 34/233 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
K ++V+G G++G V + GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ + +
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRDL +N+L +K+ DFGLA++ ++
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKVPI 183
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E YT D+WS G E++T G + G + L+
Sbjct: 184 KWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 53/234 (22%), Positives = 95/234 (40%), Gaps = 33/234 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+L+ +G G +GVV VA+K I E +E + + L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIK---EGSMSEDEFFQEAQTMMKLS 61
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRA 138
HP +V+ + + IY+V E + + L ++++ L Y +
Sbjct: 62 HPKLVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ ++ + HRDL +N L + + +KV DFG+ R D YV++
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKFP 168
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + KY+ D+W+ G + EV + GK + + VV ++
Sbjct: 169 VKWS-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 33/238 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRI--LREVKL 75
DA I +V+G G +G VC+ +K VAIK + ++ R L E +
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASI 99
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
+ HP+I+ ++ ++ + K + +V E ME+ L ++ +D T L
Sbjct: 100 MGQFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
+ +KY+ HRDL +NIL N+N KV DFGL RV D Y
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTTRG 209
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW +PE + K+T A D+WS G + EV++ G+ + S V+ +D
Sbjct: 210 GKIPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 34/234 (14%)
Query: 26 KILEVIGKGSYGVVCAAI---DTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
++LE +G GS+GVV + VA+K + DV +REV + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
+++ + ++L P + +V EL L ++ + + Q+ +
Sbjct: 81 RNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRDL +N+L +K+ DFGL R + YV
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEHRKVPF 188
Query: 193 RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
W APE S ++ A D W G E+ T G+ + G + ++H++D
Sbjct: 189 AWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 57/251 (22%), Positives = 105/251 (41%), Gaps = 33/251 (13%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLR 80
K + +GKG++G V +TG VA+K++ H + D RE+++L+ L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD---FQREIQILKALH 82
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
IV+ + + P + + + +V E + S L ++ + L + Q+ +
Sbjct: 83 SDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
++Y+ + HRDL +NIL + +K+ DFGLA++ D YV
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK------DYYVVREPGQSP 193
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITDLLGT 249
WY APE + ++ D+WS G + E+ T K P + + D
Sbjct: 194 IFWY-APE--SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD--VP 248
Query: 250 PSPETIAVVRN 260
+ ++
Sbjct: 249 ALSRLLELLEE 259
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 72/307 (23%), Positives = 121/307 (39%), Gaps = 49/307 (15%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++IL+VIG+G++G V + + A+K ++ ++ E +L
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 84 IVEIKRIMLPPSKREFKD---IYVVFELMES-DL-HQVIKANDDLTREHHQFFLYQMLRA 138
I + F+D +Y+V + DL + K D L E +F+L +M+ A
Sbjct: 136 ITTLHY--------AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ +H + HRD+KP NIL + N +++ DFG D + V T Y +P
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SV-AVGTPDYISP 245
Query: 199 EL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
E+ +Y P D WS+G E+L G+ F +S+V I
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------------ 293
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALA 312
M K + +V A L++RLI + R E+
Sbjct: 294 --------------MNHKERFQFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKK 338
Query: 313 DPYFKGL 319
P+F G+
Sbjct: 339 HPFFSGI 345
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 56/249 (22%), Positives = 107/249 (42%), Gaps = 33/249 (13%)
Query: 8 KELKDKDFFTEYGDANRYKILE-VIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHIS 64
+E++ K+ + D + + +G G++G V VA+K + + +
Sbjct: 4 EEIRPKEVYL---DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 65 DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDL 123
+L E +++ L +P IV + I S +V E+ E L++ ++ N +
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 114
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
++ ++Q+ +KY+ +N HRDL +N+L K+ DFGL++ +D
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--- 171
Query: 184 VFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
Y A +WY APE + K++ D+WS G + E + G+ + G
Sbjct: 172 ---NYYKAQTHGKWPVKWY-APE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
Query: 236 ---VVHQLD 241
V L+
Sbjct: 226 GSEVTAMLE 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRI--LREVKL 75
R ++ IG+G +G V I VAIK SD++R L+E
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALT 69
Query: 76 LRLLRHPDIVEIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFL 132
+R HP IV++ ++ P ++++ EL +L ++ L +
Sbjct: 70 MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+ AL Y+ + HRD+ +N+L ++N +K+ DFGL+R Y
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKA 174
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 175 SKGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 29/236 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
+A+R I ++IG G G VC G+ VAIK + + L E ++
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMG 105
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQM 135
HP+I+ ++ ++ + +V E ME+ L ++ +D T L +
Sbjct: 106 QFDHPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
++Y+ HRDL +N+L ++N KV DFGL+RV D Y T
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAYTTTGGK 215
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW APE F ++ A D+WS G + EVL G+ + + V+ ++
Sbjct: 216 IPIRWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 37/291 (12%), Positives = 69/291 (23%), Gaps = 65/291 (22%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR 80
RY++L G A+DT +VA+ + L L +
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
P + + ++ VV E + L +V + + + + A
Sbjct: 90 KPGVARVLDVV-----HTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAA 142
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H A V P + + + + + A
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------- 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
P DI IG +L + P V +A
Sbjct: 180 ---------NPQDDIRGIGASLYALLVNRWPLPEAGV---------------RSGLAPAE 215
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
+ A P+ ++ + R + D R +
Sbjct: 216 RDTA---------GQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 72/331 (21%), Positives = 120/331 (36%), Gaps = 61/331 (18%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFE 61
+ L+ DF +IL+VIG+G++ V TG+ A+K ++
Sbjct: 51 VRLKEVRLQRDDF----------EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML 100
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DL-HQV 116
+ E +L I ++ F+D +Y+V E DL +
Sbjct: 101 KRGEVSCFREERDVLVNGDRRWITQLHF--------AFQDENYLYLVMEYYVGGDLLTLL 152
Query: 117 IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
K + + E +F+L +++ A+ +H HRD+KP NIL + +++ DFG
Sbjct: 153 SKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212
Query: 177 FSDTPMTVFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
+D + V T Y +PE+ G Y P D W++G E+ G+ F
Sbjct: 213 RADGTVRS-LV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
S I + K + L V A
Sbjct: 271 YADSTAETYGKI--------------------------VHYKEHLSLPLVDEGVPEEARD 304
Query: 292 LLQRLIAFDPKDR---PTAEEALADPYFKGL 319
+QRL+ P+ R A + P+F GL
Sbjct: 305 FIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 54/235 (22%), Positives = 102/235 (43%), Gaps = 33/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 274
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLR 137
HP++V++ + Y++ E M +L ++ + +++ + Q+
Sbjct: 275 HPNLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
A++Y+ N HR+L +N L N +KV DFGL+R+ DT Y A
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKF 381
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 382 PIKWT-APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 51/238 (21%), Positives = 91/238 (38%), Gaps = 34/238 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLL 76
+ L+V+G G +G V + GE V IK I D + + +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAI 69
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQ 134
L H IV + + S + +V + + L ++ + L + + Q
Sbjct: 70 GSLDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-- 192
+ + + Y+ + HR+L +N+L + +++V DFG+A + D +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSE 176
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E F KYT D+WS G E++T G + G V L+
Sbjct: 177 AKTPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 33/234 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D L+ +G G +GVV VAIK I E + E K++ L
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIK---EGSMSEDEFIEEAKVMMNLS 77
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
H +V++ + + + I+++ E M + L ++ + + A
Sbjct: 78 HEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
++Y+ + HRDL +N L N +KV DFGL+R D +Y ++
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--------EYTSSVGSKFP 184
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW PE +SK++ DIW+ G + E+ + GK + + +
Sbjct: 185 VRWS-PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 71/328 (21%), Positives = 122/328 (37%), Gaps = 61/328 (18%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFE 61
+K +D+ ++++VIG+G++G V T + A+K +
Sbjct: 59 NKIRDLRMKAEDY----------EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 108
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVI 117
SD+ E ++ P +V++ F+D +Y+V E M DL ++
Sbjct: 109 KRSDSAFFWEERDIMAFANSPWVVQLFY--------AFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-RVA 176
N D+ + +F+ +++ AL +H+ HRD+KP N+L + + LK+ DFG ++
Sbjct: 161 S-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 177 FSDTPMTVFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
T V T Y +PE Y D WS+G E+L G F
Sbjct: 220 KEGMVRC--DT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
S+V I M K + F ++ A L+
Sbjct: 277 SLVGTYSKI--------------------------MNHKNSLT-FPDDNDISKEAKNLIC 309
Query: 295 RLIAFDPKDR---PTAEEALADPYFKGL 319
+ D + R EE +FK
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLFFKND 336
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 30/237 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLL 76
+ +VIG G +G V + + K VAIK + + + L E ++
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 100
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQ 134
H +I+ ++ ++ SK + + ++ E ME+ L + ++ D + L
Sbjct: 101 GQFSHHNIIRLEGVI---SKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-- 192
+ +KY+ N HRDL +NIL N+N KV DFGL+RV D Y +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGG 210
Query: 193 ----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW APE + K+T A D+WS G + EV+T G+ + S V+ ++
Sbjct: 211 KIPIRWT-APE--AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEA---FLQEAQVMKKLR 320
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLR 137
H +V++ ++ + IY+V E M L +K Q Q+
Sbjct: 321 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
+ Y+ N HRDL+ NIL N KV DFGLAR+ + +Y A
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKF 426
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + + ++T D+WS G + E+ T G+ +PG V+ Q++
Sbjct: 427 PIKWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHPD 83
+ E IG+G++G V + VA+K E + ++ L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKY 141
IV + + ++++ IY+V EL++ D ++ L + + ++Y
Sbjct: 174 IVRLIGVC---TQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ + HRDL +N L LK+ DFG++R V +W APE
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APE-- 285
Query: 202 GSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+ + +Y+ D+WS G + E + G +P S ++
Sbjct: 286 -ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 66/323 (20%), Positives = 123/323 (38%), Gaps = 57/323 (17%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDI 84
V+G+G +G V A TG+ A KK++ + + E K+L + I
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DL----HQVIKANDDLTREHHQFFLYQMLRAL 139
V + + + +V +M D+ + V + N F+ Q++ L
Sbjct: 248 VSLAYAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+++H N+ +RDLKP+N+L + + +++ D GLA + T Y T + APE
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT---KGYAGTPGFMAPE 359
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
L +Y ++D +++G E++ + F R
Sbjct: 360 LLLG--EEYDFSVDYFALGVTLYEMIAARGPFRA-------------------------R 392
Query: 260 NEKA-RKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR-----PTAEEALA 312
EK K L + + V +P P + + L+ DP+ R + +
Sbjct: 393 GEKVENKELKQRVLEQAV----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448
Query: 313 DPYFKGL--AKIER---EPSCQP 330
P F+ + ++E P P
Sbjct: 449 HPLFRDISWRQLEAGMLTPPFVP 471
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 73/307 (23%), Positives = 121/307 (39%), Gaps = 53/307 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++ V+GKG +G VCA TG+ A KK+ + L E ++L +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRALK 140
+V + + +V LM DL H F+ ++ L+
Sbjct: 246 VVSLAYAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLAR-VAFSDTPMTVFWTDYVATRWYRAPE 199
+H + +RDLKP+NIL + + +++ D GLA V T V T Y APE
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-----RVGTVGYMAPE 355
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + +YT + D W++GC+ E++ G+ F R
Sbjct: 356 VVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQ-------------------------R 388
Query: 260 NEKA-RKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR-----PTAEEALA 312
+K R+ + + K+ P ++ P A L +L+ DP +R +A E
Sbjct: 389 KKKIKREEVERLVKEVPE----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
Query: 313 DPYFKGL 319
P FK L
Sbjct: 445 HPLFKKL 451
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEA---FLQEAQVMKKLR 237
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLR 137
H +V++ ++ + IY+V E M L +K Q Q+
Sbjct: 238 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
+ Y+ N HRDL+ NIL N KV DFGLAR+ + +Y A
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKF 343
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + + ++T D+WS G + E+ T G+ +PG V+ Q++
Sbjct: 344 PIKWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 54/240 (22%), Positives = 101/240 (42%), Gaps = 40/240 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRI--LREVKL 75
+ ++G+G +G V + T+ VA+K + + + + E +
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVI 66
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
++ L HP IV++ I+ +++ EL +L ++ N + L +
Sbjct: 67 MKNLDHPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
Q+ +A+ Y+ + N HRD+ +NIL + +K+ DFGL+R + DY
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKAS 172
Query: 193 ------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 173 VTRLPIKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 29/230 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRL 78
+ K+L+ IGKG +G V + G KVA+K I + DA L E ++
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQ 242
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQM 135
LRH ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 243 LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
A++Y+ N HRDL +N+L + + KV DFGL + A S +W
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT 353
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
APE K++ D+WS G + E+ + G+ +P VV +++
Sbjct: 354 -APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 34/233 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
K ++V+G G++G V + GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ + +
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRDL +N+L +K+ DFGLA++ ++
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKVPI 183
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E YT D+WS G E++T G + G + L+
Sbjct: 184 KWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 66/296 (22%), Positives = 110/296 (37%), Gaps = 47/296 (15%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL 79
K + +G+G +G V + TGE VA+K K +H S +E+ +LR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTL 90
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
H I++ K + +V E + L + + + F Q+
Sbjct: 91 YHEHIIKYKGCC---EDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEG 146
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ Y+H + HRDL +N+L + + +K+ DFGLA+ Y
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY------YRVREDGDSP 200
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
WY APE K+ A D+WS G E+LT S +L+G
Sbjct: 201 VFWY-APE--CLKEYKFYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIAQ 252
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPT 306
+ + + + L + P P+ P + L++ + RPT
Sbjct: 253 GQ----MTVLRLTELLERGERLPR-------PDKCPAEVYHLMKNCWETEASFRPT 297
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 32/241 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLR 77
+ EVIG+G +G V K A+K ++ + + I + + L E +++
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 81
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQM 135
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 82 DFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
+ +KY+ + HRDL +N + + +KV DFGLAR ++ +Y +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNK 189
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+W A E K+T D+WS G + E++T G P +P + +
Sbjct: 190 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
Query: 245 D 245
Sbjct: 247 Q 247
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-24
Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 31 IGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G G++G V + + VAIK + E +D ++RE +++ L +P IV +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 89 RIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTAN 146
+ + + +V E+ LH+ + + + + L+Q+ +KY+ N
Sbjct: 77 GVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPE 199
HRDL +N+L K+ DFGL++ +D Y A +WY APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY-APE 183
Query: 200 LCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 184 ---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-24
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 37/236 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
K++E +G G +G V KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 81 HPDIVEIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQML 136
H +V + ++ P IY++ E ME+ L +K LT Q+
Sbjct: 67 HQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT---- 192
+ ++ N HRDL+ NIL + K+ DFGLAR+ + +Y A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--------EYTAREGAK 171
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + +T D+WS G + E++T G+ +PG + V+ L+
Sbjct: 172 FPIKWT-APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 32/241 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLR 77
+ EVIG+G +G V K A+K ++ + + I + + L E +++
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 145
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQM 135
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 146 DFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
+ +K++ + HRDL +N + + +KV DFGLAR ++ ++ +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEFDSVHNK 253
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+W A E K+T D+WS G + E++T G P +P + +
Sbjct: 254 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
Query: 245 D 245
Sbjct: 311 Q 311
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-24
Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 30/244 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
D N + +++G+G +G V KVA+K + + L E ++
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN------DDLTREHHQF 130
HP+++ + + + S + V+ M+ DLH + + + +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD-Y 189
F+ + ++Y+ N HRDL +N + + + V DFGL++ ++ D Y
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYY 203
Query: 190 VAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241
+W A E YT D+W+ G E+ T G +PG D
Sbjct: 204 RQGRIAKMPVKWI-AIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260
Query: 242 LITD 245
+
Sbjct: 261 YLLH 264
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+ + +G G +G V A KVA+K + + L E +++ L+H +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLV 246
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALKYM 142
++ ++ + IY++ E M L +K+++ + + F Q+ + ++
Sbjct: 247 KLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWY 195
N HRDL+ NIL +A+ K+ DFGLARV + +Y A +W
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN--------EYTAREGAKFPIKWT 352
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
APE F +T D+WS G + E++T G+ +PG S V+ L+
Sbjct: 353 -APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVF 60
+ ++ + F ++ +G GS+G V +G A+K V
Sbjct: 31 ETPSQNTAQLDQF----------DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 61 -----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELME-- 110
EH + RIL+ V P +V+++ FKD +Y+V E +
Sbjct: 81 KLKQIEHTLNEKRILQAV------NFPFLVKLEF--------SFKDNSNLYMVMEYVAGG 126
Query: 111 ---SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167
S L ++ + ++ R F+ Q++ +Y+H+ ++ +RDLKP+N+L + ++V
Sbjct: 127 EMFSHLRRIGRFSEPHAR----FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227
DFG A+ T WT T APE+ S Y A+D W++G + E+ G
Sbjct: 183 TDFGFAKRVKGRT-----WT-LCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAG 234
Query: 228 KPLF 231
P F
Sbjct: 235 YPPF 238
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 7e-23
Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 31/227 (13%)
Query: 30 VIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+G G++G V + + VAIK + E +D ++RE +++ L +P IV +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRL 401
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTA 145
+ + + +V E+ LH+ + + + + L+Q+ +KY+
Sbjct: 402 IGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAP 198
N HR+L +N+L K+ DFGL++ +D Y A +WY AP
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY-AP 508
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
E F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 509 E--CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 36/233 (15%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++ IG+G +G V I VAIK + S + L+E +R HP
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHP 451
Query: 83 DIVEIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
IV++ ++ P ++++ EL +L ++ L + YQ+ AL
Sbjct: 452 HIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRD+ +N+L ++N +K+ DFGL+R Y
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKLPI 556
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 557 KWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 54/245 (22%), Positives = 99/245 (40%), Gaps = 31/245 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
++ + ++GKG +G V A KVA+K + SD LRE ++
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 78 LLRHPDIVEIKRIMLPP-SKREFKDIYVVFELMES-DLHQVIKAN------DDLTREHHQ 129
HP + ++ + L +K V+ M+ DLH + A+ +L +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
F+ + ++Y+ + N HRDL +N + + + V DFGL+R ++ DY
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDY 192
Query: 190 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240
+ +W A E + YT D+W+ G E++T G+ + G
Sbjct: 193 YRQGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 241 DLITD 245
+ +
Sbjct: 250 NYLIG 254
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 35/240 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
+ VIGKG +GVV + + AIK + + E + LRE L+R
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMR 77
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQM 135
L HP+++ + IMLPP +V+ M DL Q I++ + T + F Q+
Sbjct: 78 GLNHPNVLALIGIMLPPEGL----PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV 133
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
R ++Y+ HRDL +N + + + +KV DFGLAR +Y +
Sbjct: 134 ARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR--------EYYSVQQH 185
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E ++T D+WS G + E+LT G P + + H L
Sbjct: 186 RHARLPVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-22
Identities = 37/239 (15%), Positives = 76/239 (31%), Gaps = 40/239 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGE-------KVAIKKIHDVFEHISDAIRILREVKLLRL 78
E +G+G++ + + G+ +V +K + H + + ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAASMMSK 68
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQML 136
L H +V + + + +V E ++ L +K N + + Q+
Sbjct: 69 LSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 137 RALKYMHTANVYHRDLKPKNIL--------ANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
A+ ++ + H ++ KNIL +K+ D G++ D
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------D 175
Query: 189 Y--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
W PE C A D WS G E+ + G + +
Sbjct: 176 ILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-22
Identities = 74/310 (23%), Positives = 124/310 (40%), Gaps = 67/310 (21%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
++IL +G GS+G V H G A+K K V E +L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHP 66
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-----SDLHQVIKANDDLTREHHQFFLYQ 134
I+ + F+D I+++ + +E S L + + + + + F+ +
Sbjct: 67 FIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK----FYAAE 114
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ AL+Y+H+ ++ +RDLKP+NIL + N +K+ DFG A+ T +T T
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YT-LCGTPD 168
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ + Y +ID WS G + E+L G F + + + I
Sbjct: 169 YIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI----------- 215
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEE 309
+ + P P + LL RLI D R E+
Sbjct: 216 ---------------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTED 255
Query: 310 ALADPYFKGL 319
P+FK +
Sbjct: 256 VKNHPWFKEV 265
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 4e-21
Identities = 78/311 (25%), Positives = 133/311 (42%), Gaps = 64/311 (20%)
Query: 26 KILEVIGKGSYGVVCAA---IDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLR 80
++L V+GKG YG V +TG+ A+K K + + D E +L ++
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVF------ELMESDLHQVIKANDDLTREHHQFFLYQ 134
HP IV++ K +Y++ EL + ++ + F+L +
Sbjct: 80 HPFIVDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAE 129
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ AL ++H + +RDLKP+NI+ N +K+ DFGL + + D +T + T
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIE 186
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE L S + A+D WS+G + ++LTG P F G++ +D I
Sbjct: 187 YMAPEILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI---------- 233
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AE 308
++ K +P P + A LL++L+ + R P A
Sbjct: 234 ----------------LKCKLNLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAG 272
Query: 309 EALADPYFKGL 319
E A P+F+ +
Sbjct: 273 EVQAHPFFRHI 283
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 68/303 (22%), Positives = 127/303 (41%), Gaps = 50/303 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L+++GKG++G V + TG A+K + +V + + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ +K + + V E +L + T E +F+ +++ AL+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LC 201
H+ +V +RD+K +N++ + + +K+ DFGL + SD + T Y APE L
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLE 178
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ Y A+D W +G + E++ G+ F + +LI
Sbjct: 179 D---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------ 217
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYF 316
+ ++ P + P A LL L+ DPK R A+E + +F
Sbjct: 218 --------LMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
Query: 317 KGL 319
+
Sbjct: 265 LSI 267
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 68/301 (22%), Positives = 125/301 (41%), Gaps = 49/301 (16%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIV 85
L+++GKG++G V + TG A+K + +V + L E ++L+ RHP +
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+K + + V E +L + + + +F+ +++ AL Y+H+
Sbjct: 212 ALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 145 A-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
NV +RDLK +N++ + + +K+ DFGL + D + T Y APE+
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED 323
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ Y A+D W +G + E++ G+ F + +LI
Sbjct: 324 --NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------------------- 361
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYFKG 318
+ ++ P + P A LL L+ DPK R A+E + +F G
Sbjct: 362 ------LMEEIRFP-----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
Query: 319 L 319
+
Sbjct: 411 I 411
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 70/324 (21%), Positives = 125/324 (38%), Gaps = 59/324 (18%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVF 60
++ + +LK +DF + +++GKGS+G V A T + AIK + DV
Sbjct: 6 ERPSLQIKLKIEDF----------ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV 55
Query: 61 EHISDAIRILREVKLLRL-LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK 118
D + E ++L L HP + + ++ V E + DL I+
Sbjct: 56 LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQ 110
Query: 119 ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VA 176
+ F+ +++ L+++H+ + +RDLK NIL + + +K+ DFG+ + +
Sbjct: 111 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
T + T Y APE+ KY ++D WS G + E+L G+ F G+
Sbjct: 171 GDAKTNT-----FCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
I P P ++ A LL +L
Sbjct: 224 EELFHSI--------------------------RMDNPFYP-----RWLEKEAKDLLVKL 252
Query: 297 IAFDPKDR-PTAEEALADPYFKGL 319
+P+ R + P F+ +
Sbjct: 253 FVREPEKRLGVRGDIRQHPLFREI 276
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 5e-20
Identities = 60/305 (19%), Positives = 112/305 (36%), Gaps = 53/305 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
+ L V+GKGS+G V + T E A+K + DV D + E + L + P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+ ++ + +Y V E + DL I+ H F+ ++ L +
Sbjct: 403 FLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWYRAPE 199
+ + + +RDLK N++ ++ +K+ DFG+ + + T T + T Y APE
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-----FCGTPDYIAPE 512
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ Y ++D W+ G + E+L G+ F G+ I
Sbjct: 513 IIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI---------------- 554
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADP 314
M P ++ A+ + + L+ P R +
Sbjct: 555 ----------MEHNVAYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599
Query: 315 YFKGL 319
+F+ +
Sbjct: 600 FFRYI 604
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 3e-19
Identities = 70/310 (22%), Positives = 127/310 (40%), Gaps = 64/310 (20%)
Query: 26 KILEVIGKGSYGVVCAA---IDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLR 80
++L+V+G+GS+G V + + A+K K + D +R E +L +
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVN 84
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVF------ELMESDLHQVIKANDDLTREHHQFFLYQ 134
HP IV++ K +Y++ +L + L + + ++ + F+L +
Sbjct: 85 HPFIVKLHYAFQTEGK-----LYLILDFLRGGDLF-TRLSKEVMFTEEDVK----FYLAE 134
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ AL ++H+ + +RDLKP+NIL + +K+ DFGL++ + + T
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVE 191
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ +T + D WS G + E+LTG F GK + +I
Sbjct: 192 YMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI----------- 238
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEE 309
++ K +P + P A LL+ L +P +R EE
Sbjct: 239 ---------------LKAKLGMP-----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE 278
Query: 310 ALADPYFKGL 319
+F +
Sbjct: 279 IKRHSFFSTI 288
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 59/257 (22%), Positives = 101/257 (39%), Gaps = 52/257 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
+ +G+G++G V A VA+K + + S++ R RE
Sbjct: 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREA 94
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF-- 130
+LL +L+H IV + E + + +VFE M DL++ ++++ +
Sbjct: 95 ELLTMLQHQHIVRFFGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 131 -------------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
Q+ + Y+ + HRDL +N L +K+ DFG++R
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD-- 207
Query: 178 SDTPMTVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
++ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ------IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGK 258
Query: 229 PLFPGKSVVHQLDLITD 245
+ S +D IT
Sbjct: 259 QPWYQLSNTEAIDCITQ 275
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 49/256 (19%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+ +G+G++G V A T VA+K + D + RE +L
Sbjct: 13 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAEL 70
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---------DDLTR 125
L L+H IV+ + + + +VFE M+ DL++ ++A+ +
Sbjct: 71 LTNLQHEHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 126 EHHQFFLYQML-------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178
+ L QML + Y+ + + HRDL +N L AN +K+ DFG++R
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--- 182
Query: 179 DTPMTVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
V+ TDY RW PE + K+T D+WS G I E+ T GK
Sbjct: 183 -----VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 230 LFPGKSVVHQLDLITD 245
+ S ++ IT
Sbjct: 235 PWFQLSNTEVIECITQ 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 65/306 (21%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
+ +L VIG+GSY V T A+K + ++ D + E + HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V + S+ ++ V E + DL ++ L EH +F+ ++ AL Y
Sbjct: 71 FLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
+H + +RDLK N+L ++ +K+ D+G+ + T + + T Y APE L
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEIL 182
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G Y ++D W++G + E++ G+ F D
Sbjct: 183 RG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------------------- 220
Query: 261 EKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR------PTAEEALAD 313
+ YL ++ + + + P ++ A +L+ + DPK+R +
Sbjct: 221 QNTEDYLFQVILEKQI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 277 PFFRNV 282
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 7e-19
Identities = 60/308 (19%), Positives = 110/308 (35%), Gaps = 59/308 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-------HDVFEHISDAIRILREVKLLR 77
+ L V+GKGS+G V + T E A+K + D E R+L
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--- 78
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
+ P + ++ + +Y V E + DL I+ H F+ ++
Sbjct: 79 --KPPFLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L ++ + + +RDLK N++ ++ +K+ DFG+ + D T + T Y
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT---KTFCGTPDYI 188
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ Y ++D W+ G + E+L G+ F G+ I
Sbjct: 189 APEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------------- 233
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AEEAL 311
M P ++ A+ + + L+ P R P +
Sbjct: 234 -------------MEHNVAYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275
Query: 312 ADPYFKGL 319
+F+ +
Sbjct: 276 EHAFFRYI 283
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 37/167 (22%), Positives = 67/167 (40%), Gaps = 30/167 (17%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
+++ + IG G++G + + +T E VAIK E + L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 81 H-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I ++ K +V EL+ L + D F L
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSLEDLFDLCD------RTFSLKTVLMIA 111
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL-----ANANCKLKVCDFGLAR 174
Q++ ++Y+H+ N+ +RD+KP+N L + + DF LA+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 64/306 (20%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
+ +L VIG+GSY V T A++ + ++ D + E + HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V + S+ ++ V E + DL ++ L EH +F+ ++ AL Y
Sbjct: 114 FLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
+H + +RDLK N+L ++ +K+ D+G+ + T + + T Y APE L
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEIL 225
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G Y ++D W++G + E++ G+ F D
Sbjct: 226 RG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------------------- 263
Query: 261 EKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR------PTAEEALAD 313
+ YL ++ + + + P ++ A +L+ + DPK+R +
Sbjct: 264 QNTEDYLFQVILEKQI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 320 PFFRNV 325
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 72/305 (23%), Positives = 116/305 (38%), Gaps = 58/305 (19%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHPDI 84
L+VIGKGS+G V A A+K + + I+ E LL+ ++HP +
Sbjct: 42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 85 VEIKRIMLPPSKREFKDIYVVF------ELMESDLHQVIKANDDLTREHHQFFLYQMLRA 138
V + K +Y V EL H ++ +F+ ++ A
Sbjct: 102 VGLHFSFQTADK-----LYFVLDYINGGELF---YH--LQRERCFLEPRARFYAAEIASA 151
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T T + T Y AP
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPEYLAP 208
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y +D W +G + E+L G P F ++ D I
Sbjct: 209 EVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--------------- 251
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PTAEEALADP 314
+ K + PN+ A LL+ L+ D R E +
Sbjct: 252 -----------LNKPLQLK-----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295
Query: 315 YFKGL 319
+F +
Sbjct: 296 FFSLI 300
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-18
Identities = 54/259 (20%), Positives = 100/259 (38%), Gaps = 54/259 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
+ + +E +G+ +G V + VAIK + + +R E
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEA 63
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---------DDL 123
L L+HP++V + ++ +K + + ++F DLH+ + DD
Sbjct: 64 MLRARLQHPNVVCLLGVV---TKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 124 TREHHQFFLYQML-------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
+ ++Y+ + +V H+DL +N+L +K+ D GL R
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE- 177
Query: 177 FSDTPMTVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-- 226
V+ DY RW APE + K++ DIWS G + EV +
Sbjct: 178 -------VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEVFSYG 227
Query: 227 GKPLFPGKSVVHQLDLITD 245
+P + G S +++I +
Sbjct: 228 LQP-YCGYSNQDVVEMIRN 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 49/252 (19%), Positives = 91/252 (36%), Gaps = 46/252 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
++ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 84
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFL 132
++ H +IV + L + +++ ELM DL ++ + +
Sbjct: 85 LIISKFNHQNIVRCIGVSL-----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 133 YQML-------RALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVAFSDTPM 182
+L +Y+ + HRD+ +N L K+ DFG+AR
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 192
Query: 183 TVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
++ Y +W PE +T D WS G + E+ + G +P
Sbjct: 193 -IYRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 234 KSVVHQLDLITD 245
KS L+ +T
Sbjct: 249 KSNQEVLEFVTS 260
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 68/305 (22%), Positives = 134/305 (43%), Gaps = 46/305 (15%)
Query: 27 ILEVIGKGSYG---VVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRH 81
+L+V+G G+YG +V TG+ A+K + + + E ++L +R
Sbjct: 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 82 -PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
P +V + +K ++++ + + +L + + T Q ++ +++ AL
Sbjct: 118 SPFLVTLHYAFQTETK-----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+++H + +RD+K +NIL ++N + + DFGL++ +D + + T Y AP+
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YD-FCGTIEYMAPD 230
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ S + A+D WS+G + E+LTG F + I+ +
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI------------ 278
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AEEALADP 314
++ +PP P + LA L+QRL+ DPK R P A+E
Sbjct: 279 ----------LKSEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323
Query: 315 YFKGL 319
+F+ +
Sbjct: 324 FFQKI 328
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-18
Identities = 50/254 (19%), Positives = 97/254 (38%), Gaps = 54/254 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRI--LREVKL 75
+ + +G+GS+G+V + + +VAIK ++ E S RI L E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASV 81
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF---- 130
++ +V + ++ + + V+ ELM DL +++ +
Sbjct: 82 MKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 131 ------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
++ + Y++ HRDL +N + + +K+ DFG+ R +
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--------I 188
Query: 185 FWTDYVATRWYR------------APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+ TDY YR +PE +T D+WS G + E+ T + +
Sbjct: 189 YETDY-----YRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
Query: 232 PGKSVVHQLDLITD 245
G S L + +
Sbjct: 242 QGLSNEQVLRFVME 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 67/307 (21%), Positives = 118/307 (38%), Gaps = 56/307 (18%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
++ + V+GKGS+G V A TG+ A+K + DV D + E + L HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+ ++ P + ++ V E + DL I+ + +F+ +++ AL +
Sbjct: 85 FLTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLA--RVAFSDTPMTVFWTDYVATRWYRAPE 199
+H + +RDLK N+L + K+ DFG+ + T T + T Y APE
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-----FCGTPDYIAPE 194
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L Y PA+D W++G + E+L G F ++ + I
Sbjct: 195 ILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--------------- 236
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR------PTAEEALA 312
+ + P + A +L+ + +P R L
Sbjct: 237 -----------LNDEVVYP-----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280
Query: 313 DPYFKGL 319
P+FK +
Sbjct: 281 HPFFKEI 287
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 49/252 (19%), Positives = 91/252 (36%), Gaps = 46/252 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
++ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 125
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFL 132
++ H +IV + L + +++ ELM DL ++ + +
Sbjct: 126 LIISKFNHQNIVRCIGVSL-----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 133 YQML-------RALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVAFSDTPM 182
+L +Y+ + HRD+ +N L K+ DFG+AR
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 233
Query: 183 TVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
++ Y +W PE +T D WS G + E+ + G +P
Sbjct: 234 -IYRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 234 KSVVHQLDLITD 245
KS L+ +T
Sbjct: 290 KSNQEVLEFVTS 301
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 30/166 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
NRY++ IG GS+G + D GE+VAIK E + L E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 81 H-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I I+ E +V EL+ L + +F L
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCS------RKFSLKTVLLLA 111
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLAR 174
QM+ ++Y+H+ N HRD+KP N L N + + DFGLA+
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 28/165 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
N++++ IG GS+G + + T E+VAIK E++ L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 81 -HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I ++ E +V +L+ L + + L
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSLEDLFNFCS------RKLSLKTVLMLA 109
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLAR 174
QM+ ++++H+ + HRD+KP N L ++ + DFGLA+
Sbjct: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 32/168 (19%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
YK+ IG+GS+GV+ + ++VAIK FE L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 81 H-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I + +E +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL------ANANCKLKVCDFGLAR 174
QML ++ +H ++ +RD+KP N L NAN + V DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN-MIYVVDFGMVK 159
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 79.9 bits (196), Expect = 7e-17
Identities = 52/349 (14%), Positives = 93/349 (26%), Gaps = 75/349 (21%)
Query: 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------------HDVFEHI 63
F+ + + E IG+G +G V I HT VAIK I FE I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 64 SDAIRILREVKLLRLL---RHPDIVEIKRIML-------------------------PPS 95
I I +E+ LL R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKP 154
+ +++V E + + + L+Q+ +L + HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
N+L K+ + T+ + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK------SSTIPSCGLQVSII------------DYTLSRLE 232
Query: 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK-------ARKYL 267
+F +V + LF G +Q D I L+ + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFD-IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + + ++ F +A + L
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 34/177 (19%), Positives = 68/177 (38%), Gaps = 35/177 (19%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
N++ + + IG G +G++ A T+ EK A + E+ + + E+K + +
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAK 92
Query: 82 PDIVEIKRIMLPPSKREFKDIY--------------VVFELMESDLHQVIKANDDLTREH 127
D ++ Y +V E + DL ++ ++
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDL-------QKISGQN 145
Query: 128 HQFFL-------YQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLAR 174
F +ML L+Y+H H D+K N+L N + ++ + D+GL+
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 62/251 (24%), Positives = 110/251 (43%), Gaps = 50/251 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREVKL 75
+R K+ + +G+G++G V A T T VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN------------- 120
L + H ++V +L + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 121 ---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
D LT EH + +Q+ + ++++ + HRDL +NIL + +K+CDFGLAR +
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 178 SDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
D DYV +W APE F YT D+WS G + E+ + G
Sbjct: 200 KD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 230 LFPGKSVVHQL 240
+PG + +
Sbjct: 250 PYPGVKIDEEF 260
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 56/272 (20%), Positives = 105/272 (38%), Gaps = 76/272 (27%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIHDVFEHISDAIRI--LREVKL 75
N + + IG+G++G V A + + VA+K + E S ++ RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 76 LRLLRHPDIVEIKRIML--PPSKREFKDIYVVFELMES-DLHQVIKANDD---------- 122
+ +P+IV++ + P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 123 --------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
L+ Q+ + Y+ HRDL +N L N +K+
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 169 DFGLARVAFSDTPMTVFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIW 215
DFGL+R ++ DY Y+ PE S F+++YT D+W
Sbjct: 217 DFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTESDVW 260
Query: 216 SIGCIFAEVLT--GKPLFPGKSVVHQLDLITD 245
+ G + E+ + +P + G + + + D
Sbjct: 261 AYGVVLWEIFSYGLQP-YYGMAHEEVIYYVRD 291
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 62/279 (22%), Positives = 102/279 (36%), Gaps = 62/279 (22%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDV 59
K D + D N K +VIG+G++G V A G + AIK++ +
Sbjct: 5 HHHHHGKNNPDPTIYPVL-DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63
Query: 60 FEHISDAIRILREVKLL-RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES- 111
D E+++L +L HP+I+ +L +Y+ E
Sbjct: 64 ASK-DDHRDFAGELEVLCKLGHHPNIIN----LLGACEHRGY-------LYLAIEYAPHG 111
Query: 112 DLHQVIKANDDLTREHHQF----------------FLYQMLRALKYMHTANVYHRDLKPK 155
+L ++ + L + F + R + Y+ HRDL +
Sbjct: 112 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171
Query: 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKY 208
NIL N K+ DFGL+R + YV RW A E +S Y
Sbjct: 172 NILVGENYVAKIADFGLSR--GQEV--------YVKKTMGRLPVRWM-AIE--SLNYSVY 218
Query: 209 TPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITD 245
T D+WS G + E+++ G P + G + + +
Sbjct: 219 TTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQ 256
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 62/251 (24%), Positives = 98/251 (39%), Gaps = 49/251 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLL- 76
NR + +G G++G V A + VA+K + H+++ ++ E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLS 81
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF----- 130
L H +IV +L V+ E DL ++ D
Sbjct: 82 YLGNHMNIVN----LLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 131 -------------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
F YQ+ + + ++ + N HRDL +NIL K+CDFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 178 SDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
+D ++YV +W APE F YT D+WS G E+ + G
Sbjct: 197 ND-------SNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 230 LFPGKSVVHQL 240
+PG V +
Sbjct: 247 PYPGMPVDSKF 257
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 59/254 (23%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLL- 76
N + + +G G++G V A G+ KVA+K + H + ++ E+K++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMS 104
Query: 77 RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQ 129
L +H +IV +L P + V+ E DL ++ +
Sbjct: 105 HLGQHENIVN----LLGACTHGGP-------VLVITEYCCYGDLLNFLRRKSRVLETDPA 153
Query: 130 F--------------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR- 174
F F Q+ + + ++ + N HRD+ +N+L K+ DFGLAR
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 175 -------VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT- 226
+ + + V W APE F YT D+WS G + E+ +
Sbjct: 214 IMNDSNYIVKGNARLPVKWM---------APE--SIFDCVYTVQSDVWSYGILLWEIFSL 262
Query: 227 GKPLFPGKSVVHQL 240
G +PG V +
Sbjct: 263 GLNPYPGILVNSKF 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 59/266 (22%), Positives = 105/266 (39%), Gaps = 64/266 (24%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIHDVFEHISDAIRI--LREVKL 75
+ + +G+G +G V A + G VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN-------------- 120
L+ + HP +++ + ++ + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQD-GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 121 ----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170
LT F +Q+ + ++Y+ + HRDL +NIL K+K+ DF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 171 GLARVAFSDTPMTVFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIF 221
GL+R V+ D YV +W A E S F YT D+WS G +
Sbjct: 195 GLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLL 242
Query: 222 AEVLT--GKPLFPGKSVVHQLDLITD 245
E++T G P +PG +L+
Sbjct: 243 WEIVTLGGNP-YPGIPPERLFNLLKT 267
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 26/180 (14%), Positives = 61/180 (33%), Gaps = 40/180 (22%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTG--------EKVAIKKIHDVFEHISDAIRILREVK 74
++K+ + + G++ A T T +K ++K + R+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKDG--RLFNEQN 94
Query: 75 LL-RLLRHPDIVEIKRIMLPPS----------KREFKDIYVVFELMESDLHQVIKANDDL 123
R + + + K++ P + K ++V + L + +
Sbjct: 95 FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP-- 152
Query: 124 TREHHQFFL-------YQMLRALKYMHTANVYHRDLKPKNILANANCKLKV--CDFGLAR 174
H ++L AL+++H H ++ +NI + + +V +G A
Sbjct: 153 ---KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 62/263 (23%), Positives = 110/263 (41%), Gaps = 63/263 (23%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE---KVAIKKIHDVFEHISDAIRILREVKL 75
++ + + +G+G++G V A ID + VA+K + D D ++ E+++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEM 93
Query: 76 L-RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES-DLHQVIKAN------- 120
+ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 94 MKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 121 ---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171
+ +T + YQ+ R ++Y+ + HRDL +N+L N +K+ DFG
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 202
Query: 172 LARVAFSDTPMTVFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223
LAR + D Y T +W APE F YT D+WS G + E
Sbjct: 203 LARDINNI--------DYYKKTTNGRLPVKWM-APE--ALFDRVYTHQSDVWSFGVLMWE 251
Query: 224 VLT-GKPLFPGKSVVHQLDLITD 245
+ T G +PG V L+ +
Sbjct: 252 IFTLGGSPYPGIPVEELFKLLKE 274
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 59/259 (22%), Positives = 110/259 (42%), Gaps = 55/259 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE---KVAIKKIHDVFEHISDAIRI--LREV 73
++ + + +G+G +G V A ID + VA+K + + ++ + E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 137
Query: 74 KLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN----------- 120
+++ + +H +I+ +L ++ +YV+ E +L + ++A
Sbjct: 138 EMMKMIGKHKNIIN----LLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 121 -----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
+ +T + YQ+ R ++Y+ + HRDL +N+L N +K+ DFGLAR
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 176 AFSDTPMTVFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT- 226
+ D Y T +W APE F YT D+WS G + E+ T
Sbjct: 253 INNI--------DYYKKTTNGRLPVKWM-APE--ALFDRVYTHQSDVWSFGVLMWEIFTL 301
Query: 227 GKPLFPGKSVVHQLDLITD 245
G +PG V L+ +
Sbjct: 302 GGSPYPGIPVEELFKLLKE 320
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 37/177 (20%), Positives = 69/177 (38%), Gaps = 32/177 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A +K+ IG+G +G + A D ++ E V V SD + E+K +
Sbjct: 34 AAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAK 92
Query: 82 PDIVEIKRIMLPPS--------------KREFKDIYVVFELMESDLHQVIKANDDLTREH 127
P+ ++ K +++ + SDL ++ +AN
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------ 146
Query: 128 HQFFL-------YQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLAR 174
+F ++L L+Y+H H D+K N+L N + ++ + D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDYGLAY 202
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 59/257 (22%), Positives = 109/257 (42%), Gaps = 51/257 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAI-------DTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+R + + +G+G++G V A + KVA+K + D ++ E+++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEM 127
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN------------- 120
+ + +H +I+ +L ++ +YV+ E +L + ++A
Sbjct: 128 MKMIGKHKNIIN----LLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 121 ---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD-- 240
Query: 178 SDTPMTVFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
+ D Y T +W APE F YT D+WS G + E+ T G
Sbjct: 241 ------IHHIDYYKKTTNGRLPVKWM-APE--ALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
Query: 229 PLFPGKSVVHQLDLITD 245
+PG V L+ +
Sbjct: 292 SPYPGVPVEELFKLLKE 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 56/241 (23%), Positives = 91/241 (37%), Gaps = 88/241 (36%)
Query: 30 VIGKGSYGVV-CAAIDTHTGEKVAIKKIHDV-------FEHISDAIRILREVKLLRLLRH 81
+IG G +G V + G KVA+K+ F E++ L RH
Sbjct: 46 LIGHGVFGKVYKGVLRD--GAKVALKRRTPESSQGIEEF---------ETEIETLSFCRH 94
Query: 82 PDIV-------EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY- 133
P +V E ++L +++ ME N +L + H LY
Sbjct: 95 PHLVSLIGFCDERNEMIL------------IYKYME---------NGNL--KRH---LYG 128
Query: 134 -----QML-------------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
+ R L Y+HT + HRD+K NIL + N K+ DFG+++
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK- 187
Query: 176 AFSDTPMTVFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAEVLTGK 228
++ T +++T Y PE +F + T D++S G + EVL +
Sbjct: 188 KGTELDQT-----HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 229 P 229
Sbjct: 239 S 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 61/258 (23%), Positives = 102/258 (39%), Gaps = 58/258 (22%)
Query: 23 NRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLL- 76
+ +V+G G++G V A T +VA+K + + S+ ++ E+K++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMT 103
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME------------------------SD 112
+L H +IV +L IY++FE
Sbjct: 104 QLGSHENIVN----LLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
+ + + LT E F YQ+ + ++++ + HRDL +N+L +K+CDFGL
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 173 AR-VAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAE 223
AR + YV +W APE S F YT D+WS G + E
Sbjct: 219 ARDIMSDSN--------YVVRGNARLPVKWM-APE---SLFEGIYTIKSDVWSYGILLWE 266
Query: 224 VLT-GKPLFPGKSVVHQL 240
+ + G +PG V
Sbjct: 267 IFSLGVNPYPGIPVDANF 284
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 5e-12
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 61/228 (26%)
Query: 30 VIGKGSYGVV-CAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHPDIV- 85
+G+G +GVV ++ VA+KK+ + + ++ ++ +E+K++ +H ++V
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 86 ------EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL--YQML- 136
+ + L V+ M N L L L
Sbjct: 95 LLGFSSDGDDLCL------------VYVYMP---------NGSL--LDRLSCLDGTPPLS 131
Query: 137 ------------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA--FSDTPM 182
+ ++H + HRD+K NIL + K+ DFGLAR + F+ T M
Sbjct: 132 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 183 TVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
T + V T Y APE L G + TP DI+S G + E++TG P
Sbjct: 192 T---SRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 18/140 (12%)
Query: 109 MESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
+E + D LT EH + +Q+ + ++++ + HRDL +NIL + +K+C
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 169 DFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 222 AEVLT-GKPLFPGKSVVHQL 240
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 43/219 (19%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
++G+G +G V G VA+K++ + + + EV+++ + H +++ ++
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRG 94
Query: 90 IMLPPSKREFKDIYVVFELM-----ESDLHQVIKANDDL---TREHHQFFLYQM------ 135
+ P++R +V+ M S L + ++ L R
Sbjct: 95 FCMTPTER-----LLVYPYMANGSVASCLRERPESQPPLDWPKR---------QRIALGS 140
Query: 136 LRALKYMH---TANVYHRDLKPKNILANANCKLKVCDFGLARVA-FSDTPMTVFWTDYVA 191
R L Y+H + HRD+K NIL + + V DFGLA++ + DT +T T
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRG 197
Query: 192 TRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
T + APE G K + D++ G + E++TG+
Sbjct: 198 TIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 1e-07
Identities = 60/404 (14%), Positives = 117/404 (28%), Gaps = 115/404 (28%)
Query: 43 IDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101
+D TGE + K I VFE DA + K D+ ++ + +L SK E
Sbjct: 7 MDFETGEHQYQYKDILSVFE---DAFVDNFDCK--------DVQDMPKSIL--SKEEIDH 53
Query: 102 I----------YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQM--------LRALKYM 142
I +F + S ++++ +++ R +++F + + + Y+
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI 113
Query: 143 HTANVYHRD-----------LKPKNILANANCKLKVCD---------FG---LARVAFSD 179
+ + D L+P L A +L+ G +A
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS 173
Query: 180 T------PMTVFWTDYVATRWYRAPE--------LCGSFFSKYTPAIDIWSIGCIFAEVL 225
+FW + + +PE L +T D S + +
Sbjct: 174 YKVQCKMDFKIFW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 226 TGKP--LFPGKSVVHQLDLITD-----------------LLGTPSPETIAVVRNEKARKY 266
+ L K + L L+ LL T + +
Sbjct: 231 QAELRRLLKSKPYENCL-LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA-DPYFKGL-AKIER 324
+ LL + + P+D P E L +P + A+ R
Sbjct: 290 SLDHHSMT----LTP-----DEVKSLLLKYLDCRPQDLP--REVLTTNPRRLSIIAESIR 338
Query: 325 EPSCQPISKLEFEFER-RRVTKDDIRELIYREILEYHPQLLKDY 367
+ ++ + V D + +I + P +
Sbjct: 339 DGLAT--------WDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 374 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.87 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.74 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.65 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.48 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.02 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.95 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.7 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.58 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.5 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.42 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.41 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.4 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.37 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.12 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.89 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.77 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.4 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.9 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.83 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.73 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-73 Score=531.52 Aligned_cols=349 Identities=48% Similarity=0.864 Sum_probs=298.5
Q ss_pred hhccccccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccce
Q 017301 10 LKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89 (374)
Q Consensus 10 ~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 89 (374)
++...+...+.+.++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|+.++||||+++++
T Consensus 41 ~~~~~~~~~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 120 (398)
T 4b99_A 41 LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120 (398)
T ss_dssp -------CCCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccCCCCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEee
Confidence 33444455567788999999999999999999999999999999999876666677778999999999999999999999
Q ss_pred eecCCC-cCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEe
Q 017301 90 IMLPPS-KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (374)
Q Consensus 90 ~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~ 168 (374)
++.... ..+..++|||||||+|+|.+++..++.+++..++.+++||+.||+|||++||+||||||+|||++.+|.+||+
T Consensus 121 ~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~ 200 (398)
T 4b99_A 121 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIG 200 (398)
T ss_dssp ECCCSSCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred eeecccccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEe
Confidence 986542 3455789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCC-CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 169 DFGLARVAFSDT-PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 169 DFg~a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
|||+|+...... .........+||++|||||++.+. ..|+.++||||+||++|+|++|++||.+.+..+++..|....
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 999998653322 122234567999999999998763 467999999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCC
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~ 327 (374)
+.|+...+..........++..+....+.++...++.+|++++|||.+||++||.+|||+.|+|+||||+....+..++.
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~ 359 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPD 359 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCC
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccC
Confidence 99999888877777788888888888888888888999999999999999999999999999999999999887777776
Q ss_pred CCCCCCcchhhhhccCCHHHHHHHHHHHHHHhCc
Q 017301 328 CQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361 (374)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
+.+ .+++.++....+.+++++.+++|+.+||+
T Consensus 360 ~~~--~~~~~~~~~~~~~~~~k~~i~~ei~~~~~ 391 (398)
T 4b99_A 360 CAP--PFDFAFDREALTRERIKEAIVAEIEDFHA 391 (398)
T ss_dssp CSS--CCCCHHHHSCCCHHHHHHHHHHHHHHHHH
T ss_pred CCC--CCCCccchhhcCHHHHHHHHHHHHHHHHH
Confidence 554 35667778889999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-66 Score=461.01 Aligned_cols=255 Identities=31% Similarity=0.538 Sum_probs=206.0
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.++|++++.||+|+||+||+|+++.+|+.||+|++++.... ......+.+|+.+|+.++||||+++++++. +..
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECC
Confidence 37899999999999999999999999999999999754322 233457889999999999999999999994 445
Q ss_pred cEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
.+|+|||||+|+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 69999999999999999999999999999999999999999999999999999999999999999999999997643322
Q ss_pred CcccccccccccccccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.....+||+.|||||++.+ ..| +.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 167 ----~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------ 228 (275)
T 3hyh_A 167 ----FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------ 228 (275)
T ss_dssp ------------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------
T ss_pred ----ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------
Confidence 2245689999999999987 454 689999999999999999999999877655544443210
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
......+|+.+++||.+||+.||++|||++|+|+||||+.
T Consensus 229 -------------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 -------------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 0112458999999999999999999999999999999963
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-66 Score=469.46 Aligned_cols=260 Identities=25% Similarity=0.439 Sum_probs=223.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++++.||+|+||+||+|+++.+|+.||+|++.+.. ........+.+|+.+|+.++||||+++++++. +.
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~ 104 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DD 104 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence 3467999999999999999999999999999999996432 11223456889999999999999999999994 44
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.++|||||||.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 569999999996 9999999989999999999999999999999999999999999999999999999999999987543
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... .......+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.+.-
T Consensus 185 ~~~-~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~----------- 250 (311)
T 4aw0_A 185 ESK-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE----------- 250 (311)
T ss_dssp TTT-CCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------
T ss_pred CCC-cccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 322 122356799999999999988 789999999999999999999999999988766665554310
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHH------HhcCCCCCcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE------ALADPYFKGL 319 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~------lL~hp~~~~~ 319 (374)
. .....+|+++++||.+||+.||.+|||++| +++||||+++
T Consensus 251 ---------------~-----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 251 ---------------Y-----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp ---------------C-----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred ---------------C-----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 0 112468999999999999999999999988 5899999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-65 Score=468.70 Aligned_cols=257 Identities=29% Similarity=0.517 Sum_probs=220.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
...|+++++||+|+||+||+|+++.+|+.||||+++..... ....+.+|+.+|+.++||||+++++++.+ ...
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 46799999999999999999999999999999999643222 23457899999999999999999999944 456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|||||||.| +|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 9999999996 99998876 469999999999999999999999999999999999999999999999999998654332
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. .....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 225 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------ 287 (346)
T 4fih_A 225 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------------ 287 (346)
T ss_dssp C---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC------------
T ss_pred C---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC------------
Confidence 2 2356789999999999987 7899999999999999999999999999887666655533111
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
+....+..+|+++++||.+||+.||++|||++|+|+||||+..
T Consensus 288 ----------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 288 ----------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp ----------------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ----------------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 1112234689999999999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-66 Score=473.56 Aligned_cols=258 Identities=27% Similarity=0.421 Sum_probs=218.5
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.-++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|+.++||||+++++++. +..
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~ 96 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENG 96 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECC
Confidence 347999999999999999999999999999999999876666666778999999999999999999999994 445
Q ss_pred cEEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 101 DIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
.+|||||||.| +|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 69999999985 999999754 357999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. .......+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 177 ~~---~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------- 242 (350)
T 4b9d_A 177 ST---VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--------- 242 (350)
T ss_dssp HH---HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---------
T ss_pred CC---cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---------
Confidence 22 112245689999999999988 7899999999999999999999999999887666655543110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
......+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 243 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 243 ---------------------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ---------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 0123468999999999999999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-64 Score=454.92 Aligned_cols=262 Identities=25% Similarity=0.339 Sum_probs=217.9
Q ss_pred CCCCCe-eEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 20 GDANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y-~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
...+|| ++.++||+|+||+||+|.++.++..||+|++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~ 100 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KG 100 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TT
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CC
Confidence 344676 7888999999999999999999999999999766556666778999999999999999999999985432 22
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEecC-CCCeEEeeecccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANA-NCKLKVCDFGLAR 174 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~~-~~~vkl~DFg~a~ 174 (374)
...+|||||||.| +|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 3568999999995 99999999889999999999999999999999998 999999999999974 7899999999997
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
..... .....+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+.+....+.....
T Consensus 181 ~~~~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~--------- 243 (290)
T 3fpq_A 181 LKRAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--------- 243 (290)
T ss_dssp GCCTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT---------
T ss_pred eCCCC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH---------
Confidence 54322 1245689999999999865 599999999999999999999999987654433322111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.... ........++++++||.+||+.||++|||++|+|+||||+.
T Consensus 244 -----------------~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 244 -----------------SGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------TTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------cCCC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0000 00112357889999999999999999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-65 Score=463.24 Aligned_cols=258 Identities=27% Similarity=0.449 Sum_probs=214.2
Q ss_pred CCCCeeEeceeeccCCeeEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
.+++|++++.||+|+||+||+|++. .+++.||+|++++..........+.+|+.+|++++||||+++++++.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~----- 96 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ----- 96 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----
Confidence 4578999999999999999999974 46789999999754322223345778999999999999999999994
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
+...+|+|||||.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 44569999999995 99999999899999999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... .....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.+.
T Consensus 177 ~~~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------- 241 (304)
T 3ubd_A 177 IDHEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA---------- 241 (304)
T ss_dssp ----C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred cCCCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC----------
Confidence 33221 2245689999999999987 78999999999999999999999999998876666555431
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
.. .....+|+++++||.+||+.||++||| ++|+++||||+++
T Consensus 242 ----------------~~-----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 242 ----------------KL-----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp ----------------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred ----------------CC-----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 00 112458999999999999999999998 5899999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-64 Score=470.90 Aligned_cols=258 Identities=29% Similarity=0.513 Sum_probs=221.9
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..+.|+++++||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~ 221 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GD 221 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CC
Confidence 34679999999999999999999999999999999974332 223457899999999999999999999954 45
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|||||||.| +|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 69999999996 99998875 46999999999999999999999999999999999999999999999999999865433
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. .....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 301 ~~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~----------- 364 (423)
T 4fie_A 301 VP---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP----------- 364 (423)
T ss_dssp CC---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----------
T ss_pred Cc---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----------
Confidence 22 2356789999999999987 7899999999999999999999999998887666655432110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
+....+..+|+.+++||.+||+.||.+|||+.|+|+||||+..
T Consensus 365 -----------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 365 -----------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp -----------------CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 1122345789999999999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-62 Score=466.75 Aligned_cols=353 Identities=37% Similarity=0.655 Sum_probs=299.5
Q ss_pred hccccccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCcccccee
Q 017301 11 KDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90 (374)
Q Consensus 11 ~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 90 (374)
...+..+.+.+.++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+|+.++||||++++++
T Consensus 14 ~~~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 93 (432)
T 3n9x_A 14 LYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93 (432)
T ss_dssp CCTTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 34556778889999999999999999999999999999999999998766676777889999999999999999999999
Q ss_pred ecCCCcCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeee
Q 017301 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (374)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DF 170 (374)
+..........+|+||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 94 IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp CCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred EecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccC
Confidence 97765555577999999999999999999888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcc-------------------cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-----
Q 017301 171 GLARVAFSDTPMT-------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT----- 226 (374)
Q Consensus 171 g~a~~~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt----- 226 (374)
|+|+......... ......+||++|+|||++... ..++.++|||||||++|+|++
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccc
Confidence 9998654332110 123567899999999986442 579999999999999999998
Q ss_pred ------CCCCCCCCC-----------------hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCC
Q 017301 227 ------GKPLFPGKS-----------------VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP 283 (374)
Q Consensus 227 ------g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (374)
|.++|.+.+ ..+++..+...+|.|+.+.+..........++.......+.+....++
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 566666654 467889999999999999999999999999999888888888888889
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchhhhhccCCHHHHHHHHHHHHHHhCccc
Q 017301 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363 (374)
Q Consensus 284 ~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (374)
.+++.+.+||.+||++||.+|||++|+|+||||+++.....++.+.......+. +....+.+++++.+++|+..|+|.+
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~ 411 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPEL 411 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTC
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCccc
Confidence 999999999999999999999999999999999998776666544322222222 2357889999999999999999987
Q ss_pred hh
Q 017301 364 LK 365 (374)
Q Consensus 364 ~~ 365 (374)
..
T Consensus 412 ~~ 413 (432)
T 3n9x_A 412 VI 413 (432)
T ss_dssp CC
T ss_pred cC
Confidence 64
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-62 Score=471.17 Aligned_cols=349 Identities=41% Similarity=0.712 Sum_probs=286.6
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..+...++|++++.||+|+||+||+|+++.+++.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 47 SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp SSCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CcCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 34567799999999999999999999999999999999998766676777889999999999999999999999977765
Q ss_pred CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
.....+|+||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 127 ~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 127 EKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp TTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred ccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 66678999999999999999999889999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCc------------------------ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh------
Q 017301 177 FSDTPM------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT------ 226 (374)
Q Consensus 177 ~~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt------ 226 (374)
...... .......+||++|+|||++... ..|+.++|||||||++|+|++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 432111 0123556899999999986432 579999999999999999999
Q ss_pred -----CCCCCCCCC--------------------hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCcccc
Q 017301 227 -----GKPLFPGKS--------------------VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK 281 (374)
Q Consensus 227 -----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (374)
|+++|.+.+ ..+++..+...+|.|..+.+..........++..+...........
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 788887765 3678899999999999999999999999999888888888888888
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchhhhhccCCHHHHHHHHHHHHHHhCc
Q 017301 282 FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361 (374)
Q Consensus 282 ~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
++..++.+.+||.+||++||.+|||++|+|+||||+++.....++.+.......+. +...++.+++++.+++|+..|+|
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~ 444 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHP 444 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTCT
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhCc
Confidence 99999999999999999999999999999999999998765555443322222222 33568899999999999999999
Q ss_pred cchhcc
Q 017301 362 QLLKDY 367 (374)
Q Consensus 362 ~~~~~~ 367 (374)
++..-.
T Consensus 445 ~~~~~~ 450 (458)
T 3rp9_A 445 EIQLPR 450 (458)
T ss_dssp TCCCCC
T ss_pred cccCCC
Confidence 876544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-63 Score=455.15 Aligned_cols=259 Identities=26% Similarity=0.339 Sum_probs=216.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.++||||+++++++. +...
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~-----~~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVR-----EGPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEE-----ETTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 4678999999999999999999999999999999975322 246999999999999999999994 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC-CeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~-~vkl~DFg~a~~~~~~ 179 (374)
+|||||||.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+.....
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999995 9999999988999999999999999999999999999999999999999987 6999999999865433
Q ss_pred CCcc--cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 180 TPMT--VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 180 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----------- 271 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE----------- 271 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-----------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-----------
Confidence 2111 11234579999999999988 78999999999999999999999999887765555444321
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHH-------------hcCCCCCcCccC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA-------------LADPYFKGLAKI 322 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~l-------------L~hp~~~~~~~~ 322 (374)
+.+.....+.+|+.+.+||.+||+.||.+|||+.|+ |+|||+....++
T Consensus 272 -----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 272 -----------------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp -----------------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred -----------------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 111223356789999999999999999999999997 679999876543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-61 Score=449.28 Aligned_cols=337 Identities=39% Similarity=0.735 Sum_probs=284.1
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..+.+.++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++.....
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 45577899999999999999999999999999999999997666666667788999999999999999999999976532
Q ss_pred -CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 -REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 -~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
.....+|+||||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 99 LDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 23456899999998899999987 5699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
.... ....++|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....|.|+.+.+
T Consensus 178 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 4332 2456799999999988653 56899999999999999999999999999999999999999999999999
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLE 335 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~ 335 (374)
..+.......++..+.......+...++..++.+.+||.+||+.||.+|||+.++|+||||+.+.....++...+ +.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~---~~ 327 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK---YD 327 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC---CC
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCCC---CC
Confidence 999999999999988887777777888899999999999999999999999999999999999887776666553 45
Q ss_pred hhhhhccCCHHHHHHHHHHHHHHhCccch
Q 017301 336 FEFERRRVTKDDIRELIYREILEYHPQLL 364 (374)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (374)
+.++....+.++|++.+++|++.++|...
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (367)
T 1cm8_A 328 DSFDDVDRTLDEWKRVTYKEVLSFKPPRQ 356 (367)
T ss_dssp CC-----CCHHHHHHHHHHHHHTCCC---
T ss_pred CChhhhcCCHHHHHHHHHHHHHHhccccc
Confidence 66677788899999999999999998854
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-61 Score=450.45 Aligned_cols=337 Identities=42% Similarity=0.793 Sum_probs=281.5
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS- 95 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 95 (374)
..+.+.++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++....
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 23 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp EEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 4566789999999999999999999999999999999999876666667778899999999999999999999996542
Q ss_pred cCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
......+|+|||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 103 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp GGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred cccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 233466899999998899988876 5799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
.... .....||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+.+..|.|..+.+
T Consensus 182 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 182 TADE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccc------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4322 2446899999999998653 57899999999999999999999999999999999999999999999999
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLE 335 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~ 335 (374)
..+.......++..+.......+...++..++.+.+||.+||++||.+|||+.++|+||||+.+..+..++.+.+ +.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~ 331 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YD 331 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CC
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CC
Confidence 999999888998888777777777778899999999999999999999999999999999999887776666554 45
Q ss_pred hhhhhccCCHHHHHHHHHHHHHHhCccch
Q 017301 336 FEFERRRVTKDDIRELIYREILEYHPQLL 364 (374)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (374)
+.++....+.++|++++|+|+..|+|..+
T Consensus 332 ~~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 360 (367)
T 2fst_X 332 QSLESRDLLIDEWKSLTYDEVISFVPPPL 360 (367)
T ss_dssp GGGSSCCCCHHHHHHHHHHHHHHCCCCC-
T ss_pred cchhhccCCHHHHHHHHHHHHHHhccCcc
Confidence 66777788999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-61 Score=449.58 Aligned_cols=286 Identities=28% Similarity=0.435 Sum_probs=222.1
Q ss_pred CCCCeeEeceeeccCCeeEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCc
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 96 (374)
..++|++++.||+|+||+||+|+++ .+++.||+|++... ....++.+|+++|+.+ +||||+++++++.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~---- 90 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFR---- 90 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE----
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEE----
Confidence 4578999999999999999999875 46789999998643 2234677999999998 6999999999994
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC-CCeEEeeecccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLAR 174 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~-~~vkl~DFg~a~ 174 (374)
...++|+|||||+| +|.+++. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 91 -~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 91 -KNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp -ETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred -ECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 44679999999985 9999984 59999999999999999999999999999999999999877 799999999997
Q ss_pred cccCCCCc-------------------------ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 017301 175 VAFSDTPM-------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229 (374)
Q Consensus 175 ~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~ 229 (374)
........ .......+||++|+|||++.+. ..|+.++||||+||++|+|++|+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCC
Confidence 54322110 1112456899999999998763 468999999999999999999998
Q ss_pred CC-CCCChhhHHHHHHHhhCCCCHHHHhhhc-----------CHHHHHHHHHhcCCC------------CCCccccCCCC
Q 017301 230 LF-PGKSVVHQLDLITDLLGTPSPETIAVVR-----------NEKARKYLTEMRKKP------------PVPLFQKFPNV 285 (374)
Q Consensus 230 pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~------------~~~~~~~~~~~ 285 (374)
|| .+.+..+++..|....|++......... ..........+.... .......+..+
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 88 5667788889999888865443322110 111122222111100 01112345678
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 286 s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
|++++|||++||++||.+||||+|+|+||||+++
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-60 Score=449.33 Aligned_cols=340 Identities=39% Similarity=0.730 Sum_probs=269.5
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 99 (374)
+.++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.+. ||||+++++++...+ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---D 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---S
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---C
Confidence 347999999999999999999999999999999999876667777788899999999997 999999999996532 3
Q ss_pred CcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
..+|+||||++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred CEEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 46899999999999999987 47999999999999999999999999999999999999999999999999999764321
Q ss_pred C------------------CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 017301 180 T------------------PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241 (374)
Q Consensus 180 ~------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 241 (374)
. .........+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 011223456899999999998653 578999999999999999999999999999999999
Q ss_pred HHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCC---CCCccccC-------------CCCChHHHHHHHHhccCCCCCCC
Q 017301 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKP---PVPLFQKF-------------PNVDPLALRLLQRLIAFDPKDRP 305 (374)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-------------~~~s~~~~~li~~~L~~dp~~Rp 305 (374)
.+...++.|..+.+..........++..+.... .......+ ..+++.+.+||.+||++||.+||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 999999999999887777665555555443322 11111112 26799999999999999999999
Q ss_pred CHHHHhcCCCCCcCccCCCCCCCCCCCCcchhhhhccCCHHHHHHHHHHHHHHhCccchhc
Q 017301 306 TAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKD 366 (374)
Q Consensus 306 t~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (374)
|++|+|+||||+.+..+..++.+.......+. .....+.+++++.+|+|+..+++++..+
T Consensus 322 t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (388)
T 3oz6_A 322 SANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELISN 381 (388)
T ss_dssp CHHHHTTSTTTTTTCCGGGCCCCSSCCCCC-------CCHHHHHHHHHHHHHHHHHHHTCC
T ss_pred CHHHHhCCHHHHHhcCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhhhhhhhh
Confidence 99999999999988777666665543322222 2346788999999999999998877654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-60 Score=453.14 Aligned_cols=334 Identities=36% Similarity=0.663 Sum_probs=262.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-CC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-RE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~ 98 (374)
...++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++..... ++
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 44689999999999999999999999999999999998766666777789999999999999999999999976532 34
Q ss_pred CCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..++|+||||++++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 567999999999999888864 499999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. .....+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..+...+|.|.++.+...
T Consensus 217 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 217 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp CC----CC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred Cc----ccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 22 2345689999999999988 68999999999999999999999999999999999999999999999887765
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCC------------ChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNV------------DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (374)
. .....++..............++.. ++.+++||.+||++||.+|||++|+|+||||+.+..+....
T Consensus 291 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~ 369 (464)
T 3ttj_A 291 Q-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE 369 (464)
T ss_dssp C-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHS
T ss_pred c-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCccccc
Confidence 4 3444444433333222222222221 56799999999999999999999999999999765443222
Q ss_pred CCCCCCCcchhhhhccCCHHHHHHHHHHHHHHhCccc
Q 017301 327 SCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363 (374)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (374)
. .+.......++....+.+++++.+++|+.++++..
T Consensus 370 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 405 (464)
T 3ttj_A 370 A-PPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKT 405 (464)
T ss_dssp C-CC-----------CCCHHHHHHHHHHHHHC-----
T ss_pred C-CCCccCCcchhhccCCHHHHHHHHHHHHHHhhhcc
Confidence 2 12223455667778889999999999998776543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=432.15 Aligned_cols=263 Identities=27% Similarity=0.427 Sum_probs=200.6
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc------
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK------ 96 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------ 96 (374)
+.|++++.||+|+||+||+|+++.+|+.||||+++.. ........+.+|+.+|+.++||||+++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 3589999999999999999999999999999999643 233445678999999999999999999999865432
Q ss_pred -CCCCcEEEEEccCcc-cHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeec
Q 017301 97 -REFKDIYVVFELMES-DLHQVIKANDD---LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (374)
Q Consensus 97 -~~~~~~~lv~e~~~~-~L~~~l~~~~~---l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg 171 (374)
....++|+|||||.| +|.+++..... .++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 123458999999985 99999987654 3456688999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcc---------cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 017301 172 LARVAFSDTPMT---------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242 (374)
Q Consensus 172 ~a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 242 (374)
+|+......... ...+..+||+.|||||++.+ ..|+.++|||||||++|+|++ ||.+.. +....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~ 236 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT 236 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH
Confidence 998654332211 12245689999999999988 789999999999999999996 775432 22222
Q ss_pred HHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
+........+. .++..++.+.+||++||+.||.+|||+.|+|+||||+++.
T Consensus 237 ~~~~~~~~~p~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 237 LTDVRNLKFPP---------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHTTCCCH---------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHhcCCCCC---------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 22221111111 1123467788999999999999999999999999998763
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=433.56 Aligned_cols=341 Identities=45% Similarity=0.815 Sum_probs=289.1
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
.++..++|++++.||+|+||+||+|.+..++..||+|++... ........+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 345678999999999999999999999999999999999742 3444556788999999999999999999999776655
Q ss_pred CCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
....+|+|||+++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEcccCcCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 56679999999999999999764 69999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
............+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.|..+.+..
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 433322233556899999999987542 5689999999999999999999999999999999999999999999999988
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchh
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (374)
..+.....+..........+....++.+++.+.+||.+||++||.+|||+.++|+||||++......++...+. +.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~--~~~~ 336 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP--FKFD 336 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSC--CCCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCc--CCcc
Confidence 88888888877777776666677778899999999999999999999999999999999987655444443332 3344
Q ss_pred hhhccCCHHHHHHHHHHHHHHhCccc
Q 017301 338 FERRRVTKDDIRELIYREILEYHPQL 363 (374)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (374)
.+....+.+++++++++|...++|..
T Consensus 337 ~~~~~~~~~~~~~~~~~e~~~~~~~~ 362 (364)
T 3qyz_A 337 MELDDLPKEKLKELIFEETARFQPGY 362 (364)
T ss_dssp -----CCHHHHHHHHHHHTGGGCC--
T ss_pred cccccCCHHHHHHHHHHHHHHhhhhc
Confidence 45667889999999999999998864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-58 Score=430.04 Aligned_cols=335 Identities=39% Similarity=0.732 Sum_probs=284.0
Q ss_pred ccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 16 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
...+...++|++.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus 35 ~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 35 KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp TEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 34566789999999999999999999999999999999999876666666778899999999999999999999996543
Q ss_pred c-CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 96 K-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 96 ~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
. ......|+||||+.++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 115 ~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQTDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp SSTTCCCCEEEEECCCEEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred CcccceeEEEEEccccccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 2 12234599999999999888843 59999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.
T Consensus 193 ~~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 193 HADAE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccC------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 54332 2345789999999988653 5689999999999999999999999999999999999999999999999
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKL 334 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~ 334 (374)
+..........+...............++.+++.+.+||.+||+.||.+|||+.++|+||||+.+..+........ .+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~--~~ 343 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PF 343 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CC
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccccccc--Cc
Confidence 8888888888888877777666666777889999999999999999999999999999999998765544333221 12
Q ss_pred chhhhhccCCHHHHHHHHHHHHHHhCc
Q 017301 335 EFEFERRRVTKDDIRELIYREILEYHP 361 (374)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
....+....+.+++++.+++|+.+|+|
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 344 DDSLEHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp CCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred CcchhhcccchHHHHHHHHHHHHhccc
Confidence 233455678899999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=453.29 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=213.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc----CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
-+.|++++.||+|+||+||+|+++.+|+.||||++++.. ..........+++.+++.++||||+++++++.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~----- 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH----- 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE-----
Confidence 467999999999999999999999999999999996421 11122223334567777889999999999994
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
+..++|+|||||.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 44569999999995 99999999899999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.... ....+||+.|||||++.+. ..|+.++|+|||||++|+|++|++||.+.+..+........
T Consensus 343 ~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---------- 406 (689)
T 3v5w_A 343 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------- 406 (689)
T ss_dssp SSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH----------
T ss_pred CCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh----------
Confidence 4332 2456899999999998642 57999999999999999999999999875433222111110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
.... ......+|+++++||.+||+.||.+|++ ++++++||||+++
T Consensus 407 -------------~~~~-----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 407 -------------LTMA-----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp -------------HHCC-----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred -------------cCCC-----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 0011 1123468999999999999999999998 8999999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-58 Score=414.51 Aligned_cols=257 Identities=22% Similarity=0.268 Sum_probs=206.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.+++++.++||+|+||+||+|+.. ..||||+++...........+.+|+.+|++++||||+++++++.. ..
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence 578999999999999999999753 369999998655566667789999999999999999999998732 24
Q ss_pred EEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+|||||||++ +|.+++... +++++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 7999999995 999999764 57999999999999999999999999999999999999999999999999999864332
Q ss_pred CCccccccccccccccccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. .......+||+.|||||++.+. ...|+.++|||||||++|||+||+.||.+.+....+..+....
T Consensus 186 ~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~----------- 253 (307)
T 3omv_A 186 SG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG----------- 253 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT-----------
T ss_pred Cc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC-----------
Confidence 21 1123456899999999998642 2469999999999999999999999998876554443332110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..........+++++.+.+||.+||+.||++|||+.+++++
T Consensus 254 --------------~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 254 --------------YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp --------------CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred --------------CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01111123345789999999999999999999999988653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-58 Score=452.05 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=224.8
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+-++|++++.||+|+||+||+|+++.+|+.||+|++... .......+.+|+.+|+.++||||+++++++. +..
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~ 227 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDN 227 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----CSS
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECC
Confidence 347899999999999999999999999999999998653 3445567889999999999999999999994 446
Q ss_pred cEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC--CCeEEeeecccccc
Q 017301 101 DIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--CKLKVCDFGLARVA 176 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~--~~vkl~DFg~a~~~ 176 (374)
++|||||||.| +|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 69999999985 99999964 4689999999999999999999999999999999999999864 88999999999875
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.... .....+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 308 ~~~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~------ 375 (573)
T 3uto_A 308 DPKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM------ 375 (573)
T ss_dssp CTTS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC------
T ss_pred cCCC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC------
Confidence 4332 2345689999999999988 789999999999999999999999999988777666554322211
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
....++.+|+.+++||.+||+.||.+|||+.|+|+||||+....
T Consensus 376 ---------------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 376 ---------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp ---------------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred ---------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 12234678999999999999999999999999999999986543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-58 Score=413.11 Aligned_cols=257 Identities=24% Similarity=0.336 Sum_probs=211.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
.++|++.+.||+|+||+||+|.+. .++..||||+++.. .....+.+.+|+.+|++++||||+++++++..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--- 86 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--- 86 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee---
Confidence 467999999999999999999865 46789999999743 34556679999999999999999999999954
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAN-------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~-------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~ 162 (374)
...+|||||||++ +|.+++... ..+++..+..|+.||+.||+|||+++|+||||||+|||++.+
T Consensus 87 --~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 87 --GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp --SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 3458999999994 999999764 369999999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHH
Q 017301 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (374)
Q Consensus 163 ~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~ 241 (374)
+.+||+|||+|+........ .......||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999864332211 11234579999999999987 789999999999999999998 899999888766555
Q ss_pred HHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.+..... . ...+.+|+.+.+||.+||+.||++|||+.++ |+|++++.
T Consensus 242 ~i~~~~~-------------------------~-----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 242 CITQGRV-------------------------L-----QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp HHHHTCC-------------------------C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred HHHcCCC-------------------------C-----CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 4432110 0 1124688999999999999999999999999 45776653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=417.31 Aligned_cols=333 Identities=39% Similarity=0.735 Sum_probs=281.2
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 96 (374)
.+...++|++.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.....
T Consensus 19 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 19 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98 (353)
T ss_dssp EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred ccccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence 3455789999999999999999999999999999999998765565666788999999999999999999999965432
Q ss_pred CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
.....+|+||||+.++|.+++.. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 99 ~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 99 RNFYDFYLVMPFMQTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp GGCCCCEEEEECCSEEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred ccceeEEEEeccccCCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 12235699999999998887753 5999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+.
T Consensus 177 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 177 DAE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp -------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred CCC------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 322 2345789999999988653 568999999999999999999999999999999999999999999999888
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcch
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (374)
.........++..+...........++.+++.+.+||.+||+.||.+|||+.++|+||||+....++..+.... .+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~--~~~~ 327 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDD 327 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCC
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC--CCcc
Confidence 88888777777777666555566667789999999999999999999999999999999998765544433222 2344
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCc
Q 017301 337 EFERRRVTKDDIRELIYREILEYHP 361 (374)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
..+....+.++|++.+++|+.+|.|
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 328 SLEHEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp TTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred chhhccCCHHHHHHHHHHHHHhhcc
Confidence 5566788999999999999999876
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-56 Score=413.38 Aligned_cols=337 Identities=43% Similarity=0.800 Sum_probs=277.6
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
.+...++|++++.||+|+||+||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++......
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 445679999999999999999999999999999999999642 3444556788999999999999999999998765555
Q ss_pred CCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
.....|+||||+.++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 85 NFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp TCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 5678999999999999999987 469999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcc-------cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 017301 178 SDTPMT-------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 178 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 322111 112345789999999987542 568999999999999999999999999999999999998888887
Q ss_pred CH-HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCC
Q 017301 251 SP-ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQ 329 (374)
Q Consensus 251 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~ 329 (374)
.. .............+...+......+....++.+++.+.+||.+||+.||.+|||+.++|+||||+....+...+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~ 322 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGE 322 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccC
Confidence 63 33444455556666666655555555566778999999999999999999999999999999999887666555544
Q ss_pred CCC--CcchhhhhccCCHHHHHHHHHHHHH
Q 017301 330 PIS--KLEFEFERRRVTKDDIRELIYREIL 357 (374)
Q Consensus 330 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (374)
+++ .+++...+...+.+++++++++|+.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 323 PIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred CCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 443 3445556778999999999999974
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-57 Score=413.33 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=203.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
.+.|++.++||+|+||+||+|..+ .++..||||+++.. .....+.+.+|+.+|++++||||+++++++..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--- 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE--- 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE---
Confidence 357899999999999999999864 46889999999743 34556679999999999999999999999944
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAN---------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~---------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~ 160 (374)
...+|||||||.+ +|.+++... +++++..+..|+.||+.||+|||+++|+||||||+|||++
T Consensus 115 --~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 --GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp --SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 4559999999995 999999753 3589999999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 017301 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (374)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 239 (374)
.++.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999865332211 11234579999999999988 789999999999999999999 8999998887665
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
+..+.... .. .....+++.+.+|+.+||+.||++|||+.+++++
T Consensus 270 ~~~i~~g~-------------------------~~-----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 270 IDCITQGR-------------------------EL-----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHTC-------------------------CC-----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCC-------------------------CC-----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 55443211 01 1124688999999999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-57 Score=409.99 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=208.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
.+.++++++||+|+||+||+|... .+++.||||+++.... ....+.+.+|+.+|++++||||+++++++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--- 100 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTK--- 100 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE---
Confidence 467899999999999999999853 4678999999975432 2334678999999999999999999999954
Q ss_pred CCCCcEEEEEccCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe
Q 017301 97 REFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (374)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~ 159 (374)
...+|||||||. |+|.+++... ..+++..+..|+.||+.||+|||+++|+||||||+|||+
T Consensus 101 --~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 --DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp --SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 345899999999 5999999653 358999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhh
Q 017301 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVH 238 (374)
Q Consensus 160 ~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 238 (374)
+.++.+||+|||+|+....... .......+||+.|||||++.+ ..|+.++|||||||++|||+| |..||.+.+..+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred CCCCCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999986533221 112245679999999999987 789999999999999999998 899999988765
Q ss_pred HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.+..+.... .. ...+.+++.+.+|+.+||+.||.+|||+.+++++
T Consensus 256 ~~~~i~~~~-------------------------~~-----~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 256 VVEMIRNRQ-------------------------VL-----PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHTTC-------------------------CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCC-------------------------CC-----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 554443210 01 1124688999999999999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-56 Score=418.81 Aligned_cols=331 Identities=36% Similarity=0.662 Sum_probs=256.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-cCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~ 98 (374)
...++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.... ...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3468999999999999999999999999999999999865556666778889999999999999999999996543 233
Q ss_pred CCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...+|+||||++++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ccceEEEEEcCCCCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 457999999999999999864 589999999999999999999999999999999999999999999999999976433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.|.++.+...
T Consensus 180 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 180 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp --------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cc----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 21 1244679999999999987 67999999999999999999999999999999999999999999988877654
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCC------------CChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPN------------VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (374)
. .....+...............++. .++.+++||.+||+.||.+|||++++|+||||+.+..+....
T Consensus 254 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~ 332 (371)
T 2xrw_A 254 Q-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 332 (371)
T ss_dssp C-HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHT
T ss_pred h-hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccC
Confidence 3 223333332222111111111111 156789999999999999999999999999998764432211
Q ss_pred CCCCCCCcchhhhhccCCHHHHHHHHHHHHHHhC
Q 017301 327 SCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360 (374)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (374)
. .+........+.+..+.++|++++|.++..+.
T Consensus 333 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 333 A-PPPKIPDKQLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp C-CCCCCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred C-CCCCCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence 1 11112234445667888999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-56 Score=404.87 Aligned_cols=293 Identities=39% Similarity=0.645 Sum_probs=237.6
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..-+..++|++++.||+|+||+||+|.+. +|+.||+|++............+.+|+.+++.++||||+++++++.
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 89 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH---- 89 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc----
Confidence 44577899999999999999999999985 5899999999755444444567889999999999999999999994
Q ss_pred CCCCcEEEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 REFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
....+|+||||++++|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 90 -~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 90 -SERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp -CSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred -cCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 445699999999999999887654 599999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+.+..+
T Consensus 169 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 169 FGIPVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TTSCCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred cCCCcc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 543221 12445789999999998653 56899999999999999999999999999999999999999999887765
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
........... .........+.....+.+++++.+||.+||++||.+|||++++|+||||+++.
T Consensus 245 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 245 PQVQELPLWKQ-RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GGGTTSHHHHS-CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhhccchhhh-cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 54433211100 00011111222334567899999999999999999999999999999998763
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=401.99 Aligned_cols=260 Identities=26% Similarity=0.474 Sum_probs=224.3
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++. ..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~ 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TE 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence 3457899999999999999999999999999999999866666666778899999999999999999999994 44
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+|+||||+.+ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 569999999975 9999999888999999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccccccccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. .....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 167 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------- 229 (328)
T 3fe3_A 167 GG----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG----------- 229 (328)
T ss_dssp SC----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CC----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 22 2355689999999999877 444 57999999999999999999999988766555444321
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.. .....+++.+.+||++||+.||.+|||++++|+||||+....
T Consensus 230 ---------------~~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 230 ---------------KY-----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp ---------------CC-----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred ---------------CC-----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 00 111357899999999999999999999999999999987543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=399.25 Aligned_cols=287 Identities=37% Similarity=0.599 Sum_probs=234.4
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++. ....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 6899999999999999999999999999999999765555556677889999999999999999999994 34569
Q ss_pred EEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|+||||+++++.+.+.. ++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988877765 56899999999999999999999999999999999999999999999999999976533221
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCC-CCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
......||+.|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+..+.+..+....+.+....+.....
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22455789999999998762 3489999999999999999987655 788888888899999888887765543221
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.. .+................+.+++.+++||.+||+.||.+|||++|+|+||||+++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cc--cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 10 00000000001122234457899999999999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=407.41 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=208.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCC-CCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~ 95 (374)
.++|++++.||+|+||+||+|.+..+ ++.||+|.++.. ........+.+|+.+|++++| |||+++++++...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 46899999999999999999987654 368999999753 333456678999999999975 8999999998543
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceE
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL 158 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil 158 (374)
...+|||||||.+ +|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 141 ---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 2358999999995 999999753 34899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChh
Q 017301 159 ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237 (374)
Q Consensus 159 ~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~ 237 (374)
++.++.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999865443221 22345679999999999987 789999999999999999998 89999887644
Q ss_pred hHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
+.+..+.. .- ... .....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 295 ~~~~~~i~-----------------------~g-~~~-----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLK-----------------------EG-TRM-----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHH-----------------------HT-CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHH-----------------------cC-CCC-----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 33322211 00 001 1124578999999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=402.70 Aligned_cols=332 Identities=35% Similarity=0.655 Sum_probs=265.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC---------ChHHHHHHHHHHHHHHhCCCCCcccccee
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---------HISDAIRILREVKLLRLLRHPDIVEIKRI 90 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 90 (374)
...++|++++.||+|+||+||+|.+.. |..||+|++..... .......+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 456899999999999999999998854 99999999864322 22334678899999999999999999999
Q ss_pred ecCCCcCCCCcEEEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEee
Q 017301 91 MLPPSKREFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (374)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~D 169 (374)
+..........+|+||||+.|+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 9765545566799999999999999987654 799999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
||++........ .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.
T Consensus 178 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 178 FNLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp TTC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cCcccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999975333221 2345799999999988653 56899999999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCC-CCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCC
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPP-VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC 328 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~ 328 (374)
+...............++.......+ .......+..++.+.+||.+||+.||.+|||+.++|+||||+++..+......
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 332 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG 332 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc
Confidence 99888777776666665544333322 22334456789999999999999999999999999999999987644333221
Q ss_pred CCCCCcchhhhhccCCHHHHHHHHHHHHHHhC
Q 017301 329 QPISKLEFEFERRRVTKDDIRELIYREILEYH 360 (374)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (374)
.. ..+.+.....+..++++.++.|+.+++
T Consensus 333 ~~---~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 333 LS---ERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp CC---CCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred cc---cccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 11 223445667778999999999998875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=402.61 Aligned_cols=266 Identities=28% Similarity=0.442 Sum_probs=226.3
Q ss_pred ccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhCCCCCccccceee
Q 017301 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIM 91 (374)
Q Consensus 16 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 91 (374)
++...+.++|++++.||+|+||+||+|.++.+|+.||+|+++...... .....+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 445567789999999999999999999999999999999997543221 1245688999999999999999999999
Q ss_pred cCCCcCCCCcEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC----CeE
Q 017301 92 LPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLK 166 (374)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~----~vk 166 (374)
. ....+|+||||+. |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 85 ~-----~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 85 E-----NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp E-----CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred E-----eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEE
Confidence 4 4456999999997 59999999888999999999999999999999999999999999999998877 799
Q ss_pred EeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 017301 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (374)
Q Consensus 167 l~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 246 (374)
|+|||++........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 160 l~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 233 (361)
T 2yab_A 160 LIDFGLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233 (361)
T ss_dssp ECCCSSCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred EEecCCceEcCCCCc----cccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 999999986543321 245679999999999987 68999999999999999999999999998877666655443
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.....+. .++.+++.+++||.+||..||.+|||+.++|+||||+..
T Consensus 234 ~~~~~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 234 SYDFDEE---------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp CCCCCHH---------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCCCch---------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 2222211 135688999999999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-55 Score=395.92 Aligned_cols=284 Identities=38% Similarity=0.638 Sum_probs=228.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++++.||+|+||+||+|.+ .+|+.||+|++............+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence 6899999999999999999998 678999999997543333334567899999999999999999999944 3568
Q ss_pred EEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|+||||+.++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999999864 6799999999999999999999999999999999999999999999999999976533221
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 12345789999999998652 46899999999999999999999999999998888888888887765544322110
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
..+........+.+.....+.+++.+.+||.+||+.||.+|||+.++|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0000011111222333445678999999999999999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=396.10 Aligned_cols=290 Identities=37% Similarity=0.666 Sum_probs=230.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++. ....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCe
Confidence 47899999999999999999999999999999999766555555667889999999999999999999994 3456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
.++||||+++ +|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 8999999997 777777777889999999999999999999999999999999999999999999999999997654322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ......||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+....+....+...+........
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 12445799999999988653 5689999999999999999999999999999999988888888877654332211
Q ss_pred HHHHHHHHHhcCC---CCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCC
Q 017301 261 EKARKYLTEMRKK---PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (374)
Q Consensus 261 ~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (374)
... ....... ...+....++.+++.+.+||.+||+.||.+|||++++|+||||+++...+
T Consensus 233 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 233 NQY---FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp CGG---GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred ccc---cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 110 0000000 00111223467899999999999999999999999999999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=398.38 Aligned_cols=289 Identities=34% Similarity=0.564 Sum_probs=231.8
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhC---CCCCccccceeecCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLL---RHPDIVEIKRIMLPP 94 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~ 94 (374)
..++|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 45799999999999999999999999999999999863221 111123455677766665 599999999999765
Q ss_pred CcCCCCcEEEEEccCcccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecc
Q 017301 95 SKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
.......+++|||+++++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 5444456899999999999999988654 99999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
|+....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..
T Consensus 167 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 167 ARIYSYQMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp TTTSTTCCC----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccCCCcc----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 976533222 245679999999999977 67999999999999999999999999999999999999998888876
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..+........ .......+.+.....+.+++.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 241 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 241 DDWPRDVSLPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TTSCSSCSSCG----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhccchhhccc----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 65432211100 0111222333334456789999999999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-55 Score=400.85 Aligned_cols=288 Identities=36% Similarity=0.631 Sum_probs=230.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++++.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEE
Confidence 689999999999999999999999999999999864321 1111234579999999999999999999943 3558
Q ss_pred EEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|+||||++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 9999999999999998754 599999999999999999999999999999999999999999999999999975432221
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....+....+.|.+..+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ---TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ---ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 22445789999999998653 56899999999999999999999999999999999999999999987766544322
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
...... ..............+.+++.+.+||.+||+.||.+|||++|+|+||||.++..
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTY-NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHT-CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhccc-ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 111100 11111222223445678999999999999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=398.01 Aligned_cols=293 Identities=35% Similarity=0.557 Sum_probs=224.0
Q ss_pred ccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 16 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
.......++|++++.||+|+||+||+|.+..+++.||+|+++...........+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 103 (329)
T 3gbz_A 27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH--- 103 (329)
T ss_dssp -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE---
T ss_pred CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe---
Confidence 34455678999999999999999999999999999999999765444444556789999999999999999999994
Q ss_pred cCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec-----CCCCeEEeee
Q 017301 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-----ANCKLKVCDF 170 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~-----~~~~vkl~DF 170 (374)
....+|+||||++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 104 --~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 104 --HNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp --ETTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred --cCCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 345699999999999999999998999999999999999999999999999999999999994 4455999999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
|+++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.|
T Consensus 182 g~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 182 GLARAFGIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257 (329)
T ss_dssp THHHHHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred CCccccCCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99976533221 12445789999999998763 458999999999999999999999999999999999998888887
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccc-cCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
....+....... .+.............. ....+++.+.+||.+||+.||.+|||++++|+||||++.
T Consensus 258 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 258 DDTTWPGVTALP--DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp CTTTSTTGGGST--TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred chhhhhhhhhhh--hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 765543221100 0000000000000000 001268899999999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=398.86 Aligned_cols=288 Identities=34% Similarity=0.618 Sum_probs=219.0
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|.++.+|+.||+|+++.... ......+.+|+.+++.++||||+++++++. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIH-----TENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCe
Confidence 4789999999999999999999999999999999874322 223346778999999999999999999994 4456
Q ss_pred EEEEEccCcccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 102 IYVVFELMESDLHQVIKAN------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 9999999999999998753 3589999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+
T Consensus 158 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 158 FGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 543221 12345789999999998652 46899999999999999999999999999999999999998888876554
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCc-----cccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPL-----FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
....... .+........+... ......+++.+.+||.+||+.||.+|||+.++|+||||++...
T Consensus 234 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 234 PSVTKLP--KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGGGGCT--TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhhhh--hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 4322100 00000000000000 0112357889999999999999999999999999999998654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=407.74 Aligned_cols=262 Identities=27% Similarity=0.456 Sum_probs=223.1
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++. +..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECC
Confidence 457899999999999999999999999999999999765544555667889999999999999999999994 445
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec---CCCCeEEeeecccccc
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVA 176 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~---~~~~vkl~DFg~a~~~ 176 (374)
..|+||||+.| +|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|...
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 68999999986 9999999999999999999999999999999999999999999999998 4578999999999765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 164 ~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-------- 230 (444)
T 3soa_A 164 EGEQQ---AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY-------- 230 (444)
T ss_dssp CTTCC---BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------
T ss_pred cCCCc---eeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC--------
Confidence 43322 2245689999999999987 6899999999999999999999999998876665555433111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
......++.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 231 -------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 231 -------------------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp -------------------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred -------------------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 11122346789999999999999999999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=393.67 Aligned_cols=257 Identities=26% Similarity=0.455 Sum_probs=218.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CC
Confidence 4689999999999999999999999999999999864311 11234467889999999999999999999944 45
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|+||||+.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 69999999986 99999998889999999999999999999999999999999999999999999999999999753322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 159 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-------------- 219 (337)
T 1o6l_A 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------------- 219 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred CC---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--------------
Confidence 21 2245689999999999987 6799999999999999999999999988776554444322
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
... .....+++.+.+||.+||+.||.+|| +++++++||||+++
T Consensus 220 ------------~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 220 ------------EEI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ------------CCC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ------------CCC-----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 000 11235789999999999999999999 99999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-54 Score=399.39 Aligned_cols=258 Identities=24% Similarity=0.413 Sum_probs=215.2
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
..++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|..+++.+ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----- 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT----- 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-----
Confidence 34789999999999999999999999999999999874311 122344577899999988 69999999999944
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...+|+||||+.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 4569999999986 999999988899999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 176 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------- 239 (353)
T 3txo_A 176 CNGV---TTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----------- 239 (353)
T ss_dssp C------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cCCc---cccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 2221 2245689999999999987 67999999999999999999999999998876665555331
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH------HHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~~lL~hp~~~~~ 319 (374)
.. .....+++.+.+||++||+.||.+||++ +++++||||+++
T Consensus 240 ---------------~~-----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 240 ---------------EV-----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp ---------------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred ---------------CC-----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 00 1123478999999999999999999999 899999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=389.68 Aligned_cols=258 Identities=24% Similarity=0.441 Sum_probs=221.8
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++++.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+++.++||||+++++++. ...
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~ 74 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFE-----SME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETT
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCC
Confidence 468999999999999999999999999999999998632 244556889999999999999999999994 345
Q ss_pred cEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC--CCCeEEeeecccccc
Q 017301 101 DIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLARVA 176 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~--~~~vkl~DFg~a~~~ 176 (374)
.+|+||||+.| +|.+.+...+ .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 69999999986 9999997654 7999999999999999999999999999999999999987 789999999999865
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..........
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--- 225 (321)
T 1tki_A 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE--- 225 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH---
T ss_pred CCCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh---
Confidence 4332 1244579999999999987 678999999999999999999999999988776666555433222221
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.++.+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 226 ------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 226 ------------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ------------------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 235689999999999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=393.06 Aligned_cols=304 Identities=33% Similarity=0.528 Sum_probs=237.9
Q ss_pred cccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 017301 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (374)
Q Consensus 15 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 94 (374)
.++.-+..++|++++.||+|+||+||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 9 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp CCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred cccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence 34455677999999999999999999999999999999999875544434445677999999999999999999998654
Q ss_pred Cc---CCCCcEEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeee
Q 017301 95 SK---REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (374)
Q Consensus 95 ~~---~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DF 170 (374)
.. .....+|+||||++++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp --------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 21 124568999999999988888764 57999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCC-cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 171 GLARVAFSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 171 g~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
|+|+....... .........||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+.......+....+.
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99976542221 12223456789999999988653 46899999999999999999999999999999999999998888
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccC--CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
+.+..+.................. ........ ...++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSC-CCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred CChhhccccccchhhccccccccc-ccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 877655443221100000000000 00000000 01377899999999999999999999999999998644
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=384.42 Aligned_cols=261 Identities=27% Similarity=0.455 Sum_probs=218.9
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
..+..++|++++.||+|+||+||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 88 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV---- 88 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEE----
Confidence 335568999999999999999999999999999999998643322 24467899999999999999999999954
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
...+|+||||+.| +|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 89 -~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 89 -GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 3458999999975 999999775 6999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 167 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-------- 233 (297)
T 3fxz_A 167 TPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-------- 233 (297)
T ss_dssp CSTTC---CBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS--------
T ss_pred CCccc---ccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 43322 2245679999999999987 6789999999999999999999999988776554443322110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
+.......+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 234 --------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 234 --------------------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp --------------------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred --------------------CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 0011123578899999999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=388.39 Aligned_cols=263 Identities=28% Similarity=0.441 Sum_probs=222.6
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 94 (374)
....++|++.+.||+|+||+||+|.+..+|+.||+|+++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN- 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-
Confidence 345678999999999999999999999999999999987533221 134568899999999999999999999943
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC----CeEEee
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCD 169 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~----~vkl~D 169 (374)
...+|+||||+.+ +|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 86 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 86 ----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp ----SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred ----CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 4569999999975 9999999888999999999999999999999999999999999999998887 799999
Q ss_pred ecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 162 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 162 FGLAHKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235 (326)
T ss_dssp CTTCEECCTTSC----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred CCCCeECCCCCc----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence 999986543221 234579999999999977 67999999999999999999999999988776665554432222
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
... ..++.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 236 ~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 236 FED---------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp CCH---------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred cCc---------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 111 1124678999999999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-53 Score=394.39 Aligned_cols=261 Identities=28% Similarity=0.465 Sum_probs=222.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++++.||+|+||+||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++. +..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 346899999999999999999999999999999999765555566678899999999999999999999994 445
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC---CeEEeeecccccc
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLARVA 176 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~---~vkl~DFg~a~~~ 176 (374)
..|+||||+.| +|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 68999999986 9999999888999999999999999999999999999999999999998654 5999999999765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 182 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------- 248 (362)
T 2bdw_A 182 NDSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD------- 248 (362)
T ss_dssp TTCC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-------
T ss_pred cCCc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-------
Confidence 4322 1245689999999999987 68999999999999999999999999988765555444321111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.....+..+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 249 --------------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 249 --------------------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp --------------------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred --------------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 1112234678999999999999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=393.58 Aligned_cols=256 Identities=31% Similarity=0.526 Sum_probs=214.3
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~ 81 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----P 81 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----C
Confidence 357999999999999999999999999999999998642111 1112467899999999999999999999944 3
Q ss_pred CcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
..+|+||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred CEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 56899999999999999988889999999999999999999999999999999999999999999999999999764332
Q ss_pred CCcccccccccccccccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
. .....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|+.||.+.......
T Consensus 162 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------------ 217 (336)
T 3h4j_B 162 N----FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------------ 217 (336)
T ss_dssp B----TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------------------
T ss_pred c----ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------------------
Confidence 2 2345689999999999877 444 78999999999999999999999875432111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.............+++.+.+||++||+.||.+|||++++++||||+.
T Consensus 218 -------------~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 218 -------------KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp -------------CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred -------------HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 11111112223457899999999999999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=386.60 Aligned_cols=254 Identities=26% Similarity=0.459 Sum_probs=217.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|+.+++.++||||+++++++. +..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence 4789999999999999999999999999999999864211 1122445778999999999999999999994 445
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|+||||+.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 69999999986 99999999889999999999999999999999999999999999999999999999999999764332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus 160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------- 218 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------- 218 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------
T ss_pred ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 134589999999999987 67999999999999999999999999988765554444321
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
.. ...+.+++.+.+||.+||+.||.+|| +++++++||||+++
T Consensus 219 -------------~~-----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 219 -------------EL-----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp -------------CC-----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred -------------CC-----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 00 11245789999999999999999999 99999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=398.03 Aligned_cols=288 Identities=35% Similarity=0.632 Sum_probs=231.0
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-CCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~ 100 (374)
..+|++++.||+|+||+||+|.+..++. ||+|++...... ..+|+.+++.++||||+++++++..... ....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4689999999999999999999887766 888877532211 2369999999999999999999975543 3345
Q ss_pred cEEEEEccCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec-CCCCeEEeeeccccc
Q 017301 101 DIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARV 175 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~-~~~~vkl~DFg~a~~ 175 (374)
.+|+||||+.+++...+. ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 588999999987766554 356899999999999999999999999999999999999999 789999999999986
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+.+.++.|..+.+
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCCC----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 533322 2345789999999998663 46899999999999999999999999999999999999999999998876
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCcccc-CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQK-FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIER 324 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~ 324 (374)
......... .......+.+.... .+.+++.+.+||.+||++||.+|||+.++|+||||+++.....
T Consensus 267 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 267 KTMNPNYME---HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp HHHCGGGSS---SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred HhhChhhhh---hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence 543221100 00111111122222 2348899999999999999999999999999999998765443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=386.72 Aligned_cols=273 Identities=21% Similarity=0.201 Sum_probs=195.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
..+|.+.++||+|+||+||+|.+ +|+.||||+++.. ........+|+..+..++||||+++++++...+ .....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceE
Confidence 46799999999999999999976 5899999998642 122223345777777889999999999996543 12246
Q ss_pred EEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC--------CccccCCCCCceEecCCCCeEEeeecc
Q 017301 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA--------NVYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
+|||||||+ |+|.+++... ++++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 899999999 5999999865 589999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCcc-cccccccccccccccccccccC----CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 173 ARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 173 a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
|+......... ......+||+.|||||++.+.. ..|+.++|||||||+||||+||.+||........
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~-------- 226 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-------- 226 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC--------
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc--------
Confidence 98654433221 1223468999999999986521 2467899999999999999999988754432110
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCC---ccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVP---LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
|..... ...................+ ........+..+.+|+.+||+.||++|||+.++++.
T Consensus 227 --p~~~~~--~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 227 --PYYDLV--PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp --TTTTTS--CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred --cchhcc--cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 000000 00001111111111111111 111111233467899999999999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=396.20 Aligned_cols=287 Identities=31% Similarity=0.648 Sum_probs=229.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc----
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK---- 96 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 96 (374)
..++|++++.||+|+||+||+|.+..+|+.||+|++...... ..+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 357999999999999999999999999999999998643221 2379999999999999999999865432
Q ss_pred -----------------------------CCCCcEEEEEccCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhh
Q 017301 97 -----------------------------REFKDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMH 143 (374)
Q Consensus 97 -----------------------------~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~al~~LH 143 (374)
....++++||||++++|.+.+. .+..+++..++.++.||+.||+|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 2345689999999998777665 4568999999999999999999999
Q ss_pred hCCccccCCCCCceEec-CCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHH
Q 017301 144 TANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 222 (374)
Q Consensus 144 ~~~i~H~dikp~Nil~~-~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ 222 (374)
++||+||||||+|||++ .++.+||+|||+|+....... .....||+.|+|||++.+. ..++.++||||+||++|
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHH
Confidence 99999999999999997 678999999999986533322 2345789999999988763 45899999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccc-cCCCCChHHHHHHHHhccCCC
Q 017301 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDP 301 (374)
Q Consensus 223 ~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp 301 (374)
+|++|++||.+.+..+++..+.+..|.|..+.+.......... ............ .....++.+.+||.+||+.||
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV---RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--C---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccc---cCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999999999987665433210000 000000111111 123478899999999999999
Q ss_pred CCCCCHHHHhcCCCCCcCcc
Q 017301 302 KDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 302 ~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.+|||+.|+|+||||+.+..
T Consensus 311 ~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHHH
T ss_pred hhCCCHHHHhcCHHHHHHHh
Confidence 99999999999999987643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=391.50 Aligned_cols=290 Identities=33% Similarity=0.591 Sum_probs=230.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++. ..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 96 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KK 96 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cC
Confidence 3458999999999999999999999999999999998766555556667889999999999999999999994 44
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+||||+.+ +|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 568999999997 6666667677899999999999999999999999999999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+...+......
T Consensus 177 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 177 PGE---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred Ccc---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 221 12345799999999998762 46899999999999999999999999999999888888888887776543221
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
...........-......+....++.+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 110000000000000111122334678999999999999999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=391.76 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=217.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
..++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|..+++.+ +||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----- 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----- 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-----
Confidence 45899999999999999999999999999999999974311 112234567899998876 89999999999944
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...+|+||||+.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 4569999999985 999999988889999999999999999999999999999999999999999999999999997533
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+...
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 233 (345)
T 1xjd_A 170 LGDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD----------- 233 (345)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cCCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 2221 1245689999999999987 67999999999999999999999999988766555444221
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHH-HHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~-~lL~hp~~~~~ 319 (374)
.. .....+++.+.+||.+||+.||.+|||+. ++++||||+++
T Consensus 234 ---------------~~-----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 234 ---------------NP-----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp ---------------CC-----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ---------------CC-----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 00 11135789999999999999999999998 99999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=394.52 Aligned_cols=297 Identities=22% Similarity=0.299 Sum_probs=221.3
Q ss_pred CCCCCeeEeceeecc--CCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 20 GDANRYKILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
+..++|++++.||+| +||+||+|++..+|+.||+|+++...........+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---- 97 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA---- 97 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----
Confidence 567899999999999 99999999999999999999998665555666778899999999999999999999954
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
...+|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+.
T Consensus 98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 98 -DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred -CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 3569999999985 999999875 679999999999999999999999999999999999999999999999999986
Q ss_pred cccCCCCc----ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC-
Q 017301 175 VAFSDTPM----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT- 249 (374)
Q Consensus 175 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~- 249 (374)
........ .......+||+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 53222111 1112334789999999998764357899999999999999999999999887766554433221100
Q ss_pred -------CCHHHHhhh----cCHHHHHHHHH---hcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 017301 250 -------PSPETIAVV----RNEKARKYLTE---MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (374)
Q Consensus 250 -------~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~ 315 (374)
+........ ........... .......+.......+++.+.+||.+||+.||.+|||+.++|+|||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 000000000 00000000000 0000001111234568999999999999999999999999999999
Q ss_pred CCcCcc
Q 017301 316 FKGLAK 321 (374)
Q Consensus 316 ~~~~~~ 321 (374)
|+++..
T Consensus 337 f~~~~~ 342 (389)
T 3gni_B 337 FKQIKR 342 (389)
T ss_dssp GGGC--
T ss_pred HHHHhh
Confidence 998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=393.67 Aligned_cols=267 Identities=22% Similarity=0.392 Sum_probs=213.9
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
..++|++++.||+|+||+||+|+++.+++.||+|++++.... ......+.+|..+++.+ +||||+++++++..
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----- 124 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----- 124 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----
Confidence 357899999999999999999999999999999999754332 22334577899999877 89999999999944
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...+|+||||+.| +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 4569999999986 999999988899999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+.... ..
T Consensus 205 ~~~~---~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~------ 266 (396)
T 4dc2_A 205 RPGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NT------ 266 (396)
T ss_dssp CTTC---CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CC------
T ss_pred cCCC---ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hh------
Confidence 2221 2345689999999999988 7899999999999999999999999975432110000 00
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH------HHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~~lL~hp~~~~~ 319 (374)
.....+.+. .... .....+++.+.+||++||+.||.+||++ +++++||||+++
T Consensus 267 --~~~~~~~i~--~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 267 --EDYLFQVIL--EKQI-----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp --HHHHHHHHH--HCCC-----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred --HHHHHHHHh--cccc-----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 000001111 1111 1124689999999999999999999995 899999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=385.80 Aligned_cols=266 Identities=22% Similarity=0.391 Sum_probs=215.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 99 (374)
.++|++++.||+|+||+||+|+++.+++.||+|++++... .......+.+|..+++.+ +||||+++++++.. .
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----C
Confidence 4689999999999999999999999999999999975432 344556788999999988 89999999999944 4
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+|+||||+.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 569999999985 9999999888899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...........
T Consensus 163 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---------------- 221 (345)
T 3a8x_A 163 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------- 221 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------------
T ss_pred CCC---cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc----------------
Confidence 221 2245689999999999987 6789999999999999999999999975321100000
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH------HHHhcCCCCCcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGL 319 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~~lL~hp~~~~~ 319 (374)
.. .......+..... .....+++.+.+||.+||+.||.+||++ .++++||||+++
T Consensus 222 ~~--~~~~~~~i~~~~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 222 NT--EDYLFQVILEKQI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp -C--HHHHHHHHHHCCC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred cc--HHHHHHHHHcCCC----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 00 0000011111110 1124689999999999999999999995 899999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=390.55 Aligned_cols=289 Identities=23% Similarity=0.413 Sum_probs=234.9
Q ss_pred hhhccccccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-----CCC
Q 017301 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----HPD 83 (374)
Q Consensus 9 ~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~ 83 (374)
++.+-.+....-..++|++++.||+|+||+||+|.+..+++.||+|+++. .......+.+|+.+++.+. |||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 55556666666778999999999999999999999999999999999863 2344556778999999986 999
Q ss_pred ccccceeecCCCcCCCCcEEEEEccCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC
Q 017301 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (374)
Q Consensus 84 i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~ 161 (374)
|+++++++.. ...+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 98 iv~~~~~~~~-----~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 98 IVKYHGKFMY-----YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172 (360)
T ss_dssp BCCEEEEEEE-----TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred eecccceeeE-----CCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcc
Confidence 9999999944 35689999999889999998764 5999999999999999999999999999999999999975
Q ss_pred -------------------------CCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHH
Q 017301 162 -------------------------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (374)
Q Consensus 162 -------------------------~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwS 216 (374)
++.+||+|||+|+...... ....||+.|+|||++.+ ..++.++||||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Diws 244 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILN--LGWDVSSDMWS 244 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTT--CCCCTTHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcC--CCCCCccchHH
Confidence 7889999999997643321 34579999999999987 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHH-------------------HHhcCCCCCC
Q 017301 217 IGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL-------------------TEMRKKPPVP 277 (374)
Q Consensus 217 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~ 277 (374)
|||++|+|++|+.||.+.+..+.+..+....+.++...+..........+. .......+
T Consensus 245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~-- 322 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP-- 322 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC--
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc--
Confidence 999999999999999999999999999988888777654432211110000 00000000
Q ss_pred ccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 278 LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 278 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
......++.+.+||.+||+.||.+|||+.++|+||||+
T Consensus 323 --~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 323 --LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp --HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred --ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 00012357788999999999999999999999999995
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-53 Score=390.33 Aligned_cols=290 Identities=38% Similarity=0.599 Sum_probs=228.0
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh---HHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
...++|++++.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 82 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG---- 82 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe----
Confidence 34589999999999999999999999999999999986432211 11235779999999999999999999994
Q ss_pred CCCCcEEEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 REFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
....+|+||||++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 83 -~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 83 -HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp -CTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred -eCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 345589999999999999987654 689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.+
T Consensus 162 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 162 FGSPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTSCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccCCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 533221 22456799999999998652 45899999999999999999999999999999999999888888876654
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
....... .+. ........+....++.+++.+.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 238 ~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 238 PDMCSLP--DYV-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp SSTTSST--TCC-CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhhccCc--ccc-cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 4321100 000 00011111222334678899999999999999999999999999999987543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=395.82 Aligned_cols=282 Identities=31% Similarity=0.521 Sum_probs=229.5
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC------CCCCccccceeecC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL------RHPDIVEIKRIMLP 93 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~ 93 (374)
....+|++++.||+|+||+||+|.+..+++.||+|+++.. ......+.+|+.+++.+ +|+||+++++.+..
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 3457899999999999999999999999999999999742 33345667788888776 57799999999843
Q ss_pred CCcCCCCcEEEEEccCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC--eEEee
Q 017301 94 PSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--LKVCD 169 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~--vkl~D 169 (374)
..++|+||||+.++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|
T Consensus 171 -----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 171 -----RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp -----TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred -----CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence 35699999999999999998764 5999999999999999999999999999999999999999987 99999
Q ss_pred ecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
||+|+..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.
T Consensus 246 FG~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~ 317 (429)
T 3kvw_A 246 FGSSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM 317 (429)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cccceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999754322 234579999999999987 67999999999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCC-----------------------------CCccc-cCCCCChHHHHHHHHhccC
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPP-----------------------------VPLFQ-KFPNVDPLALRLLQRLIAF 299 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~-~~~~~s~~~~~li~~~L~~ 299 (374)
|+...+...... ..++........ ..... .....++.+.+||.+||++
T Consensus 318 p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~ 395 (429)
T 3kvw_A 318 PSQKLLDASKRA--KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW 395 (429)
T ss_dssp CCHHHHHTBTTH--HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCS
T ss_pred CCHHHHHhhhhh--hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCC
Confidence 998876543221 111110000000 00000 0113478899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCcC
Q 017301 300 DPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 300 dp~~Rpt~~~lL~hp~~~~~ 319 (374)
||.+|||+.|+|+||||+..
T Consensus 396 dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 396 DPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp STTTSCCHHHHHTSTTTC--
T ss_pred ChhhCCCHHHHhCChhhccC
Confidence 99999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=382.83 Aligned_cols=300 Identities=39% Similarity=0.643 Sum_probs=232.9
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS- 95 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 95 (374)
..+...++|++++.||+|+||+||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 3456679999999999999999999999999999999998642 3455667889999999999999999999985432
Q ss_pred --------cCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec-CCCCeE
Q 017301 96 --------KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLK 166 (374)
Q Consensus 96 --------~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~-~~~~vk 166 (374)
.......|+||||++|+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+||+++ .++.+|
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 134467899999999999999865 5799999999999999999999999999999999999997 567899
Q ss_pred EeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 017301 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (374)
Q Consensus 167 l~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 246 (374)
|+|||+++................+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998654332222223445689999999987543 56899999999999999999999999999988888888777
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.+.+..+........ ...+..........+.....+.+++.+.+||.+||+.||.+|||+.++|+||||+....
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 241 IPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp SCCCCHHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred cCCCchhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 776665543322111 11112222222233334445678999999999999999999999999999999987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=393.69 Aligned_cols=288 Identities=34% Similarity=0.602 Sum_probs=230.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-CCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~ 101 (374)
.+|++++.||+|+||+||+|.+..+|+.||||++..... ...+|+.+|+.++||||+++++++..... .+..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 479999999999999999999999999999999864321 12379999999999999999999865322 23345
Q ss_pred EEEEEccCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC-CCeEEeeecccccc
Q 017301 102 IYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVA 176 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~-~~vkl~DFg~a~~~ 176 (374)
+++||||+.+++.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999998777664 35689999999999999999999999999999999999999965 56899999999865
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+.+.+|.|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43322 2346799999999998652 478999999999999999999999999999999999999999999887664
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccc-cCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIER 324 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~ 324 (374)
...... ..+ .+......++.. ..+.+++.+.+||.+||+.||.+|||+.++|+||||+.+.....
T Consensus 283 ~~~~~~-~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 283 EMNPNY-TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 348 (420)
T ss_dssp HHCSCC-CCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred hhChhh-hhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence 332100 000 000000001111 12457899999999999999999999999999999998765443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=388.67 Aligned_cols=256 Identities=21% Similarity=0.381 Sum_probs=219.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
...++|++++.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.+|+.++||||+++++++..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----- 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----
Confidence 456899999999999999999999999999999999864211 11234567889999999999999999999943
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...+|+||||+.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 4569999999975 999999988889999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 193 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 253 (350)
T 1rdq_E 193 GR------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----------- 253 (350)
T ss_dssp SC------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CC------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 32 134589999999999987 67899999999999999999999999988765555444321
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
.. .....+++.+.+||.+||+.||.+||+ ++++++||||+++
T Consensus 254 ---------------~~-----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 254 ---------------KV-----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ---------------CC-----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ---------------CC-----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 00 112357899999999999999999998 9999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=372.86 Aligned_cols=264 Identities=28% Similarity=0.466 Sum_probs=224.9
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++. ..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EE 77 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cC
Confidence 4568999999999999999999999999999999999766556666778889999999999999999999994 44
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC---eEEeeeccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLARV 175 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~---vkl~DFg~a~~ 175 (374)
...|+||||+.+ +|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||.+..
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 568999999986 99999988888999999999999999999999999999999999999987655 99999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 158 ~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 224 (284)
T 3kk8_A 158 VNDSEA----WHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY------- 224 (284)
T ss_dssp CCSSCB----CCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------
T ss_pred cccCcc----ccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc-------
Confidence 543222 234579999999999987 6789999999999999999999999988776555444332111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
......+..+++.+.+||.+||+.||.+|||+.++|+||||++...
T Consensus 225 --------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 225 --------------------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp --------------------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred --------------------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 1111224568899999999999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=388.78 Aligned_cols=258 Identities=22% Similarity=0.381 Sum_probs=217.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
..++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|..++..+ +||+|+++++++. .
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-----C
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-----c
Confidence 45789999999999999999999999999999999874311 112234577899999887 7999999999994 3
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...+|+||||+.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 4569999999985 999999988889999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+...
T Consensus 173 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------- 236 (353)
T 2i0e_A 173 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------- 236 (353)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cCCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 2221 2245689999999999987 67899999999999999999999999988766555444321
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
.. .....+++.+.+||.+||+.||.+|| +++++++||||+++
T Consensus 237 ---------------~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 237 ---------------NV-----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp ---------------CC-----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred ---------------CC-----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 00 11246889999999999999999999 47999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=389.89 Aligned_cols=261 Identities=25% Similarity=0.446 Sum_probs=216.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.++|++++.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-----EE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 478999999999999999999999999999999986421 111224567899999999999999999999944 45
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|+||||+.| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 69999999985 99999999889999999999999999999999999999999999999999999999999999865432
Q ss_pred CCccccccccccccccccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
. .....+||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 169 ~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------ 232 (384)
T 4fr4_A 169 T----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF------------ 232 (384)
T ss_dssp C----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH------------
T ss_pred C----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH------------
Confidence 2 22456899999999998642 145899999999999999999999999865433222111110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-HHHHhcCCCCCcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-AEEALADPYFKGL 319 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~~lL~hp~~~~~ 319 (374)
.. .. ......+++.+.+||.+||+.||.+||+ ++++++||||+++
T Consensus 233 ---------~~--~~-----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 233 ---------ET--TV-----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp ---------HH--CC-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred ---------hh--cc-----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 00 00 1112467899999999999999999998 9999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=385.57 Aligned_cols=264 Identities=27% Similarity=0.409 Sum_probs=204.8
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
+.....++|++++.||+|+||+||+|++..+++.||+|++...... ...+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~--- 87 (361)
T 3uc3_A 14 PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILT--- 87 (361)
T ss_dssp CCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred cCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEee---
Confidence 3445678999999999999999999999999999999999753322 2457799999999999999999999954
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC--eEEeeeccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--LKVCDFGLA 173 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~--vkl~DFg~a 173 (374)
...+|+||||+.+ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|
T Consensus 88 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 88 --PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred --CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 3568999999975 99999988888999999999999999999999999999999999999987765 999999998
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
+...... .....+||+.|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.+.......+..
T Consensus 166 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~------- 232 (361)
T 3uc3_A 166 KSSVLHS----QPKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ------- 232 (361)
T ss_dssp -------------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH-------
T ss_pred ccccccC----CCCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH-------
Confidence 7432221 1234579999999999877 45554 48999999999999999999987654332222211
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.+..... .......+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 233 ----------------~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 233 ----------------RILSVKY--SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ----------------HHHTTCC--CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ----------------HHhcCCC--CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 1111000 011123578999999999999999999999999999999653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=381.16 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=209.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEEC---CCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
..++|++++.||+|+||+||+|++. .+|+.||+|+++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence 4578999999999999999999985 6899999999975432 22334567789999999999999999999944
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
...+|+||||+.| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 93 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 ---GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp ---SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 4569999999985 999999988889999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 170 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------- 237 (327)
T 3a62_A 170 ESIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK------- 237 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-------
T ss_pred ccccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-------
Confidence 5332211 1244579999999999977 678999999999999999999999999887665554443210
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
....+.+++.+.+||.+||+.||.+|| ++.++++||||+++
T Consensus 238 ------------------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 238 ------------------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp ------------------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 011245789999999999999999999 89999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=382.82 Aligned_cols=265 Identities=25% Similarity=0.378 Sum_probs=215.0
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++++.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++. ..
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~ 77 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR-----EG 77 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cC
Confidence 456899999999999999999999999999999999864322 123356789999999999999999999984 44
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+||||+.+ +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 568999999986 9999998888899999999999999999999999999999999999999999999999999976433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 158 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~------------- 222 (323)
T 3tki_A 158 NNR-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------- 222 (323)
T ss_dssp TTE-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH-------------
T ss_pred CCc-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-------------
Confidence 221 1223456899999999998762 2347789999999999999999999987654322111100
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
... .....+..+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 223 ------------~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 223 ------------EKK---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp ------------TTC---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ------------ccc---ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 000 01111346789999999999999999999999999999998643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=378.82 Aligned_cols=263 Identities=27% Similarity=0.427 Sum_probs=222.4
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 94 (374)
....++|++++.||+|+||+||+|.+..+|+.||+|+++...... .....+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 85 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-- 85 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe--
Confidence 345678999999999999999999999999999999987533221 13456889999999999999999999994
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC----CeEEee
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCD 169 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~----~vkl~D 169 (374)
....+|+||||+.+ +|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|
T Consensus 86 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 86 ---NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp ---CSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred ---cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 34569999999975 9999999888899999999999999999999999999999999999999887 799999
Q ss_pred ecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 163 fg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 236 (321)
T 2a2a_A 163 FGLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236 (321)
T ss_dssp CTTCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred CccceecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc
Confidence 999976543321 234579999999999877 67899999999999999999999999988776655554432222
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..+ ..++.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 237 ~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 237 FDE---------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CCH---------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred cCh---------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 111 1124678999999999999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=385.32 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=212.8
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
...++|++++.||+|+||+||+|.++.+|+.||+|++...... ..+|+.++.++ +||||+++++++. +
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~-----~ 87 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYD-----D 87 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEE-----C
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEE-----c
Confidence 3457899999999999999999999999999999999754322 34688888877 7999999999994 4
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC----CCeEEeeeccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN----CKLKVCDFGLA 173 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~----~~vkl~DFg~a 173 (374)
...+|+||||+.| +|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||+..+ +.+||+|||++
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 4569999999985 999999998899999999999999999999999999999999999998543 34999999999
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
........ .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........
T Consensus 168 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~----------- 231 (342)
T 2qr7_A 168 KQLRAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI----------- 231 (342)
T ss_dssp EECBCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH-----------
T ss_pred ccCcCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH-----------
Confidence 86543322 1245689999999999877 5688999999999999999999999986432111111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccC
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (374)
+..+...........++.+++.+.+||++||+.||.+|||+.++|+||||.++...
T Consensus 232 -------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~ 287 (342)
T 2qr7_A 232 -------------LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287 (342)
T ss_dssp -------------HHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGS
T ss_pred -------------HHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccc
Confidence 11111111111123346789999999999999999999999999999999876443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=385.02 Aligned_cols=264 Identities=25% Similarity=0.440 Sum_probs=194.3
Q ss_pred CCeeEe---ceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCC
Q 017301 23 NRYKIL---EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 23 ~~Y~~~---~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 98 (374)
++|.+. +.||+|+||+||+|.++.+++.||+|++... ....+.+|+.+++.+. ||||+++++++. +
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~ 77 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFH-----D 77 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----c
Confidence 456664 7899999999999999999999999998642 3446778999999997 999999999994 4
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC---CeEEeeecccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLAR 174 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~---~vkl~DFg~a~ 174 (374)
....|+||||+.+ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 4568999999986 9999999999999999999999999999999999999999999999998765 79999999997
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.....
T Consensus 158 ~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------------- 218 (325)
T 3kn6_A 158 LKPPDNQ---PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-------------- 218 (325)
T ss_dssp ECCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C--------------
T ss_pred ecCCCCC---cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc--------------
Confidence 5433221 2245678999999999977 67999999999999999999999999875431100
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.........+...........++.+++.+.+||.+||+.||.+|||+.++++||||++...
T Consensus 219 ------~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 219 ------TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp ------CCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred ------ccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 0001111222222221112223468999999999999999999999999999999987543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=395.86 Aligned_cols=293 Identities=33% Similarity=0.571 Sum_probs=215.6
Q ss_pred CCCCeeE-eceeeccCCeeEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 21 DANRYKI-LEVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 21 ~~~~Y~~-~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
..+.|++ +++||+|+||+||+|+++ .+++.||+|++...... ..+.+|+.+|+.++||||+++++++...
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 90 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSH--- 90 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEET---
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecC---
Confidence 3456877 558999999999999965 57889999998754222 3567899999999999999999999543
Q ss_pred CCCcEEEEEccCcccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe----cCCCC
Q 017301 98 EFKDIYVVFELMESDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCK 164 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~----~~~~~ 164 (374)
....+|+||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 23568999999999999888632 249999999999999999999999999999999999999 67789
Q ss_pred eEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--------
Q 017301 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-------- 236 (374)
Q Consensus 165 vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-------- 236 (374)
+||+|||+|+...............+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999998654432222233456899999999998763 4589999999999999999999999987654
Q ss_pred -hhHHHHHHHhhCCCCHHHHhhhcC-HHHHHHHHHhcCCCCCC------ccccCCCCChHHHHHHHHhccCCCCCCCCHH
Q 017301 237 -VHQLDLITDLLGTPSPETIAVVRN-EKARKYLTEMRKKPPVP------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308 (374)
Q Consensus 237 -~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 308 (374)
.+++..+...+|.|....|..... ................. ........++.+.+||.+||++||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 478888999999988776654432 11222222211111000 0011223478899999999999999999999
Q ss_pred HHhcCCCCCcCcc
Q 017301 309 EALADPYFKGLAK 321 (374)
Q Consensus 309 ~lL~hp~~~~~~~ 321 (374)
|+|+||||++...
T Consensus 330 e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 330 QAMQDPYFLEDPL 342 (405)
T ss_dssp HHHTSGGGTSSSC
T ss_pred HHhcChhhccCCC
Confidence 9999999987543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=387.56 Aligned_cols=261 Identities=29% Similarity=0.445 Sum_probs=212.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
..++|++++.||+|+||+||+|.++.+|+.||+|++.... ........+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 96 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS----- 96 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 3578999999999999999999999999999999985321 11112456889999999999999999999994
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC---eEEee
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCD 169 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~---vkl~D 169 (374)
....+|+||||+.| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEec
Confidence 34569999999995 998877542 35899999999999999999999999999999999999987655 99999
Q ss_pred ecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
||++........ .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .....+......
T Consensus 177 fg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~ 250 (351)
T 3c0i_A 177 FGVAIQLGESGL---VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYK 250 (351)
T ss_dssp CTTCEECCTTSC---BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCC
T ss_pred CcceeEecCCCe---eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCC
Confidence 999976543321 1245679999999999987 6789999999999999999999999987532 222222221111
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..+ ..++.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 251 ~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 251 MNP---------------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp CCH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CCc---------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 111 1234688999999999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=387.22 Aligned_cols=260 Identities=26% Similarity=0.428 Sum_probs=219.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++++.||+|+||+||+|.+..+|+.||+|++... .......+.+|+.+|+.++||||+++++++. ..
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~ 120 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DK 120 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CS
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eC
Confidence 4567899999999999999999999999999999998643 2334557889999999999999999999994 34
Q ss_pred CcEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC--CCCeEEeeeccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLARV 175 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~--~~~vkl~DFg~a~~ 175 (374)
..+|+||||+.| +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 569999999985 9999997654 7999999999999999999999999999999999999974 47799999999986
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 201 ~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~------- 267 (387)
T 1kob_A 201 LNPDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW------- 267 (387)
T ss_dssp CCTTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC-------
T ss_pred cCCCcc----eeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------
Confidence 543221 234579999999999987 6789999999999999999999999998876555544432110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
......+..+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 268 --------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 268 --------------------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp --------------------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred --------------------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 11122345789999999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=379.50 Aligned_cols=292 Identities=34% Similarity=0.588 Sum_probs=234.1
Q ss_pred CCCCeeEeceeeccCCeeEEEEEEC-CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC---CCCCccccceeecCCCc
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~ 96 (374)
..++|++++.||+|+||+||+|.+. .+|+.||+|+++...........+.+|+.+++.+ +||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3479999999999999999999995 6789999999864332222222455677766655 89999999999864333
Q ss_pred CCCCcEEEEEccCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 97 REFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.....+++||||+.++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 3456799999999999999998754 49999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+....+.+....
T Consensus 169 ~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCGGG----GGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCCC----CccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 543221 2245678999999999887 6789999999999999999999999999999888888888888877655
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (374)
+........ .........+.....+.+++.+.+||.+||+.||.+|||+.++|+||||+++...
T Consensus 243 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 243 WPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp SCTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred Cccccccch----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 432111000 0111122223334456789999999999999999999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=370.39 Aligned_cols=273 Identities=25% Similarity=0.312 Sum_probs=219.3
Q ss_pred hhhhccccccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCcccc
Q 017301 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87 (374)
Q Consensus 8 ~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 87 (374)
+++..+. .........|++.+.||+|+||+||+|.+..++..||+|++............+.+|+.+++.++||||+++
T Consensus 12 ~~l~~~~-~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 90 (290)
T 1t4h_A 12 EELETKA-VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90 (290)
T ss_dssp ------C-CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred HHHhhhh-hhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeee
Confidence 3444444 233345667899999999999999999999999999999998665566667788999999999999999999
Q ss_pred ceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEec-CCC
Q 017301 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILAN-ANC 163 (374)
Q Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~-~~~ 163 (374)
++++.... .....+|+||||+.+ +|.+++...+.+++..++.++.||+.||.|||+.| |+||||||+||+++ .++
T Consensus 91 ~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~ 169 (290)
T 1t4h_A 91 YDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG 169 (290)
T ss_dssp EEEEEEES-SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS
T ss_pred eeeecccc-CCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC
Confidence 99885432 234668999999985 99999998888999999999999999999999999 99999999999997 788
Q ss_pred CeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 017301 164 KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243 (374)
Q Consensus 164 ~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 243 (374)
.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........
T Consensus 170 ~~kl~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 241 (290)
T 1t4h_A 170 SVKIGDLGLATLKRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 241 (290)
T ss_dssp CEEECCTTGGGGCCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH
T ss_pred CEEEeeCCCcccccccc-----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH
Confidence 99999999997543322 234579999999998864 5899999999999999999999999876543332211
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.. .... ........++.+.+||.+||+.||.+|||+.++|+||||++
T Consensus 242 ~~--------------------------~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 242 VT--------------------------SGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HT--------------------------TTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred Hh--------------------------ccCC--ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 11 0000 01112346788999999999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=403.71 Aligned_cols=259 Identities=30% Similarity=0.496 Sum_probs=215.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|+++.++..||+|++............+.+|+.+++.++||||+++++++. ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 45799999999999999999999999999999999754433334557889999999999999999999994 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC---CCeEEeeeccccccc
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARVAF 177 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~---~~vkl~DFg~a~~~~ 177 (374)
+|+|||||.+ +|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.. +.+||+|||+|....
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 8999999986 999999888899999999999999999999999999999999999999764 459999999997654
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 191 ~~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------- 255 (494)
T 3lij_A 191 NQK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT-------- 255 (494)
T ss_dssp TTB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------
T ss_pred CCc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 332 2245679999999999864 5899999999999999999999999998876665555432211
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.....++.+|+.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 256 -------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 256 -------------------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp -------------------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred -------------------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 1122346789999999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=393.96 Aligned_cols=264 Identities=25% Similarity=0.361 Sum_probs=217.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++++.||+|+||+||+|+++.+++.||+|++++... .......+.+|+.+++.++||||+++++++. +.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----EC
Confidence 45789999999999999999999999999999999864210 0011223678999999999999999999994 44
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..+|+||||+.| +|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 569999999975 999998764 699999999999999999999999999999999999999999999999999976433
Q ss_pred CCCcccccccccccccccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
... ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 221 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------- 291 (410)
T 3v8s_A 221 EGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS------- 291 (410)
T ss_dssp TSE--EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-------
T ss_pred CCc--ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc-------
Confidence 221 1224568999999999987621 12788999999999999999999999998876666555431000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (374)
. .....+.+|+.+++||.+||+.+|.+ ||+++++++||||+++
T Consensus 292 -----------------~---~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 292 -----------------L---TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp -----------------C---CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred -----------------c---cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 0 01112468999999999999999988 9999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=386.76 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=211.5
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHH-HHhCCCCCccccceeecCCCcC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKL-LRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
...++|++++.||+|+||+||+|+++.+++.||+|++++... .......+.+|..+ ++.++||||+++++++..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~---- 110 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT---- 110 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC----
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe----
Confidence 345789999999999999999999999999999999975432 22334456677776 567899999999999944
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
...+|+||||+.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 111 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 111 -ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 4569999999986 99999998888999999999999999999999999999999999999999999999999999753
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+...
T Consensus 190 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---------- 254 (373)
T 2r5t_A 190 IEHNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---------- 254 (373)
T ss_dssp BCCCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS----------
T ss_pred ccCCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------
Confidence 33221 1245689999999999987 68999999999999999999999999988766555444321
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (374)
. ....+.+++.+.+||.+||+.||.+||++ .++++||||+++
T Consensus 255 ----------------~-----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 255 ----------------P-----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp ----------------C-----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred ----------------c-----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 0 01124689999999999999999999986 699999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=397.83 Aligned_cols=266 Identities=26% Similarity=0.399 Sum_probs=218.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|+++++||+|+||+||+|+++.+++.||+|++++... .......+.+|+.++..++||||+++++++. +.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~ 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-----DD 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-----CS
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eC
Confidence 34789999999999999999999999999999999864211 0011123778999999999999999999994 44
Q ss_pred CcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
..+|+||||+.| +|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 569999999975 99999987 5689999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCcccccccccccccccccccccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
.... ......+||+.|+|||++.. ....|+.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus 227 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------ 298 (437)
T 4aw2_A 227 EDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------ 298 (437)
T ss_dssp TTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH------
T ss_pred cCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc------
Confidence 3322 12244689999999999862 115689999999999999999999999999887766665542100
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (374)
. .......+.+|+.+++||++||..+|++ |++++++++||||+++
T Consensus 299 ----------------~----~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 299 ----------------R----FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp ----------------H----CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred ----------------c----ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 0 0111223568999999999999998888 9999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=398.34 Aligned_cols=257 Identities=26% Similarity=0.459 Sum_probs=210.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.++|++++.||+|+||+||+|.+..+|+.||+|+++... ........+.+|+.+++.++||||+++++++.. ..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence 478999999999999999999999999999999987432 122334567789999999999999999999943 45
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.+|+||||+.+ +|.+++...+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 69999999986 999999988899999999999999999999998 9999999999999999999999999999975322
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 302 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 364 (446)
T 4ejn_A 302 DG---ATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------ 364 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CC---cccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------
Confidence 22 12345689999999999977 78999999999999999999999999988766555444321
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
.. .....+++.+.+||.+||+.||.+|| |++++|+||||+++
T Consensus 365 --------------~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 365 --------------EI-----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp --------------CC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred --------------CC-----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 00 11235789999999999999999999 99999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=375.83 Aligned_cols=260 Identities=24% Similarity=0.451 Sum_probs=207.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC------------------------hHHHHHHHHHHHHHH
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH------------------------ISDAIRILREVKLLR 77 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~~~E~~~l~ 77 (374)
.++|++.+.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47999999999999999999999999999999998643211 112346789999999
Q ss_pred hCCCCCccccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 017301 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (374)
Q Consensus 78 ~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~N 156 (374)
.++||||+++++++.... ...+|+||||+.+ +|.+++ ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999986432 3568999999985 776654 34579999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 017301 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235 (374)
Q Consensus 157 il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~ 235 (374)
||++.++.+||+|||+++....... ......||+.|+|||++.+... .++.++|||||||++|+|++|+.||.+.+
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999976543221 2245679999999999876311 14778999999999999999999998876
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 017301 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (374)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~ 315 (374)
.......+... ... ....+.+++.+.+||.+||+.||.+|||+.++|+|||
T Consensus 245 ~~~~~~~~~~~--------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 245 IMCLHSKIKSQ--------------------------ALE---FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHHHC--------------------------CCC---CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHHHHhcc--------------------------cCC---CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 54333222110 000 1113568899999999999999999999999999999
Q ss_pred CC
Q 017301 316 FK 317 (374)
Q Consensus 316 ~~ 317 (374)
|+
T Consensus 296 ~~ 297 (298)
T 2zv2_A 296 VT 297 (298)
T ss_dssp HH
T ss_pred cc
Confidence 85
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=401.26 Aligned_cols=262 Identities=32% Similarity=0.531 Sum_probs=219.9
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+|+.++||||+++++++. ..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cC
Confidence 3457899999999999999999999999999999998643222233557889999999999999999999994 44
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec---CCCCeEEeeeccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARV 175 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~---~~~~vkl~DFg~a~~ 175 (374)
..+|+||||+.+ +|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 569999999986 9999998888999999999999999999999999999999999999995 456799999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 174 ~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------ 240 (486)
T 3mwu_A 174 FQQNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA------ 240 (486)
T ss_dssp BCCC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred CCCCCc----cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------
Confidence 543321 245679999999999875 5899999999999999999999999998876665554432111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.....++.+|+.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 241 ---------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 241 ---------------------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp ---------------------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred ---------------------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 11122456899999999999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=381.20 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=202.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++.+.||+|+||+||+|.+..+++.||+|+++... ....+.+|+.+++.++||||+++++++.. ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~ 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PT 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEec-----CC
Confidence 4578999999999999999999999999999999987532 33467789999999999999999999943 35
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC---CCCeEEeeecccccc
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVA 176 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~---~~~vkl~DFg~a~~~ 176 (374)
.+|+||||+.+ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 68999999985 99999998888999999999999999999999999999999999999975 889999999999764
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH-HHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ-LDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~ 255 (374)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...... ...+.
T Consensus 202 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~----------- 264 (349)
T 2w4o_A 202 EHQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----------- 264 (349)
T ss_dssp ---------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH-----------
T ss_pred Cccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH-----------
Confidence 3321 1234579999999999987 6799999999999999999999999977654331 11111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..........++.+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 265 ----------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 265 ----------------NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp ----------------TTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred ----------------hCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 111111122345789999999999999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=395.93 Aligned_cols=261 Identities=29% Similarity=0.476 Sum_probs=218.7
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..-..++|++++.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--- 87 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--- 87 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC---
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE---
Confidence 33446899999999999999999999999999999999864211 11224568899999999999999999999944
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...+|+||||+.| +|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 88 --~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 88 --PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp --SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred --CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 3569999999975 9999999888999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 166 ~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------- 232 (476)
T 2y94_A 166 MSDGE----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-------- 232 (476)
T ss_dssp CCTTC----CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC--------
T ss_pred ccccc----cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--------
Confidence 53322 22456899999999998772 234789999999999999999999998877654444332210
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
......+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 233 -----------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 -----------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -----------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 01123578999999999999999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=398.59 Aligned_cols=262 Identities=29% Similarity=0.430 Sum_probs=219.7
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh-----------HHHHHHHHHHHHHHhCCCCCccccc
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-----------SDAIRILREVKLLRLLRHPDIVEIK 88 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~i~~~~ 88 (374)
.+.++|++++.||+|+||+||+|.++.++..||+|++....... .....+.+|+.+|+.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45689999999999999999999999999999999987532211 2245688999999999999999999
Q ss_pred eeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC---C
Q 017301 89 RIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---K 164 (374)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~---~ 164 (374)
+++. ....+|+|||||.| +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 113 ~~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 113 DVFE-----DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEE-----CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred EEEE-----cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 9994 44569999999986 9999998888999999999999999999999999999999999999998876 6
Q ss_pred eEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 017301 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (374)
Q Consensus 165 vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 244 (374)
+||+|||+|....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus 188 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999998654332 1245679999999999864 58999999999999999999999999988777666655
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
........ ..++.+|+.+++||++||++||.+|||+.++|+||||+...
T Consensus 261 ~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 261 KGKYYFDF---------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HCCCCCCH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred cCCCCCCc---------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 42222111 12356899999999999999999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=375.26 Aligned_cols=252 Identities=28% Similarity=0.333 Sum_probs=206.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|+++++||+|+||+||+|.+..+|+.||+|++...............|+..+..+ +||||+++++++. +...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 679999999999999999999999999999999876655556666666777766655 8999999999994 4456
Q ss_pred EEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999999999988764 469999999999999999999999999999999999999999999999999987653322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...... +.. +...+
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~~-------- 271 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLPP-------- 271 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCCH--------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCCc--------
Confidence 1 234569999999998865 589999999999999999999877655332111 100 00000
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.....+++.+.+||.+||+.||.+|||+.++|+||||++
T Consensus 272 -------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 -------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 112457899999999999999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=390.78 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=215.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|..++..++||||+++++++. +.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ-----DE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE-----CS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eC
Confidence 35789999999999999999999999999999999864211 1112234678999999999999999999994 44
Q ss_pred CcEEEEEccCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
.++|+||||+. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 56999999997 5999999874 479999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCccccccccccccccccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
.... ......+||+.|+|||++.+. ...|+.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus 214 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---- 287 (412)
T 2vd5_A 214 ADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE---- 287 (412)
T ss_dssp TTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred CCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----
Confidence 3321 112346899999999998621 14689999999999999999999999999887666655542100
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCC---CCHHHHhcCCCCCcC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFKGL 319 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---pt~~~lL~hp~~~~~ 319 (374)
.. ........+|+.+++||++||+ +|.+| |+++++++||||+++
T Consensus 288 ----------------~~------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 288 ----------------HL------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp ----------------HC------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ----------------Cc------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 00 0001124689999999999999 99998 599999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=382.13 Aligned_cols=293 Identities=33% Similarity=0.571 Sum_probs=222.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc--CCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK--REF 99 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~~ 99 (374)
.++|++.+.||+|+||+||+|.+..+|+.||+|++...... .....+++..++.++||||+++++++..... ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 47899999999999999999999999999999988643222 2245577888888999999999999865432 223
Q ss_pred CcEEEEEccCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhh--hCCccccCCCCCceEecC-CCCeEEeeecc
Q 017301 100 KDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMH--TANVYHRDLKPKNILANA-NCKLKVCDFGL 172 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~al~~LH--~~~i~H~dikp~Nil~~~-~~~vkl~DFg~ 172 (374)
..+++||||+.++|...+. ....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 4588999999998766554 4567999999999999999999999 999999999999999997 89999999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
++....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....+.+..
T Consensus 179 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 179 AKKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CBCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ceecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 976543322 2345789999999998652 45899999999999999999999999999999999999999999988
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccc----cCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQ----KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~ 325 (374)
+.+.......... ........+... .....++.+.+||.+||+.||.+|||+.++|+||||+++......
T Consensus 254 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 327 (360)
T 3e3p_A 254 EVLRKLNPSHTDV---DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK 327 (360)
T ss_dssp HHHHHHCTTCCCG---GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCC
T ss_pred HHHHhcccchhhc---cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcccc
Confidence 7765433211000 000001111111 122367889999999999999999999999999999988655443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=366.64 Aligned_cols=259 Identities=31% Similarity=0.469 Sum_probs=220.2
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++.+.||+|+||+||+|.+..++..||+|++...... ....+.+|+.+++.++||||+++++++. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~ 78 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFE-----DN 78 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC
Confidence 3457899999999999999999999999999999998754332 2456889999999999999999999994 34
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe---cCCCCeEEeeeccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARV 175 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~---~~~~~vkl~DFg~a~~ 175 (374)
...|+||||+.+ +|.+.+...+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 568999999986 999999888889999999999999999999999999999999999999 7788999999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......+..
T Consensus 159 ~~~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 229 (277)
T 3f3z_A 159 FKPGK----MMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK-- 229 (277)
T ss_dssp CCTTS----CBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH--
T ss_pred ccCcc----chhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch--
Confidence 54322 1244579999999999865 48999999999999999999999999887766655554432222211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.+..+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 230 -------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 230 -------------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp -------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred -------------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 124678999999999999999999999999999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=366.66 Aligned_cols=258 Identities=30% Similarity=0.462 Sum_probs=209.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++.+.||+|+||+||+|.+..++..||+|++...... .....+.+|+.+++.++||||+++++++. ..
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DY 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHhee-----cC
Confidence 4568999999999999999999999999999999998754322 23457889999999999999999999994 44
Q ss_pred CcEEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe---cCCCCeEEeeec
Q 017301 100 KDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFG 171 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~---~~~~~vkl~DFg 171 (374)
..+|+||||+.+ +|.+.+.. ...+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 568999999986 99988854 4679999999999999999999999999999999999999 456789999999
Q ss_pred ccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 173 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--- 242 (285)
T 3is5_A 173 LAELFKSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--- 242 (285)
T ss_dssp CCCC--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---
T ss_pred cceecCCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc---
Confidence 9976433221 234579999999999754 688999999999999999999999988775443332211000
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
........+++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 243 -------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 243 -------------------------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -------------------------CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -------------------------ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 011112347899999999999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=398.78 Aligned_cols=263 Identities=29% Similarity=0.477 Sum_probs=222.7
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
...++|++++.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++. .
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~ 97 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----D 97 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 345789999999999999999999999999999999864332 2234567889999999999999999999994 4
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe---cCCCCeEEeeecccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLAR 174 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~---~~~~~vkl~DFg~a~ 174 (374)
...+|+||||+.+ +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 4569999999985 999999998999999999999999999999999999999999999999 567889999999997
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 178 ~~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~----- 245 (484)
T 3nyv_A 178 HFEASKK----MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT----- 245 (484)
T ss_dssp HBCCCCS----HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----
T ss_pred Ecccccc----cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 6543322 244579999999999865 5899999999999999999999999998876665555432111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.....++.+|+.+++||.+||+.||.+|||+.++|+||||+....
T Consensus 246 ----------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 246 ----------------------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp ----------------------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred ----------------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 111223568999999999999999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=367.97 Aligned_cols=256 Identities=26% Similarity=0.423 Sum_probs=213.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.++|++++.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++. ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cCC
Confidence 4789999999999999999999999999999999864211 1112346788999999999999999999994 345
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
..++||||+.+ +|.+.+.....+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 68999999995 99999988888999999999999999999999999999999999999999999999999998643322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 163 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 224 (279)
T 3fdn_A 163 R-----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----------- 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----------
T ss_pred c-----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-----------
Confidence 2 234579999999999887 6789999999999999999999999988776554444322110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.....+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 225 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 225 --------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred --------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 11234788999999999999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=375.52 Aligned_cols=273 Identities=24% Similarity=0.334 Sum_probs=218.0
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
+.....++|++++.||+|+||+||+|.+..+++.||+|+++.... .......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 344567899999999999999999999999999999999976433 3344567889999999999999999999985443
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
. .....|+||||+.| +|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~-~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 86 P-AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp T-TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred C-CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 1 22346999999975 999999988899999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~----- 237 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI----- 237 (311)
T ss_dssp -----------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-----
T ss_pred cccccccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-----
Confidence 65443322222344579999999999987 68999999999999999999999999988765544333221111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
+.....+.+++.+.+||.+||+.||.+||++.++|.|+|++..
T Consensus 238 ----------------------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 238 ----------------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ----------------------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------------------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1112235689999999999999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=372.59 Aligned_cols=286 Identities=30% Similarity=0.496 Sum_probs=229.5
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEE-CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC------cccccee
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAID-THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD------IVEIKRI 90 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------i~~~~~~ 90 (374)
.....++|++++.||+|+||+||+|.+ ..+++.||+|+++.. ......+.+|+.+++.++|++ +++++++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 344568999999999999999999998 568899999998642 344566788999998887654 8899988
Q ss_pred ecCCCcCCCCcEEEEEccCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-------
Q 017301 91 MLPPSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA------- 161 (374)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~------- 161 (374)
+. ...++|+||||++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 86 ~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 86 FE-----HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EE-----ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred cc-----cCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 84 345699999999889999998765 6899999999999999999999999999999999999987
Q ss_pred ------------CCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 017301 162 ------------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229 (374)
Q Consensus 162 ------------~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~ 229 (374)
++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEHH------STLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSCC------CSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccccccccccCCCceEeeCcccccCcccc------ccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCC
Confidence 6689999999997643321 34579999999999987 679999999999999999999999
Q ss_pred CCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH--------------HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHH
Q 017301 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNE--------------KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQR 295 (374)
Q Consensus 230 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 295 (374)
||.+.+..+....+....+..+...+...... ....+........ ..........++.+.+||.+
T Consensus 233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 311 (339)
T 1z57_A 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPL-KEFMLSQDVEHERLFDLIQK 311 (339)
T ss_dssp SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHHHHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcch-hhhcccchhhHHHHHHHHHH
Confidence 99999998888888888888777665433221 1111111111100 00111112345678999999
Q ss_pred hccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 296 LIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 296 ~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
||+.||.+|||+.++|+||||+.+.
T Consensus 312 ~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 312 MLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HhCcCcccccCHHHHhcCHHHHHHh
Confidence 9999999999999999999998764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=375.16 Aligned_cols=288 Identities=31% Similarity=0.572 Sum_probs=221.7
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCC
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 95 (374)
..++..++|++++.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++.++ ||||+++++++....
T Consensus 30 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp CCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred hcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 3455678999999999999999999999999999999998742 2356789999999997 999999999996432
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC-CeEEeeeccc
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLA 173 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~-~vkl~DFg~a 173 (374)
....++||||+.+ +|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 105 ---~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 105 ---SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp ---TCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ---CCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 3568999999996 88888754 89999999999999999999999999999999999999777 7999999999
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC-CCChhhHHHHHHHhhCCCCH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP-GKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~~~~~ 252 (374)
+....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||. +.+..+.+..+....+.+..
T Consensus 179 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~ 253 (330)
T 3nsz_A 179 EFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253 (330)
T ss_dssp EECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred eEcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence 76543322 2345799999999998653 568999999999999999999998884 45556666666665554332
Q ss_pred HHH-hhhcCHHHHHHHHHhcCCCCCCccc-----cCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 253 ETI-AVVRNEKARKYLTEMRKKPPVPLFQ-----KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 253 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
... ..........+.............. ....+++.+.+||.+||++||.+|||++++|+||||+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 111 1110000001111111111111111 1123789999999999999999999999999999999764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=377.37 Aligned_cols=273 Identities=25% Similarity=0.392 Sum_probs=224.4
Q ss_pred hhccccccccCCCCCeeEe-ceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCcccc
Q 017301 10 LKDKDFFTEYGDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEI 87 (374)
Q Consensus 10 ~~~~~~~~~~~~~~~Y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~ 87 (374)
..+..|...-...++|.+. +.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.+. ||||+++
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 3445555666677899988 8999999999999999999999999999765544444567889999999995 6999999
Q ss_pred ceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC---
Q 017301 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--- 161 (374)
Q Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~--- 161 (374)
++++. ....+|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 95 ~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 95 HEVYE-----NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp EEEEE-----CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTT
T ss_pred EEEEE-----eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCC
Confidence 99994 44568999999986 999888653 67999999999999999999999999999999999999988
Q ss_pred CCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 017301 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241 (374)
Q Consensus 162 ~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 241 (374)
++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 170 ~~~~kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 243 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL 243 (327)
T ss_dssp BCCEEECCGGGCEEC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCcEEEeeCccccccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence 78999999999986543322 234579999999999977 688999999999999999999999999887665554
Q ss_pred HHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.+...... .....++.+++.+.+||.+||+.||.+|||++++|+||||+++.
T Consensus 244 ~i~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 244 NISQVNVD---------------------------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HHHHTCCC---------------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred HHHhcccc---------------------------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 44332211 11223457899999999999999999999999999999998763
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=368.81 Aligned_cols=261 Identities=27% Similarity=0.440 Sum_probs=217.2
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
....++|++.+.||+|+||+||+|.+..+|+.||+|+++.... .....+.+|+.+++.++||||+++++++. .
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 77 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYE-----S 77 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcc-----c
Confidence 3456789999999999999999999999999999999974322 23346789999999999999999999984 3
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe---cCCCCeEEeeecccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLAR 174 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~---~~~~~vkl~DFg~a~ 174 (374)
....|+||||+.+ +|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 78 TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred CCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 4568999999985 999999888889999999999999999999999999999999999999 778899999999987
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 158 ~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~------ 224 (304)
T 2jam_A 158 MEQNG-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY------ 224 (304)
T ss_dssp CCCCB-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC------
T ss_pred ecCCC-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC------
Confidence 53222 1234579999999999987 6799999999999999999999999988776554444332111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
......++.+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 225 ---------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 225 ---------------------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ---------------------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ---------------------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 011122356889999999999999999999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=370.72 Aligned_cols=281 Identities=25% Similarity=0.367 Sum_probs=208.3
Q ss_pred CCCCeeEe-ceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 21 DANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
..++|++. +.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~----- 82 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEE----- 82 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----
Confidence 45789995 789999999999999999999999999975432 2345678999999885 79999999999943
Q ss_pred CCcEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC---eEEeeecccc
Q 017301 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLAR 174 (374)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~---vkl~DFg~a~ 174 (374)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 456999999998 599999998888999999999999999999999999999999999999988776 9999999987
Q ss_pred cccCCCC----ccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 175 VAFSDTP----MTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 175 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
....... ........+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~----- 237 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD----- 237 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc-----
Confidence 5432211 11112345699999999998641 13578899999999999999999999987653210000
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
... ............+...........++.+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 238 ---~~~----~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 238 ---RGE----ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp ----------CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ---ccc----cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 000 000000011111111111111122346889999999999999999999999999999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=378.06 Aligned_cols=281 Identities=32% Similarity=0.499 Sum_probs=224.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CC-----CccccceeecCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP-----DIVEIKRIMLPP 94 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~i~~~~~~~~~~ 94 (374)
..++|++++.||+|+||+||+|.+..+++.||+|+++.. ......+.+|+.+++.++ |+ +++++++.+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~- 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF- 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-
Confidence 358999999999999999999999999999999999742 234456778888888875 55 48888888843
Q ss_pred CcCCCCcEEEEEccCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhh--hCCccccCCCCCceEec--CCCCeEEe
Q 017301 95 SKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMH--TANVYHRDLKPKNILAN--ANCKLKVC 168 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH--~~~i~H~dikp~Nil~~--~~~~vkl~ 168 (374)
...+|+||||++++|.+++... ..+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||+
T Consensus 128 ----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 128 ----RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ----TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred ----CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 3569999999999999999875 46999999999999999999999 47999999999999995 47789999
Q ss_pred eecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 017301 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (374)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 248 (374)
|||+|+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+
T Consensus 204 DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 204 DFGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp CCTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999765332 234579999999999987 6799999999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCC------CCcc----------------------ccCCC-------CChHHHHHH
Q 017301 249 TPSPETIAVVRNEKARKYLTEMRKKPP------VPLF----------------------QKFPN-------VDPLALRLL 293 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~----------------------~~~~~-------~s~~~~~li 293 (374)
.++...+.... ....++..+..... .... ....+ .++.+.+||
T Consensus 276 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 353 (382)
T 2vx3_A 276 IPPAHILDQAP--KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 353 (382)
T ss_dssp SCCHHHHTTCT--THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHH
T ss_pred CCCHHHHHhhH--HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHH
Confidence 98877654322 22222222111000 0000 00000 013789999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 294 QRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 294 ~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.+||++||.+|||+.|+|+||||+..
T Consensus 354 ~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 354 LRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHhcCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=381.57 Aligned_cols=284 Identities=27% Similarity=0.411 Sum_probs=223.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC--------CCCccccceeec
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--------HPDIVEIKRIML 92 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~ 92 (374)
..++|++++.||+|+||+||+|++..+++.||+|+++.. ......+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 358999999999999999999999999999999999742 344567889999999885 788999999985
Q ss_pred CCCcCCCCcEEEEEccCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCC------
Q 017301 93 PPSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANC------ 163 (374)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~------ 163 (374)
... .....+|+||||+++++.+.+... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 112 ~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 112 ISG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred ecC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 322 134568999999998888888765 4699999999999999999999998 999999999999998775
Q ss_pred -------------------------------------------CeEEeeecccccccCCCCccccccccccccccccccc
Q 017301 164 -------------------------------------------KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200 (374)
Q Consensus 164 -------------------------------------------~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~ 200 (374)
.+||+|||+|+..... ....+||+.|+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChh
Confidence 7999999999765332 234579999999999
Q ss_pred ccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC------hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhc---
Q 017301 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR--- 271 (374)
Q Consensus 201 ~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 271 (374)
+.+ ..++.++|||||||++|+|++|+.||.+.+ ....+..+....+.++...+....... .++....
T Consensus 265 ~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~ 340 (397)
T 1wak_A 265 LIG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK--EFFTKKGDLK 340 (397)
T ss_dssp HHT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG--GTBCTTSSBS
T ss_pred hcC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc--cccCCccccc
Confidence 987 679999999999999999999999998765 456777788888888776543222110 0000000
Q ss_pred ---CCCCCC-------ccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 272 ---KKPPVP-------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 272 ---~~~~~~-------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
...+.. ........++.+.+||.+||+.||.+|||+.++|+||||++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000000 00001123467889999999999999999999999999963
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=369.19 Aligned_cols=256 Identities=29% Similarity=0.514 Sum_probs=213.6
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
..|...+.||+|+||+||+|++..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 117 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEEL 117 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEE
Confidence 358888999999999999999999999999999864332 234567899999999999999999999954 3458
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|+||||+.+ +|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 118 ~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp EEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 999999986 89888764 4699999999999999999999999999999999999999999999999999976543322
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 197 ~---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------------- 258 (321)
T 2c30_A 197 K---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP------------- 258 (321)
T ss_dssp C---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-------------
T ss_pred c---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-------------
Confidence 1 245679999999999977 6789999999999999999999999988776544433322100
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
+.......+++.+.+||.+||+.||.+|||+.++|+||||.+.
T Consensus 259 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 259 ---------------PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp ---------------CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ---------------CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 0011123578899999999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=375.25 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=214.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++++.||+|+||+||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~ 126 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----E 126 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----C
Confidence 346799999999999999999999999999999999754333 2334578899999999999999999999954 3
Q ss_pred CcEEEEEccCcccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMESDLHQVIK-ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+||||+.|+|.+.+. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 4689999999999988886 456899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCcccccccccccccccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
. ....||+.|+|||++.+ ....++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 207 ~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~------------ 267 (348)
T 1u5q_A 207 A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------ 267 (348)
T ss_dssp B-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------
T ss_pred C-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------------
Confidence 1 34579999999998843 125789999999999999999999999988775544433221
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
...+. .....+++.+.+||.+||+.||.+|||++++|+||||..
T Consensus 268 --------------~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 268 --------------NESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp --------------SCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------------cCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 00100 112357889999999999999999999999999999964
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=363.27 Aligned_cols=261 Identities=28% Similarity=0.433 Sum_probs=220.9
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
...++|++.+.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 86 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----- 86 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-----
Confidence 45689999999999999999999999999999999986543 234455678899999999999999999999943
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
....|+||||+.+ +|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 4568999999995 999999888889999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+..
T Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------ 229 (294)
T 2rku_A 167 YDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------------ 229 (294)
T ss_dssp STTCC---BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------------
T ss_pred cCccc---cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh------------
Confidence 32221 234579999999999877 6789999999999999999999999988765443322211
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.. ......+++.+.+||.+||+.||.+|||+.++|+||||+....
T Consensus 230 --------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 230 --------------NE-----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp --------------TC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred --------------cc-----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 00 0112457889999999999999999999999999999986543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=372.56 Aligned_cols=263 Identities=26% Similarity=0.342 Sum_probs=207.8
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCC--CCccccceeecCCCcCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH--PDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~ 98 (374)
..++|++++.||+|+||+||+|.+ .+++.||+|++............+.+|+.+|+.++| |||+++++++..
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----- 80 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----- 80 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----
Confidence 457899999999999999999987 468899999997655566666788999999999986 999999999843
Q ss_pred CCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...+|+|||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 45699999988889999999999999999999999999999999999999999999999997 67899999999976543
Q ss_pred CCCccccccccccccccccccccccc---------CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
... .......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... ...+...
T Consensus 160 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~--- 233 (343)
T 3dbq_A 160 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAI--- 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHH---
T ss_pred ccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHH---
Confidence 321 1122356799999999997531 146888999999999999999999999764321 1111110
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..... ........++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 234 --------------------~~~~~---~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 234 --------------------IDPNH---EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp --------------------HCTTS---CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred --------------------hcCCc---ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 00000 011123456789999999999999999999999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=372.98 Aligned_cols=260 Identities=28% Similarity=0.474 Sum_probs=216.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC--h----HHHHHHHHHHHHHHhC-CCCCccccceeecCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--I----SDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 94 (374)
.++|++.+.||+|++|.||+|.+..+|+.||||++...... . .....+.+|+.+++.+ +||||+++++++.
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 170 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE-- 170 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe--
Confidence 36899999999999999999999999999999998653321 1 1234577899999999 7999999999984
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccc
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
.....|+||||+.| +|.+++.....+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++
T Consensus 171 ---~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 171 ---SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp ---BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ---eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 34568999999996 99999998888999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCccccccccccccccccccccccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
........ ....+||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 248 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 323 (365)
T 2y7j_A 248 CHLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ 323 (365)
T ss_dssp EECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 76543321 2446799999999987532 135888999999999999999999999887765555444332111
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
... ..+...++.+.+||.+||+.||.+|||+.++|+||||+
T Consensus 324 ~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 324 FSS---------------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CCH---------------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCC---------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 111 11246788999999999999999999999999999996
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=364.34 Aligned_cols=262 Identities=28% Similarity=0.473 Sum_probs=217.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
.++|++++.||+|+||+||+|.+..+++.||+|+++...... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN---- 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----
Confidence 367999999999999999999999999999999987532211 135578899999999999999999999944
Q ss_pred CCCcEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC----CeEEeeecc
Q 017301 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDFGL 172 (374)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~----~vkl~DFg~ 172 (374)
....++||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 80 -KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred -CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 356899999997 49999998888899999999999999999999999999999999999998877 799999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
+........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 159 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T 3bhy_A 159 AHKIEAGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 232 (283)
T ss_dssp CEECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH
T ss_pred ceeccCCCc----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc
Confidence 976533221 234579999999999877 67899999999999999999999999988765555444322111111
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
..++.+++.+.+||.+||+.||.+|||+.++|+||||+.+..
T Consensus 233 ---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 233 ---------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ---------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ---------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 122467889999999999999999999999999999987643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=375.26 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=206.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-----
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK----- 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----- 96 (374)
.++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|+.++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 367999999999999999999999999999999997533 33455678899999999999999999998854321
Q ss_pred -----------------------------------------------CCCCcEEEEEccCcc-cHHHHHHhCC---CCCH
Q 017301 97 -----------------------------------------------REFKDIYVVFELMES-DLHQVIKAND---DLTR 125 (374)
Q Consensus 97 -----------------------------------------------~~~~~~~lv~e~~~~-~L~~~l~~~~---~l~~ 125 (374)
.....+|+||||+.+ +|.+++.... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 122348999999996 9999998765 3466
Q ss_pred HHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcc---------ccccccccccccc
Q 017301 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT---------VFWTDYVATRWYR 196 (374)
Q Consensus 126 ~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~---------~~~~~~~gt~~y~ 196 (374)
..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... .......||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 6789999999999999999999999999999999999999999999998654432111 1123457999999
Q ss_pred ccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCC
Q 017301 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV 276 (374)
Q Consensus 197 aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (374)
|||++.+ ..++.++|||||||++|+|++|..|+.. ....+........+
T Consensus 244 aPE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~------------------------ 292 (332)
T 3qd2_B 244 SPEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFP------------------------ 292 (332)
T ss_dssp CHHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCC------------------------
T ss_pred ChHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCC------------------------
Confidence 9999987 6889999999999999999998766421 11111111111110
Q ss_pred CccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 277 PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 277 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..+...++.+.+||.+||+.||.+|||+.++|+||||+++
T Consensus 293 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 293 ---LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp ---HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ---cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 0112346778999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-51 Score=377.24 Aligned_cols=268 Identities=28% Similarity=0.426 Sum_probs=214.2
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
..++|++++.||+|+||+||+|.+..++..||+|++.... ........+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----- 98 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE----- 98 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-----
Confidence 3578999999999999999999999999999999986421 12344567889999999999999999999994
Q ss_pred CCCcEEEEEccCcc-cHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHH
Q 017301 98 EFKDIYVVFELMES-DLHQVIKA----------------------------------------NDDLTREHHQFFLYQML 136 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qi~ 136 (374)
.....|+||||+.| +|.+++.. ...+++..++.++.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 34569999999985 99998852 11246788899999999
Q ss_pred HHHHHhhhCCccccCCCCCceEecCCC--CeEEeeecccccccCCCC-cccccccccccccccccccccccCCCCCccch
Q 017301 137 RALKYMHTANVYHRDLKPKNILANANC--KLKVCDFGLARVAFSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAID 213 (374)
Q Consensus 137 ~al~~LH~~~i~H~dikp~Nil~~~~~--~vkl~DFg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 213 (374)
.||+|||++||+||||||+||+++.++ .+||+|||+++....... .........||+.|+|||++.+....++.++|
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999999998776 899999999976433221 11123456799999999998654467899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHH
Q 017301 214 IWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLL 293 (374)
Q Consensus 214 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 293 (374)
||||||++|+|++|..||.+.+..+....+...... .....+..+++.+.+||
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li 311 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC---------------------------FENPNYNVLSPLARDLL 311 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------------------TTSGGGGGSCHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc---------------------------cCCcccccCCHHHHHHH
Confidence 999999999999999999988876655444331111 11112245789999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 294 QRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 294 ~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.+||+.||.+|||+.++|+||||+++.
T Consensus 312 ~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 312 SNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHcCCChhHCCCHHHHhcChhhccCh
Confidence 999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=379.07 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=211.1
Q ss_pred CCeeE--eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 23 NRYKI--LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 23 ~~Y~~--~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+.|.+ .+.||+|+||.||+|.+..+|+.||+|+++.. .......+.+|+.+++.++||||+++++++.. ..
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KN 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CC
Confidence 44555 67899999999999999999999999998743 23455678899999999999999999999943 45
Q ss_pred cEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe--cCCCCeEEeeecccccc
Q 017301 101 DIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA--NANCKLKVCDFGLARVA 176 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~--~~~~~vkl~DFg~a~~~ 176 (374)
.+|+||||+.+ +|.+.+... ..+++..+..++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 68999999985 998888654 469999999999999999999999999999999999999 56678999999999865
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 240 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------- 306 (373)
T 2x4f_A 240 KPREK----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD------- 306 (373)
T ss_dssp CTTCB----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------
T ss_pred CCccc----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Confidence 43322 234579999999999877 67899999999999999999999999998876666555432111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.....++.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 307 --------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 307 --------------------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp --------------------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred --------------------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1112345789999999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=364.43 Aligned_cols=257 Identities=24% Similarity=0.407 Sum_probs=216.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++++.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.. .
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 86 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----R 86 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----C
Confidence 34789999999999999999999999999999999863211 11123467899999999999999999999943 4
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+||||+.+ +|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 568999999985 9999999888899999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+...
T Consensus 167 ~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------ 227 (284)
T 2vgo_A 167 LR-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------ 227 (284)
T ss_dssp SC-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred cc-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc------------
Confidence 21 134579999999999887 67899999999999999999999999887655443333210
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
. ....+.+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 228 --------------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 228 --------------D-----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp --------------C-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred --------------c-----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 0 011245789999999999999999999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=365.19 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=198.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|.+..+|+.||+|+++...........+.++...++.++||||+++++++.. ...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cCC
Confidence 478999999999999999999999999999999997543333333344455556888899999999999954 345
Q ss_pred EEEEEccCcccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 102 IYVVFELMESDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
.|+||||++++|.+++.. ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 899999999988777653 56899999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCcccccccccccccccccccccc--cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh-hHHHHHHHhhCCCCHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLGTPSPE 253 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~ 253 (374)
..... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||...... ..+....
T Consensus 161 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------- 227 (290)
T 3fme_A 161 VDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV--------- 227 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH---------
T ss_pred ccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh---------
Confidence 43322 133479999999999631 1157899999999999999999999999764322 1111111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
....+. .....+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 228 -----------------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 228 -----------------EEPSPQ---LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp -----------------HSCCCC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -----------------ccCCCC---cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 111110 1123578999999999999999999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=365.31 Aligned_cols=268 Identities=20% Similarity=0.380 Sum_probs=216.9
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
..++|++++.||+|+||.||+|.+..+++.||+|+++.... .......+.+|+.+++.++||||+++++++... +
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---E 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---C
Confidence 35799999999999999999999999999999999864211 123456788999999999999999999998543 2
Q ss_pred CCcEEEEEccCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....|+||||+.++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 80 KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp --CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 346899999999888888876 457999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
...... .......||+.|+|||++.+....++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 160 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~---------- 228 (305)
T 2wtk_C 160 HPFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG---------- 228 (305)
T ss_dssp CTTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC----------
T ss_pred Cccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC----------
Confidence 432221 122455799999999998763234578999999999999999999999887655444333210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (374)
. ......+++.+.+||.+||+.||.+|||+.++++||||+......
T Consensus 229 -----------------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 229 -----------------S----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp -----------------C----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred -----------------C----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 0 011245789999999999999999999999999999998765433
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=397.81 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=215.2
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
-..++|++++.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+|+.++||||+++++++. .
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----T 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----e
Confidence 345789999999999999999999999999999999864211 1122345778999999999999999999994 3
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...+|+||||+.| +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 4569999999975 9999998754 499999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.
T Consensus 336 ~~~~~~----~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~----------- 398 (576)
T 2acx_A 336 VPEGQT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------- 398 (576)
T ss_dssp CCTTCC----EECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH-----------
T ss_pred cccCcc----ccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH-----------
Confidence 543321 234589999999999987 679999999999999999999999998765321111111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
..+..... .....+|+.+.+||.+||+.||.+|| |++++++||||+++
T Consensus 399 ---------~~i~~~~~-------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 399 ---------RLVKEVPE-------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp ---------HHHHHCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ---------HHhhcccc-------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 11111110 11246899999999999999999999 89999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=369.51 Aligned_cols=262 Identities=28% Similarity=0.423 Sum_probs=221.7
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
....++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 112 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED---- 112 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 345679999999999999999999999999999999986543 234456678899999999999999999999943
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
...+|+||||+.+ +|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 113 -~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 113 -NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp -SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 4568999999995 99999988888999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+...
T Consensus 192 ~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 256 (335)
T 2owb_A 192 EYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---------- 256 (335)
T ss_dssp CSTTCC---BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----------
T ss_pred ccCccc---ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC----------
Confidence 432221 234579999999999877 67899999999999999999999999887654443332210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
. ......+++.+.+||.+||+.||.+|||+.++|+||||+....
T Consensus 257 ----------------~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 257 ----------------E-----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp ----------------C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ----------------C-----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 0 0112357889999999999999999999999999999987543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=404.89 Aligned_cols=258 Identities=22% Similarity=0.385 Sum_probs=219.1
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
..++|++++.||+|+||+||+|.++.+++.||+|++++... .......+.+|..+|..+ +||+|+.+++++ ..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 35789999999999999999999999999999999874211 112234577899999887 699999999998 44
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...+|+||||+.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 4569999999985 999999988899999999999999999999999999999999999999999999999999997533
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....|...
T Consensus 494 ~~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------- 557 (674)
T 3pfq_A 494 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------- 557 (674)
T ss_dssp CTTC---CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----------
T ss_pred cCCc---ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 2221 2345689999999999987 78999999999999999999999999998876665554321
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCH-----HHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~~lL~hp~~~~~ 319 (374)
.. .....+++.+.+||++||+.||.+||++ +++++||||+++
T Consensus 558 ---------------~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 558 ---------------NV-----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp ---------------CC-----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred ---------------CC-----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 00 1124689999999999999999999997 999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=383.02 Aligned_cols=260 Identities=33% Similarity=0.526 Sum_probs=204.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC------ChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 5789999999999999999999999999999999864321 11122347799999999999999999999732
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC---CeEEeeec
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFG 171 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~---~vkl~DFg 171 (374)
...|+||||+.+ +|.+.+..++.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 212 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 347999999985 9999998888999999999999999999999999999999999999997654 59999999
Q ss_pred ccccccCCCCcccccccccccccccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH-HHHHhhCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD-LITDLLGT 249 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~-~i~~~~~~ 249 (374)
+|+...... .....+||+.|+|||++.+ ....++.++|||||||++|+|++|.+||.+......+. .+....
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~-- 361 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-- 361 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC--
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC--
Confidence 998654322 2245679999999999753 12568889999999999999999999998765432222 111111
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.......++.+++.+.+||.+||+.||.+|||++++|+||||++
T Consensus 362 -------------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 362 -------------------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp -------------------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred -------------------------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 11111223568999999999999999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=381.69 Aligned_cols=265 Identities=27% Similarity=0.397 Sum_probs=204.9
Q ss_pred cCCCCCeeEe-ceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHH-hCCCCCccccceeecCCCc
Q 017301 19 YGDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR-LLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 19 ~~~~~~Y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~ 96 (374)
....++|.+. +.||+|+||+||+|.++.+|+.||+|+++.. ..+.+|+.++. ..+||||+++++++....
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~- 128 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY- 128 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc-
Confidence 3456778886 7899999999999999999999999998631 24567888874 458999999999884321
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC---CCCeEEeee
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDF 170 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~---~~~vkl~DF 170 (374)
.+..++|+||||+.| +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 224568999999985 9999998754 5999999999999999999999999999999999999998 788999999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
|+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......
T Consensus 209 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------- 274 (400)
T 1nxk_A 209 GFAKETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------- 274 (400)
T ss_dssp TTCEECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS--------
T ss_pred ccccccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH--------
Confidence 9997643322 1245689999999999977 7899999999999999999999999987653221000
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
....+... ........+..+++.+.+||++||+.||.+|||+.++|+||||.+..
T Consensus 275 ------------~~~~i~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 275 ------------MKTRIRMG---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp ------------HHHHHHHT---CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ------------HHHHHHcC---cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 00000100 00111123457899999999999999999999999999999997643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=369.85 Aligned_cols=284 Identities=30% Similarity=0.501 Sum_probs=226.8
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCC-cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC------ccccceeec
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD------IVEIKRIML 92 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------i~~~~~~~~ 92 (374)
-..++|++++.||+|+||+||+|.+..++ ..||+|+++.. ......+.+|+.+++.++|++ ++.+++++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 34689999999999999999999998777 68999998642 344556778999999887665 778777773
Q ss_pred CCCcCCCCcEEEEEccCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe-----------
Q 017301 93 PPSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----------- 159 (374)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~----------- 159 (374)
...++|+||||+++++.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 93 -----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 93 -----FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp -----ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred -----eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 345689999999989988887654 79999999999999999999999999999999999999
Q ss_pred --------cCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 017301 160 --------NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (374)
Q Consensus 160 --------~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf 231 (374)
+.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccCCCcEEEeecCccccccccc------cCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCC
Confidence 567899999999997643322 34579999999999987 67999999999999999999999999
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHhhhcCHH--------------HHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhc
Q 017301 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEK--------------ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297 (374)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 297 (374)
.+.+..+.+..+.+..+.++...+....... ...+........ ..........++.+.+||.+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L 318 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRML 318 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcc-cccccccchhHHHHHHHHHHHh
Confidence 9999998888998888888776654332211 111111111000 0000111223567899999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCcCc
Q 017301 298 AFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 298 ~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
+.||.+|||+.++|+||||+++.
T Consensus 319 ~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 319 EFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp CSSTTTSCCHHHHTTSGGGGGCC
T ss_pred cCChhhCcCHHHHhcChhhcCCC
Confidence 99999999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=374.74 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=211.1
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh------HHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI------SDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 94 (374)
..++|++++.||+|+||+||+|++..+++.||+|+++...... .....+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-- 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 3578999999999999999999999999999999997543211 12335668999999999999999999994
Q ss_pred CcCCCCcEEEEEccCc-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecc
Q 017301 95 SKREFKDIYVVFELME-S-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
....+++||||+. | +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 100 ---~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 100 ---NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp ---CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ---eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 4456899999986 5 9999999988999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
+........ ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||......
T Consensus 177 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------- 236 (335)
T 3dls_A 177 AAYLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------- 236 (335)
T ss_dssp CEECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------
T ss_pred ceECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------
Confidence 976543322 234579999999999877 444 88999999999999999999999653210
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
... .......+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 237 ------------------~~~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 237 ------------------VEA-----AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ------------------TTT-----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ------------------Hhh-----ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 000 001123478999999999999999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=375.72 Aligned_cols=262 Identities=26% Similarity=0.346 Sum_probs=208.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC--CCCccccceeecCCCcCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~ 99 (374)
..+|++++.||+|+||+||+|.+.. ++.||+|++............+.+|+.+|+.++ ||||+++++++...
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~----- 128 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----- 128 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----
Confidence 3569999999999999999998865 899999999765555566678899999999997 59999999998543
Q ss_pred CcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
..+|+|||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 129 ~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 4599999977789999999988999999999999999999999999999999999999995 578999999999765332
Q ss_pred CCccccccccccccccccccccccc---------CCCCCccchHHHHHHHHHHHHhCCCCCCCCChh-hHHHHHHHhhCC
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLGT 249 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~ 249 (374)
.. .......+||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.... ..+..+.
T Consensus 208 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~----- 281 (390)
T 2zmd_A 208 TT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII----- 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH-----
T ss_pred Cc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh-----
Confidence 21 1122456799999999998541 136889999999999999999999999765321 1111111
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
..... .......++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 282 ---------------------~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 282 ---------------------DPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp ---------------------CTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ---------------------Ccccc---CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 00000 011123477899999999999999999999999999997543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=362.24 Aligned_cols=266 Identities=28% Similarity=0.343 Sum_probs=213.7
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
....++|++++.||+|+||+||+|.+..++..||+|++.... ........+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~----- 81 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE----- 81 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----
Confidence 345689999999999999999999999999999999986433 34455567889999999999999999999983
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....+|+||||+.| +|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 82 EDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred eCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 44568999999986 99999998889999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+........
T Consensus 162 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~------------- 224 (294)
T 4eqm_A 162 SETSLT--QTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH------------- 224 (294)
T ss_dssp ---------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH-------------
T ss_pred cccccc--ccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------
Confidence 332211 1234579999999999987 67899999999999999999999999887754432221
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.....+.......+.+++.+.++|.+||+.||.+||+..+.+.+.|..-+
T Consensus 225 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 225 -------------IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp -------------HSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred -------------hhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 11111111122345789999999999999999999976666677665433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=389.00 Aligned_cols=255 Identities=17% Similarity=0.229 Sum_probs=201.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHH---HHHhCCCCCccccc-------ee
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVK---LLRLLRHPDIVEIK-------RI 90 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~---~l~~l~h~~i~~~~-------~~ 90 (374)
.++|++.+.||+|+||+||+|.+..+|+.||+|++... .........+.+|+. .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 57899999999999999999999999999999998743 223345667889995 55555799999998 44
Q ss_pred ecCCCc-------CCCC-----cEEEEEccCcccHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHhhhCCccccC
Q 017301 91 MLPPSK-------REFK-----DIYVVFELMESDLHQVIKANDDLTR-------EHHQFFLYQMLRALKYMHTANVYHRD 151 (374)
Q Consensus 91 ~~~~~~-------~~~~-----~~~lv~e~~~~~L~~~l~~~~~l~~-------~~~~~i~~qi~~al~~LH~~~i~H~d 151 (374)
+...+. .+.. ..|+||||++|+|.+++...+.+++ ..+..++.||+.||+|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 432211 0111 3799999999999999987655555 77888999999999999999999999
Q ss_pred CCCCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCC-----------CCCccchHHHHHHH
Q 017301 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGCI 220 (374)
Q Consensus 152 ikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----------~~~~~~DiwSlG~i 220 (374)
|||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.+ . .++.++|||||||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999975322 1234567 99999999876 4 78999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCC
Q 017301 221 FAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300 (374)
Q Consensus 221 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 300 (374)
+|+|++|+.||.+.+....... .....+.+++.+.+||.+||+.|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEW-----------------------------------IFRSCKNIPQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHHHHSSCCC------CCSGG-----------------------------------GGSSCCCCCHHHHHHHHHHTCSS
T ss_pred HHHHHHCCCCCcccccccchhh-----------------------------------hhhhccCCCHHHHHHHHHHcCCC
Confidence 9999999999976543221110 11123578999999999999999
Q ss_pred CCCCCCHHHHhcCCCCCcCc
Q 017301 301 PKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 301 p~~Rpt~~~lL~hp~~~~~~ 320 (374)
|.+|||+.++|+||||+++.
T Consensus 348 p~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 348 KEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp GGGCCCHHHHHTSHHHHHHH
T ss_pred chhCCCHHHHhhChHHHHHH
Confidence 99999999999999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=362.91 Aligned_cols=258 Identities=27% Similarity=0.465 Sum_probs=192.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.. .
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----S 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----S
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----C
Confidence 34789999999999999999999999999999999863211 11123567899999999999999999999843 4
Q ss_pred CcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...|+||||+.+ +|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 568999999985 999999875 579999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+
T Consensus 164 ~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------- 224 (278)
T 3cok_A 164 MPHEK---HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV-------------- 224 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--------------
T ss_pred CCCCc---ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--------------
Confidence 32211 134578999999999877 67899999999999999999999999876543222110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.. ........+++.+.+||.+||+.||.+|||++++|+||||...
T Consensus 225 -------------~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 225 -------------VL----ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -------------CS----SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -------------hh----cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 00 0111224578999999999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=389.85 Aligned_cols=262 Identities=21% Similarity=0.334 Sum_probs=214.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++++.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~ 257 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----K 257 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----C
Confidence 45789999999999999999999999999999999864221 11223467889999999999999999999943 4
Q ss_pred CcEEEEEccCcc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 100 KDIYVVFELMES-DLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
..+|+||||+.| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 569999999995 999999763 369999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
........ ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+.......+.
T Consensus 338 ~~~~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~---------- 402 (543)
T 3c4z_A 338 ELKAGQTK---TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---------- 402 (543)
T ss_dssp ECCTTCCC---BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH----------
T ss_pred eccCCCcc---cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH----------
Confidence 65433221 234589999999999987 689999999999999999999999998764211111110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
..+.... ....+.+++.+.+||.+||+.||.+||+ ++++++||||+++
T Consensus 403 -------------~~i~~~~----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 403 -------------QRVLEQA----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp -------------HHHHHCC----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred -------------HHHhhcc----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 0010000 0112468999999999999999999995 5899999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=374.78 Aligned_cols=286 Identities=22% Similarity=0.329 Sum_probs=220.6
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
-..++|++++.||+|+||+||+|.+..++..||+|++... ........+.+|+.+++.++||||+++++++.. .
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 103 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----D 103 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----T
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----C
Confidence 3467999999999999999999999999999999998754 234556678899999999999999999999854 3
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
..+|+||||+.+ +|.+++...+.+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 568999999986 9999999888899999999999999999999996 99999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..............
T Consensus 184 ~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3eqc_A 184 DSM-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256 (360)
T ss_dssp HHC---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred ccc-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence 221 234579999999999987 6799999999999999999999999998776544332211111100000000
Q ss_pred ---------------hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 258 ---------------VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 258 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.................... .....+++.+.+||.+||+.||.+|||++++|+||||++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -----------------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccCCCcccccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 00001111222222211111 11234788999999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=358.68 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=214.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++. ....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNI 79 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCE
Confidence 4689999999999999999999999999999999864322 234567889999999999999999999984 3456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
.|+||||+.+ +|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 8999999986 999999888889999999999999999999999999999999999999999999999999997643322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.........
T Consensus 160 ~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------------- 221 (276)
T 2yex_A 160 R-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---------------- 221 (276)
T ss_dssp E-ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH----------------
T ss_pred c-hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh----------------
Confidence 1 1122456799999999998762 234778999999999999999999998765432211100
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.... .....+..+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 222 ----------~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 222 ----------KEKK--TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ----------HTTC--TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ----------hhcc--cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 0000 0111234678999999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=359.96 Aligned_cols=266 Identities=27% Similarity=0.422 Sum_probs=218.9
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC---C----hHHHHHHHHHHHHHHhCC-CCCcccccee
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---H----ISDAIRILREVKLLRLLR-HPDIVEIKRI 90 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~ 90 (374)
.+..++|++.+.||+|+||.||+|.++.+|+.||+|++..... . ......+.+|+.+++.+. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 3567899999999999999999999999999999999864321 1 122446789999999995 9999999999
Q ss_pred ecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEee
Q 017301 91 MLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (374)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~D 169 (374)
+. .....|+||||+.+ +|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus 93 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 93 YE-----TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp EE-----CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred ec-----cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEec
Confidence 84 34568999999985 9999999888899999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCcccccccccccccccccccccc----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 017301 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (374)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 245 (374)
||++........ .....||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 168 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 168 FGFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp CTTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccchhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 999976543221 234579999999998752 124688899999999999999999999988776554443332
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.... .....++.+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 244 ~~~~---------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 244 GNYQ---------------------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp TCCC---------------------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred CCcc---------------------------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 1110 11112346789999999999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=359.51 Aligned_cols=252 Identities=22% Similarity=0.272 Sum_probs=207.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+..+..+ +||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----DD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CC
Confidence 4689999999999999999999999999999999986655556667888999999999 89999999999843 35
Q ss_pred cEEEEEccCcc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC-------------
Q 017301 101 DIYVVFELMES-DLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN------------- 162 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~------------- 162 (374)
..++||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 68999999986 999999764 679999999999999999999999999999999999999844
Q ss_pred ------CCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 017301 163 ------CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236 (374)
Q Consensus 163 ------~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 236 (374)
..+||+|||.+...... ....||+.|+|||++.+. ..++.++|||||||++|+|++|.+|+.....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred cccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 47999999999765332 223599999999998762 3667899999999999999999987754432
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
. ..+. ... .......+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 237 ~---~~~~---------------------------~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 237 W---HEIR---------------------------QGR---LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp H---HHHH---------------------------TTC---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred H---HHHH---------------------------cCC---CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 1 1110 000 011224688999999999999999999999999999999
Q ss_pred CcC
Q 017301 317 KGL 319 (374)
Q Consensus 317 ~~~ 319 (374)
++.
T Consensus 284 ~~~ 286 (289)
T 1x8b_A 284 LSA 286 (289)
T ss_dssp ---
T ss_pred hhh
Confidence 863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=364.63 Aligned_cols=280 Identities=22% Similarity=0.388 Sum_probs=213.7
Q ss_pred hhhhhhhccccccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCC
Q 017301 5 QTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPD 83 (374)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 83 (374)
+....+.+-++.......++|++++.||+|+||.||+|.+..+|+.||+|++..... ....+.+|+.+++.+ +|||
T Consensus 6 ~~~~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~ 82 (326)
T 2x7f_A 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRN 82 (326)
T ss_dssp ----------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTT
T ss_pred CCCCcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCC
Confidence 334455555655666778999999999999999999999999999999999864322 234677899999998 7999
Q ss_pred ccccceeecCCCcC-CCCcEEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe
Q 017301 84 IVEIKRIMLPPSKR-EFKDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (374)
Q Consensus 84 i~~~~~~~~~~~~~-~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~ 159 (374)
|+++++++...... ....+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 83 i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~ 162 (326)
T 2x7f_A 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL 162 (326)
T ss_dssp BCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred eeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE
Confidence 99999999654321 24578999999986 999999865 479999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeecccccccCCCCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 017301 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236 (374)
Q Consensus 160 ~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 236 (374)
+.++.+||+|||++........ ......||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+.
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 239 (326)
T 2x7f_A 163 TENAEVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239 (326)
T ss_dssp CTTCCEEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cCCCCEEEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 9999999999999876433211 12345799999999998621 15688999999999999999999999987765
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
......+.. ...+ ......+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 240 ~~~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~ 290 (326)
T 2x7f_A 240 MRALFLIPR--------------------------NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290 (326)
T ss_dssp HHHHHHHHH--------------------------SCCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHHhhc--------------------------Cccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence 443332211 0000 01124678999999999999999999999999999999
Q ss_pred CcC
Q 017301 317 KGL 319 (374)
Q Consensus 317 ~~~ 319 (374)
+..
T Consensus 291 ~~~ 293 (326)
T 2x7f_A 291 RDQ 293 (326)
T ss_dssp HCC
T ss_pred hhC
Confidence 754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=357.96 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=206.5
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.. .
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----P 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----C
Confidence 34799999999999999999999999999999999864211 11223467899999999999999999999844 3
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+||||+.+ +|.+++...+.+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 568999999985 9999999888899999999999999999999999999999999999999999999999999976433
Q ss_pred CCCcccccccccccccccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. ......||+.|+|||++.+ .. .+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 164 ~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------- 226 (276)
T 2h6d_A 164 GE----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG----------- 226 (276)
T ss_dssp -----------------CCTGGGTT--SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred Cc----ceecccCCccccCHHHHcC--CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-----------
Confidence 21 1234578999999999876 34 368999999999999999999999887654443332210
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
. ......+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 227 ----------------~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 227 ----------------V----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ----------------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ----------------c----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 0 01123568899999999999999999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=360.30 Aligned_cols=260 Identities=32% Similarity=0.538 Sum_probs=217.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.. ...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CCe
Confidence 478999999999999999999999999999999997544444445678899999999999999999999843 456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC---CCeEEeeeccccccc
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARVAF 177 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~---~~vkl~DFg~a~~~~ 177 (374)
.|+|||++.+ +|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 8999999985 999999887889999999999999999999999999999999999999764 469999999997654
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 176 ~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 238 (287)
T 2wei_A 176 QNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK---------- 238 (287)
T ss_dssp CCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred CCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------
Confidence 3321 234468999999999865 48899999999999999999999999877655444332211
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.......+..+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 239 -----------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 239 -----------------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp -----------------CCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred -----------------CCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 1111122356889999999999999999999999999999998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=359.93 Aligned_cols=266 Identities=23% Similarity=0.386 Sum_probs=212.4
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
......++|++++.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 88 (302)
T 2j7t_A 13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHD-- 88 (302)
T ss_dssp SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--
T ss_pred cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--
Confidence 34566789999999999999999999999999999999986432 23345788999999999999999999999543
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
..+|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 89 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 89 ---GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred ---CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 458999999986 89888865 5679999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCCcccccccccccccccccccccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
...... .......||+.|+|||++.. ....++.++|||||||++|+|++|..||...+.......+...
T Consensus 166 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----- 237 (302)
T 2j7t_A 166 KNLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----- 237 (302)
T ss_dssp HHHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----
T ss_pred cccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc-----
Confidence 422111 11133578999999998731 1157889999999999999999999999887755443332211
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
..+ .......++..+.+||.+||+.||.+|||+.++++||||+...
T Consensus 238 ---------------------~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 238 ---------------------DPP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ---------------------CCC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ---------------------CCc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 000 0011235688999999999999999999999999999998653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=371.07 Aligned_cols=287 Identities=23% Similarity=0.352 Sum_probs=222.8
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-----------CCCccccce
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----------HPDIVEIKR 89 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~ 89 (374)
..++|++++.||+|+||+||+|.+..+++.||+|++.. .......+.+|+.+++.++ ||||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 35799999999999999999999999999999999864 2334556778999988876 899999999
Q ss_pred eecCCCcCCCCcEEEEEccCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEec------
Q 017301 90 IMLPPSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILAN------ 160 (374)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~------ 160 (374)
++.... .....+++|||+++++|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+|||++
T Consensus 94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 986432 223468999999988999999873 4699999999999999999999998 999999999999994
Q ss_pred CCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-----
Q 017301 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS----- 235 (374)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~----- 235 (374)
..+.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~------~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcceEEEcccccccccCCCC------CCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 34479999999997654321 34479999999999987 678999999999999999999999998765
Q ss_pred -hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHH--hcCCC-CCC----------ccccCCCCChHHHHHHHHhccCCC
Q 017301 236 -VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTE--MRKKP-PVP----------LFQKFPNVDPLALRLLQRLIAFDP 301 (374)
Q Consensus 236 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~----------~~~~~~~~s~~~~~li~~~L~~dp 301 (374)
....+..+...++.++...+....... .++.. ..... ... .....+..++.+.+||.+||+.||
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTR--TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHH--HHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhh--hhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 456777788888888776554332211 11000 00000 000 000112345678999999999999
Q ss_pred CCCCCHHHHhcCCCCCcCcc
Q 017301 302 KDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 302 ~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.+|||+.++|+||||++...
T Consensus 323 ~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCTT
T ss_pred cccCCHHHHhhChhhhcccC
Confidence 99999999999999997643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=357.32 Aligned_cols=262 Identities=30% Similarity=0.434 Sum_probs=216.9
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence 35799999999999999999999999999999999976555556667889999999999999999999987542 234
Q ss_pred cEEEEEccCcc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCC-----ccccCCCCCceEecCCCCeEEeee
Q 017301 101 DIYVVFELMES-DLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDF 170 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~LH~~~-----i~H~dikp~Nil~~~~~~vkl~DF 170 (374)
.+|+||||+.+ +|.+++... ..+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 68999999986 999999753 34999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
|+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 161 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--- 232 (279)
T 2w5a_A 161 GLARILNHDTS---FAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--- 232 (279)
T ss_dssp CHHHHC---CH---HHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---
T ss_pred chheeeccccc---cccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc---
Confidence 99976533221 1234578999999999877 678999999999999999999999998876544433332110
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
. ......+++.+.+||.+||+.||.+|||+.++|+|+|+.+-.
T Consensus 233 ------------------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 233 ------------------------F---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp ------------------------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred ------------------------c---ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 0 011235789999999999999999999999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=359.13 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=205.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|+||+||+|.+ +|..||+|++............+.+|+.+++.++||||+++++++.. ...
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----TTC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCc
Confidence 57999999999999999999976 58899999998665566666788999999999999999999999943 345
Q ss_pred EEEEEccCcc-cHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 102 IYVVFELMES-DLHQVIKANDD---LTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~---l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
+++||||+.+ +|.+++...+. +++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 8999999986 99999987653 999999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 189 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------- 255 (309)
T 3p86_A 189 KASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-------- 255 (309)
T ss_dssp ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC--------
T ss_pred cccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------
Confidence 433211 1234579999999999987 678999999999999999999999998877654443322110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc--CCCCCc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKG 318 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~--hp~~~~ 318 (374)
. .......+++.+.+||.+||+.||.+|||+.++++ +++++.
T Consensus 256 ----------------~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 256 ----------------K-----RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ----------------C-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ----------------C-----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 01122468899999999999999999999999988 455543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=378.42 Aligned_cols=269 Identities=17% Similarity=0.184 Sum_probs=194.0
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHHHHHHHhC--CCCCccccce-------eec
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-SDAIRILREVKLLRLL--RHPDIVEIKR-------IML 92 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l--~h~~i~~~~~-------~~~ 92 (374)
..|++++.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.+++.+ +||||++++. ++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45999999999999999999999999999999998654422 3444667775444444 6999887553 332
Q ss_pred CCCcC------------CCCcEEEEEccCcccHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHhhhCCccccCCC
Q 017301 93 PPSKR------------EFKDIYVVFELMESDLHQVIKAND-DLTREHH------QFFLYQMLRALKYMHTANVYHRDLK 153 (374)
Q Consensus 93 ~~~~~------------~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~------~~i~~qi~~al~~LH~~~i~H~dik 153 (374)
..+.. ...++|+||||++++|.+++...+ .+++... ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 22110 114589999999999999998643 3444444 5677999999999999999999999
Q ss_pred CCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 017301 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (374)
Q Consensus 154 p~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~ 233 (374)
|+|||++.++.+||+|||+|+...... ....+|+.|+|||++.+....++.++|||||||++|+|++|+.||.+
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTRG------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCEE------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCCCc------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998643211 13467799999999865335789999999999999999999999987
Q ss_pred CChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 234 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
....... ...... ..............+.+++.+.+||.+||+.||.+|||+.++|+|
T Consensus 296 ~~~~~~~-----~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 296 VTPGIKG-----SWKRPS-----------------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCTTCTT-----CCCBCC-----------------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred cCccccc-----chhhhh-----------------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 6432100 000000 000001111122335789999999999999999999999999999
Q ss_pred CCCCcC
Q 017301 314 PYFKGL 319 (374)
Q Consensus 314 p~~~~~ 319 (374)
|||+++
T Consensus 354 p~f~~~ 359 (371)
T 3q60_A 354 PEFLQL 359 (371)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999865
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=363.45 Aligned_cols=260 Identities=33% Similarity=0.530 Sum_probs=208.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC------ChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 4689999999999999999999999999999999874321 112233577999999999999999999998432
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC---eEEeeec
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFG 171 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~---vkl~DFg 171 (374)
..|+||||+.+ +|.+++..+..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||
T Consensus 88 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 -----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -----SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -----ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 27999999986 99999998889999999999999999999999999999999999999987665 9999999
Q ss_pred ccccccCCCCcccccccccccccccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH-HHHHHhhCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT 249 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~-~~i~~~~~~ 249 (374)
++....... ......||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+......+ ..+......
T Consensus 163 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 163 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp TCEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred cceeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 997653321 1234579999999998742 1256889999999999999999999999876543222 112111111
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.. ...+..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 239 ~~---------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 239 FI---------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CC---------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred cC---------------------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 01 1112467899999999999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=357.36 Aligned_cols=259 Identities=26% Similarity=0.381 Sum_probs=216.7
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
....++|++++.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 91 (303)
T 3a7i_A 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----- 91 (303)
T ss_dssp ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence 3556889999999999999999999999999999999875432 2345678899999999999999999999854
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...+|+||||+++ +|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 3468999999986 99998865 579999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+..
T Consensus 171 ~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 233 (303)
T 3a7i_A 171 DTQI---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------------ 233 (303)
T ss_dssp TTBC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------
T ss_pred cccc---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc------------
Confidence 3221 1244579999999999977 6789999999999999999999999987765443322211
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
. .+ ......+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 234 --------------~-~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 234 --------------N-NP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp --------------S-CC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred --------------C-CC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0 00 11124678999999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=374.09 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=210.4
Q ss_pred CCeeEeceeeccCCeeEEEEEEC---CCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 96 (374)
++|++++.||+|+||+||+|++. .+++.||+|+++.... .......+.+|+.+++.+ .||||+++++++..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 130 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 130 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee---
Confidence 79999999999999999999984 5899999999864221 112233456799999999 69999999999843
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...+|+||||+.+ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 131 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 --ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred --CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 4568999999985 9999999888899999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ......+||+.|+|||++.+....++.++|||||||++|+|++|+.||...........+..
T Consensus 209 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------- 276 (355)
T 1vzo_A 209 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 276 (355)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH----------
T ss_pred cccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH----------
Confidence 432221 12244679999999999876335688999999999999999999999976543222221111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
...... ....+.+++.+.+||.+||+.||.+|| |++++++||||+.+
T Consensus 277 -------------~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 277 -------------RILKSE----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp -------------HHHHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred -------------HHhccC----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 000000 011246789999999999999999999 99999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=359.36 Aligned_cols=257 Identities=27% Similarity=0.453 Sum_probs=209.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++.++||||+++++++.. ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CC
Confidence 4678999999999999999999999999999999987532 23457889999999999999999999954 34
Q ss_pred cEEEEEccCcc-cHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 101 DIYVVFELMES-DLHQVIK-ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~-~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.+|+||||+.+ +|.+++. ....+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 68999999986 9999987 456899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 178 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------ 240 (314)
T 3com_A 178 TMA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN------------ 240 (314)
T ss_dssp TBS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------
T ss_pred hcc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC------------
Confidence 221 1234579999999999877 67899999999999999999999999877654333222110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
. .+.......+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 241 --------------~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 241 --------------P--PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp --------------C--CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred --------------C--CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 0 00111123468899999999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=359.42 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=209.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
-..++|++.+.||+|+||+||+|.+..++. .||+|+++.. ........+.+|+.+++.++||||+++++++.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 120 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVT---- 120 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence 346799999999999999999999986655 5999999753 23455667899999999999999999999994
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.....|+||||+.+ +|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 121 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 121 -RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp -GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred -eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 34458999999985 999999754 589999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
................+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---- 273 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL---- 273 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC----
T ss_pred ccccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC----
Confidence 75444332222334456788999999977 678999999999999999999 99999887766554443321111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 274 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 --------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112467899999999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=361.02 Aligned_cols=273 Identities=25% Similarity=0.368 Sum_probs=193.9
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
-..++|++++.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 85 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK----- 85 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS-----
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----
Confidence 346899999999999999999999999999999998864321 23345678999999999999999999999543
Q ss_pred CcEEEEEccCcc-cHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeee
Q 017301 100 KDIYVVFELMES-DLHQVIKA--------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~--------~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DF 170 (374)
...|+||||+.+ +|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 458999999975 99999874 456999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCC--cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 017301 171 GLARVAFSDTP--MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (374)
Q Consensus 171 g~a~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 248 (374)
|++........ .........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.............
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 99875433211 11112345799999999988642 3588999999999999999999999988765544322211000
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.... ...........+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 245 ~~~~---------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 245 PSLE---------------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCTT---------------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred Cccc---------------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 0000 00011123456889999999999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=360.94 Aligned_cols=286 Identities=19% Similarity=0.305 Sum_probs=210.6
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
....++|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 80 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--- 80 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---
Confidence 4556899999999999999999999999999999999974322 123456779999999999999999999985432
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe----cCCCCeEEeee
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDF 170 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~----~~~~~vkl~DF 170 (374)
...+|+||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 2468999999985 9999998654 39999999999999999999999999999999999998 77788999999
Q ss_pred cccccccCCCCccccccccccccccccccccccc------CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh-HHHHH
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLI 243 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i 243 (374)
|+++....... .....||+.|+|||++... ...++.++|||||||++|+|++|..||....... ....+
T Consensus 161 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 161 GAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred CCceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 99986544322 2345799999999987521 2578899999999999999999999997544322 12222
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 017301 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (374)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~ 315 (374)
.+.....++..+........ ..+. .....+ ........+++.+.+||++||+.||.+|||++|+|+||=
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~-~~~~-~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAEN-GPID-WSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTT-CCEE-EESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccC-Cccc-cCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 22221111111000000000 0000 000000 000111234567889999999999999999999999873
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=358.94 Aligned_cols=270 Identities=22% Similarity=0.338 Sum_probs=197.7
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecC
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLP 93 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 93 (374)
...-..++|++++.||+|+||+||+|.+..++. .||+|+++...........+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 334456899999999999999999999887765 89999997654445567788999999999999999999999965
Q ss_pred CCcC-CCCcEEEEEccCcc-cHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCe
Q 017301 94 PSKR-EFKDIYVVFELMES-DLHQVIKAND------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (374)
Q Consensus 94 ~~~~-~~~~~~lv~e~~~~-~L~~~l~~~~------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~v 165 (374)
.... .....++||||+.+ +|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 5322 12235999999996 9999986532 59999999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 017301 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (374)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 244 (374)
||+|||+++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 177 kl~Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYR-QGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp EECCCCC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred EEeecccccccccccccc-ccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 999999997653332111 1223456788999999877 679999999999999999999 999999877665544432
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-------HHHHhcCCCCC
Q 017301 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-------AEEALADPYFK 317 (374)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-------~~~lL~hp~~~ 317 (374)
... .....+.+++.+.+||.+||+.||.+||| .+++++|||+.
T Consensus 254 ~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 254 GGN------------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp TTC------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred cCC------------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 210 01123467899999999999999999999 88888899987
Q ss_pred cC
Q 017301 318 GL 319 (374)
Q Consensus 318 ~~ 319 (374)
..
T Consensus 304 ~~ 305 (323)
T 3qup_A 304 ST 305 (323)
T ss_dssp --
T ss_pred CC
Confidence 64
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=362.60 Aligned_cols=269 Identities=25% Similarity=0.387 Sum_probs=189.3
Q ss_pred ccccccCCCCCeeEec-eeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHH-HHHHhCCCCCccccceee
Q 017301 14 DFFTEYGDANRYKILE-VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV-KLLRLLRHPDIVEIKRIM 91 (374)
Q Consensus 14 ~~~~~~~~~~~Y~~~~-~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~ 91 (374)
...+.+.+.++|.+.+ .||+|+||+||+|.++.+|+.||+|++... .. ..+|+ ..++.++||||+++++++
T Consensus 19 p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~----~~~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK----ARQEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp -CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH----HHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH----HHHHHHHHHHhcCCCChHHHHHHH
Confidence 3456677889999965 699999999999999999999999998642 11 12233 345667899999999998
Q ss_pred cCCCcCCCCcEEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC---CCe
Q 017301 92 LPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKL 165 (374)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~---~~v 165 (374)
.... .....+++||||+.+ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+
T Consensus 92 ~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 92 ENMH-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EEEE-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred hhcc-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceE
Confidence 5432 223568999999986 9999998764 69999999999999999999999999999999999999864 459
Q ss_pred EEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 017301 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (374)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 245 (374)
||+|||+++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 171 kl~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (336)
T 3fhr_A 171 KLTDFGFAKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243 (336)
T ss_dssp EECCCTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred EEeccccceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence 999999997543321 234578999999999876 6788999999999999999999999976653322111000
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.............+..+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 244 -----------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 244 -----------------------RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred -----------------------hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0000001111123457899999999999999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=359.09 Aligned_cols=264 Identities=25% Similarity=0.429 Sum_probs=191.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHH-HHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++++.||+|+||+||+|.+..+|+.||+|+++.... ......+.+|+. +++.++||||+++++++...
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~----- 93 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE----- 93 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----
Confidence 35899999999999999999999999999999999975432 334445566666 67778999999999999543
Q ss_pred CcEEEEEccCcccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeeccc
Q 017301 100 KDIYVVFELMESDLHQVIKA-----NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
...|+||||+.++|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 46899999999998888863 56899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccc--cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
+....... .....||+.|+|||++.. ....++.++|||||||++|+|++|..||.+.+... ..+..
T Consensus 174 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~------ 241 (327)
T 3aln_A 174 GQLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQ------ 241 (327)
T ss_dssp CC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CC------
T ss_pred eecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHH------
Confidence 76533221 133479999999999832 11568999999999999999999999997653210 00000
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
......+.........+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 242 -----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 242 -----------------VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp -----------------CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -----------------HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 000011111112234688999999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=360.44 Aligned_cols=253 Identities=24% Similarity=0.393 Sum_probs=208.0
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 93 (374)
.++|++++.||+|+||+||+|.+. .++..||+|+++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 478999999999999999999874 34568999999754 3344566789999999999 89999999999943
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~N 156 (374)
...+|+||||+.+ +|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 3458999999986 9999998653 47899999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 017301 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (374)
Q Consensus 157 il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 235 (374)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999865432211 11233467889999999877 679999999999999999999 999998876
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..+....+... .. ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 311 ~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKEG---------------------------HR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHTT---------------------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcC---------------------------CC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55444332211 00 01124678899999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=363.95 Aligned_cols=257 Identities=21% Similarity=0.323 Sum_probs=208.6
Q ss_pred CCCeeEeceeeccCCeeEEEEE-----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
.++|++++.||+|+||+||+|. +..++..||+|+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 4789999999999999999999 5567889999998643 334555678899999999999999999999944
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC---Ce
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KL 165 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~-------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~---~v 165 (374)
....|+||||+.+ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 146 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 --SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred --CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 3457999999975 999999764 3589999999999999999999999999999999999999655 49
Q ss_pred EEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 017301 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (374)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 244 (374)
||+|||+|+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999754222111 11133468999999999877 679999999999999999998 999998887655544432
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
.... ......+++.+.+||.+||+.||.+|||+.++++|.++-
T Consensus 301 ~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGR------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCC------------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2110 011245788999999999999999999999999997753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=352.32 Aligned_cols=263 Identities=22% Similarity=0.354 Sum_probs=194.9
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++++.||+|+||+||+|.+..+|+.||+|++............+..+..+++.++||||+++++++.. ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CC
Confidence 3579999999999999999999999999999999997543333333344455567888899999999999954 34
Q ss_pred cEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~-~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.+|+||||+++.+..+... ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 6899999997666666654 56899999999999999999999996 999999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHhhCCCCHHH
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQLDLITDLLGTPSPET 254 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 254 (374)
... .....||+.|+|||++.+ ....++.++|||||||++|+|++|+.||..... .+.+..+..
T Consensus 178 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (318)
T 2dyl_A 178 DKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--------- 244 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH---------
T ss_pred Ccc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc---------
Confidence 221 234579999999999852 115688999999999999999999999986432 222222111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
... +.......+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 245 -----------------~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 245 -----------------EEP--PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp -----------------SCC--CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred -----------------cCC--CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 000 11112246789999999999999999999999999999998653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=351.01 Aligned_cols=265 Identities=26% Similarity=0.321 Sum_probs=207.4
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC--CCCccccceeecCCCc
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSK 96 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~ 96 (374)
....++|++++.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.++ ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--- 99 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--- 99 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC---
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec---
Confidence 344578999999999999999999885 5889999999765555566778899999999997 5999999999844
Q ss_pred CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
...+|+|||+.+++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++. +.+||+|||++...
T Consensus 100 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 100 --DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp --SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred --CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 346899999877899999999889999999999999999999999999999999999999964 78999999999765
Q ss_pred cCCCCccccccccccccccccccccccc---------CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
..... ........||+.|+|||++.+. ...++.++|||||||++|+|++|..||....... ..+...
T Consensus 177 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~- 252 (313)
T 3cek_A 177 QPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAI- 252 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHH-
T ss_pred cCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--HHHHHH-
Confidence 33222 1122345799999999998641 1368889999999999999999999997653211 111100
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..... ........++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 253 ----------------------~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 253 ----------------------IDPNH---EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp ----------------------HCTTS---CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ----------------------Hhccc---ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 00000 011123457889999999999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=362.85 Aligned_cols=273 Identities=19% Similarity=0.314 Sum_probs=211.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh---------------HHHHHHHHHHHHHHhCCCCCccc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---------------SDAIRILREVKLLRLLRHPDIVE 86 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~i~~ 86 (374)
.++|++++.||+|+||.||+|.+ +|+.||+|++....... .....+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 57999999999999999999998 89999999986321110 11167889999999999999999
Q ss_pred cceeecCCCcCCCCcEEEEEccCcc-cHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCc
Q 017301 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQV------IKA--NDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKN 156 (374)
Q Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~------l~~--~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~N 156 (374)
+++++.. ...+|+||||+.+ +|.++ +.. ...+++..++.++.|++.||+|||+ +||+||||||+|
T Consensus 108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999954 3568999999996 99988 665 5689999999999999999999999 999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCC
Q 017301 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKS 235 (374)
Q Consensus 157 il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwSlG~il~~lltg~~pf~~~~ 235 (374)
|+++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|||||||++|+|++|..||.+.+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999765332 22456799999999998762 25655 9999999999999999999998876
Q ss_pred h-hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 017301 236 V-VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (374)
Q Consensus 236 ~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp 314 (374)
. .+....+...... .+...... .............+.+++.+.+||.+||+.||.+|||+.++|+||
T Consensus 257 ~~~~~~~~i~~~~~~-~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 257 SLVELFNNIRTKNIE-YPLDRNHF-----------LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp CSHHHHHHHTSCCCC-CCCSSSSS-----------TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred cHHHHHHHHhccCcC-Cccchhhh-----------hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 5 3333332211000 00000000 000000000111256899999999999999999999999999999
Q ss_pred CCCcC
Q 017301 315 YFKGL 319 (374)
Q Consensus 315 ~~~~~ 319 (374)
||++.
T Consensus 325 ~f~~~ 329 (348)
T 2pml_X 325 WLADT 329 (348)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=344.41 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=206.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSS
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCc
Confidence 479999999999999999999986 5778999999754333 3467899999999999999999999943 445
Q ss_pred EEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.|+||||+.+ +|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 8999999986 999999764 46899999999999999999999999999999999999999999999999999754322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 160 ~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------- 225 (269)
T 4hcu_A 160 Q--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------- 225 (269)
T ss_dssp H--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred c--cccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----------
Confidence 1 111234457788999999877 679999999999999999999 9999988776554443322100
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.......++.+.+||.+||+.||.+|||+.++++|
T Consensus 226 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 226 --------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 01123468899999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=349.06 Aligned_cols=260 Identities=24% Similarity=0.400 Sum_probs=210.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++++.||+|+||+||+|.+..+++.||+|++.. ........+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 80 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DK 80 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CC
Confidence 35899999999999999999999999999999999854 344566778999999999999999999999953 35
Q ss_pred cEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 101 DIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
..++||||+.+ +|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 68999999986 99999987 56799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCcc-----------cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 179 DTPMT-----------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 179 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------ 232 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------ 232 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------
Confidence 32211 01124579999999999987 789999999999999999999999987643211000
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
........... ..+.+++.+.+||.+||+.||.+|||+.++++ |+..+
T Consensus 233 ------------~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 233 ------------GLNVRGFLDRY----------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp ------------SBCHHHHHHHT----------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred ------------hhhhhcccccc----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 00011111110 12467889999999999999999999999987 56554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=346.84 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=204.7
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|.....||+|+||+||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 94 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFI 94 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcE
Confidence 34555568999999999999999999999999987532 2345578899999999999999999999943 3568
Q ss_pred EEEEccCcc-cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-CCCeEEeeeccccccc
Q 017301 103 YVVFELMES-DLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAF 177 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~-~~~vkl~DFg~a~~~~ 177 (374)
++||||+.+ +|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999999975 9999998652 5678999999999999999999999999999999999987 8999999999997653
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......||+.|+|||++.+....++.++|||||||++|+|++|+.||.............
T Consensus 175 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------------- 238 (295)
T 2clq_A 175 GINP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV------------- 238 (295)
T ss_dssp C--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-------------
T ss_pred CCCC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-------------
Confidence 3221 123457999999999986632348899999999999999999999997543221110000
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
...... ......+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 239 -----------~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 239 -----------GMFKVH----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -----------HHHCCC----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -----------cccccc----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 000000 11224678999999999999999999999999999999854
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=347.35 Aligned_cols=263 Identities=28% Similarity=0.402 Sum_probs=201.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC------
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS------ 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 95 (374)
.++|++++.||+|+||+||+|.+..+++.||+|++.. .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 4689999999999999999999999999999999863 2344567889999999999999999999885432
Q ss_pred --cCCCCcEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeec
Q 017301 96 --KREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (374)
Q Consensus 96 --~~~~~~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg 171 (374)
......+|+||||+.+ +|.+++...+ .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 1234678999999985 9999998654 67889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC-----------cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-hhH
Q 017301 172 LARVAFSDTP-----------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQ 239 (374)
Q Consensus 172 ~a~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~ 239 (374)
++........ .........||+.|+|||++.+. ..++.++|||||||++|+|++ ||..... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9976432210 01122345789999999998752 468999999999999999998 5543211 111
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
... +...............++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 238 ~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 238 LKK---------------------------LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHH---------------------------HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHh---------------------------ccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 111 1111111111122456778999999999999999999999999999974
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=358.55 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=208.6
Q ss_pred CCCeeEeceeeccCCeeEEEEE-----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 95 (374)
.++|++++.||+|+||+||+|. +..+++.||+|+++.. ........+.+|+.+++.+ +||||+++++++...+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 4899999999999999999998 5667799999999753 3344556789999999999 7999999999985432
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCCC----------------------------------------------------
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKANDD---------------------------------------------------- 122 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~---------------------------------------------------- 122 (374)
..+++||||+.+ +|.+++.....
T Consensus 100 ----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 100 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp ----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 348999999996 99999986543
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCccccccc
Q 017301 123 --------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (374)
Q Consensus 123 --------------l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~ 188 (374)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~ 254 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGD 254 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC-EEC--
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc-hhccc
Confidence 899999999999999999999999999999999999999999999999999765333221 22345
Q ss_pred ccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHH
Q 017301 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267 (374)
Q Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 267 (374)
..||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.............
T Consensus 255 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--------------------- 311 (359)
T 3vhe_A 255 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--------------------- 311 (359)
T ss_dssp CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---------------------
T ss_pred cCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---------------------
Confidence 578999999999877 689999999999999999998 99999887644333222110
Q ss_pred HHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.. . ......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 312 --~~-~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 312 --GT-R-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp --TC-C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CC-C-----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 00 0 01124578899999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=349.38 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=203.3
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
.-..++|++.+.||+|+||+||+|.+.. ++..||+|+++...........+.+|+.+++.++||||+++++++....
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3456899999999999999999998765 5568999999765555666678899999999999999999999997665
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEe
Q 017301 96 KREFKDIYVVFELMES-DLHQVIK------ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~------~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~ 168 (374)
.......++||||+.+ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 4444567999999995 9999984 33579999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhh
Q 017301 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 247 (374)
|||++......... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus 190 Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 190 DFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp SCSCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred ecCcceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 99999765332211 11233457889999999977 689999999999999999999 899998877655444332210
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
. ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 267 ~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 R------------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp C------------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred C------------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 01124678999999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=357.58 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=209.7
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhCC--CCCccccceeec
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLR--HPDIVEIKRIML 92 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~ 92 (374)
....++|++++.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 356789999999999999999999999999999999986432211 11234567999999996 599999999994
Q ss_pred CCCcCCCCcEEEEEccCc--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec-CCCCeEEee
Q 017301 93 PPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCD 169 (374)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~-~~~~vkl~D 169 (374)
. ....++|||++. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 119 ~-----~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 R-----PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp C-----SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred c-----CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 3 356899999997 59999999888999999999999999999999999999999999999999 678999999
Q ss_pred ecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
||+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||..... +.
T Consensus 194 fg~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~----- 256 (320)
T 3a99_A 194 FGSGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II----- 256 (320)
T ss_dssp CTTCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH-----
T ss_pred Ccccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh-----
Confidence 99997654322 2345799999999988662 3347889999999999999999999965321 00
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.... .....+++.+.+||.+||+.||.+|||++++++||||++..
T Consensus 257 ---------------------~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 257 ---------------------RGQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp ---------------------HCCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ---------------------cccc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 0000 11246789999999999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=345.06 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=204.9
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
-..++|++++.||+|+||+||+|.+. ++..||+|+++..... ...+.+|+.+++.++||||+++++++. ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~ 91 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQ 91 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEe-----cC
Confidence 45689999999999999999999775 6778999999754333 345789999999999999999999994 44
Q ss_pred CcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
..+|+||||+.+ +|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 568999999975 99999976 4579999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 172 ~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------- 240 (283)
T 3gen_A 172 DDE--YTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------- 240 (283)
T ss_dssp CHH--HHSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------
T ss_pred ccc--cccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC-------
Confidence 221 111233457788999999887 678999999999999999998 99999887765544443321110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
......++.+.+||.+||+.||.+|||+.++++|
T Consensus 241 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 -----------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1123468899999999999999999999999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=345.80 Aligned_cols=260 Identities=18% Similarity=0.201 Sum_probs=208.2
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
-..++|++++.||+|+||+||+|.+..+++.||+|++..... ...+.+|+.+++.+ +|+|++++++++ ..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~ 77 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFG-----QE 77 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeec-----CC
Confidence 346899999999999999999999999999999999864322 23467899999999 799999999988 34
Q ss_pred CCcEEEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC-----eEEeeecc
Q 017301 99 FKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-----LKVCDFGL 172 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~-----vkl~DFg~ 172 (374)
....|+||||++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+
T Consensus 78 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 78 GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred CceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 45689999999779999998754 6999999999999999999999999999999999999987776 99999999
Q ss_pred cccccCCCCcc----cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 017301 173 ARVAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (374)
Q Consensus 173 a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 248 (374)
++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 98654432211 11245679999999999887 6789999999999999999999999988543322222111100
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.. ...+.....+.+++.+.+||.+||+.||.+|||++++++.
T Consensus 236 --------------------~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 236 --------------------KK---QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp --------------------HH---HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred --------------------hc---cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00 0001111234688999999999999999999999999873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=352.95 Aligned_cols=255 Identities=18% Similarity=0.192 Sum_probs=205.7
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
-..++|++++.||+|+||+||+|.+..+|+.||+|++..... ...+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----- 76 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPC----- 76 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEec-----
Confidence 346899999999999999999999999999999999864322 22467899999999 89999999999844
Q ss_pred CCcEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC-----eEEeeecc
Q 017301 99 FKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-----LKVCDFGL 172 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~-----vkl~DFg~ 172 (374)
....|+||||++++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 77 GKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred CCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 456899999997799999987 468999999999999999999999999999999999999998887 99999999
Q ss_pred cccccCCCCccc----ccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh-
Q 017301 173 ARVAFSDTPMTV----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL- 247 (374)
Q Consensus 173 a~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~- 247 (374)
|+.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 986543322111 1245689999999999988 679999999999999999999999998865443332222110
Q ss_pred --CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 248 --GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 248 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
...+.. ......+ .+.+||..||+.||.+|||++++++
T Consensus 235 ~~~~~~~~--------------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 TKRATPIE--------------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHSCHH--------------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCCHH--------------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000000 0012233 8999999999999999999999887
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=349.13 Aligned_cols=272 Identities=21% Similarity=0.339 Sum_probs=207.0
Q ss_pred CCCCCeeEeceeeccCCeeEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
-..++|++++.||+|+||+||+|+ +..+++.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 345899999999999999999998 6678999999998743 3455567889999999999999999999985432
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccc
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
...+++||||+.+ +|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 85 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 85 ---RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp ---HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred ---CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 2457999999975 9999998765 5999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
+................+++.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~ 234 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQG 234 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCT
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCcccc
Confidence 865443322222234467888999999887 67999999999999999999999998654321 11111211110
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. .........+...... .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 235 ~------~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 235 Q------MIVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp H------HHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c------hhHHHHHHHHhccCcC---CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 0011112222222111 123468899999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=341.98 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=205.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|.+. ++..||+|+++..... ...+.+|+.+++.++||||+++++++. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYP 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSS
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCc
Confidence 478999999999999999999775 5778999999754332 345789999999999999999999983 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.|+||||+.+ +|.+++...+ .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 8999999985 8999998754 5999999999999999999999999999999999999999999999999999765433
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...+.......+.....
T Consensus 158 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (268)
T 3sxs_A 158 QYV--SSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR---------- 223 (268)
T ss_dssp CEE--ECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred hhh--cccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC----------
Confidence 221 1234456788999999877 678999999999999999999 9999988776544433321100
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.......++.+.+||.+||+.||.+|||+.++++|
T Consensus 224 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 224 --------------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01113468899999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=348.86 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=209.9
Q ss_pred CCCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
..++|++.+.||+|+||.||+|.+. .++..||+|+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--
Confidence 3579999999999999999999973 45689999998743 334556678899999999999999999999843
Q ss_pred cCCCCcEEEEEccCc-ccHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 017301 96 KREFKDIYVVFELME-SDLHQVIKANDD------------------------LTREHHQFFLYQMLRALKYMHTANVYHR 150 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~------------------------l~~~~~~~i~~qi~~al~~LH~~~i~H~ 150 (374)
....|+||||+. ++|.+++..... +++..+..++.||+.||+|||++||+||
T Consensus 98 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 98 ---DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred ---CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 345899999998 499999987543 8999999999999999999999999999
Q ss_pred CCCCCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCC
Q 017301 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (374)
Q Consensus 151 dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~ 229 (374)
||||+||+++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchheEEEcCCCCEEEccccccccccccccc-eeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999765433221 11234467889999999877 678999999999999999999 999
Q ss_pred CCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHH
Q 017301 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (374)
Q Consensus 230 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~ 309 (374)
||.+.+.......+.... .......+++.+.+||.+||+.||.+|||+.+
T Consensus 252 p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGH------------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp SSTTCCGGGHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHhhcCC------------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 998877654443332110 01122468899999999999999999999999
Q ss_pred HhcC
Q 017301 310 ALAD 313 (374)
Q Consensus 310 lL~h 313 (374)
++++
T Consensus 302 l~~~ 305 (314)
T 2ivs_A 302 ISKD 305 (314)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=342.96 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=198.3
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
..++|++++.||+|+||+||+|.+..+ +..||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 87 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---- 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc----
Confidence 357999999999999999999998654 457999988643 334455678899999999999999999999732
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...|+||||+.+ +|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 88 --NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred --CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 347999999996 9999998654 799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~------- 234 (281)
T 1mp8_A 166 MEDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE------- 234 (281)
T ss_dssp ---------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred cCccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-------
Confidence 5432211 1133457788999999876 678999999999999999997 999998877655544332110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
. ....+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus 235 --------------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 235 --------------------R---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp --------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------C---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 11235688999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=343.30 Aligned_cols=251 Identities=22% Similarity=0.407 Sum_probs=211.3
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
-..++|++.+.||+|+||+||+|.+..++..||+|++... ......+.+|+.+++.++||||+++++++. ..
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~ 81 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----RE 81 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cC
Confidence 4568899999999999999999999999999999998743 234567889999999999999999999984 34
Q ss_pred CcEEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
..+|+||||+.+ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 558999999995 999999874 35999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 162 ~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~------- 230 (288)
T 3kfa_A 162 TGDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------- 230 (288)
T ss_dssp CSSSS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-------
T ss_pred cCCcc--ccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC-------
Confidence 43322 12244567889999999877 678999999999999999999 9999988775544433322100
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 231 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 -----------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1112467899999999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=367.57 Aligned_cols=259 Identities=27% Similarity=0.389 Sum_probs=193.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..+|.+.+.||+|+||+|+. ....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++. ...
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~ 91 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEK-----DRQ 91 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEE-----ETT
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEe-----cCC
Confidence 35799999999999999763 3457899999999864321 1245799999999 7999999999984 445
Q ss_pred cEEEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-----CCCeEEeeecccc
Q 017301 101 DIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-----NCKLKVCDFGLAR 174 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~-----~~~vkl~DFg~a~ 174 (374)
.+|+|||+|+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ...+||+|||+|+
T Consensus 92 ~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 92 FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 689999999999999998754 4566677899999999999999999999999999999953 2358899999998
Q ss_pred cccCCCCccccccccccccccccccccccc-CCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
...............+||+.|+|||++.+. ...++.++|||||||++|+|++ |..||....... ...+ .+.
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~---~~~--- 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANIL---LGA--- 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHH---TTC---
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHH---hcc---
Confidence 654332222223456799999999998642 2567889999999999999999 899996543321 1111 111
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
............+..+.+||.+||+.||.+|||+.++|+||||..+
T Consensus 245 ---------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 245 ---------------------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp ---------------------CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ---------------------CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 0001011112235568899999999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=344.04 Aligned_cols=254 Identities=20% Similarity=0.298 Sum_probs=206.9
Q ss_pred CCCCeeEec-eeeccCCeeEEEEE--ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 21 DANRYKILE-VIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 21 ~~~~Y~~~~-~lg~G~~g~V~~a~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
..++|++.+ .||+|+||+||+|. +..+++.||+|+++...........+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC----
Confidence 357999998 99999999999995 45678899999998654444556678899999999999999999999822
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
...|+||||+.+ +|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 90 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 --ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred --CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 347999999985 99999999888999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..............+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---------- 235 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------- 235 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----------
T ss_pred ccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------
Confidence 443332222233456788999999876 678899999999999999999 9999988775543333221
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... ......+++.+.++|.+||+.||.+|||+.++++
T Consensus 236 -----------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 236 -----------------GER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 1112467899999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=354.65 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=209.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 93 (374)
.++|++++.||+|+||+||+|.+.. .+..||+|+++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4799999999999999999999753 3358999999754 3445567788999999999 89999999999944
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~N 156 (374)
...+|+||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 147 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 147 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred -----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 3458999999986 9999998754 49999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 017301 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (374)
Q Consensus 157 il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 235 (374)
||++.++.+||+|||+|+........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999765432211 11234467889999999887 789999999999999999999 999998877
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..+....+... .. ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 299 ~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKEG---------------------------HR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTT---------------------------CC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcC---------------------------CC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55444333211 00 11124678999999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=345.23 Aligned_cols=256 Identities=27% Similarity=0.355 Sum_probs=200.5
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
...++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----- 105 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI----- 105 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----
Confidence 345899999999999999999999999999999999875432 33345678899999999999999999999843
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...+|+||||+.+ +|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 4568999999986 999999988889999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 186 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------------- 248 (309)
T 2h34_A 186 DEKL--TQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN------------- 248 (309)
T ss_dssp -------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-------------
T ss_pred cccc--ccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-------------
Confidence 3221 11234579999999999877 678999999999999999999999998765432111111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-CHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-t~~~lL~ 312 (374)
... .......+.+++.+.+||.+||+.||.+|| |++++++
T Consensus 249 --------------~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 249 --------------QAI-PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp --------------SCC-CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred --------------cCC-CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 111 111223467899999999999999999999 7888765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=346.20 Aligned_cols=256 Identities=24% Similarity=0.355 Sum_probs=202.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCC----cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
-..++|++.+.||+|+||+||+|.+..++ ..||+|+++... .......+.+|+.+++.++||||+++++++.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 116 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--- 116 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe---
Confidence 45689999999999999999999987553 359999997532 3445567889999999999999999999984
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccc
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
.....++||||+.+ +|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 117 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 117 --KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp --SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred --cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 34568999999986 999999765 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
+................+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---- 268 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---- 268 (333)
T ss_dssp ----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----
T ss_pred hhhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc----
Confidence 865443222222233456788999999877 678999999999999999999 9999988765544433321100
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
. .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 269 ---------------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 269 ---------------------L-----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ---------------------C-----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------C-----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 1124578899999999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=356.49 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=196.3
Q ss_pred CCCCeeEeceeeccCCeeEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
..++|++.+.||+|+||+||+|++. .++..||+|+++... .......+.+|+.+++.++||||+++++++..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---- 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK---- 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----
Confidence 3468999999999999999999876 467789999987532 34556678999999999999999999999943
Q ss_pred CCCcEEEEEccCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 98 EFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...+|+||||+. ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 118 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 118 -SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred -CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 345899999997 49999998754 799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
...............+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~------ 268 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR------ 268 (373)
T ss_dssp -----------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE------
T ss_pred cccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 5433222111122345778999999877 679999999999999999998 9999988776544433321100
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 269 ------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 269 ------------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ------------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0112357889999999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=339.73 Aligned_cols=261 Identities=21% Similarity=0.253 Sum_probs=199.2
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
+.--..++|++.+.||+|+||+||+|.+. ..||+|+++...........+.+|+.+++.++||||++++++...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 91 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--- 91 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---
Confidence 33345678999999999999999999753 359999998766666677789999999999999999999996522
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
...++||||+.+ +|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 92 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 92 ---PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp ---SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred ---CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecc
Confidence 347999999985 99999964 4579999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCccccccccccccccccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
....... ........||+.|+|||++... ...++.++|||||||++|+|++|+.||.+....+.+..+....
T Consensus 169 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------ 241 (289)
T 3og7_A 169 EKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG------ 241 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT------
T ss_pred ccccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc------
Confidence 5432221 1122445799999999988521 2568889999999999999999999998866544433322110
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
............+++.+.+||.+||+.||.+|||+.++++
T Consensus 242 -------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 242 -------------------SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -------------------SCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------ccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1111122233568899999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=338.94 Aligned_cols=253 Identities=24% Similarity=0.293 Sum_probs=204.1
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHH-----HHHHHHHHHHHhCCCCCccccceeecCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-----IRILREVKLLRLLRHPDIVEIKRIMLPP 94 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 94 (374)
-..++|++.+.||+|+||+||+|.+..+++.||+|++.......... ..+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 45689999999999999999999999999999999986533322221 5688999999999999999999998432
Q ss_pred CcCCCCcEEEEEccCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEecCCCC-----e
Q 017301 95 SKREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCK-----L 165 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~~~~~-----v 165 (374)
.++||||+. ++|.+.+... ..+++..+..++.|++.||+|||++| |+||||||+||+++.++. +
T Consensus 96 -------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 -------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 279999998 5998888654 47999999999999999999999999 999999999999988776 9
Q ss_pred EEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 017301 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (374)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 245 (374)
||+|||+++..... .....||+.|+|||++.+....++.++|||||||++|+|++|+.||...+.........
T Consensus 169 kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~- 241 (287)
T 4f0f_A 169 KVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM- 241 (287)
T ss_dssp EECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH-
T ss_pred EeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH-
Confidence 99999999743221 24457999999999985433668899999999999999999999998765332211000
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
...... .......+++.+.+||.+||+.||.+|||+.++++
T Consensus 242 ---------------------~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 242 ---------------------IREEGL-----RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ---------------------HHHSCC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------HhccCC-----CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000000 01123467899999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=350.94 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=208.9
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 94 (374)
-..++|++++.||+|+||+||+|.+. .+++.||+|+++... .......+.+|+.+++.++||||+++++++..
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV- 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-
Confidence 34579999999999999999999987 455899999987532 34455678899999999999999999999943
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKAN------------------------DDLTREHHQFFLYQMLRALKYMHTANVYH 149 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H 149 (374)
...+|+||||+.+ +|.+++... ..+++..+..++.||+.||+|||++||+|
T Consensus 122 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 122 ----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred ----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3558999999986 999999864 56899999999999999999999999999
Q ss_pred cCCCCCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CC
Q 017301 150 RDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228 (374)
Q Consensus 150 ~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~ 228 (374)
|||||+||+++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCC
Confidence 999999999999999999999999764332111 11234468899999999877 679999999999999999999 99
Q ss_pred CCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHH
Q 017301 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308 (374)
Q Consensus 229 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 308 (374)
.||.+.+..+....+.. ... ......+++.+.+||.+||+.||.+|||+.
T Consensus 275 ~p~~~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 324 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVRD---------------------------GNI---LACPENCPLELYNLMRLCWSKLPADRPSFC 324 (343)
T ss_dssp CTTTTSCHHHHHHHHHT---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CcCCCCChHHHHHHHhC---------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 99988765544433221 000 011246788999999999999999999999
Q ss_pred HHhcC
Q 017301 309 EALAD 313 (374)
Q Consensus 309 ~lL~h 313 (374)
+++++
T Consensus 325 ~~~~~ 329 (343)
T 1luf_A 325 SIHRI 329 (343)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=350.28 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=201.1
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhC----CCCCccccce
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLL----RHPDIVEIKR 89 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~~i~~~~~ 89 (374)
.....++|++++.||+|+||+||+|.+..+++.||+|+++...... .....+.+|+.+++.+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3455689999999999999999999999999999999996533221 1223456799999988 8999999999
Q ss_pred eecCCCcCCCCcEEEEEcc-Cc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec-CCCCeE
Q 017301 90 IMLPPSKREFKDIYVVFEL-ME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLK 166 (374)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~-~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~-~~~~vk 166 (374)
++.. ....++|||+ +. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++ .++.+|
T Consensus 106 ~~~~-----~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 106 WFET-----QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EC----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEE
T ss_pred EEec-----CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEE
Confidence 9843 3457999998 55 59999999888899999999999999999999999999999999999999 789999
Q ss_pred EeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 017301 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (374)
Q Consensus 167 l~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 246 (374)
|+|||++....... .....||+.|+|||++.+. ...+.++|||||||++|+|++|+.||..... +.
T Consensus 181 l~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~-- 246 (312)
T 2iwi_A 181 LIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE------IL-- 246 (312)
T ss_dssp ECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH--
T ss_pred EEEcchhhhcccCc-----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hh--
Confidence 99999998654322 2345799999999988662 2335589999999999999999999965321 00
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
. .. ......+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 247 ---------------------~---~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 247 ---------------------E---AE-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp ---------------------H---TC-----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ---------------------h---hc-----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 0 00 011246789999999999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=344.46 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=208.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 95 (374)
.++|++++.||+|+||+||+|.+ ..+++.||+|+++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 47999999999999999999984 457789999999753 3334556788999999999 89999999999944
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKAND------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~------------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~N 156 (374)
....++||||+.+ +|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ---CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 3458999999986 9999998754 48999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 017301 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (374)
Q Consensus 157 il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 235 (374)
|+++.++.+||+|||++......... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999765443321 12234567889999999877 679999999999999999999 999998766
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.......... .... ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~-----------------------~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIK-----------------------EGFR------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHH-----------------------HTCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhc-----------------------cCCC------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 4433322211 1000 01124578999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=358.09 Aligned_cols=252 Identities=21% Similarity=0.353 Sum_probs=206.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|+||+||+|.+..+++.||+|+++.. ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCC
Confidence 46899999999999999999999999999999998743 233444568899999999999999999999943 345
Q ss_pred EEEEEccCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+|+||||+. |+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 899999998 49999997654 6999999999999999999999999999999999999999999999999999753322
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. ........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 267 ~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------- 332 (377)
T 3cbl_A 267 VY-AASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG----------- 332 (377)
T ss_dssp EE-ECCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-----------
T ss_pred ce-eecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 11 000112235778999999876 678999999999999999998 999998876544433322100
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 333 --------------~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 333 --------------RL-----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --------------CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CC-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 112357889999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=351.16 Aligned_cols=274 Identities=22% Similarity=0.220 Sum_probs=206.0
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
-..++|++++.||+|+||+||+|.+. ++.||+|++... ........+|+.+++.++||||+++++++.... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCC
Confidence 34589999999999999999999765 889999998642 233445667999999999999999999986543 223
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC----------CccccCCCCCceEecCCCCeEEe
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA----------NVYHRDLKPKNILANANCKLKVC 168 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~----------~i~H~dikp~Nil~~~~~~vkl~ 168 (374)
..+|+||||+.+ +|.+++... .+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 458999999986 999999775 599999999999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 017301 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (374)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 245 (374)
|||+|+........ .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+............
T Consensus 174 DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 174 DFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred cCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999765443221 122346799999999998652 12456688999999999999999999987654332222222
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCc-cccC--CCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPL-FQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
....+.... ...........+. ...+ ...++.+.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLED-----------MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHH-----------HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhh-----------hhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222222221 1111111111111 1111 112345899999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=338.60 Aligned_cols=257 Identities=21% Similarity=0.241 Sum_probs=206.0
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++++.||+|+||+||+|++..+++.||+|++...... ..+.+|+.+++.++|++++..+..+.. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~ 77 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA----EG 77 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEE----ET
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccC----CC
Confidence 3568999999999999999999999999999999998654322 247789999999999988877766632 33
Q ss_pred CcEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe---cCCCCeEEeeeccccc
Q 017301 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARV 175 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~---~~~~~vkl~DFg~a~~ 175 (374)
...++||||++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 56899999997799999974 4579999999999999999999999999999999999999 4788999999999986
Q ss_pred ccCCCCcc----cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh---hHHHHHHHhhC
Q 017301 176 AFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV---HQLDLITDLLG 248 (374)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~ 248 (374)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. .....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 54432211 11245579999999999987 67999999999999999999999999875432 12222211000
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. +.....+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 236 ~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 ST--------------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HS--------------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CC--------------------------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 00 001112467899999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=348.53 Aligned_cols=253 Identities=21% Similarity=0.344 Sum_probs=199.5
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEE----EEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKV----AIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..++|++++.||+|+||+||+|.+..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--
Confidence 4578999999999999999999998887754 777665322 223345788999999999999999999999543
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
..++|+|++.+ +|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 90 ----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 ----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ----SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred ----CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 26888998885 99999987 4579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 166 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----- 237 (327)
T 3poz_A 166 LLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----- 237 (327)
T ss_dssp HHTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----
T ss_pred EccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC-----
Confidence 65443221 11234457889999999887 789999999999999999999 9999988766544333321110
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
....+..+..+.+|+.+||+.||.+|||+.+++++
T Consensus 238 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 238 -------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 01124578899999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=350.04 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=205.8
Q ss_pred CCCCeeEeceeeccCCeeEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 94 (374)
..++|++++.||+|+||+||+|.+ ..++..||+|+++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence 347999999999999999999997 3466789999997432 223445788999999999 89999999999954
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKAND-----------------------DLTREHHQFFLYQMLRALKYMHTANVYHR 150 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~ 150 (374)
...+|+||||+.+ +|.+++.... .+++..+..++.||+.||+|||++||+||
T Consensus 121 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 121 ----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred ----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 3458999999985 9999998653 37999999999999999999999999999
Q ss_pred CCCCCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCC
Q 017301 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (374)
Q Consensus 151 dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~ 229 (374)
||||+||+++.++.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999765443321 12234567889999999877 679999999999999999998 999
Q ss_pred CCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHH
Q 017301 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (374)
Q Consensus 230 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~ 309 (374)
||.+.+.......+.. .... ......+++.+.+||.+||+.||.+|||+.+
T Consensus 274 p~~~~~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQ--------------------------NGFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp SSTTCCCSHHHHHHHH--------------------------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CcccCCcHHHHHHHHh--------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9988764433322211 0000 0112457899999999999999999999999
Q ss_pred HhcCC
Q 017301 310 ALADP 314 (374)
Q Consensus 310 lL~hp 314 (374)
+++|.
T Consensus 325 l~~~l 329 (344)
T 1rjb_A 325 LTSFL 329 (344)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=340.56 Aligned_cols=257 Identities=20% Similarity=0.230 Sum_probs=202.1
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++++.||+|+||+||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+.. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----EG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecC----CC
Confidence 456899999999999999999999999999999998754322 2246789999999999988887777643 33
Q ss_pred CcEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe---cCCCCeEEeeeccccc
Q 017301 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARV 175 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~---~~~~~vkl~DFg~a~~ 175 (374)
...++||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 56899999998799999985 4579999999999999999999999999999999999999 7889999999999986
Q ss_pred ccCCCCcc----cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh---HHHHHHHhhC
Q 017301 176 AFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH---QLDLITDLLG 248 (374)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~---~~~~i~~~~~ 248 (374)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... ....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 54432211 11235679999999999987 679999999999999999999999998754322 1111111000
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. .+.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 236 ~--------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 236 S--------------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp H--------------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred c--------------------------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 0 0011112467899999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=335.79 Aligned_cols=250 Identities=15% Similarity=0.204 Sum_probs=207.1
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++.+.||+|+||+||+|.+. ++.||+|+++...........+.+|+.+++.++||||+++++++.... ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---AP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CC
Confidence 3478999999999999999999874 889999999876556666778999999999999999999999985542 25
Q ss_pred cEEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 101 DIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
..++||||+.+ +|.+++.... .+++..+..++.|++.||+|||++| |+||||||+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 68999999985 9999998765 4899999999999999999999999 99999999999999999999999998754
Q ss_pred ccCCCCccccccccccccccccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
... ....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 163 ~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------ 228 (271)
T 3kmu_A 163 FQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL------ 228 (271)
T ss_dssp TSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC------
T ss_pred ecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC------
Confidence 211 234689999999998762 12344489999999999999999999988776544333221100
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 229 ------------------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 229 ------------------R-----PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ------------------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------C-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0122468899999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=338.87 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=208.9
Q ss_pred CCCeeEec-eeeccCCeeEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILE-VIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~-~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.++|.+.+ .||+|+||+||+|.+. .++..||+|+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-----
Confidence 47888877 9999999999999854 46788999999754 344556778899999999999999999999832
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
...++||||+.+ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 248999999996 999999754 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..............+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~---------- 228 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------- 228 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT----------
T ss_pred ccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc----------
Confidence 443322222233457889999999876 678999999999999999998 9999988765444333221
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~ 315 (374)
... ....+.+++.+.+||.+||+.||.+|||+.++++|.+
T Consensus 229 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 229 -----------------GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -----------------CCc---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 000 1123468899999999999999999999999998743
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=350.03 Aligned_cols=267 Identities=15% Similarity=0.146 Sum_probs=201.2
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECC---CCcEEEEEEecCccCChHH---------HHHHHHHHHHHHhCCCCCccccc
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISD---------AIRILREVKLLRLLRHPDIVEIK 88 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~ 88 (374)
..++|++++.||+|+||+||+|.+.. ++..||+|++......... ...+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45799999999999999999999987 7889999998753221111 11356788899999999999999
Q ss_pred eeecCCCcCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC--CeE
Q 017301 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC--KLK 166 (374)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~--~vk 166 (374)
+++.... .....+|+||||++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9986532 2346799999999669999998887899999999999999999999999999999999999999887 999
Q ss_pred EeeecccccccCCCC----cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--hhHH
Q 017301 167 VCDFGLARVAFSDTP----MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQL 240 (374)
Q Consensus 167 l~DFg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~ 240 (374)
|+|||+|+....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ....
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999976532211 1111245579999999999887 6789999999999999999999999965322 1111
Q ss_pred HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..........+... .... ....+++.+.+||.+||+.||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~-------------~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQSV-------------LKWA---------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTHHH-------------HHHS---------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhhcccccHHH-------------Hhhc---------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11111111111110 0000 01268899999999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=344.95 Aligned_cols=253 Identities=20% Similarity=0.371 Sum_probs=208.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
.++|++.+.||+|+||+||+|.+. .+++.||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 99 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 99 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---
Confidence 478999999999999999999876 46789999998743 333455678899999999999999999999943
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCe
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~----------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~v 165 (374)
....|+||||+.+ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+
T Consensus 100 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 100 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred --CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 3458999999985 999998752 357999999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 017301 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (374)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 244 (374)
||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 178 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EECcCcccccccccccc-ccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 99999999754332211 11233467889999999877 678999999999999999999 899998876554443322
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.. . .......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 255 ~~---------------------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EG---------------------------G---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TT---------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC---------------------------C---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 10 0 011234678999999999999999999999999996
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=335.23 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=205.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSS
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCC
Confidence 579999999999999999999986 6788999999754332 3467899999999999999999999944 345
Q ss_pred EEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.|+||||+.+ +|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 8999999985 999999875 46899999999999999999999999999999999999999999999999999754321
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
. ........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus 158 ~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~----------- 222 (267)
T 3t9t_A 158 Q--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------- 222 (267)
T ss_dssp H--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----------
T ss_pred c--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 1 111233467888999999877 678999999999999999999 899998877554443332110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
. .......++.+.+||.+||+.||.+|||+.+++++
T Consensus 223 ----------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 223 ----------------R---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ----------------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------c---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 01123468899999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=337.80 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=203.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.++|++.+.||+|+||+||+|.+.. ++..||+|++... ........+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---- 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC----
Confidence 5789999999999999999998653 3456999998754 2345567788999999999999999999998432
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
..|+||||+.+ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 86 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 --PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred --CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 35899999995 999999764 46999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~------ 233 (281)
T 3cc6_A 164 EDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL------ 233 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC------
T ss_pred cccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC------
Confidence 432211 1233457889999999876 678999999999999999998 99999877655544333221100
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 234 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 ------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 1123578899999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=346.27 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=205.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEE-----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
..++|++++.||+|+||+||+|. +..++..||+|++... ........+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS- 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-
Confidence 45799999999999999999998 5678889999998643 3345556788999999999999999999999543
Q ss_pred cCCCCcEEEEEccCc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC---CC
Q 017301 96 KREFKDIYVVFELME-SDLHQVIKAND-------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CK 164 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~---~~ 164 (374)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..
T Consensus 106 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 106 ----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred ----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 45799999997 49999998753 48999999999999999999999999999999999999844 45
Q ss_pred eEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 017301 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLI 243 (374)
Q Consensus 165 vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 243 (374)
+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYR-KGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EEECccccccccccccccc-cCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 9999999997543322111 1233467899999999877 678999999999999999998 99999887655444333
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
.... .......+++.+.+||.+||+.||.+|||+.++++|.|+-
T Consensus 259 ~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGG------------------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCC------------------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2110 0011246789999999999999999999999999998864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=360.43 Aligned_cols=262 Identities=27% Similarity=0.350 Sum_probs=193.2
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
...+.|.+.+.||+|+||+||.+ ...+|+.||||++... ....+.+|+.+|+.+ +||||+++++++. .
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~ 80 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSET-----T 80 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEE-----C
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEe-----c
Confidence 35577888999999999999875 4568999999998642 234567899999876 8999999999984 4
Q ss_pred CCcEEEEEccCcccHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC---------
Q 017301 99 FKDIYVVFELMESDLHQVIKANDDLT-------REHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--------- 162 (374)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~-------~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~--------- 162 (374)
...+|+|||||+|+|.+++....... +..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp SSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred CCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 45699999999999999998765332 23456799999999999999999999999999999754
Q ss_pred ----CCeEEeeecccccccCCCCc-cccccccccccccccccccccc-----CCCCCccchHHHHHHHHHHHHh-CCCCC
Q 017301 163 ----CKLKVCDFGLARVAFSDTPM-TVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLF 231 (374)
Q Consensus 163 ----~~vkl~DFg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~~llt-g~~pf 231 (374)
+.+||+|||+|+........ ........||+.|+|||++.+. ...++.++|||||||++|+|++ |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 47999999999865433211 1112345799999999998651 2468999999999999999999 99999
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 017301 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (374)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL 311 (374)
.+..... ..+... ...... ......+.+++.+.+||.+||+.||.+|||+.++|
T Consensus 241 ~~~~~~~--~~i~~~-----------------------~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 241 GDKYSRE--SNIIRG-----------------------IFSLDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp CSTTTHH--HHHHHT-----------------------CCCCCC-CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCchhhH--HHHhcC-----------------------CCCccc-ccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 7654322 111110 000000 00000113457899999999999999999999999
Q ss_pred cCCCCCc
Q 017301 312 ADPYFKG 318 (374)
Q Consensus 312 ~hp~~~~ 318 (374)
+||||..
T Consensus 295 ~hp~f~~ 301 (434)
T 2rio_A 295 RHPLFWP 301 (434)
T ss_dssp TSGGGSC
T ss_pred hCCccCC
Confidence 9999974
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=348.75 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=204.1
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcE----EEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecC
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLP 93 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 93 (374)
..-..++|++++.||+|+||+||+|.+..+++. ||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 334458999999999999999999999888876 77777643221 122234668999999999999999999883
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeec
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg 171 (374)
....++||||+.+ +|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 86 -----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 86 -----GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp -----BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred -----CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCC
Confidence 2348999999985 999999875 579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 161 ~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--- 234 (325)
T 3kex_A 161 VADLLPPDDKQ-LLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE--- 234 (325)
T ss_dssp GGGGSCCCTTC-CC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC---
T ss_pred cccccCccccc-ccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC---
Confidence 99875433221 12244568889999999977 679999999999999999999 999998876544433332110
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 235 ---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 235 ---------------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---------------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---------------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001123467788999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=343.93 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=207.4
Q ss_pred CCCCeeEeceeeccCCeeEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeec
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIML 92 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 92 (374)
..++|++++.||+|+||+||+|.+. .++..||+|+++.. ........+.+|+.+++.+ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3579999999999999999999975 45678999998753 3345566788999999999 8999999999984
Q ss_pred CCCcCCCCcEEEEEccCcc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q 017301 93 PPSKREFKDIYVVFELMES-DLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPK 155 (374)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~ 155 (374)
. ...+|+||||+.+ +|.+++.... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 112 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 112 Q-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp S-----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred c-----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 3 3458999999986 9999998654 3899999999999999999999999999999999
Q ss_pred ceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 017301 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234 (374)
Q Consensus 156 Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~ 234 (374)
||+++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCCEEEccccccccccccccc-cccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999999999999765432211 11233457889999999877 678999999999999999999 99999887
Q ss_pred ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
+..+....+.... .......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKEGH------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCC------------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6554443332110 001124678999999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=353.75 Aligned_cols=268 Identities=16% Similarity=0.142 Sum_probs=202.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCC-----CcEEEEEEecCccCChHHH---------HHHHHHHHHHHhCCCCCcccc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDA---------IRILREVKLLRLLRHPDIVEI 87 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~---------~~~~~E~~~l~~l~h~~i~~~ 87 (374)
.++|++++.||+|+||+||+|.+..+ ++.||+|++.......... .....|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45999999999999999999998765 5889999986432111111 123346667778889999999
Q ss_pred ceeecCCCcCCCCcEEEEEccCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec--CCCC
Q 017301 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANCK 164 (374)
Q Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~--~~~~ 164 (374)
++++.... ....+.|+||||++++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 99986542 223568999999977999999876 6899999999999999999999999999999999999999 8899
Q ss_pred eEEeeecccccccCCCCcc----cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 017301 165 LKVCDFGLARVAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240 (374)
Q Consensus 165 vkl~DFg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 240 (374)
+||+|||+|+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.......
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 9999999997643321111 11134569999999999987 67999999999999999999999999864332222
Q ss_pred HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
........ .......+..... ...+++.+.+||..||+.||.+|||+.++++
T Consensus 271 ~~~~~~~~-----------~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIRY-----------RENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHH-----------HHCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHh-----------hhhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 11111000 0011111211111 1467899999999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=335.82 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=193.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC--hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
.++|++.+.||+|+||+||+|.+. ++.||+|+++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----E 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----C
Confidence 478999999999999999999874 889999998643222 1224568899999999999999999999944 3
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCC---ccccCCCCCceEecC--------CCCeEE
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN---VYHRDLKPKNILANA--------NCKLKV 167 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~---i~H~dikp~Nil~~~--------~~~vkl 167 (374)
...|+||||+.+ +|.+++. ...+++..+..++.|++.||+|||++| |+||||||+||+++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 458999999985 8888875 457999999999999999999999999 899999999999986 678999
Q ss_pred eeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
+|||++........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 158 ~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-- 228 (271)
T 3dtc_A 158 TDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-- 228 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT--
T ss_pred ccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc--
Confidence 99999975433222 24479999999999877 6789999999999999999999999988765433322211
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.... ......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 229 ------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 229 ------------------------NKLA---LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------------------------SCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCC---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0000 11224678899999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=345.49 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=191.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCC---cC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS---KR 97 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~---~~ 97 (374)
..+|++.+.||+|+||+||+|.+..+++.||+|++... .......+.+|+.+++.+. ||||+++++++.... ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 45899999999999999999999999999999988532 3445567889999999996 999999999985322 13
Q ss_pred CCCcEEEEEccCcccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEecCCCCeEEeeecc
Q 017301 98 EFKDIYVVFELMESDLHQVIKA---NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
....+++||||+.|+|.+++.. .+.+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 3456899999999999998865 567999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcc---------cccccccccccccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 017301 173 ARVAFSDTPMT---------VFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242 (374)
Q Consensus 173 a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 242 (374)
++......... .......||+.|+|||++.. ....++.++|||||||++|+|++|..||.+.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 97654332211 01124568999999999831 115788999999999999999999999976543211100
Q ss_pred HHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 017301 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (374)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~ 315 (374)
. . ........++.+.+||.+||+.||.+|||+.++++|.+
T Consensus 265 ---------------------------~---~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 ---------------------------K---Y---SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------------------------C---CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ---------------------------c---c---cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0 0 00112356778999999999999999999999999743
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=346.59 Aligned_cols=271 Identities=22% Similarity=0.350 Sum_probs=212.9
Q ss_pred CCCCeeEeceeeccCCeeEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 21 DANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..++|++++.||+|+||+||+|+ +..+++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 96 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP-- 96 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--
Confidence 35799999999999999999998 5778999999999743 345556788999999999999999999988643
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
+...+|+||||+.+ +|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 97 -GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp -SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred -CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 33568999999975 99999986 4569999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
................||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~--- 245 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGCER--- 245 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHCC------
T ss_pred ecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-----hhccccc---
Confidence 76444333333344568889999999877 6789999999999999999999999976432211 0000000
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.................. ...+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 246 ----~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 246 ----DVPALSRLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp -----CCHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----ccccHHHHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001111222222222111 1235689999999999999999999999999764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=342.67 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=208.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 94 (374)
..++|++++.||+|+||+||+|.+ ..+++.||+|+++.. ........+.+|+.+++.+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 357999999999999999999984 457789999999754 3334556788999999999 699999999998543
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCce
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKANDD----------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~----------------l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Ni 157 (374)
...+|+||||+.+ +|.+++..... +++..+..++.||+.||.|||++||+||||||+||
T Consensus 104 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 104 ----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 2358999999995 99999987654 89999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 017301 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (374)
Q Consensus 158 l~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 236 (374)
+++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999976543322 122244568899999999877 678999999999999999998 9999987654
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
......... ... . ......+++.+.++|.+||+.||.+|||+.++++|
T Consensus 257 ~~~~~~~~~-----------------------~~~---~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLK-----------------------EGT---R---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHH-----------------------HTC---C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhc-----------------------cCc---c---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 332221111 000 0 01123578899999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=340.01 Aligned_cols=246 Identities=16% Similarity=0.258 Sum_probs=200.2
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCC-------cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLP 93 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 93 (374)
..++|++.+.||+|+||+||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3578999999999999999999998877 479999986432 2345678899999999999999999999954
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC-------
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK------- 164 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~-l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~------- 164 (374)
. ...|+||||+.+ +|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 84 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 G-----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp T-----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred C-----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 3 457999999985 99999987664 999999999999999999999999999999999999998887
Q ss_pred -eEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChhhHHHH
Q 017301 165 -LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDL 242 (374)
Q Consensus 165 -vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~ 242 (374)
+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++| .+||...+.......
T Consensus 159 ~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeeeccCcccccccCc-------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 999999998643221 234688999999998653 4689999999999999999995 455555443222211
Q ss_pred HHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.. ... ......++.+.+||.+||+.||.+|||+.++++|
T Consensus 231 ~~---------------------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 231 YE---------------------------DRH-----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HH---------------------------TTC-----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hh---------------------------ccC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11 000 1123457789999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=343.33 Aligned_cols=253 Identities=21% Similarity=0.348 Sum_probs=200.2
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEE----EEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKV----AIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..++|++++.||+|+||+||+|.+..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--
Confidence 4589999999999999999999998888765 666664322 223456788999999999999999999999643
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
..++|++++.+ +|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 90 ----~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 90 ----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ----SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ----CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 26889999885 99999986 4579999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 166 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----- 237 (327)
T 3lzb_A 166 LLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----- 237 (327)
T ss_dssp ---------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----
T ss_pred EccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 65433221 11233457889999999987 789999999999999999999 9999988776554433321110
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
....+.+++.+.+||.+||+.||.+|||+.++++.
T Consensus 238 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 238 -------------------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11124578899999999999999999999999983
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=339.97 Aligned_cols=270 Identities=22% Similarity=0.373 Sum_probs=209.2
Q ss_pred CCCeeEeceeeccCCeeEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
.++|++++.||+|+||.||+|+ +..+++.||+|+++... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG-- 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--
Confidence 4679999999999999999998 67789999999997532 2233456889999999999999999999996532
Q ss_pred CCCcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...+++||||+.+ +|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus 97 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 97 -GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 2458999999986 99999954 56799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...............||..|+|||++.+ ..++.++|||||||++|+|++|..|+.... ..+....+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-- 246 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQ-- 246 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGG--
T ss_pred ccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccc--
Confidence 6544332233345678889999999877 678899999999999999999998864322 1222222222211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
................ ...+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 -----~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 247 -----MTVTRLVNTLKEGKRL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp -----GHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred -----cCHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 1112222222222211 223568899999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=343.27 Aligned_cols=254 Identities=23% Similarity=0.361 Sum_probs=206.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCc-----EEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 94 (374)
..++|++.+.||+|+||+||+|.+..++. .||+|+++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 35789999999999999999999877664 7999998753 2334566788999999999 89999999999943
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKA--------------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~ 159 (374)
...+|+||||+.+ +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 122 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 122 ----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp ----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred ----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 3458999999986 99999875 3468999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhh
Q 017301 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVH 238 (374)
Q Consensus 160 ~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 238 (374)
+.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCCCeEEECccccccccccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999999865433221 12234567889999999877 679999999999999999998 999998765443
Q ss_pred HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
....+.. .... . ......++.+.+||.+||+.||.+|||+.++++
T Consensus 275 ~~~~~~~-----------------------~~~~-~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 275 KFYKLVK-----------------------DGYQ-M-----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHH-----------------------HTCC-C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHh-----------------------cCCC-C-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 3322211 1000 0 112346889999999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=337.42 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=196.8
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
+...++|++.+.||+|+||.||+|.+..+|+.||+|+++.. .........+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 103 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE---- 103 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----
Confidence 34567999999999999999999999999999999999753 2344556678899999999999999999999954
Q ss_pred CCCcEEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
....++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 104 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 104 -DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp -TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred -CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 3468999999996 99998864 45799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
+........ ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....
T Consensus 183 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~--------- 247 (310)
T 2wqm_A 183 GRFFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC--------- 247 (310)
T ss_dssp -------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHH---------
T ss_pred eeeecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHH---------
Confidence 876433221 1234578999999999877 678999999999999999999999997653210 0000
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..+......+ .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 248 ---------------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 248 ---------------KKIEQCDYPP--LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp ---------------HHHHTTCSCC--CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------HHhhcccCCC--CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0011100000 1124578899999999999999999999999873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=345.54 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=202.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEE--EEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
.++|++.+.||+|+||+||+|++..++..+ |+|.++.. ........+.+|+.+++.+ +||||+++++++. .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~ 97 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----H 97 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----E
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeee-----e
Confidence 378999999999999999999999888865 99988643 2223445688999999999 8999999999994 3
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~ 161 (374)
...+|+||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 4569999999975 9999998654 7999999999999999999999999999999999999999
Q ss_pred CCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHH
Q 017301 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (374)
Q Consensus 162 ~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 240 (374)
++.+||+|||+++...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCeEEEcccCcCccccccc----cccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 9999999999987432211 1123457888999999877 678999999999999999998 99999887654433
Q ss_pred HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..+.. ... ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 252 EKLPQ---------------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHGGG---------------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhc---------------------------CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22211 100 11124678999999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=341.27 Aligned_cols=264 Identities=25% Similarity=0.313 Sum_probs=196.8
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--CCCCCccccceeecCCCcC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL--LRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~~~ 97 (374)
...++|++++.||+|+||+||+|.+ +++.||+|++... ....+.+|..++.. ++||||+++++++.... .
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSR-H 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-T
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-C
Confidence 3568999999999999999999976 6899999998642 23345566666666 78999999999875432 2
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh--------hCCccccCCCCCceEecCCCCeEEe
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH--------TANVYHRDLKPKNILANANCKLKVC 168 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~i~H~dikp~Nil~~~~~~vkl~ 168 (374)
....+|+||||+.+ +|.+++.. ..+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 34568999999985 99999954 47999999999999999999999 9999999999999999999999999
Q ss_pred eecccccccCCCCcc-cccccccccccccccccccccCC----CCCccchHHHHHHHHHHHHhC----------CCCCCC
Q 017301 169 DFGLARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPG 233 (374)
Q Consensus 169 DFg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DiwSlG~il~~lltg----------~~pf~~ 233 (374)
|||+|+......... .......||+.|+|||++.+... .++.++|||||||++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997654433221 11234579999999999876211 345789999999999999999 788865
Q ss_pred CChhh-HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 234 KSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 234 ~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..... ....+... ..........+........++.+.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 236 VVPNDPSFEDMRKV--------------------VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TSCSSCCHHHHHHH--------------------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCCcchhhhhHH--------------------HhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 43211 11111110 0000000000100011124567999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=349.22 Aligned_cols=260 Identities=13% Similarity=0.177 Sum_probs=200.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECC--------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTH--------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLP 93 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 93 (374)
.++|++.+.||+|+||+||+|.+.. .++.||+|++... ..+.+|+.+++.++||||+++++.+..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 5899999999999999999999987 4889999998643 356789999999999999985433211
Q ss_pred CC-----------cCCCCcEEEEEccCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec
Q 017301 94 PS-----------KREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (374)
Q Consensus 94 ~~-----------~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~ 160 (374)
.. .......|+||||++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 00 0124568999999977999999986 7899999999999999999999999999999999999999
Q ss_pred CCC--CeEEeeecccccccCCCCc----ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 017301 161 ANC--KLKVCDFGLARVAFSDTPM----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (374)
Q Consensus 161 ~~~--~vkl~DFg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 234 (374)
.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 998 8999999999764332111 111234579999999999987 67999999999999999999999999875
Q ss_pred C-hhhHH-HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 235 S-VVHQL-DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 235 ~-~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. ....+ .........+. ........+..+++.+.+||.+||+.||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPG----------------------PFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCC----------------------CEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChh----------------------hhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 21111 11111000000 000001112357899999999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=361.60 Aligned_cols=249 Identities=22% Similarity=0.406 Sum_probs=208.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
..+|++.+.||+|+||+||+|.++.++..||+|+++.... ....+.+|+.+|+.++||||+++++++.. ...
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCc
Confidence 4679999999999999999999999999999999975432 24568899999999999999999999943 345
Q ss_pred EEEEEccCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
+|+||||+. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 899999999 5999999864 4689999999999999999999999999999999999999999999999999986533
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 371 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------- 437 (495)
T 1opk_A 371 DTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------- 437 (495)
T ss_dssp CCE--ECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------
T ss_pred Cce--eecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 221 11233456788999999877 678999999999999999999 9999988776544433321100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 438 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 ---------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0112467899999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=333.21 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=203.1
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.-+|.+.+.||+|+||+||+|.+..++. .||+|.+.. .........+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 95 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE--- 95 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS---
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC---
Confidence 3577888999999999999999765544 799999874 334455667889999999999999999999995432
Q ss_pred CCcEEEEEccCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
...++||||+. ++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 96 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 96 -GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp -SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred -CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 23489999997 599999987 457899999999999999999999999999999999999999999999999999754
Q ss_pred cCCCC-cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 177 FSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 177 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
..... .........+|+.|+|||.+.+ ..++.++|||||||++|+|++| .+||...+..+....+.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~------ 246 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR------ 246 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC------
T ss_pred cCCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC------
Confidence 32211 1111234568899999999987 6789999999999999999995 566665554443333221110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 247 ------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0112457889999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=334.08 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=202.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
..+|++.+.||+|+||+||+|.+..++ ..+|+|.+.. .........+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---- 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----
Confidence 468999999999999999999965433 4689999875 33445566788999999999999999999997433
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
....++||||+.+ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 2457999999996 999999764 46899999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCc-ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 177 FSDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 177 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
...... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~------ 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC------
T ss_pred cccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC------
Confidence 332211 111234567889999999877 678999999999999999999 6678877665444333221100
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
......+++.+.++|.+||+.||.+|||+.++++
T Consensus 251 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 ------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112357889999999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=341.55 Aligned_cols=261 Identities=23% Similarity=0.381 Sum_probs=203.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||.||+|.+..+++.||+|++.. ........+.+|+.+++.++||||+++++++.... .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCce
Confidence 5789999999999999999999999999999998864 23455667889999999999999999999986322 23356
Q ss_pred EEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 102 IYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
.|+||||+.+ +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999996 99998875 467999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCcc------ccccccccccccccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 177 FSDTPMT------VFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 177 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
....... .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------- 253 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG----------- 253 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-----------
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-----------
Confidence 2211110 011234579999999998652 1237889999999999999999999995321100
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
........ .... ....+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 254 -----------~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 254 -----------DSVALAVQ---NQLS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -----------SCHHHHHH---CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------chhhHHhh---ccCC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00000000 1000 11124678999999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=333.03 Aligned_cols=243 Identities=25% Similarity=0.404 Sum_probs=196.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|.+ +|+.||+|+++.. .....+.+|+.+++.++||||+++++++... ...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~ 89 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 89 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCc
Confidence 48999999999999999999976 4889999998743 2445688999999999999999999987543 235
Q ss_pred EEEEEccCcc-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
+|+||||+.+ +|.+++...+. +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999986 99999986543 89999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. ....+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus 170 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~------------ 229 (278)
T 1byg_A 170 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 229 (278)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------------
T ss_pred cc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------
Confidence 21 23357889999999877 678999999999999999998 9999987765443332211
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. .......+++.+.++|.+||+.||.+|||+.++++
T Consensus 230 ---------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 230 ---------------GY---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CC---CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 00 01123467899999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=340.93 Aligned_cols=271 Identities=22% Similarity=0.316 Sum_probs=207.9
Q ss_pred CCCCCe-eEeceeeccCCeeEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 017301 20 GDANRY-KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (374)
Q Consensus 20 ~~~~~Y-~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 94 (374)
...++| ++++.||+|+||+||+|. +..+++.||+|+++.. ........+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 345666 999999999999998775 4458899999999754 3345566788999999999999999999998653
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccc
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
+ ...+++||||+.+ +|.+++... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 106 ~---~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 106 G---AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp T---TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred C---CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccc
Confidence 2 3568999999985 999999765 4999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
.................+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+.....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~ 254 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQ 254 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccc
Confidence 876544332222344568889999999877 67889999999999999999999999654321 11111111111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. ........+..... ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 255 ~-------~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 255 M-------TVLRLTELLERGER---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp H-------HHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h-------hHHHHHHHHhcccC---CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 01111111222111 1123568899999999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=331.63 Aligned_cols=247 Identities=25% Similarity=0.372 Sum_probs=203.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|.+. ++..||+|+++.... ....+.+|+.+++.++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC------CC
Confidence 479999999999999999999875 567899999875432 24567899999999999999999998842 23
Q ss_pred EEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.|+||||+.+ +|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 7999999975 9999997543 699999999999999999999999999999999999999999999999999976543
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+...
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~----------- 226 (279)
T 1qpc_A 162 NEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG----------- 226 (279)
T ss_dssp SCEE--CCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred cccc--cccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-----------
Confidence 2211 1233457788999999876 678999999999999999999 99999887765444333211
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 227 ----------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 227 ----------------YR---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ----------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------cC---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 0112467899999999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=348.43 Aligned_cols=270 Identities=23% Similarity=0.301 Sum_probs=206.1
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
....++|++.+.||+|+||+||+|.+ .+++.||+|++.... ......+.+|+.+++.++||||+++++++. .
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 106 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCD-----E 106 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----C
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C
Confidence 34568999999999999999999986 478999999886532 234567889999999999999999999984 3
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~----~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a 173 (374)
....|+||||+.+ +|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 4568999999985 9999886543 5899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.........
T Consensus 187 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~------ 257 (321)
T 2qkw_B 187 KKGTELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV------ 257 (321)
T ss_dssp EECSSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH------
T ss_pred ccccccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh------
Confidence 764332211 11234568999999999877 678999999999999999999999998765332211110000
Q ss_pred HHhhhcCHHHHHHHHHhcCCC-CCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 017301 254 TIAVVRNEKARKYLTEMRKKP-PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp 314 (374)
..... ..+.... +.......+..+..+.+++.+||+.||++|||+.++++|.
T Consensus 258 --~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 258 --ESHNN-------GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp --HHHTT-------TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --hcccc-------ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00000 0000000 0000011123456788999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=353.56 Aligned_cols=244 Identities=25% Similarity=0.411 Sum_probs=202.5
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++++.||+|+||+||+|.+. |+.||+|+++... ....+.+|+.+|+.++||||+++++++.... .
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~ 260 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----G 260 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----S
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----C
Confidence 3478999999999999999999764 7899999997542 3456889999999999999999999985432 3
Q ss_pred cEEEEEccCcc-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 101 DIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
.+|+||||+.+ +|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 58999999985 99999987543 7999999999999999999999999999999999999999999999999997542
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 341 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------- 404 (450)
T 1k9a_A 341 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------- 404 (450)
T ss_dssp ------------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC--------
T ss_pred ccc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 221 22357888999999977 689999999999999999998 9999988765544433321100
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 405 ----------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 ----------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112467899999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=355.23 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=204.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|+||+||+|.+. ++..||+|+++.... ....+.+|+.+|+.++||||+++++++.. ..
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Cc
Confidence 468999999999999999999875 467899999975332 35578899999999999999999999842 34
Q ss_pred EEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
+|+||||+.+ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 7999999985 999999754 2689999999999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. ........+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 337 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------- 404 (454)
T 1qcf_A 337 NE--YTAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-------- 404 (454)
T ss_dssp HH--HHTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC--------
T ss_pred Cc--eeccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 11 111123356788999999876 679999999999999999999 99999988766555443321111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.....+++.+.+||.+||+.||.+|||++++++
T Consensus 405 ----------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 405 ----------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 112467899999999999999999999999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=332.03 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=192.8
Q ss_pred ccccCCCCCeeEe-ceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHH-HhCCCCCccccceeecC
Q 017301 16 FTEYGDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIVEIKRIMLP 93 (374)
Q Consensus 16 ~~~~~~~~~Y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~ 93 (374)
.....+.++|.+. +.||+|+||.||+|.+..+++.||+|+++.. ....+|+.++ +..+||||+++++++..
T Consensus 10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 3445566788887 7899999999999999999999999998631 2456788887 56689999999999854
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC---CCCeEE
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKV 167 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~---~~~vkl 167 (374)
.. .....+|+||||+.+ +|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||
T Consensus 83 ~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 83 LY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp EE-TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred hc-CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEE
Confidence 21 224568999999986 9999998764 6999999999999999999999999999999999999998 788999
Q ss_pred eeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
+|||++.... + ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 162 ~Dfg~a~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-- 212 (299)
T 3m2w_A 162 TDFGFAKETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-- 212 (299)
T ss_dssp CCCTTCEECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--
T ss_pred eccccccccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--
Confidence 9999885321 1 3567899999999999999999999977653211100000
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.............+..+++.+.+||.+||+.||.+|||+.++|+||||++...
T Consensus 213 ---------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 213 ---------------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp ---------------------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred ---------------------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 00000000000112468999999999999999999999999999999987543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=367.09 Aligned_cols=246 Identities=21% Similarity=0.294 Sum_probs=201.2
Q ss_pred ceeeccCCeeEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAID--THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
+.||+|+||+||+|.+ +.+++.||||+++...........+.+|+.+|+.++||||+++++++.. ...++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 4799999999999954 5677899999998655555556788999999999999999999998832 2379999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
||+.+ +|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...........
T Consensus 449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99985 99999999889999999999999999999999999999999999999999999999999999865443322222
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (374)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 529 ~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---------------- 590 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---------------- 590 (635)
T ss_dssp ------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------------
T ss_pred ccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 233457788999999977 689999999999999999998 9999998876655444332110
Q ss_pred HHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 591 --------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 --------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0112467899999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=333.99 Aligned_cols=249 Identities=28% Similarity=0.386 Sum_probs=204.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC------
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS------ 95 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 95 (374)
.++|++++.||+|+||.||+|.+..+++.||+|+++... ..+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 468999999999999999999999999999999987432 24568999999999999999999874311
Q ss_pred -----cCCCCcEEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEE
Q 017301 96 -----KREFKDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (374)
Q Consensus 96 -----~~~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl 167 (374)
......+|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 1123558999999996 999999754 57999999999999999999999999999999999999999999999
Q ss_pred eeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 164 ~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----------- 226 (284)
T 2a19_B 164 GDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSK----------- 226 (284)
T ss_dssp CCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----------
T ss_pred Ccchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----------
Confidence 99999976543321 234579999999999877 6789999999999999999999988732110
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
....+.... ....+++.+.+||.+||+.||.+|||+.++++|++.-
T Consensus 227 ------------------~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 227 ------------------FFTDLRDGI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ------------------HHHHHHTTC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------HHHHhhccc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011111111 1135788999999999999999999999999998753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=336.00 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=199.5
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECC-CCc--EEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecC
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTH-TGE--KVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLP 93 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~-~~~--~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 93 (374)
..-..++|++++.||+|+||+||+|.+.. +++ .||+|+++.... .......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 34456899999999999999999998643 333 689998865322 23455678899999999999999999999854
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeec
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg 171 (374)
. ..++||||+.+ +|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 93 ~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 93 P------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp S------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred C------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccc
Confidence 3 26999999985 999998764 579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
++.................+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---- 240 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---- 240 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS----
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc----
Confidence 99865444332222334567889999999877 678899999999999999999 99999887765444333210
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. .......+++.+.++|.+||+.||.+|||+.++++
T Consensus 241 -----------------------~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 241 -----------------------GE--RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -----------------------CC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CC--CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 01122467899999999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=330.39 Aligned_cols=243 Identities=29% Similarity=0.433 Sum_probs=193.6
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|+||+||+|.+. ++.||+|++... .....+.+|+.+++.++||||+++++++.. .
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~ 73 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN-------P 73 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------T
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------C
Confidence 478999999999999999999764 789999998632 345678899999999999999999998742 2
Q ss_pred EEEEEccCcc-cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhh---CCccccCCCCCceEecCCCC-eEEeeeccc
Q 017301 102 IYVVFELMES-DLHQVIKAND---DLTREHHQFFLYQMLRALKYMHT---ANVYHRDLKPKNILANANCK-LKVCDFGLA 173 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~LH~---~~i~H~dikp~Nil~~~~~~-vkl~DFg~a 173 (374)
.|+||||+.+ +|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+||+++.++. +||+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 6999999985 9999998765 47899999999999999999999 89999999999999998887 799999999
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+
T Consensus 154 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~---------- 214 (307)
T 2eva_A 154 CDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IM---------- 214 (307)
T ss_dssp -----------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HH----------
T ss_pred cccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HH----------
Confidence 754322 123469999999999987 68999999999999999999999999764322110 00
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
....... .......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 215 --------------~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 215 --------------WAVHNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp --------------HHHHTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------HHHhcCC---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0000100 011234688999999999999999999999999983
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=357.80 Aligned_cols=256 Identities=17% Similarity=0.200 Sum_probs=196.6
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCC-CCccc---------cceee
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRH-PDIVE---------IKRIM 91 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~i~~---------~~~~~ 91 (374)
..|++.+.||+|+||+||+|.+..+|+.||||+++.... .......+.+|+.+++.++| +|... ..+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 348899999999999999999999999999999873322 22234568899999999976 22211 11111
Q ss_pred c------------CCCcCCCCcEEEEEccCcccHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q 017301 92 L------------PPSKREFKDIYVVFELMESDLHQVIKA-------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDL 152 (374)
Q Consensus 92 ~------------~~~~~~~~~~~lv~e~~~~~L~~~l~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~di 152 (374)
. .........++++|+++.++|.+++.. ...+++..+..++.||+.||+|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 1 111111345789999999999988841 235778889999999999999999999999999
Q ss_pred CCCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccc--------cCCCCCccchHHHHHHHHHHH
Q 017301 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWSIGCIFAEV 224 (374)
Q Consensus 153 kp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~DiwSlG~il~~l 224 (374)
||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+ ....++.++|||||||++|+|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 999999999999999999998764332 244577 99999999831 115688899999999999999
Q ss_pred HhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCC
Q 017301 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304 (374)
Q Consensus 225 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 304 (374)
++|+.||.+.+....... .....+.+++.+.+||.+||+.||.+|
T Consensus 311 ltg~~Pf~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEW-----------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHSSCCCCTTGGGSCSGG-----------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred HHCCCCCCCcchhhhHHH-----------------------------------HHhhcccCCHHHHHHHHHHccCChhhC
Confidence 999999987653221110 111234678999999999999999999
Q ss_pred CCHHHHhcCCCCCcCc
Q 017301 305 PTAEEALADPYFKGLA 320 (374)
Q Consensus 305 pt~~~lL~hp~~~~~~ 320 (374)
||+.++|+||||+.+.
T Consensus 356 pt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 356 LLPLQAMETPEYEQLR 371 (413)
T ss_dssp CCHHHHTTSHHHHHHH
T ss_pred cCHHHHHhCHHHHHHH
Confidence 9999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=354.32 Aligned_cols=284 Identities=19% Similarity=0.306 Sum_probs=206.6
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
....++|++.+.||+|+||+||+|++..+|+.||+|++..... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 80 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--- 80 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---
Confidence 3456899999999999999999999999999999999974322 223456779999999999999999999985432
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe----cCCCCeEEeee
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDF 170 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~----~~~~~vkl~DF 170 (374)
....|+||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 2468999999985 9999997643 39999999999999999999999999999999999998 77778999999
Q ss_pred cccccccCCCCccccccccccccccccccccccc------CCCCCccchHHHHHHHHHHHHhCCCCCCCCChh-hHHHHH
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLI 243 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i 243 (374)
|+++...... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... .....+
T Consensus 161 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 161 GAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp GGCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred CCceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 9997643322 22345799999999987531 135778999999999999999999999754321 112222
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.+.....++..+........ ..+. .....+ ........+++.+.++|.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~-~~~~-~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAEN-GPID-WSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTT-CCEE-EESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHHhcCCCcccchhheeccC-CCcc-cCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 22222221111110000000 0000 000000 0001112345678899999999999999999998663
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=338.68 Aligned_cols=269 Identities=19% Similarity=0.314 Sum_probs=203.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...++|++.+.||+|+||+||+|.+ .+|+.||+|++...... .....+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 99 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP----- 99 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-----
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC-----
Confidence 4568999999999999999999974 46899999998753221 1122578999999999999999999999543
Q ss_pred CcEEEEEccCcc-cHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhhhC---CccccCCCCCceEecCCCCeEEeeec
Q 017301 100 KDIYVVFELMES-DLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTA---NVYHRDLKPKNILANANCKLKVCDFG 171 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~----~l~~~~~~~i~~qi~~al~~LH~~---~i~H~dikp~Nil~~~~~~vkl~DFg 171 (374)
...++||||+.+ +|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 457999999986 9999998653 499999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus 180 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------ 243 (326)
T 3uim_A 180 LAKLMDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND------------ 243 (326)
T ss_dssp SCEECCSSSS--CEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT------------
T ss_pred cccccCcccc--cccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccc------------
Confidence 9986543322 12244569999999999877 6789999999999999999999999952110000
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCC-C-----c-cccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPV-P-----L-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.................. . . ....+..++.+.+|+.+||+.||.+|||+.++++|-.-..
T Consensus 244 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 244 -------DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp -------SCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred -------cchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 000000111100000000 0 0 0011123467899999999999999999999999865433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=343.11 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=195.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
.+|++.+.||+|+||+||+|.+..++ ..||+|.++.. ........+.+|+.+++.++||||+++++++... .
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----S
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----C
Confidence 46889999999999999999875433 46899988643 3335567889999999999999999999987433 2
Q ss_pred CcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...|+||||+.+ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 357999999986 999999865 468999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCc-ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 178 SDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--------- 312 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--------- 312 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT---------
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC---------
Confidence 32211 111233467889999999877 689999999999999999999 78888776654433322210
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.. ......+++.+.++|.+||+.||.+|||+.+++++
T Consensus 313 -----------------~~----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 313 -----------------RR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -----------------CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 01124578899999999999999999999999884
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=371.81 Aligned_cols=287 Identities=25% Similarity=0.337 Sum_probs=210.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-cCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~ 99 (374)
..++|++++.||+|+||+||+|.+..+|+.||+|+++.. ........+.+|+.+++.++||||+++++++.... ....
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 348999999999999999999999999999999998753 34455667889999999999999999999875422 1235
Q ss_pred CcEEEEEccCcc-cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCC---eEEeeecc
Q 017301 100 KDIYVVFELMES-DLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGL 172 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~---vkl~DFg~ 172 (374)
...|+||||+.| +|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 668999999975 9999998754 6899999999999999999999999999999999999997765 99999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
+........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......... .......
T Consensus 171 a~~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~---~i~~~~~ 241 (676)
T 3qa8_A 171 AKELDQGEL----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG---KVREKSN 241 (676)
T ss_dssp CCBTTSCCC----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST---TCC----
T ss_pred ccccccccc----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh---hhhcccc
Confidence 986543322 244679999999999987 7899999999999999999999999987543211100 0000000
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.......... ... ......+ ......+.+++.+.+||.+||.+||.+|||+.++|+||||+.+..
T Consensus 242 ~~~~~~~~l~--g~~-~~~~~lp-~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 242 EHIVVYDDLT--GAV-KFSSVLP-TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp --CCSCCCCS--SSC-CCCSSSC-CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhhhhhhhc--ccc-ccccccC-CchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 0000000000 000 0000000 001122336678999999999999999999999999999987653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=350.73 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=201.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|+||+||+|.+.. +..||+|+++..... ...+.+|+.+|+.++||||+++++++.. ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 4689999999999999999998864 467999998754322 3568899999999999999999999843 34
Q ss_pred EEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
+|+||||+.+ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 7999999985 999999743 4699999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 333 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------- 399 (452)
T 1fmk_A 333 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 399 (452)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred Ccee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 2211 1123456788999999877 679999999999999999999 9999998776554443322100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc--CCCCC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFK 317 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~--hp~~~ 317 (374)
. ...+.+++.+.+||.+||+.||.+|||++++++ ..++.
T Consensus 400 ----------------~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 400 ----------------M-----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ----------------C-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ----------------C-----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 0 112467889999999999999999999999987 34544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=334.77 Aligned_cols=269 Identities=22% Similarity=0.297 Sum_probs=205.7
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 95 (374)
.+.....|..++.||+|+||+||+|.+ +++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 26 ~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 101 (307)
T 2nru_A 26 NFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-- 101 (307)
T ss_dssp TTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--
Confidence 344556677789999999999999975 68899999987532 233445678899999999999999999999944
Q ss_pred cCCCCcEEEEEccCcc-cHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeec
Q 017301 96 KREFKDIYVVFELMES-DLHQVIKA---NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~---~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg 171 (374)
....|+||||+.+ +|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 102 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 178 (307)
T 2nru_A 102 ---GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFG 178 (307)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred ---CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence 3458999999975 99999874 3469999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
++......... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+........
T Consensus 179 ~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 254 (307)
T 2nru_A 179 LARASEKFAQT-VMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE 254 (307)
T ss_dssp TCEECCSCSSC-EECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS
T ss_pred ccccccccccc-ccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh
Confidence 99765432221 12234579999999998865 478899999999999999999999987665433322222111100
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
. ....+ +... ........++.+.+++.+||+.||.+|||+.+++++
T Consensus 255 ~---------~~~~~---~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 255 K---------TIEDY---IDKK----MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp C---------CHHHH---SCSS----CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred h---------hhhhh---cccc----ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 00000 0000 001112245678899999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=334.40 Aligned_cols=271 Identities=21% Similarity=0.352 Sum_probs=208.9
Q ss_pred CCCCeeEeceeeccCCeeEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 21 DANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
..++|++++.||+|+||.||+|. +..+++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG- 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC-
Confidence 45789999999999999999998 5678999999999753 3345567889999999999999999999985432
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
...+++||||+.+ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 116 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 --RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred --CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 2358999999985 999999876 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQ 266 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCCTH
T ss_pred hccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccchh
Confidence 75443322222234467788999999877 6788999999999999999999998864321 1112222211100
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. ........+...... .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 267 ~------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 267 M------IVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp H------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h------hHHHHHHHhhcCCCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 011111222221111 123568899999999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=349.77 Aligned_cols=259 Identities=19% Similarity=0.240 Sum_probs=204.0
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++.+..+..+. ....
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~ 76 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFG----VEGD 76 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEE----EETT
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEE----eeCC
Confidence 458999999999999999999999999999999988643322 23678999999998766555555442 2335
Q ss_pred cEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEe---cCCCCeEEeeecccccc
Q 017301 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARVA 176 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~---~~~~~vkl~DFg~a~~~ 176 (374)
..++||||++++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 77 ~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 6899999998899999985 5679999999999999999999999999999999999999 58899999999999865
Q ss_pred cCCCCcc----cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 177 FSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~---- 230 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---- 230 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH----
T ss_pred cCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh----
Confidence 4433211 11235679999999999988 6799999999999999999999999988654333322221100
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..... ........+++.+.+||..||+.||.+||++.+|++
T Consensus 231 --------~~~~~-----------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 231 --------KKVAT-----------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp --------HHHHS-----------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --------ccccc-----------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00000 000111357889999999999999999999998876
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=359.40 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=199.8
Q ss_pred CCCeeEec-eeeccCCeeEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILE-VIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~-~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.++|.+.+ .||+|+||+||+|.++ .++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----
Confidence 34566666 8999999999999875 356679999997542 22345678899999999999999999999843
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
..+|+||||+.+ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 248999999985 999999754 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..............+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-------- 556 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-------- 556 (613)
T ss_dssp C--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC--------
T ss_pred cCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 432221111122345688999999977 689999999999999999998 999999877655444332210
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
. ....+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 557 -------------------~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 557 -------------------R---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -------------------C---CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -------------------C---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 0112468899999999999999999999999865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=337.50 Aligned_cols=281 Identities=20% Similarity=0.230 Sum_probs=196.5
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++++.||+|+||+||+|.+ +++.||+|++.... ........|+..+..++||||+++++.+.........
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 458999999999999999999965 68999999986321 1111223344445568999999999866544334455
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC---------CccccCCCCCceEecCCCCeEEeee
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA---------NVYHRDLKPKNILANANCKLKVCDF 170 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~---------~i~H~dikp~Nil~~~~~~vkl~DF 170 (374)
.+|+||||+.+ +|.+++.... .++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred eEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 78999999975 9999997754 58999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCC-----cccccccccccccccccccccccC-----CCCCccchHHHHHHHHHHHHhCCCCC-CCCChhhH
Q 017301 171 GLARVAFSDTP-----MTVFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLTGKPLF-PGKSVVHQ 239 (374)
Q Consensus 171 g~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~DiwSlG~il~~lltg~~pf-~~~~~~~~ 239 (374)
|+|+....... .........||+.|+|||++.+.. ..++.++|||||||++|+|++|..|| .+......
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99976543211 111223457999999999986521 24567899999999999999996555 43332211
Q ss_pred HHHHHHhh-CCCCHHHHhhhcCHHHHHHHHHhcCCCC-CCccccC---CCCChHHHHHHHHhccCCCCCCCCHHHHhc--
Q 017301 240 LDLITDLL-GTPSPETIAVVRNEKARKYLTEMRKKPP-VPLFQKF---PNVDPLALRLLQRLIAFDPKDRPTAEEALA-- 312 (374)
Q Consensus 240 ~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~-- 312 (374)
...+.... ..+.... .......... ......+ ...++.+.+||.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFED-----------MQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp CCTTHHHHCSSCCHHH-----------HHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHhhhcccCCCchHHH-----------HHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 11111111 1111111 1111111111 1111111 124457999999999999999999999955
Q ss_pred ----CCCCCc
Q 017301 313 ----DPYFKG 318 (374)
Q Consensus 313 ----hp~~~~ 318 (374)
++|-++
T Consensus 314 ~~ll~~~~~~ 323 (336)
T 3g2f_A 314 AELMMIWERN 323 (336)
T ss_dssp HHHHHCCCC-
T ss_pred HHHHHHHHhc
Confidence 677654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=340.37 Aligned_cols=245 Identities=15% Similarity=0.184 Sum_probs=193.2
Q ss_pred CCCeeEeceeeccCCeeEEEE-----EECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC---CCCccccceeecC
Q 017301 22 ANRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLP 93 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~ 93 (374)
.++|++.+.||+|+||+||+| .+..+++.||+|+++.. ....+.+|+.+++.++ |+||+.+++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 478999999999999999999 46788999999998742 2335667778777776 9999999999954
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC------
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKA-----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA------ 161 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~------ 161 (374)
. ...|+||||+.+ +|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 139 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 139 Q-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp S-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred C-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 3 458999999984 99999973 567999999999999999999999999999999999999998
Q ss_pred -----CCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 017301 162 -----NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236 (374)
Q Consensus 162 -----~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 236 (374)
++.+||+|||+|+....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999975432222 223356689999999999988 6799999999999999999999999965432
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 017301 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (374)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp 314 (374)
.... . . ..... ...++...+++..||+.+|.+|++..+.|.+.
T Consensus 291 ~~~~-----------------------------~-~----~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 291 GECK-----------------------------P-E----GLFRR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp TEEE-----------------------------E-C----SCCTT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred Ccee-----------------------------e-c----hhccc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 1000 0 0 00000 12356788999999999999997665555543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=334.84 Aligned_cols=263 Identities=25% Similarity=0.324 Sum_probs=191.7
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--CCCCCccccceeecCCCcC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL--LRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~~~ 97 (374)
...++|++++.||+|+||+||+|.+. ++.||+|++... ......+|..++.. ++||||+++++++.... .
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGT-G 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-G
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-C
Confidence 44579999999999999999999875 899999998532 22334455555554 48999999999986543 2
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC--------CccccCCCCCceEecCCCCeEEe
Q 017301 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA--------NVYHRDLKPKNILANANCKLKVC 168 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~i~H~dikp~Nil~~~~~~vkl~ 168 (374)
....+|+||||+.+ +|.+++... .+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 23568999999986 999999765 699999999999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCCc-ccccccccccccccccccccccCCCCCcc------chHHHHHHHHHHHHhC----------CCCC
Q 017301 169 DFGLARVAFSDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPA------IDIWSIGCIFAEVLTG----------KPLF 231 (374)
Q Consensus 169 DFg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~------~DiwSlG~il~~lltg----------~~pf 231 (374)
|||+|+........ ........||+.|+|||++.+ ..++.. +|||||||++|+|++| ..||
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999765433221 111234579999999999876 344443 9999999999999999 5566
Q ss_pred CCCChhh-HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 017301 232 PGKSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (374)
Q Consensus 232 ~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~l 310 (374)
....... .... ..............+.......+++.+.+||.+||+.||.+|||+.++
T Consensus 263 ~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 263 HDLVPSDPSYED--------------------MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp TTTSCSSCCHHH--------------------HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhhcCCCCchhh--------------------hHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 4432110 0000 000000000000011000112355678999999999999999999999
Q ss_pred hcC
Q 017301 311 LAD 313 (374)
Q Consensus 311 L~h 313 (374)
++|
T Consensus 323 l~~ 325 (337)
T 3mdy_A 323 KKT 325 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=333.96 Aligned_cols=254 Identities=21% Similarity=0.263 Sum_probs=198.9
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++.+.||+|+||+||+|.+.. .+|+|+++...........+.+|+.+++.++||||+++++++... .
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----P 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----S
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence 35899999999999999999998753 499999875433333344567899999999999999999999543 4
Q ss_pred cEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 101 DIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.+++||||+.+ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||+++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 58999999985 9999998755 799999999999999999999999999999999999998 67999999999875432
Q ss_pred CCC--ccccccccccccccccccccccc-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 179 DTP--MTVFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 179 ~~~--~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
... .........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--- 258 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG--- 258 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT---
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC---
Confidence 111 11122345689999999998641 145788999999999999999999999887654443332210
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
..+ ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 259 -----------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 259 -----------------------MKP---NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp -----------------------CCC---CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred -----------------------CCC---CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 0111357889999999999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=352.60 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=205.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|+||+||+|.+.. +..||||+++..... ...+.+|+.+|+.++||||+++++++.. ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence 4689999999999999999998864 467999999754322 3568899999999999999999999843 34
Q ss_pred EEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
+|+||||+.+ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 7999999985 999999743 4699999999999999999999999999999999999999999999999999975432
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. ........++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+....+.+..+.....
T Consensus 416 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------- 482 (535)
T 2h8h_A 416 NE--YTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 482 (535)
T ss_dssp HH--HHTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred Cc--eecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 11 111123456788999999877 679999999999999999999 9999988776554443322100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC--CCCC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD--PYFK 317 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h--p~~~ 317 (374)
......+++.+.+||.+||+.||++|||++++++. .++.
T Consensus 483 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 ---------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 01124678899999999999999999999999873 4443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.02 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=203.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
.++|++++.||+|+||+||+|.+..+ +..||+|.++.. ........+.+|+.+++.++||||+++++++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 46899999999999999999998654 457999988643 334455678899999999999999999999832
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
..+|+||||+.+ +|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 247999999995 9999998654 6899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 542 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~------- 610 (656)
T 2j0j_A 542 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------- 610 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC-------
T ss_pred CCCcce--eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 332211 1233457789999999877 689999999999999999997 9999998876655444332110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
....+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 611 -----------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 611 -----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112467899999999999999999999999976
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=327.93 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=198.3
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--CCCCCccccceeecCCCcCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL--LRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~~~~ 98 (374)
..++|++.+.||+|+||+||+|.+ +|+.||+|++... ....+.+|..+++. ++||||+++++++.... ..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~ 111 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GT 111 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cc
Confidence 357899999999999999999987 5899999998632 33456788888887 68999999999986543 22
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh--------hCCccccCCCCCceEecCCCCeEEee
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH--------TANVYHRDLKPKNILANANCKLKVCD 169 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~i~H~dikp~Nil~~~~~~vkl~D 169 (374)
...+|+||||+.+ +|.+++... .+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred cceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 2468999999996 999999764 6999999999999999999999 89999999999999999999999999
Q ss_pred ecccccccCCCCcc-cccccccccccccccccccccCC----CCCccchHHHHHHHHHHHHhC----------CCCCCCC
Q 017301 170 FGLARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPGK 234 (374)
Q Consensus 170 Fg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DiwSlG~il~~lltg----------~~pf~~~ 234 (374)
||++.......... .......||+.|+|||++.+... .++.++|||||||++|+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 99997654433211 12244579999999999876211 233689999999999999999 6777654
Q ss_pred Chhh-HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCC-Ccccc--CCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 017301 235 SVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV-PLFQK--FPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (374)
Q Consensus 235 ~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~~l 310 (374)
.... ....+ .......... ..... ....++.+.+||.+||+.||.+|||+.++
T Consensus 271 ~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 271 VPSDPSVEEM-----------------------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp SCSSCCHHHH-----------------------HHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CcCcccHHHH-----------------------HHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 3211 00001 1111111000 00000 11234578899999999999999999999
Q ss_pred hcC
Q 017301 311 LAD 313 (374)
Q Consensus 311 L~h 313 (374)
++|
T Consensus 328 ~~~ 330 (342)
T 1b6c_B 328 KKT 330 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 885
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=340.67 Aligned_cols=254 Identities=17% Similarity=0.166 Sum_probs=188.2
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC------ChHHHHHHHHHHHHHHhCC---------CCCcc
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------HISDAIRILREVKLLRLLR---------HPDIV 85 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~~i~ 85 (374)
..++|++++.||+|+||+||+|++ +|+.||+|++..... .......+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999987 689999999975321 1223356778888888875 66666
Q ss_pred ccceeec-----------------CCC--------cCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 017301 86 EIKRIML-----------------PPS--------KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139 (374)
Q Consensus 86 ~~~~~~~-----------------~~~--------~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al 139 (374)
++.+++. ... ......+|+||||+.+ ++.+.+.. +.+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 6655542 100 0124679999999974 55555543 5689999999999999999
Q ss_pred HHhh-hCCccccCCCCCceEecCCC--------------------CeEEeeecccccccCCCCccccccccccccccccc
Q 017301 140 KYMH-TANVYHRDLKPKNILANANC--------------------KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198 (374)
Q Consensus 140 ~~LH-~~~i~H~dikp~Nil~~~~~--------------------~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aP 198 (374)
+||| ++||+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~y~aP 246 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCCTTCS
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeecccCh
Confidence 9999 99999999999999999887 8999999999865332 34799999999
Q ss_pred ccccccCCCCCccchHHHHHHH-HHHHHhCCCCCCCCChhh-HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCC
Q 017301 199 ELCGSFFSKYTPAIDIWSIGCI-FAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV 276 (374)
Q Consensus 199 E~~~~~~~~~~~~~DiwSlG~i-l~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (374)
|++.+ .. +.++||||+|++ .+++++|..||.+..... ....+.. . ......
T Consensus 247 E~~~g--~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~-----------------------~-~~~~~~ 299 (336)
T 2vuw_A 247 DLFTG--DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK-----------------------Q-MTFKTK 299 (336)
T ss_dssp GGGCC--CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHH-----------------------T-CCCSSC
T ss_pred hhhcC--CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhh-----------------------h-hccCcc
Confidence 99987 33 889999998777 777888999884321100 1111110 0 011111
Q ss_pred CccccCCCCChHHHHHHHHhccCCCCCCCCHHHHh-cCCCCC
Q 017301 277 PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL-ADPYFK 317 (374)
Q Consensus 277 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL-~hp~~~ 317 (374)
.....++.+++.+++||++||+.| |++|+| +||||+
T Consensus 300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 111122346888999999999987 999999 999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=315.42 Aligned_cols=229 Identities=16% Similarity=0.090 Sum_probs=185.1
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
-..++|++.+.||+|+||+||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----- 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT----- 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----
Confidence 3558999999999999999999999999999999999764433 3455678899999999999999999999843
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
....|+||||+.| +|.+++..+ ....++..++.|++.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred CCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 3568999999985 999999653 4666789999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
|++ .++.++|||||||++|+|++|+.||.+.+....+.....
T Consensus 175 -----------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~------------ 216 (286)
T 3uqc_A 175 -----------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER------------ 216 (286)
T ss_dssp -----------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB------------
T ss_pred -----------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH------------
Confidence 222 367899999999999999999999988764321100000
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.............+.+++.+.+||.+||+.||.+| |+.++++
T Consensus 217 ------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 217 ------------DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp ------------CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred ------------HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 00000111112245789999999999999999999 9999988
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=355.11 Aligned_cols=247 Identities=26% Similarity=0.342 Sum_probs=199.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..++|++++.||+|+||+||+|.+.. +|+.||+|++... ........+.+|+.+++.++||||+++++++...+....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 35899999999999999999999976 7899999998643 333455678899999999999999999999965543233
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+||||++| +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 347999999996 88887755 79999999999999999999999999999999999999886 899999999976433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
. ....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+..... .+..
T Consensus 234 ~-------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~~~------ 287 (681)
T 2pzi_A 234 F-------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPED------ 287 (681)
T ss_dssp C-------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CCTT------
T ss_pred C-------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccccccc----------cccc------
Confidence 2 34579999999999866 34889999999999999999999987532110 0000
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
......++.+.+||.+||+.||.+||++.+.+.|+|+.-
T Consensus 288 ---------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 ---------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 000123577899999999999999999999999988753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=295.93 Aligned_cols=187 Identities=17% Similarity=0.122 Sum_probs=133.4
Q ss_pred eeeccCCeeEEEEEECCCCcEEEEEEecCccC--------ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCCCC
Q 017301 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--------HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..+.|+.|.+..++..-.|+.||+|++.+... .......+.+|+.+|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 45778888888888888999999999964321 122345688999999999 699999999999 5556
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+||||||++| +|.+.+...+++++. .|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 79999999997 999999999888875 48899999999999999999999999999999999999999999865433
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~p 230 (374)
.. .....+||+.|+|||++.+ .+..++|+||+|++++.|.++..+
T Consensus 393 ~~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C---CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred Cc---cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 22 2245689999999999876 467789999999999887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-30 Score=248.34 Aligned_cols=189 Identities=20% Similarity=0.246 Sum_probs=141.8
Q ss_pred eEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-h-----HHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-I-----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
...+.||+|+||+||+| ...+..+++|+....... . .....+.+|+.+|++++||||+++..+....
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----- 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL----- 411 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----
Confidence 34678999999999999 456889999987532211 1 1234578999999999999999554444322
Q ss_pred CcEEEEEccCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
...|+||||++ ++|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+|+....
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 23599999998 599999876 5689999999999999999999999999999998 999999999986533
Q ss_pred CCCcc----cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 017301 179 DTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (374)
Q Consensus 179 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf 231 (374)
..... ......+||+.|+|||++.+....|+..+|+||..+-..+.+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21111 012356899999999998764456888899999999999888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=207.95 Aligned_cols=145 Identities=16% Similarity=0.159 Sum_probs=114.6
Q ss_pred CeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh----------------HHHHHHHHHHHHHHhCCCCCcccc
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----------------SDAIRILREVKLLRLLRHPDIVEI 87 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~~i~~~ 87 (374)
.|.+++.||+|+||.||+|.+ .+|+.||+|+++...... .....+.+|+.+|+.++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 344559999999999999999 889999999986422110 13456889999999999 4 666
Q ss_pred ceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeE
Q 017301 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLK 166 (374)
Q Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vk 166 (374)
.+++.. +..|+||||++| +|.+ +. ......++.|++.||.|||+.||+||||||+|||++ ++.+|
T Consensus 167 ~~~~~~------~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 167 PKVYAW------EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp CCEEEE------ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred CeEEec------cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence 665522 336999999986 8887 42 124557999999999999999999999999999999 99999
Q ss_pred EeeecccccccCCCCccccccccccccccccccccc
Q 017301 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202 (374)
Q Consensus 167 l~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 202 (374)
|+|||+|+. +..++|||++.
T Consensus 233 l~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 233 IIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp ECCCTTCEE----------------TTSTTHHHHHH
T ss_pred EEECCCCeE----------------CCCCCHHHHHH
Confidence 999999852 33478898764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.1e-23 Score=181.84 Aligned_cols=139 Identities=18% Similarity=0.157 Sum_probs=108.9
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcE--EEEEEecCccCCh----------------------HHHHHHHHHHHHHHh
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHI----------------------SDAIRILREVKLLRL 78 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~~----------------------~~~~~~~~E~~~l~~ 78 (374)
.-|.+.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3478999999999999999998778999 9999975421110 112357889999999
Q ss_pred CCCCCcc--ccceeecCCCcCCCCcEEEEEccCcc------cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh-hCCccc
Q 017301 79 LRHPDIV--EIKRIMLPPSKREFKDIYVVFELMES------DLHQVIKANDDLTREHHQFFLYQMLRALKYMH-TANVYH 149 (374)
Q Consensus 79 l~h~~i~--~~~~~~~~~~~~~~~~~~lv~e~~~~------~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH-~~~i~H 149 (374)
+.|+++. .++.. ...++||||+++ +|.+.... .++..+..++.|++.||.||| +.||+|
T Consensus 127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givH 194 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVH 194 (258)
T ss_dssp HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 9887642 22221 135899999963 67766543 235578899999999999999 999999
Q ss_pred cCCCCCceEecCCCCeEEeeeccccc
Q 017301 150 RDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 150 ~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
|||||+|||++. .++|+|||+|..
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEE
T ss_pred CCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999998 899999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=167.10 Aligned_cols=139 Identities=14% Similarity=0.165 Sum_probs=99.9
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC---------------ChHH-----HHHHHHHHHHHHhCCCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---------------HISD-----AIRILREVKLLRLLRHP 82 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---------------~~~~-----~~~~~~E~~~l~~l~h~ 82 (374)
.-|.++++||.|++|.||+|.+. +|+.||||+++.... .... .....+|+..|.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34899999999999999999874 699999998753110 0000 01134577777777544
Q ss_pred CccccceeecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC
Q 017301 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (374)
Q Consensus 83 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~ 161 (374)
++... ..+... ..+|||||++| +|.++. ..+.+..++.||+.+|.+||++|||||||||.|||++.
T Consensus 174 gv~vp-~p~~~~------~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 174 GFPVP-EPIAQS------RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE 240 (397)
T ss_dssp TCSCC-CEEEEE------TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred CCCCC-eeeecc------CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence 43222 111111 13799999997 664432 12345678999999999999999999999999999988
Q ss_pred CC----------CeEEeeeccccc
Q 017301 162 NC----------KLKVCDFGLARV 175 (374)
Q Consensus 162 ~~----------~vkl~DFg~a~~ 175 (374)
++ .+.|+||+.+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 389999998864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=6.4e-13 Score=117.43 Aligned_cols=138 Identities=12% Similarity=0.131 Sum_probs=105.1
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 101 (374)
+.|++...++.|+.+.||++.. .+..+++|+...... .....+.+|+.+++.+. +..+.+++++... .+.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~ 84 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGW 84 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCc
Confidence 4588999999999999999964 368999999864211 11234778999999885 6677788877732 345
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh------------------------------------
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT------------------------------------ 144 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~------------------------------------ 144 (374)
.|+|||+++| +|.+.+. +......++.++..+|+.||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred eEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 8999999998 7776531 122345788899999999998
Q ss_pred -----------------------CCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 145 -----------------------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 145 -----------------------~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876556799999774
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.29 E-value=7e-12 Score=113.29 Aligned_cols=187 Identities=17% Similarity=0.254 Sum_probs=118.5
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCc--cccceeecCCCcCCCCcEEE
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDI--VEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--~~~~~~~~~~~~~~~~~~~l 104 (374)
++.++.|....||++ +..+++|+... ......+.+|..+|+.+. +..+ ...+... .........|+
T Consensus 25 i~~~~~G~~n~v~~v-----~~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI-----NRDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEES-----TTSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCE
T ss_pred eEecCCCCcceEEEE-----CCEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceE
Confidence 456999999999987 25688998642 234567889999998884 3333 2332222 11122234589
Q ss_pred EEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------
Q 017301 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT--------------------------------------- 144 (374)
Q Consensus 105 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~--------------------------------------- 144 (374)
||++++| .+.+.... .++..+...++.+++..++.||+
T Consensus 94 vm~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999998 66543322 46777788888888888888885
Q ss_pred -------------------CCccccCCCCCceEecC--CCCeEEeeecccccccCCCCccccccc-----------cccc
Q 017301 145 -------------------ANVYHRDLKPKNILANA--NCKLKVCDFGLARVAFSDTPMTVFWTD-----------YVAT 192 (374)
Q Consensus 145 -------------------~~i~H~dikp~Nil~~~--~~~vkl~DFg~a~~~~~~~~~~~~~~~-----------~~gt 192 (374)
..++|+|++|.||+++. .+.+.|+||+.+............... ....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 13699999999999998 455789999998653221100000000 0000
Q ss_pred ccccc-cccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 017301 193 RWYRA-PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (374)
Q Consensus 193 ~~y~a-PE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf 231 (374)
..... |+.... .....+.|++|.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r----~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK----YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH----HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH----HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00111 222111 112368999999999999998766
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=6.2e-12 Score=110.73 Aligned_cols=133 Identities=16% Similarity=0.070 Sum_probs=93.9
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCcCCCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFK 100 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~~~ 100 (374)
..|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++..... .+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~ 88 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AG 88 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SS
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CC
Confidence 4566655445666799999953 56778999987643 1134667888888885444 4556666532 24
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCC---------------------------------
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--------------------------------- 146 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------------------------------- 146 (374)
..++|||+++| ++ . .. ..+ ...++.+++..|..||+..
T Consensus 89 ~~~~v~e~i~G~~l-~-~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 89 RDWLLLGEVPGQDL-L-SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp CEEEEEECCSSEET-T-TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCEEEEEecCCccc-C-cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 48999999998 66 3 21 122 2356778888888888754
Q ss_pred -------------------------ccccCCCCCceEecCCCCeEEeeecccc
Q 017301 147 -------------------------VYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 147 -------------------------i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
++|+|++|.||+++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877656799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=8.7e-11 Score=108.63 Aligned_cols=144 Identities=16% Similarity=0.238 Sum_probs=103.1
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEec--CccCChHHHHHHHHHHHHHHhCC--CCCccccceeecCCCcCCCC
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~ 100 (374)
...++.|+.|.++.||++... +..+++|+.. .. ........+.+|+.+++.+. +..+++++..+...+ ..+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~-~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g 114 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKS-KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIG 114 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCC-CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccC
Confidence 345778999999999999643 5688888764 21 11123446778999999987 445677777764331 124
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT----------------------------------- 144 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~----------------------------------- 144 (374)
..|+|||+++| .+.+. .-..++......++.+++.+|+.||+
T Consensus 115 ~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 57999999998 44321 12246788888999999999999997
Q ss_pred -----------------------CCccccCCCCCceEecCCCC--eEEeeeccccc
Q 017301 145 -----------------------ANVYHRDLKPKNILANANCK--LKVCDFGLARV 175 (374)
Q Consensus 145 -----------------------~~i~H~dikp~Nil~~~~~~--vkl~DFg~a~~ 175 (374)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999998754 68999999865
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.5e-07 Score=84.71 Aligned_cols=134 Identities=21% Similarity=0.240 Sum_probs=89.9
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCC---CccccceeecCCCcCCCCcEEE
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP---DIVEIKRIMLPPSKREFKDIYV 104 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~~~~~~~~~~~~l 104 (374)
++.++.|....||+. +..+++|+.. .......+.+|..+|+.+.+. .+.+.+.... ...+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEE
Confidence 456889999999988 5778889753 223456788999999998743 2344444432 12244689
Q ss_pred EEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC--------------------------------------
Q 017301 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-------------------------------------- 145 (374)
Q Consensus 105 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~-------------------------------------- 145 (374)
|||+++| .+....-. .++......+..++...|+.||+.
T Consensus 91 v~e~i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999998 55542211 234445555555555555555532
Q ss_pred ----------------------CccccCCCCCceEecC---CCCe-EEeeecccccc
Q 017301 146 ----------------------NVYHRDLKPKNILANA---NCKL-KVCDFGLARVA 176 (374)
Q Consensus 146 ----------------------~i~H~dikp~Nil~~~---~~~v-kl~DFg~a~~~ 176 (374)
.++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 4565 79999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=4.2e-07 Score=80.15 Aligned_cols=131 Identities=16% Similarity=0.183 Sum_probs=91.1
Q ss_pred eeeccCCe-eEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCcEEEEEc
Q 017301 30 VIGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFE 107 (374)
Q Consensus 30 ~lg~G~~g-~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~lv~e 107 (374)
.+..|..+ .||+......+..+++|+-.. .....+.+|...|+.+. +--+.+++.+..+ .+..|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEE
Confidence 34555554 699988777788899998642 34556788999998885 3335566666532 245799999
Q ss_pred cCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC-----------------------------------------
Q 017301 108 LMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA----------------------------------------- 145 (374)
Q Consensus 108 ~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~----------------------------------------- 145 (374)
+++| ++.+..... ......+..++...|..||+.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9998 776655432 123344556666666666631
Q ss_pred -----------------CccccCCCCCceEecCCCCeEEeeecccc
Q 017301 146 -----------------NVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 146 -----------------~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 15899999999999987666799999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=9.9e-07 Score=82.42 Aligned_cols=78 Identities=17% Similarity=0.083 Sum_probs=47.3
Q ss_pred EeceeeccCCeeEEEEEECCCCcEEEEEEecCccC--C---hHHHHHHHHHHHHHHhCCC--CC-ccccceeecCCCcCC
Q 017301 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--H---ISDAIRILREVKLLRLLRH--PD-IVEIKRIMLPPSKRE 98 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~---~~~~~~~~~E~~~l~~l~h--~~-i~~~~~~~~~~~~~~ 98 (374)
-.+.||.|..+.||++....+++.+++|....... . .....++..|..+|+.+.. |. +.+++.+. .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~---- 107 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T---- 107 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T----
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C----
Confidence 46789999999999997666678999998653211 0 0112345678888887742 33 33444332 1
Q ss_pred CCcEEEEEccCcc
Q 017301 99 FKDIYVVFELMES 111 (374)
Q Consensus 99 ~~~~~lv~e~~~~ 111 (374)
...++|||+++|
T Consensus 108 -~~~~lvmE~l~g 119 (397)
T 2olc_A 108 -EMAVTVMEDLSH 119 (397)
T ss_dssp -TTTEEEECCCTT
T ss_pred -CccEEEEEeCCC
Confidence 124899999986
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.24 E-value=3.3e-06 Score=76.92 Aligned_cols=30 Identities=27% Similarity=0.348 Sum_probs=27.2
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 145 ~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888889999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=3.8e-06 Score=77.16 Aligned_cols=85 Identities=8% Similarity=0.139 Sum_probs=51.3
Q ss_pred eeEecee-eccCCeeEEEEEEC--C----CCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCC-C--CCccccceeecC
Q 017301 25 YKILEVI-GKGSYGVVCAAIDT--H----TGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR-H--PDIVEIKRIMLP 93 (374)
Q Consensus 25 Y~~~~~l-g~G~~g~V~~a~~~--~----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~~ 93 (374)
-...+.| +.|....+|++... . ++..+++|+...... .......+.+|+.+++.+. + ..+.+++.....
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 88889999988643 0 266889997643210 0001134567888887774 2 345666666533
Q ss_pred CCcCCCCcEEEEEccCcc
Q 017301 94 PSKREFKDIYVVFELMES 111 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~ 111 (374)
.+ ..+..|+|||+++|
T Consensus 102 ~~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GD--VLGTPFFLMDYVEG 117 (357)
T ss_dssp ST--TTSSCEEEEECCCC
T ss_pred CC--ccCCceEEEEecCC
Confidence 21 11345899999987
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.95 E-value=0.00013 Score=60.93 Aligned_cols=96 Identities=18% Similarity=0.138 Sum_probs=65.4
Q ss_pred cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHh-hhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccccccc
Q 017301 112 DLHQVIKA-NDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189 (374)
Q Consensus 112 ~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~L-H~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~ 189 (374)
+|.+++.. +.+++++++|.++.|.+.+|.-+ +.+.-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 79999986 55899999999999999998876 222222334457999999999987764 2110
Q ss_pred cccccccccccccccCCCCCccchHHHHHHHHHHHHh
Q 017301 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226 (374)
Q Consensus 190 ~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt 226 (374)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhh
Confidence 1122366888753 345678899999999999885
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.93 E-value=9.5e-05 Score=69.46 Aligned_cols=32 Identities=16% Similarity=0.272 Sum_probs=28.4
Q ss_pred hhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 143 H~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
+...++|+|++|.|||++.++ +.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 466899999999999998876 99999998865
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00027 Score=63.09 Aligned_cols=68 Identities=13% Similarity=0.046 Sum_probs=41.4
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCc-cccceeecCCCcCCCCcEEEEE
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
++.|+.|....+|++ ..+++|+..... .......+|+.+++.+...++ .+++... .. .-++++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~-----~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PA-----TGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT-----TCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CC-----CCEEEE
Confidence 788999999999999 568889875321 111123457777777643233 3444432 11 126899
Q ss_pred ccC-cc
Q 017301 107 ELM-ES 111 (374)
Q Consensus 107 e~~-~~ 111 (374)
|++ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00038 Score=62.45 Aligned_cols=74 Identities=18% Similarity=0.103 Sum_probs=53.5
Q ss_pred eEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC---CCCccccceeecCCCcCCCCcE
Q 017301 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
.-.+.|+.|....+|+... .+..+++|+... .....+.+|...|+.+. ...+++++..... ....
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCce
Confidence 3467799999999999964 467889998653 12456778988888874 2456666666532 2457
Q ss_pred EEEEccCcc
Q 017301 103 YVVFELMES 111 (374)
Q Consensus 103 ~lv~e~~~~ 111 (374)
|+|||+++|
T Consensus 107 ~lvme~l~G 115 (312)
T 3jr1_A 107 FLLLEALNK 115 (312)
T ss_dssp EEEEECCCC
T ss_pred EEEEEeccC
Confidence 999999986
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0015 Score=57.84 Aligned_cols=77 Identities=10% Similarity=0.001 Sum_probs=51.2
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCC---CccccceeecCCCcCCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP---DIVEIKRIMLPPSKREF 99 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~~~~~~~~ 99 (374)
.+..-+..+|.|..+.||++.. .+|+.|++|+...... .....+.+|...|+.+.-. -+++++..- .
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---~---- 84 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---D---- 84 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---T----
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc---C----
Confidence 3456688899999999999964 5788999998643211 1123467899999888522 233333321 1
Q ss_pred CcEEEEEccCcc
Q 017301 100 KDIYVVFELMES 111 (374)
Q Consensus 100 ~~~~lv~e~~~~ 111 (374)
-++|||++.+
T Consensus 85 --~~lv~e~l~~ 94 (288)
T 3f7w_A 85 --RTLAMEWVDE 94 (288)
T ss_dssp --TEEEEECCCC
T ss_pred --ceEEEEeecc
Confidence 2789999863
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0006 Score=61.70 Aligned_cols=32 Identities=28% Similarity=0.427 Sum_probs=27.5
Q ss_pred hCCccccCCCCCceEecCC----CCeEEeeeccccc
Q 017301 144 TANVYHRDLKPKNILANAN----CKLKVCDFGLARV 175 (374)
Q Consensus 144 ~~~i~H~dikp~Nil~~~~----~~vkl~DFg~a~~ 175 (374)
...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999874 6799999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0003 Score=63.32 Aligned_cols=148 Identities=13% Similarity=0.085 Sum_probs=77.1
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCC-
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPS- 95 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~- 95 (374)
++. +...-++.|+.|....+|++... +..+++|+..... ....+..|+.+++.+...+ +.+++... .+.
T Consensus 19 ~~~-~~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~ 90 (322)
T 2ppq_A 19 YDV-GSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGEL 90 (322)
T ss_dssp BCC-CCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCS
T ss_pred CCC-CcceEeeccCCCcccceEEEEeC--CccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCE
Confidence 444 34445677888988999999643 3368899876421 1223456777776664222 22332211 000
Q ss_pred -cCCCCcEEEEEccCcc-cH-----------HHH---HHh-CCC--------CCHHHHHHH---------------HHHH
Q 017301 96 -KREFKDIYVVFELMES-DL-----------HQV---IKA-NDD--------LTREHHQFF---------------LYQM 135 (374)
Q Consensus 96 -~~~~~~~~lv~e~~~~-~L-----------~~~---l~~-~~~--------l~~~~~~~i---------------~~qi 135 (374)
....+..+++|++++| .+ ... ++. ... ......... -..+
T Consensus 91 ~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l 170 (322)
T 2ppq_A 91 LGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEI 170 (322)
T ss_dssp CEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHH
T ss_pred EEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHH
Confidence 0012346899999986 21 001 111 001 111100000 0113
Q ss_pred HHHHHHhhh-------CCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 136 LRALKYMHT-------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 136 ~~al~~LH~-------~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
...++.+.+ .+++|+|++|.|||++.++.+.++||+.+.
T Consensus 171 ~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 171 RPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 334444442 369999999999999887555799999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00069 Score=63.71 Aligned_cols=72 Identities=15% Similarity=0.164 Sum_probs=47.5
Q ss_pred EeceeeccCCeeEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCc-cccceeecCCCcCC
Q 017301 27 ILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKRE 98 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~ 98 (374)
-++.|+.|....||++.... .+..+++|+.... .. ...+.+|..+++.+...++ +++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~ 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIF-----SG 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC
Confidence 46678889889999997542 3578999987432 11 1344578888888753333 5555554 11
Q ss_pred CCcEEEEEccCcc
Q 017301 99 FKDIYVVFELMES 111 (374)
Q Consensus 99 ~~~~~lv~e~~~~ 111 (374)
.+|+||++|
T Consensus 148 ----g~v~e~l~G 156 (429)
T 1nw1_A 148 ----GRLEEYIPS 156 (429)
T ss_dssp ----EEEECCCCE
T ss_pred ----CEEEEEeCC
Confidence 388999876
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00049 Score=63.44 Aligned_cols=140 Identities=12% Similarity=0.156 Sum_probs=80.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPP 94 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 94 (374)
+..+ ++.|..|-...+|++.... .+..+++++.... ........+|..+++.+. +.-..++++.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--- 123 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVF--- 123 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE---
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEc---
Confidence 3444 4568788888999997532 3578999985321 112345568999988885 32235555554
Q ss_pred CcCCCCcEEEEEccCcc-cHH--------------HHH---HhC-----CCC--CHHHHHHHHHHHHH------------
Q 017301 95 SKREFKDIYVVFELMES-DLH--------------QVI---KAN-----DDL--TREHHQFFLYQMLR------------ 137 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~--------------~~l---~~~-----~~l--~~~~~~~i~~qi~~------------ 137 (374)
.+ .+||||++| .+. +.+ ... ... -+..+..+..++..
T Consensus 124 --~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~ 197 (379)
T 3feg_A 124 --PE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLL 197 (379)
T ss_dssp --TT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHH
T ss_pred --CC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhh
Confidence 21 289999886 221 111 111 111 23455555544422
Q ss_pred -------HHHHh----hh----CCccccCCCCCceEecCC----CCeEEeeeccccc
Q 017301 138 -------ALKYM----HT----ANVYHRDLKPKNILANAN----CKLKVCDFGLARV 175 (374)
Q Consensus 138 -------al~~L----H~----~~i~H~dikp~Nil~~~~----~~vkl~DFg~a~~ 175 (374)
.+..| .. ..++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 198 ~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 198 EMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 12222 22 258999999999999876 6899999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.006 Score=54.81 Aligned_cols=138 Identities=15% Similarity=0.082 Sum_probs=75.5
Q ss_pred ceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCc--CCCCcEEE
Q 017301 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSK--REFKDIYV 104 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~--~~~~~~~l 104 (374)
..|+ |....||++.. .+|+.+++|+...... ....+..|..+++.+.... +++++.. .+.. ...+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence 4466 77889998843 3466799999863211 2334556888777774222 3333332 1110 11245688
Q ss_pred EEccCcc-cH-----HH------HH---H---hC------CCCCHHHH----------------------HHHHHHHHHH
Q 017301 105 VFELMES-DL-----HQ------VI---K---AN------DDLTREHH----------------------QFFLYQMLRA 138 (374)
Q Consensus 105 v~e~~~~-~L-----~~------~l---~---~~------~~l~~~~~----------------------~~i~~qi~~a 138 (374)
+|++++| .+ .. .+ + .. ..++.... ...+..++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 9999986 21 11 11 1 00 01121111 1111222222
Q ss_pred HHHh----hhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 139 LKYM----HTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 139 l~~L----H~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
+.-+ ....++|+|++|.||+++ + .+.++||+.+..
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2222 234689999999999998 4 799999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0023 Score=58.10 Aligned_cols=31 Identities=16% Similarity=0.300 Sum_probs=27.6
Q ss_pred CCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 145 ANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 145 ~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
.+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.012 Score=55.68 Aligned_cols=73 Identities=19% Similarity=0.204 Sum_probs=45.7
Q ss_pred EeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCc-cccceeecCCCcCCCCcEEEE
Q 017301 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIYVV 105 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~~lv 105 (374)
-++.|+.|-...+|++.....+..+++|+....... .....+|..+++.+...++ .++++.+ .. .+|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v 179 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFF-----TN----GRI 179 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEE
Confidence 356788898999999976544578999987432111 1112478888888865444 4555555 11 359
Q ss_pred EccCcc
Q 017301 106 FELMES 111 (374)
Q Consensus 106 ~e~~~~ 111 (374)
|||++|
T Consensus 180 ~e~I~G 185 (458)
T 2qg7_A 180 EEFMDG 185 (458)
T ss_dssp EECCCS
T ss_pred EEeeCC
Confidence 999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0058 Score=56.02 Aligned_cols=73 Identities=7% Similarity=0.005 Sum_probs=41.6
Q ss_pred EeceeeccCCeeEEEEEECC--------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCC-ccccceeecCCCcC
Q 017301 27 ILEVIGKGSYGVVCAAIDTH--------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKR 97 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~ 97 (374)
-+..|+.|..-.+|++.... .+..+++|+..... ........|..+++.+...+ ..++++.. .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~ 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF-----N 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec-----C
Confidence 35678888888999997543 13688999865321 11112346778777775333 34555443 1
Q ss_pred CCCcEEEEEccCcc
Q 017301 98 EFKDIYVVFELMES 111 (374)
Q Consensus 98 ~~~~~~lv~e~~~~ 111 (374)
-++||++++|
T Consensus 109 ----~~~v~e~i~G 118 (369)
T 3c5i_A 109 ----GGRIEEWLYG 118 (369)
T ss_dssp ----TEEEEECCCS
T ss_pred ----CcEEEEEecC
Confidence 1689999886
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.90 E-value=0.12 Score=48.08 Aligned_cols=73 Identities=10% Similarity=-0.007 Sum_probs=45.5
Q ss_pred EeceeeccCCeeEEEEEECCC-------CcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCC
Q 017301 27 ILEVIGKGSYGVVCAAIDTHT-------GEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 98 (374)
-++.|..|-...+|++..... +..+++++..... .......+|..+++.+. +.-..++++.+ .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF-----P- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C-
Confidence 356687888889999976421 5789999864321 11112346888888775 32234555433 1
Q ss_pred CCcEEEEEccCcc
Q 017301 99 FKDIYVVFELMES 111 (374)
Q Consensus 99 ~~~~~lv~e~~~~ 111 (374)
-+.||+|++|
T Consensus 145 ---~~~I~efI~G 154 (424)
T 3mes_A 145 ---EGRIEEFIDG 154 (424)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CCEEEEEeCC
Confidence 1789999986
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.83 E-value=0.037 Score=52.38 Aligned_cols=64 Identities=14% Similarity=0.085 Sum_probs=18.8
Q ss_pred eEeceeeccCCeeEEEEEECCCCcEEEE------EEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeec
Q 017301 26 KILEVIGKGSYGVVCAAIDTHTGEKVAI------KKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIML 92 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vai------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 92 (374)
.+.+.|| ||.||++.......+||+ |..+...........+.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 5566776 999999987655568888 665533333333446778889999999999999988663
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.73 E-value=0.34 Score=44.69 Aligned_cols=29 Identities=31% Similarity=0.416 Sum_probs=24.8
Q ss_pred ccccCCCCCceEe------cCCCCeEEeeeccccc
Q 017301 147 VYHRDLKPKNILA------NANCKLKVCDFGLARV 175 (374)
Q Consensus 147 i~H~dikp~Nil~------~~~~~vkl~DFg~a~~ 175 (374)
++|+|+.+.|||+ +.+..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 374 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-96 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-90 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-87 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-77 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-77 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-75 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-73 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-71 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-71 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-68 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-68 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-68 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-67 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-66 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-66 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-65 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-62 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-56 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-53 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-52 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-49 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-21 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 288 bits (738), Expect = 2e-96
Identities = 155/342 (45%), Positives = 215/342 (62%), Gaps = 5/342 (1%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
RY L IG+G+YG+VC+A D +VAIKKI FEH + R LRE+K+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRH 65
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+I+ I I+ P+ + KD+Y+V LM +DL++++K L+ +H +FLYQ+LR LKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ANV HRDLKP N+L N C LK+CDFGLARVA D T F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ YT +IDIWS+GCI AE+L+ +P+FPGK + QL+ I +LG+PS E + + N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
KAR YL + K VP + FPN D AL LL +++ F+P R E+ALA PY +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363
EP + +F+ E + K+ ++ELI+ E + P
Sbjct: 304 PSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPGY 343
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 273 bits (698), Expect = 3e-90
Identities = 141/346 (40%), Positives = 207/346 (59%), Gaps = 12/346 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
T + RY+ L +G G+YG VCAA DT TG +VA+KK+ F+ I A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 77 RLLRHPDIVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ ++H +++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR LKY+H+A++ HRDLKP N+ N +C+LK+ DFGLAR T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ + + Y +DIWS+GCI AE+LTG+ LFPG + QL LI L+GTP E +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ +E AR Y+ + + P + F +PLA+ LL++++ D R TA +ALA Y
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
F + EP P + FE R + D+ + L Y E++ + P
Sbjct: 304 FAQYHDPDDEPVADPY---DQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (681), Expect = 1e-87
Identities = 134/346 (38%), Positives = 207/346 (59%), Gaps = 12/346 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
T + Y+ L+ +G G+YG VC+A+D TG KVAIKK++ F+ A R RE++LL
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 77 RLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ +RH +++ + + P + F D Y+V M +DL +++K ++ L + QF +YQM
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQM 130
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L+ L+Y+H A + HRDLKP N+ N +C+LK+ DFGLAR A S+ T YV TRWY
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ + + +YT +DIWS+GCI AE++TGK LF G + QL I + GTP E +
Sbjct: 185 RAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+++++A+ Y+ + + N PLA+ LL++++ D + R TA EALA PY
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
F+ L E EP Q K + F+ T D+ + + Y+E+L + P
Sbjct: 304 FESLHDTEDEPQVQ---KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 5e-77
Identities = 121/354 (34%), Positives = 190/354 (53%), Gaps = 23/354 (6%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
+ + RY+ L+ IG G+ G+VCAA D VAIKK+ F++ + A R RE+ L+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 77 RLLRHPDIVEIKRIMLPPSK-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ + H +I+ + + P EF+D+Y+V ELM+++L QVI+ D E + LYQM
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQM 128
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L +K++H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M T YV TR+Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ Y +DIWS+GCI E++ K LFPG+ + Q + + + LGTP PE +
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPN------------VDPLALRLLQRLIAFDPKD 303
+ R Y+ K + + FP+ A LL +++ DP
Sbjct: 243 KKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREIL 357
R + ++AL PY + P + + + R T ++ +ELIY+E++
Sbjct: 302 RISVDDALQHPYINVWYDPAEVEAPPP-QIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 6e-77
Identities = 102/301 (33%), Positives = 155/301 (51%), Gaps = 7/301 (2%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++Y+ L IG+G++G V A TG+KVA+KK+ E I LRE+K+L+LL+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMESDLHQV-IKANDDLTREHHQFFLYQMLRA 138
++V + I + + IY+VF+ E DL + T + + +L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR-VAFSDTPMTVFWTDYVATRWYRA 197
L Y+H + HRD+K N+L + LK+ DFGLAR + + +T+ V T WYR
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PEL Y P ID+W GCI AE+ T P+ G + HQL LI+ L G+ +PE
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 258 VRNEKARKYLTEMR-KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
V N + + L ++ +K V K DP AL L+ +L+ DP R +++AL +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 317 K 317
Sbjct: 309 W 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 2e-75
Identities = 102/330 (30%), Positives = 168/330 (50%), Gaps = 19/330 (5%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 84 IVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVI----KANDDLTREHHQFFLYQMLRA 138
IV ++ +++ + + +V + + +++V +A L + + ++YQ+ R+
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 139 LKYMHTANVYHRDLKPKNILANANCKL-KVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H+ + HRD+KP+N+L + + + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PEL YT +ID+WS GC+ AE+L G+P+FPG S V QL I +LGTP+ E I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ +++ P +F P P A+ L RL+ + P R T EA A +F
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVF--RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
Query: 318 GLAKIEREPSCQPISKLEFEFERRRVTKDD 347
L + + F F + ++ +
Sbjct: 308 ELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (578), Expect = 7e-73
Identities = 108/312 (34%), Positives = 153/312 (49%), Gaps = 22/312 (7%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI---RILREVKLLRLLRHPD 83
L+ +G+G + V A D +T + VAIKKI + LRE+KLL+ L HP+
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKYM 142
I+ + S I +VF+ ME+DL +IK N + H + ++ L+ L+Y+
Sbjct: 62 IIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLKP N+L + N LK+ DFGLA+ S +T V TRWYRAPEL
Sbjct: 117 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL- 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y +D+W++GCI AE+L P PG S + QL I + LGTP+ E + +
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
+ P +PL F L L+Q L F+P R TA +AL YF
Sbjct: 233 DYVT---FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN---- 285
Query: 323 EREPSCQPISKL 334
P P +L
Sbjct: 286 --RPGPTPGCQL 295
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (578), Expect = 1e-72
Identities = 100/307 (32%), Positives = 157/307 (51%), Gaps = 16/307 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-- 79
+Y+ + IG+G+YG V A D G VA+K++ + +REV +LR L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 80 -RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQML 136
HP++V + + + +VFE ++ DL + + + E + ++Q+L
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ T V T WYR
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYR 182
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ S Y +D+WS+GCIFAE+ KPLF G S V QL I D++G P E
Sbjct: 183 APEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + K P+ + ++D L LL + + F+P R +A AL+ PYF
Sbjct: 241 RDVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
Query: 317 KGLAKIE 323
+ L + +
Sbjct: 297 QDLERCK 303
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 1e-71
Identities = 65/311 (20%), Positives = 123/311 (39%), Gaps = 28/311 (9%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ ++ + +G G+ GVV +G +A K IH + + +I+RE+++L P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSP 64
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV +I + E M+ L QV+K + + +++ L Y
Sbjct: 65 YIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 142 MHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+ + + HRD+KP NIL N+ ++K+CDFG++ + +V TR Y +PE
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPER 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
+ Y+ DIWS+G E+ G+ P + + + ET R
Sbjct: 175 L--QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 261 EKARKYLTEMRKKPPVPLFQKFPN-------------VDPLALRLLQRLIAFDPKDRPTA 307
M +PP+ +F+ + + + +P +R
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 308 EEALADPYFKG 318
++ + + K
Sbjct: 293 KQLMVHAFIKR 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 8e-71
Identities = 107/300 (35%), Positives = 161/300 (53%), Gaps = 13/300 (4%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
++ +E IG+G+YGVV A + TGE VA+KKI E +RE+ LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKY 141
IV++ ++ +K +Y+VFE + DL + + A+ + + +L+Q+L+ L +
Sbjct: 63 IVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H+ V HRDLKP+N+L N +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPEIL 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y+ A+DIWS+GCIFAE++T + LFPG S + QL I LGTP
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP--GVT 231
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
Y K + P +D LL +++ +DP R +A+ ALA P+F+ + K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 215 bits (549), Expect = 1e-68
Identities = 104/295 (35%), Positives = 152/295 (51%), Gaps = 11/295 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y LE IG+G+YGVV A + + GE A+KKI E +RE+ +L+ L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV++ ++ + + + V L + + L + FL Q+L + Y
Sbjct: 61 NIVKLYDVI----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H V HRDLKP+N+L N +LK+ DFGLAR +T + T WYRAP++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLM 173
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
KY+ IDIWS+GCIFAE++ G PLFPG S QL I +LGTP+ + V +
Sbjct: 174 G-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--E 230
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
KY P+P +D + LL +++ DP R TA++AL YFK
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-68
Identities = 105/298 (35%), Positives = 148/298 (49%), Gaps = 11/298 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y+ LE IG+G+YG V A + T E VA+K++ + LRE+ LL+ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV + ++ + K V + N DL E + FL+Q+L+ L +
Sbjct: 62 NIVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ NV HRDLKP+N+L N N +LK+ +FGLAR + V T WYR P++
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVVTLWYRPPDVLF 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y+ +ID+WS GCIFAE+ PLFPG V QL I LLGTP+ E +
Sbjct: 175 G-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT-- 231
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
K Y L P ++ LLQ L+ +P R +AEEAL PYF
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 3e-68
Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 40/295 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y E IG+G+ G V A+D TG++VAI++++ + I+ E+ ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV +++VV E + + + + L+AL+++
Sbjct: 78 NIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ V HRD+K NIL + +K+ DFG + + V T ++ APE+
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y P +DIWS+G + E++ G+P + ++ + L LI
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------------------- 228
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
P Q + + L R + D + R +A+E L + K
Sbjct: 229 ---------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 215 bits (549), Expect = 4e-68
Identities = 95/326 (29%), Positives = 164/326 (50%), Gaps = 27/326 (8%)
Query: 7 KKELKDKDFFT-EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD 65
+E D + E+G+ + Y+++ +G+G Y V AI+ EKV +K + V +
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--- 74
Query: 66 AIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDL 123
+I RE+K+L LR P+I+ + I+ P R +VFE + +D Q+ + L
Sbjct: 75 --KIKREIKILENLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT---L 126
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL-ANANCKLKVCDFGLARVAFSDTPM 182
T +F++Y++L+AL Y H+ + HRD+KP N++ + + KL++ D+GLA
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 185
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLD 241
+ VA+R+++ PEL + Y ++D+WS+GC+ A ++ K P F G QL
Sbjct: 186 ---YNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF------PNVDPLALRLLQR 295
I +LGT N + ++ + +++F V P AL L +
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301
Query: 296 LIAFDPKDRPTAEEALADPYFKGLAK 321
L+ +D + R TA EA+ PYF + K
Sbjct: 302 LLRYDHQSRLTAREAMEHPYFYTVVK 327
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 213 bits (543), Expect = 2e-67
Identities = 75/327 (22%), Positives = 137/327 (41%), Gaps = 43/327 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y +V+G G++ V A D T + VAIK I + E+ +L ++HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHP 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+IV + I +Y++ +L+ +L I T ++Q+L A+KY
Sbjct: 68 NIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 142 MHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+H + HRDLKP+N+L + + K+ + DFGL+++ + ++ T Y AP
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS----TACGTPGYVAP 178
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y+ A+D WSIG I +L G P F ++ + I
Sbjct: 179 EVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI--------------- 221
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
K + ++ A ++ L+ DP+ R T E+AL P+ G
Sbjct: 222 ------------LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269
Query: 319 LAKIEREPSCQPISKLEFEFERRRVTK 345
+++ +++ F + + +
Sbjct: 270 DTALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 7e-67
Identities = 74/344 (21%), Positives = 149/344 (43%), Gaps = 54/344 (15%)
Query: 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILRE 72
K+ + +Y I E +G+G +G+V ++T + + K + +D + + +E
Sbjct: 1 KELY------EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKE 51
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQF 130
+ +L + RH +I+ + +++ ++FE + D+ + I + +L
Sbjct: 52 ISILNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVS 106
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
+++Q+ AL+++H+ N+ H D++P+NI+ + +K+ +FG AR + +T
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT- 165
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
Y APE+ + A D+WS+G + +L+G F ++ ++ I +
Sbjct: 166 ---APEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
T E F + A+ + RL+ + K R TA
Sbjct: 221 TFDEE---------------------------AFKEISIEAMDFVDRLLVKERKSRMTAS 253
Query: 309 EALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELI 352
EAL P+ K KIER S + I L+ + K D+ ++
Sbjct: 254 EALQHPWLKQ--KIER-VSTKVIRTLKHRRYYHTLIKKDLNMVV 294
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-66
Identities = 68/298 (22%), Positives = 119/298 (39%), Gaps = 45/298 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
++I +GKG +G V A + + +A+K + E ++ REV++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
P+I+ + ++ +Y++ E +++ ++ + ++ ++ AL
Sbjct: 66 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y H+ V HRD+KP+N+L + +LK+ DFG + A S T T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDYLPPEM 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
+ +D+WS+G + E L GKP F + I
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------- 216
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
R + P V A L+ RL+ +P RP E L P+
Sbjct: 217 ---------SRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-66
Identities = 64/296 (21%), Positives = 117/296 (39%), Gaps = 37/296 (12%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ +++ +G+G+YG V A++ T E VA+K + D+ + I +E+ + ++L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHE 63
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLH-QVIKANDDLTREHHQFFLYQMLRALKY 141
++V+ + Y+ E I+ + + Q F +Q++ + Y
Sbjct: 64 NVVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + HRD+KP+N+L + LK+ DFGLA V F T Y APEL
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELL 177
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ +D+WS G + +L G+ + S Q
Sbjct: 178 KR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------------------ 218
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
K + +D L LL +++ +P R T + D ++
Sbjct: 219 ----------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 211 bits (537), Expect = 4e-66
Identities = 70/332 (21%), Positives = 131/332 (39%), Gaps = 45/332 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y I E +G G++GVV + TG A K + H SD + +E++ + +LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 83
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVI-KANDDLTREHHQFFLYQMLRALK 140
+V + + ++ +++E M +L + + ++ ++ + ++ Q+ + L
Sbjct: 84 TLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 141 YMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+MH N H DLKP+NI+ + +LK+ DFGL + V T + AP
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV----TTGTAEFAAP 194
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ D+WS+G + +L+G F G++ L +
Sbjct: 195 EVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--------------- 237
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ F + +++L+ DP R T +AL P+
Sbjct: 238 ------------KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285
Query: 319 LAKIEREPSCQPISKLEFEFERRRVTKDDIRE 350
R+ P S+ + + D E
Sbjct: 286 GNAPGRDSQI-PSSRYTKIRDSIKTKYDAWPE 316
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 210 bits (535), Expect = 1e-65
Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 44/300 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y ILE +G G++GVV ++ TG K I+ + D + E+ ++ L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 86
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALK 140
++ + + ++ ++ E + +L I A D ++ ++ Q LK
Sbjct: 87 KLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 141 YMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+MH ++ H D+KP+NI+ +K+ DFGLA D + AT + AP
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAP 197
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ D+W+IG + +L+G F G+ + L +
Sbjct: 198 EIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--------------- 240
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
++ F +V P A ++ L+ +P+ R T +AL P+ KG
Sbjct: 241 ------------KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 206 bits (525), Expect = 3e-65
Identities = 73/307 (23%), Positives = 124/307 (40%), Gaps = 49/307 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-------RILREVKLL 76
Y+ E++G+G VV I T ++ A+K I A L+EV +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 77 RLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQ 134
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+L + +H N+ HRDLKP+NIL + + +K+ DFG + + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 195 YRAPELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
Y APE+ Y +D+WS G I +L G P F + + L +I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
++ + L+ R + P+ R TAEEA
Sbjct: 228 --------------------MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 311 LADPYFK 317
LA P+F+
Sbjct: 268 LAHPFFQ 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (526), Expect = 6e-65
Identities = 76/355 (21%), Positives = 134/355 (37%), Gaps = 50/355 (14%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
D EL KD + + L IG GS+G V A D E VAIKK+ +
Sbjct: 1 DPDVAELFFKDDPEK-----LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 55
Query: 64 SDAI-RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND 121
++ I++EV+ L+ LRHP+ ++ + L ++V E S +
Sbjct: 56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK 110
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
L + L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A +
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168
Query: 182 MTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
+V T ++ APE + +Y +D+WS+G E+ KP + + L
Sbjct: 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
I + + P + + + +
Sbjct: 224 YHI--------------------------AQNESPAL---QSGHWSEYFRNFVDSCLQKI 254
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYRE 355
P+DRPT+E L + +K + E + +++++++E
Sbjct: 255 PQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK-DAVRELDNLQYRKMKKILFQE 308
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 6e-64
Identities = 79/304 (25%), Positives = 117/304 (38%), Gaps = 48/304 (15%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A Y++L IG GSYG G+ + K++ ++ ++ EV LLR L+H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----LTREHHQFFLYQML 136
P+IV ++ + +Y+V E E DL VI L E + Q+
Sbjct: 63 PNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 137 RALKYMH-----TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
ALK H V HRDLKP N+ + +K+ DFGLAR+ DT +V
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVG 176
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T +Y +PE Y DIWS+GC+ E+ P F S I +
Sbjct: 177 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 228
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
K +P ++ R++ RP+ EE L
Sbjct: 229 -------------------GKFRRIP-----YRYSDELNEIITRMLNLKDYHRPSVEEIL 264
Query: 312 ADPY 315
+P
Sbjct: 265 ENPL 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 7e-64
Identities = 60/300 (20%), Positives = 107/300 (35%), Gaps = 43/300 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
++I+ +G G++G V A + T A K I + + + E+ +L HP+
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPN 70
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI--KANDDLTREHHQFFLYQMLRALKY 141
IV++ +++++ E + + LT Q Q L AL Y
Sbjct: 71 IVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + HRDLK NIL + +K+ DFG++ ++ T ++ APE+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---DSFIGTPYWMAPEVV 182
Query: 202 GSFFSK---YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
SK Y D+WS+G E+ +P + + L I
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------------- 228
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
K P + L++ + + R T + L P+
Sbjct: 229 --------------KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 8e-64
Identities = 83/351 (23%), Positives = 141/351 (40%), Gaps = 46/351 (13%)
Query: 23 NRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLR 80
+ YK+ +V+G G G V + T EK A+K + D + REV+ R +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQ 63
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLR 137
P IV I + K + +V E ++ +L I+ D T + +
Sbjct: 64 CPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 138 ALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
A++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+ S +T T +
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY----TPY 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ G KY + D+WS+G I +L G P F + +
Sbjct: 179 YVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------- 225
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
T +R ++ V L++ L+ +P R T E + P
Sbjct: 226 ------------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLK 365
+ K+ + P L+ + ER K+++ + ++Y +K
Sbjct: 274 WIMQSTKVPQTPLHTSRV-LKEDKERWEDVKEEMTSALATMRVDYEQIKIK 323
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-62
Identities = 68/301 (22%), Positives = 122/301 (40%), Gaps = 41/301 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D K IG+GS+ V +DT T +VA ++ D S+ R E ++L+ L+
Sbjct: 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP+IV K + K I +V ELM S L +K + + + + Q+L+ L
Sbjct: 67 HPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGL 125
Query: 140 KYMHTAN--VYHRDLKPKNIL-ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
+++HT + HRDLK NI +K+ D GLA + + V + T +
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-----IGTPEFM 180
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ + KY ++D+++ G E+ T + + Q+
Sbjct: 181 APEM---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------- 221
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ +T K P +++ I + +R + ++ L +F
Sbjct: 222 -------YRRVTSGVKPASFD-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
Query: 317 K 317
+
Sbjct: 270 Q 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 9e-62
Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 47/304 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
V++ K +Y + +L + I+ +F+ +++ AL+Y
Sbjct: 69 FFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + HRDLKP+NIL N + +++ DFG A+V ++ +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ D+W++GCI +++ G P F + I
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------ 222
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA------LADPY 315
++ + P P A L+++L+ D R EE A P+
Sbjct: 223 --------IKLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 316 FKGL 319
F+ +
Sbjct: 270 FESV 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 6e-59
Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 47/305 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y E +G G + VV + TG + A K I I REV +L+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLR 137
++HP+++ + + D+ ++ EL+ L + + LT E FL Q+L
Sbjct: 70 IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 138 ALKYMHTANVYHRDLKPKNILAN----ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+H+ + H DLKP+NI+ ++K+ DFGLA + T
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTP 180
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
+ APE+ D+WSIG I +L+G F G + L ++ + E
Sbjct: 181 EFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 238
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
F N LA ++RL+ DPK R T +++L
Sbjct: 239 ---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 314 PYFKG 318
P+ K
Sbjct: 272 PWIKP 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 190 bits (483), Expect = 7e-59
Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 33/295 (11%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR 80
++RY++ E++G G V A D VA+K + D+ S +R RE + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP IV + + Y+V E ++ L ++ +T + + +AL
Sbjct: 66 HPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H + HRD+KP NI+ +A +KV DFG+AR + T Y +PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
D++S+GC+ EVLTG+P F G S V
Sbjct: 185 QARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV--------------- 227
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEALAD 313
++ P+P + + ++ + +A +P++R TA E AD
Sbjct: 228 ------------REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 3e-57
Identities = 57/295 (19%), Positives = 104/295 (35%), Gaps = 38/295 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + + IG GS+G V VA+K ++ EV +LR R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRA 138
H +I+ + +V + E S L+ + + Q +
Sbjct: 63 HVNILLFMGYS------TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ Y+H ++ HRDLK NI + + +K+ DFGLA V + F + + AP
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAP 175
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E + + Y+ D+++ G + E++TG+ + + Q+ +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------------- 222
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
R L + N RL+ + +RP + LA
Sbjct: 223 ------------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-56
Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 45/301 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLL-RLLR 80
+ + +++GKGS+G V A T + AIK + DV D + E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP + + + ++++ V E + DL I++ F+ +++ L
Sbjct: 62 HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 116
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+++H+ + +RDLK NIL + + +K+ DFG+ + + T Y APE
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPE 173
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ KY ++D WS G + E+L G+ F G+ I
Sbjct: 174 ILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---------------- 215
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKG 318
P P ++ A LL +L +P+ R + P F+
Sbjct: 216 ----------RMDNPFYP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260
Query: 319 L 319
+
Sbjct: 261 I 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-55
Identities = 66/307 (21%), Positives = 118/307 (38%), Gaps = 57/307 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLR 77
++Y++ ++G G +G V + I VAIK + + + + R+ EV LL+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 78 LLR--HPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLY 133
+ ++ + P ++ E E DL I L E + F +
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
Q+L A+++ H V HRD+K +NIL + N +LK+ DFG + +TD+ T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGT 172
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
R Y PE + + + +WS+G + +++ G F +
Sbjct: 173 RVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------- 216
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+R + V L++ +A P DRPT EE
Sbjct: 217 -----------------IRGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
Query: 313 DPYFKGL 319
P+ + +
Sbjct: 255 HPWMQDV 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-55
Identities = 68/304 (22%), Positives = 127/304 (41%), Gaps = 48/304 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
N + L+++GKG++G V + TG A+K + +V + + E ++L+ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALK 140
P + +K + + V E L + T E +F+ +++ AL+
Sbjct: 65 PFLTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+H+ +V +RD+K +N++ + + +K+ DFGL + SD + T Y APE+
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEV 176
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
+ Y A+D W +G + E++ G+ F + +LI
Sbjct: 177 LED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----------------- 217
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPY 315
+ ++ P + P A LL L+ DPK R A+E + +
Sbjct: 218 ---------LMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
Query: 316 FKGL 319
F +
Sbjct: 264 FLSI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 179 bits (454), Expect = 1e-53
Identities = 65/307 (21%), Positives = 116/307 (37%), Gaps = 49/307 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
N + + +IG+G +G V TG+ A+K + + + + A+ + L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
P IV + P K + + +LM DLH + + + +F+ +++
Sbjct: 64 GDCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 118
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L++MH V +RDLKP NIL + + +++ D GLA P T Y A
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMA 173
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ Y + D +S+GC+ ++L G F +
Sbjct: 174 PEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----------------- 215
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALA 312
E+ + + + P LL+ L+ D R A+E
Sbjct: 216 -----------EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
Query: 313 DPYFKGL 319
P+F+ L
Sbjct: 265 SPFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 174 bits (442), Expect = 2e-52
Identities = 66/302 (21%), Positives = 118/302 (39%), Gaps = 51/302 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++IL +G GS+G V H G A+K + ++ + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKYM 142
I+ + ++ + I+++ + +E + +F+ ++ AL+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+NIL + N +K+ DFG A+ T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ Y +ID WS G + E+L G F + + + I
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYFK 317
+ + P P + LL RLI D R E+ P+FK
Sbjct: 214 -------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
Query: 318 GL 319
+
Sbjct: 262 EV 263
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 9e-51
Identities = 55/302 (18%), Positives = 111/302 (36%), Gaps = 49/302 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+++ ++ +G GS+G V +G A+K + + L E ++L+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
P +V+++ K V+ + ++ ++ + H +F+ Q++ +Y
Sbjct: 101 PFLVKLEFSF----KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ ++ +RDLKP+N+L + ++V DFG A+ T APE+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEII 210
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
S Y A+D W++G + E+ G P F + + I
Sbjct: 211 LS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------ 250
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYF 316
+ K P + LL+ L+ D R + +F
Sbjct: 251 --------VSGKVRFP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
Query: 317 KG 318
Sbjct: 298 AT 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-50
Identities = 63/295 (21%), Positives = 112/295 (37%), Gaps = 52/295 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ K+L+ IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD--LTREHHQFFLYQMLR 137
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 59 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
A++Y+ N HRDL +N+L + + KV DFGL + A S + A
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTA 168
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE K++ D+WS G + E+ + G+ +P + + +
Sbjct: 169 PEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 215
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
K P P +++ D RP+ +
Sbjct: 216 --------------GYKMDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 9e-50
Identities = 56/307 (18%), Positives = 100/307 (32%), Gaps = 44/307 (14%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
NRY++ IG GS+G + D GE+VAIK +H ++ E K+ ++++
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQG 61
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
+ R E +V EL+ S + + + QM+ ++
Sbjct: 62 GVGIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 141 YMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVAFSDTPMTVFW----TDYVATR 193
Y+H+ N HRD+KP N L + + DFGLA+ + T
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y + + + D+ S+G + G + G +
Sbjct: 178 RYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ------------ 223
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE---EA 310
KY KK P+ L + D+P +
Sbjct: 224 -----------KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272
Query: 311 LADPYFK 317
+ + +
Sbjct: 273 FRNLFHR 279
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-49
Identities = 71/316 (22%), Positives = 111/316 (35%), Gaps = 55/316 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+G +G V T VAIK + L+E ++++ LR
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKKLR 70
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME---SDLHQVIKANDDLTREHHQFFLYQMLR 137
H +V++ ++ + IY+V E M + L Q+
Sbjct: 71 HEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ Y+ N HRDL+ NIL N KV DFGLAR+ + + A
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTA 182
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE ++T D+WS G + E+ T G+ +PG LD + P P
Sbjct: 183 PEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---- 236
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DP 314
P L+ + +P++RPT E A +
Sbjct: 237 --------------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
Query: 315 YFKGLAKIEREPSCQP 330
YF EP QP
Sbjct: 271 YFTST-----EPQYQP 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-49
Identities = 62/308 (20%), Positives = 126/308 (40%), Gaps = 44/308 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIH--DVFEHISDAIRILREVKLLR 77
+++L+V+G G+YG V TG+ A+K + + + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML 136
+R + + L + + ++++ + + +L + + T Q ++ +++
Sbjct: 84 HIRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL+++H + +RD+K +NIL ++N + + DFGL++ F + +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMA 198
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
+ G S + A+D WS+G + E+LTG F + I
Sbjct: 199 PDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI------------- 244
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEAL 311
++ +PP P + LA L+QRL+ DPK R A+E
Sbjct: 245 ---------SRRILKSEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
Query: 312 ADPYFKGL 319
+F+ +
Sbjct: 291 EHLFFQKI 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-49
Identities = 56/297 (18%), Positives = 111/297 (37%), Gaps = 45/297 (15%)
Query: 30 VIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+G G++G V + VA+K + + + +L E +++ L +P IV +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
I E + +V E+ E L++ ++ N + ++ ++Q+ +KY+ +N
Sbjct: 74 IGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRDL +N+L K+ DFGL++ +D T + APE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--Y 185
Query: 207 KYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265
K++ D+WS G + E + G+ + G ++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------------------- 223
Query: 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE---ALADPYFKGL 319
E ++ P L+ +D ++RP L + Y+ +
Sbjct: 224 ---EKGERMGCP-----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-48
Identities = 68/322 (21%), Positives = 121/322 (37%), Gaps = 35/322 (10%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A + E IGKG +G V GE+VA+K E + E+ +LRH
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRH 56
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
+I+ + + +++V + E L + +T E L
Sbjct: 57 ENILGFIAADNKDNGT-WTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLA 114
Query: 141 YMHTA--------NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT-PMTVFWTDYVA 191
++H + HRDLK KNIL N + D GLA S T + + V
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 192 TRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
T+ Y APE+ + + DI+++G +F E+ + G +QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
PS E + RK + E + +P +P + + ++++ + R TA
Sbjct: 234 SDPSVEEM--------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 308 EEALADPYFKGLAKIEREPSCQ 329
L+++ ++ +
Sbjct: 286 LRIKKT-----LSQLSQQEGIK 302
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-48
Identities = 62/310 (20%), Positives = 119/310 (38%), Gaps = 48/310 (15%)
Query: 23 NRYKILEV-IGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLLRLL 79
+ I ++ +G G++G V + ++ VAIK + E +D ++RE +++ L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQL 66
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLR 137
+P IV + + + + + +V E+ LH+ + +++ + L+Q+
Sbjct: 67 DNPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+KY+ N HRDL +N+L K+ DFGL++ +D + + A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE K++ D+WS G E L+ G+ + + I
Sbjct: 181 PECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------- 225
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE---ALAD 313
E K+ P P P L+ + +DRP +
Sbjct: 226 ------------EQGKRMECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
Query: 314 PYFKGLAKIE 323
Y+ +K+E
Sbjct: 269 CYYSLASKVE 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (412), Expect = 4e-48
Identities = 71/321 (22%), Positives = 123/321 (38%), Gaps = 51/321 (15%)
Query: 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILRE 72
F + D + KI +VIG G +G VC+ G++ VAIK + + L E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSE 77
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQF 130
++ HP+++ ++ ++ + + ++ E ME+ +D T
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVG 132
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT--D 188
L + +KY+ N HRDL +NIL N+N KV DFGL+R DT + +
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247
+ AP + K+T A D+WS G + EV++ G+ + + ++ I
Sbjct: 193 GKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---- 246
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
E + P P + +L+ D RP
Sbjct: 247 ---------------------EQDYRLPPP-----MDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 308 EEALADPYFKGLAKIEREPSC 328
+ + L K+ R P+
Sbjct: 281 GQIVNT-----LDKMIRNPNS 296
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (408), Expect = 1e-47
Identities = 51/298 (17%), Positives = 95/298 (31%), Gaps = 43/298 (14%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
YK+ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALK 140
+ + +E +V +L+ L ++ + + QML ++
Sbjct: 60 CTGIPN----VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 141 YMHTANVYHRDLKPKNILANANC-----KLKVCDFGLARVAFSDTPMTVFW----TDYVA 191
+H ++ +RD+KP N L + V DFG+ + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T Y + + + D+ ++G +F L G + G
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ---------- 223
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
KY KK PL + + + P +
Sbjct: 224 -------------KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (412), Expect = 1e-47
Identities = 62/335 (18%), Positives = 114/335 (34%), Gaps = 37/335 (11%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
RY ++ +G G + V A D VA+K + + E+KLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDA 69
Query: 83 DIVEIKRIMLP------------PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF 130
D + + + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 131 FLYQMLRALKYMHTA-NVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPMTVFWTD 188
Q+L L YMH + H D+KP+N+L + +A + + +T+
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTN 188
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV------VHQLDL 242
+ TR YR+PE+ + + DIWS C+ E++TG LF +
Sbjct: 189 SIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 243 ITDLLGTPSPETIAVVRNEK----ARKYLTEMRKKPPVPL-------FQKFPNVDPLALR 291
I +LLG + + + +R L + K PL ++ +
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 292 LLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326
L ++ DP+ R A + P+ K +E
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-47
Identities = 61/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
K++E +G G +G V + KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDL---HQVIKANDDLTREHHQFFLYQMLR 137
H +V + ++ + IY++ E ME+ + LT Q+
Sbjct: 67 HQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ ++ N HRDL+ NIL + K+ DFGLAR+ + + A
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA--REGAKFPIKWTA 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE + +T D+WS G + E++T G+ +PG + + + P+
Sbjct: 179 PEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--- 233
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DP 314
N +L++ P+DRPT + + +
Sbjct: 234 ---------------------------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
Query: 315 YF 316
+F
Sbjct: 267 FF 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-47
Identities = 61/303 (20%), Positives = 106/303 (34%), Gaps = 44/303 (14%)
Query: 16 FTEYGDANRYKILEVIGKGSYGVVCAAI---DTHTGEKVAIKKIH-DVFEHISDAIRILR 71
T ++LE +G GS+GVV + VA+K + DV +R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQ 129
EV + L H +++ + ++ + +V EL S L ++ K
Sbjct: 61 EVNAMHSLDHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS 114
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
+ Q+ + Y+ + HRDL +N+L +K+ DFGL R + V
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248
+ APE + ++ A D W G E+ T G+ + G + L I
Sbjct: 175 KVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----- 227
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
+ ++ P P + ++ + A P+DRPT
Sbjct: 228 -------------------DKEGERLPRP-----EDCPQDIYNVMVQCWAHKPEDRPTFV 263
Query: 309 EAL 311
Sbjct: 264 ALR 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-47
Identities = 57/296 (19%), Positives = 102/296 (34%), Gaps = 46/296 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D L+ +G G +GVV VAIK I E + E K++ L
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLS 57
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRA 138
H +V++ + + + I+++ E M L+ + + + + A
Sbjct: 58 HEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
++Y+ + HRDL +N L N +KV DFGL+R D + + P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS--VGSKFPVRWSPP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E+ SK++ DIW+ G + E+ + GK + + + I L P
Sbjct: 171 EVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH---- 224
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
++ +RPT + L++
Sbjct: 225 --------------------------LASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 5e-47
Identities = 68/323 (21%), Positives = 119/323 (36%), Gaps = 69/323 (21%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKL 75
+ +V+G G++G V A + +VA+K + + + S+ ++ E+K+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKM 93
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----------- 122
+ +L H +IV + IY++FE DL +++ +
Sbjct: 94 MTQLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 123 ------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170
LT E F YQ+ + ++++ + HRDL +N+L +K+CDF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
GLAR SD+ V + APE F YT D+WS G + E+ + G
Sbjct: 209 GLARDIMSDSNYVVRGN-ARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA 289
+PG V + + K P
Sbjct: 266 PYPGIPVDANFYKL------------------------IQNGFKMDQP-----FYATEEI 296
Query: 290 LRLLQRLIAFDPKDRPTAEEALA 312
++Q AFD + RP+ +
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-46
Identities = 66/294 (22%), Positives = 108/294 (36%), Gaps = 46/294 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D + ++ IG G +G+V +KVAIK I + D + E +++ L
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEED---FIEEAEVMMKLS 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHH-QFFLYQMLRA 138
HP +V++ + L + I +VFE ME L ++ L +
Sbjct: 59 HPKLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ Y+ A V HRDL +N L N +KV DFG+ R D T + +P
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASP 171
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E+ FS+Y+ D+WS G + EV + GK + +S ++ I+ P
Sbjct: 172 EVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR---- 225
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+++ P+DRP L
Sbjct: 226 --------------------------LASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (392), Expect = 3e-45
Identities = 55/292 (18%), Positives = 108/292 (36%), Gaps = 40/292 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G G YG V + VA+K + + + L+E +++ ++
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIK 71
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
HP++V++ + ++ + + L + +++ + Q+ A++
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAME 129
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ N HRDL +N L N +KV DFGL+R+ DT + APE
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPES 187
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+K++ D+W+ G + E+ T G +PG + +L+ PE
Sbjct: 188 LAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE------ 239
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
L++ ++P DRP+ E
Sbjct: 240 ------------------------GCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 9e-45
Identities = 61/339 (17%), Positives = 123/339 (36%), Gaps = 52/339 (15%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+K ++V+G G++G V + GE VAIK++ + ++ IL E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMASVD 69
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
+P + + I L + + + L V + D++ ++ + Q+ + +
Sbjct: 70 NPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ + HRDL +N+L +K+ DFGLA++ ++ + A E
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALES 184
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
YT D+WS G E++T G + G ++
Sbjct: 185 ILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------------- 228
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
++ P P P ++ + D RP E + +
Sbjct: 229 -----------GERLPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIE-----F 267
Query: 320 AKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
+K+ R+P L + + R YR +++
Sbjct: 268 SKMARDPQ----RYLVIQGDERMHLPSPTDSNFYRALMD 302
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-44
Identities = 68/314 (21%), Positives = 120/314 (38%), Gaps = 50/314 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLL 76
+ +VIG G +G V + + K VAIK + + + L E ++
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 63
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQ 134
H +I+ ++ ++ ++K + ++ E ME + + + + + + L
Sbjct: 64 GQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ +KY+ N HRDL +NIL N+N KV DFGL+RV D T +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253
+ APE K+T A D+WS G + EV+T G+ + S + I D P+P
Sbjct: 179 WTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP- 235
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ +L+ + + RP + ++
Sbjct: 236 -----------------------------MDCPSAIYQLMMQCWQQERARRPKFADIVSI 266
Query: 314 PYFKGLAKIEREPS 327
L K+ R P
Sbjct: 267 -----LDKLIRAPD 275
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 6e-44
Identities = 67/299 (22%), Positives = 110/299 (36%), Gaps = 47/299 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLR 77
R ++ IG+G +G V I VAIK + S + L+E +R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMR 63
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQM 135
HP IV++ ++ ++++ EL + L + YQ+
Sbjct: 64 QFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL Y+ + HRD+ +N+L ++N +K+ DFGL+R T + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKW 175
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE ++T A D+W G E+L G F G + I +
Sbjct: 176 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--------- 224
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
++ P+P PN P L+ + A+DP RP E A
Sbjct: 225 ----------------GERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 2e-43
Identities = 57/320 (17%), Positives = 106/320 (33%), Gaps = 70/320 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR 77
N + + IG+G++G V A + VA+K + + RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-------------- 122
+P+IV++ + + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 123 ----------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
L+ Q+ + Y+ HRDL +N L N +K+ DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+R +S D + RW + + +YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
G + + + D P N
Sbjct: 244 YGMAHEEVIYYVRD-------------------------GNILACP-----ENCPLELYN 273
Query: 292 LLQRLIAFDPKDRPTAEEAL 311
L++ + P DRP+
Sbjct: 274 LMRLCWSKLPADRPSFCSIH 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-42
Identities = 65/317 (20%), Positives = 111/317 (35%), Gaps = 64/317 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
NR + +G G++G V A I + VA+K + H+++ ++ E+K+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKV 79
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----------- 122
L L H +IV + V+ E DL ++ D
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 123 -------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
L E F YQ+ + + ++ + N HRDL +NIL K+CDFGLAR
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+D+ V + +W + YT D+WS G E+ + G +PG
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
V + + + P + +++
Sbjct: 252 PVDSKFYKMIK------------------------EGFRMLSP-----EHAPAEMYDIMK 282
Query: 295 RLIAFDPKDRPTAEEAL 311
DP RPT ++ +
Sbjct: 283 TCWDADPLKRPTFKQIV 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-42
Identities = 63/313 (20%), Positives = 110/313 (35%), Gaps = 63/313 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLL-R 77
D N K +VIG+G++G V A G + AIK++ + D E+++L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCK 66
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-------------- 122
L HP+I+ + +Y+ E +L ++ +
Sbjct: 67 LGHHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 123 --LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L+ + F + R + Y+ HRDL +NIL N K+ DFGL+R
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239
T+ + A E S YT D+WS G + E+++ G + G +
Sbjct: 182 KKTMG----RLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF 299
+ + + P N D L+++
Sbjct: 236 YEKLPQ-------------------------GYRLEKP-----LNCDDEVYDLMRQCWRE 265
Query: 300 DPKDRPTAEEALA 312
P +RP+ + L
Sbjct: 266 KPYERPSFAQILV 278
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-42
Identities = 55/291 (18%), Positives = 104/291 (35%), Gaps = 44/291 (15%)
Query: 29 EVIGKGSYGVVCAAID---THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
EVIG+G +G V A+K ++ + I + + L E +++ HP+++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ--FFLYQMLRALKYMH 143
+ I L VV M+ + N+ F Q+ + +K++
Sbjct: 92 SLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW-TDYVATRWYRAPELCG 202
+ HRDL +N + + +KV DFGLAR + +V T + A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ K+T D+WS G + E++T G P +P + +
Sbjct: 208 T--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------------- 249
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
++ P ++ + + RP+ E ++
Sbjct: 250 ---------GRRLLQP-----EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-41
Identities = 58/319 (18%), Positives = 114/319 (35%), Gaps = 65/319 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-------KVAIKKIHDVFEHISDAIRILREV 73
+R + + +G+G++G V A + KVA+K + D ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEM 69
Query: 74 KLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIK------------- 118
+++ + +H +I+ + + +YV+ E +L + ++
Sbjct: 70 EMMKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 119 ---ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+ +W L YT D+WS G + E+ T G +PG
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
V L+ + + P N +++
Sbjct: 242 PVEELFKLLKE-------------------------GHRMDKP-----SNCTNELYMMMR 271
Query: 295 RLIAFDPKDRPTAEEALAD 313
P RPT ++ + D
Sbjct: 272 DCWHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-41
Identities = 53/320 (16%), Positives = 110/320 (34%), Gaps = 62/320 (19%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKL 75
+ + +G+GS+G+V + +VAIK +++ + I L E +
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASV 76
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----------LT 124
++ +V + ++ V+ ELM DL +++ +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 125 REHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
++ + Y++ HRDL +N + + +K+ DFG+ R +T
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYR 190
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLI 243
+ + +PE +T D+WS G + E+ T + + G S L +
Sbjct: 191 KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
+ P N + L++ ++PK
Sbjct: 249 ME-------------------------GGLLDKP-----DNCPDMLFELMRMCWQYNPKM 278
Query: 304 RPTAEEALA------DPYFK 317
RP+ E ++ +P F+
Sbjct: 279 RPSFLEIISSIKEEMEPGFR 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 8e-40
Identities = 59/314 (18%), Positives = 112/314 (35%), Gaps = 59/314 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+R K+ + +G+G++G V A T T VA+K + + H + L
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN-------------- 120
+ + H ++V + P + V+ E + +L +++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 121 --DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178
D LT EH + +Q+ + ++++ + HRDL +NIL + +K+CDFGLAR +
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVV 237
D + +W + YT D+WS G + E+ + +PG +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297
+ + + P P + +
Sbjct: 244 EEFCRR------------------------LKEGTRMRAP-----DYTTPEMYQTMLDCW 274
Query: 298 AFDPKDRPTAEEAL 311
+P RPT E +
Sbjct: 275 HGEPSQRPTFSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.3 bits (218), Expect = 3e-21
Identities = 24/203 (11%), Positives = 60/203 (29%), Gaps = 27/203 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--------DVFEHISDAIRILREVKLL 76
I +++G+G V + +K + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQML 136
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD-YVATRWY 195
+ + + H DL N+L + + + DF + + + D ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIG 218
Y DI S
Sbjct: 173 S---------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 374 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.52 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.14 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.87 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.16 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.01 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.73 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-65 Score=474.17 Aligned_cols=334 Identities=40% Similarity=0.749 Sum_probs=280.6
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
+.|.+.++|++++.||+|+||+||+|.++.+|+.||||+++...........+.+|+.+|+.++||||+++++++...+.
T Consensus 12 ~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 34568899999999999999999999999999999999998766666667789999999999999999999999976542
Q ss_pred -CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 -REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 -~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
....++|+||||++.+|..+++. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|+.
T Consensus 92 ~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 23456899999998788887765 4799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
.... .+...||+.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+....+..+....+.++.+.+
T Consensus 171 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 171 ADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CCSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCCc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 5332 2456899999999998653 46789999999999999999999999999999999999999999999998
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLE 335 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~ 335 (374)
..........+...............++.+++.+.+||.+||.+||.+|||+.|+|+||||+++...+.++..+ +..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~---~~~ 320 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYD 320 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCC
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC---CCC
Confidence 88888888888887777777777778889999999999999999999999999999999999987766666544 344
Q ss_pred hhhhhccCCHHHHHHHHHHHHHHhCc
Q 017301 336 FEFERRRVTKDDIRELIYREILEYHP 361 (374)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
..++....+.+++++++++|+++|+|
T Consensus 321 ~~~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 321 DSFDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp CC-----CCHHHHHHHHHHHHHTCCC
T ss_pred CchhhhhcCHHHHHHHHHHHhhcCCC
Confidence 55666677899999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-64 Score=462.71 Aligned_cols=342 Identities=45% Similarity=0.803 Sum_probs=285.1
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
.+.+..||++++.||+|+||+||+|.++.+|+.||||+++.. ........+.+|+.+|+.++||||+++++++...+..
T Consensus 3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 456778999999999999999999999999999999999753 3445566789999999999999999999999777655
Q ss_pred CCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...++|+++++++|+|.+++..+ ++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 56678898888888999999765 69999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
............+||+.|+|||++... ..++.++||||+||++|+|++|++||.+.+..++...+....+.+.......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 443333334567899999999998553 5788999999999999999999999999999999999999999999888777
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcchh
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (374)
...................+....++.+|+.+++||.+||+.||.+|||+.|+|+||||+....+...+...+. ..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~--~~~~ 317 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP--FKFD 317 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSC--C---
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCc--cCCC
Confidence 77776777766666666666667788999999999999999999999999999999999987665555443332 3445
Q ss_pred hhhccCCHHHHHHHHHHHHHHhCccch
Q 017301 338 FERRRVTKDDIRELIYREILEYHPQLL 364 (374)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (374)
.+....+.+++++++++|...++|+..
T Consensus 318 ~~~~~~~~~~l~~l~~~e~~~~~~~~~ 344 (345)
T d1pmea_ 318 MELDDLPKEKLKELIFEETARFQPGYR 344 (345)
T ss_dssp -----CCHHHHHHHHHHHSGGGSTTTC
T ss_pred hhhhhCCHHHHHHHHHHHHHhcCCCCC
Confidence 566678899999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-63 Score=462.05 Aligned_cols=336 Identities=42% Similarity=0.789 Sum_probs=287.6
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
+.+++++||++++.||+|+||+||+|+++.+|+.||||++++..........+.+|+.+|+.++|||++++++++.....
T Consensus 12 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp SEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 34667899999999999999999999999999999999998766666777788999999999999999999999976543
Q ss_pred -CCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 -REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 -~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
++...+++++++++|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|..
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred cccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence 33445667666666799998865 4799999999999999999999999999999999999999999999999999865
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
... ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+....+.+..+..
T Consensus 171 ~~~------~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 171 TDD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp CTG------GGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCc------ccccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 422 22456799999999987663 45789999999999999999999999999999999999999999999888
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCCCCCCCCcc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLE 335 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~ 335 (374)
..........+...............+..+++.++|||++||+.||.+||||.|+|+||||+++..+..++...+. .
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~---~ 320 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---D 320 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC---C
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC---C
Confidence 8777777777776666666666666678899999999999999999999999999999999998877777766554 4
Q ss_pred hhhhhccCCHHHHHHHHHHHHHHhCccc
Q 017301 336 FEFERRRVTKDDIRELIYREILEYHPQL 363 (374)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (374)
+.++....+.+++++++++|+.++.|.+
T Consensus 321 ~~~~~~~~~~~~~k~~~~~e~~~~~p~~ 348 (348)
T d2gfsa1 321 QSFESRDLLIDEWKSLTYDEVISFVPPP 348 (348)
T ss_dssp CGGGGCCCCHHHHHHHHHHHHHTCCCCC
T ss_pred CcccchhcCHHHHHHHHHHHhhccCCCC
Confidence 5777889999999999999999998863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-64 Score=446.47 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=215.4
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++++.||+|+||+||+|+++.+|+.||+|+++.... ......+.+|+.+|++++||||+++++++.. ..
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~ 76 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE-----GN 76 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Cc
Confidence 45789999999999999999999999999999999975322 2234568899999999999999999999944 45
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|+|||||.| +|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 69999999985 99999988889999999999999999999999999999999999999999999999999999865433
Q ss_pred CCcccccccccccccccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. .......+||+.|+|||++.+ .. ++.++|||||||++|+|++|++||.+.+..........
T Consensus 157 ~~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~------------- 220 (271)
T d1nvra_ 157 NR-ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------- 220 (271)
T ss_dssp TE-ECCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH-------------
T ss_pred Cc-cccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh-------------
Confidence 22 122355689999999999877 44 46789999999999999999999987654332221111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
.. ......++.+|+.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 221 -------------~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 221 -------------EK--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp -------------TT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -------------cC--CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 00 0111223568999999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-64 Score=443.49 Aligned_cols=253 Identities=26% Similarity=0.445 Sum_probs=217.7
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++|++++.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++. +...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence 679999999999999999999999999999999864221 1122456789999999999999999999994 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+|||||.+ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999995 999999988899999999999999999999999999999999999999999999999999997543322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 161 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-------------- 219 (263)
T d2j4za1 161 -----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------- 219 (263)
T ss_dssp -----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------------
T ss_pred -----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Confidence 234579999999999988 68999999999999999999999999988766555443321
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
. ......+|+.+++||.+||+.||.+|||++|+|+||||++
T Consensus 220 -------------~----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -------------E----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------C----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 0 0112357899999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-63 Score=445.09 Aligned_cols=258 Identities=27% Similarity=0.469 Sum_probs=219.2
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
+..++|++++.||+|+||+||+|+++.+|+.||+|+++..... ..+.+.+|+.+|+.++||||+++++++.. .
T Consensus 17 dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~ 89 (293)
T d1yhwa1 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV-----G 89 (293)
T ss_dssp CTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred CcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----C
Confidence 3457899999999999999999999999999999998754322 24568899999999999999999999944 4
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.++|+|||||.| +|.+++..+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 569999999996 999887664 699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 169 ~~~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~---------- 233 (293)
T d1yhwa1 169 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---------- 233 (293)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS----------
T ss_pred ccc---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 322 2245689999999999987 7899999999999999999999999998876655544432110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
+.....+.+|+.+++||.+||+.||.+|||++|+|+||||+.
T Consensus 234 ------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 234 ------------------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ------------------CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------------------CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 001122468999999999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-62 Score=443.95 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=207.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
++.++|++++.||+|+||+||+|+++.+|+.||+|++...... .....+.+|+.+|+.++||||+++++++. +.
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~ 79 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYE-----SG 79 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 4567899999999999999999999999999999999754322 22346779999999999999999999994 44
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec---CCCCeEEeeeccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARV 175 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~---~~~~vkl~DFg~a~~ 175 (374)
..+|+|||||.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+.
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 569999999995 9999999999999999999999999999999999999999999999995 478899999999976
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+.+.
T Consensus 160 ~~~~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--------- 224 (307)
T d1a06a_ 160 EDPGS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA--------- 224 (307)
T ss_dssp -----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT---------
T ss_pred ccCCC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc---------
Confidence 43322 1245689999999999988 78999999999999999999999999988766555444321
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
........++.+|+.+.+||.+||+.||++|||++|+|+||||++.
T Consensus 225 ------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 225 ------------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ------------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ------------------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1111223346789999999999999999999999999999999863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-62 Score=434.13 Aligned_cols=260 Identities=25% Similarity=0.330 Sum_probs=216.4
Q ss_pred CCCCe-eEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 21 DANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y-~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
..+|| ++.++||+|+||+||+|+++.++..||+|++............+.+|+++|++++||||+++++++.... ...
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~ 84 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 84 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccC
Confidence 34566 7788999999999999999999999999999765555566778899999999999999999999985432 234
Q ss_pred CcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCceEec-CCCCeEEeeeccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILAN-ANCKLKVCDFGLARV 175 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~--i~H~dikp~Nil~~-~~~~vkl~DFg~a~~ 175 (374)
..+|+||||+++ +|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+.
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 568999999996 99999998889999999999999999999999998 99999999999996 478999999999975
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+......+....
T Consensus 165 ~~~~~-----~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i----------- 225 (270)
T d1t4ha_ 165 KRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV----------- 225 (270)
T ss_dssp CCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH-----------
T ss_pred ccCCc-----cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH-----------
Confidence 43321 235689999999999865 58999999999999999999999998765443322111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (374)
..... ........++++.+||.+||+.||++|||++|+|+||||+
T Consensus 226 ---------------~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 226 ---------------TSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ---------------TTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---------------HcCCC--CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 00000 0011235788999999999999999999999999999995
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-62 Score=435.34 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=209.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.+.|++++.||+|+||+||+|+++.+|+.||+|+++...........+.+|+.+|++++||||+++++++.+.. ...
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCE
Confidence 46799999999999999999999999999999999876556666778899999999999999999999986432 245
Q ss_pred EEEEEccCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCC-----ccccCCCCCceEecCCCCeEEeeec
Q 017301 102 IYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFG 171 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~LH~~~-----i~H~dikp~Nil~~~~~~vkl~DFg 171 (374)
+|+|||||.+ +|.+++.. +..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 8999999985 99998863 467999999999999999999999976 9999999999999999999999999
Q ss_pred ccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
+|+....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 160 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~----- 229 (269)
T d2java1 160 LARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----- 229 (269)
T ss_dssp HHHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----
T ss_pred ceeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----
Confidence 9986543322 2245689999999999987 78999999999999999999999999988765554443221
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
. .......+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus 230 ----------------------~---~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 230 ----------------------K---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ----------------------C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----------------------C---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0 011224689999999999999999999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-62 Score=441.34 Aligned_cols=259 Identities=25% Similarity=0.447 Sum_probs=217.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|++++||||+++++++. +..
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECC
Confidence 467999999999999999999999999999999986421 11123456889999999999999999999994 445
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|+|||||.| +|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 69999999995 99999999899999999999999999999999999999999999999999999999999999865433
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+.+.
T Consensus 162 ~~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------------- 225 (288)
T d1uu3a_ 162 SKQ-ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225 (288)
T ss_dssp ---------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-------------
T ss_pred Ccc-cccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-------------
Confidence 221 22345689999999999987 78999999999999999999999999988766555444321
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHH------HhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE------ALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~------lL~hp~~~~~ 319 (374)
.. .....+|+.+++||++||+.||.+|||++| +++||||+++
T Consensus 226 --------------~~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 226 --------------EY----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp --------------CC----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred --------------CC----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 00 112468999999999999999999999998 5889999876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-61 Score=447.40 Aligned_cols=328 Identities=36% Similarity=0.658 Sum_probs=255.4
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc-CCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~ 99 (374)
..++|+++++||+|+||+||+|+++.+|+.||||++...........++.+|+.+|++++||||+++++++..... +..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4479999999999999999999999999999999998766666667789999999999999999999999975533 355
Q ss_pred CcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.++|+|||||.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp CEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 7899999999998888775 46899999999999999999999999999999999999999999999999998764433
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
. .....++|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+...+...+....+.+.++.+....
T Consensus 173 ~----~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 173 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp ------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred c----ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 2 2245679999999999987 689999999999999999999999999999999999999999999888776654
Q ss_pred CHHHHHHHHHhcCCCCCCccccC------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccCCCCCC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKF------------PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~ 327 (374)
. ....+...............+ ...|+.+.+||++||.+||++||||+|+|+||||+....+.....
T Consensus 247 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~ 325 (355)
T d2b1pa1 247 P-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA 325 (355)
T ss_dssp H-HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTC
T ss_pred h-hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccC
Confidence 3 333333332222211111111 124678899999999999999999999999999997643322222
Q ss_pred CCCCCCcchhhhhccCCHHHHHHHHHHHHHH
Q 017301 328 CQPISKLEFEFERRRVTKDDIRELIYREILE 358 (374)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (374)
. +....+.+.+.+..+.++|+++|++|+++
T Consensus 326 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (355)
T d2b1pa1 326 P-PPQIYDKQLDEREHTIEEWKELIYKEVMN 355 (355)
T ss_dssp C-CC-------CCCCCCHHHHHHHHHHHHHC
T ss_pred C-CCCCCCcchhhhhcCHHHHHHHHHHHhcC
Confidence 2 22345556677888999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-61 Score=437.48 Aligned_cols=265 Identities=28% Similarity=0.438 Sum_probs=224.9
Q ss_pred cccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC----ChHHHHHHHHHHHHHHhCCCCCccccceeec
Q 017301 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE----HISDAIRILREVKLLRLLRHPDIVEIKRIML 92 (374)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 92 (374)
..-.+.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|++++||||+++++++.
T Consensus 4 ~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (293)
T d1jksa_ 4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83 (293)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 344566899999999999999999999999999999999864322 1123567889999999999999999999994
Q ss_pred CCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC----CeEE
Q 017301 93 PPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKV 167 (374)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~----~vkl 167 (374)
+..++|+|||||.| +|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||
T Consensus 84 -----~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 84 -----NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp -----CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred -----ECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEe
Confidence 44569999999995 9999999888999999999999999999999999999999999999998776 4999
Q ss_pred eeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
+|||+|........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 159 ~DfG~a~~~~~~~~----~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 159 IDFGLAHKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232 (293)
T ss_dssp CCCTTCEECTTSCB----CSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred cchhhhhhcCCCcc----ccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence 99999976543321 245679999999999987 689999999999999999999999999988776665554322
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..... ..++.+|+.+++||++||+.||++|||++|+|+||||+..
T Consensus 233 ~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 233 YEFED---------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp CCCCH---------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCCc---------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 22121 1235689999999999999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-62 Score=443.89 Aligned_cols=283 Identities=36% Similarity=0.559 Sum_probs=227.0
Q ss_pred EeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChH---HHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEE
Q 017301 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS---DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (374)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 103 (374)
.++.||+|+||+||+|+++.+|+.||||+++....... ....+.+|+.+|+.++||||+++++++.. ..++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCcee
Confidence 57899999999999999999999999999864322211 12468899999999999999999999944 45689
Q ss_pred EEEccCcccHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCc
Q 017301 104 VVFELMESDLHQ-VIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (374)
Q Consensus 104 lv~e~~~~~L~~-~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~ 182 (374)
+||||+.+++.. +...+..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 999999985444 444566899999999999999999999999999999999999999999999999999976443322
Q ss_pred ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 017301 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (374)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (374)
.....+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+.+..++|..+.+.......
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred --cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 12456899999999988652 568999999999999999999999999999999999999999998876543322110
Q ss_pred HHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
.. .........+....++.+++.+.+||.+||+.||++||||+|+|+||||++...
T Consensus 233 ~~---~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 233 DY---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp TC---CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hh---hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 00 001111222333445678999999999999999999999999999999987543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-63 Score=451.97 Aligned_cols=283 Identities=22% Similarity=0.346 Sum_probs=218.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|+++.+|+.||+|+++.... ......+.+|+.+|+.++||||+++++++.+ ..+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 4689999999999999999999999999999999975432 3445678899999999999999999999954 456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+|+|||||.| +|.+++.+++.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999996 999999988899999999999999999999997 59999999999999999999999999999864332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH-HHHHHhhCCCCHHHHh--
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGTPSPETIA-- 256 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~-- 256 (374)
. ....+||+.|+|||++.+ ..|+.++||||+||++|+|++|+.||.+.+..... .......+.+......
T Consensus 159 ~-----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 159 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp T-----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred c-----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 2 245689999999999988 78999999999999999999999999887654321 1111122211111000
Q ss_pred ------------hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 257 ------------VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
........+.........+.... ...+|+++++||.+||++||.+|||++|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000111222222222221111 12368899999999999999999999999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-62 Score=437.12 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=217.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..+.|++++.||+|+||+||+|+++.+|+.||+|+++... ....+.+.+|+.+|++++||||+++++++.. ..
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~ 82 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY-----EN 82 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CC
Confidence 3467999999999999999999999999999999997532 2344568899999999999999999999944 45
Q ss_pred cEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 101 DIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
.+|+|||||.| +|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 69999999985 99998765 56799999999999999999999999999999999999999999999999999965322
Q ss_pred CCCccccccccccccccccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
.. ......+||+.|+|||++... ...|+.++|||||||++|+|++|++||.+.+..+.+..+....
T Consensus 163 ~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~-------- 231 (288)
T d2jfla1 163 TI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE-------- 231 (288)
T ss_dssp HH---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--------
T ss_pred Cc---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--------
Confidence 11 122456899999999997431 2568999999999999999999999999887766655443210
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
. +.....+.+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 232 ------------------~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 232 ------------------P--PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ------------------C--CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ------------------C--CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0 111122468999999999999999999999999999999964
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-61 Score=441.98 Aligned_cols=256 Identities=26% Similarity=0.457 Sum_probs=221.1
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
+.|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|+.+|+.++||||+++++++. +...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-----cccc
Confidence 579999999999999999999999999999999974321 1123456789999999999999999999994 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+|||||.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999995 999999999999999999999999999999999999999999999999999999999999998644322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+...
T Consensus 160 ~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-------------- 220 (337)
T d1o6la_ 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------- 220 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred c---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--------------
Confidence 2 2345789999999999988 78999999999999999999999999998876555444321
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
. ......+|+++++||++||+.||.+|+ +++++++||||+++
T Consensus 221 ------------~-----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 221 ------------E-----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ------------C-----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ------------C-----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 0 011246899999999999999999999 49999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-61 Score=438.36 Aligned_cols=288 Identities=37% Similarity=0.618 Sum_probs=233.1
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
++|++++.||+|+||+||+|.+..+|+.||+|+++...........+.+|+++|++++||||+++++++. +..++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 5899999999999999999999999999999999754333333567889999999999999999999994 44569
Q ss_pred EEEEccCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 103 YVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 103 ~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
|+||||+.+++.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999877776654 4579999999999999999999999999999999999999999999999999997654332
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. ......||+.|+|||++... ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+.....
T Consensus 157 ~---~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B---CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c---cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 2 23456899999999987663 4568899999999999999999999999999999999888888877655443211
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
. ..+................+.+|+.+.+||++||+.||.+|||++|+|+||||+++.+
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 233 M--PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp S--TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred c--cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 1 0011111111122223345678999999999999999999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-61 Score=443.49 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=222.4
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+-++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|++++||||+++++++. +.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~ 96 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDN 96 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETT
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence 346899999999999999999999999999999999753 3345567889999999999999999999994 446
Q ss_pred cEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC--CCCeEEeeecccccc
Q 017301 101 DIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLARVA 176 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~--~~~vkl~DFg~a~~~ 176 (374)
++|+|||||.| +|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 69999999985 99999854 567999999999999999999999999999999999999964 578999999999865
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 177 ~~~~~----~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----- 245 (350)
T d1koaa2 177 DPKQS----VKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD----- 245 (350)
T ss_dssp CTTSC----EEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-----
T ss_pred ccccc----cceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence 43322 245689999999999987 7899999999999999999999999999887766665544222211
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
...++.+|+.+++||.+||+.||.+|||++|+|+||||+...
T Consensus 246 ----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 246 ----------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp ----------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred ----------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 122356899999999999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.1e-61 Score=442.29 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=224.2
Q ss_pred ccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
...+.++|++++.||+|+||+||+|+++.+|+.||+|+++.. .......+.+|+.+|++++||||+++++++.
T Consensus 24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~----- 96 (352)
T d1koba_ 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFE----- 96 (352)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----
T ss_pred CCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 334557899999999999999999999999999999998753 2344567889999999999999999999994
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec--CCCCeEEeeeccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANCKLKVCDFGLA 173 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~--~~~~vkl~DFg~a 173 (374)
+..++|+|||||.| +|.+.+...+ ++++.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 97 ~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 97 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp CSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred ECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccc
Confidence 44569999999995 9998877654 799999999999999999999999999999999999997 5689999999999
Q ss_pred ccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 017301 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (374)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (374)
+....... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 177 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---- 246 (352)
T d1koba_ 177 TKLNPDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE---- 246 (352)
T ss_dssp EECCTTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC----
T ss_pred eecCCCCc----eeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----
Confidence 87544322 245679999999999987 78999999999999999999999999998877666555432211
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.....++.+|+.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 247 -----------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 247 -----------------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -----------------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1123346789999999999999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-61 Score=437.51 Aligned_cols=290 Identities=34% Similarity=0.602 Sum_probs=235.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCC-CcEEEEEEecCccCChHHHHHHHHHHHHHHhC---CCCCccccceeecCCCcC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~ 97 (374)
.++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.+ +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 37999999999999999999999765 66799999865433323233455677776655 799999999999765445
Q ss_pred CCCcEEEEEccCcccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 98 EFKDIYVVFELMESDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~--~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...++|++||++.+++..+.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 557799999999986555443 345799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
.... .......||+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.+..+++..+....+.+....+
T Consensus 166 ~~~~----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hccc----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 4322 22356789999999999987 78999999999999999999999999999999999999999998887655
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCcc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (374)
........ .........+.....+.+++.+.+||.+||++||++|||++|+|+||||+++..
T Consensus 240 ~~~~~~~~----~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccchh----hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 43221110 011222333444456678999999999999999999999999999999998753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-61 Score=435.80 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=216.0
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.+|++++.||+|+||+||+|++..+|+.||||+++..... ......+.+|+.+|++++||||+++++++.. ...
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence 5799999999999999999999999999999999754433 3344578899999999999999999999954 356
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+|||||.+ +|..++..++++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999999996 66666777888999999999999999999999999999999999999999999999999999754322
Q ss_pred Cccccccccccccccccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
...+||+.|+|||++.+. ...|+.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~------------- 229 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------- 229 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------------
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-------------
Confidence 345799999999998652 246899999999999999999999999887765554443221
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
..+. .....+|+.+.+||.+||+.||.+|||++++|+||||..
T Consensus 230 -------------~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 230 -------------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------------CCCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------CCCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 1110 112457899999999999999999999999999999964
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-60 Score=434.13 Aligned_cols=253 Identities=26% Similarity=0.476 Sum_probs=219.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
+.|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++. +...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence 569999999999999999999999999999999864321 1123456889999999999999999999994 4456
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
+|+|||||.| +|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 9999999996 999999999999999999999999999999999999999999999999999999999999998654322
Q ss_pred CcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 159 ------~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 216 (316)
T d1fota_ 159 ------YTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 216 (316)
T ss_dssp ------CCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred ------ccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 34689999999999987 68999999999999999999999999988776555544321
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
. ....+.+|+.+.++|.+||+.||.+|+ |++++|+||||+++
T Consensus 217 ------------~-----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 217 ------------E-----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp ------------C-----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ------------C-----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 0 011246899999999999999999996 99999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.9e-60 Score=421.50 Aligned_cols=261 Identities=28% Similarity=0.427 Sum_probs=220.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC-------hHHHHHHHHHHHHHHhCC-CCCccccceeecC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-------ISDAIRILREVKLLRLLR-HPDIVEIKRIMLP 93 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 93 (374)
.++|++++.||+|+||+||+|+++.+|+.||||++++.... ......+.+|+.+|++++ ||||+++++++.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE- 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-
Confidence 57999999999999999999999999999999998753321 112345789999999997 999999999994
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecc
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
+..++|+|||||+| +|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ----~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 81 ----TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp ----CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ----cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 44569999999985 9999999988999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccccccccccccccc----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 248 (374)
|+....... .....||+.|+|||++.+ ....++.++||||+||++|+|++|+.||.+.+.......+...-.
T Consensus 157 a~~~~~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 157 SCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp CEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred eeEccCCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 986544322 245689999999998753 124578899999999999999999999999887665554433111
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
......++++|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 233 ---------------------------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 233 ---------------------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ---------------------------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ---------------------------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 1111223578999999999999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-60 Score=438.46 Aligned_cols=254 Identities=21% Similarity=0.382 Sum_probs=219.8
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++. ...
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----ccc
Confidence 478999999999999999999999999999999986421 11123456889999999999999999999994 445
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
.+|+||||+.| +|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 68999999996 99999998889999999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+....
T Consensus 195 ------~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------ 254 (350)
T d1rdqe_ 195 ------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------------ 254 (350)
T ss_dssp ------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred ------cccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC------------
Confidence 234689999999999988 789999999999999999999999999887665555443211
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (374)
....+.+|+.+.+||++||+.||.+|+ |++++|+||||+++
T Consensus 255 -------------------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 255 -------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp -------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred -------------------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 011246899999999999999999995 99999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-60 Score=427.95 Aligned_cols=284 Identities=38% Similarity=0.634 Sum_probs=231.4
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
+||+++++||+|+||+||+|+++ +|+.||||+++...........+.+|+.+|++++||||+++++.+... ...
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence 69999999999999999999985 789999999976543334456788999999999999999999999544 458
Q ss_pred EEEEccCcccHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMESDLHQ-VIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~~L~~-~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
|++||++.+++.. +....+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||.|........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9999999985544 445577899999999999999999999999999999999999999999999999999976543322
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (374)
......|++.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....+.+....+......
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 12345789999999998653 56899999999999999999999999999999999999999998876654432211
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 017301 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (374)
...........+.+.....+.+++.+.|||++||++||++|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1111122223333444556788999999999999999999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=428.64 Aligned_cols=258 Identities=24% Similarity=0.438 Sum_probs=221.9
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
..++|++++.||+|+||+||+|+++.+|+.||+|+++.. ......+.+|+.+|+.++||||+++++++. +..
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~ 74 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFE-----SME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETT
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECC
Confidence 458899999999999999999999999999999999753 233456789999999999999999999994 445
Q ss_pred cEEEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC--CCeEEeeecccccc
Q 017301 101 DIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--CKLKVCDFGLARVA 176 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~--~~vkl~DFg~a~~~ 176 (374)
++|+|||||.| +|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 69999999996 9999998765 79999999999999999999999999999999999999854 47999999999865
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.... ......+|+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+....+.+.....+.
T Consensus 155 ~~~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~---- 224 (321)
T d1tkia_ 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE---- 224 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH----
T ss_pred ccCC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh----
Confidence 3322 1244579999999999887 68999999999999999999999999998887776666543322222
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..++.+|+.+++||.+||..||.+|||++|+|+||||++-
T Consensus 225 -----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 225 -----------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -----------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -----------------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 2235689999999999999999999999999999999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-59 Score=433.80 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=213.2
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCcc----CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ..........+++.+++.++||||+++++++..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~----- 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----- 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-----
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-----
Confidence 67999999999999999999999999999999986321 111222233455777888899999999999944
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...+|+|||||.| +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 4569999999995 999999998899999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
... ....+||+.|+|||++.+. ..|+.++|||||||++|+|+||+.||.+.+..+........
T Consensus 159 ~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~----------- 221 (364)
T d1omwa3 159 KKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------- 221 (364)
T ss_dssp SSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS-----------
T ss_pred CCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------
Confidence 332 2345899999999998642 56899999999999999999999999876544332222111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (374)
.. ........+|+.+++||.+||+.||.+||| |+++++||||+++
T Consensus 222 -------------~~----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 222 -------------LT----MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp -------------SS----CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred -------------cc----CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 11 111223468999999999999999999999 8999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-59 Score=425.04 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=216.8
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHH-hCCCCCccccceeecCCCcCCCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLR-LLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
++|++++.||+|+||+||+|.++.+|+.||||++++... .......+.+|..++. .++||||+++++++.+ ..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence 579999999999999999999999999999999964211 1122345566777665 6899999999999944 45
Q ss_pred cEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
++|+|||||.+ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 69999999995 99999999899999999999999999999999999999999999999999999999999999754332
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (374)
.. ......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------------- 218 (320)
T d1xjda_ 157 DA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------------- 218 (320)
T ss_dssp TC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred cc---cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------
Confidence 22 2345689999999999988 78999999999999999999999999998876655444320
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHH-HHhcCCCCCcC
Q 017301 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKGL 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~-~lL~hp~~~~~ 319 (374)
.. ...+.+|+.+.+||++||+.||.+|||+. ++++||||+++
T Consensus 219 -------------~~-----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 219 -------------NP-----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp -------------CC-----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -------------CC-----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 00 11245899999999999999999999996 89999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-59 Score=427.14 Aligned_cols=298 Identities=34% Similarity=0.549 Sum_probs=231.5
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc---
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK--- 96 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 96 (374)
+..+||++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.++|||++++++++.....
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 44699999999999999999999999999999999987554444445678899999999999999999999865421
Q ss_pred CCCCcEEEEEccCcccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 REFKDIYVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l-~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
....++|+|||++.+++.... .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 223579999999998665555 4456899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCC-cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 176 AFSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 176 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
...... ........+||+.|+|||++.+. ..|+.++||||+||++|+|++|++||.+.+.......+....+.+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 443221 11222446799999999998763 5789999999999999999999999999999999999999999988776
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccC--CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
+.................... .....+ ...++.++|||.+||++||++|||++|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKR-KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp STTCCCC-------CCSSCCB-CHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred ccccchhhhhhhhcccccccc-cchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 655544333332221111110 000000 1247788999999999999999999999999999853
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-59 Score=429.48 Aligned_cols=286 Identities=35% Similarity=0.594 Sum_probs=232.2
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-cCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~~~ 101 (374)
-+|+.+++||+|+||+||+|+++.+|+.||||++..... ...+|+.+|++++||||+++++++.... ..+..+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 479999999999999999999999999999999975322 1237999999999999999999986543 234567
Q ss_pred EEEEEccCcccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC-CeEEeeecccccc
Q 017301 102 IYVVFELMESDLHQVI----KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVA 176 (374)
Q Consensus 102 ~~lv~e~~~~~L~~~l----~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~-~vkl~DFg~a~~~ 176 (374)
+|+|||||++++...+ .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999998665554 3456899999999999999999999999999999999999999875 8999999999765
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... ....+||+.|+|||++.+. ..|+.++||||+||++|+|++|++||.+.+..+++..+.+.+|.+..+.+.
T Consensus 174 ~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTTSC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cCCcc----cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 43322 2456899999999987653 578999999999999999999999999999999999999999999987765
Q ss_pred hhcCHHHHHHHHHhcCCCCCCc-cccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCccC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (374)
......... ........+. ....+..++.+.+||.+||++||.+||||.|+|+||||+++...
T Consensus 249 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 249 EMNPNYTEF---KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HHCC---CC---CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hhccchhhc---cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 433221100 0011111111 12245689999999999999999999999999999999987654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-58 Score=414.26 Aligned_cols=287 Identities=36% Similarity=0.573 Sum_probs=234.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
+||++++.||+|+||+||+|++..+|+.||||+++...........+.+|+.+|+.++||||+++++++.. ..+.
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-----~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-----ccce
Confidence 68999999999999999999999999999999997655555667789999999999999999999999944 4568
Q ss_pred EEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 017301 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~ 181 (374)
++|++++.+ ++..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999997 7788888888999999999999999999999999999999999999999999999999999986544322
Q ss_pred cccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCC-CCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 017301 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (374)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (374)
. .....+++.|+|||++.+. ..++.++||||+||++|+|++|+.| |.+.+..+.+..+....+.+....+.....
T Consensus 157 ~---~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 C---YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp C---CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred c---ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 1 2345678899999988763 4578999999999999999999876 567777778888888888877654332211
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
.. ..................+.+++.+.+||++||++||.+||||+|+|+||||+++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cc--cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 00 00000000111223344567899999999999999999999999999999998764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-59 Score=416.31 Aligned_cols=251 Identities=26% Similarity=0.418 Sum_probs=208.7
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhCC--CCCccccceeecCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLR--HPDIVEIKRIMLPP 94 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~ 94 (374)
..++|++++.||+|+||+||+|++..+|+.||||++++..... ....++.+|+.+|++++ ||||+++++++.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~-- 79 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE-- 79 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe--
Confidence 4689999999999999999999999999999999986432111 11234568999999986 899999999994
Q ss_pred CcCCCCcEEEEEccCcc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCC-CCeEEeeec
Q 017301 95 SKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFG 171 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~-~~vkl~DFg 171 (374)
....+|+|||++.+ ++.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 80 ---~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 80 ---RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp ---CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ---eCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccc
Confidence 44568999999973 888999888899999999999999999999999999999999999999854 789999999
Q ss_pred ccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
+|+...... .+...||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +..
T Consensus 157 ~a~~~~~~~-----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~------ 218 (273)
T d1xwsa_ 157 SGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------ 218 (273)
T ss_dssp TCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH------
T ss_pred cceeccccc-----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hhh------
Confidence 997643322 2456899999999998762 3456789999999999999999999975321 110
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
.. ....+.+|+++++||++||+.||++|||++|+|+||||+++
T Consensus 219 --------------------~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 219 --------------------GQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp --------------------CC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --------------------cc-----cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 00 01124689999999999999999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.5e-58 Score=411.40 Aligned_cols=267 Identities=25% Similarity=0.368 Sum_probs=213.4
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
...++|++.+.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++...+ ..
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CC
Confidence 356899999999999999999999999999999999976543 3445567899999999999999999999986543 23
Q ss_pred CCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
...+|+||||+.| +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+....
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 3458999999996 999999998899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
............+||+.|+|||++.+ ..++.++|||||||++|+|+||++||.+.+..+....+..
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~------------ 228 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------------ 228 (277)
T ss_dssp ----------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------------
T ss_pred cccccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh------------
Confidence 44433334456789999999999987 6899999999999999999999999998876555443322
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~ 316 (374)
..+.+.....+.+|+.+.+||.+||+.||.+||+..+.|.|+|.
T Consensus 229 ---------------~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 229 ---------------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp ---------------CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---------------cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 11222233456789999999999999999999954444456664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-59 Score=425.27 Aligned_cols=264 Identities=27% Similarity=0.402 Sum_probs=209.6
Q ss_pred cCCCCCeeEec-eeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh-CCCCCccccceeecCCCc
Q 017301 19 YGDANRYKILE-VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL-LRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 19 ~~~~~~Y~~~~-~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~ 96 (374)
..+.++|++++ .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.+ .+||||+++++++.+..
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~- 78 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY- 78 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-
T ss_pred CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-
Confidence 34457899875 599999999999999999999999998632 346689988654 58999999999985421
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC---CCCeEEeee
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDF 170 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~---~~~vkl~DF 170 (374)
....++|+|||||+| +|.+++... ..+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 223569999999985 999999875 36999999999999999999999999999999999999986 467999999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 250 (374)
|+|+....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|+||++||.+.+.......+.....
T Consensus 159 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~-- 230 (335)
T d2ozaa1 159 GFAKETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-- 230 (335)
T ss_dssp TTCEECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC--
T ss_pred ceeeeccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh--
Confidence 99986544322 245689999999999987 7899999999999999999999999987765443332221110
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcC
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (374)
..........++.+|+++.+||++||+.||++|||+.|+|+||||.+.
T Consensus 231 ---------------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 231 ---------------------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ---------------------SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ---------------------cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 000000011123578999999999999999999999999999999753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.5e-57 Score=414.78 Aligned_cols=293 Identities=30% Similarity=0.544 Sum_probs=225.0
Q ss_pred ccccccccCCCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCcccccee
Q 017301 12 DKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRI 90 (374)
Q Consensus 12 ~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~ 90 (374)
.+.....++..++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+|+.++ ||||++++++
T Consensus 24 ~~~~~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~ 98 (328)
T d3bqca1 24 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADI 98 (328)
T ss_dssp GGGCCCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred hhhcccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEE
Confidence 334455577889999999999999999999999999999999998742 2346789999999996 9999999999
Q ss_pred ecCCCcCCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCC-CeEEe
Q 017301 91 MLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVC 168 (374)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~-~vkl~ 168 (374)
+... ...++|+|||||.+ +|.... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 99 ~~~~---~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 99 VKDP---VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp EECT---TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEec---CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeec
Confidence 8543 23569999999996 776543 4699999999999999999999999999999999999998765 59999
Q ss_pred eecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhh
Q 017301 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLL 247 (374)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~ 247 (374)
|||+|+....... ....++|+.|+|||++.+. ..++.++||||+||++|+|++|+.||.... ..++...+...+
T Consensus 173 DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~ 247 (328)
T d3bqca1 173 DWGLAEFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247 (328)
T ss_dssp CGGGCEECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred ccccceeccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence 9999986543322 2456799999999998763 468999999999999999999999987654 455666677766
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCC-c-----cccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcCc
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVP-L-----FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (374)
|.+....+...................... . ......+|++++|||++||++||.+|||++|+|+||||+.+.
T Consensus 248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 655433222111100000000011111110 0 111234789999999999999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=399.06 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=206.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|.. +..||||+++...........+.+|+.+|++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 47899999999999999999964 3469999997655555667789999999999999999999998732 34
Q ss_pred EEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+|+|||||++ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 7999999995 999999754 57999999999999999999999999999999999999999999999999999765332
Q ss_pred CCccccccccccccccccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. ........||+.|+|||++.+. ...|+.++|||||||++|||+||+.||.+.+....+........
T Consensus 158 ~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~---------- 226 (276)
T d1uwha_ 158 SG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY---------- 226 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS----------
T ss_pred CC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC----------
Confidence 22 1223456799999999998642 24589999999999999999999999988765544433322111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..........++++.+.+||.+||+.||++|||+++++++
T Consensus 227 ---------------~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 227 ---------------LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---------------CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1111223345688999999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-57 Score=402.15 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=203.8
Q ss_pred ceeeccCCeeEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcEEEEE
Q 017301 29 EVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 29 ~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
++||+|+||+||+|... .+++.||||+++...........+.+|+.+|++++||||+++++++... ..|+||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence 46999999999999854 4567899999976544445566899999999999999999999998432 369999
Q ss_pred ccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCcccc
Q 017301 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (374)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (374)
|||++ +|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...........
T Consensus 87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99985 99999999999999999999999999999999999999999999999999999999999999875544333333
Q ss_pred cccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 017301 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (374)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (374)
.....||+.|+|||++.+ ..++.++|||||||++|||+| |++||.+.+..+....+.+.
T Consensus 167 ~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~------------------ 226 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG------------------ 226 (277)
T ss_dssp ----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------------
T ss_pred ccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC------------------
Confidence 344578999999999877 678999999999999999998 89999988765544433210
Q ss_pred HHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHh---cCCCC
Q 017301 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL---ADPYF 316 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL---~hp~~ 316 (374)
... .....+|+.+.+||.+||+.||++|||+++++ +|+|+
T Consensus 227 -------~~~-----~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 227 -------ERM-----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -------CCC-----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CCC-----CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 000 11246889999999999999999999999984 56554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-56 Score=397.73 Aligned_cols=255 Identities=22% Similarity=0.400 Sum_probs=208.3
Q ss_pred ccccC-CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 017301 16 FTEYG-DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (374)
Q Consensus 16 ~~~~~-~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 94 (374)
+..|. ..++|++++.||+|+||+||+|+++.+|+.||||+++.... ..+.+.+|+.+|++++||||+++++++..
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~- 84 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR- 84 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEee-
Confidence 34454 34689999999999999999999999999999999875433 24568899999999999999999999944
Q ss_pred CcCCCCcEEEEEccCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeec
Q 017301 95 SKREFKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg 171 (374)
...+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 85 ----~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 85 ----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred ----CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccc
Confidence 345899999999 5999998754 578999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCC-CCCCChhhHHHHHHHhhCCC
Q 017301 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTP 250 (374)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~ 250 (374)
+|+........ ......||+.|+|||++.+ ..|+.++|||||||++|+|++|..| |.+.+.......+..
T Consensus 161 ~a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~----- 231 (287)
T d1opja_ 161 LSRLMTGDTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----- 231 (287)
T ss_dssp CTTTCCSSSSE--EETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----
T ss_pred ceeecCCCCce--eeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-----
Confidence 99865443222 2244568899999999887 6899999999999999999997655 444443332222211
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
... ......+++.+.+||.+||+.||++|||++++++
T Consensus 232 ----------------------~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 232 ----------------------DYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ----------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCC---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 000 1123468899999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-55 Score=397.86 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=199.5
Q ss_pred CCCCCeeEeceeeccCCeeEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
-..++|++.+.||+|+||+||+|.++.+++ .||+|.+... ........+.+|+.+|++++||||+++++++...
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-- 99 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-- 99 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--
Confidence 345789999999999999999999987765 5888887643 3344556789999999999999999999999443
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
..+|+|||||.+ +|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 100 ---~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 100 ---TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred ---CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence 458999999995 999988774 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcc--cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 175 VAFSDTPMT--VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 175 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
......... .......||+.|+|||++.+ ..++.++|||||||++|||+| |++||.+.+..+....+.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~--- 251 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR--- 251 (299)
T ss_dssp -------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 654332211 11123467899999999887 789999999999999999998 8999998876655544432110
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
. .....+++.+.+||.+||+.||++|||+.+++++
T Consensus 252 ----------------------~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 252 ----------------------L-----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ----------------------C-----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------C-----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 1124678999999999999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=391.01 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=197.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
+++|++++.||+|+||+||+|+++ +++.||||+++..... .+.+.+|+.++++++||||+++++++... ..
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~ 74 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----AP 74 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccC-----Cc
Confidence 578999999999999999999875 5678999999754332 34688999999999999999999999543 45
Q ss_pred EEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+|+||||+.+ +|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred eEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC
Confidence 8999999984 999988765 56899999999999999999999999999999999999999999999999999765433
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.... .....||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+......
T Consensus 155 ~~~~--~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--------- 221 (263)
T d1sm2a_ 155 QYTS--STGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------- 221 (263)
T ss_dssp ------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC---------
T ss_pred Ccee--ecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC---------
Confidence 2221 234578999999999987 689999999999999999999 57777776655544443321110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
......++.+.+||.+||+.||++|||++++++|
T Consensus 222 ---------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 ---------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1113568899999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-56 Score=397.04 Aligned_cols=256 Identities=22% Similarity=0.356 Sum_probs=212.0
Q ss_pred CCeeEece-eeccCCeeEEEEEECC--CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 23 NRYKILEV-IGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 23 ~~Y~~~~~-lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ........+.+|+.+|++++||||+++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------
Confidence 67888885 9999999999998764 4457999999753 344556789999999999999999999999843
Q ss_pred CcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
..+|+|||||++ +|.+++.. ++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 237999999995 99998865 4579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
.............||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+....+.+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~--------- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC---------
T ss_pred ccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence 54433333345578999999999877 679999999999999999998 899999877655544432210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHH---hcCCCCC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA---LADPYFK 317 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~l---L~hp~~~ 317 (374)
. ....+.+|+++.+||.+||+.||++|||+.++ |+|+|++
T Consensus 230 ----------------~-----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 230 ----------------R-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----------------C-----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------C-----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0 01235688999999999999999999999888 5678764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=403.37 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=208.3
Q ss_pred cccCC-CCCeeEeceeeccCCeeEEEEEECCCCc-----EEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccce
Q 017301 17 TEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKR 89 (374)
Q Consensus 17 ~~~~~-~~~Y~~~~~lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~ 89 (374)
.+|.+ .++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+++ +||||+++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 34433 3689999999999999999999876544 69999886432 223445688999999998 8999999999
Q ss_pred eecCCCcCCCCcEEEEEccCcc-cHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHhhhC
Q 017301 90 IMLPPSKREFKDIYVVFELMES-DLHQVIKAND-----------------------DLTREHHQFFLYQMLRALKYMHTA 145 (374)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~al~~LH~~ 145 (374)
++.. ...+|+|||||++ +|.+++.... .+++..+..++.||+.||+|||++
T Consensus 109 ~~~~-----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~ 183 (325)
T d1rjba_ 109 ACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183 (325)
T ss_dssp EECS-----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEee-----CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9944 4558999999995 9999997642 489999999999999999999999
Q ss_pred CccccCCCCCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHH
Q 017301 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (374)
Q Consensus 146 ~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll 225 (374)
||+||||||+|||++.++.+||+|||+|+........ .......||+.|+|||++.+ ..|+.++|||||||++|||+
T Consensus 184 ~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHT
T ss_pred CeeeccCchhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHH
Confidence 9999999999999999999999999999865443322 22345678999999999887 78999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCC
Q 017301 226 T-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304 (374)
Q Consensus 226 t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 304 (374)
| |.+||.+.+....+..+..... . ......+|+.+.+||.+||+.||++|
T Consensus 261 t~g~~Pf~~~~~~~~~~~~~~~~~------------------------~-----~~~p~~~~~~l~~li~~cl~~dP~~R 311 (325)
T d1rjba_ 261 SLGVNPYPGIPVDANFYKLIQNGF------------------------K-----MDQPFYATEEIYIIMQSCWAFDSRKR 311 (325)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTC------------------------C-----CCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCC------------------------C-----CCCCCcCCHHHHHHHHHHcCCChhHC
Confidence 8 8999988765544433322100 0 01124678999999999999999999
Q ss_pred CCHHHHhcC
Q 017301 305 PTAEEALAD 313 (374)
Q Consensus 305 pt~~~lL~h 313 (374)
||+++|++|
T Consensus 312 Pt~~ei~~~ 320 (325)
T d1rjba_ 312 PSFPNLTSF 320 (325)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-56 Score=394.07 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=210.1
Q ss_pred cccccCC-CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecC
Q 017301 15 FFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLP 93 (374)
Q Consensus 15 ~~~~~~~-~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 93 (374)
+...|.+ .++|++++.||+|+||+||+|+++ ++..||||+++..... ...+.+|+.+|++++||||+++++++..
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 4455544 369999999999999999999875 6788999999754332 3468899999999999999999998743
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeee
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DF 170 (374)
..+|+||||+.+ +|.+++... .++++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 80 ------~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DF 153 (272)
T d1qpca_ 80 ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF 153 (272)
T ss_dssp ------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred ------CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccc
Confidence 236999999995 998877543 36999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChhhHHHHHHHhhCC
Q 017301 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
|+|+....... .......||+.|+|||++.+ ..++.++|||||||++|||+|| .+||...+..+.+..+....
T Consensus 154 Gla~~~~~~~~--~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-- 227 (272)
T d1qpca_ 154 GLARLIEDNEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-- 227 (272)
T ss_dssp TTCEECSSSCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--
T ss_pred cceEEccCCcc--ccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--
Confidence 99986543321 12244578999999999877 6799999999999999999995 56666665544433332110
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc--CCCCCc
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKG 318 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~--hp~~~~ 318 (374)
.. .....+++.+.+||.+||+.||++|||++++++ |+||+.
T Consensus 228 -----------------------~~-----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 -----------------------RM-----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -----------------------CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------------CC-----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 00 112468899999999999999999999999998 788753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-55 Score=386.24 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=209.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
++.|+++++||+|+||+||+|+++ +++.||||+++..... ...+.+|+.++++++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~ 73 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRP 73 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEee-----CCc
Confidence 578999999999999999999974 7889999999764333 3468899999999999999999999943 345
Q ss_pred EEEEEccCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 017301 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (374)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~ 179 (374)
+++||||+. |+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999998 588888665 457999999999999999999999999999999999999999999999999999765433
Q ss_pred CCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 017301 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+....+......
T Consensus 154 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--------- 220 (258)
T d1k2pa_ 154 EYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------- 220 (258)
T ss_dssp SCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred Cce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 222 2234678999999999987 689999999999999999998 89999988876555444321110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
......++.+.+||.+||+.||++|||++++|+|
T Consensus 221 ---------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 ---------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ---------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1123577899999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-56 Score=403.96 Aligned_cols=264 Identities=25% Similarity=0.407 Sum_probs=215.0
Q ss_pred CCeeEeceeeccCCeeEEEEEEC---CCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhCCC-CCccccceeecCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPSK 96 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~ 96 (374)
++|++++.||+|+||+||+|.+. .+|+.||+|++++... .......+.+|+.+|++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---- 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---- 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec----
Confidence 67999999999999999999874 4789999999864321 12234457789999999976 89999999994
Q ss_pred CCCCcEEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
....+|++|||+.+ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 100 -~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 100 -TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred -cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 44569999999995 9999999999999999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... .......|++.|+|||.+.+....++.++|||||||+||+|++|..||.+.+..+....+....
T Consensus 179 ~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-------- 248 (322)
T d1vzoa_ 179 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-------- 248 (322)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--------
T ss_pred hccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--------
Confidence 433222 1234567999999999987644568889999999999999999999998877655444432210
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcCc
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (374)
..... .....+|+.+.+||.+||++||.+|| |++|+|+||||+++.
T Consensus 249 --------------~~~~~-----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 249 --------------LKSEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp --------------HHCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred --------------ccCCC-----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 01111 12246899999999999999999999 589999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-54 Score=384.66 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=196.3
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCC----cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 97 (374)
++.|++.+.||+|+||+||+|..+.++ ..||||+++... .......+.+|+.+|++++||||+++++++..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~---- 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK---- 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec----
Confidence 467999999999999999999877654 479999997533 33445678899999999999999999999944
Q ss_pred CCCcEEEEEccCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 017301 98 EFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (374)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~ 175 (374)
...+++||||+.+ ++.+.+... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 -~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 -YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred -CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 3458999999996 788777654 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCC-CCCCCCChhhHHHHHHHhhCCCCHHH
Q 017301 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPET 254 (374)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (374)
...............||+.|+|||++.+ ..++.++|||||||++|||++|. +||.+.+..+....+....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-------
T ss_pred ccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-------
Confidence 5443332222344578999999999987 78999999999999999999965 5555554433333222110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. .....+++.+.+||.+||+.||++|||+.++++
T Consensus 231 ------------------~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 231 ------------------RL-----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ------------------CC-----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CC-----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 01 112457889999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=384.22 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=198.2
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 99 (374)
++|++++.||+|+||+||+|++..++ ..||+|.++.. ........+.+|+.+|++++||||+++++++..
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 68999999999999999999987544 46889988643 334555678999999999999999999999832
Q ss_pred CcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 017301 100 KDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (374)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~ 177 (374)
..+|+||||+.+ +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 347999999995 88887765 4579999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 017301 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (374)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (374)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+....
T Consensus 160 ~~~~~--~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~--------- 226 (273)
T d1mp8a_ 160 DSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--------- 226 (273)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---------
T ss_pred CCcce--eccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------
Confidence 32221 1234568999999999987 789999999999999999998 899999887766554443210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.....+++|+.+.+||.+||+.||.+|||+.++++|
T Consensus 227 ---------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 227 ---------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 012235789999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=381.39 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=203.4
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|+++.+ +.||||+++..... .+.+.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence 47899999999999999999998655 57999999754333 3568899999999999999999998843 23
Q ss_pred EEEEEccCcc-cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
+|+||||+.+ +|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 6999999995 88888754 35799999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++| .+||.+.+..+.+..+.....
T Consensus 166 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--------- 232 (285)
T d1fmka3 166 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 232 (285)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred CCce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 2221 1234578999999999977 7899999999999999999995 555666655444443322110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc--CCCCCcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKGL 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~--hp~~~~~ 319 (374)
....+.+++.+.+||.+||+.||++|||++++++ |+||+..
T Consensus 233 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 233 ---------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---------------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1123568899999999999999999999999988 8999764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=386.88 Aligned_cols=251 Identities=21% Similarity=0.345 Sum_probs=200.3
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCC
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 98 (374)
..|++++.||+|+||+||+|.+..+|+ .||+|.++... .....+.+.+|+.+|++++||||+++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 579999999999999999999988876 58888876432 223456789999999999999999999999543
Q ss_pred CCcEEEEEccCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 017301 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (374)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~ 176 (374)
..++++|++. ++|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 --~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp --SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred --CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 2577777777 5888877764 57999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 017301 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (374)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (374)
...... .......||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+.+..
T Consensus 162 ~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-------- 230 (317)
T d1xkka_ 162 GAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------- 230 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC--------
T ss_pred cccccc-ccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 433221 12234568999999999887 689999999999999999998 789998877655444433211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
.. ...+.+++.+.+||.+||+.||.+|||+.++++|
T Consensus 231 -----------------~~-----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 231 -----------------RL-----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp -----------------CC-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CC-----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 01 1124678999999999999999999999999988
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=379.04 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=200.2
Q ss_pred cCCCCCeeEeceeeccCCeeEEEEEECC-CC--cEEEEEEecCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 017301 19 YGDANRYKILEVIGKGSYGVVCAAIDTH-TG--EKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (374)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~-~~--~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 94 (374)
+-..++|++++.||+|+||+||+|+... ++ ..||||++++... .....+.+.+|+.+|++++||||+++++++...
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~ 83 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 83 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec
Confidence 3445789999999999999999998643 33 3789999875433 234456789999999999999999999999542
Q ss_pred CcCCCCcEEEEEccCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecc
Q 017301 95 SKREFKDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 95 ~~~~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
.+++||||+.+ ++.+.+.. .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 84 ------~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl 157 (273)
T d1u46a_ 84 ------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 157 (273)
T ss_dssp ------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ------chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchh
Confidence 36999999984 88877654 45799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCC
Q 017301 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPS 251 (374)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (374)
++................|+..|+|||++.+ ..++.++|||||||++|||+| |..||.+.+..+....+.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~-- 233 (273)
T d1u46a_ 158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-- 233 (273)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC--
T ss_pred hhhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC--
Confidence 9876554443333345568889999999987 689999999999999999998 89999988876665544321000
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
....+.+|+.+.+||.+||+.||++|||+.++++
T Consensus 234 ---------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 234 ---------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1123568899999999999999999999999964
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=379.03 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=198.6
Q ss_pred ccCC-CCCeeEeceeeccCCeeEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCcccccee
Q 017301 18 EYGD-ANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRI 90 (374)
Q Consensus 18 ~~~~-~~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~ 90 (374)
+|.+ .++|++++.||+|+||+||+|.+.. +++.||+|+++.. ........+.+|..++.++ .|+||+.++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3433 3689999999999999999999754 4568999998743 3334455677888888776 68999999998
Q ss_pred ecCCCcCCCCcEEEEEccCcc-cHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 017301 91 MLPPSKREFKDIYVVFELMES-DLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (374)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dik 153 (374)
+... ...+++|||||++ +|.+++... ..+++..+..++.||+.||+|||++||+|||||
T Consensus 86 ~~~~----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlK 161 (299)
T d1ywna1 86 CTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 161 (299)
T ss_dssp ECST----TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred eccC----CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCC
Confidence 8543 2458999999994 999999753 248999999999999999999999999999999
Q ss_pred CCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhC-CCCCC
Q 017301 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFP 232 (374)
Q Consensus 154 p~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~ 232 (374)
|+|||++.++.+||+|||+|+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++| .+||.
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccceeECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999865433221 22345679999999999987 7899999999999999999986 57887
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
+.+....+..... .. .. ......+++.+.+||.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-----------------------~~-~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~ 289 (299)
T d1ywna1 239 GVKIDEEFCRRLK-----------------------EG-TR-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289 (299)
T ss_dssp TCCCSHHHHHHHH-----------------------HT-CC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHh-----------------------cC-CC-----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7654433322211 00 00 0112457899999999999999999999999998
Q ss_pred C
Q 017301 313 D 313 (374)
Q Consensus 313 h 313 (374)
|
T Consensus 290 ~ 290 (299)
T d1ywna1 290 H 290 (299)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=371.45 Aligned_cols=244 Identities=25% Similarity=0.400 Sum_probs=197.2
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
.++|++++.||+|+||+||+|+. +|..||+|++++. ...+.+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~ 75 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GG 75 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----Cc
Confidence 35799999999999999999987 4789999999753 23456889999999999999999999985432 34
Q ss_pred EEEEEccCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 017301 102 IYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~ 178 (374)
+|+||||+.+ +|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 7999999985 9999986543 589999999999999999999999999999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 017301 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (374)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (374)
.. ....+|+.|+|||++.+ ..++.++|||||||++|||+| |++||...+..+....+.+.
T Consensus 156 ~~------~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~----------- 216 (262)
T d1byga_ 156 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------- 216 (262)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----------
T ss_pred CC------ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 22 23468899999999977 689999999999999999998 78999887665554443210
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
. .....+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 217 ----------------~---~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 217 ----------------Y---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ----------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------C---CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0 011234678999999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-52 Score=376.63 Aligned_cols=252 Identities=22% Similarity=0.310 Sum_probs=206.7
Q ss_pred CCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 96 (374)
.++|++++.||+|+||+||+|+.+ .++..||||+++.. ........+.+|+.+|++++||||+++++++..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--- 87 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAV--- 87 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeecc---
Confidence 368999999999999999999865 35678999998743 334456678999999999999999999999954
Q ss_pred CCCCcEEEEEccCc-ccHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 017301 97 REFKDIYVVFELME-SDLHQVIKAND------------------------DLTREHHQFFLYQMLRALKYMHTANVYHRD 151 (374)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~------------------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~d 151 (374)
....++||||+. |+|.+++.... .+++..+..|+.|++.||+|||++||+|||
T Consensus 88 --~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 88 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred --CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 345899999998 49999986532 488999999999999999999999999999
Q ss_pred CCCCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCC-CC
Q 017301 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PL 230 (374)
Q Consensus 152 ikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~-~p 230 (374)
|||+|||++.++.+||+|||+|+........ .......||+.|+|||.+.+ ..|+.++|||||||++|||++|. +|
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccc-cccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999999999999999764332211 12234578999999999987 78999999999999999999985 78
Q ss_pred CCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 017301 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (374)
Q Consensus 231 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~l 310 (374)
|.+.+..+....+.+. . .......+++.+.+||.+||+.||++|||+.|+
T Consensus 243 ~~~~~~~e~~~~v~~~---------------------------~---~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDG---------------------------N---ILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp TTTSCHHHHHHHHHTT---------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHcC---------------------------C---CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 8887766555443221 0 011234688999999999999999999999999
Q ss_pred hc
Q 017301 311 LA 312 (374)
Q Consensus 311 L~ 312 (374)
++
T Consensus 293 ~~ 294 (301)
T d1lufa_ 293 HR 294 (301)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=371.73 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=203.0
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCC-------cEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-------EKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 93 (374)
.++|++++.||+|+||.||+|++..++ ..||+|+++... .......+.+|...+.++ +||||+++++++..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 579999999999999999999976554 479999987543 334556788899988888 79999999999954
Q ss_pred CCcCCCCcEEEEEccCcc-cHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 017301 94 PSKREFKDIYVVFELMES-DLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (374)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~N 156 (374)
...+++||||+.+ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus 91 -----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 91 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp -----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 3458999999995 999999754 358999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 017301 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (374)
Q Consensus 157 il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 235 (374)
||++.++.+||+|||+++........ .......||+.|+|||.+.+ ..|+.++|||||||++|+|++ |.+||.+.+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999999865443322 22345678999999999987 789999999999999999998 789998877
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.......+... .. ......+++.+.+||.+||+.||.+|||+.++|+
T Consensus 243 ~~~~~~~i~~~---------------------------~~---~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEG---------------------------HR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTT---------------------------CC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcC---------------------------CC---CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 65443332210 00 0112468899999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=375.87 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=202.5
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcE--EEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCcCC
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 98 (374)
.++|++.++||+|+||+||+|.++.+|.. ||||.++... .....+.+.+|+.+|+++ +||||+++++++..
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----- 82 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----- 82 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----
Confidence 36999999999999999999999888874 6777775322 223455789999999998 69999999999954
Q ss_pred CCcEEEEEccCcc-cHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC
Q 017301 99 FKDIYVVFELMES-DLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (374)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~ 161 (374)
...+|+||||+++ +|.+++..+ ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence 3459999999995 999999654 57899999999999999999999999999999999999999
Q ss_pred CCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCC-CCCCCCChhhHH
Q 017301 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQL 240 (374)
Q Consensus 162 ~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~ 240 (374)
++.+||+|||+|+........ ....||+.|+|||.+.+ ..|+.++|||||||++|+|++|. +||.+.+..+..
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~~----~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~ 236 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236 (309)
T ss_dssp GGCEEECCTTCEESSCEECCC--------CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCceEEccccccccccccccc----cceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999754332221 23468999999999977 78999999999999999999965 678877655544
Q ss_pred HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..+.+. .. ......+++.+.+||.+||+.||++|||+.++++|
T Consensus 237 ~~i~~~--------------------------~~----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 237 EKLPQG--------------------------YR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHGGGT--------------------------CC----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhc--------------------------CC----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 333210 00 11234688999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=371.34 Aligned_cols=256 Identities=20% Similarity=0.357 Sum_probs=210.4
Q ss_pred ccCC-CCCeeEeceeeccCCeeEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceee
Q 017301 18 EYGD-ANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIM 91 (374)
Q Consensus 18 ~~~~-~~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 91 (374)
.|.+ .++|++++.||+|+||+||+|.++. ++..||||+++.. ........+.+|+.++++++||||+++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 4533 4899999999999999999998753 3578999999753 3445556789999999999999999999999
Q ss_pred cCCCcCCCCcEEEEEccCc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEec
Q 017301 92 LPPSKREFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (374)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~ 160 (374)
.. ....++||||+. |+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 93 ~~-----~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 93 SQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 167 (308)
T ss_dssp CS-----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred ec-----CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec
Confidence 43 345899999998 5999988642 2478899999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChhhH
Q 017301 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQ 239 (374)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~ 239 (374)
.++++||+|||+|+....... ........||+.|+|||.+.+ ..++.++|||||||++|||+|| .+||.+.+..+.
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~ 244 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred CCceEEEeecccceeccCCcc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999986543322 122244578999999999887 7899999999999999999998 588888776655
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
+..+.+.. .....+.+++.+.+||.+||+.||++|||+.++++
T Consensus 245 ~~~i~~~~------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 245 LRFVMEGG------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCC------------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 54443210 01122467899999999999999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=368.46 Aligned_cols=257 Identities=25% Similarity=0.352 Sum_probs=210.0
Q ss_pred ccCC-CCCeeEeceeeccCCeeEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhC-CCCCcccccee
Q 017301 18 EYGD-ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRI 90 (374)
Q Consensus 18 ~~~~-~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~ 90 (374)
+|.+ .++|++++.||+|+||.||+|... .+++.||||+++.. ........+.+|+.+++.+ +||||++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4543 489999999999999999999853 46679999999754 3445566788999999999 69999999999
Q ss_pred ecCCCcCCCCcEEEEEccCcc-cHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 017301 91 MLPPSKREFKDIYVVFELMES-DLHQVIKAND------------------DLTREHHQFFLYQMLRALKYMHTANVYHRD 151 (374)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~------------------~l~~~~~~~i~~qi~~al~~LH~~~i~H~d 151 (374)
+.. ...+|+|||||.+ +|.+++.... .+++..+..++.||+.||+|||++||+|||
T Consensus 96 ~~~-----~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrD 170 (311)
T d1t46a_ 96 CTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170 (311)
T ss_dssp ECS-----SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred Eee-----CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 944 3458999999985 9999987543 589999999999999999999999999999
Q ss_pred CCCCceEecCCCCeEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHh-CCCC
Q 017301 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPL 230 (374)
Q Consensus 152 ikp~Nil~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~llt-g~~p 230 (374)
|||+||+++.++.+|++|||.++....... ........||+.|+|||++.+ ..++.++|||||||++|+|+| |.+|
T Consensus 171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 171 LAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cccccccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCC
Confidence 999999999999999999999986544332 223345689999999999987 789999999999999999998 6777
Q ss_pred CCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 017301 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (374)
Q Consensus 231 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~l 310 (374)
|.+.+....+..+...-. .. .....+++.+.+||.+||+.||.+|||++++
T Consensus 248 ~~~~~~~~~~~~~i~~~~------------------------~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~i 298 (311)
T d1t46a_ 248 YPGMPVDSKFYKMIKEGF------------------------RM-----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (311)
T ss_dssp STTCCSSHHHHHHHHHTC------------------------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHhcCC------------------------CC-----CCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 777665444433322100 00 1123578999999999999999999999999
Q ss_pred hc
Q 017301 311 LA 312 (374)
Q Consensus 311 L~ 312 (374)
|+
T Consensus 299 l~ 300 (311)
T d1t46a_ 299 VQ 300 (311)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-51 Score=371.71 Aligned_cols=264 Identities=20% Similarity=0.251 Sum_probs=203.5
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 100 (374)
+++||++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.++|++++..+..+.. ...
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~ 76 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA----EGD 76 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEE----ETT
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEe----cCC
Confidence 457999999999999999999999999999999998653222 246789999999998877666655532 335
Q ss_pred cEEEEEccCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC---CCCeEEeeecccccc
Q 017301 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVA 176 (374)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~---~~~vkl~DFg~a~~~ 176 (374)
..++||||+++++.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+..
T Consensus 77 ~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 77 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 6899999999988777765 558999999999999999999999999999999999999754 457999999999875
Q ss_pred cCCCCcc----cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 017301 177 FSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (374)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (374)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~---- 230 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---- 230 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH----
T ss_pred cccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc----
Confidence 4432211 11245679999999999988 6799999999999999999999999987665443322211100
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHH---HHhcCCCCC
Q 017301 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE---EALADPYFK 317 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~---~lL~hp~~~ 317 (374)
... ..+.....+++|+++.+||..||+.||++|||+. ++|+|+|.+
T Consensus 231 ---------------~~~----~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 231 ---------------KKM----STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ---------------HHH----HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------------ccC----CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 000 0011122357899999999999999999999987 456777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.3e-50 Score=359.71 Aligned_cols=258 Identities=18% Similarity=0.214 Sum_probs=204.6
Q ss_pred CCCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCC-CCccccceeecCCCcCCC
Q 017301 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPSKREF 99 (374)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~ 99 (374)
++++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|++.++.++| +|++.+++++ ...
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~ 73 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFG-----QEG 73 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EET
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecC
Confidence 35899999999999999999999999999999999864322 2245678889998875 8999998888 344
Q ss_pred CcEEEEEccCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecC-----CCCeEEeeeccc
Q 017301 100 KDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-----NCKLKVCDFGLA 173 (374)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~-----~~~vkl~DFg~a 173 (374)
...|+||||++++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 74 ~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 74 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 5689999999999999997754 7999999999999999999999999999999999999964 578999999999
Q ss_pred ccccCCCCcc----cccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 017301 174 RVAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (374)
Q Consensus 174 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 249 (374)
+......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~- 230 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE- 230 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH-
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh-
Confidence 8754332211 12245689999999999988 7899999999999999999999999987654333222211000
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 017301 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~ 312 (374)
.. ...+.....+++++++.+++..|+..+|++||+.+.+.+
T Consensus 231 --------------------~~--~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 231 --------------------KK--QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp --------------------HH--HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------------------cc--CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 00 000111223568899999999999999999999877654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=362.13 Aligned_cols=251 Identities=21% Similarity=0.287 Sum_probs=198.0
Q ss_pred eEeceeeccCCeeEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCcE
Q 017301 26 KILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (374)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 102 (374)
...++||+|+||+||+|++..++ ..||||+++. .........+.+|+.+|++++||||+++++++... ....
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCce
Confidence 34678999999999999986543 3699999874 33455667899999999999999999999997533 2458
Q ss_pred EEEEccCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 017301 103 YVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (374)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~DFg~a~~~~~~~ 180 (374)
++|||||++ +|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999995 9998887543 67888899999999999999999999999999999999999999999999998654332
Q ss_pred Cc-ccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHhhCCCCHHHHhhh
Q 017301 181 PM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQLDLITDLLGTPSPETIAVV 258 (374)
Q Consensus 181 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 258 (374)
.. ........||+.|+|||.+.+ ..++.++|||||||++|||++|..||..... .+....+..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~------------- 249 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT-------------
T ss_pred cccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------------
Confidence 21 122234578999999999877 6899999999999999999997777654332 211111110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
. ... ...+.+++.+.+||.+||+.||++|||+.|+++|
T Consensus 250 -----------g-~~~-----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 250 -----------G-RRL-----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -----------T-CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------C-CCC-----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 011 1124578899999999999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-49 Score=369.69 Aligned_cols=282 Identities=22% Similarity=0.336 Sum_probs=209.5
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-----------CCCccccceee
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----------HPDIVEIKRIM 91 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~ 91 (374)
+||+++++||+|+||+||+|+++.+|+.||||++++. ......+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 6899999999999999999999999999999999743 233456678888888775 57889998887
Q ss_pred cCCCcCCCCcEEEEEccCc--ccHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCceEecCCCC--
Q 017301 92 LPPSKREFKDIYVVFELME--SDLHQVI--KANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCK-- 164 (374)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~--~~L~~~l--~~~~~l~~~~~~~i~~qi~~al~~LH~-~~i~H~dikp~Nil~~~~~~-- 164 (374)
.... ....+++++++. ++..... .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 90 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKG---PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEE---TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred eecc---ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 5422 233555555554 3433333 344589999999999999999999998 89999999999999987654
Q ss_pred ----eEEeeecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-----
Q 017301 165 ----LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS----- 235 (374)
Q Consensus 165 ----vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~----- 235 (374)
++++|||.|....... ...+||+.|+|||++.+ ..++.++||||+||++++|++|+.||.+.+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeeccccccccccc------ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 9999999987543322 34579999999999887 789999999999999999999999997654
Q ss_pred -hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHH--hcCCC-CCC----------ccccCCCCChHHHHHHHHhccCCC
Q 017301 236 -VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTE--MRKKP-PVP----------LFQKFPNVDPLALRLLQRLIAFDP 301 (374)
Q Consensus 236 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~----------~~~~~~~~s~~~~~li~~~L~~dp 301 (374)
..+.+......+|.++...+....... .+... ..... ... ........++.+.|||.+||.+||
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTR--TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHH--HHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccccc--cccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 345666777788887776554322211 11000 00000 000 001112346789999999999999
Q ss_pred CCCCCHHHHhcCCCCCcCc
Q 017301 302 KDRPTAEEALADPYFKGLA 320 (374)
Q Consensus 302 ~~Rpt~~~lL~hp~~~~~~ 320 (374)
.+||||+|+|+||||++..
T Consensus 317 ~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTCBCHHHHHTCGGGTTCT
T ss_pred hHCcCHHHHhcCcccCCCC
Confidence 9999999999999999654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=361.59 Aligned_cols=273 Identities=21% Similarity=0.198 Sum_probs=194.9
Q ss_pred CCCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCcCCCCc
Q 017301 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 101 (374)
..+|.+.+.||+|+||+||+|+. +|+.||||+++.. .........|+..++.++||||+++++++...+ .....
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceE
Confidence 46899999999999999999975 6899999998642 122222334666667789999999999997553 23346
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh--------CCccccCCCCCceEecCCCCeEEeeecc
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT--------ANVYHRDLKPKNILANANCKLKVCDFGL 172 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~--------~~i~H~dikp~Nil~~~~~~vkl~DFg~ 172 (374)
+|+|||||.+ +|.+++.+. .+++.....++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 8999999985 999999875 58999999999999999999996 5999999999999999999999999999
Q ss_pred cccccCCCCc-ccccccccccccccccccccccCC----CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 017301 173 ARVAFSDTPM-TVFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (374)
Q Consensus 173 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 247 (374)
++........ ........||+.|+|||++.+... .++.++|||||||+||||+||.+||........... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~~~~ 233 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLVP 233 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTSC
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-hccc
Confidence 9876443322 122345689999999999865211 267789999999999999999988854332110000 0000
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCC---CccccCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 017301 248 GTPSPETIAVVRNEKARKYLTEMRKKPPV---PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~~lL~h 313 (374)
..+. .............. +...........+.+|+.+||+.||.+|||+.|++++
T Consensus 234 ~~~~-----------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPS-----------VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCC-----------HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccch-----------HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0001 11111111111111 1111111223458899999999999999999999763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=2.6e-27 Score=198.35 Aligned_cols=171 Identities=16% Similarity=0.090 Sum_probs=121.1
Q ss_pred eeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCC----------------hHHHHHHHHHHHHHHhCCCCCccccc
Q 017301 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----------------ISDAIRILREVKLLRLLRHPDIVEIK 88 (374)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~~i~~~~ 88 (374)
|.++++||+|+||+||+|.+. +|+.||||+++..... ........+|+..+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 578999999999999999885 7899999987531110 01123355789999999999998877
Q ss_pred eeecCCCcCCCCcEEEEEccCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCceEecCCCCeEEe
Q 017301 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (374)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~~~i~H~dikp~Nil~~~~~~vkl~ 168 (374)
+.. . .+++||++++... ..++...+..++.|++.||+|||++||+||||||+|||+++++ ++|+
T Consensus 81 ~~~-----~----~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEEC
T ss_pred Eec-----C----CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEE
Confidence 654 1 2799999997321 1255566788999999999999999999999999999999765 9999
Q ss_pred eecccccccCCCCcccccccccccccccccccccccCCCCCccchHHHHHHH
Q 017301 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (374)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~i 220 (374)
|||.|+......... .....+. .-.+.+ . ..|+.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~~-~l~rd~~----~~~~~f-~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWRE-ILERDVR----NIITYF-S--RTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHH-HHHHHHH----HHHHHH-H--HHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHH-HHHHHHH----HHHHHH-c--CCCCCcccHHHHHHH
Confidence 999997543221110 0000000 001112 1 468889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.52 E-value=1.7e-07 Score=80.18 Aligned_cols=138 Identities=12% Similarity=0.144 Sum_probs=87.1
Q ss_pred CCeeEeceeeccCCeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCcCCCCc
Q 017301 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (374)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 101 (374)
..|+.++..+.++.+.||+.. ..+..+++|........ ....+.+|...++.+. +--+.+++... ...+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCc
Confidence 467777776666668999884 46677888987543221 1224567888887764 33355555554 22345
Q ss_pred EEEEEccCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh------------------------------------
Q 017301 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT------------------------------------ 144 (374)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~LH~------------------------------------ 144 (374)
.|+||++++| .+.+..... .....+..++...++.||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 7999999998 654433211 1122233444444444442
Q ss_pred -----------------------CCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 145 -----------------------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 145 -----------------------~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 126899999999999977656799999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.14 E-value=4.6e-06 Score=75.46 Aligned_cols=77 Identities=19% Similarity=0.104 Sum_probs=45.6
Q ss_pred eceeeccCCeeEEEEEECCCCcEEEEEEecCcc----C-ChHHHHHHHHHHHHHHhCC-C-C-CccccceeecCCCcCCC
Q 017301 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----E-HISDAIRILREVKLLRLLR-H-P-DIVEIKRIMLPPSKREF 99 (374)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~-~~~~~~~~~~E~~~l~~l~-h-~-~i~~~~~~~~~~~~~~~ 99 (374)
.+.||.|....||++.+..+++.+++|.-.... . ......+...|...|+.+. + | .+++++.+- .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~----- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T----- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C-----
Confidence 567899999999999887788899999653211 0 0112234556888877663 2 3 344444332 1
Q ss_pred CcEEEEEccCcc
Q 017301 100 KDIYVVFELMES 111 (374)
Q Consensus 100 ~~~~lv~e~~~~ 111 (374)
...++|||++++
T Consensus 104 ~~~~lvmE~L~~ 115 (392)
T d2pula1 104 EMAVTVMEDLSH 115 (392)
T ss_dssp TTTEEEECCCTT
T ss_pred CCCEEEEeccCC
Confidence 123789999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.87 E-value=1.6e-05 Score=67.00 Aligned_cols=71 Identities=8% Similarity=-0.019 Sum_probs=43.8
Q ss_pred eeeccC-CeeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCC--CccccceeecCCCcCCCCcEEEEE
Q 017301 30 VIGKGS-YGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP--DIVEIKRIMLPPSKREFKDIYVVF 106 (374)
Q Consensus 30 ~lg~G~-~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~~~~~~lv~ 106 (374)
.+..|. .+.||+... ..+..+++|...... ...+.+|...|+.+... .+.+++.+... .+..++||
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEE
Confidence 344444 367898864 456678889765321 22355677777766432 24555655432 24579999
Q ss_pred ccCcc
Q 017301 107 ELMES 111 (374)
Q Consensus 107 e~~~~ 111 (374)
++++|
T Consensus 86 ~~i~G 90 (255)
T d1nd4a_ 86 GEVPG 90 (255)
T ss_dssp ECCSS
T ss_pred Eeeec
Confidence 99986
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.16 E-value=0.0011 Score=57.70 Aligned_cols=71 Identities=14% Similarity=0.063 Sum_probs=41.0
Q ss_pred eeEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCC--CcCCCCcEEEEEccCcc
Q 017301 37 GVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP--SKREFKDIYVVFELMES 111 (374)
Q Consensus 37 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~~~~~lv~e~~~~ 111 (374)
-.||++.. .+|..|++|+.+... .....+..|+..+..|...++....-..... ........+.+++++.|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 47999964 578889999876432 2334566788888777533222111111111 11223457888888865
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.01 E-value=0.0018 Score=57.88 Aligned_cols=74 Identities=15% Similarity=0.134 Sum_probs=48.2
Q ss_pred CeeEeceeeccCCeeEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCC
Q 017301 24 RYKILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (374)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 95 (374)
..+ ++.|+.|-.=.+|++.... .++.|++++.-.. . ......+|..+++.+. +.-..++++.+
T Consensus 44 ~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~---~~idr~~E~~i~~~ls~~gl~Pkll~~~---- 114 (395)
T d1nw1a_ 44 HLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E---TESHLVAESVIFTLLSERHLGPKLYGIF---- 114 (395)
T ss_dssp GEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C---CHHHHHHHHHHHHHHHHTTSSSCEEEEE----
T ss_pred ceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c---hhhHHHHHHHHHHHHHhCCCCCeEEEEc----
Confidence 344 5678888888999997643 3456777776421 1 1234557888888885 43345666665
Q ss_pred cCCCCcEEEEEccCcc
Q 017301 96 KREFKDIYVVFELMES 111 (374)
Q Consensus 96 ~~~~~~~~lv~e~~~~ 111 (374)
.+ .+|+||+.|
T Consensus 115 -~~----g~I~efi~g 125 (395)
T d1nw1a_ 115 -SG----GRLEEYIPS 125 (395)
T ss_dssp -TT----EEEECCCCE
T ss_pred -CC----ceEEEEecc
Confidence 11 688999886
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.73 E-value=0.0039 Score=53.61 Aligned_cols=30 Identities=30% Similarity=0.282 Sum_probs=26.5
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 017301 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (374)
Q Consensus 145 ~~i~H~dikp~Nil~~~~~~vkl~DFg~a~ 174 (374)
.|+||+|+.++||+++.+...-++||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988766899999874
|